
<html lang="en"     class="pb-page"  data-request-id="6d5b2f1c-e5d8-479c-83aa-31e1409cab96"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b01541;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry" /></meta><meta name="dc.Creator" content="Arun K.  Ghosh" /></meta><meta name="dc.Creator" content="Margherita  Brindisi" /></meta><meta name="dc.Description" content="The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and ..." /></meta><meta name="Description" content="The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 2, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01541" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01541" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01541" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01541" /></link>
        
    
    

<title>Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01541" /></meta><meta property="og:title" content="Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0074.jpeg" /></meta><meta property="og:description" content="The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and drug design in order to establish key drug–target interactions and fine-tune crucial drug-like properties. In this perspective, we highlight physicochemical and conformational properties of urea derivatives. We provide outlines of traditional reagents and chemical procedures for the preparation of ureas. Also, we discuss newly developed methodologies mainly aimed at overcoming safety issues associated with traditional synthesis. Finally, we provide a broad overview of urea-based medicinally relevant compounds, ranging from approved drugs to recent medicinal chemistry developments." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01541"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01541">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01541&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01541&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01541&amp;href=/doi/10.1021/acs.jmedchem.9b01541" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2751-2788</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01138" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01518" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Arun K. Ghosh</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arun K. Ghosh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#5938323e31362a3119292c2b3d2c3c773c3d2c"><span class="__cf_email__" data-cfemail="b9d8d2ded1d6cad1f9c9cccbddccdc97dcddcc">[email protected]</span></a>. Department of Chemistry and Department of Medicinal Chemistry Purdue University, 560 Oval Drive, West Lafayette, IN 47907. Phone: (765)-494-5323. Fax: (765)-496-1612.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arun+K.++Ghosh">Arun K. Ghosh</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2472-1841" title="Orcid link">http://orcid.org/0000-0003-2472-1841</a></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Margherita Brindisi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Margherita Brindisi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">Department of Excellence of Pharmacy, University of Naples Federico II, 80131 Naples, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Margherita++Brindisi">Margherita Brindisi</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9119-3773" title="Orcid link">http://orcid.org/0000-0001-9119-3773</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01541&amp;href=/doi/10.1021%2Facs.jmedchem.9b01541" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2751–2788</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 2, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 September 2019</li><li><span class="item_label"><b>Published</b> online</span>2 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01541" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01541</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2751%26pageCount%3D38%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DArun%2BK.%2BGhosh%252C%2BMargherita%2BBrindisi%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D6%26contentID%3Dacs.jmedchem.9b01541%26title%3DUrea%2BDerivatives%2Bin%2BModern%2BDrug%2BDiscovery%2Band%2BMedicinal%2BChemistry%26numPages%3D38%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2788%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01541"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7389</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">37</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01541" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;K. Ghosh&quot;},{&quot;first_name&quot;:&quot;Margherita&quot;,&quot;last_name&quot;:&quot;Brindisi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2751-2788&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01541&quot;},&quot;abstract&quot;:&quot;The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and drug design in order to establish key drug–target interactions and fine-tune crucial drug-like properties. In this perspective, we highlight physicochemical and conformational properties of urea derivatives. We provide outlines of traditional reagents and chemical procedures for the preparation of ureas. Also, we discuss newly developed methodologies mainly aimed at overcoming safety issues associated with traditional synthesis. Finally, we provide a broad overview of urea-based medicinally relevant compounds, ranging from approved drugs to recent medicinal chemistry developments.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01541&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01541" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01541&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01541" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01541&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01541" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01541&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01541&amp;href=/doi/10.1021/acs.jmedchem.9b01541" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01541" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01541" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01541%26sid%3Dliteratum%253Aachs%26pmid%3D31789518%26genre%3Darticle%26aulast%3DGhosh%26date%3D2020%26atitle%3DUrea%2BDerivatives%2Bin%2BModern%2BDrug%2BDiscovery%2Band%2BMedicinal%2BChemistry%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D6%26spage%3D2751%26epage%3D2788%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/jmcmar.2020.63.issue-6/20200326/jmcmar.2020.63.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0074.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0074.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and drug design in order to establish key drug–target interactions and fine-tune crucial drug-like properties. In this perspective, we highlight physicochemical and conformational properties of urea derivatives. We provide outlines of traditional reagents and chemical procedures for the preparation of ureas. Also, we discuss newly developed methodologies mainly aimed at overcoming safety issues associated with traditional synthesis. Finally, we provide a broad overview of urea-based medicinally relevant compounds, ranging from approved drugs to recent medicinal chemistry developments.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">This paper was published ASAP on December 2, 2019, with incorrect versions of the abstract graphic and Figure 19. The corrected version was reposted on December 4, 2019.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of urea by the German chemist Fredrich Wöhler in 1828 marked the beginning of organic chemistry.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Since then, rapid evolution of organic chemistry and further developments in synthesis enabled medicinal chemistry and drug discovery in the latter half of the 20th century.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Urea and its derivatives (<b>1</b> and <b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) have a central role in drug development and medicinal chemistry due to the capability of the urea functionality to form multiple stable hydrogen bonds with protein and receptor targets. Such drug–target interactions are responsible for specific biological activity, drug actions, and drug properties. It is not surprising that a large number of urea derivatives are utilized in a broad range of medicinal applications. In particular, a urea functionality is incorporated to modulate drug potency and selectivity and improve drug properties in the development of anticancer, antibacterial, anticonvulsive, anti-HIV, antidiabetic agents, and other medicinal compounds.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> With the advances of protein structures and identification of new disease targets, there is a growing interest in urea-based derivatives for drug design and development.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of urea and selected urea derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One of the early examples of urea derivatives as a medicinal agent is the development of compound <b>3</b> by Bayer’s laboratories in Germany. Urea derivative <b>3</b> is a colorless derivative of trypan red and has shown potent antitrypanosomal activity. Further optimization of urea compound <b>3</b> led to the discovery of suramin (<b>4</b>) with potent antitrypanosomal properties. Suramin is used as an effective therapy during the early stage of sleeping sickness in humans that is caused by the protozoan parasites <i>T. Gambiense</i> and <i>T. Rhodesiense</i>.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Urea-derived Glibenclamide (<b>5</b>), also known as glyburide, is a potent antidiabetic drug that prolongs the hypoglycemic effect. It was used to treat patients with type II diabetes.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Today, there are many urea containing compounds that are FDA approved drugs for a variety of human diseases.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> We will outline these approved therapies in the next section.</div><div class="NLM_p">Beyond their presence in approved drugs, oligoureas play a pivotal role as starting motifs for the generation of artificial β-sheets<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> and peptidomimetics.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Urea derivatives are also widely employed as linkers for the development of antibody–drug conjugates as well as in combinatorial chemistry building blocks.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Due to the importance of urea derivatives in the syntheses of medicinal agents and other applications in material science and organocatalytic reactions, a variety of methods have been developed for their syntheses.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Traditional syntheses of urea-containing compounds involve the reaction of amines with phosgene, carbon monoxide, or isocyanates. However, these synthetic procedures have relevant safety and environmental issues due to the use of toxic agents. Alternative routes involving reactions of amines with less toxic agents such as ethylene carbonate or diethyl carbonate have been developed. Also, many other direct routes to urea derivatives from amines and CO<sub>2</sub> in the presence of numerous catalysts were investigated. A number of ionic liquids were also examined as suitable solvents for the syntheses of urea derivatives.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p last">In recent years, urea containing compounds have received much attention due to their growing application in drug design and medicinal chemistry.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> In the present perspective, we plan to outline physicochemical properties of urea derivatives, highlighting the key role of the urea functionality in the drug–target interaction. We outline the chemical methodologies for the synthesis of urea derivatives. We cover the most recent methodologies that highlight the progress in terms of both process safety and efficiency. Finally, we provide a broad overview of the relevance of the urea functionality and urea derivatives in modern drug discovery and medicinal chemistry.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Conformation of Urea Derivatives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The urea functionality shows a certain degree of conformational restriction due to the presence and delocalization of nonbonded electrons on nitrogens into the adjacent carbonyl group. Accordingly, three resonance structures can be drawn for ureas (namely A, B, and C; <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Data on the X-ray structure of <i>N,N′</i>-diphenyl-<i>N,N′</i>-diethylurea revealed that the two urea nitrogens adopt a geometry between trigonal and tetrahedral. The amide groups displayed a nonplanar distortion of approximately 30° with amide C–N bond lengths of 1.37 Å.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Possible resonance structures for the urea moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Substitution on the nitrogen atoms of the urea moiety plays a key role on the conformational preferences of urea derivatives.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, three conformations (<b>6a</b>–<b>c</b>) are possible for <i>N,N′</i>-diphenylureas. In solution and in solid state, they are generally characterized by a <i>trans,trans</i> conformation.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> Interestingly, sequential introduction of <i>N</i>-methyl group(s) to the free NHs of <i>N,N</i>′-diphenylurea prompted the shift from <i>trans,trans</i> (<b>7</b>) to <i>cis,cis</i> (<b>8a</b>) conformation. Thus, <i>N,N</i>′-diaryl-<i>N,N</i>′-dimethylurea exhibits intrinsic preference for a <i>cis,cis</i> conformation (<b>8a</b>) over <i>trans,cis</i> conformation (<b>8b</b>), characterized by the two aromatic portions located in a face-to-face arrangement, thus allowing π–π stacking interactions.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conformations of <i>N,N′</i>-diphenyl urea, <i>N</i>-methyl-<i>N,N′</i>-diphenyl urea, and <i>N,N′</i>-dimethyl-<i>N,N′</i>-diphenyl urea.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extensive NMR studies and ultraviolet spectra analysis in solution on several substituted diphenylureas were performed to obtain insight into the stacking of the aromatic rings. Interestingly, the conformation from the X-ray crystallographic data and the conformations adopted in solution are in good agreement. These studies supported similar hybridization of the nitrogens and relative positions of the aromatic rings.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div><div class="NLM_p">Theoretical studies suggest that the conformation showing the two aromatic rings with a face to face disposition in a mirror image relationship is disfavored as shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. The X-ray structural studies revealed a staggered relationship where the overlap of the HOMO of one ring with the LUMO of the other is enhanced (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. HOMO and LUMO overlap in substituted diarylureas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recent studies on the conformational preferences of urea derivatives employing a combination of IR, NMR, and computational studies (DFT-D, M06-2X, quantum calculations, molecular dynamics) highlighted a more dynamic behavior of the <i>N,N′-</i>aryl ureas and <i>N,N′-</i>diaryl-<i>N,N′-</i>dialkyl ureas, although still in favor of the predominant isomer from the solid state studies.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> In studies with synthetic retinoids and cytokinins, the stereochemical alteration following <i>N</i>-methylation of aromatic amides was utilized in modulating the biological activity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Similarly, stereochemical switching through <i>N</i>-methylation of ureas from a transoid structure to the preferred bis-<i>cis-N,N</i>′-dimethyl-<i>N,N′</i>-diphenylureas has been exploited. This strategy is particularly attractive in molecular design due to ease of introduction of the <i>N</i>-methylurea substructure in organic molecules. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, the <i>N,N</i>′-dimethyl-<i>N,N′</i>-dinaphthylurea (<b>9</b>) and <i>N</i>-methyl derivative of poly(phenyleneureido)benzene (<b>10</b>) formed nice π-stacked aromatic arrays as observed based upon NMR and X-ray crystallographic studies.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This concept has been successfully applied to the construction of conformationally defined oligomers (foldamers) and dynamic helical structures as biomimetics.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Formation of π-stacked aromatic arrays using substituted diarylureas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Employing <i>N,N</i>′-diaryl ureas to relay stereochemical information over long distances, thus achieving stereochemical control over conformation, is another important feature of this functional group. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, reduction of <i>N,N</i>′-diaryl urea <b>11</b> containing a chiral sulfinyl group proceeded with excellent diastereoselectivity, providing alcohol <b>13</b> as the major diastereomer (dr 95:5), even though the chiral sulfinyl group is localized many bond lengths away. Presumably, the observed remote diastereoselectivity is due to the defined conformation of the chiral <i>N,N</i>′-diaryl urea <b>12</b> which resulted in the preferential nucleophilic attack from the <i>Re</i>-face of the carbonyl center affording alcohol <b>13</b>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stereoselective reduction of acylurea <b>11</b> containing a chiral sulfinyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Oligomeric aromatic ureas characterized by <i>N,N′</i>-dimethylated urea moieties display a multilayered structure due to the (<i>cis,cis</i>)-urea arrangement. Such derivatives, containing a chiral center on the R2 group, display a dynamic helical architecture (all-<i>S</i> or all-<i>R</i> axis configuration) in solution when the phenyl moieties are connected through urea linkages at the <i>meta</i> positions. These dual dynamic helical and aromatic multilayered properties can be exploited to construct aromatic functional molecules with unique physicochemical properties.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">3.  Physicochemical Properties of Ureas</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The oral bioavailability of a drug depends upon many factors including solubility, dissociation, permeability, first-pass metabolism, and efflux properties. Drug solubility in water is vitally important for drug absorption, bioavailability, and drug administration. The development of appropriate formulations for poorly soluble drugs is a major challenge in drug design and development. The structure of a drug molecule typically contains multiple functional groups which determine the overall hydrophobic or hydrophilic nature of the molecule. This hydrophobic/hydrophilic balance affects the capability of a given drug to cross biological membranes.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">The presence of a urea functionality plays an important role in a drug’s aqueous solubility and permeability due to its dual nature as a hydrogen bond donor and acceptor. For a central nervous system (CNS) acting drug, a moderate level of lipophilicity would allow the drug to cross the blood–brain barrier (BBB) by a passive diffusion process. The hydrogen bonding capability<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> in addition to ionization, polar surface area, and flexibility also strongly affects drug transport across the BBB.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a></div><div class="NLM_p">Hydrotropic solubilization involves the addition of one solute to promote the solubility of another and is a strategy explored in pharmaceutical formulations. Hydrotropes are mostly aromatic or nonaromatic anions but can also be represented by neutral compounds, such as ureas.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Hydrotropic solubilization strategy was employed for the solubilization of nifedipine, a poorly soluble antihypertensive drug, by a series of urea analogues in an aqueous environment. The solubilizing effect ranking followed the trend butylurea > ethylurea > methylurea > urea.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Sometimes, urea containing drugs show poor pharmacokinetic properties due to solubility and permeability issues. Many strategies have been developed to circumvent these issues. They are shown below.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.1.  Modulation of the Hydrogen Bonding Ability of Ureas</h3><div class="NLM_p">In order to modulate hydrogen bonding capability, electron donating and electron withdrawing functionalities have been introduced on the substituents on the urea nitrogen atoms. The nature of aliphatic moieties placed on the urea nitrogen has been shown to affect self-association properties thus controlling drug solubility in nonpolar solvents.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> A representative example is the <i>N,N′</i>-di(2,6-diisopropylphenyl)urea (DIPPU, <b>14</b>) which is the only diaryl urea that is soluble in carbon tetrachloride among eight other symmetrical diaryl ureas examined. DIPPU does not form a supramolecular polymer. When the branched alkyl moieties are not too large, the corresponding dialkylureas self-assemble to form supramolecular polymers in solution (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> However, DIPPU stabilizes the out-<i>trans</i> conformation due to large steric bulk of the alkyl chain on the aromatic rings. Therefore, the formation of dimers occurs through hydrogen bonding of the N–H groups in the out conformation as shown (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Association pattern of <i>N</i>,<i>N</i>′-disubstituted ureas; (B) proposed association pattern for DIPPU (<b>14</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.2.  Engagement of the Urea Moiety in the Formation of Intramolecular Hydrogen Bonding</h3><div class="NLM_p">This strategy can be exploited to increase permeability and solubility with the formation of a transient or pseudoring structure. This can be achieved by engagement of a urea functionality in a novel monocyclic template that mimics a bicyclic structure.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, based on the structure of a bicyclic kinase inhibitor (<b>15</b>), a series of pyrimidin-4-ylureas (<b>16</b>) were designed. This monocyclic structural template could function as suitable bioisostere due to its tendency to form resonance-assisted intramolecular hydrogen bonds.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The feasibility of this approach was demonstrated since this compound class exhibits multikinase inhibitory activity. A cocrystal structure revealed the hypothetical binding mode. Furthermore, NMR and theoretical studies substantiated the existence of an intramolecular hydrogen bond and its existence in water medium.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Construction of pseudoring systems exploiting intramolecular hydrogen bonding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.3.  Disruption of the Planarity of Urea Derivatives</h3><div class="NLM_p">In this approach, water solubility is enhanced by disrupting the molecular planarity of the solutes in order to reduce their crystal packing energy.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The strategy involves the breaking of the urea symmetry by introducing a substituent on one of the urea nitrogens which disrupts planarity.<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52−54)</a> A practical example is shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>. <i>N</i>-Methyl-<i>N</i>-1-naphthyl urea (<b>18</b>) acts as a disruptor of cytokine-mediated STAT1 signaling in β-cells. Incorporation of a methyl group on the urea nitrogen of <b>17</b> provided <i>N</i>-methyl-<i>N</i>-1-naphthyl urea (<b>18</b>). The presence of a methyl group disrupts the existence of planar conformations, due to steric clash between hydrogens at C-2 or C-8 positions of the quinoline ring and the appended <i>N</i>-methyl group. Compound <b>18</b> showed a 110-fold solubility increase over compound <b>17</b>. This data also well correlated with a decreased melting point for compound <b>18</b> compared to compound <b>17</b> (∼145 °C vs ∼171 °C, respectively).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Disruption of the planarity of urea derivatives through urea alkylation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another strategy to disrupt planarity is represented by the insertion of substituents at the <i>ortho</i> position of the <i>N</i>-aryl group of arylureas. Thus, the presence of two halogen atoms at the <i>ortho</i> position of the urea functionality could promote the formation of intermolecular hydrogen bonds due to a better conformational preorganization of the monomer. FT-IR and <i>ab initio</i> calculations revealed that an intramolecular hydrogen bond is formed when phenylureas are functionalized with chlorine or bromine atoms at the <i>ortho</i> positions. This halogen effect is at least in part due to the significant influence of the substituents on the dihedral angle (φ) between the urea functionality and the aromatic groups. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, in the absence of substituents in compound <b>19</b>, the most stable conformation for the compound is coplanar (φ = 0°), while in the presence of chlorine or bromine substituents (compounds <b>20</b> and <b>21</b>), the energy surface is completely flat with φ values ranging from 60° to 120°.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Disruption of urea planarity by introduction of <i>ortho</i>-substituents at the aryl urea system.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.4.  Stacking Interactions of Ureas with Aromatic Rings</h3><div class="NLM_p">Although the hydrogen bonding ability of the urea moiety has been long known and studied, this functionality can also be involved in other types of important interactions, especially those involving urea functionality and aromatic side chains in proteins.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> Several crystal structures of proteins bound to urea/urea derivatives have been identified to exhibit π-stacking-like favorable interactions. Moreover, perpendicular orientation of urea with respect to aromatic groups leads to NH-π type interactions. Such a complex hydrophilic/hydrophobic combination of interactions involving the urea moiety could likely be exploited in the future design of ligand molecules for drug discovery purposes.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Several protein structures in the Protein Data Bank contain urea and urea derivatives as ligands or cosolvents. Quite interestingly, 38% of the structures containing urea and 25% of those containing urea derivatives were found to fall within the geometric requirements for a stacking arrangement with aromatic rings (e.g., PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IPU">3IPU</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EV9">4EV9</a>).<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> The relevance of stacking interactions between urea and aromatic side chains in urea transporters (UTs) has been modeled by Priyakumar and co-workers.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(61)</a> UTs are trimeric transmembrane proteins with a parallel arrangement of aromatic rings in the pore which allows stacking of urea and urea homologues (e.g., formamide, acetamide, and dimethylurea). This results in lowering of the energy barrier for urea based solute to transport.<a onclick="showRef(event, 'ref62 ref61'); return false;" href="javascript:void(0);" class="ref ref62 ref61">(62,63)</a></div><div class="NLM_p">The aromatic ring stacking interactions play an important role in urea-assisted protein denaturation. Using Trp-cage miniprotein, Priyakumar and co-workers<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(61)</a> investigated distortion of the protein hydrophobic core in the presence of urea and showed that aqueous urea optimally solvates aromatic groups in the protein. Furthermore, studies suggested the presence of stacking and NH−π interactions involving aromatic groups and urea. In particular, three kinds of interactions were shown between the Trp6 side-chain and urea: (i) stacking, where the urea moiety and indole ring were parallel to each other, (ii) NH−π interaction, where one of the NH bonds of the urea was perpendicular to the indole ring; (iii) typical hydrogen-bonding interaction between the urea oxygen atom and the nitrogen atom of the Trp side chain. Stacking and NH−π interactions with urea are responsible for stabilizing Trp6 in the unfolded state (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L2Y">1L2Y</a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(61)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Representation of the stacking interaction between Trp6 and urea; (B) NH−π interaction between the tryptophan 6 side-chain and urea. Part of the Trp-cage miniprotein is shown in magenta; carbon atoms, nitrogen, and hydrogen atoms are shown in green, blue, and yellow, respectively. The figure is modified based upon published structures.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(61)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Urea-assisted RNA unfolding is another phenomenon which can be explained by the engagement of an extrahelical state via favorable π–π, NH−π, and hydrogen bonding interactions with the urea moiety. Both urea and water can establish NH−π and hydrogen bonding interactions with nucleic acid structures. However, stacking interactions are only possible with urea, and this explains its strong denaturing actions. These effects also rely upon the base composition and nature of nucleic acids.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">4.  Importance of Urea Functionality in Drug–Receptor Interaction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The bioactivity of drugs is governed by molecular recognition through drug and target protein interactions. Among the multiple forces that are involved in protein–ligand interactions, hydrogen bonds play a key role due to their ability to stabilize the drug–receptor interaction.<a onclick="showRef(event, 'ref44 ref66'); return false;" href="javascript:void(0);" class="ref ref44 ref66">(44,66)</a> The donor–acceptor hydrogen bonding capability of urea derivatives is one of the most important elements of their molecular recognition and bioactivity. A few examples describing key interactions involving urea functionality in biologically active compounds are presented here.</div><div class="NLM_p">A series of potent HIV protease inhibitors have been developed featuring a urea substructure. In 1993, Getman and co-workers reported a novel class of HIV-1 protease inhibitors incorporating the (hydroxyethyl)urea isostere. Compound <b>22</b> (SC-52151) exhibited good inhibitory activity on HIV-1 protease (IC<sub>50</sub> = 6.3 nM) and excellent selectivity over other aspartyl proteases, such as renin and cathepsin D. As shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, X-ray structural studies of a related inhibitor <b>23</b> containing a <i>n</i>-butyl chain complexed with HIV-1 protease revealed that the inhibitor binds in an extended conformation with the (<i>R</i>)-hydroxyl group positioned symmetrically between the two catalytic aspartates of the enzyme. The urea carbonyl group appears to be involved in water-mediated hydrogen bonding with the Ile50 and Ile50′ residues. The P2′ <i>n</i>-butyl substituent of the urea derivative is occupying the S1′-binding site, and the P1′ isobutyl group has occupied the S2′ subsite.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structure of HIV-1 protease inhibitor <b>23</b> and highlight of the interaction with protease. Hydrogen bonding interactions are shown by blue dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HIV protease inhibitors featuring a cyclic urea substructure have also been designed and developed into a number of preclinical candidates. One of the specific design objectives was to replace the structural water molecule found in cocrystal structures of HIV protease and linear inhibitors using the urea functionality. The resulting inhibitors maximized interactions in the protease active site and maintained good activity against mutant proteases.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>24</b> (DMP450) and a number of other urea-based inhibitors exhibited broad spectrum antiviral activity against multidrug-resistant HIV-1 variants.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The cocrystal structure (PDB id: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMP">1DMP</a>) of DMP450-bound HIV-1 protease revealed that the urea functionality nicely mimicked the flap ligand-bridging water molecule (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). Also, the conformationally locked cyclic core allowed optimal interaction and accommodation of ligands within the S1, S1′, S2, and S2′ subpockets of the HIV protease active site.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. X-ray structure of urea derivative <b>24</b> and HIV-1 protease complex (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMP">1DMP</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The urea moiety also plays a prominent role in molecular recognition of sorafenib (<b>25</b>) and lenvatinib (<b>26</b>) by the protein kinase active site (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a> and <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>). The X-ray crystal structures of vascular endothelial growth factor receptor 2 (VEGFR2) in complex with either lenvatinib or sorafenib were determined. These protein–ligand complexes with lenvatinib and sorafenib highlighted the importance of the urea functionality. As shown, the urea functionality is involved in critical hydrogen bonding with main-chain atoms of Asp1046 and the side-chain atoms of Glu885 (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a> and <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The quinoline moiety of lenvatinib and the pyridine core of sorafenib occupied nearly identical positions and formed a hydrogen bond with Cys919.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. X-ray structure of sorafenib (<b>25</b>) and VEGFR2 complex (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ASD">4ASD</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. X-ray structure of lenvatinib (<b>26</b>) and VEGFR2 complex (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WZD">3WZD</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Urea derivative <b>27</b> is a potent Map kinase inhibitor that has undergone human clinical trials for the treatment of inflammatory diseases. Interestingly, the <i>N</i>-pyrazole-<i>N</i>-aryl urea occupies the binding domain on p38 that is exposed when the conserved binding loop containing Asp168, Phe169, and Gly170 adopts a DFG-out conformation (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>). The X-ray structural studies revealed that both urea NHs form strong hydrogen bonds with the Glu71 side chain carboxylic acid while the urea carbonyl forms a strong hydrogen bond with the Asp168 backbone amide NH. The naphthalene moiety binds in the kinase specificity pocket. The ethoxymorpholine chain adopts a Gauche conformation and orients the morpholine oxygen to form a strong hydrogen bond with the backbone NH of Met109 in the ATP binding region of p38.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. X-ray structure of MAP kinase inhibitor BIRB 796 (<b>27</b>) with human p38 MAP kinase (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KV2">1KV2</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example of the key role of urea functionality in drug–target interactions is shown in urea-derived soluble epoxide hydrolase (sEH) inhibitors. The sEH is involved in the metabolism of endogenous mediators (e.g., epoxides of linoleic acid, arachidonic acid, and other lipids).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The catalytic mechanism of sEH as shown in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>A, involves a SN2-type reaction in which the epoxide is first activated by forming hydrogen bonds with Tyr381 and/or Tyr465 residues. Subsequent nucleophilic attack by Asp333 forms the acylenzyme intermediate which is attacked by a water molecule activated by His523. The resulting tetrahedral intermediate finally collapses to provide the diol product (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>A). 1,3-Disubstituted ureas have become interesting structural templates for sEH inhibition.<a onclick="showRef(event, 'ref72 ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref74 ref75">(72−75)</a> The X-ray structural studies with the urea-derived inhibitor 4-(3-cyclohexylureido)-ethanoic acid (<b>28</b>) demonstrated that the urea moiety is able to mimic the transition state of the sEH-catalyzed epoxide ring opening, establishing strong hydrogen bonding interactions with Asp333 and Tyr381 residues (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>B).<a onclick="showRef(event, 'ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref76 ref77 ref78">(76−78)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. (A) Transition state for sEH-catalyzed oxirane ring opening; (B) Interaction of inhibitor <b>28</b> in the enzyme active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PF-04457845 (<b>29</b>) is a highly potent inhibitor of fatty acid amide hydrolase (FAAH).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> FAAH is a serine hydrolase responsible for the metabolism of signaling lipids, such as the endocannabinoid anandamide.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> FAAH is considered a potential therapeutic target for the treatment of pain and nervous system disorders. Thus, small-molecule FAAH inhibitors would exert their beneficial effects without the potential drawbacks associated with direct stimulation of cannabinoid receptors.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a></div><div class="NLM_p">Compound <b>29</b> contains a benzylidenepiperidine pyridazine urea. The X-ray and kinetic studies demonstrated that these urea-containing derivatives are able to covalently and irreversibly inhibit FAAH through involvement of the Ser241-Ser217-Lys142 catalytic triad as shown in <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>. The urea functionality interacts with the catalytic Ser241 nucleophile, thus generating a tetrahedral intermediate (<b>30</b>) and subsequently inducing carbamoylation (inactivation) of the FAAH enzyme through formation of carbamate <b>31</b>.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> Recently, PF-04457845 has been shown to reduce cannabis withdrawal symptoms and cannabis use, in a phase IIa clinical trial.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Mechanism of FAAH inhibition by urea derivative PF-04457845 (<b>29</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">5.  Urea Containing FDA Approved Drugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Urea substructures are characteristic of several FDA approved drugs as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>. Many urea containing compounds are also undergoing clinical development which will be discussed later. In this section, approved urea derivatives for therapeutic applications are highlighted.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of urea containing FDA approved drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">5.1.  Sorafenib</h3><div class="NLM_p last">Sorafenib (<b>25</b>, Nexavar, Bayer and Onyx Pharmaceuticals, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a diaryl urea multikinase inhibitor acting on c-RAF, B-RAF, c-KIT, FLT3, platelet derived growth factor receptor (PDGFR) α and β, and vascular endothelial growth factor receptor (VEGFR) 1, 2, and 3, among others.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> It was approved in 2007 for the therapy of hepatocellular carcinoma and advanced renal cell carcinoma and is under evaluation for acute myeloid leukemia (AML).<a onclick="showRef(event, 'ref13 ref86'); return false;" href="javascript:void(0);" class="ref ref13 ref86">(13,86)</a> Sorafenib is converted by UDP-glucuronosyltransferase 1A9 (UGT1A9) to its glucuronide and by CYP3A4 to its active metabolite sorafenib <i>N</i>-oxide.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87,88)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">5.2.  Boceprevir</h3><div class="NLM_p last">Boceprevir (<b>32</b>, Victrelis, Merck, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a urea containing protease inhibitor useful against hepatitis C virus (HCV). Boceprevir reversibly binds the active site of nonstructural protein 3 (NS3) and displays high potency in the replicon system alone or combined with interferon α-2b and ribavirin.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Boceprevir is a diastereomeric mixture of two compounds differing in the stereochemical configuration at the cyclobutylmethyl functionality appended to its ketoamide end. In January 2015, Merck announced market withdrawing for boceprevir due to the striking superiority of newer agents (e.g., ledipasvir/sofosbuvir). Oxidative metabolites of boceprevir are formed upon interaction with CYP3A4 and CYP3A5, while the keto-reduced metabolites mostly form upon transformations mediated by aldo-keto reductases AKR1C2 and AKR1C3. Since boceprevir metabolism encompasses two diverse enzymatic pathways, the drug undergoes drug–drug interaction to a lesser extent.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">5.3.  Ritonavir</h3><div class="NLM_p last">Ritonavir (<b>33</b>, Norvir, ABT-538, A-84538, AbbVie, Inc., <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) features a thiazolyl methyl urea substructure. In 1996, it was approved as inhibitor of the HIV protease.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Ritonavir displayed an EC<sub>50</sub> of 0.025 μM, plasma half-life of 1.2 h, and bioavailability of 78%. Ritonavir showed an excellent pharmacokinetic profile due to the higher stability of the thiazole moieties toward oxidative metabolism. Ritonavir inhibits CYP3A4 irreversibly binding to the heme iron via the thiazole nitrogen<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> thus increasing plasma concentrations of other CYP3A4 substrate anti-HIV drugs, improving their efficacy.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">5.4.  Lisuride</h3><div class="NLM_p last">Lisuride (<b>34</b>, Dopergin, Proclacam, or Revanil, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a urea-based ergot-related dopamine agonist used for the therapy of Parkinson’s disease (PD). Lisuride also binds the serotonin 5-HT1A, 5-HT2<i>A</i>/2C, and histamine H1 receptors.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Studies aimed at examining the metabolism of 14C-lisuride hydrogen maleate in humans and rhesus monkeys demonstrated that 2-keto-3-hydroxy-lisuride was the main metabolic derivative. Parallel metabolic transformations of lisuride were identified, including hydroxylation of the phenyl ring, oxidative <i>N</i>-deethylation, monooxygenation at C2 and C9, and oxidation of C2/C3 and C9/C10 double bonds.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">5.5.  Cariprazine</h3><div class="NLM_p last">Cariprazine (<b>35</b>, Vraylar in the United States and Reagila in Europe, Gedeon Richter and Actavis, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a urea-containing dopamine D3/D2 receptor partial agonist, acting as atypical antipsychotic for treating schizophrenia and bipolar disorders.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> Cariprazine received FDA approval on September 2015. It is highly metabolized by cytochrome CYP3A4 with the formation of active metabolites and, to a limited extent, by CYP2D6.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Cariprazine displays a mean half-life of 2–5 days (1.5–12.5 mg dose). It generates two clinically relevant metabolites by modification of its urea moiety: desmethyl-cariprazine and didesmethyl-cariprazine, this latter displaying an extended half-life with respect to cariprazine.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">5.6.  Telcagepant</h3><div class="NLM_p last">Telcagepant (<b>36</b>, code name MK-0974, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) was a urea containing oral calcitonin gene-related peptide (CGRP) receptor antagonist launched by Merck as an investigational drug for the treatment and prevention of migraine; it was the first orally available drug in this class.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> A Phase IIa clinical trial evaluating telcagepant for the prophylaxis of episodic migraine was halted on March 26, 2009 after the observation of a significant increase of serum transaminase levels upon treatment.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> MK-0974 undergoes significant oxidative metabolism (CYP3A) in monkey intestinal microsomes. The drug is mainly metabolized as pyridine <i>N</i>-oxide, and its metabolism is slower in rat than in monkey intestinal microsomes.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">5.7.  Zileuton</h3><div class="NLM_p last">Zileuton (<b>37</b>, Zyflo, Cornerstone Therapeutics Inc., <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a benzothiophene <i>N</i>-hydroxyurea. It is an inhibitor of 5-lipoxygenase (5-LOX), and it alleviates allergic and inflammatory states by suppressing leukotriene biosynthesis.<a onclick="showRef(event, 'ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref101 ref102">(101,102)</a> Zileuton inhibits 5-LOX by coordinating the iron ion in the active site, and it also displays weak reducing properties. Zileuton and its <i>N</i>-dehydroxylated metabolite are oxidatively metabolized by CYP450 isoenzymes 1A2, 2C9, and 3A4. Interactions of zileuton with other drugs are related to inhibition of CYP1A2.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">5.8.  Celiprolol</h3><div class="NLM_p last">Celiprolol (<b>38</b>, brand names Cardem, Selectol, Celipres, Celipro, Celol, Cordiax, Dilanorm, Acer Therapeutics, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a β-blocker characterized by a unique pharmacologic profile: it behaves as a β1-andrenoceptor antagonist with partial β2 agonist activity. Based on these properties, it can be defined as a selective adrenoreceptor modulator with antihypertensive and antianginal properties.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Recently, the unique properties of celiprolol prompted investigation into its use for the treatment of a rare connective tissue disorder, namely Ehlers–Danlos syndrome.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Celiprolol is minimally metabolized, with only a very low percentage of a dose being excreted.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">5.9.  Carmofur</h3><div class="NLM_p last">Carmofur (<b>39</b>, HCFU, 1-hexylcarbamoyl-5-fluorouracil, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a pyrimidine analogue used as an antineoplastic agent, and it is an orally available lipophilic-masked derivative of 5-fluorouracil. Its carbamoyl moiety is cleaved <i>in vivo</i> to release 5-FU. Carmofur has been employed for the therapy of colorectal cancer,<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> although causing delayed leukoencephalopathy.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Significant side effects and no survival advantage in patients with stage II hepatocellular carcinoma led to clinical trial discontinuation.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">5.10.  Lenvatinib</h3><div class="NLM_p last">Lenvatinib (<b>26</b>, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a multikinase urea-based inhibitor targeting VEGF receptors 1–3, fibroblast growth factor receptors 1–4, PDGFR α, and RET and KIT proto-oncogenes.<a onclick="showRef(event, 'ref110 ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref110 ref111 ref112">(110−112)</a> Lenvatinib is approved for treating radioiodine-refractory differentiated thyroid cancer, and combined with Everolimus, it is used to treat advanced renal cell carcinoma.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Moreover, lenvatinib is under study for the treatment of hepatocellular carcinoma. The main metabolic products isolated from human liver microsomes derive from demethylation, decyclopropylation, <i>O</i>-dearylation, and <i>N</i>-oxidation.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> CYP-related metabolism was reported in human, monkeys, dogs, and rats, while non-CYP-mediated metabolism, mainly ascribable to the action of aldehyde oxidase, has been found in monkeys and humans.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">5.11.  RG7112</h3><div class="NLM_p last">RG7112 (<b>40</b>, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a urea-containing small-molecule acting as an MDM2 antagonist. MDM2 downregulates the tumor suppressor p53.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> RG7112 underwent a phase I clinical trial in patients with hematologic malignancies. The main goal of the study was the estimation of the posology and safety profile. The secondary goals involved the assessment of pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> RG7112 is mainly metabolized by CYP3A4/5 and also behaves as a moderate inhibitor of CYP3A4/5 and P-glycoprotein (P-gp).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">6.  Procedures for the Synthesis of Urea Derivatives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The urea functionality is present in drug molecules, agrochemicals, resins, and dyes. For this reason, a variety of synthetic methodologies for the preparation of urea derivatives have been developed (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The classical approach for the preparation of urea derivatives involves reagents such as phosgene or its derivative, triphosgene. Urea synthesis typically proceeds through an isocyanate intermediate, which upon reaction with a second amine forms the urea derivatives (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Over the years, a series of environmentally friendly phosgene substitutes were developed in order to overcome the hazardous nature of phosgene. In particular, carbonates, <i>N,N</i>′-carbonyldiimidazole, 1,1′-carbonylbisbenzotriazole, <i>S</i>-methylthiocarbamate, formamides, and chloroformates have been utilized for the synthesis of urea derivatives. Also, Curtius, Lossen, and Hofmann rearrangements have been employed to generate urea derivatives through the isocyanate intermediates.</div><figure id="sch1" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0036.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Traditional Methodologies for the Synthesis of Ureas</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recently, carbon monoxide has been utilized as a reliable alternative to phosgene. Accordingly, catalytic oxidative carbonylation employs amines, an oxidant, and carbon monoxide as starting materials to provide ureas. These reactions are appealing in terms of atom economy standards, with the only byproducts being the reduced form of the oxidant. Various transition metal catalysts including Pd, Co, Ni, Ru, Mn, and Au have been employed to afford urea derivatives. However, outcomes varied and often reaction conditions were harsh. As a result, complex mixtures of ureas, oxamides, and formamides were obtained.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">6.1.  Synthesis of Urea Derivatives Using Phosgene or Phosgene Equivalents</h3><div class="NLM_p">The reaction of amines with phosgene represents the most traditional methodology for the generation of urea derivatives. This methodology is commonly preferred for the generation of symmetrical ureas, but also unsymmetrical urea derivatives can be prepared efficiently. In general, amines react with phosgene in the presence of a base to provide the desired isocyanate intermediates.<a onclick="showRef(event, 'ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref119 ref120">(119,120)</a> Subsequent reactions of the isocyanates with diverse amine nucleophiles provide <i>N,N</i>-disubstituted or <i>N,N,N′</i>-trisubstituted unsymmetrical urea derivatives. This methodology is widely employed in drug discovery and pharmaceutical research since it represents a convenient method to generate urea derivatives.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> A synthesis of a triazole urea derivative containing a β-lactam ring is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Beta-lactam derivative <b>41</b> was reacted with phosgene and 1,2,4-triazole (<b>42</b>) to provide triazole urea <b>43</b>, a potent and selective monoacylglycerol lipase (MAGL) inhibitor.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><figure id="sch2" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0037.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Formation of Urea-Containing MAGL Inhibitor <b>43</b> Using Phosgene</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Bis(trichloromethyl)carbonate (<b>46</b>, BTC, or triphosgene) is a crystalline and stable solid, allowing safe handling. For this reason, it has been considered a safer replacement to phosgene.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, the vapor pressure is sufficiently high to easily result in toxic concentrations, therefore safety concerns are also associated with its prolonged use.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> The use of triphosgene in the synthesis of urea derivative <b>47</b>, a potent antitrypanosomal agent, is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Aniline derivative <b>44</b> was reacted with BTC in the presence of Et<sub>3</sub>N. The resulting intermediate was reacted with amine <b>45</b> to provide <b>47</b>.</div><figure id="sch3" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0038.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Formation of the Urea Derivative <b>47</b> Using Triphosgene</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">6.2.  Synthesis of Urea Derivatives via Safer Phosgene Substitutes</h3><div class="NLM_p"><i>N,N</i>′-Carbonyldiimidazole (<b>50</b>, CDI) is a widely exploited alternative to phosgene reagent for the preparation of ureas. CDI is a crystalline solid and is commercially available. CDI does not produce chlorine or chlorinated byproducts and is thus a safer and less toxic alternative to the use of BTC and phosgene for the generation of biologically active unsymmetrical ureas.<a onclick="showRef(event, 'ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref125 ref126">(125,126)</a> As shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, CDI has been used for the synthesis of urea derivative <b>51</b>, a potent inhibitor of the DCN1–UBE2M interaction, starting from amine <b>48</b> and aniline <b>49</b>.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div><figure id="sch4" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0039.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Formation of Urea Derivative <b>51</b> Using CDI (<b>50</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">1,l′-Carbonylbisbenzotriazole (CBT, <b>53</b>) was proposed as a safer and milder alternative to phosgene for the preparation of unsymmetrical urea derivatives. As an example, compound <b>53</b> reacts with secondary amine <b>52</b> to provide the corresponding carbamoyl benzotriazole derivative <b>54</b>. Intermediate <b>54</b> is subsequently treated with a different secondary amine (<b>55</b>), to smoothly provide tetrasubstituted unsymmetrical urea derivative <b>56</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Steric hindrance of the substituents placed on the secondary amine is the main factor influencing reaction outcome. For cyclic and aliphatic amine derivatives, the reaction proceeds at room temperature and provides good yields, while it may require higher temperatures or reflux condition for aromatic amines.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="sch5" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0040.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Formation of Urea Derivatives Using 1,l′-Carbonylbisbenzotriazole (<b>53</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The aminolysis of a urethane derivative is a well-known procedure for the synthesis of ureas. Urethanes are usually generated from carbonates or chloroformates.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> Urethanes can also be prepared by reacting amine derivatives with carbon dioxide or by utilizing other safer and more recent methodologies.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Urethanes react with amines with varying efficacy, depending upon the nature of the leaving alkoxide group.<a onclick="showRef(event, 'ref5 ref129 ref132'); return false;" href="javascript:void(0);" class="ref ref5 ref129 ref132">(5,129,132)</a></div><div class="NLM_p">As an example, addition of one equivalent of the indoline <b>58</b> to phenylcarbamate <b>57</b> in the presence of triethylamine followed by heating to reflux resulted in almost quantitative conversion to the urea <b>59</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). The product was isolated in 78% yield and >99% purity through the addition of water and collection by filtration.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><figure id="sch6" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0041.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Formation of Urea Derivatives through Aminolysis of Carbamates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the effective synthesis of unsymmetrical tetrasubstituted ureas, Batey and co-workers formed imidazolium salts and developed effective carbamoyl transfer reagents.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> As shown in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>, carbamoylimidazolium salts are readily synthesized by reaction of secondary amines with CDI and successive alkylation with iodomethane to form salt <b>61</b>.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Addition of primary or secondary amines to these salts in the presence of triethylamine efficiently provided disubstituted or tetrasubstituted ureas, respectively. The resulting byproducts (namely <i>N</i>-methylimidazole and triethylamine hydrochloride salt) could be washed away by treatment of the organic layer with a dilute acid. The protocol was not successful for poorly nucleophilic aromatic amines. However, their conversion to anilide anions, upon treatment with KHMDS or <i>n</i>-BuLi led to more reactive nucleophiles. Reaction of these anions with imidazolium salts smoothly provided the corresponding ureas in good yields.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><figure id="sch7" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0042.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Urea Derivatives Using Carbamoylimidazolium Salts</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Artuso and co-workers validated <i>S</i>,<i>S</i>-dimethyl dithiocarbonate (DMDTC, <b>63</b>) as a valuable replacement of phosgene for the in-water carbonylation of amines for the convenient generation of mono-, di-, and trisubstituted urea derivatives (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). Symmetrical disubstituted ureas were prepared using a 1:2 molar ratio of DMDTC and amine, respectively, at 60 °C. Unsymmetrical urea derivative <b>65</b> was synthesized in two steps involving: (i) formation of the <i>S</i>-methyl <i>N</i>-alkylthiocarbamate derivative <b>64</b> (room temperature); and (ii) reaction of this intermediate with butylamine (50–70 °C). This protocol provided urea derivatives in excellent yields and purity. The protocol allowed for easy and straightforward isolation of reaction products.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><figure id="sch8" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0043.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Urea Derivatives Using <i>S</i>,<i>S</i>-Dimethyl Dithiocarbonate (<b>63</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As part of safer phosgene substitutes to be exploited under mild reaction conditions, Yoon and co-workers examined the use of phenyl 4,5-dichloro-6-oxopyridazine-1(6<i>H</i>)-carboxylate (<b>68</b>). Compound <b>68</b> was synthesized from 4,5-dichloropyridazin-3(2<i>H</i>)-one (<b>66</b>) and phenyl chloroformate (<b>67</b>) in the presence of triethylamine (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>). The compound showed stability even at high temperature. Unsymmetrical ureas were synthesized through this protocol in a one pot fashion starting from compound <b>68</b>. Upon reaction of anilines with <b>68</b> to form the corresponding <i>N</i>-aryl carbamates, aliphatic amines were added and refluxed until disappearance of the carbamate to efficiently provide <i>N-</i>aryl-<i>N</i>-alkyl urea derivatives.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><figure id="sch9" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0044.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Urea Derivatives Using Phenyl 4,5-Dichloro-6-oxopyridazine-1(6<i>H</i>)-carboxylate (<b>68</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Padiya and co-workers described a useful protocol for synthesis of urea derivatives (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>) in water. It turns out, CDI reacts with amines in aqueous medium to afford the corresponding <i>N</i>-substituted carbonylimidazolides in good yields. Carbonylimidazolides (such as compound <b>69</b>) derived from primary amines react in situ with an amine nucleophile (e.g., compound <b>70</b>) providing the corresponding urea <b>71</b>. Compounds <b>72</b> and <b>73</b> are other examples of urea derivatives which can be efficiently prepared through this procedure. Due to product precipitation from the reaction mixture, a high degree of purity was observed.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><figure id="sch10" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0045.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Urea Derivatives <b>71–73</b> Using CDI in Water Medium</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Moroz and co-workers investigated <i>bis</i>(2,2,2-trifluoroethyl) carbonate (<b>76</b>) as a convenient alternative to traditional carbonates. Carbonate <b>76</b> was prepared by reaction of triphosgene (<b>75</b>) and trifluoroethanol (<b>74</b>). The reaction provided <b>76</b> and its trifluoroethylchloroformate counterpart in a nearly 1:3 ratio. Moreover, trifluoroethylchloroformate could provide <b>76</b> by further treatment with trifluoroethanol and triethylamine (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>).</div><figure id="sch11" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0046.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Urea Derivatives Using <i>Bis</i>(2,2,2-trifluoroethyl) Carbonate <b>76</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Trifluoroethyl carbonate <b>76</b> smoothly reacts with alkyl amines with high regioselectivity providing trifluoroethyl carbamates (<b>77</b>), rather than symmetrical ureas. Further reaction with amines in the presence of a base provided urea derivatives. This protocol displays a wide scope and utility, since it allowed the straightforward synthesis of ureas in the presence of potentially competing functionalities (e.g., amino, hydroxyl and phenolic groups, pyrazole moieties) (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37">6.3.  Urea Synthesis Using Rearrangements</h3><div class="NLM_p">The Hofmann rearrangement is a common method to access ureas through the formation of their amine precursors. This reaction involves the generation of a primary amine from a carboxamide derivative in the presence of sodium hydroxide and bromine, encompassing the formation of an intermediate isocyanate. The intermediate isocyanate could be converted into urea derivatives by in situ trapping with a suitable amine nucleophile.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> To improve the overall process, a variety of alternative oxidants and different bases arose over years, such as diacetoxyiodobenzene PhI(OAc)<sub>2</sub>,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> MeOBr,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a><i>N</i>-bromosuccinimide (NBS)-CH<sub>3</sub>ONa,<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> (NBS)-KOH,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> lead(IV) acetate,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> and benzyltrimethylammonium tribromide.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Hofmann rearrangement has been utilized in the synthesis of 2-pyridylureas as glucokinase activators. As shown in <a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>, carboxamide <b>78</b> was subjected to Hofmann rearrangement with NBS and potassium hydroxide to provide aniline <b>79</b>. It was subsequently converted to urea derivative <b>80</b>, precursor of the target compound <b>81</b>.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div><figure id="sch12" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0047.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Formation of the Urea Derivative <b>81</b> Using a Key Hofmann Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Curtius rearrangement of an acyl azide provides the corresponding isocyanate. This can undergo in situ reaction with a variety of nucleophiles, thus affording urea and carbamate derivatives or other <i>N</i>-acyl compounds. A one-pot Curtius rearrangement starting from carboxylic acid derivatives using diphenylphosphoryl azide (DPPA) provides the corresponding isocyanate derivatives for urea synthesis.<a onclick="showRef(event, 'ref147 ref148 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref147 ref148 ref149 ref150">(147−150)</a> The use of Curtius rearrangement for the synthesis of urea derivative <b>83</b> is shown in <a class="ref internalNav" href="#sch13" aria-label="Scheme 13">Scheme 13</a>. Compound <b>83</b> is a potent inhibitor of human influenza virus replication. Carboxylic acid precursor <b>82</b> was reacted with DPPA and triethylamine, and subsequent reaction with morpholine provided urea derivative <b>83</b>.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a></div><figure id="sch13" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0048.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Formation of Urea Derivative <b>83</b> Using the Curtius Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Lossen rearrangement is the conversion of hydroxamic acids into isocyanates. The transformation is initiated by exposure of the hydroxamic acid to base or heat. The resulting anion is rapidly converted into the corresponding isocyanate. The isocyanate could then easily provide the desired urea derivatives. As shown in <a class="ref internalNav" href="#sch14" aria-label="Scheme 14">Scheme 14</a>, valine-derived hydroxamic acid <b>84</b> was treated with alanine methyl ester <b>85</b> in the presence of EDCI, providing the urea derivative <b>86</b> in 81% yield.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><figure id="sch14" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0049.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Formation of Urea Derivative <b>86</b> Using the Lossen Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dubé and collaborators explored the potential of an inventive CDI-mediated Lossen rearrangement. The proposed protocol is characterized by operational simplicity and mildness, leading to only imidazole and CO<sub>2</sub> as the stoichiometric byproducts (<a class="ref internalNav" href="#sch15" aria-label="Scheme 15">Scheme 15</a>). The authors proved the electronic nature of the transformation and provided a wide exploration of the reaction scope. Morpholine trapping of isocyanates quantitatively affords the corresponding urea derivatives. Therefore, this nucleophile was employed to examine the outcome of the protocol employing hydroxamates deriving from aryl, heteroaryl, and aliphatic hydroxamic acids. Diverse ureas were generated in good yields and acceptable purity grades according to this protocol, which also represents a green alternative to traditional Curtius and Hofmann rearrangements.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a></div><figure id="sch15" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0050.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Synthesis of Urea Derivatives Using CDI-Mediated Lossen Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sureshbabu and co-workers reported the ultrasonication-mediated formation of hydroxamates from aromatic acids and <i>N</i>-protected amino acids using 1-propanephosphonic acid cyclic anhydride (<b>87</b>, T3P) as the carboxy activator as shown in <a class="ref internalNav" href="#sch16" aria-label="Scheme 16">Scheme 16</a>. Compound <b>87</b> activates hydroxamates, to form isocyanates via a Lossen rearrangement, thus ultimately affording, upon reaction with suitable nucleophiles, the corresponding urea derivatives. The reported methodology was applied to the synthesis of several <i>N</i><sub>α</sub>-protected amino acid hydroxamates and for the preparation of peptidomimetics.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><figure id="sch16" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0051.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 16. Synthesis of Urea Derivatives Using a Lossen Rearrangement Mediated by 1-Propanephosphonic Acid Cyclic Anhydride (<b>87</b>, T3P)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mandal and co-workers proposed the use of 2-cyano-2-(4-nitrophenylsulfonyloxyimino)acetate (<b>88</b>, 4-NBsOXY) for both the generation of hydroxamic acids and the subsequent Lossen rearrangement. As shown in <a class="ref internalNav" href="#sch17" aria-label="Scheme 17">Scheme 17</a>, activation of the carboxylic acids with reagent <b>88</b> (1 equiv) in the presence of DIPEA and catalytic DMAP followed by the addition of hydroxylamine led to the corresponding hydroxamic acid derivatives. For amino acids, there was no detectable racemization. Urea derivatives were obtained via Lossen rearrangement from the generated hydroxamic acids by reaction of <b>88</b> (1 equiv) with DIPEA (0 °C for 90 min) and subsequent addition of amine at room temperature. Interestingly, the side products 4-nitrobenzenesulfonic acid and Oxyma [ethyl 2-cyano-2-(hydroxyimino)acetate] can be used to regenerate <b>88</b>.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></div><figure id="sch17" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0052.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 17. Synthesis of Urea Derivatives Using a Lossen Rearrangement Mediated by 2-Cyano-2-(4-nitrophenylsulfonyloxyimino)acetate (<b>88</b>, 4-NBsOXY)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Lebel and co-worker synthesized aromatic carbamates and urea derivatives from aromatic acids exploiting a Curtius rearrangement in the presence of di-<i>tert</i>-butyl dicarbonate or chloroformates and sodium azide as shown in <a class="ref internalNav" href="#sch18" aria-label="Scheme 18">Scheme 18</a>. The reaction possibly involved the generation of an intermediate azidoformate. Final amine trapping of the acyl azides affords urea derivatives.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></div><figure id="sch18" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0053.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 18. Synthesis of Urea Derivatives Using Curtius Rearrangement via Formation of the Azidoformate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sureshbabu and collaborators developed a simple one-pot protocol for the preparation of neoglycopeptides and urea-containing peptidomimetics employing a Curtius rearrangement in the presence of Deoxo-Fluor (<b>90</b>, <i>bis</i>(2-methoxyethyl)aminosulfur trifluoride) and TMSN<sub>3</sub> under ultrasonication conditions as shown in <a class="ref internalNav" href="#sch19" aria-label="Scheme 19">Scheme 19</a>. The method could involve four sequential steps: (i) generation of acyl fluoride, (ii) azide formation, (iii) rearrangement into isocyanate, and (iv) reaction with the selected amine to provide urea derivatives. The conditions represent a racemization-free procedure.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><figure id="sch19" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Scheme 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0054.jpeg" id="gr38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 19. Synthesis of Urea Derivatives <b>91</b> and <b>93</b> Using Curtius Rearrangement under Ultrasonication Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thakur and co-workers reported a simple protocol for the preparation of unsymmetrical ureas starting from (hetero)aromatic carboxylic acids and amines by using DPPA as outlined in <a class="ref internalNav" href="#sch20" aria-label="Scheme 20">Scheme 20</a>. This one-pot, microwave-accelerated method was reported to provide urea derivatives in an extremely rapid fashion (1–5 min) and in excellent yields. The method was applied to the synthesis of cannabinoid 1 and α7 nicotinic receptor ligands (e.g., compound <b>94</b>, PSNCBAM-1).<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><figure id="sch20" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Scheme 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0055.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0055.jpeg" id="gr39" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 20. Synthesis of Urea Derivatives Using Curtius Rearrangement under Microwave Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0055.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hu and co-workers reported a Hofmann rearrangement using iodosylbenzene (PhIO) as the oxidizing agent to form the corresponding one-carbon shorter isocyanates from amide derivatives as shown in <a class="ref internalNav" href="#sch21" aria-label="Scheme 21">Scheme 21</a>. Nucleophilic attack of amines finally generated the corresponding urea or carbamate derivatives. Several amides and amines were employed as substrates. Symmetric and asymmetric ureas were also prepared in good to excellent yield.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><figure id="sch21" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Scheme 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0056.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0056.jpeg" id="gr40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 21. PhIO-Induced Hofmann Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0056.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Chien and co-workers proposed the Tienmann rearrangement with benzenesulfonyl chlorides (TsCl or <i>o</i>-NsCl) to generate the corresponding <i>N</i>-substituted cyanamide derivatives as shown in <a class="ref internalNav" href="#sch22" aria-label="Scheme 22">Scheme 22</a>. Acidic hydrolysis of the cyanamide derivatives would then afford <i>N</i>-monosubstituted ureas. <i>N</i>-monosubstituted ureas could also be prepared from nitriles in a one-pot fashion, encompassing the transformation of nitriles into amidoximes and subsequent Tienmann rearrangement followed by hydrolysis.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a></div><figure id="sch22" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Scheme 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0057.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0057.jpeg" id="gr41" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 22. Synthesis of Urea Derivatives Using Tienmann Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0057.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Sanz and co-workers reported the synthesis of novel benzylidene urea derivatives upon reaction of <i>o</i>-lithiated carbamates with nitriles according to a 1,5-<i>O</i> → <i>N</i> carbamoyl migration, namely a Snieckus–Fries-type rearrangement as outlined in <a class="ref internalNav" href="#sch23" aria-label="Scheme 23">Scheme 23</a>. Several <i>O</i>-aryl <i>N,N</i>-diethylcarbamates were treated with (hetero)aromatic nitriles behaving as the electrophiles, affording the desired benzylidene ureas in high yields.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><figure id="sch23" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Scheme 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0058.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0058.jpeg" id="gr42" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 23. Synthesis of Urea Derivatives Using Snieckus–Fries-Type Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0058.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50">6.4.  Synthesis of Ureas via Metal-Catalyzed Methods</h3><div class="NLM_p">Recently, many routes utilizing phosgene alternatives have been developed employing carbon dioxide or carbon monoxide as the carbonyl group source.<a onclick="showRef(event, 'ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref162 ref163">(162,163)</a> Carbonylation of amines employing Pd-based catalysts has been broadly investigated since 1966, when it was first described.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> In this procedure, Pd(II) is reduced to Pd(0). Its reoxidation to the active form of the catalyst is a crucial step which is facilitated by the use of oxidizing agents such as a molecular oxygen, aromatic nitrocompounds, iodine, and quinones. The use of molecular oxygen as the oxidizing agent became attractive due to both sustainability and atom economy perspectives as water is the only coproduct formed. Accordingly, several methods encompassing the use of molecular oxygen are increasingly appealing. Unfortunately, most of the protocols take place in potentially harmful conditions, since they use carbon monoxide and molecular oxygen in volume proportions very close to the flammability range.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></div><div class="NLM_p">Fukuoka and co-workers<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> and Chaudhari and co-workers<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> described the preparation of urea derivatives form alkylamines by exploiting oxidative carbonylation in the presence of Pd/C and molecular oxygen, promoted by iodide salts. Similar results were obtained by Gabriele and co-workers, who synthesized linear and cyclic ureas in moderate to good yields utilizing PdI<sub>2</sub> and molecular oxygen.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Mechanistically, the different reactivities of amine derivatives were ascribed to their capability to form the isocyanate intermediates upon conversion of the carbamoylpalladium complex generated in pre-equilibrium with starting materials. Pd(0) is then reoxidized to Pd(II) by addition of I<sub>2</sub>, which is in turn regenerated through oxygen-mediated oxidation of HI.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div><div class="NLM_p">In addition to Pd-based catalysts, Au, Co, Ni, Rh, Ru, and other transition metals have also proven useful in affording urea derivatives.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch24" aria-label="Scheme 24">Scheme 24</a>, dicobalt octacarbonyl was used as a CO-free methodology to synthesize symmetrical and unsymmetrical urea derivatives under high-density microwave irradiation conditions. Reaction of cyclohexylamine <b>95</b> with dicobalt octacarbonyl led to the corresponding isocyanate derivative <b>96</b>, which, upon reaction with an excess of secondary amine <b>97</b>, provided trisubstituted unsymmetrical urea derivative <b>98</b> in moderate yields.<a onclick="showRef(event, 'ref5 ref169'); return false;" href="javascript:void(0);" class="ref ref5 ref169">(5,169)</a></div><figure id="sch24" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Scheme 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0059.jpeg" id="gr43" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 24. Dicobalt Octacarbonyl Promoted Generation of Urea Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nitroarenes show a great potential for the preparation of ureas via reductive carbonylation. Homogeneous catalysts such as Pd and Ru are generally required for these reactions. In 1975, Heck described the synthesis of <i>N,N</i>-diarylureas through reaction of nitroarenes and CO with anilines in the presence of Pd(II) salts, organic phosphines, a tertiary amine, and tetrabutylammonium chloride at 90 °C. A combination of symmetrical and unsymmetrical ureas as well as amines derived from the reduction of the initial nitroarenes were isolated. Subsequently, it was found that portionwise addition of amines during the reaction could be a suitable strategy to increase the yield of unsymmetrical aryl-alkyl ureas. As shown in <a class="ref internalNav" href="#sch25" aria-label="Scheme 25">Scheme 25</a>, nitroarene <b>99</b> was converted into urea derivative <b>100</b> using catalytic amounts of Pd(OAc)<sub>2</sub> and dppp as ligand in the presence of acetic acid as the cocatalyst. The reaction yielded the desired urea in 98% conversion and 57% selectivity.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></div><figure id="sch25" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Scheme 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0060.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0060.jpeg" id="gr44" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 25. Generation of Urea Derivatives from Nitroarenes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0060.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pd-catalyzed carbonylation is a renowned strategy to synthesize compounds containing carbonyl functionalities. Accordingly, transition metal mediated reaction of amines with CO and an oxidant provides a useful approach to generate urea derivatives.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Buchwald and co-workers investigated a one-pot protocol for the preparation of aryl isocyanates employing a Pd-catalyzed cross coupling between aryl chlorides and triflates in the presence of sodium cyanate as depicted in <a class="ref internalNav" href="#sch26" aria-label="Scheme 26">Scheme 26</a>.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> The resulting aryl isocyanates were reacted with an amine nucleophile to provide unsymmetrical <i>N,N′-</i>di- and <i>N,N,N′-</i>trisubstituted ureas. The methodology offers a broad substrate scope. The reaction protocol was applied in the synthesis of Omecamtiv Mecarbil (<b>102</b>), a phase-II clinical trial activator of cardiac myosin.</div><figure id="sch26" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Scheme 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0061.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0061.jpeg" id="gr45" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 26. Synthesis of Urea Derivatives Using Cross Coupling of Aryl Chlorides and Triflates with Sodium Cyanate in the Presence of Ligand <b>101</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0061.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Lemaire and co-workers developed a Pd-catalyzed procedure for the reductive alkylation of monosubstituted ureas using aldehydes and molecular hydrogen as a clean reducing agent as outlined in <a class="ref internalNav" href="#sch27" aria-label="Scheme 27">Scheme 27</a>. The protocol used dry methanol, which behaves as a dehydrating agent and allows the generation of an imine from a hemiaminal precursor. Imine hydrogenation ultimately provides <i>N,N</i>-disubstituted urea derivatives. The reaction scope was investigated in optimized conditions (H<sub>2</sub> at 5 bar, 5% Pd/C (2.5 mol %), MeOH as the solvent, 100 °C) employing decanal and diverse urea derivatives. The desired <i>N</i>,<i>N</i>-disubstituted ureas were smoothly formed in good to excellent yields. The methodology was also implemented in solvent-free conditions.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><figure id="sch27" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Scheme 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0062.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0062.jpeg" id="gr46" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 27. Pd-Catalyzed Reductive Alkylation of Urea Derivatives with Aldehydes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0062.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch27"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Solvent free conditions.</p></p></figure><div class="NLM_p">The metal-catalyzed carbonylation of nitrenes with amines is gaining interest for the synthesis of unsymmetrical ureas. Recently, Zhang and co-workers described a Pd/C-catalyzed carbonylation of benzyl, alkyl, and aryl azides with amines to synthesize unsymmetrical urea derivatives as described in <a class="ref internalNav" href="#sch28" aria-label="Scheme 28">Scheme 28</a>. The use of Pd/C offers advantages compared to general homogeneous catalysts in terms of safe handling, simple removal of catalyst by filtration, and recycling potential. Notably, the use of a phosphorus ligand such as XPhos increased the reaction yields, and toluene was selected as the best performing solvent. Due to the higher reactivity of aryl azides, reaction could be implemented at room temperature. This cross-coupling protocol proceeded even in an aqueous media containing 5% PhMe and 5% <i>n</i>Bu<sub>4</sub>NCl.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><figure id="sch28" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Scheme 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0063.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0063.jpeg" id="gr47" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 28. Pd/C-Catalyzed Carbonylation of Benzyl, Alkyl, and Aryl Azides with XPhos</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0063.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch28"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>PhMe, 60 °C, 12 h.</p><p class="last"><span class="fn-label"><sup>b</sup></span>5% <i>n</i>Bu<sub>4</sub>NCl, H<sub>2</sub>O/PhMe 20:1, rt, 24 h.</p></p></figure><div class="NLM_p">Mancuso and co-workers reported a catalytic system involving the use of PdI<sub>2</sub> in the presence of an excess of KI for the oxidative carbonylation of primary amines providing 1,2-disubstituted symmetric urea derivatives. The reaction with a mixture of a primary and a secondary amine leads to the formation of trisubstituted urea derivatives as outlined in <a class="ref internalNav" href="#sch29" aria-label="Scheme 29">Scheme 29</a>. The protocol has been applied to synthesis of β-amino alcohols bearing a primary amine group for their conversion into the corresponding oxazolidinones. Conceivably, either the carbamoyl–palladium complex I or the isocyanate derivative II could provide the desired symmetric urea derivatives.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a></div><figure id="sch29" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Scheme 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0064.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0064.jpeg" id="gr48" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 29. Synthesis of Urea Derivatives by Oxidative Carbonylation Using PdI<sub>2</sub> and KI</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0064.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The use of an appropriate ionic liquid such as 1-butyl-3-methylimidazolium tetrafluoroborate, ([bmim][BF<sub>4</sub>]) in the presence of the PdI<sub>2</sub>/KI catalytic system has been shown to provide tetrasubstituted oxamides from secondary amines through an oxidative double carbonylation.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Also, carbonylation protocols employing a Pd(II)/Ag(I) catalytic system have been developed.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Wu and collaborators developed several carbonylation protocols utilizing formic acid<a onclick="showRef(event, 'ref175 ref176 ref177 ref178 ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref175 ref176 ref177 ref178 ref179 ref180">(175−180)</a> or Mo(CO)<sub>6</sub> as a CO source.</div><figure id="sch30" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Scheme 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0065.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0065.jpeg" id="gr49" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 30. Synthesis of Urea Derivatives by Carbonylation with Mo(CO)<sub>6</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0065.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of unsymmetrical urea derivatives through a Pd/C-catalyzed carbonylation of nitroarenes using stoichiometric Mo(CO)<sub>6</sub> is shown in <a class="ref internalNav" href="#sch30" aria-label="Scheme 30">Scheme 30</a>.<a onclick="showRef(event, 'ref181 ref182 ref183'); return false;" href="javascript:void(0);" class="ref ref181 ref182 ref183">(181−183)</a> An NaI additive was crucial for the conversion, but its exact function is not clear. Also, the use of Pd(OAc)<sub>2</sub> in place of Pd/C provided slightly lower yields. Monodentate ligands performed better than bidentate ligands. From inexpensive and stable nitroarenes several unsymmetrical ureas, including the herbicide neburon (<b>103</b>), were synthesized in good yields. Beyond palladium, ruthenium is another metal of growing use for the synthesis of urea derivatives.</div><div class="NLM_p">Hong and co-workers very recently reported the synthesis of urea derivatives using ruthenium pincer complex as shown in <a class="ref internalNav" href="#sch31" aria-label="Scheme 31">Scheme 31</a>.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> The method shows high atom economy and produces hydrogen as the only byproduct, and only low Ru catalyst loadings are required. The method was extended to the synthesis of unsymmetrical ureas via a sequential one-pot two-step protocol with initial generation of the formamide from an amine and methanol, and subsequent reaction of the formamide with a second amine derivative.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></div><figure id="sch31" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Scheme 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0066.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0066.jpeg" id="gr50" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 31. Synthesis of Urea Derivatives Using Ruthenium Pincer Complex (<b>104</b>, Ru-MACHO-BH) as the Precatalyst</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0066.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Gunanathan and co-workers also reported “amine–amide” metal–ligand cooperation using a ruthenium pincer complex with DMF as the carbon monoxide surrogate as shown in <a class="ref internalNav" href="#sch32" aria-label="Scheme 32">Scheme 32</a>. The use of 2 mol % of the catalyst <b>105</b> and 10 equiv of DMF provided the best reaction conditions for the generation of symmetrical arylmethyl-, arylalkyl-, and <i>N,N</i>-dialkylurea derivatives. Moreover, the protocol was extended to the preparation of unsymmetrical urea derivatives. After the generation of formamide derivatives, diverse amines were added and temperature was increased to efficiently provide the desired unsymmetrical urea derivatives.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a></div><figure id="sch32" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Scheme 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0067.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0067.jpeg" id="gr51" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 32. Synthesis of Urea Derivatives Using Ruthenium Pincer Complex <b>105</b> and DMF</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0067.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although Pd, Ru, and Rh have been the metals of choice for oxidative carbonylation, there are issues with the excessive cost of the catalysts and with the toxicity of the solvents. The use of other metals such as tungsten,<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> cobalt,<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> and copper-complex<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> have been explored for the synthesis of cyclic urethanes. As shown in <a class="ref internalNav" href="#sch33" aria-label="Scheme 33">Scheme 33</a>, Nacci and co-workers developed a copper-based system for the synthesis of 2-oxazolidinones, urea derivatives, and urethanes in an aqueous medium without the use of additives. Copper(II) chloride was the optimum catalyst, and the reactions proceeded efficiently in water under homogeneous conditions at 100 °C and in approximately 4 h.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a></div><figure id="sch33" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Scheme 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0068.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0068.jpeg" id="gr52" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 33. Synthesis of Urea Derivatives Using a Copper-Catalyzed Reaction</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0068.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch33"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61">6.5.  Synthesis of Urea Derivatives Using Urethanes and Isonitriles</h3><div class="NLM_p">Syntheses of ureas starting from Boc-protected and Cbz-protected amines were carried out. As shown in <a class="ref internalNav" href="#sch34" aria-label="Scheme 34">Scheme 34</a>, trifluoromethanesulfonyl anhydride was used to generate the isocyanate intermediate which provided the desired urea derivative upon reaction with a suitable amine.<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190,191)</a></div><figure id="sch34" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Scheme 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0069.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0069.jpeg" id="gr53" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 34. One-Pot Synthesis of Urea Derivatives from Boc-Amines and Cbz-Amines</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0069.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The use of 2-substituted pyridines such as 2-chloropyridine (<b>106</b>) demonstrated high efficacy. In order to obtain satisfactory yields, the optimum amount of nucleophile is 3 equiv. The protocol was successfully applied to anilines, sterically hindered <i>tert</i>-butylamines, and secondary amines, affording trisubstituted ureas. Moreover, cyclic amines and noncyclic secondary amines led to high yields. The protocol was applied to chiral substrates with no racemization or epimerization.</div><div class="NLM_p">Bana and co-workers designed a continuous-flow system involving two contiguous microreactors to synthesize nonsymmetric ureas from Boc<i>-</i>protected amines under mild conditions as outlined in <a class="ref internalNav" href="#sch35" aria-label="Scheme 35">Scheme 35</a>. In-line FT-IR was employed for monitoring the process. The setup was applied to the synthesis of a series of urea derivatives, and it was successfully used for the preparation of the active pharmaceutical ingredient cariprazine.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Riesco-Domínguez and co-workers recently described the continuous flow synthesis of two libraries of urea derivatives containing a piperidin-4-one scaffold.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a></div><figure id="sch35" data-index="54" class="article__inlineFigure"><h2 class="fig-label">Scheme 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0070.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0070.jpeg" id="gr54" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 35. Synthesis of Urea Derivatives by a Continuous-Flow Process</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0070.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ganem and co-workers developed a simple and effective protocol for the oxidation of isonitrile derivatives to isocyanates employing DMSO as the oxidizing agent and trifluoroacetic anhydride as the catalyst as outlined in <a class="ref internalNav" href="#sch36" aria-label="Scheme 36">Scheme 36</a>. Isocyanate formation is completed within a few minutes, with dimethyl sulfide being the sole byproduct. The resulting isocyanates were used to synthesize urea derivatives.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a></div><figure id="sch36" data-index="55" class="article__inlineFigure"><h2 class="fig-label">Scheme 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0071.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0071.jpeg" id="gr55" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 36. Synthesis of Ureas from Isonitriles via the Intermediate Isocyanates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0071.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Wang and co-workers reported the synthesis of urea derivatives employing oximes as recyclable starting materials by an intermolecular oxidative C–O bond formation between oxime derivatives and isocyanides as shown in <a class="ref internalNav" href="#sch37" aria-label="Scheme 37">Scheme 37</a>.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a></div><figure id="sch37" data-index="56" class="article__inlineFigure"><h2 class="fig-label">Scheme 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0072.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0072.jpeg" id="gr56" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 37. Synthesis of Urea Derivatives Using Oximes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0072.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">1-Phenylethan-1-one oxime (<b>107</b>) and cyclohexyl isocyanide were used to set up optimum reaction conditions to form the corresponding carbamoyl oxime as shown. The use of 20% NIS in the presence of aqueous TBHP, with 1,4-dioxane as the solvent at 90 °C, represented the best reaction conditions.</div><div class="NLM_p">Peterson and co-workers reported the synthesis of urea libraries starting from carbamic acids prepared from the DBU-catalyzed reaction of amines with gaseous carbon dioxide as outlined in <a class="ref internalNav" href="#sch38" aria-label="Scheme 38">Scheme 38</a>. The desired urea derivatives were synthesized by reacting carbamic acids from primary amines with Mitsunobu reagents to generate isocyanates in situ, which then reacted with primary and secondary amines. The resulting isocyanates efficiently formed trisubstituted urea derivatives upon treatment with secondary amines.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> The methodology was used successfully with benzylamine, and then extended to anilines.</div><figure id="sch38" data-index="57" class="article__inlineFigure"><h2 class="fig-label">Scheme 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0073.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0073.jpeg" id="gr57" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 38. Synthesis of Urea Derivatives via Carbamic Acids</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0073.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch38"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">7.  Recent Design of Urea Derivatives in Drug Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As described earlier, urea functionality is a structural feature in a variety of FDA approved drugs. In this section, we cover design of urea-based compounds in medicinal chemistry and drug discovery in the past 10 years in a range of medicinal chemistry fields.</div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68">7.1.  Urea-Containing Anticancer Agents</h3><div class="NLM_p">Urea derivatives have been designed and synthesized to show broad biological properties, particularly potent antitumor activity. In particular, diarylurea derivatives have been designed as anticancer agents, targeting protein kinase or microtubules.</div><div id="sec7_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">7.1.1.  Kinase Inhibitors</h4><div class="NLM_p">In recent years, a series of kinase inhibitors containing aryl urea substructures have been introduced in the market for the treatment of cancers or tested clinically. Among them, linifanib was approved for the therapy of colorectal cancer,<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> Sorafenib is used for advanced renal cell carcinoma,<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> and tandutinib is employed in the treatment of kidney cancer<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> and acute leukemia.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> Meanwhile, Gedatolisib (PKI-587) is in phase II trials for treatment of acute myeloid leukemia.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> In recent years, a considerable effort has been directed toward the design of antitumor agents containing urea derivatives, especially in the fields of kinase inhibitors.</div><div class="NLM_p">Epidermal growth factor receptor (EGFR) overexpression has been observed in many cancer types.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> Homo- or heterodimerization are able to activate EGFR; subsequent autophosphorylation of tyrosine at the intracellular kinase domain stimulates Ras/Raf/MAPK and the PI3K/AKt/mTOR pathways.<a onclick="showRef(event, 'ref203 ref204'); return false;" href="javascript:void(0);" class="ref ref203 ref204">(203,204)</a> Several small molecule EGFR inhibitors have been developed for antitumor therapy. EGFR inhibitors belonging to the second generation feature a Michael acceptor group and show higher selectivity compared to first generation inhibitors. They are more prone to overcoming drug resistance.</div><div class="NLM_p">Mowafy and collaborators reported a series of inhibitors incorporating a urea moiety at the C-6 position of the quinazoline core that behaves as a hydrogen bond acceptor. A number of derivatives were potent EGFR inhibitors. 6-Ureido-anilinoquinazoline derivative <b>109</b> (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) displayed an IC<sub>50</sub> value of 0.061 μM, showing remarkable growth inhibitory activity against tumor cells characterized by EGFR overexpression, namely nonsmall cell lung cancer (EKVX NCI-H322 M cell line), renal cancer (A498, TK-10 cell lines), and breast cancer (MDA-MB-468 cell line). Docking studies unveiled a binding mode similar to gefitinib and supported an extra interaction with Cys-773 residue at the kinase gatekeeper.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a></div><figure id="fig20" data-index="58" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0020.jpeg" id="gr58" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. EGFR inhibitor <b>108</b> and urea-containing EGFR inhibitors <b>109</b> and <b>110</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SAR studies show that replacement of the amino-2-cyanoacrylate with amino-methylene malonate resulted in increased potency for compound <b>108</b>. Further substitution with urea resulted in the very potent compound <b>109</b>. The urea moiety of compound <b>109</b> established a key hydrogen bonding interaction with Cys793 which is absent in gefitinib. This hydrogen bonding interaction may be responsible for the enhanced binding affinity and also for particular ligand positioning.</div><div class="NLM_p">Further modification of the anilinoquinazoline scaffold containing a C-6 urea and a C-7 tetrahydrofuranyl ether led to compound <b>110</b>, which is a reversible inhibitor of EGFR. Compound <b>110</b> effectively inhibited EGFR and its autophosphorylation in A431 human epithelial carcinoma cells. Further studies later established that compound <b>109</b> behaved as an irreversible EGFR inhibitor.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a></div><div class="NLM_p">A series of potent multikinase inhibitors was designed utilizing established pharmacophores for kinase inhibition such as 4-anilinoquinazoline and unsymmetrical diarylurea derivatives. Among them, compound <b>111</b> (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) exhibited significant potency toward BRAF, BRAF V600E, EGFR, and VEGFR-2. Docking studies showed that the compound might nicely fit the DFG-out conformation of BRAF.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a></div><figure id="fig21" data-index="59" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0021.jpeg" id="gr59" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Urea-containing multikinase inhibitors <b>111</b>–<b>113</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further modification on the aryl group resulted in diaryl ureas (<b>112</b>) as dual EGFR and VEGFR-2 inhibitors. The SAR studies established that a terminal diaryl urea moiety with a chlorine atom at the <i>ortho</i>-position of the urea group was optimal for high inhibitory potency. Compound <b>113</b> exhibited potent inhibition of EGFR (IC<sub>50</sub> = 1 nM) and VEGFR-2 (IC<sub>50</sub> = 79 nM), and good antiproliferative activities on HT-29 (colorectal adenocarcinoma), H460 (lung cancer), and MCF-7 (breast cancer) cell lines. Docking studies suggested binding of <b>113</b> with the DFG-out conformation of VEGFR-2.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a></div><div class="NLM_p">Angiogenesis is a complex process triggered by the production of a range of pro-angiogenic and antiangiogenic factors.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> The altered equilibrium between these factors is implicated in the etiology of different diseases, such as cancer.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> The discovery of compounds that are able to block the autophosphorylation of the pro-angiogenic VEGFR-2 has represented a major area of therapeutic intervention for the treatment of several cancers.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a></div><div class="NLM_p">Eldehna and co-workers developed 1-(4-((2-oxoindolin-3-ylidene)amino)phenyl)-3-arylureas as novel agents that are potentially effective against HepG2 hepatocellular carcinoma through VEGFR-2 inhibition. Urea derivative <b>114</b> (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>) emerged as the most active compound (IC<sub>50</sub> = 0.31 μM), exhibiting good activity against HepG2 cells as well. Docking studies suggested the involvement of the urea linker in two key hydrogen bonding interactions.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a></div><figure id="fig22" data-index="60" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0022.jpeg" id="gr60" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Urea-containing VEGFR-2 inhibitors <b>114</b>–<b>116</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Gao and co-workers reported a set of VEGFR-2 inhibitors containing a biphenyl urea and an oxime moiety. Urea derivative <b>115</b> showed potent enzyme inhibitory activity (IC<sub>50</sub> = 5.3 nM) and excellent antiproliferative potency against several cancer cell lines (among them A549, MCF-7, and HT29 cells).<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> Structurally, the salicylaldoxime portion allowed the generation of a pseudo six-membered ring formed through intramolecular hydrogen bond interaction between the oxime functionality and the adjacent hydroxyl group in order to mimic the planar quinazoline of known ATP-competitive inhibitors. The intramolecular hydrogen bond stabilizes the planar conformation and confers structural rigidity. The conformational similarity of salicylaldoxime to quinazoline led to the hypothesis that both of them could act with the hinge region of VEGFR-2. Docking studies highlighted three crucial hydrogen bonding interactions of urea and salicylaldoxime moieties with VEGFR-2.</div><div class="NLM_p">Further modification and introduction of aromatic–heterocyclic templates as hinge-binding fragments via a core-refining approach led to potent inhibitor <b>116</b>, which showed excellent VEGFR-2 inhibitory activity (IC<sub>50</sub> = 0.50 nM) and significant antiproliferative activity (A549 and SMMC-7721 cell lines).<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a></div><div class="NLM_p">Ravez and co-workers reported multityrosine kinase inhibitors based on a 7-aminoalkoxy-4-aryloxy-quinazoline urea derivative. Compound <b>117</b> (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>) displayed one-digit nanomolar inhibition toward VEGFR-1 (IC<sub>50</sub> = 5 nM), VEGFR-2 (IC<sub>50</sub> = 4 nM), VEGFR-3 (IC<sub>50</sub> = 8 nM), PDGFR-ß (IC<sub>50</sub> = 9 nM), and c-Kit (IC<sub>50</sub> = 9 nM). This compound also showed excellent activity on PC3, MCF7, and HT29 tumor cell lines and HUVEC (human umbilical vein endothelial cells). The potential of compound <b>117</b> to reduce the induction of a weblike network of capillary tubes and invasion was also evaluated in HUVEC cells.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></div><figure id="fig23" data-index="61" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0023.jpeg" id="gr61" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Urea-containing kinase inhibitors as antitumor agents <b>117</b>–<b>120</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Raf kinases, namely A-Raf, B-Raf, and C-Raf (Raf-1), play a crucial role in the MAPK cascade (Ras-Raf-MEK-ERK), thus regulating cell survival and proliferation.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> In this context, B-Raf represents an attractive target for cancer.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> Substitution of a glutamic acid with a valine at residue 600 (V600E) represents the most common aberration in B-Raf (>90%).<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> This point mutation is mainly related to melanoma insurgence with a 60% frequency.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a></div><div class="NLM_p">Yang and co-workers developed a series of bis-aryl ureas based upon a 2-amino-3-purinylpyridine moiety as novel DFG-out B-Raf<sup>V600E</sup> inhibitors. Compound <b>118</b> displayed good inhibitory activity against B-Raf<sup>V600E</sup> (IC<sub>50</sub> = 12 nM) and potent antiproliferative activities toward the melanoma A375 cell line (B-Raf<sup>V600E</sup>, IC<sub>50</sub> = 27.27 μM). The compound was further optimized and led to a subsequent series of bis-aryl amides active in an A375 xenograft mouse model.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a></div><div class="NLM_p">El-Damasy and collaborators developed benzothiazole amides and ureas linked to a pyridylamide moiety by an aryl-ether tether at the 6-position of the benzothiazole ring. The best compound of the series was the 3,5-<i>bis</i>-trifluoromethylphenyl urea <b>119</b>, which effectively inhibited B-Raf<sup>V600E</sup> and C-Raf with an IC<sub>50</sub> of 1.23 μM and 0.566 μM, respectively. The compound also showed antiproliferative activity on 57 human tumor cell lines. Docking studies indicated comparable binding mode with the two homologous kinases and the role of the urea moiety in forming crucial hydrogen bonding interactions, as well. Profiling on CYP450 and <i>h</i>ERG channel ruled out the possibility of drug–drug interactions and cardiac toxicity.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a></div><div class="NLM_p">The same authors further designed 2-amido and ureido quinoline derivatives bearing a 2-<i>N</i>-methylamido-pyridin-4-yloxy group at the 5-position of quinoline. The 4-chloro-3-trifluoromethylphenyl urea derivative <b>120</b> was one of the best compounds of the series against BRAF<sup>V600E</sup> (IC<sub>50</sub> values of 316 nM) and C-Raf kinases (IC<sub>50</sub> values of 61 nM). Compound <b>120</b> showed antiproliferative activity on several cancer cell lines such as RCC and NSCL.</div><div class="NLM_p">Recently, researchers from Eli Lilly developed the urea-based clinical candidate LY3009120 (<b>121</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> Compound <b>121</b> behaves as a type IIa kinase inhibitor toward A-Raf, B-Raf, and C-Raf kinases with an IC<sub>50</sub> of 44, 31–47, and 42 nM, respectively. Unlike more selective BRAF inhibitors, compound <b>121</b> displayed minimal paradoxical pathway activation in Raf wild-type cells. The compound was found to be active <i>in vivo</i> against B-Raf and K-Ras mutated colorectal cancer xenograft models.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a> The compound is currently under evaluation in phase I clinical trials.</div><figure id="fig24" data-index="62" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0024.jpeg" id="gr62" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Urea derivatives as kinase inhibitors <b>121</b>–<b>123</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">FMS-like tyrosine kinase 3 (FLT3) belongs to the type III split-kinase domain family of receptor tyrosine kinases (RTKs).<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a> Upon binding of FLT3 ligand to the receptor, dimerization and autophosphorylation occur, thus prompting FLT3 kinase activation and promoting proliferation of leukemic cells. Therefore, small molecule inhibitors of FLT3 have been explored as a viable therapeutic option for AML.<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a></div><div class="NLM_p">Urea derivative <b>122</b> (Quizartinib, AC220) has been developed as an exceedingly potent and selective FLT3 inhibitor (IC<sub>50</sub> = 1.6 nM) with favorable drug properties and good tolerability in tumor xenografts. Compound <b>122</b> has also demonstrated a comparable efficacy and tolerability profile in humans and is presently in phase II clinical trials.<a onclick="showRef(event, 'ref224 ref225'); return false;" href="javascript:void(0);" class="ref ref224 ref225">(224,225)</a></div><div class="NLM_p last">Increased levels of FLT3<sup>+</sup> dendritic cells (DCs) are seen in human psoriatic lesions.<a onclick="showRef(event, 'ref226'); return false;" href="javascript:void(0);" class="ref ref226">(226)</a> Therefore, inhibition of FLT3 could be potentially exploited as a therapeutic option for psoriasis through interference with DCs. Recently, Li and colleagues developed compound <b>123</b> as a potent FLT3 inhibitor with an IC<sub>50</sub> value of 5 nM. <i>In vitro</i> studies indicated the ability of <b>123</b> to lower the production of DCs and reduce cytokine secretion of DCs. The compound demonstrated promising antipsoriatic effects <i>in vivo</i> in the murine K14-VEGF model, displaying no recurrence 15 days after the last administration.<a onclick="showRef(event, 'ref227'); return false;" href="javascript:void(0);" class="ref ref227">(227)</a></div></div><div id="sec7_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">7.1.2.  Microtubule-Targeting Agents</h4><div class="NLM_p">Microtubules (MTs) are highly dynamic structures containing heterodimers of α- and β-tubulin. The MT polymerization and depolymerization balance plays a key role in mitosis and vesicular transport.<a onclick="showRef(event, 'ref228'); return false;" href="javascript:void(0);" class="ref ref228">(228)</a> Disruption and interference with MT dynamics would lead to mitotic catastrophe causing cell death.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a> Several clinical anticancer agents target MTs, including some natural derivatives. Urea functionality has been incorporated in a variety of microtubule targeting agents (MTAs).</div><div class="NLM_p">Song and co-workers synthesized a series of 3-haloacylamino benzoylurea derivatives as MTAs. 6-Fluoro derivative <b>124</b> (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>) showed excellent potency toward nine human cancer cell lines, including Bel-7402 (hepatoma), MCF-7, DU-145, and PC-3 (prostate cancer) and LOVO (colon cancer), DND-1A (melanoma), and MIA Paca (pancreatic cancer) with IC<sub>50</sub> values ranging from 0.01 to 0.30 μM. This compound showed a strong anticancer effect against human hepatocarcinoma in a mouse model with over 86% tumor growth inhibition. The direct effects of <b>124</b> were assessed on purified tubulin, demonstrating that the compound selectively inhibited the process of MT assembly without affecting the disassembly process.<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a></div><figure id="fig25" data-index="63" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0025.jpeg" id="gr63" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Urea-containing microtubule targeting agents <b>124</b>–<b>127</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Diaryl urea derivative <b>125</b> was reported as a dual acting compound displaying both receptor tyrosine kinase (Flt3, FGFR1, cKit, and PDGFRβ) inhibitory activity and tubulin polymerization enhancer properties. The compound demonstrated antiproliferative effects in several cancer cell lines and inhibited tumor growth in LoVo and HT29 mice xenografts. Compound <b>125</b> showed significant antiangiogenic effect, and this may be due to combination of microtubule disruption and VEGFR inhibition.<a onclick="showRef(event, 'ref231'); return false;" href="javascript:void(0);" class="ref ref231">(231)</a></div><div class="NLM_p last">Boger and co-workers reported several formerly inaccessible C20′ urea derivatives of vinblastine with the aim of improving their affinity for tubulin and cellular activity. A very interesting finding was the steric tolerance for the size of a C20′ substituent. The importance of the presence of a hydrogen bond donor on the C20′ position was also demonstrated. Moreover, the insertion of a sterically demanding urea functionality is responsible for enhancing potency as much as 10-fold, and can be of great utility to modulate the physicochemical properties of these compounds. Representative compound <b>126</b>, bearing the large biphenyl urea moiety, binds to tubulin with higher affinity than vinblastine. The compound also displayed good cell growth inhibitory activity against the HCT116 (human colon cancer) and HCT116/VM46 (resistant human colon cancer) cancer cell lines.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> Gagné-Boulet and co-workers incorporated cyclic and acyclic urea substructures while developing combretastatin analogues. Representative compound <b>127</b>, containing an imidazoline-2-one moiety and a trimethoxyphenyl group, displayed antiproliferative activity in the low nanomolar range on a variety of tumor cell lines (e.g., HT29, M21, MCF7, and HT1080). The compound efficiently arrested the cell cycle in the G2/M phase by binding to the colchicine-binding site and leading to the depolymerization of MTs.<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a></div></div><div id="sec7_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">7.1.3.  Urea-Derived Anticancer Agents with Unknown Mechanisms of Actions</h4><div class="NLM_p">Post-translational modifications of histones can influence chromatin architecture, thus holding a key importance in the regulation of gene expression. Histone acetyltransferases (HATs) and histone deacetylases (HDAC) act on histone lysine tails by attaching or removing acetyl groups, respectively.<a onclick="showRef(event, 'ref234'); return false;" href="javascript:void(0);" class="ref ref234">(234)</a> These processes play a key role in controlling cell division, cell–cell communication, survival, and invasion. Therefore, their inhibition is an attractive anticancer strategy.<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a></div><div class="NLM_p">Kozikowski and co-workers developed a series of selective urea-based HDAC6 inhibitors. Compound <b>128</b> (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>) shows potent inhibitory potency against HDAC6 with an IC<sub>50</sub> value of 5.02 nM and a selectivity of ∼600-fold with respect to the HDAC1 isoform. This compound inhibited the growth of B16 melanoma cells.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a></div><figure id="fig26" data-index="64" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0026.jpeg" id="gr64" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Urea containing anticancer agents <b>128</b>–<b>131</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Schnekenburger and co-workers discovered urea derivative <b>129</b> as an HDAC class III sirtuins 1 and 2 (SIRT1/2) inhibitor with IC<sub>50</sub> values of 6.2 and 4.2 μM on SIRT1 and 2, respectively. Compound <b>129</b> showed comparable potency and was evaluated on the NCI-60 cell line and exhibited promising antiproliferative activity on several cancer cell lines. Moreover, neither mutation of p53 nor overexpression of MDR efflux pumps significantly reduced the anticancer activity of <b>129</b>. The therapeutic efficacy of <b>129</b> was confirmed in 3D glioblastoma spheroids and in zebrafish xenografts.<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a></div><div class="NLM_p">Prostate-specific membrane antigen (PSMA) is a well-known biomarker for prostate cancer.<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> PSMA expression in prostate cancer is generally 10–100-fold higher than in healthy prostate tissue.<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> Harada and co-workers developed unsymmetrical urea-containing compounds targeting PSMA through a nucleophilic conjugate addition between cysteine- and maleimide-containing reagents. Compound <b>130</b> ([<sup>123</sup>I]-IGLCE) displayed high affinity for PSMA, thus supporting the importance of the phenyl ring and succinimidyl moiety.<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a></div><div class="NLM_p last">Hepsin is a cell surface serine protease overexpressed in the vast majority of prostate tumors.<a onclick="showRef(event, 'ref241'); return false;" href="javascript:void(0);" class="ref ref241">(241)</a> PSMA and hepsin may constitute effective targets for imaging in prostate cancer since both of them feature an extracellular enzymatic active site. Azam and co-workers developed the heterobivalent urea containing compound <b>131</b>, targeting both hepsin and PSMA with IC<sub>50</sub> values of 2.8 μM and 28 nM, respectively. <i>In vitro</i> imaging studies demonstrated selective binding and retention to both PSMA and hepsin in cells highly expressing PC3/ML-PSMA-HPN.<a onclick="showRef(event, 'ref242'); return false;" href="javascript:void(0);" class="ref ref242">(242)</a></div></div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72">7.2.  Urea Derivatives for Neurological and Neurodegenerative Diseases</h3><div class="NLM_p">Urea derivatives are structural features in many compounds for the treatment of neurological and neurodegenerative diseases such as Parkinson disease (PD), Alzheimer’s disease (AD), and many other CNS disorders. Azam and co-workers designed 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-<i>d</i>]pyrimidin-7-yl urea derivatives that reduced haloperidol-induced catalepsy and oxidative stress in a PD animal model. Compound <b>132</b> (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>), administered 30 min prior to haloperidol, was able to reduce oxidative stress, restore enzyme activities, and reinstate the levels of glutathione and malondialdehyde.<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> Ghiron and co-workers developed urea containing selective agonists of α7 nicotinic acetylcholine receptor for possible treatment of schizophrenia and AD. Compound <b>133</b> displayed good <i>in vitro</i> profile. It was investigated in diverse <i>in vivo</i> behavioral models, showing efficacy after oral administration on perceptual processing and cognition and ability to reduce pharmacologically induced deficits.<a onclick="showRef(event, 'ref244 ref245'); return false;" href="javascript:void(0);" class="ref ref244 ref245">(244,245)</a> Further optimization of drug-like properties led to compound <b>134</b>, which displayed the desired activity/selectivity and showed a good preliminary ADME profile.<a onclick="showRef(event, 'ref246'); return false;" href="javascript:void(0);" class="ref ref246">(246)</a></div><figure id="fig27" data-index="65" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0027.jpeg" id="gr65" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Urea derivatives <b>132</b>–<b>134</b> for neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Elkhamhawy and co-workers developed a series of quinazoline urea derivatives that block β-amyloid peptide (Aβ)-mediated mitochondrial permeability transition pore (mPTP) opening as evaluated by JC-1 assay. Compound <b>135</b> (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>) is the most active nonpeptidyl mPTP blocker possessing improved inhibitory profile with respect to the reference cyclosporin A (CsA), showing potential as a novel AD treatment. Compound <b>135</b> showed very low toxicity and excellent cell viability in an MTT assay.<a onclick="showRef(event, 'ref247'); return false;" href="javascript:void(0);" class="ref ref247">(247)</a></div><figure id="fig28" data-index="66" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0028.jpeg" id="gr66" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Urea derivatives <b>135</b>–<b>137</b> for neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Hoang and co-workers developed human glutaminyl cyclase (QC) inhibitors as potent anti-AD agents. Based on the putative active conformation of a prototype inhibitor, novel <i>N</i>-substituted urea derivatives were developed as conformationally restricted analogues, potentially favoring a bent bioactive conformation (<i>Z–E</i> conformer). Among them, compound <b>136</b> showed the best inhibitory profile on human QC (IC<sub>50</sub> = 6.1 nM) and favorable drug disposition properties. When assayed in the 5XFAD mouse model, compound <b>136</b> effectively reduced the concentrations of pyroform Aβ in the brain after 4 weeks of i.p. administration.<a onclick="showRef(event, 'ref248'); return false;" href="javascript:void(0);" class="ref ref248">(248)</a></div><div class="NLM_p">Disfunction of beta 2-adrenergic receptor (β<sub>2</sub>AR) has been recently related to AD and other neurodegenerative disorders, although the mechanisms involved are still poorly understood. Gaiser and co-workers recently developed bitopic urea-based ligands in order to target the orthosteric binding site (OBS) and a metastable binding site (MBS) on β<sub>2</sub>AR. The compounds were designed on the basis of docking studies involving the antagonist (<i>S</i>)-alprenolol into the OBS and a MBS. In general, the conceived ligands showed potency and affinity comparable to a (<i>S</i>)-alprenolol. Among them, bitopic ligand <b>137</b> demonstrated pIC<sub>50</sub> of 8.8 on β<sub>2</sub>AR, as determined by a cell-based cAMP assay.<a onclick="showRef(event, 'ref249'); return false;" href="javascript:void(0);" class="ref ref249">(249)</a></div><div class="NLM_p">Kurt and co-workers developed new chemotypes as multifunctional agents in AD. In particular, urea substituted benzofuranylthiazole derivatives were shown to inhibit AChE and BuChE and behave as antioxidant agents. Among them, compound <b>138</b> (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>) showed the best inhibitory potency against BuChE with an IC<sub>50</sub> value of 2.03 μM, a value 8.5-fold more potent than that of galanthamine. Also, a number of compounds showed good ABTS cation radical scavenging ability.<a onclick="showRef(event, 'ref250'); return false;" href="javascript:void(0);" class="ref ref250">(250)</a></div><figure id="fig29" data-index="67" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0029.jpeg" id="gr67" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Urea derivatives <b>138</b>–<b>140</b> for neurobiological and neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Prakash and co-workers developed a series of urea derivatives as potential anticonvulsant agents. Compound <b>139</b> showed significant activity in the mouse model of epilepsy (MES) revealing protection in the electrically induced seizures at 30 mg/kg and 100 mg/kg 0.5 and 4 h after IP administration, respectively. This compound also displayed protective potential in the subcutaneous pentylenetetrazole model (scPTZ) (at 300 mg/kg at both time intervals), thus emerging as a promising wide-spectrum antiepileptic lead devoid of neurotoxic effects.<a onclick="showRef(event, 'ref251'); return false;" href="javascript:void(0);" class="ref ref251">(251)</a> Siddiqui and co-workers reported a series of urea derivatives with anticonvulsant activity. Compound <b>140</b> showed relevant anticonvulsant potency at a dose of 100 and 300 mg/kg in both screenings without displaying neurotoxic effects.<a onclick="showRef(event, 'ref252'); return false;" href="javascript:void(0);" class="ref ref252">(252)</a></div><div class="NLM_p">Recently, Amato and co-workers reported the diarylurea-containing compound <b>141</b> (VU0463841, <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>) as a potent and selective mGluR5 (IC<sub>50</sub> = 13 nM, other mGlus >30 μM) negative allosteric modulator with favorable CNS penetration in rats. The efficacy of <b>141</b> was demonstrated in suitable rat models of cocaine addiction. In particular, IP dosing of <b>141</b> in rats led to therapeutically relevant brain exposures, with <b>141</b> being able to dose-dependently reduce cocaine self-administration and cocaine place preference.<a onclick="showRef(event, 'ref253'); return false;" href="javascript:void(0);" class="ref ref253">(253)</a> Xu and co-workers identified urea-based compound <b>142</b> as a mean CNS-penetrating CXCR2 antagonist. The compound demonstrated promising activity upon oral administration in a cuprizone model of demyelination, thus validating the role of CXCR2 as promising target for the treatment of multiple sclerosis.<a onclick="showRef(event, 'ref254'); return false;" href="javascript:void(0);" class="ref ref254">(254)</a></div><figure id="fig30" data-index="68" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0030.jpeg" id="gr68" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Urea derivatives <b>141</b> and <b>142</b> for neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73">7.3.  Urea-Containing Antiviral, Antibacterial, and Antiparasitic Compounds</h3><div class="NLM_p">The urea functionality is a structural feature in a variety of antiviral, antibacterial, and antiparasitic agents. We provide recent examples of urea containing compounds in the design and development of these agents.</div><div id="sec7_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">7.3.1.  Antiviral Agents</h4><div class="NLM_p">Duan and co-workers reported the design of CCR5 antagonists based on a cyclic urea structure. These derivatives were designed relying upon the rationale that five- and six-membered cyclic ureas would function as stable pharmacophores. The transition from acyclic to cyclic ureas not only substantially improved the chemical stability but also led to the development of compound <b>143</b> (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>) that showed very good <i>in vivo</i> pharmacokinetic properties.<a onclick="showRef(event, 'ref255'); return false;" href="javascript:void(0);" class="ref ref255">(255)</a> A number of compounds showed high antiviral potency against HIV-1 in both human osteosarcoma (HOS) cell and peripheral blood lymphocyte (PBL) cell assays.</div><figure id="fig31" data-index="69" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0031.jpeg" id="gr69" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Urea-containing antiviral agents <b>143</b> and <b>144</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Kazmierski and co-workers developed urea-based potent HCV protease inhibitors. A number of derivatives, including <b>144</b>, established improved potency in HCV replicon assays with respect to second generation inhibitor, such as danoprevir. Oral administration of compound <b>144</b> showed favorable drug concentrations in rat liver, suggesting promising anti-HCV and pharmacokinetic profiles.<a onclick="showRef(event, 'ref256'); return false;" href="javascript:void(0);" class="ref ref256">(256)</a></div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">7.3.2.  Antibacterial Agents</h4><div class="NLM_p">DNA gyrase and topoisomerase IV (topoIV) attracted great attention as targets for effective antibiotics.<a onclick="showRef(event, 'ref257'); return false;" href="javascript:void(0);" class="ref ref257">(257)</a> They are heterotetrameric type II topoisomerase enzymes that can modify chromosome structure through breaking and joining DNA double strands. These enzymes are also important for bacterial DNA replication.<a onclick="showRef(event, 'ref258 ref259'); return false;" href="javascript:void(0);" class="ref ref258 ref259">(258,259)</a> Charifson and co-workers developed benzimidazole ureas as dual targeting agents exerting simultaneous inhibition of the ATPase function of topoisomerase IV and gyrase. Urea-derivative <b>145</b> (<a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>) showed an <i>E. coli</i> Gyrase <i>K</i><sub>i</sub> value of 6 nM and <i>S. aureus</i> TopoIV <i>K</i><sub>i</sub> value of 6 nM. Several related compounds displayed strong antibacterial activity toward clinically relevant, multidrug resistant strains. Inhibitor <b>145</b> possesses low <i>in vitro</i> spontaneous resistance frequencies and significant bactericidal activity. The compound was also shown to be effective upon oral and intravenous administration in mouse models of pneumonia and skin infections.<a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">(260)</a></div><figure id="fig32" data-index="70" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0032.jpeg" id="gr70" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Urea-derivatives <b>145</b>–<b>147</b> as antibacterial agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>145</b> behaved as a potent CYP3A4 inhibitor and displayed poor drug disposition properties. Subsequently, a number of second-generation aminobenzimidazole ureas were designed to address these issues. Compound <b>146</b> provided a dose- and time-dependent antibacterial effect. Also, investigation of metabolic properties of <b>146</b> showed that unlike compound <b>145</b>, metabolic degradation occurs away from the urea functionality.<a onclick="showRef(event, 'ref261'); return false;" href="javascript:void(0);" class="ref ref261">(261)</a></div><div class="NLM_p">Stokes and co-workers replaced the aminobenzimidazole substructure and developed benzothiazole ethyl urea derivatives such as compound <b>147</b> which inhibited both DNA gyrase (GyrB) and topoisomerase IV (ParE) with IC<sub>50</sub> values of <0.1 μg/mL. The compound did not display affinity for human topoisomerase II. Moreover, no cytotoxicity toward HepG2 cells was observed. Compound <b>147</b> showed antibacterial activity against several Gram-positive bacterial strains with minimal inhibitory concentrations (MICs) ranging from 0.008 to 0.12 μg/mL. However, it showed contrasting outcomes against Gram-negative organisms.<a onclick="showRef(event, 'ref262'); return false;" href="javascript:void(0);" class="ref ref262">(262)</a></div><div class="NLM_p">Yule and co-workers reported the synthesis and SAR of pyridine-3-carboxamide-6-yl ureas targeting DNA gyrase. Compound <b>148</b> (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>) demonstrated broad-spectrum activity on Gram positive microorganisms and antibacterial activity against a Gram-negative efflux pump mutant and single-step GyrB/ParE mutants.<a onclick="showRef(event, 'ref263'); return false;" href="javascript:void(0);" class="ref ref263">(263)</a> Linezolid was the first FDA-approved oxazolidinone antibiotic approved in 2000, and tedizolid followed after (2014). Linezolid is used to treat serious Gram-positive infections such as those caused by vancomycin-resistant <i>Enterococcus faecalis</i> (VRE) and methicillin-resistant <i>Staphylococcus aureus</i> (MRSA).<a onclick="showRef(event, 'ref264'); return false;" href="javascript:void(0);" class="ref ref264">(264)</a> However, linezolid-resistant strains have been described.<a onclick="showRef(event, 'ref265 ref266 ref267'); return false;" href="javascript:void(0);" class="ref ref265 ref266 ref267">(265−267)</a> In an effort to develop more effective oxazolidinone antibiotics, Suzuky and co-workers reported urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepine derivatives of linezolid. A number of derivatives showed potent antibacterial activity <i>in vitro</i>, and a subset underwent <i>in vivo</i> testing on a mouse model infected with <i>S. aureus</i> SR3637 strain. Compound <b>149</b> showed the best <i>in vivo</i> therapeutic effect. Furthermore, compound <b>149</b> displayed negligible monoamine oxidase (MAO)-inhibitory activity. The seven-membered heterocycles linked to a urea moiety appear to be a valuable structural template.<a onclick="showRef(event, 'ref268'); return false;" href="javascript:void(0);" class="ref ref268">(268)</a></div><figure id="fig33" data-index="71" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0033.jpeg" id="gr71" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Urea-containing antibacterial agents <b>148</b>–<b>150</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">De Rosa and co-workers also reported linezolid analogues.<a onclick="showRef(event, 'ref269'); return false;" href="javascript:void(0);" class="ref ref269">(269)</a> They performed molecular modeling studies in order to design derivatives with improved binding, particularly to ribosomes carrying mutations conferring partial or complete resistance to linezolid. In general, thiourea derivatives displayed better activities than their urea counterparts. Representative compound <b>150</b> showed a MIC higher than 100 μg/mL.</div></div><div id="sec7_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">7.3.3.  Antiparasitic Agents</h4><div class="NLM_p">Malaria is a parasitic disease caused by parasites of the genus <i>Plasmodium</i>, and it represents a major global health and economic problem. Although several drugs are used therapeutically to treat malaria, all have now succumbed to parasite drug resistance, therefore displaying significantly decreased efficacy.<a onclick="showRef(event, 'ref270 ref271 ref272'); return false;" href="javascript:void(0);" class="ref ref270 ref271 ref272">(270−272)</a></div><div class="NLM_p">Several alkylated (bis)urea polyamine derivatives were reported by Verlinden and co-workers.<a onclick="showRef(event, 'ref273'); return false;" href="javascript:void(0);" class="ref ref273">(273)</a> Compounds were tested for antimalarial potency against chloroquine (CQ)-sensitive and CQ-resistant strains of <i>Plasmodium falciparum</i>. The majority of compounds are structural analogs of compound <b>151</b> (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>). These compounds displayed inhibitory activity against <i>P. falciparum</i> in the 100–650 nM range. Compound <b>151</b> was active against CQ-resistant <i>P. falciparum</i>. The compounds in this class also showed excellent selectivity toward the parasite (>7000-fold lower IC<sub>50</sub> against <i>P. falciparum</i>) compared to the HepG2 mammalian cell line.</div><figure id="fig34" data-index="72" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0034.jpeg" id="gr72" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Urea-containing antimalarial agents <b>151</b>–<b>153</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Singh and co-workers reported β-lactam-4-aminoquinoline conjugates containing urea/oxalamide linkers as antimalarial agents.<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> The presence of a substituent on the <i>N</i>-1 nitrogen of the β-lactam ring, along with the linker structure, and the nature and length of the alkyl chain influenced the activity profiles as well as the physicochemical properties. Urea derivative <b>152</b> is the most potent compound and displayed an IC<sub>50</sub> of 42.4 nM against the CQ-resistant W2 strain of <i>P. falciparum</i>.</div><div class="NLM_p">A series of urea derivatives based upon the thiaplakortone A tricyclic scaffold was reported by Schwartz and co-workers.<a onclick="showRef(event, 'ref275'); return false;" href="javascript:void(0);" class="ref ref275">(275)</a> Compounds were assayed for their <i>in vitro</i> antimalarial potential and mammalian cell toxicity. ADME profiling was also evaluated for several analogues. Compound <b>153</b> showed an IC<sub>50</sub> value of 644 nM against 3D7 strain. This compound was well tolerated in a mouse model when administered subcutaneously at 32 mg/kg twice daily for 4 days. At this dose, compound <b>153</b> also suppressed blood stage <i>P. berghei</i> by 26%. However, oral administration at the same dose did not suppress parasitemia, most likely due to poor oral bioavailability.</div><div class="NLM_p">Human African trypanosomiasis (HAT) is a parasitic disease caused by <i>Trypanosoma brucei gambiense</i> or <i>Trypanosoma brucei rhodesiense</i>. The World Health Organization (WHO) currently counts 20000 cases with 65 million people at infection risk.<a onclick="showRef(event, 'ref276'); return false;" href="javascript:void(0);" class="ref ref276">(276)</a> There is an urgent need for innovative anti-HAT drugs.</div><div class="NLM_p">Patrick and co-workers reported 2-(2-benzamido)ethyl-4-phenylthiazole derivative <b>154</b> (<a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a></a>), as a promising hit against <i>Trypanosoma brucei</i>.<a onclick="showRef(event, 'ref277'); return false;" href="javascript:void(0);" class="ref ref277">(277)</a> However, <b>154</b> displayed poor metabolic stability. Further optimization led to urea-containing compound <b>47</b>, which exhibited good <i>in vitro</i> potency with an EC<sub>50</sub> value of 34.8 nM. This compound did not show any significant toxicity toward CRL-8155 and HepG2 human cell lines. It showed excellent half-lives in human and mouse liver microsomes (at least 60 min). Compound <b>47</b> also demonstrated promising oral bioavailability and optimum brain penetration in mice. Following oral administration, compound <b>47</b> led to 5/5 cures in both acute and chronic HAT murine models.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><figure id="fig35" data-index="73" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0035.jpeg" id="gr73" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Urea-containing antitripanosomal agents <b>47</b>, <b>154</b>, and <b>155</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Shibata and co-workers reported methionyl-tRNA synthetase (MetRS) inhibitors based on a urea structure and assessed their potential against HAT.<a onclick="showRef(event, 'ref278'); return false;" href="javascript:void(0);" class="ref ref278">(278)</a> Urea derivative <b>155</b> showed high preference for the parasitic enzyme with respect to the closest human homologue (IC<sub>50</sub><i>T. brucei</i> MetRS = 57 nM, IC<sub>50</sub> human mitochondrial MetRS > 10 μM). Compound <b>155</b> also inhibited parasite growth (EC<sub>50</sub> = 450 nM) while displaying low toxicity toward mammalian cells (CRL-8155 and HepG2). Furthermore, compound <b>155</b> showed CNS penetration in mice and also showed optimum membrane permeation ability when tested in the MDR1-MDCKII model.</div></div></div></div><div id="sec2a" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">8.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The historic first synthesis of urea by Wöhler occurred nearly 200 years ago. Today, urea and its derivatives are substructures in numerous approved drugs. The many applications of urea derivatives in modern medicinal chemistry and drug development demonstrate the broad scope and utility of urea containing compounds. The urea functionality is quite unique, and it is involved in critical drug–target interactions and modulation of drug properties. In this perspective, we highlighted the role of the urea functionality in medicinal chemistry, provided an overview of physiochemical properties, and emphasized its involvement in the formation of donor–acceptor hydrogen bonding interactions with the target enzymes or receptors. We outlined the predominant role of the urea substructure in approved drugs and compounds with clinical potential. Furthermore, we showcased recent designs and applications of urea derivatives in the development of numerous anticancer and anti-infective agents as well as agents for the potential treatment of neurodegenerative diseases. We hope that the present perspective will further stimulate the use of urea in modern medicinal chemistry and drug design.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01541" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun K. Ghosh</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2472-1841" title="Orcid link">http://orcid.org/0000-0003-2472-1841</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a9c8c2cec1c6dac1e9d9dcdbcddccc87cccddc"><span class="__cf_email__" data-cfemail="a5c4cec2cdcad6cde5d5d0d7c1d0c08bc0c1d0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margherita Brindisi</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Excellence of Pharmacy, University of
Naples Federico II, 80131 Naples, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9119-3773" title="Orcid link">http://orcid.org/0000-0001-9119-3773</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="74" class="article__inlineFigure"><h2 class="fig-label">Arun K. Ghosh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=BIO-d7e3668-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Arun K. Ghosh</b> obtained his BS and MS with honors in Chemistry from the University of Calcutta and Indian Institute of Technology, Kanpur, India, respectively. He received his Ph.D. in chemistry from the University of Pittsburgh (1985). He then carried out postdoctoral research in Professor E. J. Corey’s laboratory at Harvard University (1985–1988). He was a research fellow at Merck prior to joining the chemistry faculty at the University of Illinois, Chicago as an Assistant Professor in 1994. In 2005, he joined the Department of Chemistry and Medicinal Chemistry at Purdue University, West Lafayette. In 2009, he became the Ian P. Rothwell Distinguished Professor of Chemistry and Medicinal Chemistry. His research interests are in broad areas of synthetic organic, bioorganic, and medicinal chemistry.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="75" class="article__inlineFigure"><h2 class="fig-label">Margherita Brindisi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=BIO-d7e3673-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Margherita Brindisi</b> graduated cum laude from the University of Siena, where she also received her Ph.D. in Pharmaceutical Sciences in 2008. In 2010–2011, she worked as a postdoctoral fellow in the group of Professor Arun Ghosh at Purdue University on the development of aspartyl protease inhibitors. From 2012 to 2015 she worked as a fixed-term Researcher at the Department of Biotechnology, Chemistry and Pharmacy at the University of Siena on the development of novel treatments for cancer, parasitic diseases, and brain disorders. In 2016–2017, she again moved to Purdue University as a Visiting Researcher. Dr. Brindisi currently holds a position as Assistant Professor at the Department of Excellence of Pharmacy at the University of Naples Federico II.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support of this research by the National Institutes of Health (AI150466, AKG) and Purdue University is gratefully acknowledged. We also acknowledge MIUR Grant Dipartimento di Eccellenza (Department of Excellence, MB) 2018–2022 to the Department of Pharmacy, University of Naples Federico II. We would like to thank Suzanne Snoeberger for her help with the manuscript preparation. The authors also thank William Robinson, Josh Born, and Hannah Simpson (Purdue University) for helpful discussions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid beta</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer disease</p></td></tr><tr><td class="NLM_term">AKR</td><td class="NLM_def"><p class="first last">aldo-keto reductase</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">[bmim][BF<sub>4</sub>]</td><td class="NLM_def"><p class="first last">1-butyl-3-methylimidazolium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">BTC</td><td class="NLM_def"><p class="first last">bis(trichloromethyl)carbonate</p></td></tr><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">chemokine receptor 5</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last"><i>N,N</i>′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">CGRP</td><td class="NLM_def"><p class="first last">calcitonin gene-related peptide</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CQ</td><td class="NLM_def"><p class="first last">chloroquine</p></td></tr><tr><td class="NLM_term">CsA</td><td class="NLM_def"><p class="first last">cyclosporin A</p></td></tr><tr><td class="NLM_term">CYP450</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DBAD</td><td class="NLM_def"><p class="first last">dibenzyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo(5.4.0)undec-7-ene</p></td></tr><tr><td class="NLM_term">DC</td><td class="NLM_def"><p class="first last">dendritic cell</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N,N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DIPPU</td><td class="NLM_def"><p class="first last"><i>N,N’</i>-di(2,6-diisopropylphenyl)urea</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMDTC</td><td class="NLM_def"><p class="first last"><i>S,S</i>-dimethyldithiocarbonate</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">DNA</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenylphosphoryl azide</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">sHE</td><td class="NLM_def"><p class="first last">soluble epoxide hydrolase</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food & Drug Administration (US)</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">FMS-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">FT-IR</td><td class="NLM_def"><p class="first last">Fourier transform infrared</p></td></tr><tr><td class="NLM_term">HATs</td><td class="NLM_def"><p class="first last">histone acetyltransferase</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">Human African trypanosomiasis</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HOMO</td><td class="NLM_def"><p class="first last">highest occupied molecular orbital</p></td></tr><tr><td class="NLM_term">HOS</td><td class="NLM_def"><p class="first last">human osteosarcoma</p></td></tr><tr><td class="NLM_term">HSDD</td><td class="NLM_def"><p class="first last">hypoactive sexual desire disorder</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">infrared</p></td></tr><tr><td class="NLM_term">KHMDS</td><td class="NLM_def"><p class="first last">potassium <i>bis</i>(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">LDA</td><td class="NLM_def"><p class="first last">lithium diisopropylamide</p></td></tr><tr><td class="NLM_term">5-LOX</td><td class="NLM_def"><p class="first last">5-lipoxygenase</p></td></tr><tr><td class="NLM_term">LUMO</td><td class="NLM_def"><p class="first last">lowest unoccupied molecular orbital</p></td></tr><tr><td class="NLM_term">MAGL</td><td class="NLM_def"><p class="first last">moanoacylglycerol lipase</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistant</p></td></tr><tr><td class="NLM_term">MES</td><td class="NLM_def"><p class="first last">maximal electroshock seizure</p></td></tr><tr><td class="NLM_term">MetRS</td><td class="NLM_def"><p class="first last">methionyl-tRNA synthetase</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimal inhibitory concentration</p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>Staphylococcus aureus</i></p></td></tr><tr><td class="NLM_term">MT</td><td class="NLM_def"><p class="first last">microtubule</p></td></tr><tr><td class="NLM_term">MTA</td><td class="NLM_def"><p class="first last">microtubule targeting agent</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">4-NBsOXY</td><td class="NLM_def"><p class="first last">2-cyano-2-(4-nitrophenylsulfonyloxyimino)acetate</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NS3</td><td class="NLM_def"><p class="first last">nonstructural protein 3</p></td></tr><tr><td class="NLM_term">PBL</td><td class="NLM_def"><p class="first last">peripheral blood lymphocytes</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PDGFR</td><td class="NLM_def"><p class="first last">platelet derived growth factor receptor</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PSMA</td><td class="NLM_def"><p class="first last">prostate-specific membrane antigen</p></td></tr><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">permeability transition pore</p></td></tr><tr><td class="NLM_term">RNA</td><td class="NLM_def"><p class="first last">ribonucleic acid</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">scPTZ</td><td class="NLM_def"><p class="first last">subcutaneous pentylenetetrazole</p></td></tr><tr><td class="NLM_term">SET</td><td class="NLM_def"><p class="first last">single-electron transfer</p></td></tr><tr><td class="NLM_term">SIRT</td><td class="NLM_def"><p class="first last">sirtuin</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single photon emission computed tomography</p></td></tr><tr><td class="NLM_term">TBHP</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl hydroperoxide</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">1-propanephosphonic acid cyclic anhydride</p></td></tr><tr><td class="NLM_term">UGT1A9</td><td class="NLM_def"><p class="first last">UDP-glucuronosyltransferase 1A9</p></td></tr><tr><td class="NLM_term">VEGFR2</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor-2</p></td></tr><tr><td class="NLM_term">VRE</td><td class="NLM_def"><p class="first last">vancomycin-resistant <i>Enterococcus faecalis</i></p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 278 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wöhler, F.</span></span> <span> </span><span class="NLM_article-title">Ueber künstliche bildung des harnstoffs</span>. <i>Ann. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1828</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1002/andp.18280880206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fandp.18280880206" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1828&pages=253-256&author=F.+W%C3%B6hler&title=Ueber+k%C3%BCnstliche+bildung+des+harnstoffs&doi=10.1002%2Fandp.18280880206"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fandp.18280880206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fandp.18280880206%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6hler%26aufirst%3DF.%26atitle%3DUeber%2520k%25C3%25BCnstliche%2520bildung%2520des%2520harnstoffs%26jtitle%3DAnn.%2520Phys.%26date%3D1828%26volume%3D88%26spage%3D253%26epage%3D256%26doi%3D10.1002%2Fandp.18280880206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramberg, P. J.</span></span> <span> </span><span class="NLM_article-title">The death of vitalism and the birth of organic chemistry: Wohler’s urea synthesis and the disciplinary identity of organic chemistry</span>. <i>Ambix</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1179/amb.2000.47.3.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1179%2Famb.2000.47.3.170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11640223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXoslClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2000&pages=170-195&author=P.+J.+Ramberg&title=The+death+of+vitalism+and+the+birth+of+organic+chemistry%3A+Wohler%E2%80%99s+urea+synthesis+and+the+disciplinary+identity+of+organic+chemistry&doi=10.1179%2Famb.2000.47.3.170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The death of vitalism and the birth of organic chemistry: Wohler's urea synthesis and the disciplinary identity of organic chemistry</span></div><div class="casAuthors">Ramberg, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Ambix</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-195</span>CODEN:
                <span class="NLM_cas:coden">AMBXAO</span>;
        ISSN:<span class="NLM_cas:issn">0002-6980</span>.
    
            (<span class="NLM_cas:orgname">Black Bear Press Ltd.</span>)
        </div><div class="casAbstract">The Wohler myth is the story concerning the impact of Wohler's synthesis of urea from inorg. compds., thereby destroying the concept of vitalism and establishing the science of org. chem.  An exploratory study was conducted on the origins and history of the Wohler myth, its incorporation into the popular and textbook literature of org. chem., and the important role it played in establishing and maintaining the disciplinary identity of org. chem.  The origins of the Wohler myth during the first half of the 19th century are first examd.  Then, the dissemination of the myth by means of chem. lectures, textbooks, and popular and scholarly histories from the late 19th century to the present, is outlined.  Finally, some ways in which the Wohler myth created and still maintains a disciplinary identity for org. chem., are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodUYz11RUjrVg90H21EOLACvtfcHk0lgux04zDjpDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXoslClsw%253D%253D&md5=35e11c54f654274b1b297513671e1ee7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1179%2Famb.2000.47.3.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252Famb.2000.47.3.170%26sid%3Dliteratum%253Aachs%26aulast%3DRamberg%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520death%2520of%2520vitalism%2520and%2520the%2520birth%2520of%2520organic%2520chemistry%253A%2520Wohler%25E2%2580%2599s%2520urea%2520synthesis%2520and%2520the%2520disciplinary%2520identity%2520of%2520organic%2520chemistry%26jtitle%3DAmbix%26date%3D2000%26volume%3D47%26spage%3D170%26epage%3D195%26doi%3D10.1179%2Famb.2000.47.3.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, A.</span></span> <span> </span><span class="NLM_article-title">History and Economics of Medicinal Chemistry</span> In  <i>Medicinal Chemistry</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, A.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">1970</span>; Vol  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">19</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&pages=4-19&author=A.+Burgerauthor=A.+Burger&title=Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DA.%26atitle%3DHistory%2520and%2520Economics%2520of%2520Medicinal%2520Chemistry%26btitle%3DMedicinal%2520Chemistry%26aulast%3DBurger%26aufirst%3DA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1970%26volume%3D1%26spage%3D4%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lombardino, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, J. A.,  3rd</span></span> <span> </span><span class="NLM_article-title">The role of the medicinal chemist in drug discovery--then and now</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">853</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/nrd1523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnrd1523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15459676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVSmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=853-862&author=J.+G.+Lombardinoauthor=J.+A.+Lowe&title=The+role+of+the+medicinal+chemist+in+drug+discovery%2D%2Dthen+and+now&doi=10.1038%2Fnrd1523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A guide to drug discovery: The role of the medicinal chemist in drug discovery - then and now</span></div><div class="casAuthors">Lombardino, Joseph G.; Lowe, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">853-862</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The role of the medicinal chemist in drug discovery has undergone major changes in the past 25 yr, mainly because of the introduction of technologies such as combinatorial chem. and structure-based drug design.  As medicinal chemists with more than 50 yr of combined experience spanning the past four decades, we discuss this changing role using examples from our own and others' experience.  This historical perspective could provide insights in to how to improve the current model for drug discovery by helping the medicinal chemist regain the creative role that contributed to past successes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-y0ocbJ2mAbVg90H21EOLACvtfcHk0liDuxZZ2_80CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVSmtbk%253D&md5=aaddf4af21f9c38a92dcc970456aae93</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1523%26sid%3Dliteratum%253Aachs%26aulast%3DLombardino%26aufirst%3DJ.%2BG.%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520the%2520medicinal%2520chemist%2520in%2520drug%2520discovery--then%2520and%2520now%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D853%26epage%3D862%26doi%3D10.1038%2Fnrd1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallou, I.</span></span> <span> </span><span class="NLM_article-title">Unsymmetrical ureas. Synthetic methodologies and application in drug design</span>. <i>Org. Prep. Proced. Int.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1080/00304940709458592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F00304940709458592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Ois7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=355-383&author=I.+Gallou&title=Unsymmetrical+ureas.+Synthetic+methodologies+and+application+in+drug+design&doi=10.1080%2F00304940709458592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Unsymmetrical ureas. Synthetic methodologies and application in drug design</span></div><div class="casAuthors">Gallou, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-383</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">A review on synthetic methodologies for unsym. ureas and their application in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdRgmvCIn2LbVg90H21EOLACvtfcHk0liDuxZZ2_80CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Ois7w%253D&md5=d89da174b8ae87b13e80bcf7ce6ed3c0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F00304940709458592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304940709458592%26sid%3Dliteratum%253Aachs%26aulast%3DGallou%26aufirst%3DI.%26atitle%3DUnsymmetrical%2520ureas.%2520Synthetic%2520methodologies%2520and%2520application%2520in%2520drug%2520design%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2007%26volume%3D39%26spage%3D355%26epage%3D383%26doi%3D10.1080%2F00304940709458592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitfelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirillo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madwed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pargellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pav, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinamer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torcellini, C.</span></span> <span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2994</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1021/jm020057r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate&doi=10.1021%2Fjm020057r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0liDuxZZ2_80CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008%26doi%3D10.1021%2Fjm020057r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span>; <span class="NLM_string-name">Gemma, S.</span></span> <i>Structure-Based Design of Drugs and Other Bioactive Molecules: Tools and Strategies</i>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2F9783527665211" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+K.+Ghosh&author=S.+Gemma&title=Structure-Based+Design+of+Drugs+and+Other+Bioactive+Molecules%3A+Tools+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F9783527665211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527665211%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26btitle%3DStructure-Based%2520Design%2520of%2520Drugs%2520and%2520Other%2520Bioactive%2520Molecules%253A%2520Tools%2520and%2520Strategies%26pub%3DWiley-VCH%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span> <i>Structure-Based Drug Discovery: An overview</i>; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">London, England</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2F9781847552549" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=R.+E.+Hubbard&title=Structure-Based+Drug+Discovery%3A+An+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2F9781847552549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781847552549%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26btitle%3DStructure-Based%2520Drug%2520Discovery%253A%2520An%2520overview%26pub%3DRSC%2520Publishing%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span> <span> </span><span class="NLM_article-title">The development of drugs for treatment of sleeping sickness: a historical review</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">15</span>, <span class="refDoi"> DOI: 10.1186/1756-3305-3-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1186%2F1756-3305-3-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20219092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC3c3hs1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=15&author=D.+Steverding&title=The+development+of+drugs+for+treatment+of+sleeping+sickness%3A+a+historical+review&doi=10.1186%2F1756-3305-3-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The development of drugs for treatment of sleeping sickness: a historical review</span></div><div class="casAuthors">Steverding Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & vectors</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Only four drugs are available for the chemotherapy of human African trypanosomiasis or sleeping sickness; Suramin, pentamidine, melarsoprol and eflornithine.  The history of the development of these drugs is well known and documented. suramin, pentamidine and melarsoprol were developed in the first half of the last century by the then recently established methods of medicinal chemistry.  Eflornithine, originally developed in the 1970s as an anti-cancer drug, became a treatment of sleeping sickness largely by accident.  This review summarises the developmental processes which led to these chemotherapies from the discovery of the first bioactive lead compounds to the identification of the final drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAQwn8t9l1f7P3FVUi_gf8fW6udTcc2eZprfsrZTy8Ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3hs1ehug%253D%253D&md5=66fb9be5250960500c4a7ae5296baf5a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1756-3305-3-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-3305-3-15%26sid%3Dliteratum%253Aachs%26aulast%3DSteverding%26aufirst%3DD.%26atitle%3DThe%2520development%2520of%2520drugs%2520for%2520treatment%2520of%2520sleeping%2520sickness%253A%2520a%2520historical%2520review%26jtitle%3DParasites%2520Vectors%26date%3D2010%26volume%3D3%26spage%3D15%26doi%3D10.1186%2F1756-3305-3-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, J.</span></span> In  <i>Review of Chemotherapeutic and Chemoprophylactic Agents. The African trypanosomiasis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, H. W.</span></span>, Ed.; <span class="NLM_publisher-name">Allen & Unwin</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">1970</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&author=J.+Williamsonauthor=H.+W.+Mulligan&title=Review+of+Chemotherapeutic+and+Chemoprophylactic+Agents.+The+African+trypanosomiasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%26btitle%3DReview%2520of%2520Chemotherapeutic%2520and%2520Chemoprophylactic%2520Agents.%2520The%2520African%2520trypanosomiasis%26aulast%3DMulligan%26aufirst%3DH.%2BW.%26pub%3DAllen%2520%2526%2520Unwin%26date%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsilambros, N.</span>; <span class="NLM_string-name">Diakoumopoulou, E.</span>; <span class="NLM_string-name">Ioannidis, I.</span>; <span class="NLM_string-name">Liatis, S.</span>; <span class="NLM_string-name">Makrilakis, K.</span>; <span class="NLM_string-name">Tentolouris, N.</span>; <span class="NLM_string-name">Tsapogas, P.</span></span> <i>Diabetes in Clinical Practice: Questions and Answers from Case Studies</i>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2007</span>; p  <span class="NLM_fpage">342</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=342&author=N.+Katsilambros&author=E.+Diakoumopoulou&author=I.+Ioannidis&author=S.+Liatis&author=K.+Makrilakis&author=N.+Tentolouris&author=P.+Tsapogas&title=Diabetes+in+Clinical+Practice%3A+Questions+and+Answers+from+Case+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKatsilambros%26aufirst%3DN.%26btitle%3DDiabetes%2520in%2520Clinical%2520Practice%253A%2520Questions%2520and%2520Answers%2520from%2520Case%2520Studies%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2007%26spage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelias, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lgp5p0PPa7AXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreef, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span> <span> </span><span class="NLM_article-title">Potential role of sorafenib in the treatment of acute myeloid leukemia</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2246</span>– <span class="NLM_lpage">2255</span>, <span class="refDoi"> DOI: 10.1080/10428190802510349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F10428190802510349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19052971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKjsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=2246-2255&author=S.+Moriauthor=J.+Cortesauthor=H.+Kantarjianauthor=W.+Zhangauthor=M.+Andreefauthor=F.+Ravandi&title=Potential+role+of+sorafenib+in+the+treatment+of+acute+myeloid+leukemia&doi=10.1080%2F10428190802510349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of sorafenib in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Mori, Shahram; Cortes, Jorge; Kantarjian, Hagop; Zhang, Weiguo; Andreef, Michael; Ravandi, Farhad</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2246-2255</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The identification of aberrant cellular pathways and dysfunctional mols. important in neoplastic transformation has begun to provide us with a no. of targets for drug development.  It is likely that many of these agents will be incorporated into our existing treatment strategies that include cytotoxic agents.  Sorafenib, a multi-kinase inhibitor has been approved in the United States for the treatment of renal cell carcinoma as well as hepatocellular cancer.  Its potential role in hematol. malignancies, particularly acute myeloid leukemia (AML) is under evaluation.  Here we describe the biol. pathways in AML that are the potential targets of sorafenib action and discuss the early clin. data with the agent in solid tumors and AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEcMC8shxmbVg90H21EOLACvtfcHk0lgp5p0PPa7AXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKjsr%252FN&md5=0fb05e7866581d2f4f5c4f70204756c5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F10428190802510349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190802510349%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DS.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DAndreef%26aufirst%3DM.%26aulast%3DRavandi%26aufirst%3DF.%26atitle%3DPotential%2520role%2520of%2520sorafenib%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2008%26volume%3D49%26spage%3D2246%26epage%3D2255%26doi%3D10.1080%2F10428190802510349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheyas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1128/AAC.50.3.1013-1020.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1128%2FAAC.50.3.1013-1020.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16495264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells&doi=10.1128%2FAAC.50.3.1013-1020.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span></div><div class="casAuthors">Malcolm, B. A.; Liu, R.; Lahser, F.; Agrawal, S.; Belanger, B.; Butkiewicz, N.; Chase, R.; Gheyas, F.; Hart, A.; Hesk, D.; Ingravallo, P.; Jiang, C.; Kong, R.; Lu, J.; Pichardo, J.; Prongay, A.; Skelton, A.; Tong, X.; Venkatraman, S.; Xia, E.; Girijavallabhan, V.; Njoroge, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1013-1020</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cleavage of the hepatitis C virus (HCV) polyprotein by the viral NS3 protease releases functional viral proteins essential for viral replication.  Recent studies by Foy and coworkers strongly suggest that NS3-mediated cleavage of host factors may abrogate cellular response to alpha interferon (IFN-α).  Blockage of NS3 protease activity therefore is expected to inhibit HCV replication by both direct suppression of viral protein prodn. as well as by restoring host responsiveness to IFN.  Using structure-assisted design, a ketoamide inhibitor, SCH 503034, was generated which demonstrated potent (overall inhibition const., 14 nM) time-dependent inhibition of the NS3 protease in cell-free enzyme assays as well as robust in vitro activity in the HCV replicon system, as monitored by immunofluorescence and real-time PCR anal.  Continuous exposure of replicon-bearing cell lines to six times the 90% effective concn. of SCH 503034 for 15 days resulted in a greater than 4-log redn. in replicon RNA.  The combination of SCH 503034 with IFN was more effective in suppressing replicon synthesis than either compd. alone, supporting the suggestion of Foy and coworkers that combinations of IFN with protease inhibitors would lead to enhanced therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpEpdwyo4a_bVg90H21EOLACvtfcHk0lji9-9wAC7JwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D&md5=c21551e6d306f85039888211b1d07479</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.3.1013-1020.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.3.1013-1020.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020%26doi%3D10.1128%2FAAC.50.3.1013-1020.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, D. M.</span></span> <span> </span><span class="NLM_article-title">A new era of hepatitis C therapy begins</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1272</span>– <span class="NLM_lpage">1274</span>, <span class="refDoi"> DOI: 10.1056/NEJMe1100829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1056%2FNEJMe1100829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21449791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Cgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1272-1274&author=D.+M.+Jensen&title=A+new+era+of+hepatitis+C+therapy+begins&doi=10.1056%2FNEJMe1100829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A new era of hepatitis C therapy begins</span></div><div class="casAuthors">Jensen, Donald M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1272-1274</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYuRehu2WKbVg90H21EOLACvtfcHk0lji9-9wAC7JwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Cgs70%253D&md5=c519565d43b89d8a918a283a5e5f4fcc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1100829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1100829%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DD.%2BM.%26atitle%3DA%2520new%2520era%2520of%2520hepatitis%2520C%2520therapy%2520begins%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1272%26epage%3D1274%26doi%3D10.1056%2FNEJMe1100829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahrus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziller, J. W.</span></span> <span> </span><span class="NLM_article-title">Triurea derivatives of diethylenetriamine as potential templates for the formation of artificial beta-sheets</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1021/ja9536072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9536072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28Xks12gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=1066-1072&author=J.+S.+Nowickauthor=S.+Mahrusauthor=E.+M.+Smithauthor=J.+W.+Ziller&title=Triurea+derivatives+of+diethylenetriamine+as+potential+templates+for+the+formation+of+artificial+beta-sheets&doi=10.1021%2Fja9536072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Triurea Derivatives of Diethylenetriamine as Potential Templates for the Formation of Artificial β-Sheets</span></div><div class="casAuthors">Nowick, James S.; Mahrus, Sami; Smith, Eric M.; Ziller, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1066-72</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes synthetic and structural studies of triurea derivs. of an N,N"-disubstituted diethylenetriamine.  Diethylenetriamine triureas I (R = Me, Ph) and II are efficiently prepd. in 5 or 6 steps from N-phenylethylenediamine.  IR, 1H NMR, and x-ray crystallog. indicate that triureas I and II adopt intramolecularly hydrogen-bonded conformations, both in chloroform soln. and in the solid state.  The three urea groups form a hydrogen-bonded network.  The three R groups are aligned along the triurea backbone, pointing in roughly the same direction, like three fingers on a hand.  Mol. modeling suggests that the triurea backbone will be a suitable template for the creation of artificial β-sheets.  When mol. mechanics energy minimization calcns. are performed upon a triurea bearing three N-terminally linked peptide strands, a parallel β-sheet is formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJDqezUHMy-LVg90H21EOLACvtfcHk0liO_FxC1xgdbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks12gsQ%253D%253D&md5=eb9d481f07f6ab21513087493fe16844</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja9536072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9536072%26sid%3Dliteratum%253Aachs%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26aulast%3DMahrus%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DZiller%26aufirst%3DJ.%2BW.%26atitle%3DTriurea%2520derivatives%2520of%2520diethylenetriamine%2520as%2520potential%2520templates%2520for%2520the%2520formation%2520of%2520artificial%2520beta-sheets%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D1066%26epage%3D1072%26doi%3D10.1021%2Fja9536072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of artificial beta-sheets</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">7665</span>– <span class="NLM_lpage">7669</span>, <span class="refDoi"> DOI: 10.1021/ja9710971</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9710971" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1ykt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=7665-7669&author=D.+L.+Holmesauthor=E.+M.+Smithauthor=J.+S.+Nowick&title=Solid-phase+synthesis+of+artificial+beta-sheets&doi=10.1021%2Fja9710971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Synthesis of Artificial β-Sheets</span></div><div class="casAuthors">Holmes, Darren L.; Smith, Eric M.; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7665-7669</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The solid-phase syntheses of artificial β-sheets, e.g. I, which mimic the structure and hydrogen-bonding patterns of protein β-sheets is described.  In these compds., mol. templates induce β-sheet structures in attached peptide strands.  The templates consist of di- and triurea derivs., which hold peptide and peptidomimetic strands in proximity, and β-strand mimics, which hydrogen bond to the peptide strands.  The syntheses involve constructing the "lower" peptide strand on Merrifield resin, attaching the di- or triamine portions of the di- or triurea templates, connecting the "upper" peptide and peptidomimetic strands, and cleaving the resulting artificial β-sheets from the resin.  The artificial β-sheets were prepd. in 8-13 steps from leucine Merrifield in 33-67% overall yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs7bpgTUK17bVg90H21EOLACvtfcHk0liO_FxC1xgdbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1ykt78%253D&md5=b13d10d98e0e45a9af8c40d4654f975d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja9710971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9710971%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DSolid-phase%2520synthesis%2520of%2520artificial%2520beta-sheets%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D7665%26epage%3D7669%26doi%3D10.1021%2Fja9710971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claudon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamour, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decossas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heurtault, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mely, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamart-Gregoire, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averlant-Petit, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briand, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duportail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, G.</span></span> <span> </span><span class="NLM_article-title">Consequences of isostructural main-chain modifications for the design of antimicrobial foldamers: helical mimics of host-defense peptides based on a heterogeneous amide/urea backbone</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1002/anie.200905591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fanie.200905591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsFWl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=333-336&author=P.+Claudonauthor=A.+Violetteauthor=K.+Lamourauthor=M.+Decossasauthor=S.+Fournelauthor=B.+Heurtaultauthor=J.+Godetauthor=Y.+Melyauthor=B.+Jamart-Gregoireauthor=M.+C.+Averlant-Petitauthor=J.+P.+Briandauthor=G.+Duportailauthor=H.+Monteilauthor=G.+Guichard&title=Consequences+of+isostructural+main-chain+modifications+for+the+design+of+antimicrobial+foldamers%3A+helical+mimics+of+host-defense+peptides+based+on+a+heterogeneous+amide%2Furea+backbone&doi=10.1002%2Fanie.200905591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Consequences of Isostructural Main-Chain Modifications for the Design of Antimicrobial Foldamers: Helical Mimics of Host-Defense Peptides Based on a Heterogeneous Amide/Urea Backbone</span></div><div class="casAuthors">Claudon, Paul; Violette, Aude; Lamour, Karen; Decossas, Marion; Fournel, Sylvie; Heurtault, Beatrice; Godet, Julien; Mely, Yves; Jamart-Gregoire, Brigitte; Averlant-Petit, Marie-Christine; Briand, Jean-Paul; Duportail, Guy; Monteil, Henri; Guichard, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-336, S333/1-S333/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The design of unnatural oligomers with predictable folding patterns (i.e., foldamers) and function has attracted considerable attention over the last ten years.  Applications in biol. include the development of antimicrobial agents, cell-penetrating agents, and inhibitors of protein-protein interactions.  Non-natural oligoamides built from α-amino acid residues (e.g., peptoids) and higher homologs (e.g., β-, γ-, and δ-peptides) are the epitomes of peptidomimetic foldamers.  A substantial increase in the no. of backbones with folding propensity came from the exploration of the β- and γ-peptide families (i.e., by introduction of isosteric or isoelectronic backbone modifications).  The substitution of a urea moiety for the CH2-CO-NH units in the γ4-peptide backbone is an interesting case of quasi-isostructural replacement.  High-resoln. structural studies in soln. and in the solid state have shown that the oligourea backbone adopts a remarkably stable helical fold reminiscent of the 14-helix described for the cognate γ-peptides.  How such quasi-isostructural backbones compare in mol. recognition is presently unknown.  It was reported previously that oligoureas designed to mimic globally amphiphilic α-helical host-defense peptides display broad antibacterial activity with selectivity for prokaryotic vs. mammalian red blood cell membranes.  To better understand structure-property relationships and to gain insight into the mechanisms of membrane disruption, the authors have now undertaken detailed comparative studies of oligoureas, their γ-peptide counterparts, and various mixed amide/urea congeners bearing identical side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAqZoUQ54clbVg90H21EOLACvtfcHk0lgspDK3WWpewg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsFWl&md5=e38503875b65760a3e7d767e3046a1c5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.200905591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200905591%26sid%3Dliteratum%253Aachs%26aulast%3DClaudon%26aufirst%3DP.%26aulast%3DViolette%26aufirst%3DA.%26aulast%3DLamour%26aufirst%3DK.%26aulast%3DDecossas%26aufirst%3DM.%26aulast%3DFournel%26aufirst%3DS.%26aulast%3DHeurtault%26aufirst%3DB.%26aulast%3DGodet%26aufirst%3DJ.%26aulast%3DMely%26aufirst%3DY.%26aulast%3DJamart-Gregoire%26aufirst%3DB.%26aulast%3DAverlant-Petit%26aufirst%3DM.%2BC.%26aulast%3DBriand%26aufirst%3DJ.%2BP.%26aulast%3DDuportail%26aufirst%3DG.%26aulast%3DMonteil%26aufirst%3DH.%26aulast%3DGuichard%26aufirst%3DG.%26atitle%3DConsequences%2520of%2520isostructural%2520main-chain%2520modifications%2520for%2520the%2520design%2520of%2520antimicrobial%2520foldamers%253A%2520helical%2520mimics%2520of%2520host-defense%2520peptides%2520based%2520on%2520a%2520heterogeneous%2520amide%252Furea%2520backbone%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D333%26epage%3D336%26doi%3D10.1002%2Fanie.200905591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claudon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendem, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miclet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ennifar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, G.</span></span> <span> </span><span class="NLM_article-title">The canonical helix of urea oligomers at atomic resolution: insights into folding-induced axial organization</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1002/anie.200905592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fanie.200905592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1067-1070&author=L.+Fischerauthor=P.+Claudonauthor=N.+Pendemauthor=E.+Micletauthor=C.+Didierjeanauthor=E.+Ennifarauthor=G.+Guichard&title=The+canonical+helix+of+urea+oligomers+at+atomic+resolution%3A+insights+into+folding-induced+axial+organization&doi=10.1002%2Fanie.200905592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The canonical helix of urea oligomers at atomic resolution: Insights into folding-induced axial organization</span></div><div class="casAuthors">Fischer, Lucile; Claudon, Paul; Pendem, Nagendar; Miclet, Emeric; Didierjean, Claude; Ennifar, Eric; Guichard, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1067-1070, S1067/1-S1067/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Oligoureas (I) (n = 4, 5), (II) and (III) have been prepd. in soln. by stepwise assembly of N-Boc (Boc = tert-butoxycarbonyl) protected monomers.  All four oligoureas, including short tetramer I, are fully helical in the solid state.  The canonical 2.5 helical structure of oligoureas has been characterized at at. resoln.  The similarity between the structures reported herein and those deduced earlier from NMR studies in soln. is striking and underlines the excellent complementarities of the two techniques to analyze urea-based foldamers.  The study also demonstrates the robustness of the folding process: four acyclic residue are sufficient to drive complete helix formation with all complementary. H-bonding sites being satisfied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVGWR08q9frVg90H21EOLACvtfcHk0lgspDK3WWpewg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbw%253D&md5=b7e362c2dc5a973ee66d2cc34279e7e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.200905592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200905592%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DL.%26aulast%3DClaudon%26aufirst%3DP.%26aulast%3DPendem%26aufirst%3DN.%26aulast%3DMiclet%26aufirst%3DE.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DEnnifar%26aufirst%3DE.%26aulast%3DGuichard%26aufirst%3DG.%26atitle%3DThe%2520canonical%2520helix%2520of%2520urea%2520oligomers%2520at%2520atomic%2520resolution%253A%2520insights%2520into%2520folding-induced%2520axial%2520organization%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1067%26epage%3D1070%26doi%3D10.1002%2Fanie.200905592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L. W.</span></span> <span> </span><span class="NLM_article-title">Fast and facile synthesis of 4-nitrophenyl 2-azidoethylcarbamate derivatives from N-Fmoc-protected alpha-amino acids as activated building blocks for urea moiety-containing compound library</span>. <i>ACS Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1021/acscombsci.6b00160</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscombsci.6b00160" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=131-136&author=Y.+Y.+Chenauthor=L.+T.+Changauthor=H.+W.+Chenauthor=C.+Y.+Yangauthor=L.+W.+Hsin&title=Fast+and+facile+synthesis+of+4-nitrophenyl+2-azidoethylcarbamate+derivatives+from+N-Fmoc-protected+alpha-amino+acids+as+activated+building+blocks+for+urea+moiety-containing+compound+library&doi=10.1021%2Facscombsci.6b00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Fast and Facile Synthesis of 4-Nitrophenyl 2-Azidoethylcarbamate Derivatives from N-Fmoc-Protected α-Amino Acids as Activated Building Blocks for Urea Moiety-Containing Compound Library</span></div><div class="casAuthors">Chen, Ying-Ying; Chang, Li-Te; Chen, Hung-Wei; Yang, Chia-Ying; Hsin, Ling-Wei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-136</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fast and facile synthesis of a series of 4-nitrophenyl 2-azidoethylcarbamate derivs. as activated urea building blocks was developed.  The N-Fmoc-protected 2-aminoethyl mesylates derived from various com. available N-Fmoc-protected α-amino acids, including those having functionalized side chains with acid-labile protective groups, were directly transformed into 4-nitrophenyl 2-azidoethylcarbamate derivs. in 1 h via a one-pot two-step reaction.  These urea building blocks were utilized for the prepn. of a series of urea moiety-contg. mitoxantrone-amino acid conjugates in 75-92% yields and parallel soln.-phase synthesis of a urea compd. library consisted of 30 members in 38-70% total yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoraI1-6JXBVrVg90H21EOLACvtfcHk0lhLk9tWAz8sjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslWktA%253D%253D&md5=929d1c7f7f293c74a263d44a8b6a9765</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facscombsci.6b00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscombsci.6b00160%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BY.%26aulast%3DChang%26aufirst%3DL.%2BT.%26aulast%3DChen%26aufirst%3DH.%2BW.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26atitle%3DFast%2520and%2520facile%2520synthesis%2520of%25204-nitrophenyl%25202-azidoethylcarbamate%2520derivatives%2520from%2520N-Fmoc-protected%2520alpha-amino%2520acids%2520as%2520activated%2520building%2520blocks%2520for%2520urea%2520moiety-containing%2520compound%2520library%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2017%26volume%3D19%26spage%3D131%26epage%3D136%26doi%3D10.1021%2Facscombsci.6b00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linthicum, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. W.</span></span> <span> </span><span class="NLM_article-title">Solid-phase syntheses of unnatural biopolymers containing repeating urea units</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">909</span>, <span class="refDoi"> DOI: 10.1002/anie.199509071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fanie.199509071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2MXlsV2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=907-909&author=K.+Burgessauthor=D.+S.+Linthicumauthor=H.+W.+Shin&title=Solid-phase+syntheses+of+unnatural+biopolymers+containing+repeating+urea+units&doi=10.1002%2Fanie.199509071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-phase syntheses of unnatural biopolymers containing repeating urea units</span></div><div class="casAuthors">Burgess, Kevin; Linthicum, D. Scott; Shin, Hunwoo</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition in English</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">907-9</span>CODEN:
                <span class="NLM_cas:coden">ACIEAY</span>;
        ISSN:<span class="NLM_cas:issn">0570-0833</span>.
    
            (<span class="NLM_cas:orgname">VCH</span>)
        </div><div class="casAbstract">Oligourea compds. CH2Gu.CH2Fu.CH2Fu.CH2Au.A-amide and YG.CH2Gu.CH2Fu.L-amide, where CH2Xu denotes a urea analog of an amino acid X (e.g., CH2Au = NHCH2CHMeNHCO), were prepd. by solid-phase coupling of isocyanate intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv8eA-IXd_0LVg90H21EOLACvtfcHk0lhLk9tWAz8sjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsV2jtbk%253D&md5=12eac1470aa3b371a5fea31456febefe</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fanie.199509071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199509071%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DK.%26aulast%3DLinthicum%26aufirst%3DD.%2BS.%26aulast%3DShin%26aufirst%3DH.%2BW.%26atitle%3DSolid-phase%2520syntheses%2520of%2520unnatural%2520biopolymers%2520containing%2520repeating%2520urea%2520units%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D907%26epage%3D909%26doi%3D10.1002%2Fanie.199509071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, P. R.</span></span> <span> </span><span class="NLM_article-title">(Thio)urea organocatalysis-what can be learnt from anion recognition?</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1039/b801793j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb801793j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19421588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFaju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2009&pages=1187-1198&author=Z.+Zhangauthor=P.+R.+Schreiner&title=%28Thio%29urea+organocatalysis-what+can+be+learnt+from+anion+recognition%3F&doi=10.1039%2Fb801793j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">(Thio)urea organocatalysis - What can be learnt from anion recognition?</span></div><div class="casAuthors">Zhang, Zhiguo; Schreiner, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1187-1198</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The present crit. review outlines the close relationship and mutual interplay between mol. recognition, active site considerations in enzyme catalysis involving anions, and organocatalysis utilizing explicit hydrogen bonding.  These interconnections are generally not made although, as we demonstrate, they are quite apparent as exemplified with pertinent examples in the field of (thio)urea organocatalysis.  Indeed, the concepts of anion binding or binding with neg. (partially) charged heteroatoms is key for designing new organocatalytic transformations.  Utilizing anions through recognition with hydrogen-bonding organocatalysts is still in its infancy but bears great potential.  In turn, the discovery and mechanistic elucidation of such reactions is likely to improve the understanding of enzyme active sites (108 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvm5E0Zun2trVg90H21EOLACvtfcHk0lizpK4UseZAig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFaju7o%253D&md5=02c138763c1f2d7d38991f34c5a2541d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2Fb801793j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb801793j%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26atitle%3D%2528Thio%2529urea%2520organocatalysis-what%2520can%2520be%2520learnt%2520from%2520anion%2520recognition%253F%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2009%26volume%3D38%26spage%3D1187%26epage%3D1198%26doi%3D10.1039%2Fb801793j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serdyuk, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsogoeva, S. B.</span></span> <span> </span><span class="NLM_article-title">Bifunctional primary amine-thioureas in asymmetric organocatalysis</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">7051</span>– <span class="NLM_lpage">7071</span>, <span class="refDoi"> DOI: 10.1039/c3ob41403e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc3ob41403e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24057617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOis7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=7051-7071&author=O.+V.+Serdyukauthor=C.+M.+Heckelauthor=S.+B.+Tsogoeva&title=Bifunctional+primary+amine-thioureas+in+asymmetric+organocatalysis&doi=10.1039%2Fc3ob41403e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional primary amine-thioureas in asymmetric organocatalysis</span></div><div class="casAuthors">Serdyuk, Olga V.; Heckel, Christina M.; Tsogoeva, Svetlana B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7051-7071</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Research disclosed since the demonstration of the first examples of primary amine-thiourea organocatalysis in 2006 has shown that primary amine-based thioureas can successfully catalyze a diverse variety of highly enantioselective transformations providing a wide range of versatile org. compds.  Recent remarkable progress with these new chiral catalysts (such as primary amine-thiourea-based on tert-Bu esters of S-amino acids) is summarized in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1OR6ECsmTfbVg90H21EOLACvtfcHk0lizpK4UseZAig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOis7jP&md5=decc07248246a5fde1f72f5d0d7a4349</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc3ob41403e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob41403e%26sid%3Dliteratum%253Aachs%26aulast%3DSerdyuk%26aufirst%3DO.%2BV.%26aulast%3DHeckel%26aufirst%3DC.%2BM.%26aulast%3DTsogoeva%26aufirst%3DS.%2BB.%26atitle%3DBifunctional%2520primary%2520amine-thioureas%2520in%2520asymmetric%2520organocatalysis%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D7051%26epage%3D7071%26doi%3D10.1039%2Fc3ob41403e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis of urea derivatives from amines and CO<sub>2</sub> in the absence of catalyst and solvent</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1811</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1039/c0gc00059k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc0gc00059k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gjs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1811-1816&author=C.+Y.+Wuauthor=H.+Y.+Chengauthor=R.+X.+Liuauthor=Q.+A.+Wangauthor=Y.+F.+Haoauthor=Y.+C.+Yuauthor=F.+Y.+Zhao&title=Synthesis+of+urea+derivatives+from+amines+and+CO2+in+the+absence+of+catalyst+and+solvent&doi=10.1039%2Fc0gc00059k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of urea derivatives from amines and CO2 in the absence of catalyst and solvent</span></div><div class="casAuthors">Wu, Chaoyong; Cheng, Haiyang; Liu, Ruixia; Wang, Qiang; Hao, Yufen; Yu, Yancun; Zhao, Fengyu</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1811-1816</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Urea derivs. are obtained in mild to good yield from the reactions of primary aliph. amines with CO2 in the absence of any catalysts, org. solvents or other additives.  To optimize reaction conditions, exptl. variables including temp., pressure, the concn. of amine, reaction time etc. were studied.  Satisfactory yields were obtained at the optimized conditions that are comparable to the presence of catalyst and solvent.  The preliminary investigation of the reaction mechanism showed that alkyl ammonium alkyl carbamate was quickly formed as the intermediate, and then the final product was formed by the intramol. dehydration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTZFpcu6NtbVg90H21EOLACvtfcHk0lizpK4UseZAig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gjs7zF&md5=5bb3d88fd204652204e3575de387a232</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc0gc00059k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0gc00059k%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DR.%2BX.%26aulast%3DWang%26aufirst%3DQ.%2BA.%26aulast%3DHao%26aufirst%3DY.%2BF.%26aulast%3DYu%26aufirst%3DY.%2BC.%26aulast%3DZhao%26aufirst%3DF.%2BY.%26atitle%3DSynthesis%2520of%2520urea%2520derivatives%2520from%2520amines%2520and%2520CO2%2520in%2520the%2520absence%2520of%2520catalyst%2520and%2520solvent%26jtitle%3DGreen%2520Chem.%26date%3D2010%26volume%3D12%26spage%3D1811%26epage%3D1816%26doi%3D10.1039%2Fc0gc00059k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondekar, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadani, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chern, J. W.</span></span> <span> </span><span class="NLM_article-title">Ureas: applications in drug design</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.2174/0929867323666161129124915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F0929867323666161129124915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27897114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVChurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=622-651&author=A.+D.+Jagtapauthor=N.+B.+Kondekarauthor=A.+A.+Sadaniauthor=J.+W.+Chern&title=Ureas%3A+applications+in+drug+design&doi=10.2174%2F0929867323666161129124915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ureas: Applications in Drug Design</span></div><div class="casAuthors">Jagtap, Ajit Dhananjay; Kondekar, Nagendra Bharatrao; Sadani, Amit A.; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">622-651</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The unique hydrogen binding capabilities of ureas make them an important functional group to make drug-target interactions and thus incorporated in small mols. displaying broad range of bioactivities.  The related research and numerous excellent achievements of ureas applicability in drug design for the modulation of selectivity, stability, toxicity and pharmacokinetic profile of lead mols. have become active topic.  This review aims to provide insights in to the significance of urea in drug design by summarizing successful studies of various urea derivs. as modulators biol. targets (viz. kinases, NAMPT, sol. epoxide hydrolases, mTOR, proteases, gyrB/parE, and epigenetic enzymes such as HDAC, PRMT or DOT1L etc.).  The findings of this review confirm the importance of urea moiety in medicinal chem. and stimulate its use as a structural motif with rational decision making approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql4bGowxpMbbVg90H21EOLACvtfcHk0lgMsjT8PSOdAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVChurg%253D&md5=a3b883c65d950d7e698b40bb71a7f938</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F0929867323666161129124915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666161129124915%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DA.%2BD.%26aulast%3DKondekar%26aufirst%3DN.%2BB.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DChern%26aufirst%3DJ.%2BW.%26atitle%3DUreas%253A%2520applications%2520in%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D622%26epage%3D651%26doi%3D10.2174%2F0929867323666161129124915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sikka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashim, S. R.</span></span> <span> </span><span class="NLM_article-title">Role of aryl urea containing compounds in medicinal chemistry</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.4172/2161-0444.1000305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.4172%2F2161-0444.1000305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=479-483&author=P.+Sikkaauthor=J.+K.+Sahuauthor=A.+K.+Mishraauthor=S.+R.+Hashim&title=Role+of+aryl+urea+containing+compounds+in+medicinal+chemistry&doi=10.4172%2F2161-0444.1000305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4172%2F2161-0444.1000305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2161-0444.1000305%26sid%3Dliteratum%253Aachs%26aulast%3DSikka%26aufirst%3DP.%26aulast%3DSahu%26aufirst%3DJ.%2BK.%26aulast%3DMishra%26aufirst%3DA.%2BK.%26aulast%3DHashim%26aufirst%3DS.%2BR.%26atitle%3DRole%2520of%2520aryl%2520urea%2520containing%2520compounds%2520in%2520medicinal%2520chemistry%26jtitle%3DMed.%2520Chem.%26date%3D2015%26volume%3D5%26spage%3D479%26epage%3D483%26doi%3D10.4172%2F2161-0444.1000305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avitabile, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M.</span></span> <span> </span><span class="NLM_article-title">Crystal and molecular structure of <i>N,N’</i>-diethyl- <i>N,N’</i>-diphenylurea</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1073/pnas.67.1.426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.67.1.426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16591865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE3cXlt1Cmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1970&pages=426-433&author=P.+Ganisauthor=G.+Avitabileauthor=E.+Benedettiauthor=C.+Pedoneauthor=M.+Goodman&title=Crystal+and+molecular+structure+of+N%2CN%E2%80%99-diethyl-+N%2CN%E2%80%99-diphenylurea&doi=10.1073%2Fpnas.67.1.426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal and molecular structure of N,N'-diethyl-N,N'-diphenylurea</span></div><div class="casAuthors">Ganis, Paolo; Avitabile, Gustavo; Benedetti, Ettore; Pedone, Carlo; Goodman, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">426-33</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">N,N'-diphenyl-N,N'-diethylurea (C17H20N2O) crystallizes in the space group P21/c.  The unit cell consts. are:  a 10.42 ± 0.01, b 16.86 ± 0.02, c 10.66 ± 0.01 Å, β 125°16' ± 5'; Z = 4, d. (calcd.) = 1.16, d. (measured) = 1.16 ± 0.01.  Data for 1392 reflections were collected at room temp. on a Picker automated diffractometer.  The crystal structure was solved by direct methods and refined by block-diagonalized matrix least-squares calcns.  The mol. is characterized by a pseudo C2 symmetry; both Ph groups are trans with respect to the O atom.  The hybridization of the 2 N atoms is intermediate between trigonal and tetrahedral; the nonplanar distortion of the amide groups is ∼30°.  The amide C-N bond lengths are 1.37 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXOKgbCUdaLVg90H21EOLACvtfcHk0lgMsjT8PSOdAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXlt1Cmur0%253D&md5=c4eb0e51192817caec0677824486bc21</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.67.1.426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.67.1.426%26sid%3Dliteratum%253Aachs%26aulast%3DGanis%26aufirst%3DP.%26aulast%3DAvitabile%26aufirst%3DG.%26aulast%3DBenedetti%26aufirst%3DE.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DCrystal%2520and%2520molecular%2520structure%2520of%2520N%252CN%25E2%2580%2599-diethyl-%2520N%252CN%25E2%2580%2599-diphenylurea%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1970%26volume%3D67%26spage%3D426%26epage%3D433%26doi%3D10.1073%2Fpnas.67.1.426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanatani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azumaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, M.</span></span> <span> </span><span class="NLM_article-title">Unusual conformational preference of an aromatic secondary urea: solvent-dependent open-closed conformational switching of N,N’-bis(porphyrinyl)urea</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2290</span>– <span class="NLM_lpage">2292</span>, <span class="refDoi"> DOI: 10.1039/C2CC37583D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC2CC37583D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23198285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVOjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2290-2292&author=M.+Matsumuraauthor=A.+Tanataniauthor=I.+Azumayaauthor=H.+Masuauthor=D.+Hashizumeauthor=H.+Kagechikaauthor=A.+Muranakaauthor=M.+Uchiyama&title=Unusual+conformational+preference+of+an+aromatic+secondary+urea%3A+solvent-dependent+open-closed+conformational+switching+of+N%2CN%E2%80%99-bis%28porphyrinyl%29urea&doi=10.1039%2FC2CC37583D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual conformational preference of an aromatic secondary urea: solvent-dependent open-closed conformational switching of N,N'-bis(porphyrinyl)urea</span></div><div class="casAuthors">Matsumura, Mio; Tanatani, Aya; Azumaya, Isao; Masu, Hyuma; Hashizume, Daisuke; Kagechika, Hiroyuki; Muranaka, Atsuya; Uchiyama, Masanobu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2290-2292</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N,N'-Bis(2,3,7,8,12,13,17,18-octaethylporphyrin-5-yl)urea (3) exhibits cis-trans conformational switching depending on the solvent properties, and can adopt the cofacial porphyrin dimer structure under certain conditions.  The conformational preference can be switched by electrochem. stimulus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu1XuJhSKr2LVg90H21EOLACvtfcHk0lhjyPRMOEv25A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVOjs7o%253D&md5=7834fb599dd399decabf4dfca347453f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC2CC37583D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2CC37583D%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DM.%26aulast%3DTanatani%26aufirst%3DA.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DMasu%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DD.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DMuranaka%26aufirst%3DA.%26aulast%3DUchiyama%26aufirst%3DM.%26atitle%3DUnusual%2520conformational%2520preference%2520of%2520an%2520aromatic%2520secondary%2520urea%253A%2520solvent-dependent%2520open-closed%2520conformational%2520switching%2520of%2520N%252CN%25E2%2580%2599-bis%2528porphyrinyl%2529urea%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2013%26volume%3D49%26spage%3D2290%26epage%3D2292%26doi%3D10.1039%2FC2CC37583D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohmer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshcheryakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thondorf, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolte, M.</span></span> <span> </span><span class="NLM_article-title">3-oxa-6,8-diaza-1,2:4,5-dibenzo-cycloocta-1,4-dien-7-one: a three-dimensional network assembled by hydrogen-bonding, pi-pi and edge-to-face interactions</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">O136</span>– <span class="NLM_lpage">O139</span>, <span class="refDoi"> DOI: 10.1107/S0108270103027586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1107%2FS0108270103027586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=14767138" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=O136-O139&author=V.+Bohmerauthor=D.+Meshcheryakovauthor=I.+Thondorfauthor=M.+Bolte&title=3-oxa-6%2C8-diaza-1%2C2%3A4%2C5-dibenzo-cycloocta-1%2C4-dien-7-one%3A+a+three-dimensional+network+assembled+by+hydrogen-bonding%2C+pi-pi+and+edge-to-face+interactions&doi=10.1107%2FS0108270103027586"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0108270103027586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270103027586%26sid%3Dliteratum%253Aachs%26aulast%3DBohmer%26aufirst%3DV.%26aulast%3DMeshcheryakov%26aufirst%3DD.%26aulast%3DThondorf%26aufirst%3DI.%26aulast%3DBolte%26aufirst%3DM.%26atitle%3D3-oxa-6%252C8-diaza-1%252C2%253A4%252C5-dibenzo-cycloocta-1%252C4-dien-7-one%253A%2520a%2520three-dimensional%2520network%2520assembled%2520by%2520hydrogen-bonding%252C%2520pi-pi%2520and%2520edge-to-face%2520interactions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D2004%26volume%3D60%26spage%3DO136%26epage%3DO139%26doi%3D10.1107%2FS0108270103027586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meshcheryakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud-Neu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohmer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubscher-Bruder, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thondorf, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span></span> <span> </span><span class="NLM_article-title">Cyclic triureas-synthesis, crystal structures and properties</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1039/b718114k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb718114k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18327325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVCjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1004-1014&author=D.+Meshcheryakovauthor=F.+Arnaud-Neuauthor=V.+Bohmerauthor=M.+Bolteauthor=V.+Hubscher-Bruderauthor=E.+Jobinauthor=I.+Thondorfauthor=S.+Werner&title=Cyclic+triureas-synthesis%2C+crystal+structures+and+properties&doi=10.1039%2Fb718114k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic triureas-synthesis, crystal structures and properties</span></div><div class="casAuthors">Meshcheryakov, Denys; Arnaud-Neu, Francoise; Boehmer, Volker; Bolte, Michael; Hubscher-Bruder, Veronique; Jobin, Emilie; Thondorf, Iris; Werner, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1004-1014</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of 24-membered macrocycles is described, in which rigid xanthene units (X) and/or di-Ph ether units (D) as flexible analogs are linked via urea groups.  All four possible combinations (XXX, XXD, XDD, DDD) have been obtained with yields of 40-72% for the cyclization step.  In two cases, the resp. cyclic hexamers (XXDXXD, XXXXXX) were also isolated.  Two compds. have been characterized by a single crystal X-ray anal. of the free triurea (XXD, XDD) and one example (DDD) by its complex with tetrabutylammonium chloride.  It shows the chloride anion in the center of the macrocycle, held by six NH···Cl- hydrogen bonds.  The interaction with various other anions has been studied by 1H NMR.  Complexation consts. for chloride, bromide and acetate have been measured for all trimers by UV spectrophotometry.  Mol. dynamics simulations have been carried out to det. the conformation of the free receptors in chloroform and acetonitrile.  They show that in chloroform, intramol. hydrogen bonding occasionally facilitated by trans → cis isomerization of an amide bond dominates the conformation of the macrocycles while in acetonitrile (the solvent used for complexation measurements), the ligating urea NH protons are properly arranged for the complexation of anions, however, their strong solvation is counteractive to the complexation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbwTQgNHYxL7Vg90H21EOLACvtfcHk0lhjyPRMOEv25A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVCjurg%253D&md5=88b2040a3e51d360e7e8fc394c21c18b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fb718114k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb718114k%26sid%3Dliteratum%253Aachs%26aulast%3DMeshcheryakov%26aufirst%3DD.%26aulast%3DArnaud-Neu%26aufirst%3DF.%26aulast%3DBohmer%26aufirst%3DV.%26aulast%3DBolte%26aufirst%3DM.%26aulast%3DHubscher-Bruder%26aufirst%3DV.%26aulast%3DJobin%26aufirst%3DE.%26aulast%3DThondorf%26aufirst%3DI.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DCyclic%2520triureas-synthesis%252C%2520crystal%2520structures%2520and%2520properties%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D1004%26epage%3D1014%26doi%3D10.1039%2Fb718114k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migdal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagdon, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M.</span></span> <span> </span><span class="NLM_article-title">Conformations of substituted arylureas in solution</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2590</span>– <span class="NLM_lpage">2594</span>, <span class="refDoi"> DOI: 10.1021/jo00955a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00955a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE3sXks1GlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=2590-2594&author=G.+Leporeauthor=S.+Migdalauthor=D.+E.+Blagdonauthor=M.+Goodman&title=Conformations+of+substituted+arylureas+in+solution&doi=10.1021%2Fjo00955a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Conformations of substituted arylureas in solution</span></div><div class="casAuthors">Lepore, Giuseppina; Migdal, Samuel; Blagdon, Douglas E.; Goodman, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2590-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The conformation of N,N'-diaryl ureas in soln. is studied to obtain information about stacking interactions between arom. rings.  The only isomer which appears to exist has both arom. rings in an anti relationship to the O of the urea.  Anal. of NMR and uv spectra suggests that there is a charge-transfer interaction between the two rings, esp. when they are substituted with electron-withdrawing and electron-donating groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmciSt_ZCE27Vg90H21EOLACvtfcHk0lg0HZkoDGmbsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXks1GlsLc%253D&md5=5a62eadc7f677c2a1418acd58beedede</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00955a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00955a003%26sid%3Dliteratum%253Aachs%26aulast%3DLepore%26aufirst%3DG.%26aulast%3DMigdal%26aufirst%3DS.%26aulast%3DBlagdon%26aufirst%3DD.%2BE.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DConformations%2520of%2520substituted%2520arylureas%2520in%2520solution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D2590%26epage%3D2594%26doi%3D10.1021%2Fjo00955a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronuovo Lepore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M.</span></span> <span> </span><span class="NLM_article-title">Conformation of substituted arylureas. Crystal structures of <i>N,N</i>’-dimethyl-<i>N,N</i>’-di(<i>p</i>-nitrophenyl)urea and <i>N,N’</i>-dimethyl-<i>N,N</i>’-di(2,4-dinitrophenyl)urea</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2134</span>– <span class="NLM_lpage">2137</span>, <span class="refDoi"> DOI: 10.1021/jo00874a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00874a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE28Xkt1Sntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1976&pages=2134-2137&author=U.+Leporeauthor=G.+Castronuovo+Leporeauthor=P.+Ganisauthor=G.+Germainauthor=M.+Goodman&title=Conformation+of+substituted+arylureas.+Crystal+structures+of+N%2CN%E2%80%99-dimethyl-N%2CN%E2%80%99-di%28p-nitrophenyl%29urea+and+N%2CN%E2%80%99-dimethyl-N%2CN%E2%80%99-di%282%2C4-dinitrophenyl%29urea&doi=10.1021%2Fjo00874a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation of substituted arylureas.  Crystal structures of N,N'-dimethyl-N,N'-di(p-nitrophenyl)urea and N,N'-dimethyl-N,N'-di(2,4-dinitrophenyl)urea</span></div><div class="casAuthors">Lepore, U.; Castronuovo Lepore, G.; Ganis, P.; Germain, G.; Goodman, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2134-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The x-ray crystal and mol. structure of (p-O2NC6H4NMe)2CO (I) and the [2,4-(O2N)2C6H3NMe]2CO (II) were detd.  The benzene rings in I were anti to the carbonyl O atom and the benzene rings in II were syn to the carbonyl O atom.  The 200 MHz PMR of II in CO3CN or (CO3)2CO at -30 to +35° indicated that the crystal conformation existed as the only soln. stable conformation.  The soln. conformation of I was also the same as the crystal conformation.  I, II, and (PhNEt)2CO existed in both soln. and cryst. phases as the conformation in which the amide groups were distorted from planarity with concomitant dehydrocyclization of the N atoms from the trigonal to the tetrahedral shape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWCgpQMC60krVg90H21EOLACvtfcHk0lg0HZkoDGmbsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xkt1Sntbg%253D&md5=b27a2d3f5e01e9fbcbdae58815bdc861</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00874a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00874a014%26sid%3Dliteratum%253Aachs%26aulast%3DLepore%26aufirst%3DU.%26aulast%3DCastronuovo%2BLepore%26aufirst%3DG.%26aulast%3DGanis%26aufirst%3DP.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DConformation%2520of%2520substituted%2520arylureas.%2520Crystal%2520structures%2520of%2520N%252CN%25E2%2580%2599-dimethyl-N%252CN%25E2%2580%2599-di%2528p-nitrophenyl%2529urea%2520and%2520N%252CN%25E2%2580%2599-dimethyl-N%252CN%25E2%2580%2599-di%25282%252C4-dinitrophenyl%2529urea%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1976%26volume%3D41%26spage%3D2134%26epage%3D2137%26doi%3D10.1021%2Fjo00874a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germany, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinato, M. G.</span></span> <span> </span><span class="NLM_article-title">Theoretical and spectroscopic analysis of <i>N,N</i>’-diphenylurea and <i>N,N’</i>-dimethyl-<i>N,N’</i>-diphenylurea conformations</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">5304</span>– <span class="NLM_lpage">5315</span>, <span class="refDoi"> DOI: 10.1021/jp503539m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp503539m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=5304-5315&author=J.+F.+Galanauthor=E.+Germanyauthor=A.+Pawlowskiauthor=L.+Stricklandauthor=M.+G.+Galinato&title=Theoretical+and+spectroscopic+analysis+of+N%2CN%E2%80%99-diphenylurea+and+N%2CN%E2%80%99-dimethyl-N%2CN%E2%80%99-diphenylurea+conformations&doi=10.1021%2Fjp503539m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical and Spectroscopic Analysis of N,N'-Diphenylurea and N,N'-Dimethyl-N,N'-diphenylurea Conformations</span></div><div class="casAuthors">Galan, Jhenny F.; Germany, Edward; Pawlowski, Amanda; Strickland, Lynette; Galinato, Mary Grace I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">5304-5315</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural organization of macromols. is highly dependent on the conformational propensity of the monomer units.  Goal is to systematically quantify differences in the conformational propensities of arom. oligourea foldamer units.  Specifically, the authors study the conformational propensities of N,N'-diphenylurea and N,N'-dimethyl-N,N'-diphenylurea in different media using a combination of theor. methods, and IR and NMR spectroscopies.  Results show variation in the conformational behavior upon adding Me substituents on N,N'-diphenylurea, and varying the environments surrounding the compds.  Energetic analyses and conformational distributions in the gas phase show predominance of the cis-trans and trans-trans conformations for N,N'-diphenylurea, while cis-cis conformation is favored for N,N'-dimethyl-N,N'-diphenylurea.  In soln., results support the trans-trans conformer as the predominant conformer for N,N'-diphenylurea, whereas the cis-cis and cis-trans forms are favored in N,N'-dimethyl-N,N'-diphenylurea.  N,N'-Dimethyl-N,N'-diphenylurea also exhibits a more dynamic conformational behavior in soln., with const. fluctuations between cis-cis and cis-trans conformations.  Detailed quant. analyses are an important aspect in fine-tuning desired conformations and dynamic properties of this class of oligomers by providing a mol. basis for the behavior at the monomeric level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxlFL5HQOuJrVg90H21EOLACvtfcHk0liHmH2U1E4SzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbbK&md5=08d228d4ee94a93d698fe7f16a37b79c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjp503539m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp503539m%26sid%3Dliteratum%253Aachs%26aulast%3DGalan%26aufirst%3DJ.%2BF.%26aulast%3DGermany%26aufirst%3DE.%26aulast%3DPawlowski%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DL.%26aulast%3DGalinato%26aufirst%3DM.%2BG.%26atitle%3DTheoretical%2520and%2520spectroscopic%2520analysis%2520of%2520N%252CN%25E2%2580%2599-diphenylurea%2520and%2520N%252CN%25E2%2580%2599-dimethyl-N%252CN%25E2%2580%2599-diphenylurea%2520conformations%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2014%26volume%3D118%26spage%3D5304%26epage%3D5315%26doi%3D10.1021%2Fjp503539m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennecke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helliwell, M.</span></span> <span> </span><span class="NLM_article-title">The origin of the conformational preference of <i>N,N’</i>-diaryl-<i>N,N’</i>-dimethyl ureas</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">15056</span>– <span class="NLM_lpage">15064</span>, <span class="refDoi"> DOI: 10.1039/c0cp00571a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc0cp00571a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20953510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2gu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=15056-15064&author=J.+Claydenauthor=U.+Henneckeauthor=M.+A.+Vincentauthor=I.+H.+Hillierauthor=M.+Helliwell&title=The+origin+of+the+conformational+preference+of+N%2CN%E2%80%99-diaryl-N%2CN%E2%80%99-dimethyl+ureas&doi=10.1039%2Fc0cp00571a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The origin of the conformational preference of N,N'-diaryl-N,N'-dimethylureas</span></div><div class="casAuthors">Clayden, Jonathan; Hennecke, Ulrich; Vincent, Mark A.; Hillier, Ian H.; Helliwell, Madeleine</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">15056-15064</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Poly arom. ureas and poly arom. amides are important classes of foldamers-oligomers with well defined conformations.  We have explored the origins of the conformational preference of some N,N'-diaryl-N,N'-dimethyl ureas by a combination of NMR spectroscopy and electronic structure calcns. using both a recently developed d. functional (M06-2X) and a DFT approach (DFT-D) having empirical corrections for dispersive interactions.  We have validated the DFT-D approach for structures of this type using high level wavefunction calcns., (CCSD(T)), of the unsubstituted N,N'-diphenyl-N,N'-dimethyl urea.  For the N,N'-diaryl-N,N'-dimethyl ureas we have identified a no. of endo' conformers (i.e. having an E,E geometrical conformation about the two urea C-N bonds), both π- and tert-butyl-stacked, as well as 'exo' structures (having a Z geometrical conformation about at least one of the C-N bonds), and have computed the relative energies of these conformers as well as the barriers for their interconversion.  We find that the relative energies of the endo' structures closely follow the relative values of the dispersive interactions.  The calcns. have allowed us to assoc. different conformers with the various peaks in the NMR spectra, which point to relatively small differences in energy between the conformers.  Somewhat larger energy differences are predicted by the two computational approaches, with the M06-2X functional performing the better of the two.  It is suggested that the continuum model employed may not be sufficiently accurate to reflect the solvation of the various conformers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2J4ff-ZKva7Vg90H21EOLACvtfcHk0liHmH2U1E4SzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2gu7fK&md5=75bc72ab6e889345901662356d89e7ae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fc0cp00571a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cp00571a%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DHennecke%26aufirst%3DU.%26aulast%3DVincent%26aufirst%3DM.%2BA.%26aulast%3DHillier%26aufirst%3DI.%2BH.%26aulast%3DHelliwell%26aufirst%3DM.%26atitle%3DThe%2520origin%2520of%2520the%2520conformational%2520preference%2520of%2520N%252CN%25E2%2580%2599-diaryl-N%252CN%25E2%2580%2599-dimethyl%2520ureas%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2010%26volume%3D12%26spage%3D15056%26epage%3D15064%26doi%3D10.1039%2Fc0cp00571a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span> <span> </span><span class="NLM_article-title">Crystallographic studies on urea cytokinins</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1021/jf00004a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf00004a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXhsF2jt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=793-796&author=K.+Yamaguchiauthor=K.+Shudo&title=Crystallographic+studies+on+urea+cytokinins&doi=10.1021%2Fjf00004a036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic studies on urea cytokinins</span></div><div class="casAuthors">Yamaguchi, Kentaro; Shudo, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">793-6</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    </div><div class="casAbstract">Some heteroarom. ureas, such as N-(2-chloro-4-pyridyl)-N'-phenylurea (I) and N-(4-pyridyl)-N'-phenylurea (II), exhibit strong cytokinin activity.  However, the structure-activity relationship of urea cytokinins remains unclear.  To elucidate this problem, x-ray crystal structure anal. of I and II were performed.  All the free urea mols. take an extended trans conformation, whereas a N-methylurea mol. which is completely inactive takes a folded cis conformation in the cryst. state.  Apparently, the trans extended conformation is required for cytokinin activity in 4-pyridyl urea derivs.  However, the difference between the potent cytokinin activities of I and II as compared with the much weaker activities of related compds. could not be explained in terms of the steric structures around the urea moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUdPq2rkyR8LVg90H21EOLACvtfcHk0liHmH2U1E4SzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsF2jt74%253D&md5=4e1555c0ee3d5c432422b7971423df8a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjf00004a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf00004a036%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DShudo%26aufirst%3DK.%26atitle%3DCrystallographic%2520studies%2520on%2520urea%2520cytokinins%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D1991%26volume%3D39%26spage%3D793%26epage%3D796%26doi%3D10.1021%2Fjf00004a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azumaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span> <span> </span><span class="NLM_article-title">Aromatic architecture - use of the <i>N</i>-methylamide structure as a molecular splint</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">5474</span>– <span class="NLM_lpage">5475</span>, <span class="refDoi"> DOI: 10.1021/ja00014a060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00014a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXkslWjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=5474-5475&author=K.+Yamaguchiauthor=G.+Matsumuraauthor=H.+Kagechikaauthor=I.+Azumayaauthor=Y.+Itoauthor=A.+Itaiauthor=K.+Shudo&title=Aromatic+architecture+-+use+of+the+N-methylamide+structure+as+a+molecular+splint&doi=10.1021%2Fja00014a060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic architecture.  Use of the N-methylamide structure as a molecular splint</span></div><div class="casAuthors">Yamaguchi, Kentaro; Matsumura, Go; Kagechika, Hiroyuki; Azumaya, Isao; Ito, Yuji; Itai, Akiko; Shudo, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5474-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Crystal and soln. structures of methylamides I (R, R1 = H, CONMePh) and II were analyzed.  The N-methylamide structure in every compd. was revealed to exist in cis amide conformation in crystal and soln.  These examples show the intrinsic stability of the cis amide structure, and suggest the usefulness of the N-methylamide moiety in constructing mol. structures of various types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHtCresRdsrVg90H21EOLACvtfcHk0lhYwcTX9Ni_uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkslWjtLw%253D&md5=ea47be4f72a1be82a3d1388242528103</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja00014a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00014a060%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DG.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DItai%26aufirst%3DA.%26aulast%3DShudo%26aufirst%3DK.%26atitle%3DAromatic%2520architecture%2520-%2520use%2520of%2520the%2520N-methylamide%2520structure%2520as%2520a%2520molecular%2520splint%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D5474%26epage%3D5475%26doi%3D10.1021%2Fja00014a060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. S.</span></span> <span> </span><span class="NLM_article-title">A field guide to foldamers</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3893</span>– <span class="NLM_lpage">4012</span>, <span class="refDoi"> DOI: 10.1021/cr990120t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr990120t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFagtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=3893-4012&author=D.+J.+Hillauthor=M.+J.+Mioauthor=R.+B.+Princeauthor=T.+S.+Hughesauthor=J.+S.+Moore&title=A+field+guide+to+foldamers&doi=10.1021%2Fcr990120t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A Field Guide to Foldamers</span></div><div class="casAuthors">Hill, David J.; Mio, Matthew J.; Prince, Ryan B.; Hughes, Thomas S.; Moore, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3893-4011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review that surveyed the field of foldamers-the study of conformational in synthetic chain mols.  The products of this field are new oligomeric backbones that adopt a particular type of secondary structure through noncovalent interactions.  When one looks deeper into the chem. details making up these secondary structures, what emerges to date is that only a relatively small no. of "good folders" have as of yet been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_SHY0A3KTzbVg90H21EOLACvtfcHk0lhYwcTX9Ni_uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFagtrk%253D&md5=0e26cf01f9d4baf210aa49f3b79d348f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr990120t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr990120t%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DD.%2BJ.%26aulast%3DMio%26aufirst%3DM.%2BJ.%26aulast%3DPrince%26aufirst%3DR.%2BB.%26aulast%3DHughes%26aufirst%3DT.%2BS.%26aulast%3DMoore%26aufirst%3DJ.%2BS.%26atitle%3DA%2520field%2520guide%2520to%2520foldamers%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D3893%26epage%3D4012%26doi%3D10.1021%2Fcr990120t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span> <span> </span><span class="NLM_article-title">Relaying stereochemistry through aromatic ureas: 1,9 and 1,15 remote stereocontrol</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1039/B817527F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FB817527F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19283286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=547-549&author=J.+Claydenauthor=M.+Pickworthauthor=L.+H.+Jones&title=Relaying+stereochemistry+through+aromatic+ureas%3A+1%2C9+and+1%2C15+remote+stereocontrol&doi=10.1039%2FB817527F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Relaying stereochemistry through aromatic ureas: 1,9 and 1,15 remote stereocontrol</span></div><div class="casAuthors">Clayden, Jonathan; Pickworth, Mark; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-549</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The well-defined conformation of an N,N'-diarylurea allows a chiral sulfinyl substituent to influence diastereoselectivity in the formation of new stereogenic centers up to 14 bond lengths away.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzov9aKCBqoLVg90H21EOLACvtfcHk0lhYwcTX9Ni_uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVOntA%253D%253D&md5=8e08ce4a832c9bcccc2807f45eb67147</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FB817527F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB817527F%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DPickworth%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DRelaying%2520stereochemistry%2520through%2520aromatic%2520ureas%253A%25201%252C9%2520and%25201%252C15%2520remote%2520stereocontrol%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2009%26spage%3D547%26epage%3D549%26doi%3D10.1039%2FB817527F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, C. D.</span></span> <span> </span><span class="NLM_article-title">Polyaryl anion radicals via alkali metal reduction of arylurea oligomers</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1021/ol0496069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0496069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1aitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1605-1608&author=F.+D.+Lewisauthor=T.+L.+Kurthauthor=C.+M.+Hattanauthor=R.+C.+Reiterauthor=C.+D.+Stevenson&title=Polyaryl+anion+radicals+via+alkali+metal+reduction+of+arylurea+oligomers&doi=10.1021%2Fol0496069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Polyaryl Anion Radicals via Alkali Metal Reduction of Arylurea Oligomers</span></div><div class="casAuthors">Lewis, Frederick D.; Kurth, Todd L.; Hattan, Chris M.; Reiter, Richard C.; Stevenson, Cheryl D.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1605-1608</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N-methylated polyarylurea oligomers has been reduced with potassium metal in HMPA.  These redns. result in the transient formation of arylurea anion radicals, which undergo reductive elimination of the urea linkages.  The aryl moieties appear in the products as the anion radicals of oligoaryl systems.  The reaction is intramol., and the sequencing in the polyaryl anion radical remains the same as in the polyarylureas due to the urea-enforced π-π stacking interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxcDllphLyjbVg90H21EOLACvtfcHk0li3Uem1eB3Hvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1aitLw%253D&md5=03259d6c3fc7e260ef378de1cb189531</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fol0496069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0496069%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DF.%2BD.%26aulast%3DKurth%26aufirst%3DT.%2BL.%26aulast%3DHattan%26aufirst%3DC.%2BM.%26aulast%3DReiter%26aufirst%3DR.%2BC.%26aulast%3DStevenson%26aufirst%3DC.%2BD.%26atitle%3DPolyaryl%2520anion%2520radicals%2520via%2520alkali%2520metal%2520reduction%2520of%2520arylurea%2520oligomers%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D1605%26epage%3D1608%26doi%3D10.1021%2Fol0496069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azumaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanatani, A.</span></span> <span> </span><span class="NLM_article-title">Identification of absolute helical structures of aromatic multilayered oligo(m-phenylurea)s in solution</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">8154</span>– <span class="NLM_lpage">8163</span>, <span class="refDoi"> DOI: 10.1021/jo901934r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo901934r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cjs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=8154-8163&author=M.+Kudoauthor=T.+Hanashimaauthor=A.+Muranakaauthor=H.+Satoauthor=M.+Uchiyamaauthor=I.+Azumayaauthor=T.+Hiranoauthor=H.+Kagechikaauthor=A.+Tanatani&title=Identification+of+absolute+helical+structures+of+aromatic+multilayered+oligo%28m-phenylurea%29s+in+solution&doi=10.1021%2Fjo901934r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Absolute Helical Structures of Aromatic Multilayered Oligo(m-phenylurea)s in Solution</span></div><div class="casAuthors">Kudo, Mayumi; Hanashima, Takayuki; Muranaka, Atsuya; Sato, Hisako; Uchiyama, Masanobu; Azumaya, Isao; Hirano, Tomoya; Kagechika, Hiroyuki; Tanatani, Aya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8154-8163</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The oligomeric arom. ureas bearing N,N'-dimethylated urea bonds such as 3 (I, R1 = R2 = Me) have arom. multilayered structure, based on the (cis,cis)-urea structure, and also have dynamic helical structure (all-R or all-S axis chirality) when the benzene rings are connected at the meta positions.  The abs. helical structure of oligo(m-phenylurea)s were identified by the empirical and theor. studies on the CD and vibrational CD (VCD) spectra.  Thus, each enantiomer of oligo(m-phenylurea)s 4 (I, R1 = n-Pr) bearing a chiral ((S)- for 4a and (R)- for 4b) N-2-(methoxyethoxyethoxy)propyl group (R2) were synthesized.  Intense dispersion-type CD spectra of 4 were obsd., which indicated the induction of handedness in the helical structure.  In the VCD spectra of 4 in the film state, the signals due to the carbonyl and arom. ring vibrations were seen with neg. and pos. values for compds. 4a and 4b, resp.  The calcns. of both CD and VCD spectra of oligo(m-phenylurea)s without any chiral N-substituent gave the same assignment about the axis chirality of 4.  Thus, the abs. configurations of 4a and 4b are all-R and all-S structures, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaRTpSfN-eurVg90H21EOLACvtfcHk0li3Uem1eB3Hvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cjs73P&md5=fa734200c2e15e833380243a60daa7be</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo901934r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901934r%26sid%3Dliteratum%253Aachs%26aulast%3DKudo%26aufirst%3DM.%26aulast%3DHanashima%26aufirst%3DT.%26aulast%3DMuranaka%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DM.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DTanatani%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520absolute%2520helical%2520structures%2520of%2520aromatic%2520multilayered%2520oligo%2528m-phenylurea%2529s%2520in%2520solution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D8154%26epage%3D8163%26doi%3D10.1021%2Fjo901934r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span> <i>Fundamentals of Medicinal Chemistry</i>; <span class="NLM_publisher-name">John Wiley and Sons, Ltd.</span>: <span class="NLM_publisher-loc">West Sussex, U.K</span>., <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">70</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=56-70&author=G.+Thomas&title=Fundamentals+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DG.%26btitle%3DFundamentals%2520of%2520Medicinal%2520Chemistry%26pub%3DJohn%2520Wiley%2520and%2520Sons%252C%2520Ltd%26date%3D2003%26spage%3D56%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G. R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZZPu2RLBrUYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouritsen, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, K.</span></span> <span> </span><span class="NLM_article-title">A new look at lipid-membrane structure in relation to drug research</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1023/A:1011986613392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1023%2FA%3A1011986613392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9794491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Ghtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=1507-1519&author=O.+G.+Mouritsenauthor=K.+Jorgensen&title=A+new+look+at+lipid-membrane+structure+in+relation+to+drug+research&doi=10.1023%2FA%3A1011986613392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A new look at lipid-membrane structure in relation to drug research</span></div><div class="casAuthors">Mouritsen, Ole G.; Jorgensen, Kent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1507-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">A review with 131 refs.  Lipid-bilayer membranes are key objects in drug research in relation to (i) interaction of drugs with membrane-bound receptors, (ii) drug targeting, penetration, and permeation of cell membranes, and (iii) use of liposomes in micro-encapsulation technologies for drug delivery.  Rational design of new drugs and drug-delivery systems therefore requires insight into the phys. properties of lipid-bilayer membranes.  This mini-review provides a perspective on the current view of lipid-bilayer structure and dynamics based on information obtained from a variety of recent exptl. and theor. studies.  Special attention is paid to trans-bilayer structure, lateral mol. organization of the lipid bilayer, lipid-mediated protein assembly, and lipid-bilayer permeability.  It is argued that lipids play a major role in lipid membrane-organization and functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6YGOBjQ5P-bVg90H21EOLACvtfcHk0lhNzK5bV-ixnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Ghtbg%253D&md5=870fe751a4442a586b2734eeb3470995</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011986613392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011986613392%26sid%3Dliteratum%253Aachs%26aulast%3DMouritsen%26aufirst%3DO.%2BG.%26aulast%3DJorgensen%26aufirst%3DK.%26atitle%3DA%2520new%2520look%2520at%2520lipid-membrane%2520structure%2520in%2520relation%2520to%2520drug%2520research%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D1507%26epage%3D1519%26doi%3D10.1023%2FA%3A1011986613392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span> <i>Urea: Synthesis, Properties and Uses</i>; <span class="NLM_publisher-name">Nova
Science Publishers, Inc.</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Urea%3A+Synthesis%2C+Properties+and+Uses%3B+Nova%0AScience+Publishers%2C+Inc.%3A+New+York%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DUrea%253A%2520Synthesis%252C%2520Properties%2520and%2520Uses%26pub%3DNova%250AScience%2520Publishers%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herbig, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, D. H.</span></span> <span> </span><span class="NLM_article-title">Correlation of hydrotropic solubilization by urea with logD of drug molecules and utilization of this effect for topical formulations</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2013.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejpb.2013.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23958327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWhurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=158-160&author=M.+E.+Herbigauthor=D.+H.+Evers&title=Correlation+of+hydrotropic+solubilization+by+urea+with+logD+of+drug+molecules+and+utilization+of+this+effect+for+topical+formulations&doi=10.1016%2Fj.ejpb.2013.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of hydrotropic solubilization by urea with log D of drug molecules and utilization of this effect for topical formulations</span></div><div class="casAuthors">Herbig, Michael E.; Evers, Dirk-Heinrich</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">158-160</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Solubilization of drugs in aq. phases of liq. and semisolid environment is typically achieved by co-solvents or surfactants.  On contrast, solubilization by means of hydrotropic agents, i.e., small hydrophilic org. compds. like urea or citric acid, is little explored in the context of pharmaceutical formulations.  Esp., with regard to topical dosage forms, however, hydrotropic solubilization can provide valuable alternatives to establish solubilization approaches.  A difficulty of employing hydrotropic solubilization was that its extent could not be predicted for different drug mols.  Using a chem. heterogeneous set of 12 compds. relevant for dermatol. (with overall 16 different log D values tested), we were able to demonstrate that hydrotropic effects of urea can be predicted by log D values of drugs.  All compds. with log D values between 2 and 4.5 showed a soly. enhancement factor (EF) of >5 in 40% aq. solns. of urea.  For log D values below 2 or above 5, only EF < 5 were found.  For some compds., e.g., diclofenac (pH 4) and prednicarbate could achieved only EF > 5 at 5% urea and EF > 250 at 20% urea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYqAZk_MiPLVg90H21EOLACvtfcHk0li95NjodkfcOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWhurvJ&md5=6d70255b3c710baf2123f51a49187ebe</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2013.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2013.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DHerbig%26aufirst%3DM.%2BE.%26aulast%3DEvers%26aufirst%3DD.%2BH.%26atitle%3DCorrelation%2520of%2520hydrotropic%2520solubilization%2520by%2520urea%2520with%2520logD%2520of%2520drug%2520molecules%2520and%2520utilization%2520of%2520this%2520effect%2520for%2520topical%2520formulations%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2013%26volume%3D85%26spage%3D158%26epage%3D160%26doi%3D10.1016%2Fj.ejpb.2013.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span> <span> </span><span class="NLM_article-title">Hydrotropic solubilization by urea derivatives: a molecular dynamics simulation study</span>. <i>J. Pharm. (N. Y., NY, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">791370</span>, <span class="refDoi"> DOI: 10.1155/2013/791370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1155%2F2013%2F791370" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=791370&author=Y.+Cui&title=Hydrotropic+solubilization+by+urea+derivatives%3A+a+molecular+dynamics+simulation+study&doi=10.1155%2F2013%2F791370"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1155%2F2013%2F791370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F791370%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DY.%26atitle%3DHydrotropic%2520solubilization%2520by%2520urea%2520derivatives%253A%2520a%2520molecular%2520dynamics%2520simulation%2520study%26jtitle%3DJ.%2520Pharm.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2013%26volume%3D2013%26spage%3D791370%26doi%3D10.1155%2F2013%2F791370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boileau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouteiller, L.</span></span> <span> </span><span class="NLM_article-title"><i>N,N</i>’-disubstituted ureas: influence of substituents on the formation of supramolecular polymers</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3008</span>– <span class="NLM_lpage">3014</span>, <span class="refDoi"> DOI: 10.1002/chem.200304801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.200304801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12833282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Kgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=3008-3014&author=F.+Lortieauthor=S.+Boileauauthor=L.+Bouteiller&title=N%2CN%E2%80%99-disubstituted+ureas%3A+influence+of+substituents+on+the+formation+of+supramolecular+polymers&doi=10.1002%2Fchem.200304801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">N,N'-disubstituted ureas: Influence of substituents on the formation of supramolecular polymers</span></div><div class="casAuthors">Lortie, Frederic; Boileau, Sylvie; Bouteiller, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3008-3014</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sym. N,N'-disubstituted ureas have been synthesized and characterized.  Among them, the branched dialkylureas prepd. are highly sol. in org. media.  Moreover, the solns. obtained are very viscous in heptane, if the branched alkyl groups are not too bulky (i.e. a Me group on the α carbon, or an Et group on the β carbon).  Due to the strong, bifurcated hydrogen bonds between the urea moieties, linear supramol. polymers are formed.  The degree of assocn. of these supramol. polymers has been detd. by FTIR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLS01Bxqv2LVg90H21EOLACvtfcHk0li95NjodkfcOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Kgurs%253D&md5=20f64d39a74fe34a646a484e502da289</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fchem.200304801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200304801%26sid%3Dliteratum%253Aachs%26aulast%3DLortie%26aufirst%3DF.%26aulast%3DBoileau%26aufirst%3DS.%26aulast%3DBouteiller%26aufirst%3DL.%26atitle%3DN%252CN%25E2%2580%2599-disubstituted%2520ureas%253A%2520influence%2520of%2520substituents%2520on%2520the%2520formation%2520of%2520supramolecular%2520polymers%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2003%26volume%3D9%26spage%3D3008%26epage%3D3014%26doi%3D10.1002%2Fchem.200304801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1039/c1md00093d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space&doi=10.1039%2Fc1md00093d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span></div><div class="casAuthors">Alex, Alexander; Millan, David S.; Perez, Manuel; Wakenhut, Florian; Whitlock, Gavin A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">669-674</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Utilizing 'beyond rule of five' chem. space is becoming increasingly important in drug design, but is usually at odds with good oral absorption.  The formation of intramol. hydrogen bonds in drug mols. is hypothesised to shield polarity facilitating improved membrane permeability and intestinal absorption.  NMR based evidence for intramol. hydrogen bonding in several 'beyond rule of five' oral drugs is described.  Furthermore, the propensity for these drugs to form intramol. hydrogen bonds could be predicted for through modeling the lowest energy conformation in the gas phase.  The modulation of apparent lipophilicity through intramol. hydrogen bonding in these mols. is supported by intrinsic cell permeability and intestinal absorption data in rat and human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp93l2KJMdB2bVg90H21EOLACvtfcHk0li95NjodkfcOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D&md5=3effbdd29832ac7b57eabbc26c66217b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674%26doi%3D10.1039%2Fc1md00093d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lhlUm4DGg4Z8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guagnano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span> <span> </span><span class="NLM_article-title">Entry into a new class of protein kinase inhibitors by pseudo ring design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2007.12.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18248988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=897-900&author=P.+Furetauthor=G.+Caravattiauthor=V.+Guagnanoauthor=M.+Langauthor=T.+Meyerauthor=J.+Schoepfer&title=Entry+into+a+new+class+of+protein+kinase+inhibitors+by+pseudo+ring+design&doi=10.1016%2Fj.bmcl.2007.12.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Entry into a new class of protein kinase inhibitors by pseudo ring design</span></div><div class="casAuthors">Furet, Pascal; Caravatti, Giorgio; Guagnano, Vito; Lang, Marc; Meyer, Thomas; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">897-900</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A pyrimidin-4-yl-urea motif forming a pseudo ring by intramol. hydrogen bonding has been designed to mimic the pyrido[2,3-d]pyrimidin-7-one core structure of a well-established class of protein kinase inhibitors.  Potent inhibition of a no. of protein kinases was obtained with the first prototype compd. synthesized to probe the design concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5MZZKS4I03LVg90H21EOLACvtfcHk0lhlUm4DGg4Z8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D&md5=989b4bb7f1d5177be45d4edf31290de5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.041%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520inhibitors%2520by%2520pseudo%2520ring%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D897%26epage%3D900%26doi%3D10.1016%2Fj.bmcl.2007.12.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1021/jm101356p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry&doi=10.1021%2Fjm101356p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0lhlUm4DGg4Z8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554%26doi%3D10.1021%2Fjm101356p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dax, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheatham, W. W.</span></span> <span> </span><span class="NLM_article-title">Nonsymmetrically substituted cyclic urea HIV protease inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4079</span>– <span class="NLM_lpage">4088</span>, <span class="refDoi"> DOI: 10.1021/jm970288b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970288b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1Ogtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4079-4088&author=W.+W.+Wilkersonauthor=S.+Daxauthor=W.+W.+Cheatham&title=Nonsymmetrically+substituted+cyclic+urea+HIV+protease+inhibitors&doi=10.1021%2Fjm970288b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsymmetrically substituted cyclic urea HIV protease inhibitors</span></div><div class="casAuthors">Wilkerson, Wendell W.; Dax, Scott; Cheatham, Walter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4079-4088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of nonsym. substituted cyclic urea carboxamides was synthesized and evaluated for antiviral activity as a function of the inhibition of HIV-protease.  Selected protease inhibitors were also evaluated for oral bioavailability.  The synthesis, pharmacol., quant. structure-activity relationship (QSAR), and pharmacokinetics for the series will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfX0NHWdHBrVg90H21EOLACvtfcHk0lhlUm4DGg4Z8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1Ogtbg%253D&md5=823aa7f272a2e9f22d13550148916615</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm970288b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970288b%26sid%3Dliteratum%253Aachs%26aulast%3DWilkerson%26aufirst%3DW.%2BW.%26aulast%3DDax%26aufirst%3DS.%26aulast%3DCheatham%26aufirst%3DW.%2BW.%26atitle%3DNonsymmetrically%2520substituted%2520cyclic%2520urea%2520HIV%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4079%26epage%3D4088%26doi%3D10.1021%2Fjm970288b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scully, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of cytokine-mediated STAT1 signal transduction in beta-cells with improved aqueous solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4125</span>– <span class="NLM_lpage">4129</span>, <span class="refDoi"> DOI: 10.1021/jm400397x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400397x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Wis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4125-4129&author=S.+S.+Scullyauthor=A.+J.+Tangauthor=M.+Lundhauthor=C.+M.+Mosherauthor=K.+M.+Perkinsauthor=B.+K.+Wagner&title=Small-molecule+inhibitors+of+cytokine-mediated+STAT1+signal+transduction+in+beta-cells+with+improved+aqueous+solubility&doi=10.1021%2Fjm400397x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of cytokine-mediated STAT1 signal transduction in β-cells with improved aqueous solubility</span></div><div class="casAuthors">Scully, Stephen S.; Tang, Alicia J.; Lundh, Morten; Mosher, Carrie M.; Perkins, Kedar M.; Wagner, Bridget K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4125-4129</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported the discovery of BRD0476 I, a small mol. generated by diversity-oriented synthesis that suppresses cytokine-induced β-cell apoptosis.  Herein, we report the synthesis and biol. evaluation of I and analogs with improved aq. soly.  By replacing naphthyl with quinoline moieties, we prepd. active analogs with up to a 1400-fold increase in soly. from I.  In addn., we demonstrated that I and analogs inhibit STAT1 signal transduction induced by IFN-γ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8w_RnDRGu37Vg90H21EOLACvtfcHk0lhbhxg5QyQ1Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Wis78%253D&md5=4444398e6aa75eadcaaed87ef4a093b7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm400397x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400397x%26sid%3Dliteratum%253Aachs%26aulast%3DScully%26aufirst%3DS.%2BS.%26aulast%3DTang%26aufirst%3DA.%2BJ.%26aulast%3DLundh%26aufirst%3DM.%26aulast%3DMosher%26aufirst%3DC.%2BM.%26aulast%3DPerkins%26aufirst%3DK.%2BM.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520cytokine-mediated%2520STAT1%2520signal%2520transduction%2520in%2520beta-cells%2520with%2520improved%2520aqueous%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4125%26epage%3D4129%26doi%3D10.1021%2Fjm400397x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eid, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span> <span> </span><span class="NLM_article-title">Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1021/jm501680m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501680m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1846-1861&author=Y.+Yinauthor=K.+Zhengauthor=N.+Eidauthor=S.+Howardauthor=J.+H.+Jeongauthor=F.+Yiauthor=J.+Guoauthor=C.+M.+Parkauthor=M.+Bibianauthor=W.+Wuauthor=P.+Hernandezauthor=H.+Parkauthor=Y.+Wuauthor=J.+L.+Luoauthor=P.+V.+LoGrassoauthor=Y.+Feng&title=Bis-aryl+urea+derivatives+as+potent+and+selective+LIM+kinase+%28Limk%29+inhibitors&doi=10.1021%2Fjm501680m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Bis-aryl Urea Derivatives as Potent and Selective LIM Kinase (Limk) Inhibitors</span></div><div class="casAuthors">Yin, Yan; Zheng, Ke; Eid, Nibal; Howard, Shannon; Jeong, Ji-Hak; Yi, Fei; Guo, Jia; Park, Chul Min; Bibian, Mathieu; Wu, Weilin; Hernandez, Pamela; Park, HaJeung; Wu, Yuntao; Luo, Jun-Li; LoGrasso, Philip V.; Feng, Yangbo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1846-1861</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery/optimization of bis-aryl ureas as Limk inhibitors to obtain high potency and selectivity and appropriate pharmacokinetic properties through systematic SAR studies is reported.  Docking studies supported the obsd. SAR.  Optimized Limk inhibitors had high biochem. potency (IC50 < 25 nM), excellent selectivity against ROCK and JNK kinases (>400-fold), potent inhibition of cofilin phosphorylation in A7r5, PC-3, and CEM-SS T cells (IC50 < 1 μM), and good in vitro and in vivo pharmacokinetic properties.  In the profiling against a panel of 61 kinases, compd. I at 1 μM inhibited only Limk1 and STK16 with ≥80% inhibition.  Compds. I and II were highly efficient in inhibiting cell-invasion/migration in PC-3 cells.  In addn., compd. III was demonstrated to be effective on reducing intraocular pressure on rat eyes.  Taken together, these data demonstrated that the authors had developed a novel class of bis-aryl urea derived potent and selective Limk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6gl5J5n9-HrVg90H21EOLACvtfcHk0lhRCKw7EeFsuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWgtb4%253D&md5=67352d15ab435e75f561552f283b29b9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm501680m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501680m%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DEid%26aufirst%3DN.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DJ.%2BH.%26aulast%3DYi%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBibian%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DFeng%26aufirst%3DY.%26atitle%3DBis-aryl%2520urea%2520derivatives%2520as%2520potent%2520and%2520selective%2520LIM%2520kinase%2520%2528Limk%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1846%26epage%3D1861%26doi%3D10.1021%2Fjm501680m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannicchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouvelet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalla Cort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouteiller, L.</span></span> <span> </span><span class="NLM_article-title">Orthohalogen substituents dramatically enhance hydrogen bonding of aromatic ureas in solution</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1039/C3CC47447J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC3CC47447J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24280764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=611-613&author=I.+Giannicchiauthor=B.+Jouveletauthor=B.+Isareauthor=M.+Linaresauthor=A.+Dalla+Cortauthor=L.+Bouteiller&title=Orthohalogen+substituents+dramatically+enhance+hydrogen+bonding+of+aromatic+ureas+in+solution&doi=10.1039%2FC3CC47447J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Orthohalogen substituents dramatically enhance hydrogen bonding of aromatic ureas in solution</span></div><div class="casAuthors">Giannicchi, Ilaria; Jouvelet, Benjamin; Isare, Benjamin; Linares, Mathieu; Dalla Cort, Antonella; Bouteiller, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">611-613</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The phenylurea moiety is a ubiquitous synthon in supramol. chem.  Here we report that the introduction of chlorine or bromine atoms in the ortho positions to the urea unit is a simple and very efficient way to improve its intermol. hydrogen bond (HB) donor character.  This effect was demonstrated in soln. both in the context of self-assocn. of bis-ureas and hydrogen bonding of mono-ureas to strong HB acceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry1IyEbp2gjbVg90H21EOLACvtfcHk0lhRCKw7EeFsuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt77F&md5=e40de965ff4043092d8a4d4e63eeb0f6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC3CC47447J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CC47447J%26sid%3Dliteratum%253Aachs%26aulast%3DGiannicchi%26aufirst%3DI.%26aulast%3DJouvelet%26aufirst%3DB.%26aulast%3DIsare%26aufirst%3DB.%26aulast%3DLinares%26aufirst%3DM.%26aulast%3DDalla%2BCort%26aufirst%3DA.%26aulast%3DBouteiller%26aufirst%3DL.%26atitle%3DOrthohalogen%2520substituents%2520dramatically%2520enhance%2520hydrogen%2520bonding%2520of%2520aromatic%2520ureas%2520in%2520solution%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2014%26volume%3D50%26spage%3D611%26epage%3D613%26doi%3D10.1039%2FC3CC47447J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creighton, T. E.</span></span> <span> </span><span class="NLM_article-title">Stability of folded conformations</span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/0959-440X(91)90004-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2F0959-440X%2891%2990004-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXkvVOmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1991&pages=5-16&author=T.+E.+Creighton&title=Stability+of+folded+conformations&doi=10.1016%2F0959-440X%2891%2990004-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Stability of folded conformations</span></div><div class="casAuthors">Creighton, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-16</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    </div><div class="casAbstract">A review with 80 refs.  Significant advances have been made in understanding the thermodn. of the hydrophobic effect and of the reversible unfolding of proteins, although there is still considerable controversy.  Recent analyses suggest that the predominant factor in stabilizing the folded states of proteins is intramol. hydrogen bonding, even though in the unfolded state the polar groups form intermol. hydrogen bonds with water.  Van der Waals interactions between non-polar groups also contribute substantially, but perhaps not as much as might have been expected if protein interiors were perfectly close-packed.  The role of the solvent seems to be primarily destabilizing, and involves the favorable solvation of both polar and non-polar groups.  The effects of added stabilizers and denaturants can be understood on the basis of their alterations of the properties of water and of their interactions with the surfaces of folded and unfolded proteins.  Also, the electrostatic interactions between groups involved in salt bridges in folded proteins can be substantial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqja09cHX-Z9LVg90H21EOLACvtfcHk0lgXhxpgv1HD_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvVOmtb8%253D&md5=d38fde90fbdd2858755bff520b2a04ac</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0959-440X%2891%2990004-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0959-440X%252891%252990004-D%26sid%3Dliteratum%253Aachs%26aulast%3DCreighton%26aufirst%3DT.%2BE.%26atitle%3DStability%2520of%2520folded%2520conformations%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D1991%26volume%3D1%26spage%3D5%26epage%3D16%26doi%3D10.1016%2F0959-440X%2891%2990004-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clopton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downing, M.</span></span> <span> </span><span class="NLM_article-title">Solubility of diketopiperazine in aqueous solutions of urea</span>. <i>J. Phys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1435</span>, <span class="refDoi"> DOI: 10.1021/j100826a037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/j100826a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaF3MXht1yktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1961&pages=1432-1435&author=S.+J.+Gillauthor=J.+Hutsonauthor=J.+R.+Cloptonauthor=M.+Downing&title=Solubility+of+diketopiperazine+in+aqueous+solutions+of+urea&doi=10.1021%2Fj100826a037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Solubility of diketopiperazine in aqueous solutions of urea</span></div><div class="casAuthors">Gill, S. J.; Hutson, J.; Clopton, J. R.; Downing, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1432-5</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">The soly. was measured in aq. urea solns. as a function of temp. and urea concn. and followed a simple exponential dependence on 1/T.  The heats of soln. obtained from this temp. relation served to evaluate the H-bond interaction of diketopiperazine with urea.  The fraction of peptide-urea interactions was estd. by simple equil. considerations.  The heat of assocn. of urea with a cis peptide bond was evaluated from exptl. data as -3.4 ± 0.5 kcal.  An equil. const. was 0.096 for the assocn. of urea with the peptide bond in aq. soln.  The strong H-bond interaction between urea and peptides was further illustrated by the discovery of a 2 urea: 1 diketopiperazine solid complex which was formed in 8M urea below 30°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHG7P9fxlP7Vg90H21EOLACvtfcHk0lgXhxpgv1HD_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1yktrw%253D&md5=6c0a06c68f229dd153019629b91bc1a5</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fj100826a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100826a037%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DS.%2BJ.%26aulast%3DHutson%26aufirst%3DJ.%26aulast%3DClopton%26aufirst%3DJ.%2BR.%26aulast%3DDowning%26aufirst%3DM.%26atitle%3DSolubility%2520of%2520diketopiperazine%2520in%2520aqueous%2520solutions%2520of%2520urea%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1961%26volume%3D65%26spage%3D1432%26epage%3D1435%26doi%3D10.1021%2Fj100826a037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sliwoski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kothiwale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E. W.</span></span> <span> </span><span class="NLM_article-title">Computational methods in drug discovery</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1124/pr.112.007336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fpr.112.007336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24381236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=334-395&author=G.+Sliwoskiauthor=S.+Kothiwaleauthor=J.+Meilerauthor=E.+W.+Lowe&title=Computational+methods+in+drug+discovery&doi=10.1124%2Fpr.112.007336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Computational methods in drug discovery</span></div><div class="casAuthors">Sliwoski, Gregory; Kothiwale, Sandeepkumar; Meiler, Jens; Lowe Edward, W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">334-395, 62 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Computer-aided drug discovery/design methods have played a major role in the development of therapeutically important small mols. for over three decades.  These methods are broadly classified as either structure-based or ligand-based methods.  Structure-based methods are in principle analogous to high-throughput screening in that both target and ligand structure information is imperative.  Structure-based approaches include ligand docking, pharmacophore, and ligand design methods.  The article discusses theory behind the most important methods and recent successful applications.  Ligand-based methods use only ligand information for predicting activity depending on its similarity/dissimilarity to previously known active ligands.  We review widely used ligand-based methods such as ligand-based pharmacophores, mol. descriptors, and quant. structure-activity relationships.  In addn., important tools such as target/ligand data bases, homol. modeling, ligand fingerprint methods, etc., necessary for successful implementation of various computer-aided drug discovery/design methods in a drug discovery campaign are discussed.  Finally, computational methods for toxicity prediction and optimization for favorable physiol. properties are discussed with successful examples from literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL4miiF8oaQrVg90H21EOLACvtfcHk0lgXhxpgv1HD_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu7nL&md5=3dde38a0b60c583f832c688c2d27819f</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.007336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.007336%26sid%3Dliteratum%253Aachs%26aulast%3DSliwoski%26aufirst%3DG.%26aulast%3DKothiwale%26aufirst%3DS.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DE.%2BW.%26atitle%3DComputational%2520methods%2520in%2520drug%2520discovery%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26spage%3D334%26epage%3D395%26doi%3D10.1124%2Fpr.112.007336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fradera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosfield, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynands, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haunsø, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C.</span></span> <span> </span><span class="NLM_article-title">X-ray structures of the LXR-alpha LBD in its homodimeric form and implications for heterodimer signaling</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.jmb.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20382159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVSkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=2010&pages=120-132&author=X.+Fraderaauthor=D.+Vuauthor=O.+Nimzauthor=R.+Skeneauthor=D.+Hosfieldauthor=R.+Wynandsauthor=A.+J.+Cookeauthor=A.+Hauns%C3%B8author=A.+Kingauthor=D.+J.+Bennettauthor=R.+McGuireauthor=J.+C.+Uitdehaag&title=X-ray+structures+of+the+LXR-alpha+LBD+in+its+homodimeric+form+and+implications+for+heterodimer+signaling&doi=10.1016%2Fj.jmb.2010.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">X-Ray Structures of the LXRα LBD in Its Homodimeric Form and Implications for Heterodimer Signaling</span></div><div class="casAuthors">Fradera, Xavier; Vu, Diep; Nimz, Olaf; Skene, Robert; Hosfield, David; Wynands, Robert; Cooke, Andrew J.; Haunso, Anders; King, Angela; Bennett, D. Jonathan; McGuire, Ross; Uitdehaag, Joost C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-132</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Liver X receptors (LXRs) are nuclear receptors that are central regulators of cholesterol homeostasis, and synthetic LXR agonists have shown promise as promoters of reverse cholesterol transport and anti-inflammatory agents.  Here, we present three X-ray structures of three different agonists bound to the ligand binding domain of LXRα.  These compds. are GW3965, F3methylAA, and a benzisoxazole urea, and we show that these diverse chem. scaffolds address common structural themes, leading to high binding affinity for LXR.  Our structures show the LXRα ligand binding domain in its homodimeric form, an arrangement previously thought to be stereochem. difficult.  A comparison with existing structures of the LXRβ homodimer and LXRα:RXR (retinoid X receptor) heterodimers explains differences in dimer affinity and leads us to propose a model for allosteric activation in nuclear receptor dimers, in which an unactivated RXR partner provides an inhibitory tail wrap to the cofactor binding pocket of LXR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMF30Ry-u9e7Vg90H21EOLACvtfcHk0lg6Pf-jtNoQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVSkt7c%253D&md5=3d00f9b0e694c994fce9d8e2ee85e008</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DFradera%26aufirst%3DX.%26aulast%3DVu%26aufirst%3DD.%26aulast%3DNimz%26aufirst%3DO.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DHosfield%26aufirst%3DD.%26aulast%3DWynands%26aufirst%3DR.%26aulast%3DCooke%26aufirst%3DA.%2BJ.%26aulast%3DHauns%25C3%25B8%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DD.%2BJ.%26aulast%3DMcGuire%26aufirst%3DR.%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%26atitle%3DX-ray%2520structures%2520of%2520the%2520LXR-alpha%2520LBD%2520in%2520its%2520homodimeric%2520form%2520and%2520implications%2520for%2520heterodimer%2520signaling%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D399%26spage%3D120%26epage%3D132%26doi%3D10.1016%2Fj.jmb.2010.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madej, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanczycki, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiessen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geer, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchler-Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S. H.</span></span> <span> </span><span class="NLM_article-title">MMDB and VAST+: tracking structural similarities between macromolecular complexes</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">D297</span>– <span class="NLM_lpage">D303</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1093%2Fnar%2Fgkt1208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24319143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=D297-D303&author=T.+Madejauthor=C.+J.+Lanczyckiauthor=D.+Zhangauthor=P.+A.+Thiessenauthor=R.+C.+Geerauthor=A.+Marchler-Bauerauthor=S.+H.+Bryant&title=MMDB+and+VAST%2B%3A+tracking+structural+similarities+between+macromolecular+complexes&doi=10.1093%2Fnar%2Fgkt1208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">MMDB and VAST+: tracking structural similarities between macromolecular complexes</span></div><div class="casAuthors">Madej, Thomas; Lanczycki, Christopher J.; Zhang, Dachuan; Thiessen, Paul A.; Geer, Renata C.; Marchler-Bauer, Aron; Bryant, Stephen H.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D297-D303</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The computational detection of similarities between protein 3D structures has become an indispensable tool for the detection of homologous relationships, the classification of protein families and functional inference.  Consequently, numerous algorithms have been developed that facilitate structure comparison, including rapid searches against a steadily growing collection of protein structures.  To this end, NCBI's Mol. Modeling Database (MMDB), which is based on the Protein Data Bank (PDB), maintains a comprehensive and up-to-date archive of protein structure similarities computed with the Vector Alignment Search Tool (VAST).  These similarities have been recorded on the level of single proteins and protein domains, comprising in excess of 1.5 billion pairwise alignments.  Here we present VAST+, an extension to the existing VAST service, which summarizes and presents structural similarity on the level of biol. assemblies or macromol. complexes.  VAST+ simplifies structure neighboring results and shows, for macromol. complexes tracked in MMDB, lists of similar complexes ranked by the extent of similarity.  VAST+ replaces the previous VAST service as the default presentation of structure neighboring data in NCBI's Entrez query and retrieval system.  MMDB and VAST+ can be accessed via http://www.ncbi.nlm.nih.gov/Structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiNDUHdKvRr7Vg90H21EOLACvtfcHk0lg6Pf-jtNoQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cl&md5=6fe50e4abc811a3c32c8cc25ecfe734d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1208%26sid%3Dliteratum%253Aachs%26aulast%3DMadej%26aufirst%3DT.%26aulast%3DLanczycki%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DThiessen%26aufirst%3DP.%2BA.%26aulast%3DGeer%26aufirst%3DR.%2BC.%26aulast%3DMarchler-Bauer%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DS.%2BH.%26atitle%3DMMDB%2520and%2520VAST%252B%253A%2520tracking%2520structural%2520similarities%2520between%2520macromolecular%2520complexes%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3DD297%26epage%3DD303%26doi%3D10.1093%2Fnar%2Fgkt1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span> <span> </span><span class="NLM_article-title">Urea–aromatic stacking and concerted urea transport: conserved mechanisms in urea transporters revealed by molecular dynamics</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5190</span>– <span class="NLM_lpage">5200</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.6b00602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.6b00602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeht7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=5190-5200&author=S.+Padhiauthor=U.+D.+Priyakumar&title=Urea%E2%80%93aromatic+stacking+and+concerted+urea+transport%3A+conserved+mechanisms+in+urea+transporters+revealed+by+molecular+dynamics&doi=10.1021%2Facs.jctc.6b00602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Urea-Aromatic Stacking and Concerted Urea Transport: Conserved Mechanisms in Urea Transporters Revealed by Molecular Dynamics</span></div><div class="casAuthors">Padhi, Siladitya; Priyakumar, U. Deva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5190-5200</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea transporters are membrane proteins that selectively allow urea mols. to pass through.  It is not clear how these transporters allow rapid conduction of urea, a polar mol., in spite of the presence of a hydrophobic constriction lined by arom. rings.  The current study elucidates the mechanism that is responsible for this rapid conduction by performing free energy calcns. on transporter dvUT with a cumulative sampling time of ∼1.3 μs.  A parallel arrangement of arom. rings in the pore enables stacking of urea with these rings, which, in turn, lowers the energy barrier for urea transport.  Such interaction of the rings with urea is proposed to be a conserved mechanism across all urea-conducting proteins.  The free energy landscape for the permeation of multiple urea mols. reveals an interplay between inter-urea interaction and solvation state of the urea mols.  This is the 1st time that multiple mol. permeation through any small mol. transporter has been modeled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHuZSJkM5sSLVg90H21EOLACvtfcHk0lgkjUl5VLlp6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeht7zF&md5=df00959601b9c02095949e7913592641</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.6b00602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.6b00602%26sid%3Dliteratum%253Aachs%26aulast%3DPadhi%26aufirst%3DS.%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26atitle%3DUrea%25E2%2580%2593aromatic%2520stacking%2520and%2520concerted%2520urea%2520transport%253A%2520conserved%2520mechanisms%2520in%2520urea%2520transporters%2520revealed%2520by%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D5190%26epage%3D5200%26doi%3D10.1021%2Facs.jctc.6b00602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasavajhala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span> <span> </span><span class="NLM_article-title">Role of urea–aromatic stacking interactions in stabilizing the aromatic residues of the protein in urea-induced denatured state</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">14931</span>– <span class="NLM_lpage">14946</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b05463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b05463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sks73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=14931-14946&author=S.+Goyalauthor=A.+Chattopadhyayauthor=K.+Kasavajhalaauthor=U.+D.+Priyakumar&title=Role+of+urea%E2%80%93aromatic+stacking+interactions+in+stabilizing+the+aromatic+residues+of+the+protein+in+urea-induced+denatured+state&doi=10.1021%2Fjacs.7b05463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Urea-Aromatic Stacking Interactions in Stabilizing the Aromatic Residues of the Protein in Urea-Induced Denatured State</span></div><div class="casAuthors">Goyal, Siddharth; Chattopadhyay, Aditya; Kasavajhala, Koushik; Priyakumar, U. Deva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14931-14946</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A delicate balance of different types of intramol. interactions makes the folded states of proteins marginally more stable than the unfolded states.  Expts. use thermal, chem., or mech. stress to perturb the folding equil. for examg. protein stability and protein folding processes.  The elucidation of the mechanism by which chem. denaturants unfold proteins is crucial; this study explores the nature of urea-arom. interactions relevant in urea-assisted protein denaturation.  Free energy profiles corresponding to the unfolding of Trp-cage mini-protein in the presence and absence of urea at 3 different temps. demonstrated the distortion of the hydrophobic core to be a crucial step.  Exposure of the Trp-6 residue to the solvent was found to be favored in the presence of urea.  Previous expts. showed that urea had high affinity for arom. groups of proteins.  We showed here that this was due to the remarkable ability of urea to form stacking and NH-π interactions with arom. groups of proteins.  Urea-nucleobase stacking interactions have been shown to be crucial in urea-assisted RNA unfolding.  An examn. of these interactions using microsecond-long unrestrained simulations showed that urea-arom. stacking interactions were stabilizing and long lasting.  Further mol. dynamics simulations, thermodn. integration and quantum mech. calcns. on arom. model systems revealed that such interactions are possible for all the arom. amino acid side-chains.  Finally, we validated the ubiquitous nature of urea-arom. stacking interactions by analyzing exptl. structures of urea transporters and proteins crystd. in presence of urea or urea derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_nKDBTuumrVg90H21EOLACvtfcHk0lgkjUl5VLlp6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sks73F&md5=0b8890b9b5d9d480d100ce979aecb9db</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b05463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b05463%26sid%3Dliteratum%253Aachs%26aulast%3DGoyal%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26atitle%3DRole%2520of%2520urea%25E2%2580%2593aromatic%2520stacking%2520interactions%2520in%2520stabilizing%2520the%2520aromatic%2520residues%2520of%2520the%2520protein%2520in%2520urea-induced%2520denatured%2520state%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D14931%26epage%3D14946%26doi%3D10.1021%2Fjacs.7b05463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esteva-Font, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkman, A. S.</span></span> <span> </span><span class="NLM_article-title">Urea transporter proteins as targets for small-molecule diuretics</span>. <i>Nat. Rev. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1038/nrneph.2014.219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnrneph.2014.219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25488859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=113-123&author=C.+Esteva-Fontauthor=M.+O.+Andersonauthor=A.+S.+Verkman&title=Urea+transporter+proteins+as+targets+for+small-molecule+diuretics&doi=10.1038%2Fnrneph.2014.219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Urea transporter proteins as targets for small-molecule diuretics</span></div><div class="casAuthors">Esteva-Font, Cristina; Anderson, Marc O.; Verkman, Alan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Nephrology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-123</span>CODEN:
                <span class="NLM_cas:coden">NRNABO</span>;
        ISSN:<span class="NLM_cas:issn">1759-5061</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Conventional diuretics such as furosemide and thiazides target salt transporters in kidney tubules, but urea transporters (UTs) have emerged as alternative targets.  UTs are a family of transmembrane channels expressed in a variety of mammalian tissues, in particular the kidney.  UT knockout mice and humans with UT mutations exhibit reduced maximal urinary osmolality, demonstrating that UTs are necessary for the concn. of urine.  Small-mol. screening has identified potent and selective inhibitors of UT-A, the UT protein expressed in renal tubule epithelial cells, and UT-B, the UT protein expressed in vasa recta endothelial cells.  Data from UT knockout mice and from rodents administered UT inhibitors support the diuretic action of UT inhibition.  The kidney-specific expression of UT-A1, together with high selectivity of the small-mol. inhibitors, means that off-target effects of such small-mol. drugs should be minimal.  This Review summarizes the structure, expression and function of UTs, and looks at the evidence supporting the validity of UTs as targets for the development of salt-sparing diuretics with a unique mechanism of action.  UT-targeted inhibitors may be useful alone or in combination with conventional diuretics for therapy of various edemas and hyponatremias, potentially including those refractory to treatment with current diuretics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8QvCDHRPMp7Vg90H21EOLACvtfcHk0li7KhgWzR8OwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKksrjI&md5=ff85fb1acbbcd754235594556be3135d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnrneph.2014.219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneph.2014.219%26sid%3Dliteratum%253Aachs%26aulast%3DEsteva-Font%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DM.%2BO.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26atitle%3DUrea%2520transporter%2520proteins%2520as%2520targets%2520for%2520small-molecule%2520diuretics%26jtitle%3DNat.%2520Rev.%2520Nephrol.%26date%3D2015%26volume%3D11%26spage%3D113%26epage%3D123%26doi%3D10.1038%2Fnrneph.2014.219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaganade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazhayam, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span> <span> </span><span class="NLM_article-title">Energetic, structural and dynamic properties of nucleobase-urea interactions that aid in urea assisted RNA unfolding</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">8805</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-45010-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fs41598-019-45010-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=31217494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BB3M3osFOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=8805&author=T.+Jaganadeauthor=A.+Chattopadhyayauthor=N.+M.+Pazhayamauthor=U.+D.+Priyakumar&title=Energetic%2C+structural+and+dynamic+properties+of+nucleobase-urea+interactions+that+aid+in+urea+assisted+RNA+unfolding&doi=10.1038%2Fs41598-019-45010-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Energetic, Structural and Dynamic Properties of Nucleobase-Urea Interactions that Aid in Urea Assisted RNA Unfolding</span></div><div class="casAuthors">Jaganade Tanashree; Chattopadhyay Aditya; Pazhayam Nila M; Priyakumar U Deva</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8805</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Understanding the structure-function relationships of RNA has become increasingly important given the realization of its functional role in various cellular processes.  Chemical denaturation of RNA by urea has been shown to be beneficial in investigating RNA stability and folding.  Elucidation of the mechanism of unfolding of RNA by urea is important for understanding the folding pathways.  In addition to studying denaturation of RNA in aqueous urea, it is important to understand the nature and strength of interactions of the building blocks of RNA.  In this study, a systematic examination of the structural features and energetic factors involving interactions between nucleobases and urea is presented.  Results from molecular dynamics (MD) simulations on each of the five DNA/RNA bases in water and eight different concentrations of aqueous urea, and free energy calculations using the thermodynamic integration method are presented.  The interaction energies between all the nucleobases with the solvent environment and the transfer free energies become more favorable with respect to increase in the concentration of urea.  Preferential interactions of urea versus water molecules with all model systems determined using Kirkwood-Buff integrals and two-domain models indicate preference of urea by nucleobases in comparison to water.  The modes of interaction between urea and the nucleobases were analyzed in detail.  In addition to the previously identified hydrogen bonding and stacking interactions between urea and nucleobases that stabilize the unfolded states of RNA in aqueous solution, NH-π interactions are proposed to be important.  Dynamic properties of each of these three modes of interactions have been presented.  The study provides fundamental insights into the nature of interaction of urea molecules with nucleobases and how it disrupts nucleic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSguW6ydoBgS70AGQpJZWpJfW6udTcc2eaPZkoobkFTjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3osFOgtQ%253D%253D&md5=26182c34deec65109392b691895ec47d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-45010-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-45010-8%26sid%3Dliteratum%253Aachs%26aulast%3DJaganade%26aufirst%3DT.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3DPazhayam%26aufirst%3DN.%2BM.%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26atitle%3DEnergetic%252C%2520structural%2520and%2520dynamic%2520properties%2520of%2520nucleobase-urea%2520interactions%2520that%2520aid%2520in%2520urea%2520assisted%2520RNA%2520unfolding%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D8805%26doi%3D10.1038%2Fs41598-019-45010-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyeon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirumalai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKerell, A. D.</span></span> <span> </span><span class="NLM_article-title">Urea destabilizes RNA by forming stacking interactions and multiple hydrogen bonds with nucleic acid bases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">17759</span>– <span class="NLM_lpage">17761</span>, <span class="refDoi"> DOI: 10.1021/ja905795v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja905795v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17759-17761&author=U.+D.+Priyakumarauthor=C.+Hyeonauthor=D.+Thirumalaiauthor=A.+D.+MacKerell&title=Urea+destabilizes+RNA+by+forming+stacking+interactions+and+multiple+hydrogen+bonds+with+nucleic+acid+bases&doi=10.1021%2Fja905795v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Urea Destabilizes RNA by Forming Stacking Interactions and Multiple Hydrogen Bonds with Nucleic Acid Bases</span></div><div class="casAuthors">Priyakumar, U. Deva; Hyeon, Changbong; Thirumalai, D.; MacKerell, Alexander D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17759-17761</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea titrn. of RNA by urea is an effective approach to investigate the forces stabilizing this biol. important mol.  We used all atom mol. dynamics simulations using two urea force fields and two RNA constructs to elucidate in at. detail the destabilization mechanism of folded RNA in aq. urea solns.  Urea denatures RNA by forming multiple hydrogen bonds with the RNA bases and has little influence on the phosphodiester backbone.  Most significantly we discovered that urea engages in stacking interactions with the bases.  We also est., for the first time, the m-value for RNA, which is a measure of the strength of urea-RNA interactions.  Our work provides a conceptual understanding of the mechanism by which urea enhances RNA folding rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq2g7vhPmRr7Vg90H21EOLACvtfcHk0li7KhgWzR8OwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValur7M&md5=6eb803e34d185d39afb7cda8889a5ca1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja905795v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja905795v%26sid%3Dliteratum%253Aachs%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26aulast%3DHyeon%26aufirst%3DC.%26aulast%3DThirumalai%26aufirst%3DD.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26atitle%3DUrea%2520destabilizes%2520RNA%2520by%2520forming%2520stacking%2520interactions%2520and%2520multiple%2520hydrogen%2520bonds%2520with%2520nucleic%2520acid%2520bases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17759%26epage%3D17761%26doi%3D10.1021%2Fja905795v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. J.</span>; <span class="NLM_string-name">Johson, D. A.</span></span> <span> </span><span class="NLM_article-title">Receptors and Drug Action</span> In  <i>Foye’s Principles of Medicinal Chemistry</i>; <span class="NLM_publisher-name">Lippincott Williams and Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+J.+Maher&author=D.+A.+Johson&title=Foye%E2%80%99s+Principles+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DT.%2BJ.%26atitle%3DReceptors%2520and%2520Drug%2520Action%26btitle%3DFoye%25E2%2580%2599s%2520Principles%2520of%2520Medicinal%2520Chemistry%26pub%3DLippincott%2520Williams%2520and%2520Wilkins%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Getman, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCrescenzo, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heintz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talley, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallings, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegeman, R. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1021/jm00054a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00054a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1egtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=288-291&author=D.+P.+Getmanauthor=G.+A.+DeCrescenzoauthor=R.+M.+Heintzauthor=K.+L.+Reedauthor=J.+J.+Talleyauthor=M.+L.+Bryantauthor=M.+Clareauthor=K.+A.+Housemanauthor=J.+J.+Marrauthor=R.+A.+Muellerauthor=M.+L.+Vazquezauthor=H.-S.+Shiehauthor=W.+C.+Stallingsauthor=R.+A.+Stegeman&title=Discovery+of+a+novel+class+of+potent+HIV-1+protease+inhibitors+containing+the+%28R%29-%28hydroxyethyl%29urea+isostere&doi=10.1021%2Fjm00054a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere</span></div><div class="casAuthors">Getman, Daniel P.; DeCrescenzo, Gary A.; Heintz, Robert M.; Reed, Kathryn L.; Talley, John J.; Bryant, Martin L.; Clare, Michael; Houseman, Kathryn A.; Marr, J. Joseph; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-91</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A novel series of HIV-1 protease inhibitors is described which incorporate the hydroxyethylurea isostere.  Contrasting the hydroxyethylurea isostere with the well-known hydroxyethylene isostere, one sees that the P1' chiral α-carbon has been replaced by a trigonal nitrogen.  The inhibitors reported herein are potent and selective inhibitors of the HIV-1 protease and show excellent antiviral properties in tissue culture.  The preferred stereochem. for the key hydroxyl group is R.  As detd. by x-ray diffraction studies, these inhibitors bind to the enzyme in a previously unreported manner wherein the expected P1' and P2' substituents actually reside in the S2' and S1' subsites of the enzyme resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3NCLik_xTrrVg90H21EOLACvtfcHk0lhdr-0bskyH-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1egtLo%253D&md5=c75fb6abf68208fda73824977c7b2091</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm00054a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00054a014%26sid%3Dliteratum%253Aachs%26aulast%3DGetman%26aufirst%3DD.%2BP.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DHeintz%26aufirst%3DR.%2BM.%26aulast%3DReed%26aufirst%3DK.%2BL.%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26aulast%3DBryant%26aufirst%3DM.%2BL.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DHouseman%26aufirst%3DK.%2BA.%26aulast%3DMarr%26aufirst%3DJ.%2BJ.%26aulast%3DMueller%26aufirst%3DR.%2BA.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DShieh%26aufirst%3DH.-S.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520potent%2520HIV-1%2520protease%2520inhibitors%2520containing%2520the%2520%2528R%2529-%2528hydroxyethyl%2529urea%2520isostere%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D288%26epage%3D291%26doi%3D10.1021%2Fjm00054a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyermann, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodge, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ru, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacheler, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Viitanen, S.</span></span> <span> </span><span class="NLM_article-title">Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1126/science.8278812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1126%2Fscience.8278812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8278812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2cXitVOqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=380-384&author=P.+Y.+Lamauthor=P.+K.+Jadhavauthor=C.+J.+Eyermannauthor=C.+N.+Hodgeauthor=Y.+Ruauthor=L.+T.+Bachelerauthor=J.+L.+Meekauthor=M.+J.+Ottoauthor=M.+M.+Raynerauthor=Y.+N.+Wongauthor=C.-H.+Changauthor=P.+C.+Weberauthor=D.+A.+Jacksonauthor=T.+R.+Sharpeauthor=S.+Erickson-Viitanen&title=Rational+design+of+potent%2C+bioavailable%2C+nonpeptide+cyclic+ureas+as+HIV+protease+inhibitors&doi=10.1126%2Fscience.8278812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors</span></div><div class="casAuthors">Lam, Patrick Y. S.; Jadhav, Prabhakar K.; Eyermann, Charles J.; Hodge, C. Nicholas; Ru, Yu; Bacheler, Lee T.; Meek, Otto, Michael J.; Rayner, Marlene M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">5145</span>),
    <span class="NLM_cas:pages">380-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Mechanistic information and structure-based design methods have been used to design a series of nonpeptide cyclic ureas that are potent inhibitors of human immunodeficiency virus (HIV) protease and HIV replication.  A fundamental feature of these inhibitors is the cyclic urea carbonyl oxygen that mimics the hydrogen-bonding features of a key structural water mol.  The success of the design in both displacing and mimicking the structural water mol. was confirmed by x-ray crystallog. studies.  Highly selective, preorganized inhibitors with relatively low mol. wt. and high oral bioavailability were synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuSQfJfsq8LVg90H21EOLACvtfcHk0lhdr-0bskyH-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitVOqtLg%253D&md5=e5c975858e1dd98d8115fd3129d74344</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1126%2Fscience.8278812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8278812%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DHodge%26aufirst%3DC.%2BN.%26aulast%3DRu%26aufirst%3DY.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DMeek%26aufirst%3DJ.%2BL.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DRayner%26aufirst%3DM.%2BM.%26aulast%3DWong%26aufirst%3DY.%2BN.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DJackson%26aufirst%3DD.%2BA.%26aulast%3DSharpe%26aufirst%3DT.%2BR.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26atitle%3DRational%2520design%2520of%2520potent%252C%2520bioavailable%252C%2520nonpeptide%2520cyclic%2520ureas%2520as%2520HIV%2520protease%2520inhibitors%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D380%26epage%3D384%26doi%3D10.1126%2Fscience.8278812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodge, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacheler, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyermann, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winslow, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Viitanen, S.</span></span> <span> </span><span class="NLM_article-title">Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(96)90110-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS1074-5521%2896%2990110-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8807858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XjtVKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=301-314&author=C.+N.+Hodgeauthor=P.+E.+Aldrichauthor=L.+T.+Bachelerauthor=C.+H.+Changauthor=C.+J.+Eyermannauthor=S.+Garberauthor=M.+Grubbauthor=D.+A.+Jacksonauthor=P.+K.+Jadhavauthor=B.+Korantauthor=P.+Y.+Lamauthor=M.+B.+Maurinauthor=J.+L.+Meekauthor=M.+J.+Ottoauthor=M.+M.+Raynerauthor=C.+Reidauthor=T.+R.+Sharpeauthor=L.+Shumauthor=D.+L.+Winslowauthor=S.+Erickson-Viitanen&title=Improved+cyclic+urea+inhibitors+of+the+HIV-1+protease%3A+synthesis%2C+potency%2C+resistance+profile%2C+human+pharmacokinetics+and+X-ray+crystal+structure+of+DMP+450&doi=10.1016%2FS1074-5521%2896%2990110-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and x-ray crystal structure of DMP 450</span></div><div class="casAuthors">Hodge, C. Nicholas; Aldrich, Paul E.; Bacheler, Lee T.; Chang, Chong-Hwan; Eyermann, Charles J.; Garber, Sena; Grubb, Mary; Jackson, David A.; Jadhav, Prabharkar K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-314</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Effective HIV protease inhibitors must combine potency towards wild-type and mutant variants of HIV with oral bioavailability such that drug levels in relevant tissues continuously exceed that required for inhibition of virus replication.  Computer-aided design led to the discovery of cyclic urea inhibitors of the HIV protease.  We set out to improve the phys. properties and oral bioavailability of these compds.  We have synthesized DMP 450 (bis-methanesulfonic acid salt), a water-sol. cyclic urea compd. and a potent inhibitor of HIV replication in cell culture that also inhibits variants of HIV with single amino acid substitutions in the protease.  DMP 450 is highly selective for HIV protease, consistent with displacement of the retrovirus-specific structural water mol.  Single doses of 10 mg kg-1 DMP 450 result in plasma levels in man in excess of that required to inhibit wild-type and several mutant HIVs.  A plasmid-based, in vivo assay model suggests that maintenance of plasma levels of DMP 450 near the antiviral IC90 suppresses HIV protease activity in the animal.  We did identify mutants that are resistant to DMP 450, however; multiple mutations within the protease gene caused a significant redn. in the antiviral response.  DMP 450 is a significant advance within the cyclic urea class of HIV protease inhibitors due to its exceptional oral bioavailability.  The data presented here suggest that an optimal cyclic urea will provide clin. benefit in treating AIDS if it combines favorable pharmacokinetics with potent activity against not only single mutants of HIV, but also multiply-mutant variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB7tjY-v76kLVg90H21EOLACvtfcHk0lj8vaJxZpN3bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVKhtrs%253D&md5=950677362347d0025040bb67d9d76e53</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2896%2990110-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252896%252990110-6%26sid%3Dliteratum%253Aachs%26aulast%3DHodge%26aufirst%3DC.%2BN.%26aulast%3DAldrich%26aufirst%3DP.%2BE.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DGarber%26aufirst%3DS.%26aulast%3DGrubb%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DD.%2BA.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26aulast%3DKorant%26aufirst%3DB.%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DMaurin%26aufirst%3DM.%2BB.%26aulast%3DMeek%26aufirst%3DJ.%2BL.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DRayner%26aufirst%3DM.%2BM.%26aulast%3DReid%26aufirst%3DC.%26aulast%3DSharpe%26aufirst%3DT.%2BR.%26aulast%3DShum%26aufirst%3DL.%26aulast%3DWinslow%26aufirst%3DD.%2BL.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26atitle%3DImproved%2520cyclic%2520urea%2520inhibitors%2520of%2520the%2520HIV-1%2520protease%253A%2520synthesis%252C%2520potency%252C%2520resistance%2520profile%252C%2520human%2520pharmacokinetics%2520and%2520X-ray%2520crystal%2520structure%2520of%2520DMP%2520450%26jtitle%3DChem.%2520Biol.%26date%3D1996%26volume%3D3%26spage%3D301%26epage%3D314%26doi%3D10.1016%2FS1074-5521%2896%2990110-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemori-Kawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jestel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Konig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, J.</span></span> <span> </span><span class="NLM_article-title">Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1021/ml500394m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500394m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=89-94&author=K.+Okamotoauthor=M.+Ikemori-Kawadaauthor=A.+Jestelauthor=K.+von+Konigauthor=Y.+Funahashiauthor=T.+Matsushimaauthor=A.+Tsuruokaauthor=A.+Inoueauthor=J.+Matsui&title=Distinct+binding+mode+of+multikinase+inhibitor+lenvatinib+revealed+by+biochemical+characterization&doi=10.1021%2Fml500394m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization</span></div><div class="casAuthors">Okamoto, Kiyoshi; Ikemori-Kawada, Megumi; Jestel, Anja; von Konig, Konstanze; Funahashi, Yasuhiro; Matsushima, Tomohiro; Tsuruoka, Akihiko; Inoue, Atsushi; Matsui, Junji</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-94</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lenvatinib is an oral multikinase inhibitor that selectively inhibits vascular endothelial growth factor (VEGF) receptors 1 to 3 and other proangiogenic and oncogenic pathway-related receptor tyrosine kinases.  To elucidate the origin of the potency of lenvatinib in VEGF receptor 2 (VEGFR2) inhibition, we conducted a kinetic interaction anal. of lenvatinib with VEGFR2 and x-ray anal. of the crystal structure of VEGFR2-lenvatinib complexes.  Kinetic anal. revealed that lenvatinib had a rapid assocn. rate const. and a relatively slow dissocn. rate const. in complex with VEGFR2.  Co-crystal structure anal. demonstrated that lenvatinib binds at its ATP mimetic quinoline moiety to the ATP binding site and to the neighboring region via a cyclopropane ring, adopting an Asp-Phe-Gly (DFG)-"in" conformation.  These results suggest that lenvatinib is very distinct in its binding mode of interaction compared to the several approved VEGFR2 kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUysiHRGw3P7Vg90H21EOLACvtfcHk0li4nHdx93Ek6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtb7E&md5=5461832fad0577f2ea93b47521b4bbdc</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fml500394m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500394m%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DIkemori-Kawada%26aufirst%3DM.%26aulast%3DJestel%26aufirst%3DA.%26aulast%3Dvon%2BKonig%26aufirst%3DK.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DMatsushima%26aufirst%3DT.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DMatsui%26aufirst%3DJ.%26atitle%3DDistinct%2520binding%2520mode%2520of%2520multikinase%2520inhibitor%2520lenvatinib%2520revealed%2520by%2520biochemical%2520characterization%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D89%26epage%3D94%26doi%3D10.1021%2Fml500394m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheek, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nm0597-562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnm0597-562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9142128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXivFOltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=562-566&author=M.+F.+Moghaddamauthor=D.+F.+Grantauthor=J.+M.+Cheekauthor=J.+F.+Greeneauthor=K.+C.+Williamsonauthor=B.+D.+Hammock&title=Bioactivation+of+leukotoxins+to+their+toxic+diols+by+epoxide+hydrolase&doi=10.1038%2Fnm0597-562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase</span></div><div class="casAuthors">Moghaddam, Mehran F.; Grant, David F.; Cheek, Jeffrey M.; Greene, Jessica F.; Williamson, Kristin C.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">562-566</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Leukotoxin is a linoleic acid oxide produced by leukocytes and has been assocd. with the multiple organ failure and adult respiratory distress syndrome seen in some severe burn patients.  Leukotoxin has been reported to be toxic when injected into animals i.v.  Herein, the authors report that this lipid is not directly cytotoxic in at least two in vitro systems.  Using a baculovirus expression system the authors demonstrate that leukotoxin is only cytotoxic in the presence of epoxide hydrolases.  In addn., it is the diol metabolite that proves toxic to pulmonary alveolar epithelial cells, suggesting a crit. role for the diol in leukotoxin-assocd. respiratory disease.  In vivo data also support the toxicity of leukotoxin diol.  For the first time the authors demonstrate that sol. epoxide hydrolase can bioactivate epoxides to diols that are apparently cytotoxic.  Thus, leukotoxin should be regarded as a protoxin corresponding to the more toxic diol.  This clearly has implications for designing new clin. interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr92m-hf2QxLVg90H21EOLACvtfcHk0li4nHdx93Ek6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFOltLs%253D&md5=89d85fa2acc478a04ee3b5b21378c2e9</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnm0597-562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0597-562%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DGrant%26aufirst%3DD.%2BF.%26aulast%3DCheek%26aufirst%3DJ.%2BM.%26aulast%3DGreene%26aufirst%3DJ.%2BF.%26aulast%3DWilliamson%26aufirst%3DK.%2BC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DBioactivation%2520of%2520leukotoxins%2520to%2520their%2520toxic%2520diols%2520by%2520epoxide%2520hydrolase%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D562%26epage%3D566%26doi%3D10.1038%2Fnm0597-562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable potent soluble epoxide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1021/jm070270t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070270t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3825-3840&author=S.+H.+Hwangauthor=H.+J.+Tsaiauthor=J.+Y.+Liuauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Orally+bioavailable+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm070270t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors</span></div><div class="casAuthors">Hwang, Sung Hee; Tsai, Hsing-Ju; Liu, Jun-Yan; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3825-3840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepd. and tested as sol. epoxide hydrolase (sEH) inhibitors.  This series of compds. showed low nanomolar to picomolar activities against recombinant human sEH.  Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human hepatic microsomes.  Furthermore, these new potent inhibitors show a greater metabolic stability in vivo than previously described sEH inhibitors.  Trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (I, t-AUCB, IC50 = 1.3 ± 0.05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVS4Wx8hrt_bVg90H21EOLACvtfcHk0li4nHdx93Ek6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D&md5=ad2116c2671dc36d35b44ff93d55863d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm070270t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070270t%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOrally%2520bioavailable%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3825%26epage%3D3840%26doi%3D10.1021%2Fjm070270t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasagami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5217</span>– <span class="NLM_lpage">5226</span>, <span class="refDoi"> DOI: 10.1021/jm070705c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070705c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOlur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5217-5226&author=I.+H.+Kimauthor=H.+J.+Tsaiauthor=K.+Nishiauthor=T.+Kasagamiauthor=C.+Morisseauauthor=B.+D.+Hammock&title=1%2C3-disubstituted+ureas+functionalized+with+ether+groups+are+potent+inhibitors+of+the+soluble+epoxide+hydrolase+with+improved+pharmacokinetic+properties&doi=10.1021%2Fjm070705c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Disubstituted Ureas Functionalized with Ether Groups are Potent Inhibitors of the Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties</span></div><div class="casAuthors">Kim, In-Hae; Tsai, Hsing-Ju; Nishi, Kosuke; Kasagami, Takeo; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5217-5226</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is a therapeutic target for treating hypertension and inflammation.  1,3-Disubstituted ureas functionalized with an ether group are potent sEH inhibitors.  However, their relatively low metabolic stability leads to poor pharmacokinetic properties.  To improve their bioavailability, we investigated the effect of incorporating various polar groups on the ether function on the inhibition potencies, phys. properties, in vitro metabolic stability, and pharmacokinetic properties.  The structure-activity relationship studies showed that a hydrophobic linker between the urea group and the ether function is necessary to keep their potency.  In addn., urea-ether inhibitors having a polar group such as diethylene glycol or morpholine significantly improved their phys. properties and metabolic stability without any loss of inhibitory potency.  Furthermore, improved pharmacokinetic properties in murine and canine models were obtained with the resulting inhibitors.  These findings will facilitate the usage of sEH inhibitors in animal models of hypertension and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE4y2_2Aw6YLVg90H21EOLACvtfcHk0lgh3Rm1TlWT5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOlur7J&md5=73026ff3639b8ff905e7f79091cc8c31</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm070705c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070705c%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DNishi%26aufirst%3DK.%26aulast%3DKasagami%26aufirst%3DT.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1%252C3-disubstituted%2520ureas%2520functionalized%2520with%2520ether%2520groups%2520are%2520potent%2520inhibitors%2520of%2520the%2520soluble%2520epoxide%2520hydrolase%2520with%2520improved%2520pharmacokinetic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5217%26epage%3D5226%26doi%3D10.1021%2Fjm070705c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shihadih, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2197</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2014.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24685540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2193-2197&author=V.+Burmistrovauthor=C.+Morisseauauthor=K.+S.+Leeauthor=D.+S.+Shihadihauthor=T.+R.+Harrisauthor=G.+M.+Butovauthor=B.+D.+Hammock&title=Symmetric+adamantyl-diureas+as+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Lee, Kin Sing Stephen; Shihadih, Diyala S.; Harris, Todd R.; Butov, Gennady M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2193-2197</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of inhibitors of the sol. epoxide hydrolase (sEH) contg. two urea groups has been developed.  Inhibition potency of the described compds. ranges from 2.0 μM to 0.4 nM. 1,6-(hexamethylene)bis[(adamant-1-yl)urea] was found to be a potent slow tight binding inhibitor (IC50 = 0.5 nM) with a strong binding to sEH (Ki = 3.1 nM) and a moderately long residence time on the enzyme (koff = 1.05 × 10-3 s-1; t1/2 = 11 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi-gy0pevlO7Vg90H21EOLACvtfcHk0lgh3Rm1TlWT5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOntL0%253D&md5=35625299d7d4e014cb446bd7ec1838a5</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DShihadih%26aufirst%3DD.%2BS.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSymmetric%2520adamantyl-diureas%2520as%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2193%26epage%3D2197%26doi%3D10.1016%2Fj.bmcl.2014.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1039/c2md00288d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc2md00288d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25225606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=379-384&author=S.+X.+Huangauthor=B.+Caoauthor=C.+Morisseauauthor=Y.+Tinauthor=B.+D.+Hammockauthor=Y.+Q.+Long&title=Structure-based+optimization+of+the+piperazino-containing+1%2C3-disubstituted+ureas+affording+sub-nanomolar+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1039%2Fc2md00288d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Huang, Shao-Xu; Cao, Bin; Morisseau, Christophe; Jin, Yi; Hammock, Bruce D.; Long, Ya-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The inhibition of the sol. epoxide hydrolase (sEH) is a promising new therapy in the treatment of cardiovascular, inflammation and other disorders.  A piperazino functionality as the tertiary pharmacophore remarkably improved the drug-like profile of the 1,3-disubstituted urea sEH inhibitors.  However, the potency was more dependent on the overall best balance of the hydrophilicity and lipophilicity.  Based on the sEH-inhibitor complex structure, further structural optimization on the piperazino-contg. 1,3-disubstituted urea scaffold was conducted for an improved potency.  The 1-adamantylacetamide and para-phenylcarbonyl group were identified to be an optimal primary pharmacophore and secondary pharmacophore motif, resp., generating sub-nanomolar sEH inhibitors with favorable water soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4KGERQTtSKrVg90H21EOLACvtfcHk0livh9bpOWnGkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOqu7o%253D&md5=7517438f79da7538eec4dd028dd2b063</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1039%2Fc2md00288d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md00288d%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BX.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DTin%26aufirst%3DY.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DStructure-based%2520optimization%2520of%2520the%2520piperazino-containing%25201%252C3-disubstituted%2520ureas%2520affording%2520sub-nanomolar%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D379%26epage%3D384%26doi%3D10.1039%2Fc2md00288d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1110/ps.051720206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1110%2Fps.051720206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16322563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=58-64&author=G.+A.+Gomezauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Christianson&title=Human+soluble+epoxide+hydrolase%3A+structural+basis+of+inhibition+by+4-%283-cyclohexylureido%29-carboxylic+acids&doi=10.1110%2Fps.051720206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span></div><div class="casAuthors">Gomez, German A.; Morisseau, Christophe; Hammock, Bruce D.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">X-ray crystal structures of human sol. epoxide hydrolase (sEH) complexed with four different dialkylurea inhibitors bearing pendant carboxylate "tails" of varying length have been detd. at 2.3-3.0 Å resoln.  Similarities among inhibitor binding modes reinforce the proposed roles of Y381 and/or Y465 as general acids that protonate the epoxide ring of the substrate in concert with nucleophilic attack of D333 at the electrophilic epoxide carbon.  Addnl., the binding of these inhibitors allows us to model the binding mode of the endogenous substrate 14,15-epoxyeicosatrienoic acid.  Contrasts among inhibitor binding modes include opposite orientations of inhibitor binding in the active-site hydrophobic tunnel.  Alternative binding orientations obsd. for this series of inhibitors to human sEH, as well as the binding of certain dialkylurea inhibitors to human sEH and murine sEH, complicate the structure-based design of human sEH inhibitors with potential pharmaceutical applications in the treatment of hypertension.  Thus, with regard to the optimization of inhibitor designs targeting human sEH, it is crit. that human sEH and not murine sEH be utilized for inhibitor screening, and it is crit. that structures of human sEH-inhibitor complexes be detd. to verify inhibitor binding orientations that correlate with measured affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrqO7mSzRPrVg90H21EOLACvtfcHk0livh9bpOWnGkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D&md5=b16bb0c99a177acc885cbbb789374f2b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1110%2Fps.051720206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.051720206%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DG.%2BA.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHuman%2520soluble%2520epoxide%2520hydrolase%253A%2520structural%2520basis%2520of%2520inhibition%2520by%25204-%25283-cyclohexylureido%2529-carboxylic%2520acids%26jtitle%3DProtein%2520Sci.%26date%3D2006%26volume%3D15%26spage%3D58%26epage%3D64%26doi%3D10.1110%2Fps.051720206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8854</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.16.8849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.96.16.8849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10430859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8849-8854&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=D.+Dowdyauthor=J.+Zhengauthor=J.+F.+Greeneauthor=J.+R.+Sanbornauthor=B.+D.+Hammock&title=Potent+urea+and+carbamate+inhibitors+of+soluble+epoxide+hydrolases&doi=10.1073%2Fpnas.96.16.8849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Dowdy, Deanna; Zheng, Jiang; Greene, Jessica F.; Sanborn, James R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8849-8854</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) plays a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformations.  Herein, the authors report the discovery of substituted ureas and carbamates as potent inhibitors of sEH.  Some of these selective, competitive tight-binding inhibitors with nanomolar Ki values interacted stoichiometrically with the homogeneous recombinant murine and human sEHs.  These inhibitors enhance cytotoxicity of trans-stilbene oxide, which is active as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to its toxic diol.  They also reduce toxicity of leukotoxin in vivo in mice and prevent symptoms suggestive of acute respiratory distress syndrome.  These potent inhibitors may be valuable tools for testing hypotheses of involvement of diol and epoxide lipids in chem. mediation in vitro or in vivo systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOIwuI01SYLVg90H21EOLACvtfcHk0livh9bpOWnGkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D&md5=eeff85f27c1a33e2da6fb7f8f2ae91de</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.16.8849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.16.8849%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DDowdy%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DJ.%2BF.%26aulast%3DSanborn%26aufirst%3DJ.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPotent%2520urea%2520and%2520carbamate%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8849%26epage%3D8854%26doi%3D10.1073%2Fpnas.96.16.8849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lonsdale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grey, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulholland, A. J.</span></span> <span> </span><span class="NLM_article-title">Determinants of reactivity and selectivity in soluble epoxide hydrolase from quantum mechanics/molecular mechanics modeling</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1774</span>– <span class="NLM_lpage">1786</span>, <span class="refDoi"> DOI: 10.1021/bi201722j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201722j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Oitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1774-1786&author=R.+Lonsdaleauthor=S.+Hoyleauthor=D.+T.+Greyauthor=L.+Ridderauthor=A.+J.+Mulholland&title=Determinants+of+reactivity+and+selectivity+in+soluble+epoxide+hydrolase+from+quantum+mechanics%2Fmolecular+mechanics+modeling&doi=10.1021%2Fbi201722j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of Reactivity and Selectivity in Soluble Epoxide Hydrolase from Quantum Mechanics/Molecular Mechanics Modeling</span></div><div class="casAuthors">Lonsdale, Richard; Hoyle, Simon; Grey, Daniel T.; Ridder, Lars; Mulholland, Adrian J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1774-1786</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an enzyme involved in drug metab. that catalyzes the hydrolysis of epoxides to form their corresponding diols. sEH has a broad substrate range and shows high regio- and enantioselectivity for nucleophilic ring opening by Asp333.  Epoxide hydrolases therefore have potential synthetic applications.  We have used combined quantum mechanics/mol. mechanics (QM/MM) umbrella sampling mol. dynamics (MD) simulations (at the AM1/CHARMM22 level) and high-level ab initio (SCS-MP2) QM/MM calcns. to analyze the reactions, and determinants of selectivity, for two substrates: trans-stilbene oxide (t-SO) and trans-diphenylpropene oxide (t-DPPO).  The calcd. free energy barriers from the QM/MM (AM1/CHARMM22) umbrella sampling MD simulations show a lower barrier for Ph attack in t-DPPO, compared with that for benzylic attack, in agreement with expt.  Activation barriers in agreement with exptl. rate consts. are obtained only with the highest level of QM theory (SCS-MP2) used.  Our results show that the selectivity of the ring-opening reaction is influenced by several factors, including proximity to the nucleophile, electronic stabilization of the transition state (TS), and hydrogen bonding to two active site tyrosine residues.  The protonation state of His523 during nucleophilic attack has also been investigated, and our results show that the protonated form is most consistent with exptl. findings.  The work presented here illustrates how determinants of selectivity can be identified from QM/MM simulations.  These insights may also provide useful information for the design of novel catalysts for use in the synthesis of enantiopure compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozsUe7betCxrVg90H21EOLACvtfcHk0lj8ky3aSKL2lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Oitrc%253D&md5=928a0010368479451f4ea9dc1b39c20a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fbi201722j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201722j%26sid%3Dliteratum%253Aachs%26aulast%3DLonsdale%26aufirst%3DR.%26aulast%3DHoyle%26aufirst%3DS.%26aulast%3DGrey%26aufirst%3DD.%2BT.%26aulast%3DRidder%26aufirst%3DL.%26aulast%3DMulholland%26aufirst%3DA.%2BJ.%26atitle%3DDeterminants%2520of%2520reactivity%2520and%2520selectivity%2520in%2520soluble%2520epoxide%2520hydrolase%2520from%2520quantum%2520mechanics%252Fmolecular%2520mechanics%2520modeling%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D1774%26epage%3D1786%26doi%3D10.1021%2Fbi201722j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazerwith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesten, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beidler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattachar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesten, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomanbhoy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1021/ml100190t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor&doi=10.1021%2Fml100190t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0lgeChDUODBYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96%26doi%3D10.1021%2Fml100190t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayfield, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilula, N. B.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1038/384083a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2F384083a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8900284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=83-87&author=B.+F.+Cravattauthor=D.+K.+Giangauthor=S.+P.+Mayfieldauthor=D.+L.+Bogerauthor=R.+A.+Lernerauthor=N.+B.+Gilula&title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&doi=10.1038%2F384083a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span></div><div class="casAuthors">Cravatt, Benjamin F.; Giang, Dan K.; Mayfield, Stephen P.; Boger, Dale L.; Lerner, Richard A.; Gilula, Norton B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604</span>),
    <span class="NLM_cas:pages">83-87</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Endogenous neuromodulatory mols.. are commonly couples to specific metabolic enzymes to ensure rapid signal inactivation.  Thus, acetylcholine is hydrolyzed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases.  Previously, we reported the structure and sleep-deproved cats.  Cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results).  We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid.  We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes.  We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling mols., the fatty-acid amides.  Therefore we will hereafter refer to oelamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhJfsk7jdmLVg90H21EOLACvtfcHk0lgeChDUODBYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D&md5=155095116ad61669c06c4b6dcc25e28a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2F384083a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384083a0%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DMayfield%26aufirst%3DS.%2BP.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DLerner%26aufirst%3DR.%2BA.%26aulast%3DGilula%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520characterization%2520of%2520an%2520enzyme%2520that%2520degrades%2520neuromodulatory%2520fatty-acid%2520amides%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D83%26epage%3D87%26doi%3D10.1038%2F384083a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kathuria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaetani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fegley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Modulation of anxiety through blockade of anandamide hydrolysis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1038/nm803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnm803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12461523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivF2l" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=76-81&author=S.+Kathuriaauthor=S.+Gaetaniauthor=D.+Fegleyauthor=F.+Valinoauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=G.+La+Ranaauthor=A.+Calignanoauthor=A.+Giustinoauthor=M.+Tattoliauthor=M.+Palmeryauthor=V.+Cuomoauthor=D.+Piomelli&title=Modulation+of+anxiety+through+blockade+of+anandamide+hydrolysis&doi=10.1038%2Fnm803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of anxiety through blockade of anandamide hydrolysis</span></div><div class="casAuthors">Kathuria, Satish; Gaetani, Silvana; Fegley, Darren; Valino, Fernando; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; La Rana, Giovanna; Calignano, Antonio; Giustino, Arcangela; Tattoli, Maria; Palmery, Maura; Cuomo, Vincenzo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-81</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The psychoactive constituent of cannabis, Δ9-tetrahydrocannabinol, produces in humans subjective responses mediated by CB1 cannabinoid receptors, indicating that endogenous cannabinoids may contribute to the control of emotion.  But the variable effects of Δ9-tetrahydrocannabinol obscure the interpretation of these results and limit the therapeutic potential of direct cannabinoid agonists.  An alternative approach may be to develop drugs that amplify the effects of endogenous cannabinoids by preventing their inactivation.  Here, the authors describe a class of potent, selective, and systemically active inhibitors of fatty acid amide hydrolase, the enzyme responsible for the degrdn. of the endogenous cannabinoid anandamide.  Like clin. used anti-anxiety drugs, in rats the inhibitors exhibit benzodiazepine-like properties in the elevated zero-maze test and suppress isolation-induced vocalizations.  These effects are accompanied by augmented brain levels of anandamide and are prevented by CB1 receptor blockade.  Apparently, anandamide participates in the modulation of emotional states and fatty acid amide hydrolase inhibition is an innovative approach to anti-anxiety therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbjKypjqxPcrVg90H21EOLACvtfcHk0lgeChDUODBYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivF2l&md5=350c8a5af97b6ea4e41e9f0c821231e4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnm803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm803%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DValino%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGiustino%26aufirst%3DA.%26aulast%3DTattoli%26aufirst%3DM.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DModulation%2520of%2520anxiety%2520through%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D76%26epage%3D81%26doi%3D10.1038%2Fnm803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghatelian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardouin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1124/jpet.104.069401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fjpet.104.069401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15229230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=441-448&author=A.+H.+Lichtmanauthor=D.+Leungauthor=C.+C.+Sheltonauthor=A.+Saghatelianauthor=C.+Hardouinauthor=D.+L.+Bogerauthor=B.+F.+Cravatt&title=Reversible+inhibitors+of+fatty+acid+amide+hydrolase+that+promote+analgesia%3A+evidence+for+an+unprecedented+combination+of+potency+and+selectivity&doi=10.1124%2Fjpet.104.069401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: Evidence for an unprecedented combination of potency and selectivity</span></div><div class="casAuthors">Lichtman, Aron H.; Leung, Donmienne; Shelton, Christopher C.; Saghatelian, Alan; Hardouin, Christophe; Boger, Dale L.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-448</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is the primary catabolic regulator of several bioactive lipid amides in vivo, including the endogenous cannabinoid anandamide and the sleep-inducing substance oleamide.  Inhibitors of FAAH are considered a potential therapeutic approach for the treatment of several nervous system disorders, including pain, anxiety, and insomnia.  However, for FAAH inhibitors to achieve clin. utility, they must not only display efficacy in vivo but also selectivity for this enzyme relative to the numerous other serine hydrolases present in mammalian proteomes.  Here, we report a general strategy for evaluating the pharmacol. activity and target specificity of FAAH inhibitors and its implementation to develop the first class of selective reversible inhibitors of this enzyme that are highly efficacious in vivo.  Using a series of functional proteomics, anal. chem., and behavioral pharmacol. assays, we have identified a class of α-keto-heterocycles that show unprecedented selectivity for FAAH relative to other mammalian hydrolases, and, when administered to rodents, raise central nervous system levels of anandamide and promote cannabinoid receptor 1-dependent analgesia in several assays of pain sensation.  These studies provide further evidence that FAAH may represent an attractive therapeutic target and describe a general route by which inhibitors of this enzyme can be optimized to achieve exceptional potency, selectivity, and efficacy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-2yWRQoneprVg90H21EOLACvtfcHk0liua9k9sPX6Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKrt7k%253D&md5=53e5c721cde0d43d07413d4563ded313</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.069401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.069401%26sid%3Dliteratum%253Aachs%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DShelton%26aufirst%3DC.%2BC.%26aulast%3DSaghatelian%26aufirst%3DA.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DReversible%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520that%2520promote%2520analgesia%253A%2520evidence%2520for%2520an%2520unprecedented%2520combination%2520of%2520potency%2520and%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D441%26epage%3D448%26doi%3D10.1124%2Fjpet.104.069401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beidler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazerwith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=M.+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+characterization+of+a+highly+selective+FAAH+inhibitor+that+reduces+inflammatory+pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0liua9k9sPX6Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520selective%2520FAAH%2520inhibitor%2520that%2520reduces%2520inflammatory%2520pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everdeen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">12820</span>– <span class="NLM_lpage">12824</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806121105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.0806121105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18753625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=12820-12824&author=M.+Mileniauthor=D.+S.+Johnsonauthor=Z.+Wangauthor=D.+S.+Everdeenauthor=M.+Liimattaauthor=B.+Pabstauthor=K.+Bhattacharyaauthor=R.+A.+Nugentauthor=S.+Kamtekarauthor=B.+F.+Cravattauthor=K.+Ahnauthor=R.+C.+Stevens&title=Structure-guided+inhibitor+design+for+human+FAAH+by+interspecies+active+site+conversion&doi=10.1073%2Fpnas.0806121105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span></div><div class="casAuthors">Mileni, Mauro; Johnson, Douglas S.; Wang, Zhigang; Everdeen, Daniel S.; Liimatta, Marya; Pabst, Brandon; Bhattacharya, Keshab; Nugent, Richard A.; Kamtekar, Satwik; Cravatt, Benjamin F.; Ahn, Kay; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12820-12824</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The integral membrane enzyme fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and related amidated signaling lipids.  Genetic or pharmacol. inactivation of FAAH produces analgesic, anxiolytic, and antiinflammatory phenotypes but not the undesirable side effects of direct cannabinoid receptor agonists, indicating that FAAH may be a promising therapeutic target.  Structure-based inhibitor design has, however, been hampered by difficulties in expressing the human FAAH enzyme.  Here, we address this problem by interconverting the active sites of rat and human FAAH using site-directed mutagenesis.  The resulting humanized rat (h/r) FAAH protein exhibits the inhibitor sensitivity profiles of human FAAH but maintains the high-expression yield of the rat enzyme.  We report a 2.75-Å crystal structure of h/rFAAH complexed with an inhibitor, N-phenyl-4- (quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750), that shows strong preference for human FAAH.  This structure offers compelling insights to explain the species selectivity of FAAH inhibitors, which should guide future drug design programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq16BzSUEI2DbVg90H21EOLACvtfcHk0lgGCY3QjlF96w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP&md5=bebc9409a5e71734f651c5ab89303fad</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806121105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806121105%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEverdeen%26aufirst%3DD.%2BS.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520for%2520human%2520FAAH%2520by%2520interspecies%2520active%2520site%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D12820%26epage%3D12824%26doi%3D10.1073%2Fpnas.0806121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes-Briones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creatura, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurnauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherif, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skosnik, P. D.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial</span>. <i>Lancet Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/S2215-0366(18)30427-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS2215-0366%2818%2930427-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=30528676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BB3crpvFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=35-45&author=D.+C.+D%E2%80%99Souzaauthor=J.+Cortes-Brionesauthor=G.+Creaturaauthor=G.+Bluezauthor=H.+Thurnauerauthor=E.+Deasoauthor=K.+Bielenauthor=T.+Surtiauthor=R.+Radhakrishnanauthor=A.+Guptaauthor=S.+Guptaauthor=J.+Cahillauthor=M.+A.+Sherifauthor=A.+Makriyannisauthor=P.+T.+Morganauthor=M.+Ranganathanauthor=P.+D.+Skosnik&title=Efficacy+and+safety+of+a+fatty+acid+amide+hydrolase+inhibitor+%28PF-04457845%29+in+the+treatment+of+cannabis+withdrawal+and+dependence+in+men%3A+a+double-blind%2C+placebo-controlled%2C+parallel+group%2C+phase+2a+single-site+randomised+controlled+trial&doi=10.1016%2FS2215-0366%2818%2930427-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial</span></div><div class="casAuthors">D'Souza Deepak Cyril; Cortes-Briones Jose; Creatura Gina; Bluez Grai; Thurnauer Halle; Deaso Emma; Bielen Kim; Surti Toral; Radhakrishnan Rajiv; Gupta Aarti; Gupta Swapnil; Cahill John; Sherif Mohamed A; Morgan Peter T; Ranganathan Mohini; Skosnik Patrick D; Makriyannis Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">The lancet. Psychiatry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Cannabis is one of the most widely used drugs worldwide.  Cannabis use disorder is characterised by recurrent use of cannabis that causes significant clinical and functional impairment.  There are no approved pharmacological treatments for cannabis use disorder.  One approach is to potentiate endocannabinoid signalling by inhibiting fatty acid amide hydrolase (FAAH), the enzyme that degrades the endocannabinoid anandamide.  We aimed to test the efficacy and safety of the FAAH-inhibitor PF-04457845 in reduction of cannabis withdrawal and cannabis use in men who were daily cannabis users.  METHODS:  We did a double-blind, placebo-controlled, parallel group phase 2a trial at one site in men aged 18-55 years with cannabis dependence according to DSM-IV criteria (equivalent to cannabis use disorder in DSM-5).  After baseline assessments, participants were randomly assigned (2:1) to receive PF-04457845 (4 mg per day) or placebo using a fixed block size of six participants, stratified by severity of cannabis use and desire to quit.  Participants were admitted to hospital for 5 days (maximum 8 days) to achieve abstinence and precipitate cannabis withdrawal, after which they were discharged to continue the remaining 3 weeks of treatment as outpatients.  The primary endpoints were treatment-related differences in cannabis withdrawal symptoms during hospital admission, and week 4 (end of treatment) self-reported cannabis use and urine THC-COOH concentrations in the intention-to-treat population.  The study is registered at ClinicalTrials.gov, number NCT01618656.  FINDINGS:  Between Sept 12, 2012, and Jan 18, 2016, 46 men were randomly assigned to PF-04457845 and 24 to placebo.  Adherence to study medication was 88%, as confirmed by video-calling and pill count, and corroborated by corresponding drug and anandamide concentrations in blood.  Relative to placebo, treatment with PF-04457845 was associated with reduced symptoms of cannabis withdrawal (first day of treatment mean symptom score 11·00 [95% CI 7·78-15·57] vs 6·04 [4·43-8·24]; difference 4·96 [0·71-9·21]; padj=0·048; second day of treatment 11·74 [8·28-16·66] vs 6·02 [4·28-8·47]; difference 5·73 [1·13-10·32]; padj=0·035) and related mood symptoms during the inpatient phase.  Additionally, treatment with PF-04457845 was associated with lower self-reported cannabis use at 4 weeks (mean 1·27 joints per day [95% CI 0·82-1·97] vs 0·40 [0·25-0·62]; difference 0·88 [0·29-1·46]; p=0·0003) and lower urinary THC-COOH concentrations (mean 657·92 ng/mL [95% CI 381·60-1134·30] vs 265·55 [175·60-401·57]; difference 392·37 [17·55-767·18)]; p=0·009).  Eight (17%) patients in the PF-04457845 group and four (17%) in the placebo group discontinued during the treatment period.  During the 4-week treatment phase, 20 (43%) of 46 participants in the PF-04457845 group and 11 (46%) of 24 participants in the placebo group had an adverse event.  There were no serious adverse events.  INTERPRETATION:  PF-04457845, a novel FAAH inhibitor, reduced cannabis withdrawal symptoms and cannabis use in men, and might represent an effective and safe approach for the treatment of cannabis use disorder.  FUNDING:  United States National Institute of Drug Abuse (NIDA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuFJfQq81sAy6Ufuk_1xoTfW6udTcc2eZHTtuSwzSTF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crpvFWrtg%253D%253D&md5=dd9bcc6470045275e5a977d175d70cbf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS2215-0366%2818%2930427-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2215-0366%252818%252930427-9%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BC.%26aulast%3DCortes-Briones%26aufirst%3DJ.%26aulast%3DCreatura%26aufirst%3DG.%26aulast%3DBluez%26aufirst%3DG.%26aulast%3DThurnauer%26aufirst%3DH.%26aulast%3DDeaso%26aufirst%3DE.%26aulast%3DBielen%26aufirst%3DK.%26aulast%3DSurti%26aufirst%3DT.%26aulast%3DRadhakrishnan%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DCahill%26aufirst%3DJ.%26aulast%3DSherif%26aufirst%3DM.%2BA.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DP.%2BT.%26aulast%3DRanganathan%26aufirst%3DM.%26aulast%3DSkosnik%26aufirst%3DP.%2BD.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520a%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520%2528PF-04457845%2529%2520in%2520the%2520treatment%2520of%2520cannabis%2520withdrawal%2520and%2520dependence%2520in%2520men%253A%2520a%2520double-blind%252C%2520placebo-controlled%252C%2520parallel%2520group%252C%2520phase%25202a%2520single-site%2520randomised%2520controlled%2520trial%26jtitle%3DLancet%2520Psychiatry%26date%3D2019%26volume%3D6%26spage%3D35%26epage%3D45%26doi%3D10.1016%2FS2215-0366%2818%2930427-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. L.</span></span> <span> </span><span class="NLM_article-title">Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives</span>. <i>J. Hepatocell Carcinoma</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.2147/JHC.S45040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2147%2FJHC.S45040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27508178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ptlWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=85-99&author=C.+H.+Hsuauthor=Y.+C.+Shenauthor=Y.+Y.+Shaoauthor=C.+Hsuauthor=A.+L.+Cheng&title=Sorafenib+in+advanced+hepatocellular+carcinoma%3A+current+status+and+future+perspectives&doi=10.2147%2FJHC.S45040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives</span></div><div class="casAuthors">Hsu Chih-Hung; Shao Yu-Yun; Hsu Chiun; Shen Ying-Chun; Cheng Ann-Lii</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatocellular carcinoma</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-99</span>
        ISSN:<span class="NLM_cas:issn">2253-5969</span>.
    </div><div class="casAbstract">The approval of sorafenib, a multikinase inhibitor targeting primarily Raf kinase and the vascular endothelial growth factor receptor, in 2007 for treating advanced hepatocellular carcinoma (HCC) has generated considerable enthusiasm in drug development for this difficult-to-treat disease.  However, because several randomized Phase III studies testing new multikinase inhibitors failed, sorafenib remains the standard of first-line systemic therapy for patients with advanced HCC.  Field practice studies worldwide have suggested that in daily practice, physicians are adopting either a preemptive dose modification or a ramp-up strategy to improve the compliance of their patients.  In addition, accumulating data have suggested that patients with Child-Pugh class B liver function can tolerate sorafenib as well as patients with Child-Pugh class A liver function, although the actual benefit of sorafenib in patients with Child-Pugh class B liver function has yet to be confirmed.  Whether sorafenib can be used as an adjunctive therapy to improve the outcomes of intermediate-stage HCC patients treated with transcatheter arterial chemoembolization or early-stage HCC patients after curative therapies is being investigated in several ongoing randomized Phase III studies.  An increasing number of studies have reported that sorafenib exerts "off-target" effects, including the modulation of signaling pathways other than Raf/MEK/ERK pathway, nonapoptotic cell death mechanisms, and even immune modulation.  Finally, although sorafenib in combination with chemotherapy or other targeted therapies has the potential to improve therapeutic efficacy in treating HCC, it also increases toxicity.  Additional clinical studies are warranted to determine useful sorafenib-based combinations for the treatment of advanced HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRayDb-rrwA1Ob6AVA-44PTfW6udTcc2eZ97QhqSwyZPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ptlWhtg%253D%253D&md5=a86929d85c76bfc22bbdc1b3c2725c1c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2147%2FJHC.S45040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJHC.S45040%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DC.%2BH.%26aulast%3DShen%26aufirst%3DY.%2BC.%26aulast%3DShao%26aufirst%3DY.%2BY.%26aulast%3DHsu%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DA.%2BL.%26atitle%3DSorafenib%2520in%2520advanced%2520hepatocellular%2520carcinoma%253A%2520current%2520status%2520and%2520future%2520perspectives%26jtitle%3DJ.%2520Hepatocell%2520Carcinoma%26date%3D2014%26volume%3D1%26spage%3D85%26epage%3D99%26doi%3D10.2147%2FJHC.S45040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lathia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lettieri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallentine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaresan, P.</span></span> <span> </span><span class="NLM_article-title">Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1007/s00280-005-0068-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs00280-005-0068-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16133532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1KktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2006&pages=685-692&author=C.+Lathiaauthor=J.+Lettieriauthor=F.+Cihonauthor=M.+Gallentineauthor=M.+Radtkeauthor=P.+Sundaresan&title=Lack+of+effect+of+ketoconazole-mediated+CYP3A+inhibition+on+sorafenib+clinical+pharmacokinetics&doi=10.1007%2Fs00280-005-0068-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics</span></div><div class="casAuthors">Lathia, Chetan; Lettieri, John; Cihon, Frank; Gallentine, Martha; Radtke, Martin; Sundaresan, Pavur</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Sorafenib is a novel, small-mol. anticancer compd. that inhibits tumor cell proliferation by targeting Raf in the Raf/MEK/ERK signaling pathway, and inhibits angiogenesis by targeting tyrosine kinases such as vascular-endothelial growth factor receptor (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor (PDGFR).  In vitro microsomal data indicate that sorafenib is metabolized by two pathways: phase I oxidn. mediated by cytochrome P 450 (CYP) 3A4; and phase II conjugation mediated by UGT1A9.  Approx. 50% of an orally administered dose is recovered as unchanged drug in the feces, due to either biliary excretion or lack of absorption.  The aim of this study was to evaluate the effect of CYP3A inhibition by ketoconazole on sorafenib pharmacokinetics.  This was an open-label, non-randomized, 2-period, one-way crossover study in sixteen healthy male subjects.  A single 50 mg dose of sorafenib was administered alone (period 1) and in combination with ketoconazole 400 mg once daily (period 2) (ketoconazole was given for 7 days, and a single 50 mg sorafenib dose was administered concomitantly on day 4).  No clin. relevant change in pharmacokinetics of sorafenib and no clin. relevant adverse events or lab. abnormalities were obsd. in this study upon co-administration of the two drugs.  Plasma concns. of the main CYP3A4 generated metabolite, sorafenib N-oxide, decreased considerably upon ketoconazole co-administration.  This effect is in accordance with the in vitro finding that CYP3A4 is the primary enzyme for sorafenib N-oxide formation.  Further, these data indicate that blocking sorafenib metab. by the CYP3A4 pathway will not lead to an increase in sorafenib exposure.  This is consistent with data from a clin. mass-balance study that showed 15% of the administered dose was eliminated by glucuronidation, compared to less than 5% eliminated as oxidative metabolites.  Since there was no increase in sorafenib exposure following concomitant administration of the highly potent CYP3A4 inhibitor ketoconazole with low dose sorafenib, it is postulated that higher therapeutic doses of sorafenib may be safely co-administered with ketoconazole, as well as with other inhibitors of CYP3A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV-01_MtXZH7Vg90H21EOLACvtfcHk0ljaHBT2UNQkVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1KktLk%253D&md5=7d13ee0c45f5280fcdaf9d6982339dec</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-0068-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-0068-6%26sid%3Dliteratum%253Aachs%26aulast%3DLathia%26aufirst%3DC.%26aulast%3DLettieri%26aufirst%3DJ.%26aulast%3DCihon%26aufirst%3DF.%26aulast%3DGallentine%26aufirst%3DM.%26aulast%3DRadtke%26aufirst%3DM.%26aulast%3DSundaresan%26aufirst%3DP.%26atitle%3DLack%2520of%2520effect%2520of%2520ketoconazole-mediated%2520CYP3A%2520inhibition%2520on%2520sorafenib%2520clinical%2520pharmacokinetics%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2006%26volume%3D57%26spage%3D685%26epage%3D692%26doi%3D10.1007%2Fs00280-005-0068-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sissung, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federspiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venzon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarchoan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widemann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span> <span> </span><span class="NLM_article-title">Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2099</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-2484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1158%2F1078-0432.CCR-11-2484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22307138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2099-2107&author=C.+J.+Peerauthor=T.+M.+Sissungauthor=A.+Kimauthor=L.+Jainauthor=S.+Wooauthor=E.+R.+Gardnerauthor=C.+T.+Kirklandauthor=S.+M.+Troutmanauthor=B.+C.+Englishauthor=E.+D.+Richardsonauthor=J.+Federspielauthor=D.+Venzonauthor=W.+Dahutauthor=E.+Kohnauthor=S.+Kummarauthor=R.+Yarchoanauthor=G.+Giacconeauthor=B.+Widemannauthor=W.+D.+Figg&title=Sorafenib+is+an+inhibitor+of+UGT1A1+but+is+metabolized+by+UGT1A9%3A+implications+of+genetic+variants+on+pharmacokinetics+and+hyperbilirubinemia&doi=10.1158%2F1078-0432.CCR-11-2484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia</span></div><div class="casAuthors">Peer, Cody J.; Sissung, Tristan M.; Kim, Ae Rang; Jain, Lokesh; Woo, Sukyung; Gardner, Erin R.; Kirkland, C. Tyler; Troutman, Sarah M.; English, Bevin C.; Richardson, Emily D.; Federspiel, Joel; Venzon, David; Dahut, William; Kohn, Elise; Kummar, Shivaani; Yarchoan, Robert; Giaccone, Giuseppe; Widemann, Brigitte; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2099-2107</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Several case reports suggest sorafenib exposure and sorafenib-induced hyperbilirubinemia may be related to a (TA)5/6/7 repeat polymorphism in UGT1A1*28 (UGT, uridine glucuronosyl transferase).  We hypothesized that sorafenib inhibits UGT1A1 and individuals carrying UGT1A1*28 and/or UGT1A9 variants experience greater sorafenib exposure and greater increase in sorafenib-induced plasma bilirubin concn.  Exptl. Design: Inhibition of UGT1A1-mediated bilirubin glucuronidation by sorafenib was assessed in vitro.  UGT1A1*28 and UGT1A9*3 genotypes were ascertained with fragment anal. or direct sequencing in 120 cancer patients receiving sorafenib on five different clin. trials.  Total bilirubin measurements were collected in prostate cancer patients before receiving sorafenib (n = 41) and 19 to 30 days following treatment and were compared with UGT1A1*28 genotype.  RESULTS: Sorafenib exhibited mixed-mode inhibition of UGT1A1-mediated bilirubin glucuronidation (IC50 = 18 μmol/L; Ki = 11.7 μmol/L) in vitro.  Five patients carrying UGT1A1*28/*28 (n = 4) or UGT1A9*3/*3 (n = 1) genotypes had first dose, dose-normalized areas under the sorafenib plasma concn. vs. time curve (AUC) that were in the 93rd percentile, whereas three patients carrying UGT1A1*28/*28 had AUCs in the bottom quartile of all genotyped patients.  The Drug Metabolizing Enzymes and Transporters genotyping platform was applied to DNA obtained from six patients, which revealed the ABCC2-24C>T genotype cosegregated with sorafenib AUC phenotype.  Sorafenib exposure was related to plasma bilirubin increases in patients carrying 1 or 2 copies of UGT1A1*28 alleles (n = 12 and n = 5; R2 = 0.38 and R2 = 0.77; P = 0.032 and P = 0.051, resp.).  UGT1A1*28 carriers showed two distinct phenotypes that could be explained by ABCC2-24C>T genotype and are more likely to experience plasma bilirubin increases following sorafenib if they had high sorafenib exposure.  CONCLUSIONS: This pilot study indicates that genotype status of UGT1A1, UGT1A9, and ABCC2 and serum bilirubin concn. increases reflect abnormally high AUC in patients treated with sorafenib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFsvwIshxcLVg90H21EOLACvtfcHk0lj0An7mFqfbBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOls7o%253D&md5=896671fb72062ce112c85551b5b33834</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2484%26sid%3Dliteratum%253Aachs%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DSissung%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DL.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DGardner%26aufirst%3DE.%2BR.%26aulast%3DKirkland%26aufirst%3DC.%2BT.%26aulast%3DTroutman%26aufirst%3DS.%2BM.%26aulast%3DEnglish%26aufirst%3DB.%2BC.%26aulast%3DRichardson%26aufirst%3DE.%2BD.%26aulast%3DFederspiel%26aufirst%3DJ.%26aulast%3DVenzon%26aufirst%3DD.%26aulast%3DDahut%26aufirst%3DW.%26aulast%3DKohn%26aufirst%3DE.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DYarchoan%26aufirst%3DR.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DWidemann%26aufirst%3DB.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DSorafenib%2520is%2520an%2520inhibitor%2520of%2520UGT1A1%2520but%2520is%2520metabolized%2520by%2520UGT1A9%253A%2520implications%2520of%2520genetic%2520variants%2520on%2520pharmacokinetics%2520and%2520hyperbilirubinemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D2099%26epage%3D2107%26doi%3D10.1158%2F1078-0432.CCR-11-2484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishnani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.036996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fdmd.110.036996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21123164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVWiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=510-521&author=A.+Ghosalauthor=Y.+Yuanauthor=W.+Tongauthor=A.+D.+Suauthor=C.+Guauthor=S.+K.+Chowdhuryauthor=N.+S.+Kishnaniauthor=K.+B.+Alton&title=Characterization+of+human+liver+enzymes+involved+in+the+biotransformation+of+boceprevir%2C+a+hepatitis+C+virus+protease+inhibitor&doi=10.1124%2Fdmd.110.036996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor</span></div><div class="casAuthors">Ghosal, Anima; Yuan, Yuan; Tong, Wei; Su, Ai-Duen; Gu, Chunyan; Chowdhury, Swapan K.; Kishnani, Narendra S.; Alton, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">510-521</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Boceprevir (SCH 503034), a protease inhibitor, is under clin. development for the treatment of human hepatitis C virus infections.  In human liver microsomes, formation of oxidative metabolites after incubations with [14C]boceprevir was catalyzed by CYP3A4 and CYP3A5.  In addn., the highest turnover was obsd. in recombinant CYP3A4 and CYP3A5.  After a single radiolabeled dose to human, boceprevir was subjected to two distinct pathways, namely cytochrome P 450-mediated oxidn. and ketone redn.  Therefore, attempts were made to identify the enzymes responsible for the formation of carbonyl-reduced metabolites.  Human liver S9 and cytosol converted ∼28 and ∼68% of boceprevir to M28, resp., in the presence of an NADPH-generating system.  Screening of boceprevir with recombinant human aldo-keto reductases (AKRs) revealed that AKR1C2 and AKR1C3 exhibited catalytic activity with respect to the formation of M+2 metabolites (M28 and M31).  The formation of M28 was inhibited by 100 μM flufenamic acid (80.3%), 200 μM mefenamic acid (83.7%), and 100 μM phenolphthalein (86.1%), known inhibitors of AKRs, suggesting its formation through carbonyl redn. pathway.  Formation of M28 was also inhibited by 100 μM diazepam (75.1%), 1 mM ibuprofen (70%), and 200 μM diflunisal (89.4%).  These data demonstrated that CYP3A4 and CYP3A5 are primarily responsible for the formation of oxidative metabolites and the formation of M28 and M31, the keto-reduced metabolites, are most likely mediated by AKR1C2 and AKR1C3.  Because the biotransformation and clearance of boceprevir involves two different enzymic pathways, boceprevir is less likely to be a victim of significant drug-drug interaction with concomitant medication affecting either of these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWIBhV6dK5Z7Vg90H21EOLACvtfcHk0lj0An7mFqfbBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVWiur0%253D&md5=71b72850630971fe3e274f91172dfa1f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.036996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.036996%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DW.%26aulast%3DSu%26aufirst%3DA.%2BD.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DChowdhury%26aufirst%3DS.%2BK.%26aulast%3DKishnani%26aufirst%3DN.%2BS.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26atitle%3DCharacterization%2520of%2520human%2520liver%2520enzymes%2520involved%2520in%2520the%2520biotransformation%2520of%2520boceprevir%252C%2520a%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D510%26epage%3D521%26doi%3D10.1124%2Fdmd.110.036996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span> </span><span class="NLM_article-title">New drugs-reports of new drugs recently approved by the FDA. Ritonavir</span>.  <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume">5</span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">462</span>.<span class="refDoi"> DOI: 10.1016/S0968-0896(96)00260-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0968-0896%2896%2900260-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9113321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXit1yrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+drugs-reports+of+new+drugs+recently+approved+by+the+FDA.+Ritonavir.+Bioorg.+Med.+Chem.+1997%2C+5%2C+461%E2%80%93462.+10.1016%2FS0968-0896%2896%2900260-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">New drugs - Reports of new drugs recently approved by the FDA: ritonavir</span></div><div class="casAuthors">Ohta, Yukari; Shinkai, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-462</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ritonavir (Norvir, A 84538, or ABT 538) is a peptidomimetic inhibitor of both HIV-1 and HIV-2 proteases.  The concn. of drug that inhibits 50% of viral replication (EC50) ranged from 3.8 to 153 nM depending upon the HIV-1 isolate and the cells employed.  The av. EC50 for low passage clin. isolates was 22 nM.  In a 1090-patient study, 1.2 g of the drug used concomitantly with existing nucleoside therapy, produced a significant decrease in mean viral RNA levels of placebo and an increase in av. change of CD4 count over the first 16 wk.  After seven months the mortality rate was 4.8% for ritonavir patients and 8.4% for placebo.  Ritonavir demonstrated additive effects against HIV-1 in combination with either zidovudine (ZDV) or didanosine (ddI).  Genotypic anal. of HIV-1 isolates with reduced susceptibility to ritonavir showed mutations in the HIV protease gene at amino acid positions 84 (Ile to Val), 82 (Val to Phe), 71 (Ala to Val), and 46 (Met to Ile).  Phenotypic and genotypic changes in HIV isolates from selected patients treated with ritonavir were monitored in phase I/II trials over a period of 3-32 wk.  Mutation appeared to occur in a stepwise and ordered fashion.  The potential for HIV cross-resistance between protease inhibitors has not been fully explored.  The abs. bioavailability of ritonavir has not been detd.  After a 600 mg dose of oral soln., peak concns. of ritonavir were achieved approx. 2 and 4 h after dosing under fasting and nonfasting conditions, resp.  The isopropylthiazole oxidn. metabolite (M-2) is the major metabolite.  Studies utilizing human liver microsome have demonstrated that cytochrome P 450 3A (CYP3A) is the major isoform involved in ritonavir metab., although CYP2D6 also contributes to the formation of M-2.  Agents that increase CYP3A activity would be expected to increase the clearance of ritonavir resulting in decrease of ritonavir plasma concn.  Ritonavir can produce a large increase in plasma concns. of certain highly metabolized drugs.  Ritonavir prevents fast metab. of saquinavir allowing increased blood levels.  Addn. of saquinavir is not expected to accelerate resistance to ritonavir due to the distinct mutation profiles of both drugs.  Norvir capsules are available for oral administration in a strength of 100 mg ritonavir.  Norvir oral soln. is also available for oral administration as 80 mg/mL of ritonavir in a flavored vehicle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-nZFEUWiDMbVg90H21EOLACvtfcHk0liCyXL9AHgOeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1yrsLs%253D&md5=4522919bc7f11f511eeac80cf8863882</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2896%2900260-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252896%252900260-X%26sid%3Dliteratum%253Aachs%26atitle%3DNew%2520drugs-reports%2520of%2520new%2520drugs%2520recently%2520approved%2520by%2520the%2520FDA.%2520Ritonavir%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1997%26volume%3D5%26spage%3D461%26epage%3D462%26doi%3D10.1016%2FS0968-0896%2896%2900260-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sevrioukova, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span> <span> </span><span class="NLM_article-title">Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">18422</span>– <span class="NLM_lpage">18427</span>, <span class="refDoi"> DOI: 10.1073/pnas.1010693107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.1010693107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20937904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2ktr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=18422-18427&author=I.+F.+Sevrioukovaauthor=T.+L.+Poulos&title=Structure+and+mechanism+of+the+complex+between+cytochrome+P4503A4+and+ritonavir&doi=10.1073%2Fpnas.1010693107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir</span></div><div class="casAuthors">Sevrioukova, Irina F.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">18422-18427, S18422/1-S18422/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ritonavir is a HIV protease inhibitor routinely prescribed to HIV patients that also potently inactivates cytochrome P 4503A4 (CYP3A4), the major human drug-metabolizing enzyme.  By inhibiting CYP3A4, ritonavir increases plasma concns. of other anti-HIV drugs oxidized by CYP3A4 thereby improving clin. efficacy.  Despite the importance and wide use of ritonavir in anti-HIV therapy, the precise mechanism of CYP3A4 inhibition remains unclear.  The available data are inconsistent and suggest that ritonavir acts as a mechanism-based, competitive or mixed competitive-noncompetitive CYP3A4 inactivator.  To resolve this controversy and gain functional and structural insights into the mechanism of CYP3A4 inhibition, we investigated the ritonavir binding reaction by kinetic and equil. anal., elucidated how the drug affects redox properties of the hemoprotein, and detd. the 2.0 Å X-ray structure of the CYP3A4:ritonavir complex.  Our results show that ritonavir is a type II ligand that perfectly fits into the CYP3A4 active site cavity and irreversibly binds to the heme iron via the thiazole nitrogen, which decreases the redox potential of the protein arid precludes its redn. with the redox partner, cytochrome P 450 reductase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmlxyeZQWYLVg90H21EOLACvtfcHk0liCyXL9AHgOeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2ktr3J&md5=e279ebcfb188677e389807e73a00e1b9</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1010693107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1010693107%26sid%3Dliteratum%253Aachs%26aulast%3DSevrioukova%26aufirst%3DI.%2BF.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520complex%2520between%2520cytochrome%2520P4503A4%2520and%2520ritonavir%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D18422%26epage%3D18427%26doi%3D10.1073%2Fpnas.1010693107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertz, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnichen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latte, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurad, B.</span></span> <span> </span><span class="NLM_article-title">Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis</span>. <i>Clin. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1097/00002826-200603000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1097%2F00002826-200603000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16614540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=80-86&author=C.+Hofmannauthor=U.+Pennerauthor=R.+Dorowauthor=H.+H.+Pertzauthor=S.+Jahnichenauthor=R.+Horowskiauthor=K.+P.+Latteauthor=D.+Pallaauthor=B.+Schurad&title=Lisuride%2C+a+dopamine+receptor+agonist+with+5-HT2B+receptor+antagonist+properties%3A+absence+of+cardiac+valvulopathy+adverse+drug+reaction+reports+supports+the+concept+of+a+crucial+role+for+5-HT2B+receptor+agonism+in+cardiac+valvular+fibrosis&doi=10.1097%2F00002826-200603000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis</span></div><div class="casAuthors">Hofmann, C.; Penner, U.; Dorow, R.; Pertz, H. H.; Jaehnichen, S.; Horowski, R.; Latte, K. P.; Palla, D.; Schurad, B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Neuropharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">80-86</span>CODEN:
                <span class="NLM_cas:coden">CLNEDB</span>;
        ISSN:<span class="NLM_cas:issn">0362-5664</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Objectives: The high incidence of fibrotic cardiac valvulopathies reported in assocn. with the 8β-ergoline dopamine (DA) agonist, pergolide, and also case reports for cabergoline and bromocriptine have made it necessary to review the theor. basis and actual findings in the case of another DA agonist, the 8α-ergoline lisuride (used since the 1970s for migraine prophylaxis as well as since the 1980s for its prolactin-lowering and anti-Parkinson activity).  Methods: We have reviewed the pharmacol. of lisuride in relation to other DA agonists, and we have performed a throughout literature search as well as a search of our own and other adverse drug reaction databases for a possible relationship of lisuride with cardiac valvulopathy or for any reports of fibrosis in other locations.  Results: Our review of the pharmacol. and the literature strongly suggests that drug-induced cardiac valvulopathies are always related to a stimulatory drug effect on trophic 5-HT2B receptors.  As lisuride is devoid of such an effect, but on the contrary is an extremely potent 5-HT2B antagonist, an assocn. of lisuride therapy with cardiac valvulopathies seems to be highly unlikely.  In agreement with this hypothesis, not a single report of a cardiac valvulopathy assocd. with lisuride therapy has been identified in any database so far.Furthermore, against a background of an estd. 360,000 patient years, we have found only a very small no. of cases of any other form of fibrosis (1× retroperitoneal, 2× pleural, 2× pulmonary, 1× interstitial pulmonary changes), in part combined with other risk factors and confounding variables.  This closely matches 4 reports available from WHO (1× retroperitoneal, 3× pleural fibrosis).  In addn., only 5 other possibly related conditions (3× pleural effusion, 1× pleuritis, 1× pericarditis) were identified in the lisuride adverse drug reaction database of Schering, Berlin.  Conclusions: No link has been found between lisuride use and fibrotic cardiac valvulopathy, in agreement with the 5-HT2B receptor antagonist effect of this drug.  The very low incidence of spontaneous reports of any other fibrosis could be even compatible with an assocn. by chance in the population exposed to lisuride.  Although close monitoring for this kind of side effects is still to be recommended in the therapy with lisuride, our data do not support the concept of a class effect suggesting that all ergot-derived drugs and esp. DA receptor agonists with some chem. similarity to the ergot structure will cause or facilitate cardiac valvulopathies as obsd. with pergolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO6Rsrw9jtzLVg90H21EOLACvtfcHk0liCyXL9AHgOeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVersr4%253D&md5=a12de38613de4f88bf099762849ef0df</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1097%2F00002826-200603000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002826-200603000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DC.%26aulast%3DPenner%26aufirst%3DU.%26aulast%3DDorow%26aufirst%3DR.%26aulast%3DPertz%26aufirst%3DH.%2BH.%26aulast%3DJahnichen%26aufirst%3DS.%26aulast%3DHorowski%26aufirst%3DR.%26aulast%3DLatte%26aufirst%3DK.%2BP.%26aulast%3DPalla%26aufirst%3DD.%26aulast%3DSchurad%26aufirst%3DB.%26atitle%3DLisuride%252C%2520a%2520dopamine%2520receptor%2520agonist%2520with%25205-HT2B%2520receptor%2520antagonist%2520properties%253A%2520absence%2520of%2520cardiac%2520valvulopathy%2520adverse%2520drug%2520reaction%2520reports%2520supports%2520the%2520concept%2520of%2520a%2520crucial%2520role%2520for%25205-HT2B%2520receptor%2520agonism%2520in%2520cardiac%2520valvular%2520fibrosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2006%26volume%3D29%26spage%3D80%26epage%3D86%26doi%3D10.1097%2F00002826-200603000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humpel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommerenke, G.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1007/BF03189685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2FBF03189685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=6532807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaL2M7nvFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1984&pages=347-357&author=M.+Humpelauthor=W.+Krauseauthor=G.+A.+Hoyerauthor=H.+Wendtauthor=G.+Pommerenke&title=The+pharmacokinetics+and+biotransformation+of+14C-lisuride+hydrogen+maleate+in+rhesus+monkey+and+in+man&doi=10.1007%2FBF03189685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man</span></div><div class="casAuthors">Humpel M; Krause W; Hoyer G A; Wendt H; Pommerenke G</div><div class="citationInfo"><span class="NLM_cas:title">European journal of drug metabolism and pharmacokinetics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-57</span>
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    </div><div class="casAbstract">14C-labelled lisuride hydrogen maleate was administered intravenously (25 micrograms) and orally (200 micrograms) to three male and three female elderly volunteers.  Following i.v. injection radioimmunologically determined plasma levels of unchanged lisuride showed a three-phasic decline with half-lives of 3 minutes, 16 minutes and 2.9 hours.  The total clearance was 16 +/- 9 ml/min/kg.  Bioavailability was estimated to be 14% of oral dose.  Determination of 14C-radioactivity did not show any specific enrichment of lisuride metabolites in cellular components of blood.  The drug was almost totally metabolized and its degradation products were eliminated equally via the kidney and liver.  Total recovery was about 90% of dose.  The elimination half-life was 10 hours.  Small parts of the dose administered were renally excreted with a half-life of 23 hours.  Lisuride is metabolized extensively.  HPLC radiochromatograms of freely extractable metabolites from urine did not show marked differences between both routes of administration.  More than 15 compounds were freely extractable, only one of them represented more than 5% of dose.  Phase II reactions were quantitatively unimportant.  From rhesus monkey urine 6 metabolites were isolated.  Chemical structures were proposed for 5 of them.  They were assigned to the pattern of freely extractable human urinary metabolites and covered about 50% of radiolabel corresponding to about 13% of dose.  The main freely extractable urinary metabolite was thought to be the 2-keto-3-hydroxy-lisuride derivative.  Structures of the other four metabolites and earlier observations on the stability of the N'-ethyl-3H label led to the interpretation of independent changes of lisuride by different enzymatic processes such as oxidative N-deethylation, hydroxylation of the benzene system, monooxygenation at C2 and C9, and oxidation of double bonds at C2/C3 and C9/C10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTakQ8dVGXEZmxpATR2EQURfW6udTcc2eYuFDI6bTt2vLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7nvFKisw%253D%253D&md5=e73cc4aeab00fe072a6f1ab84dfd936d</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2FBF03189685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03189685%26sid%3Dliteratum%253Aachs%26aulast%3DHumpel%26aufirst%3DM.%26aulast%3DKrause%26aufirst%3DW.%26aulast%3DHoyer%26aufirst%3DG.%2BA.%26aulast%3DWendt%26aufirst%3DH.%26aulast%3DPommerenke%26aufirst%3DG.%26atitle%3DThe%2520pharmacokinetics%2520and%2520biotransformation%2520of%252014C-lisuride%2520hydrogen%2520maleate%2520in%2520rhesus%2520monkey%2520and%2520in%2520man%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1984%26volume%3D9%26spage%3D347%26epage%3D357%26doi%3D10.1007%2FBF03189685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agai-Csongor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domany, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogradi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galambos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vago, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlovszky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vastag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tihanyi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyertyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zajer-Balazs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemesi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szombathelyi, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3437</span>– <span class="NLM_lpage">3440</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.03.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2012.03.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22537450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFeksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3437-3440&author=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Nogradiauthor=J.+Galambosauthor=I.+Vagoauthor=G.+M.+Keseruauthor=I.+Greinerauthor=I.+Laszlovszkyauthor=A.+Gereauthor=E.+Schmidtauthor=B.+Kissauthor=M.+Vastagauthor=K.+Tihanyiauthor=K.+Saghyauthor=J.+Laszyauthor=I.+Gyertyanauthor=M.+Zajer-Balazsauthor=L.+Gemesiauthor=M.+Kapasauthor=Z.+Szombathelyi&title=Discovery+of+cariprazine+%28RGH-188%29%3A+a+novel+antipsychotic+acting+on+dopamine+D3%2FD2+receptors&doi=10.1016%2Fj.bmcl.2012.03.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors</span></div><div class="casAuthors">Agai-Csongor, Eva; Domany, Gyorgy; Nogradi, Katalin; Galambos, Janos; Vago, Istvan; Keseru, Gyorgy Miklos; Greiner, Istvan; Laszlovszky, Istvan; Gere, Aniko; Schmidt, Eva; Kiss, Bela; Vastag, Monika; Tihanyi, Karoly; Saghy, Katalin; Laszy, Judit; Gyertyan, Istvan; Zajer-Balazs, Maria; Gemesi, Larisza; Kapas, Margit; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3437-3440</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Medicinal chem. optimization of an impurity isolated during the scale-up synthesis of a pyridylsulfonamide type dopamine D3/D2 compd. (1, I) led to a series of new piperazine derivs. having affinity to both dopamine D3 and D2 receptors.  Several members of this group showed excellent pharmacokinetic and pharmacodynamic properties as demonstrated by outstanding activities in different antipsychotic tests.  The most promising representative, 2m (cariprazine) had good absorption, excellent brain penetration and advantageous safety profile.  Based on its successful clin. development we are looking forward to the NDA filing of cariprazine in 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgEXo42Fb5i7Vg90H21EOLACvtfcHk0lgvqejhLEbAtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFeksLY%253D&md5=c70cd98791c4d5c2da5ac1f3904a8b98</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.104%26sid%3Dliteratum%253Aachs%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DNogradi%26aufirst%3DK.%26aulast%3DGalambos%26aufirst%3DJ.%26aulast%3DVago%26aufirst%3DI.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DGreiner%26aufirst%3DI.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DGere%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DVastag%26aufirst%3DM.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DSaghy%26aufirst%3DK.%26aulast%3DLaszy%26aufirst%3DJ.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DZajer-Balazs%26aufirst%3DM.%26aulast%3DGemesi%26aufirst%3DL.%26aulast%3DKapas%26aufirst%3DM.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520cariprazine%2520%2528RGH-188%2529%253A%2520a%2520novel%2520antipsychotic%2520acting%2520on%2520dopamine%2520D3%252FD2%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3437%26epage%3D3440%26doi%3D10.1016%2Fj.bmcl.2012.03.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemethy, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlovszky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugovics, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazekas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornok, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orosz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyertyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agai-Csongor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domany, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tihanyi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adham, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szombathelyi, Z.</span></span> <span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.160432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horvathauthor=Z.+Nemethyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyertyanauthor=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+dopamine+D%283%29+receptor-preferring%2C+D%283%29%2FD%282%29+dopamine+receptor+antagonist-partial+agonist+antipsychotic+candidate%3A+in+vitro+and+neurochemical+profile&doi=10.1124%2Fjpet.109.160432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0lj5d5GzG62lsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DNemethy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520dopamine%2520D%25283%2529%2520receptor-preferring%252C%2520D%25283%2529%252FD%25282%2529%2520dopamine%2520receptor%2520antagonist-partial%2520agonist%2520antipsychotic%2520candidate%253A%2520in%2520vitro%2520and%2520neurochemical%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340%26doi%3D10.1124%2Fjpet.109.160432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Invernizzi, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasina, L.</span></span> <span> </span><span class="NLM_article-title">A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia</span>. <i>Ther. Clin. Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.2147/TCRM.S35137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2147%2FTCRM.S35137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23966785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGjtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=319-328&author=S.+Cacciaauthor=R.+W.+Invernizziauthor=A.+Nobiliauthor=L.+Pasina&title=A+new+generation+of+antipsychotics%3A+pharmacology+and+clinical+utility+of+cariprazine+in+schizophrenia&doi=10.2147%2FTCRM.S35137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia</span></div><div class="casAuthors">Caccia, Silvio; Invernizzi, Roberto William; Nobili, Alessandro; Pasina, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">319-328</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1178-203X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Cariprazine is a potential antipsychotic awaiting approval from the US Food and Drug Administration.  It is a dopamine D2- and D3-receptor partial agonist, with higher affinity for D3 receptors, as opposed to the D2 antagonism of most older antipsychotic agents.  Like most lipophilic antipsychotics, it undergoes extensive hepatic metab. by cytochrome P 450 (CYP), mainly the highly variable 3A4, with the formation of active metabolites.  However, the parent compd. - particularly its active didesmethyl deriv. - is cleared very slowly, with elimination half-lives in schizophrenic patients ranging from 2-5 days for cariprazine to 2-3 wk for didesmethyl-cariprazine.  Exposure to the latter was several times that for cariprazine, although didesmethyl-cariprazine did not reach steady state within the 3 wk of 12.5 mg/day dosing.  Preliminary information on its therapeutic role comes from press releases and a few abstrs. presented at scientific meetings.  In short-term controlled trials, it was more effective than placebo in reducing pos. and neg. symptoms of schizophrenia, with an ED range of 1.5-12 mg/day.  Although cariprazine was assocd. with a higher incidence of akathisia and extrapyramidal side effects than placebo, it did not cause wt. gain, metabolic abnormalities, prolactin increase or cor. QT prolongation.  Similarly, cariprazine's efficacy and tolerability for the treatment of bipolar disorder (manic/mixed and depressive episodes) was established in the dose range of 3-12 mg/day, although again no long-term data are available.  Well-designed clin. trials, mainly direct "head-to-head" comparisons with other second-generation antipsychotic agents, are needed to define the therapeutic role and safety profile of cariprazine in schizophrenia and bipolar mania.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskxYb8cxgErVg90H21EOLACvtfcHk0ljSZFKEhxRKNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGjtb%252FM&md5=0f8ad133c73e50a93dd99bdb40f4124f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.2147%2FTCRM.S35137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FTCRM.S35137%26sid%3Dliteratum%253Aachs%26aulast%3DCaccia%26aufirst%3DS.%26aulast%3DInvernizzi%26aufirst%3DR.%2BW.%26aulast%3DNobili%26aufirst%3DA.%26aulast%3DPasina%26aufirst%3DL.%26atitle%3DA%2520new%2520generation%2520of%2520antipsychotics%253A%2520pharmacology%2520and%2520clinical%2520utility%2520of%2520cariprazine%2520in%2520schizophrenia%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2013%26volume%3D9%26spage%3D319%26epage%3D328%26doi%3D10.2147%2FTCRM.S35137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Citrome, L.</span></span> <span> </span><span class="NLM_article-title">Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1517/17425255.2013.759211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1517%2F17425255.2013.759211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23320989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=193-206&author=L.+Citrome&title=Cariprazine%3A+chemistry%2C+pharmacodynamics%2C+pharmacokinetics%2C+and+metabolism%2C+clinical+efficacy%2C+safety%2C+and+tolerability&doi=10.1517%2F17425255.2013.759211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability</span></div><div class="casAuthors">Citrome, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-206</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: is an atypical antipsychotic in clin. development for the treatment of schizophrenia and bipolar mania/mixed episodes.Areas covered: The purpose of this review is to describe the chem., pharmacodynamic profile, pharmacokinetics, and clin. profile of cariprazine.Expert opinion: Cariprazine is a dopamine D3-preferring D3/D2 receptor partial agonist.  Doses ≥ 1.5 mg/d yielded 69 - 75% D2/D3 receptor occupancy as measured in positron emission tomog. scans.  Mean half-life for cariprazine was 2 - 5 d over a dose range of 1.5 - 12.5 mg.  Cariprazine produces two clin. relevant metabolites: desmethyl-cariprazine and didesmethyl-cariprazine, the latter having a longer half-life than cariprazine.  Exposure to didesmethyl-cariprazine exceeded that of the parent drug.  Cariprazine is metabolized by CYP3A4 and to a lesser extent by CYP2D6.  The efficacy and safety of cariprazine have been so far investigated only in a few short-term (unpublished) clin. trials; however, three studies in schizophrenia and three studies in bipolar mania/mixed episodes evidenced a statistically significant therapeutic effect compared to placebo for cariprazine at doses ranging from 1.5 to 12 mg/d.  There does not appear to be clin. relevant adverse effects of cariprazine on metabolic variables.  Commonly encountered adverse events assocd. with cariprazine include insomnia, extrapyramidal symptoms, akathisia, sedation, nausea, dizziness, and constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWppq7db6U-7Vg90H21EOLACvtfcHk0ljSZFKEhxRKNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt7c%253D&md5=1614e35696a45f228020448bd0698e0b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.759211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.759211%26sid%3Dliteratum%253Aachs%26aulast%3DCitrome%26aufirst%3DL.%26atitle%3DCariprazine%253A%2520chemistry%252C%2520pharmacodynamics%252C%2520pharmacokinetics%252C%2520and%2520metabolism%252C%2520clinical%2520efficacy%252C%2520safety%252C%2520and%2520tolerability%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26spage%3D193%26epage%3D206%26doi%3D10.1517%2F17425255.2013.759211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodick, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibensperger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assaid, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lines, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winner, P. K.</span></span> <span> </span><span class="NLM_article-title">Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">2115</span>– <span class="NLM_lpage">2123</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(08)61626-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0140-6736%2808%2961626-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19036425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Ojtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=2115-2123&author=T.+W.+Hoauthor=M.+D.+Ferrariauthor=D.+W.+Dodickauthor=V.+Galetauthor=J.+Kostauthor=X.+Fanauthor=H.+Leibenspergerauthor=S.+Fromanauthor=C.+Assaidauthor=C.+Linesauthor=H.+Koppenauthor=P.+K.+Winner&title=Efficacy+and+tolerability+of+MK-0974+%28telcagepant%29%2C+a+new+oral+antagonist+of+calcitonin+gene-related+peptide+receptor%2C+compared+with+zolmitriptan+for+acute+migraine%3A+a+randomised%2C+placebo-controlled%2C+parallel-treatment+trial&doi=10.1016%2FS0140-6736%2808%2961626-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial</span></div><div class="casAuthors">Ho Tony W; Ferrari Michel D; Dodick David W; Galet Vince; Kost James; Fan Xiaoyin; Leibensperger Heather; Froman Samar; Assaid Christopher; Lines Christopher; Koppen Hille; Winner Paul K</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9656</span>),
    <span class="NLM_cas:pages">2115-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Calcitonin gene-related peptide (CGRP) probably has a role in migraine pathophysiology, and antagonism of its receptors might provide treatment without the vasoconstrictor effects of triptans.  We aimed to assess the clinical profile of MK-0974 (telcagepant), an orally bioavailable antagonist of CGRP receptor.  METHODS:  In a randomised, parallel-treatment, placebo-controlled, double-blind, trial at 81 sites in the Europe and the USA, adults with migraine diagnosed by International Headache Society criteria treated moderate or severe attacks with either oral telcagepant 150 mg or 300 mg, zolmitriptan 5 mg, or placebo.  The five co-primary endpoints were pain freedom, pain relief, or absence of photophobia, phonophobia, or nausea at 2 h after treatment.  Analysis was by the full analysis set and multiplicity was controlled for with a step-down closed-testing procedure.  This trial is registered with ClinicalTrials.gov, number NCT00442936.  FINDINGS:  1380 patients were randomly assigned to receive telcagepant 150 mg (n=333) or 300 mg (354), zolmitriptan (345), or placebo (348).  Telcagepant 300 mg was more effective than placebo for pain freedom (95 [27%] of 353 patients vs 33 [10%] of 343 [p<0.0001]), pain relief (194 [55%] of 353 vs 95 [28%] of 343 [p<0.0001]), and absences of phonophobia (204 [58%] of 353 vs 126 [37%] of 342 [p<0.0001]), photophobia (180 [51%] of 353 vs 99 [29%] of 342 [p<0.0001]), and nausea (229 [65%] of 352 vs 189 [55%] of 342 [p=0.0061]).  Efficacy of telcagepant 300 mg and zolmitriptan 5 mg were much the same, and both were more effective than telcagepant 150 mg.  Adverse events were recorded for 31% taking telcagepant 150 mg, 37% taking telcagepant 300 mg, 51% taking zolmitriptan 5 mg, and 32% taking placebo.  INTERPRETATION:  Telcagepant 300 mg is effective as an acute treatment for migraine with efficacy comparable to that of zolmitriptan 5 mg, but with fewer associated adverse effects.  FUNDING:  Merck Research Laboratories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKtuWEUmAWlc-crCu0nI_sfW6udTcc2eZCU_wDXQkvdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Ojtw%253D%253D&md5=48be09dccd58a3a37069d88f5f8142f8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2808%2961626-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252808%252961626-8%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DT.%2BW.%26aulast%3DFerrari%26aufirst%3DM.%2BD.%26aulast%3DDodick%26aufirst%3DD.%2BW.%26aulast%3DGalet%26aufirst%3DV.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DLeibensperger%26aufirst%3DH.%26aulast%3DFroman%26aufirst%3DS.%26aulast%3DAssaid%26aufirst%3DC.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DKoppen%26aufirst%3DH.%26aulast%3DWinner%26aufirst%3DP.%2BK.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520MK-0974%2520%2528telcagepant%2529%252C%2520a%2520new%2520oral%2520antagonist%2520of%2520calcitonin%2520gene-related%2520peptide%2520receptor%252C%2520compared%2520with%2520zolmitriptan%2520for%2520acute%2520migraine%253A%2520a%2520randomised%252C%2520placebo-controlled%252C%2520parallel-treatment%2520trial%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D2115%26epage%3D2123%26doi%3D10.1016%2FS0140-6736%2808%2961626-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearlman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppenhaver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lines, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvinsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goadsby, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000000771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1212%2FWNL.0000000000000771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25107879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFert7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=958-966&author=T.+W.+Hoauthor=K.+M.+Connorauthor=Y.+Zhangauthor=E.+Pearlmanauthor=J.+Koppenhaverauthor=X.+Fanauthor=C.+Linesauthor=L.+Edvinssonauthor=P.+J.+Goadsbyauthor=D.+Michelson&title=Randomized+controlled+trial+of+the+CGRP+receptor+antagonist+telcagepant+for+migraine+prevention&doi=10.1212%2FWNL.0000000000000771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention</span></div><div class="casAuthors">Ho, Tony W.; Connor, Kathryn M.; Zhang, Ying; Pearlman, Eric; Koppenhaver, Janelle; Fan, Xiaoyin; Lines, Christopher; Edvinsson, Lars; Goadsby, Peter J.; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">958-966</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To evaluate whether the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant might be effective for migraine prevention.  Methods: In this randomized, double-blind, placebo-controlled, multicenter trial (ClinicalTrials.gov NCT00797667), patients experiencing 3-14 migraine days during a 4-wk baseline were randomized to telcagepant 140 mg, telcagepant 280 mg, or placebo twice daily for 12 wk.  Efficacy was assessed by mean monthly headache days and migraine/probable migraine days (headache plus ≥1 assocd. symptom).  Results: The trial was terminated following a recommendation from the Safety Monitoring Board due to hepatotoxicity concerns.  At termination, the planned 660 patients had been randomized, 656 had been treated with ≥1 dose of study medication, and 14 had completed the trial.  The mean treatment duration was 48-50 days.  Thirteen patients, all in the telcagepant groups, had an alanine aminotransferase (ALT) elevation ≥3× the upper limit of normal and 7 of these also had an aspartate aminotransferase elevation ≥3× the upper limit of normal.  Two patients had very high symptomatic transaminase elevations that occurred within 2-6 wk of treatment initiation and resolved after treatment discontinuation.  The originally planned efficacy anal. over 12 wk was not performed due to limited data at later time points, but there was evidence that telcagepant resulted in a larger redn. from baseline than placebo for mean monthly headache days (month 1: 140 mg = -2.9, 280 mg = -3.1, placebo = -1.7; p < 0.05) and migraine/probable migraine days (month 1: 140 mg = -2.7, 280 mg = -3.0, placebo = -1.6; p < 0.05).  Conclusions: These data suggest a potential role for CGRP receptor antagonism in migraine prophylaxis.  However, the obsd. aminotransferase elevations do not support the use of telcagepant for daily administration.  Classification of evidence: This study provides Class II evidence that in patients with migraine, telcagepant taken daily reduces headache days by 1.4 days per mo compared to placebo and causes 2.5% of patients to have elevations of serum ALT levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNEH1T2nja2bVg90H21EOLACvtfcHk0lhon8EqDMbK0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFert7bJ&md5=66d4abf9a3373373a1f18c3bd56487f5</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000000771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000000771%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DT.%2BW.%26aulast%3DConnor%26aufirst%3DK.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPearlman%26aufirst%3DE.%26aulast%3DKoppenhaver%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DEdvinsson%26aufirst%3DL.%26aulast%3DGoadsby%26aufirst%3DP.%2BJ.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520controlled%2520trial%2520of%2520the%2520CGRP%2520receptor%2520antagonist%2520telcagepant%2520for%2520migraine%2520prevention%26jtitle%3DNeurology%26date%3D2014%26volume%3D83%26spage%3D958%26epage%3D966%26doi%3D10.1212%2FWNL.0000000000000771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laspina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Stein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prueksaritanont, T.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1080/00498250802546861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F00498250802546861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19219746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=33-45&author=S.+Rollerauthor=D.+Cuiauthor=C.+Laspinaauthor=C.+Miller-Steinauthor=J.+Roweauthor=B.+Wongauthor=T.+Prueksaritanont&title=Preclinical+pharmacokinetics+of+MK-0974%2C+an+orally+active+calcitonin-gene+related+peptide+%28CGRP%29-receptor+antagonist%2C+mechanism+of+dose+dependency+and+species+differences&doi=10.1080%2F00498250802546861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span></div><div class="casAuthors">Roller, S.; Cui, D.; Laspina, C.; Miller-Stein, C.; Rowe, J.; Wong, B.; Prueksaritanont, T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The underlying mechanism for low oral bioavailability of MK-0974, a potent calcitonin-gene related peptide (CGRP)-receptor antagonist, in monkeys and for species-dependent non-linear pharmacokinetics in monkeys and rats were investigated.  In monkeys, MK-0974 displayed moderate clearance (14-20 mL min-1 kg-1), while oral bioavailability was 6%.  The pharmacokinetics of MK-0974 remained linear across 0.5-10 mg kg-1 i.v. dose in monkeys, but the oral area under the blood plasma concn.-time curve (AUC) increase (5-30 mg kg-1) was 15-fold over dose-proportional.  Based on a comparison of AUC following hepatic portal vein administration and cephalic vein infusion, MK-0974 exhibited a low-to-moderate hepatic extn. ratio (36%) in monkeys.  Following oral dose of [14C]MK-0974 to monkeys, the hepatic portal AUC ratio of MK-0974 vs. total radioactivity was 0.32, and the total radioactivity recovered in bile and urine was 45-83%.  MK-0974 undergoes significant oxidative metab. (cytochrome P 450 (CYP) 3A) in monkey intestinal microsomes.  In contrast, oral AUC of MK-0974 in rats was near dose-proportional (15-100 mg kg-1).  Following oral administration of [14C]MK-0974 to rats, the hepatic portal AUC ratio of MK-0974 to total radioactivity (0.67) was higher than in monkeys.  Addnl., the metabolic rate of MK-0974 was slower in rat than in monkey intestinal microsomes.  Collectively, intestinal 1st-pass metab. played a significant role in the low oral bioavailability in monkeys and contributed to the species-dependent non-linear oral pharmacokinetics in rats and monkeys of MK-0974.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSGwTRkl7ECrVg90H21EOLACvtfcHk0ljPLRfCciMKdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D&md5=4b3039fc4abdf2cfca46a7e0f1fceb53</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1080%2F00498250802546861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250802546861%26sid%3Dliteratum%253Aachs%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DLaspina%26aufirst%3DC.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DRowe%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26atitle%3DPreclinical%2520pharmacokinetics%2520of%2520MK-0974%252C%2520an%2520orally%2520active%2520calcitonin-gene%2520related%2520peptide%2520%2528CGRP%2529-receptor%2520antagonist%252C%2520mechanism%2520of%2520dose%2520dependency%2520and%2520species%2520differences%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26spage%3D33%26epage%3D45%26doi%3D10.1080%2F00498250802546861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters-Golden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Leukotrienes</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.1056/NEJMra071371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1056%2FNEJMra071371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17978293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=1841-1854&author=M.+Peters-Goldenauthor=W.+R.+Henderson&title=Leukotrienes&doi=10.1056%2FNEJMra071371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotrienes</span></div><div class="casAuthors">Peters-Golden, Marc; Henderson, William R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1841-1854</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Leukotrienes comprise a family of products of the 5-lipoxygenase pathway of arachidonic acid metab.  The cysteinyl leukotrienes C4, D4, and E4 account for the biol. activity that was previously termed "slow-reacting substance of anaphylaxis", and the efficacy of antagonists to type 1 cysteinyl leukotriene receptor (CysLT1) in asthma validates the importance of cysteinyl leukotrienes and CysLT1 in this disease.  Here, the authors discuss: synthesis of leukotrienes; leukotriene receptors; blockade of leukotriene synthesis and leukotriene receptors; leukotrienes in disease; and leukotrienes in antimicrobial defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjehKHMPz2p7Vg90H21EOLACvtfcHk0ljPLRfCciMKdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM&md5=4e617e65cf4b1f55f595bc03344fdb55</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1056%2FNEJMra071371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra071371%26sid%3Dliteratum%253Aachs%26aulast%3DPeters-Golden%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DW.%2BR.%26atitle%3DLeukotrienes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D1841%26epage%3D1854%26doi%3D10.1056%2FNEJMra071371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeberle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bramanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautebin, L.</span></span> <span> </span><span class="NLM_article-title">The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00930.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1111%2Fj.1476-5381.2010.00930.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20880396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kju73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=555-570&author=A.+Rossiauthor=C.+Pergolaauthor=A.+Koeberleauthor=M.+Hoffmannauthor=F.+Dehmauthor=P.+Bramantiauthor=S.+Cuzzocreaauthor=O.+Werzauthor=L.+Sautebin&title=The+5-lipoxygenase+inhibitor%2C+zileuton%2C+suppresses+prostaglandin+biosynthesis+by+inhibition+of+arachidonic+acid+release+in+macrophages&doi=10.1111%2Fj.1476-5381.2010.00930.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages</span></div><div class="casAuthors">Rossi, A.; Pergola, C.; Koeberle, A.; Hoffmann, M.; Dehm, F.; Bramanti, P.; Cuzzocrea, S.; Werz, O.; Sautebin, L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">555-570</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Zileuton is the only 5-lipoxygenase (5-LOX) inhibitor marketed as a treatment for asthma, and is often utilized as a selective tool to evaluate the role of 5-LOX and leukotrienes.  The aim of this study was to investigate the effect of zileuton on prostaglandin (PG) prodn. in vitro and in vivo.  Peritoneal macrophages activated with lipopolysaccharide (LPS)/interferon γ (LPS/IFNγ), J774 macrophages and human whole blood stimulated with LPS were used as in vitro models and rat carrageenan-induced pleurisy as an in vivo model.  Zileuton suppressed PG biosynthesis by interference with arachidonic acid (AA) release in macrophages.  We found that zileuton significantly reduced PGE2 and 6-keto prostaglandin F1α (PGF1α) levels in activated mouse peritoneal macrophages and in J774 macrophages.  This effect was not related to 5-LOX inhibition, because it was also obsd. in macrophages from 5-LOX knockout mice.  Notably, zileuton inhibited PGE2 prodn. in LPS-stimulated human whole blood and suppressed PGE2 and 6-keto PGF1α pleural levels in rat carrageenan-induced pleurisy.  Interestingly, zileuton failed to inhibit the activity of microsomal PGE2 synthase1 and of cyclooxygenase (COX)-2 and did not affect COX-2 expression.  However, zileuton significantly decreased AA release in macrophages accompanied by inhibition of phospholipase A2 translocation to cellular membranes.  Zileuton inhibited PG prodn. by interfering at the level of AA release.  Its mechanism of action, as well as its use as a pharmacol. tool, in exptl. models of inflammation should be reassessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpReUkH6DqnSrVg90H21EOLACvtfcHk0lj7XXLDv6kI4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kju73I&md5=2897ff2b1c5f6c13bec864e0ba210ff6</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00930.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00930.x%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DPergola%26aufirst%3DC.%26aulast%3DKoeberle%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DDehm%26aufirst%3DF.%26aulast%3DBramanti%26aufirst%3DP.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DSautebin%26aufirst%3DL.%26atitle%3DThe%25205-lipoxygenase%2520inhibitor%252C%2520zileuton%252C%2520suppresses%2520prostaglandin%2520biosynthesis%2520by%2520inhibition%2520of%2520arachidonic%2520acid%2520release%2520in%2520macrophages%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D555%26epage%3D570%26doi%3D10.1111%2Fj.1476-5381.2010.00930.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Machinist, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulka, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, B. A.</span></span> <span> </span><span class="NLM_article-title">In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">Suppl 2</span>),  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.2165/00003088-199500292-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2165%2F00003088-199500292-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8620669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XnsVSguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1995&pages=34-41&issue=Suppl+2&author=J.+M.+Machinistauthor=M.+J.+Kukulkaauthor=B.+A.+Bopp&title=In+vitro+plasma+protein+binding+of+zileuton+and+its+N-dehydroxylated+metabolite&doi=10.2165%2F00003088-199500292-00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite</span></div><div class="casAuthors">Machinist, Joseph M.; Kukulka, Michael J.; Bopp, Barbara A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis</span>)
        </div><div class="casAbstract">An ultrafiltration technique or equil. dialysis has been used to study the in vitro human plasma protein binding of racemic zileuton, its individual enantiomers, and its pharmacol. inactive metabolite N-dehydroxyzileuton.  The plasma protein binding of zileuton and N-dehydroxyzileuton over the concn. range of 0.1 to 100 mg/L averaged 93.1 ± 0.22 and 92.0 ± 0.12%, resp.  However, there appeared to be a stereoselective effect, with the R(+) enantiomer of zileuton demonstrating greater binding to plasma proteins than the S(-) enantiomer (96 vs 88%, resp.).  Zileuton was bound to both human serum albumin (40 g/L) and α1-acid glycoprotein (1 g/L), although binding affinity to albumin was approx. 3-fold greater.  Displacement interactions of zileuton with warfarin, salicylate, theophylline, naproxen, ibuprofen, prednisone, and terfenadine were minimal.  The blood to plasma concn. ratio for zileuton and N-dehydroxyzileuton ranged from 0.65 to 0.68, indicating that these compds. were mainly distributed in the plasma.  Thus, zileuton is approx. 93% bound to plasma proteins at expected therapeutic concns. in vitro, and this figure is largely unaffected by several commonly prescribed agents with which the drug may be coadministered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOdIGeCC8EI7Vg90H21EOLACvtfcHk0lj7XXLDv6kI4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsVSguw%253D%253D&md5=fcde7d7485075ba79f9c34efca05c3ee</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.2165%2F00003088-199500292-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199500292-00006%26sid%3Dliteratum%253Aachs%26aulast%3DMachinist%26aufirst%3DJ.%2BM.%26aulast%3DKukulka%26aufirst%3DM.%2BJ.%26aulast%3DBopp%26aufirst%3DB.%2BA.%26atitle%3DIn%2520vitro%2520plasma%2520protein%2520binding%2520of%2520zileuton%2520and%2520its%2520N-dehydroxylated%2520metabolite%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1995%26volume%3D29%26issue%3DSuppl%25202%26spage%3D34%26epage%3D41%26doi%3D10.2165%2F00003088-199500292-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J. A.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator</span>. <i>Am. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">683</span>, <span class="refDoi"> DOI: 10.1016/0002-8703(91)90445-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2F0002-8703%2891%2990445-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1671187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1Wgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1991&pages=677-683&author=M.+H.+Perroneauthor=J.+A.+Barrett&title=Preclinical+pharmacology+of+celiprolol%3A+a+cardioselective+beta-adrenergic+antagonist+and+mild+vasodilator&doi=10.1016%2F0002-8703%2891%2990445-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of celiprolol:  a cardioselective β-adrenergic antagonist and mild vasodilator</span></div><div class="casAuthors">Perrone, Mark H.; Barrett, John A.</div><div class="citationInfo"><span class="NLM_cas:title">American Heart Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">677-83</span>CODEN:
                <span class="NLM_cas:coden">AHJOA2</span>;
        ISSN:<span class="NLM_cas:issn">0002-8703</span>.
    </div><div class="casAbstract">A review with 13 refs.  Celiprolol is a new antihypertensive agent that represents a new generation of β-blockers.  Celiprolol distinguishes itself from other β-blockers by virtue of its cardioselectivity, vasorelaxation via β2-agonism, and the lack of bronchoconstriction and cardiodepression.  These properties obsd. in animal studies have also been documented in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIlnKMgXsLo7Vg90H21EOLACvtfcHk0lj7XXLDv6kI4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1Wgu7k%253D&md5=3715722498270b8d6b06a42560755daa</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0002-8703%2891%2990445-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-8703%252891%252990445-N%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DM.%2BH.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26atitle%3DPreclinical%2520pharmacology%2520of%2520celiprolol%253A%2520a%2520cardioselective%2520beta-adrenergic%2520antagonist%2520and%2520mild%2520vasodilator%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1991%26volume%3D121%26spage%3D677%26epage%3D683%26doi%3D10.1016%2F0002-8703%2891%2990445-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nawarskas, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng-Lai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frishman, W. H.</span></span> <span> </span><span class="NLM_article-title">Celiprolol: a unique selective adrenoceptor modulator</span>. <i>Cardiol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1097/CRD.0000000000000159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1097%2FCRD.0000000000000159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=28742547" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=247-253&author=J.+J.+Nawarskasauthor=A.+Cheng-Laiauthor=W.+H.+Frishman&title=Celiprolol%3A+a+unique+selective+adrenoceptor+modulator&doi=10.1097%2FCRD.0000000000000159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1097%2FCRD.0000000000000159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCRD.0000000000000159%26sid%3Dliteratum%253Aachs%26aulast%3DNawarskas%26aufirst%3DJ.%2BJ.%26aulast%3DCheng-Lai%26aufirst%3DA.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3DCeliprolol%253A%2520a%2520unique%2520selective%2520adrenoceptor%2520modulator%26jtitle%3DCardiol%2520Rev.%26date%3D2017%26volume%3D25%26spage%3D247%26epage%3D253%26doi%3D10.1097%2FCRD.0000000000000159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doshan, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiss, E. S.</span></span> <span> </span><span class="NLM_article-title">Celiprolol: pharmacokinetics and duration of pharmacodynamic activity</span>. <i>Br J. Clin Pract Suppl</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=2864056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaL28%252FgtVelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1985&pages=12-16&author=F.+S.+Carusoauthor=H.+D.+Doshanauthor=P.+H.+Hernandezauthor=R.+Costelloauthor=W.+Applinauthor=E.+S.+Neiss&title=Celiprolol%3A+pharmacokinetics+and+duration+of+pharmacodynamic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Celiprolol: pharmacokinetics and duration of pharmacodynamic activity</span></div><div class="casAuthors">Caruso F S; Doshan H D; Hernandez P H; Costello R; Applin W; Neiss E S</div><div class="citationInfo"><span class="NLM_cas:title">British journal of clinical practice. Supplement</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-6</span>
        ISSN:<span class="NLM_cas:issn">0262-8767</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGCOXYK4OUDLxanA7vODO6fW6udTcc2eahJeXqaF17b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28%252FgtVelug%253D%253D&md5=face8cddca1ff41083d0b64b56ccedb8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DF.%2BS.%26aulast%3DDoshan%26aufirst%3DH.%2BD.%26aulast%3DHernandez%26aufirst%3DP.%2BH.%26aulast%3DCostello%26aufirst%3DR.%26aulast%3DApplin%26aufirst%3DW.%26aulast%3DNeiss%26aufirst%3DE.%2BS.%26atitle%3DCeliprolol%253A%2520pharmacokinetics%2520and%2520duration%2520of%2520pharmacodynamic%2520activity%26jtitle%3DBr%2520J.%2520Clin%2520Pract%2520Suppl%26date%3D1985%26volume%3D40%26spage%3D12%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span> <span> </span><span class="NLM_article-title">Efficacy of oral anticancer agents for colorectal cancer</span>. <i>Dis. Colon Rectum</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">S82</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1007/s10350-006-0601-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs10350-006-0601-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17106820" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=S82-91&author=J.+Sakamotoauthor=K.+Obaauthor=T.+Matsuiauthor=M.+Kobayashi&title=Efficacy+of+oral+anticancer+agents+for+colorectal+cancer&doi=10.1007%2Fs10350-006-0601-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1007%2Fs10350-006-0601-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10350-006-0601-7%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DOba%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26atitle%3DEfficacy%2520of%2520oral%2520anticancer%2520agents%2520for%2520colorectal%2520cancer%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D2006%26volume%3D49%26spage%3DS82%26epage%3D91%26doi%3D10.1007%2Fs10350-006-0601-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbaugh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">14379</span>– <span class="NLM_lpage">14455</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWgtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=14379-14455&author=J.+Sheltonauthor=X.+Luauthor=J.+A.+Hollenbaughauthor=J.+H.+Choauthor=F.+Amblardauthor=R.+F.+Schinazi&title=Metabolism%2C+biochemical+actions%2C+and+chemical+synthesis+of+anticancer+nucleosides%2C+nucleotides%2C+and+base+analogs&doi=10.1021%2Facs.chemrev.6b00209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs</span></div><div class="casAuthors">Shelton, Jadd; Lu, Xiao; Hollenbaugh, Joseph A.; Cho, Jong Hyun; Amblard, Franck; Schinazi, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">14379-14455</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Nucleoside, nucleotide, and base analogs have been in the clinic for decades to treat both viral pathogens and neoplasms.  More than 20% of patients on anticancer chemotherapy have been treated with one or more of these analogs.  This review focuses on the chem. synthesis and biol. of anticancer nucleoside, nucleotide, and base analogs that are FDA-approved and in clin. development since 2000.  The authors highlight the cellular biol. and clin. biol. of analogs, drug resistance mechanisms, and compd. specificity towards different cancer types.  Furthermore, the authors explore analog syntheses as well as improved and scale-up syntheses.  The authors conclude with a discussion on what might lie ahead for medicinal chemists, biologists, and physicians as they try to improve analog efficacy through prodrug strategies and drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK6JmQ8iMPQrVg90H21EOLACvtfcHk0lgPAX-K1YBWhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWgtL3J&md5=84cbe9e13e6bdaff88a9d49caea2f99a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00209%26sid%3Dliteratum%253Aachs%26aulast%3DShelton%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DHollenbaugh%26aufirst%3DJ.%2BA.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DMetabolism%252C%2520biochemical%2520actions%252C%2520and%2520chemical%2520synthesis%2520of%2520anticancer%2520nucleosides%252C%2520nucleotides%252C%2520and%2520base%2520analogs%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D14379%26epage%3D14455%26doi%3D10.1021%2Facs.chemrev.6b00209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobe, T.</span></span> <span> </span><span class="NLM_article-title">Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma</span>. <i>Br. J. Surg.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1002/bjs.1800830313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fbjs.1800830313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8665186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaK283ks1amtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1996&pages=336-340&author=M.+Yamamotoauthor=S.+Ariiauthor=K.+Sugaharaauthor=T.+Tobe&title=Adjuvant+oral+chemotherapy+to+prevent+recurrence+after+curative+resection+for+hepatocellular+carcinoma&doi=10.1002%2Fbjs.1800830313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma</span></div><div class="casAuthors">Yamamoto M; Arii S; Sugahara K; Tobe T</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of surgery</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">336-40</span>
        ISSN:<span class="NLM_cas:issn">0007-1323</span>.
    </div><div class="casAbstract">Adjuvant oral chemotherapy was studied in 67 patients with stage II hepatocellular carcinoma who underwent curative resection between May 1988 and December 1990.  Patients were stratified into two groups according to preoperative liver dysfunction: 55 had stage I disease (mild dysfunction) and 12 had stage II (moderate dysfunction).  A randomized controlled study of postoperative oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) was conducted in each group.  From October 1994 HCFU administration was suspended because of side-effects in nine patients with stage I liver dysfunction and in three with stage II dysfunction who had received the drug for more than 4 weeks.  Cumulative survival and recurrence-free survival rates of patients with stage I disease in the treatment group were higher (P = 0.08 and P = 0.04 respectively) than those in the control group.  However, in patients with stage II disease no significant difference was observed (P = 0.77 and P = 1.0 respectively).  This study suggests that the potential benefits of HCFU on tumour recurrence should be weighed against the risk of adverse reactions in patients with mild liver dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQk5ElLzb1pE75XHngOXiV_fW6udTcc2eYM1dI4NDlwDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283ks1amtw%253D%253D&md5=82ca69f493676a19e4ebc82b6e16366c</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1002%2Fbjs.1800830313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbjs.1800830313%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DArii%26aufirst%3DS.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DTobe%26aufirst%3DT.%26atitle%3DAdjuvant%2520oral%2520chemotherapy%2520to%2520prevent%2520recurrence%2520after%2520curative%2520resection%2520for%2520hepatocellular%2520carcinoma%26jtitle%3DBr.%2520J.%2520Surg.%26date%3D1996%26volume%3D83%26spage%3D336%26epage%3D340%26doi%3D10.1002%2Fbjs.1800830313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uenaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, M.</span></span> <span> </span><span class="NLM_article-title">Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5459</span>– <span class="NLM_lpage">5465</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-5270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1158%2F1078-0432.CCR-07-5270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18765537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5459-5465&author=J.+Matsuiauthor=Y.+Funahashiauthor=T.+Uenakaauthor=T.+Watanabeauthor=A.+Tsuruokaauthor=M.+Asada&title=Multi-kinase+inhibitor+E7080+suppresses+lymph+node+and+lung+metastases+of+human+mammary+breast+tumor+MDA-MB-231+via+inhibition+of+vascular+endothelial+growth+factor-receptor+%28VEGF-R%29+2+and+VEGF-R3+kinase&doi=10.1158%2F1078-0432.CCR-07-5270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase</span></div><div class="casAuthors">Matsui, Junji; Funahashi, Yasuhiro; Uenaka, Toshimitsu; Watanabe, Tatsuo; Tsuruoka, Akihiko; Asada, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5459-5465</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Vascular endothelial growth factor (VEGF)-C/VEGF-receptor 3 (VEGF-R3) signal plays a significant role in lymphangiogenesis and tumor metastasis based on its effects on lymphatic vessels.  However, little is known about the effect of inhibiting VEGF-R3 on lymphangiogenesis and lymph node metastases using a small-mol. kinase inhibitor.  Exptl. Design: We evaluated the effect of E7080, a potent inhibitor of both VEGF-R2 and VEGF-R3 kinase, and bevacizumab on lymphangiogenesis and angiogenesis in a mammary fat pad xenograft model of human breast cancer using MDA-MB-231 cells that express excessive amts. of VEGF-C.  Lymphangiogenesis was detd. by lymphatic vessel d. (LVD) and angiogenesis by microvessel d. (MVD).  RESULTS: In contrast to MDA-MB-435 cells, which expressed a similar amt. of VEGF to MDA-MB-231 cells with an undetectable amt. of VEGF-C, only MDA-MB-231 exhibited lymphangiogenesis in the primary tumor.  E7080 but not bevacizumab significantly decreased LVD within the MDA-MB-231 tumor.  E7080 and bevacizumab decreased MVD in both the MDA-MB-231 and MDA-MB-435 models.  E7080 significantly suppressed regional lymph nodes and distant lung metastases of MDA-MB-231, whereas bevacizumab significantly inhibited only lung metastases.  E7080 also decreased both MVD and LVD within the metastatic nodules at lymph nodes after resection of the primary tumor.  CONCLUSIONS: Inhibition of VEGF-R3 kinase with E7080 effectively decreased LVD within MDA-MB-231 tumors, which express VEGF-C.  Simultaneous inhibition of both VEGF-R2 and VEGF-R3 kinases by E7080 may be a promising new strategy to control regional lymph node and distant lung metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrBisu80xI7Vg90H21EOLACvtfcHk0lgPAX-K1YBWhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbjP&md5=0a73511c46d0f668f09f84d89c718417</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-5270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-5270%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DUenaka%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DAsada%26aufirst%3DM.%26atitle%3DMulti-kinase%2520inhibitor%2520E7080%2520suppresses%2520lymph%2520node%2520and%2520lung%2520metastases%2520of%2520human%2520mammary%2520breast%2520tumor%2520MDA-MB-231%2520via%2520inhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor-receptor%2520%2528VEGF-R%2529%25202%2520and%2520VEGF-R3%2520kinase%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5459%26epage%3D5465%26doi%3D10.1158%2F1078-0432.CCR-07-5270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uenaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, M.</span></span> <span> </span><span class="NLM_article-title">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">671</span>, <span class="refDoi"> DOI: 10.1002/ijc.23131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fijc.23131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17943726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=664-671&author=J.+Matsuiauthor=Y.+Yamamotoauthor=Y.+Funahashiauthor=A.+Tsuruokaauthor=T.+Watanabeauthor=T.+Wakabayashiauthor=T.+Uenakaauthor=M.+Asada&title=E7080%2C+a+novel+inhibitor+that+targets+multiple+kinases%2C+has+potent+antitumor+activities+against+stem+cell+factor+producing+human+small+cell+lung+cancer+H146%2C+based+on+angiogenesis+inhibition&doi=10.1002%2Fijc.23131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span></div><div class="casAuthors">Matsui Junji; Yamamoto Yuji; Funahashi Yasuhiro; Tsuruoka Akihiko; Watanabe Tatsuo; Wakabayashi Toshiaki; Uenaka Toshimitsu; Asada Makoto</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">664-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">E7080 is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.  In this study, we show the inhibitory activity of E7080 against SCF-induced angiogenesis in vitro and tumor growth of SCF-producing human small cell lung carcinoma H146 cells in vivo.  E7080 inhibits SCF-driven tube formation of HUVEC, which express SCF receptor, KIT at the IC(50) value of 5.2 nM and it was almost identical for VEGF-driven one (IC(50) = 5.1 nM).  To assess the role of SCF/KIT signaling in tumor angiogenesis, we evaluated the effect of imatinib, a selective KIT kinase inhibitor, on tumor growth of H146 cells in nude mice.  Imatinib did not show the potent antitumor activity in vitro (IC(50) = 2,200 nM), because H146 cells did not express KIT.  However, oral administration of imatinib at 160 mg/kg clearly slowed tumor growth of H146 cells in nude mice, accompanied by decreased microvessel density.  Oral administration of E7080 inhibited tumor growth of H146 cells at doses of 30 and 100 mg/kg in a dose-dependent manner and caused tumor regression at 100 mg/kg.  While anti-VEGF antibody also slowed tumor growth, it did not cause tumor regression.  These results indicate that KIT signaling has a role in tumor angiogenesis of SCF-producing H146 cells, and E7080 causes regression of H146 tumors as a result of antiangiogenic activity mediated by inhibition of both KIT and VEGF receptor signaling.  E7080 may provide therapeutic benefits in the treatment of SCF-producing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxatmtwSKaDe98rul4nhSdfW6udTcc2ea2gKG3F3VuR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhvVGnsA%253D%253D&md5=cfa467e773fd98d6f95b0dded62d31ef</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fijc.23131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23131%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DT.%26aulast%3DUenaka%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DM.%26atitle%3DE7080%252C%2520a%2520novel%2520inhibitor%2520that%2520targets%2520multiple%2520kinases%252C%2520has%2520potent%2520antitumor%2520activities%2520against%2520stem%2520cell%2520factor%2520producing%2520human%2520small%2520cell%2520lung%2520cancer%2520H146%252C%2520based%2520on%2520angiogenesis%2520inhibition%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2008%26volume%3D122%26spage%3D664%26epage%3D671%26doi%3D10.1002%2Fijc.23131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugi, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span> <span> </span><span class="NLM_article-title">Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.canlet.2013.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23856031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=97-103&author=K.+Okamotoauthor=K.+Kodamaauthor=K.+Takaseauthor=N.+H.+Sugiauthor=Y.+Yamamotoauthor=M.+Iwataauthor=A.+Tsuruoka&title=Antitumor+activities+of+the+targeted+multi-tyrosine+kinase+inhibitor+lenvatinib+%28E7080%29+against+RET+gene+fusion-driven+tumor+models&doi=10.1016%2Fj.canlet.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models</span></div><div class="casAuthors">Okamoto, Kiyoshi; Kodama, Kotaro; Takase, Kazuma; Sugi, Naoko Hata; Yamamoto, Yuji; Iwata, Masao; Tsuruoka, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">RET gene fusions are recurrent oncogenes identified in thyroid and lung carcinomas.  Lenvatinib is a multi-tyrosine kinase inhibitor currently under evaluation in several clin. trials.  Here we evaluated lenvatinib in RET gene fusion-driven preclin. models.  In cellular assays, lenvatinib inhibited auto-phosphorylation of KIF5B-RET, CCDC6-RET, and NcoA4-RET.  Lenvatinib suppressed the growth of CCDC6-RET human thyroid and lung cancer cell lines, and as well, suppressed anchorage-independent growth and tumorigenicity of RET gene fusion-transformed NIH3T3 cells.  These results demonstrate that lenvatinib can exert antitumor activity against RET gene fusion-driven tumor models by inhibiting oncogenic RET gene fusion signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr151nVk6WXn7Vg90H21EOLACvtfcHk0lhKxd7tbFgmrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygtb7M&md5=e2399184aae74ae2c4b18997a6b7273b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DTakase%26aufirst%3DK.%26aulast%3DSugi%26aufirst%3DN.%2BH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DTsuruoka%26aufirst%3DA.%26atitle%3DAntitumor%2520activities%2520of%2520the%2520targeted%2520multi-tyrosine%2520kinase%2520inhibitor%2520lenvatinib%2520%2528E7080%2529%2520against%2520RET%2520gene%2520fusion-driven%2520tumor%2520models%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D340%26spage%3D97%26epage%3D103%26doi%3D10.1016%2Fj.canlet.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabanillas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habra, M. A.</span></span> <span> </span><span class="NLM_article-title">Lenvatinib: Role in thyroid cancer and other solid tumors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2015.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ctrv.2015.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26678514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyqu77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2016&pages=47-55&author=M.+E.+Cabanillasauthor=M.+A.+Habra&title=Lenvatinib%3A+Role+in+thyroid+cancer+and+other+solid+tumors&doi=10.1016%2Fj.ctrv.2015.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Lenvatinib: Role in thyroid cancer and other solid tumors</span></div><div class="casAuthors">Cabanillas, Maria E.; Habra, Mouhammed Amir</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite recent breakthroughs in treatment of advanced thyroid cancers, prognoses remain poor.  Treatment of advanced, progressive disease remains challenging, with limited treatment options.  Small-mol. tyrosine kinase inhibitors, including vandetanib, cabozantinib, sorafenib, and lenvatinib, which are now FDA-approved for thyroid cancer, have shown clin. benefit in advanced thyroid cancer.  Lenvatinib is approved for treatment of locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC).  It has been studied in phase II and III trials for treatment of advanced RAI-refractory DTC, and in a phase II trial for medullary thyroid cancer (MTC).  Lenvatinib targets vascular endothelial growth factor receptors 1-3 (VEGFR1-3), fibroblast growth factor receptors 1-4 (FGFR-1-4), RET, c-kit, and platelet-derived growth factor receptor α (PDGFRα).  Its antitumor activity may be due to antiangiogenic properties and direct antitumor effects.  Lenvatinib has demonstrated antitumor activity in a variety of solid tumors, including MTC, in phase I and II clin. trials.  In a phase II study in advanced RAI-refractory DTC, lenvatinib-treated patients achieved a 50% response rate (RR), with median progression-free survival (PFS) of 12.6 mo.  In a phase III trial in RAI-refractory DTC, median PFS in lenvatinib-treated patients was 18.3 mo, with a 65% overall RR, vs. 3.6 mo in placebo-treated patients, with a 2% RR.  Adverse events occurring in >50% of patients included hypertension, diarrhea, fatigue/asthenia, and decreased appetite.  Lenvatinib is a promising new agent for treatment of patients with advanced thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiDKE0T_lhrLVg90H21EOLACvtfcHk0ljJ54JkR9N2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyqu77M&md5=21c6f2d9a05bb312ea31f66ea4c56599</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2015.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DCabanillas%26aufirst%3DM.%2BE.%26aulast%3DHabra%26aufirst%3DM.%2BA.%26atitle%3DLenvatinib%253A%2520Role%2520in%2520thyroid%2520cancer%2520and%2520other%2520solid%2520tumors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2016%26volume%3D42%26spage%3D47%26epage%3D55%26doi%3D10.1016%2Fj.ctrv.2015.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubbelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosing, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebretensae, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumaker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span> <span> </span><span class="NLM_article-title">Development and validation of LC-MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>887–888</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.jchromb.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22309776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1aku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=887%E2%80%93888&publication_year=2012&pages=25-34&author=A.+C.+Dubbelmanauthor=H.+Rosingauthor=B.+Thijssenauthor=A.+Gebretensaeauthor=L.+Lucasauthor=H.+Chenauthor=R.+Shumakerauthor=J.+H.+Schellensauthor=J.+H.+Beijnen&title=Development+and+validation+of+LC-MS%2FMS+assays+for+the+quantification+of+E7080+and+metabolites+in+various+human+biological+matrices&doi=10.1016%2Fj.jchromb.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of LC-MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices</span></div><div class="casAuthors">Dubbelman, A. C.; Rosing, H.; Thijssen, B.; Gebretensae, A.; Lucas, L.; Chen, H.; Shumaker, R.; Schellens, J. H. M.; Beijnen, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">887-888</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To support clin. pharmacokinetic studies with the anticancer agent E7080 (lenvatinib), liq. chromatog. tandem mass spectrometry (LC-MS/MS) methods were developed for the quantification of E7080 and four of its metabolites in human plasma, urine and feces and of E7080 in whole blood.  Cross-analyte interferences between metabolites and parent compd. were expected and therefore accounted for early in the method development.  Plasma, urine and feces samples were extd. with acetonitrile.  Chromatog. sepn. was achieved on a 50 mm × 2.1 mm I.D.  XTerra MS C18 column, with a 0.2 mL/min flow and gradient elution starting with 100% formic acid in water, followed by an increasing percentage of acetonitrile.  Whole blood samples were extd. with di-Et ether and exts. were injected on a 150 mm × 2.1 mm I.D. Symmetry Shield RP8 column.  Detection was performed using an API3000 triple quadrupole mass spectrometer, with a turbo ion spray interface, operating in pos. ion mode.  Using 250 μL of plasma, E7080 and its metabolites could be quantified between 0.25 and 50.0 ng/mL.  The quantifiable ranges of E7080 in whole blood, urine and feces were 0.25-500 ng/mL, 1.00-500 ng/mL and 0.1-25 μg/g, using sample vols. of 250 μL, 200 μL and 250 mg, resp.  Calibration curves in all matrixes were linear with a correlation coeff. (r 2) of 0.994 or better.  At the lower limit of quantification, accuracies were within ±20% of the nominal concn. with CV values less than 20%.  At the other concns. the accuracies were within ±15% of the nominal concn. with CV values below 15%.  The developed methods have successfully been applied in a mass balance study of E7080.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34hsZv1FitLVg90H21EOLACvtfcHk0ljJ54JkR9N2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1aku74%253D&md5=0f128b8d0c1725246403921cd0c941c6</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DDubbelman%26aufirst%3DA.%2BC.%26aulast%3DRosing%26aufirst%3DH.%26aulast%3DThijssen%26aufirst%3DB.%26aulast%3DGebretensae%26aufirst%3DA.%26aulast%3DLucas%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DShumaker%26aufirst%3DR.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520LC-MS%252FMS%2520assays%2520for%2520the%2520quantification%2520of%2520E7080%2520and%2520metabolites%2520in%2520various%2520human%2520biological%2520matrices%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2012%26volume%3D887%25E2%2580%2593888%26spage%3D25%26epage%3D34%26doi%3D10.1016%2Fj.jchromb.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumaker, R.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacokinetic and pharmacodynamic profile of lenvatinib, an orally active, small-molecule, multitargeted tyrosine kinase inhibitor</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1007/s13318-017-0403-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs13318-017-0403-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=28236116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=903-914&author=Z.+Husseinauthor=H.+Mizuoauthor=S.+Hayatoauthor=M.+Namikiauthor=R.+Shumaker&title=Clinical+pharmacokinetic+and+pharmacodynamic+profile+of+lenvatinib%2C+an+orally+active%2C+small-molecule%2C+multitargeted+tyrosine+kinase+inhibitor&doi=10.1007%2Fs13318-017-0403-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor</span></div><div class="casAuthors">Hussein, Ziad; Mizuo, Hitoshi; Hayato, Seiichi; Namiki, Masayuki; Shumaker, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">903-914</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Lenvatinib is a multikinase inhibitor that targets vascular endothelial growth factor (VEGF) receptors 1-3, fibroblast growth factor receptors 1-4, platelet-derived growth factor receptor-alpha, and RET and KIT proto-oncogenes.  Lenvatinib is approved for the treatment of radioiodine-refractory differentiated thyroid cancer in the United States (US), European Union (EU), Canada, Japan, and Switzerland.  It is also approved in combination with everolimus for the treatment of advanced renal cell carcinoma following ≥1 VEGF-targeted treatment in the US and EU.  In addn., lenvatinib is under investigation for the treatment of hepatocellular carcinoma.  As lenvatinib becomes more widely available, a better understanding of its pharmacokinetic profile has become increasingly important.  Following oral administration, lenvatinib is absorbed rapidly and is metabolized extensively prior to excretion.  This metab. is mediated by multiple pathways, and several metabolites of lenvatinib have been identified.  The effect of food intake on lenvatinib exposure has also been studied and was found to not significantly influence overall exposure to the drug.  Exposure to lenvatinib is increased in patients with severe hepatic impairment, indicating that dose redn. must be considered for those patients.  The findings summarized here indicate that the clin. pharmacokinetic and pharmacodynamic profile for lenvatinib are predictable, with a dose-independent absorption and elimination profile that supports once-daily administration, and has minimal effects due to mild or moderate renal or hepatic impairment or drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN-mhaZ-ys8bVg90H21EOLACvtfcHk0ljJ54JkR9N2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2htL4%253D&md5=8dad52dfd3d856a6d94f7a99c7c18cab</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1007%2Fs13318-017-0403-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-017-0403-4%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DZ.%26aulast%3DMizuo%26aufirst%3DH.%26aulast%3DHayato%26aufirst%3DS.%26aulast%3DNamiki%26aufirst%3DM.%26aulast%3DShumaker%26aufirst%3DR.%26atitle%3DClinical%2520pharmacokinetic%2520and%2520pharmacodynamic%2520profile%2520of%2520lenvatinib%252C%2520an%2520orally%2520active%252C%2520small-molecule%252C%2520multitargeted%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2017%26volume%3D42%26spage%3D903%26epage%3D914%26doi%3D10.1007%2Fs13318-017-0403-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wovkulich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzolato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassilev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of RG7112: a small-molecule MDM2 inhibitor in clinical development</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1021/ml4000657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4000657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=466-469&author=B.+Vuauthor=P.+Wovkulichauthor=G.+Pizzolatoauthor=A.+Loveyauthor=Q.+Dingauthor=N.+Jiangauthor=J.+J.+Liuauthor=C.+Zhaoauthor=K.+Glennauthor=Y.+Wenauthor=C.+Tovarauthor=K.+Packmanauthor=L.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7112%3A+a+small-molecule+MDM2+inhibitor+in+clinical+development&doi=10.1021%2Fml4000657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Vu, Binh; Wovkulich, Peter; Pizzolato, Giacomo; Lovey, Allen; Ding, Qingjie; Jiang, Nan; Liu, Jin-Jun; Zhao, Chunlin; Glenn, Kelli; Wen, Yang; Tovar, Christian; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-469</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress.  It is controlled by its neg. regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity.  MDM2 also targets p53 for degrdn. by the proteasome.  Many tumors produce high levels of MDM2, thereby impairing p53 function.  Restoration of p53 activity by inhibiting the p53-MDM2 interaction may represent a novel approach to cancer treatment.  RG7112 (2g) is the first clin. small-mol. MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.  In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZDyQMojUKIrVg90H21EOLACvtfcHk0ljCI63oMg_UjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D&md5=3965eb84198ff25eb9bc5f4c3823e850</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fml4000657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000657%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DPizzolato%26aufirst%3DG.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7112%253A%2520a%2520small-molecule%2520MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D466%26epage%3D469%26doi%3D10.1021%2Fml4000657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andreeff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assouline, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strair, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popplewell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruvolo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blotner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jukofsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, K.</span></span> <span> </span><span class="NLM_article-title">Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">876</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-0481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1158%2F1078-0432.CCR-15-0481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26459177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFGmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=868-876&author=M.+Andreeffauthor=K.+R.+Kellyauthor=K.+Yeeauthor=S.+Assoulineauthor=R.+Strairauthor=L.+Popplewellauthor=D.+Bowenauthor=G.+Martinelliauthor=M.+W.+Drummondauthor=P.+Vyasauthor=M.+Kirschbaumauthor=S.+P.+Iyerauthor=V.+Ruvoloauthor=G.+M.+Gonzalezauthor=X.+Huangauthor=G.+Chenauthor=B.+Gravesauthor=S.+Blotnerauthor=P.+Bridgeauthor=L.+Jukofskyauthor=S.+Middletonauthor=M.+Recknerauthor=R.+Ruegerauthor=J.+Zhiauthor=G.+Nicholsauthor=K.+Kojima&title=Results+of+the+phase+I+trial+of+RG7112%2C+a+small-molecule+MDM2+antagonist+in+leukemia&doi=10.1158%2F1078-0432.CCR-15-0481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia</span></div><div class="casAuthors">Andreeff, Michael; Kelly, Kevin R.; Yee, Karen; Assouline, Sarit; Strair, Roger; Popplewell, Leslie; Bowen, David; Martinelli, Giovanni; Drummond, Mark W.; Vyas, Paresh; Kirschbaum, Mark; Iyer, Swaminathan Padmanabhan; Ruvolo, Vivian; Gonzalez, Graciela M. Nogueras; Huang, Xuelin; Chen, Gong; Graves, Bradford; Blotner, Steven; Bridge, Peter; Jukofsky, Lori; Middleton, Steve; Reckner, Monica; Rueger, Ruediger; Zhi, Jianguo; Nichols, Gwen; Kojima, Kensuke</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">868-876</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: RG7112 is a small-mol. MDM2 antagonist.  MDM2 is a neg. regulator of the tumor suppressor p53 and frequently overexpressed in leukemias.  Thus, a phase I study of RG7112 in patients with hematol. malignancies was conducted.  Exptl. Design: Primary study objectives included detn. of the dose and safety profile of RG7112.  Secondary objectives included evaluation of pharmacokinetics; pharmacodynamics, such as TP53-mutation status and MDM2 expression; and preliminary clin. activity.  Patients were divided into two cohorts: Stratum A [relapsed/refractory acute myeloid leukemia (AML; except acute promyelocytic leukemia), acute lymphoblastic leukemia, and chronic myelogenous leukemia] and Stratum B (relapsed/refractory chronic lymphocytic leukemia/small cell lymphocytic leukemia; CLL/sCLL).  Some Stratum A patients were treated at the MTD to assess clin. activity.  Results: RG7112 was administered to 116 patients (96 patients in Stratum A and 20 patients in Stratum B).  All patients experienced at least 1 adverse event, and 3 dose-limiting toxicities were reported.  Pharmacokinetic anal. indicated that twice-daily dosing enhanced daily exposure.  Antileukemia activity was obsd. in the 30 patients with AML assessed at the MTD, including 5 patients who met International Working Group (IWG) criteria for response.  Exploratory anal. revealed TP53 mutations in 14% of Stratum A patients and in 40% of Stratum B patients.  Two patients with TP53 mutations exhibited clin. activity. p53 target genes were induced only in TP53 wild-type leukemic cells.  Baseline expression levels of MDM2 correlated pos. with clin. response.  Conclusions: RG7112 demonstrated clin. activity against relapsed/refractory AML and CLL/sCLL.  MDM2 inhibition resulted in p53 stabilization and transcriptional activation of p53-target genes.  We provide proof-of-concept that MDM2 inhibition restores p53 function and generates clin. responses in hematol. malignancies.  Clin Cancer Res; 22(4); 868-76. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRuwfqK8jXXrVg90H21EOLACvtfcHk0ljCI63oMg_UjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFGmtrs%253D&md5=9fd607f309a6327c163738291413048a</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0481%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DK.%2BR.%26aulast%3DYee%26aufirst%3DK.%26aulast%3DAssouline%26aufirst%3DS.%26aulast%3DStrair%26aufirst%3DR.%26aulast%3DPopplewell%26aufirst%3DL.%26aulast%3DBowen%26aufirst%3DD.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DDrummond%26aufirst%3DM.%2BW.%26aulast%3DVyas%26aufirst%3DP.%26aulast%3DKirschbaum%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DS.%2BP.%26aulast%3DRuvolo%26aufirst%3DV.%26aulast%3DGonzalez%26aufirst%3DG.%2BM.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DBlotner%26aufirst%3DS.%26aulast%3DBridge%26aufirst%3DP.%26aulast%3DJukofsky%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DReckner%26aufirst%3DM.%26aulast%3DRueger%26aufirst%3DR.%26aulast%3DZhi%26aufirst%3DJ.%26aulast%3DNichols%26aufirst%3DG.%26aulast%3DKojima%26aufirst%3DK.%26atitle%3DResults%2520of%2520the%2520phase%2520I%2520trial%2520of%2520RG7112%252C%2520a%2520small-molecule%2520MDM2%2520antagonist%2520in%2520leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D868%26epage%3D876%26doi%3D10.1158%2F1078-0432.CCR-15-0481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolcher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemunaitis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarapa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, J.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1007/s00280-015-2830-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs00280-015-2830-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26210682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1amtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2015&pages=587-595&author=A.+Patnaikauthor=A.+Tolcherauthor=M.+Beeramauthor=J.+Nemunaitisauthor=G.+J.+Weissauthor=K.+Bhallaauthor=M.+Agrawalauthor=G.+Nicholsauthor=S.+Middletonauthor=A.+Beryozkinaauthor=N.+Sarapaauthor=R.+Peckauthor=J.+Zhi&title=Clinical+pharmacology+characterization+of+RG7112%2C+an+MDM2+antagonist%2C+in+patients+with+advanced+solid+tumors&doi=10.1007%2Fs00280-015-2830-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors</span></div><div class="casAuthors">Patnaik, Amita; Tolcher, Anthony; Beeram, Murali; Nemunaitis, John; Weiss, Glen J.; Bhalla, Kapil; Agrawal, Manish; Nichols, Gwen; Middleton, Steven; Beryozkina, Anna; Sarapa, Nenad; Peck, Richard; Zhi, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">587-595</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: RG7112, the first selective small-mol. MDM2 antagonist in clin. testing, is a non-genotoxic oral p53 activator.  To optimize its dose and schedule, a no. of clin. pharmacol. characteristics were explored in this multicenter trial in patients with advanced solid tumors.  Method: In part 1, the impact of high-energy/high-fat meal and formulations (cryst. and amorphous) on relative bioavailability was examd. in single-dose crossover designs.  In part 2, schedule optimization (4 schedules of drug administration under fasting condition and 2 cohorts with liq. supplementation) was investigated in parallel, dose escalation designs.  Clin. endpoints were pharmacokinetics (PK), pharmacodynamics (PD) including MIC-1 elevation and platelet redn., and safety/tolerability.  Results: With a single-dose treatment, a high-fat/high-energy meal and a new formulation under fasting condition, resp., enhanced overall bioavailability of RG7112 slightly over twofold.  Following multiple-dose administrations, all four schedules yielded the comparable per-cycle (28-d) exposure (AUC), as designed; liq. supplements also enhanced bioavailability.  High-dose treatments of consecutive daily dosing for 5 and 3 days resulted in higher on-treatment-day exposure to RG7112 than both weekly and low-dose/long-duration (20-day) daily schedules.  Serum MIC-1 and blood platelet profiles showed similar patterns to those of PK when the clin. pharmacol. conditions were varied, suggesting the relative importance of treatment-day exposure than overall per-cycle AUC.  Conclusion: Food (both high-fat and low-fat meals) and new formulation enhanced bioavailability.  High-dose consecutive daily treatment for 3-5 days is superior to weekly and low-dose/long-duration (20-day) daily schedules in yielding the sufficiently high drug exposure and PD effects potentially required for cancer treatment efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0X7kDb-ao7Vg90H21EOLACvtfcHk0lgiZ7vZsmcU7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1amtb%252FM&md5=1c6b7aff4b25e12c8e8b92ca966ed95f</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs00280-015-2830-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-015-2830-8%26sid%3Dliteratum%253Aachs%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DTolcher%26aufirst%3DA.%26aulast%3DBeeram%26aufirst%3DM.%26aulast%3DNemunaitis%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DAgrawal%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DG.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DBeryozkina%26aufirst%3DA.%26aulast%3DSarapa%26aufirst%3DN.%26aulast%3DPeck%26aufirst%3DR.%26aulast%3DZhi%26aufirst%3DJ.%26atitle%3DClinical%2520pharmacology%2520characterization%2520of%2520RG7112%252C%2520an%2520MDM2%2520antagonist%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2015%26volume%3D76%26spage%3D587%26epage%3D595%26doi%3D10.1007%2Fs00280-015-2830-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noronha, G.</span></span> <span> </span><span class="NLM_article-title">An improved method for the synthesis of enantiomerically pure amino-acid ester isocyanates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7364</span>– <span class="NLM_lpage">7366</span>, <span class="refDoi"> DOI: 10.1021/jo00052a069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00052a069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=7364-7366&author=J.+S.+Nowickauthor=N.+A.+Powellauthor=T.+M.+Nguyenauthor=G.+Noronha&title=An+improved+method+for+the+synthesis+of+enantiomerically+pure+amino-acid+ester+isocyanates&doi=10.1021%2Fjo00052a069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the synthesis of enantiomerically pure amino acid ester isocyanates</span></div><div class="casAuthors">Nowick, James S.; Powell, Noel A.; Nguyen, Tram M.; Noronha, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7364-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Enantiomerically pure amino acid ester isocyanates OCNCHRCOOR1 (R = Me, CH2CH2CO2Et, R1 = Et; R = CHMe2, iso-Bu, sec-Bu, CH2Ph, CH2CH2SMe, CH2OCMe3, R 1 = Me) were prepd. in excellent yield (72-95%) from the corresponding amino acid ester hydrochlorides.  The reaction procedure involves addn. of a soln. of phosgene in toluene (1.3 equiv) to a mixt. of the amino acid ester hydrochloride and pyridine (4.0 equiv) in dry methylene chloride at 0°.  After 2 h, the isocyanate is isolated by rapid aq. workup at 0°, and is then purified by kugelrohr distn.  The isocyanates were detd. to be enantiomerically pure (>99% ee) by 1H NMR anal. of the urea adducts with (R)-1-phenylethylamine.  The mild reaction conditions permit the prepn. of amino acid ester isocyanates contg. acid-sensitive functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQL1Lj7C_frVg90H21EOLACvtfcHk0lgiZ7vZsmcU7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Grtw%253D%253D&md5=43f57607f0621ef10b032544dfdca193</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjo00052a069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00052a069%26sid%3Dliteratum%253Aachs%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DNguyen%26aufirst%3DT.%2BM.%26aulast%3DNoronha%26aufirst%3DG.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520synthesis%2520of%2520enantiomerically%2520pure%2520amino-acid%2520ester%2520isocyanates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D7364%26epage%3D7366%26doi%3D10.1021%2Fjo00052a069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groszek, G.</span></span> <span> </span><span class="NLM_article-title">A convenient method of synthesis of unsymmetrical urea derivatives</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1021/op020055g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op020055g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1WmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=759-761&author=G.+Groszek&title=A+convenient+method+of+synthesis+of+unsymmetrical+urea+derivatives&doi=10.1021%2Fop020055g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Method of Synthesis of Unsymmetrical Urea Derivatives</span></div><div class="casAuthors">Groszek, Grazyna</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">759-761</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method for the prepn. of unsym. urea derivs. that may contain functional groups such as hydroxyl, amine, amide, and carboxyl is described.  The method consists of a one-pot modified Curtius rearrangement starting with appropriate arom. acid chloride and carried out in a nonaq. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZDiuzMhT63rVg90H21EOLACvtfcHk0lhDsUeSZMxh-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1WmtL8%253D&md5=8e508af629d9b6ae6f9a35472a0e88a4</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fop020055g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop020055g%26sid%3Dliteratum%253Aachs%26aulast%3DGroszek%26aufirst%3DG.%26atitle%3DA%2520convenient%2520method%2520of%2520synthesis%2520of%2520unsymmetrical%2520urea%2520derivatives%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D759%26epage%3D761%26doi%3D10.1021%2Fop020055g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maramai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabellieri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonfiglio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittaluga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span> <span> </span><span class="NLM_article-title">Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2612</span>– <span class="NLM_lpage">2632</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01812</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01812" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XislOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2612-2632&author=M.+Brindisiauthor=S.+Maramaiauthor=S.+Gemmaauthor=S.+Brogiauthor=A.+Grilloauthor=L.+Di+Cesare+Mannelliauthor=E.+Gabellieriauthor=S.+Lamponiauthor=S.+Saponaraauthor=B.+Gorelliauthor=D.+Tedescoauthor=T.+Bonfiglioauthor=C.+Landryauthor=K.+M.+Jungauthor=A.+Armirottiauthor=L.+Luongoauthor=A.+Ligrestiauthor=F.+Piscitelliauthor=C.+Bertucciauthor=M.+P.+Dehouckauthor=G.+Campianiauthor=S.+Maioneauthor=C.+Ghelardiniauthor=A.+Pittalugaauthor=D.+Piomelliauthor=V.+Di+Marzoauthor=S.+Butini&title=Development+and+pharmacological+characterization+of+selective+blockers+of+2-arachidonoyl+glycerol+degradation+with+efficacy+in+rodent+models+of+multiple+sclerosis+and+pain&doi=10.1021%2Facs.jmedchem.5b01812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain</span></div><div class="casAuthors">Brindisi, Margherita; Maramai, Samuele; Gemma, Sandra; Brogi, Simone; Grillo, Alessandro; Di Cesare Mannelli, Lorenzo; Gabellieri, Emanuele; Lamponi, Stefania; Saponara, Simona; Gorelli, Beatrice; Tedesco, Daniele; Bonfiglio, Tommaso; Landry, Christophe; Jung, Kwang-Mook; Armirotti, Andrea; Luongo, Livio; Ligresti, Alessia; Piscitelli, Fabiana; Bertucci, Carlo; Dehouck, Marie-Pierre; Campiani, Giuseppe; Maione, Sabatino; Ghelardini, Carla; Pittaluga, Anna; Piomelli, Daniele; Di Marzo, Vincenzo; Butini, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2612-2632</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of compd. I, a potent β-lactam-based monoacylglycerol lipase (MGL) inhibitor characterized by an irreversible and stereoselective mechanism of action, high membrane permeability, high brain penetration evaluated using a human in vitro blood-brain barrier model, high selectivity in binding and affinity-based proteomic profiling assays, and low in vitro toxicity.  Mode-of-action studies demonstrate that I, by blocking MGL, increases 2-arachidonoylglycerol and behaves as a cannabinoid (CB1/CB2) receptor indirect agonist.  Administration of I in mice suffering from exptl. autoimmune encephalitis ameliorates the severity of the clin. symptoms in a CB1/CB2-dependent manner.  Moreover, I produced analgesic effects in a rodent model of acute inflammatory pain, which was antagonized by CB1 and CB2 receptor antagonists/inverse agonists. 4a also relieves the neuropathic hypersensitivity induced by oxaliplatin.  Given these evidence, I, as MGL selective inhibitor, could represent a valuable lead for the future development of therapeutic options for multiple sclerosis and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1V_wJf1i3LrVg90H21EOLACvtfcHk0lhDsUeSZMxh-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislOnsbw%253D&md5=ff512d8a6ccec5ee5dcd606643797ddc</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01812%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DGrillo%26aufirst%3DA.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DSaponara%26aufirst%3DS.%26aulast%3DGorelli%26aufirst%3DB.%26aulast%3DTedesco%26aufirst%3DD.%26aulast%3DBonfiglio%26aufirst%3DT.%26aulast%3DLandry%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DDehouck%26aufirst%3DM.%2BP.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DPittaluga%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DButini%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520pharmacological%2520characterization%2520of%2520selective%2520blockers%2520of%25202-arachidonoyl%2520glycerol%2520degradation%2520with%2520efficacy%2520in%2520rodent%2520models%2520of%2520multiple%2520sclerosis%2520and%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2612%26epage%3D2632%26doi%3D10.1021%2Facs.jmedchem.5b01812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cotarca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasi, J.</span></span> <span> </span><span class="NLM_article-title">Bis(trichloromethyl)carbonate (BTC, triphosgene): a safer alternative to phosgene?</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1439</span>– <span class="NLM_lpage">1446</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.7b00220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.7b00220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlehtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=1439-1446&author=L.+Cotarcaauthor=T.+Gellerauthor=J.+Repasi&title=Bis%28trichloromethyl%29carbonate+%28BTC%2C+triphosgene%29%3A+a+safer+alternative+to+phosgene%3F&doi=10.1021%2Facs.oprd.7b00220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Bis(trichloromethyl)carbonate (BTC, Triphosgene): A Safer Alternative to Phosgene?</span></div><div class="casAuthors">Cotarca, Livius; Geller, Thomas; Repasi, Jozsef</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1439-1446</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bis(trichloromethyl)carbonate (BTC, triphosgene) is a versatile compd. which enables highly efficient syntheses.  Also, due to its solid state, it is a very convenient compd. for small-scale phosgenation.  Consequently, this compd. is favored as a phosgene substitute in research and development and small-scale prodn.  Although BTC is highly toxic, safe handling is possible as long as its properties and chem. reactivity are understood and considered; however, branding as "safe phosgene" or "safer phosgene" is misleading.  The BTC solid state leads to the misconception there is no significant exposure; however, its vapor pressure is sufficiently high to easily result in toxic concns.  Also, proper monitoring is not yet possible.  Proper BTC use could be more complex than handling phosgene itself; however, handling BTC is normally always assocd. with phosgene and it has its own toxicity.  Hence, BTC use will become more regulated in the future, directly increasing responsibility in route selection during process development.  A stringent safety concept for phosgenation using BTC is necessary.  Due to its interconnection with phosgene, BTC safety concepts will likely be an extended version of the safety concept for phosgene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Jo9CuBcfYLVg90H21EOLACvtfcHk0lhDsUeSZMxh-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlehtb7J&md5=81fba7be0c64ea6a4ce32c59144ad211</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.7b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.7b00220%26sid%3Dliteratum%253Aachs%26aulast%3DCotarca%26aufirst%3DL.%26aulast%3DGeller%26aufirst%3DT.%26aulast%3DRepasi%26aufirst%3DJ.%26atitle%3DBis%2528trichloromethyl%2529carbonate%2520%2528BTC%252C%2520triphosgene%2529%253A%2520a%2520safer%2520alternative%2520to%2520phosgene%253F%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2017%26volume%3D21%26spage%3D1439%26epage%3D1446%26doi%3D10.1021%2Facs.oprd.7b00220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randad, R. S.</span></span> <span> </span><span class="NLM_article-title">A safe and efficient method for preparation of <i>N,N’</i>-unsymmetrically disubstituted ureas utilizing triphosgene</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1021/jo00086a061</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00086a061" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2cXjt1Citrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=1937-1938&author=P.+Majerauthor=R.+S.+Randad&title=A+safe+and+efficient+method+for+preparation+of+N%2CN%E2%80%99-unsymmetrically+disubstituted+ureas+utilizing+triphosgene&doi=10.1021%2Fjo00086a061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A Safe and Efficient Method for Preparation of N,N'-Unsymmetrically Disubstituted Ureas Utilizing Triphosgene</span></div><div class="casAuthors">Majer, Pavel; Randad, Ramnarayan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1937-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A convenient, one-pot procedure for the synthesis of N,N'-unsym. disubstituted ureas utilizing com. available triphosgene was described.  The reaction is operationally simple, offers high yields, short reaction time, and high selectivity toward nitrogen nucleophiles.  The isolation of reactive intermediate, the isocyanate, is unnecessary.  Application of this method to the synthesis of various HIV-protease inhibitors is currently under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEq-cTk15G4rVg90H21EOLACvtfcHk0lgSZ5l3OrXsjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjt1Citrg%253D&md5=b100e65453cd7bf70498fa2ccd201fea</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjo00086a061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00086a061%26sid%3Dliteratum%253Aachs%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DRandad%26aufirst%3DR.%2BS.%26atitle%3DA%2520safe%2520and%2520efficient%2520method%2520for%2520preparation%2520of%2520N%252CN%25E2%2580%2599-unsymmetrically%2520disubstituted%2520ureas%2520utilizing%2520triphosgene%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D1937%26epage%3D1938%26doi%3D10.1021%2Fjo00086a061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creason, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R. R.</span></span> <span> </span><span class="NLM_article-title">Urea derivatives of 2-aryl-benzothiazol-5-amines: a new class of potential drugs for human African trypanosomiasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">971</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2lt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=957-971&author=D.+A.+Patrickauthor=J.+R.+Gillespieauthor=J.+McQueenauthor=M.+A.+Hulversonauthor=R.+M.+Ranadeauthor=S.+A.+Creasonauthor=Z.+M.+Herbstauthor=M.+H.+Gelbauthor=F.+S.+Bucknerauthor=R.+R.+Tidwell&title=Urea+derivatives+of+2-aryl-benzothiazol-5-amines%3A+a+new+class+of+potential+drugs+for+human+African+trypanosomiasis&doi=10.1021%2Facs.jmedchem.6b01163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African Trypanosomiasis</span></div><div class="casAuthors">Patrick, Donald A.; Gillespie, J. Robert; McQueen, Joshua; Hulverson, Matthew A.; Ranade, Ranae M.; Creason, Sharon A.; Herbst, Zackary M.; Gelb, Michael H.; Buckner, Frederick S.; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">957-971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A previous publication from this lab explored the antitrypanosomal activities of novel derivs. of 2-(2-benzamido)ethyl-4-phenylthiazole, which had been identified as a hit against Trypanosoma brucei, the causative agent of human African trypanosomiasis.  While a no. of these compds., particularly the urea analogs, were quite potent, these mols. as a whole exhibited poor metabolic stability.  The present work describes the synthesis of 65 new analogs arising from medicinal chem. optimization at different sites on the mol.  The most promising compds. were the urea derivs. of 2-aryl-benzothiazol-5-amines.  One such analog, (S)-2-(3,4-difluorophenyl)-5-(3-fluoro-N-pyrrolidylamido)benzothiazole (I) was chosen for in vivo efficacy studies based upon in vitro activity, metabolic stability, and brain penetration.  This compd. attained 5/5 cures in murine models of both early and late stage human African trypanosomiasis, representing a new lead for the development of drugs to combat this neglected disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOeaBymSHTgLVg90H21EOLACvtfcHk0lgSZ5l3OrXsjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2lt7nN&md5=aaf065ffbba4f4e702119f9c4c81d822</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01163%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DMcQueen%26aufirst%3DJ.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DCreason%26aufirst%3DS.%2BA.%26aulast%3DHerbst%26aufirst%3DZ.%2BM.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DUrea%2520derivatives%2520of%25202-aryl-benzothiazol-5-amines%253A%2520a%2520new%2520class%2520of%2520potential%2520drugs%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D957%26epage%3D971%26doi%3D10.1021%2Facs.jmedchem.6b01163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaltenbach, R. F.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugiel, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, R. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacheler, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordova, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klabe, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Viitanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, S. P.</span></span> <span> </span><span class="NLM_article-title">The synthesis of symmetrical and unsymmetrical P1/P1’ cyclic ureas as HIV protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(98)00175-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0960-894X%2898%2900175-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9871711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlSntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1077-1082&author=M.+Patelauthor=R.+F.+Kaltenbachauthor=D.+A.+Nugielauthor=R.+J.+McHughauthor=P.+K.+Jadhavauthor=L.+T.+Bachelerauthor=B.+C.+Cordovaauthor=R.+M.+Klabeauthor=S.+Erickson-Viitanenauthor=S.+Garberauthor=C.+Reidauthor=S.+P.+Seitz&title=The+synthesis+of+symmetrical+and+unsymmetrical+P1%2FP1%E2%80%99+cyclic+ureas+as+HIV+protease+inhibitors&doi=10.1016%2FS0960-894X%2898%2900175-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitors</span></div><div class="casAuthors">Patel, Mona; Kaltenbach, Robert F., III; Nugiel, David A.; Mchugh, Robert J., Jr.; Jadhay, Prabhakar K.; Bacheler, Lee T.; Cordova, Beverly C.; Klabe, Ronald M.; Erickson-Viitanen, Susan; Garber, Sena; Reid, Carol; Seitz, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1077-1082</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Cyclic urea SD146 (I, R = R1 = benzyl), a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor soly. and bioavailability, which precluded further development of the compd.  In an effort to improve upon the pharmacokinetic profile of the compd., several analogs modified at the P1/P1' residues, e.g., I (R = R1 = Et, hexyl, cyclohexyl, para-substituted benzyl; R = Et, iso-Bu, hexyl, R1 = benzyl), were prepd. and evaluated.  Several of these compds. displayed significant improvement of phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv1Fo8Td9Ma7Vg90H21EOLACvtfcHk0liHIlvpbXWvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlSntbo%253D&md5=f893f08c99e11b2406077f59988dc386</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900175-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900175-9%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DKaltenbach%26aufirst%3DR.%2BF.%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DMcHugh%26aufirst%3DR.%2BJ.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DCordova%26aufirst%3DB.%2BC.%26aulast%3DKlabe%26aufirst%3DR.%2BM.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DGarber%26aufirst%3DS.%26aulast%3DReid%26aufirst%3DC.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26atitle%3DThe%2520synthesis%2520of%2520symmetrical%2520and%2520unsymmetrical%2520P1%252FP1%25E2%2580%2599%2520cyclic%2520ureas%2520as%2520HIV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1077%26epage%3D1082%26doi%3D10.1016%2FS0960-894X%2898%2900175-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matzen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Amsterdam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautenberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyfried, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottcher, H.</span></span> <span> </span><span class="NLM_article-title">5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1157</span>, <span class="refDoi"> DOI: 10.1021/jm9811054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9811054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1149-1157&author=L.+Matzenauthor=C.+van+Amsterdamauthor=W.+Rautenbergauthor=H.+E.+Greinerauthor=J.+Hartingauthor=C.+A.+Seyfriedauthor=H.+Bottcher&title=5-HT+reuptake+inhibitors+with+5-HT%281B%2F1D%29+antagonistic+activity%3A+a+new+approach+toward+efficient+antidepressants&doi=10.1021%2Fjm9811054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activity: a new approach toward efficient antidepressants</span></div><div class="casAuthors">Matzen, Lisa; Van Amsterdam, Christoph; Rautenberg, Wilfried; Greiner, Hartmut E.; Harting, Juergen; Seyfried, Christoph A.; Boettcher, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1149-1157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of the authors' research program toward new, potential antidepressants, a series of unsym. ureas has been prepd. and evaluated as 5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activities.  The design of these compds. was based on coupling of various indole derivs., previously shown to inhibit 5-HT reuptake, to three different aniline moieties, which are part of known 5-HT1B/1D ligands.  Binding expts. in rat frontal cortex using [125I]iodocyanopindolol, in calf striatum using [3H]5-HT, and in rat hippocampus using [3H]8-OH-DPAT as radioligands, resp., revealed significantly higher affinity at the 5-HT1B receptor as compared to the affinities for the 5-HT1A and 5-HT1D receptors for a no. of compds., among them 4-(5-fluoro-1H-indol-3-yl)piperidine-1-carboxylic acid [4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]amide I (R = R2 = H; R1 = F), the corresponding 4-fluoro-1H-indol-3-yl analog I (R = F; R1 = R2 = H), and the corresponding 6-fluoro-1H-indol-3-yl analog I (R = R1 = H; R2 = F).  Conformational restriction of the aniline moiety in I only slightly enhanced the 5-HT1B affinity, whereas introduction of an aniline moiety with higher conformational flexibility resulted in a less potent 5-HT1B receptor ligand as compared to I.  The functional 5-HT1B/1D antagonistic activity was investigated using the rabbit saphenous vein model as well as the [3H]5-HT release from guinea pig cortical slices.  All new compds. tested in the rabbit saphenous vein model were shown to antagonize the sumatriptan-evoked contractile responses with pA2 values ranging from 7.3 to 8.7.  These observations were consistent with the results of the cortical slice model, in which the ureas were found to block the sumatriptan-induced inhibition of potassium-evoked [3H]5-HT release.  The 5-HT reuptake inhibition of the ureas detd. in rat brain synaptosomes was found to be either increased or decreased as compared to the uncoupled indole derivs. indicating that the reuptake inhibition shown by the ureas is not only due to the indole part but also affected by the aniline moiety of the mol.  Among this series of compds. described the ureas I seem to be the most interesting candidates showing both 5-HT reuptake inhibition and 5-HT1B/1D antagonism in vitro.  This dual pharmacol. profile should in theory lead to a pronounced enhancement in serotonergic neurotransmission and consequently to a more efficient treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPoXyqYo-xI7Vg90H21EOLACvtfcHk0liHIlvpbXWvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D&md5=339f7c7e7c49ff88559984852971fdd2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm9811054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9811054%26sid%3Dliteratum%253Aachs%26aulast%3DMatzen%26aufirst%3DL.%26aulast%3Dvan%2BAmsterdam%26aufirst%3DC.%26aulast%3DRautenberg%26aufirst%3DW.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3DHarting%26aufirst%3DJ.%26aulast%3DSeyfried%26aufirst%3DC.%2BA.%26aulast%3DBottcher%26aufirst%3DH.%26atitle%3D5-HT%2520reuptake%2520inhibitors%2520with%25205-HT%25281B%252F1D%2529%2520antagonistic%2520activity%253A%2520a%2520new%2520approach%2520toward%2520efficient%2520antidepressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1149%26epage%3D1157%26doi%3D10.1021%2Fjm9811054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammill, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhasin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable inhibitor of defective in cullin neddylation 1 (DCN1)-mediated cullin neddylation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2694</span>– <span class="NLM_lpage">2706</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2694-2706&author=J.+T.+Hammillauthor=D.+Bhasinauthor=D.+C.+Scottauthor=J.+Minauthor=Y.+Chenauthor=Y.+Luauthor=L.+Yangauthor=H.+S.+Kimauthor=M.+C.+Connellyauthor=C.+Hammillauthor=G.+Holbrookauthor=C.+Jeffriesauthor=B.+Singhauthor=B.+A.+Schulmanauthor=R.+K.+Guy&title=Discovery+of+an+orally+bioavailable+inhibitor+of+defective+in+cullin+neddylation+1+%28DCN1%29-mediated+cullin+neddylation&doi=10.1021%2Facs.jmedchem.7b01282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation</span></div><div class="casAuthors">Hammill, Jared T.; Bhasin, Deepak; Scott, Daniel C.; Min, Jaeki; Chen, Yizhe; Lu, Yan; Yang, Lei; Kim, Ho Shin; Connelly, Michele C.; Hammill, Courtney; Holbrook, Gloria; Jeffries, Cynthia; Singh, Bhuvanesh; Schulman, Brenda A.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2694-2706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the discovery, validation, and structure-activity relationships of a series of piperidinyl ureas that potently inhibit the DCN1-UBE2M interaction.  The authors demonstrated that compd. I inhibits both the DCN1-UBE2M protein-protein interaction and DCN1-mediated cullin neddylation in biochem. assays and reduces levels of steady-state cullin neddylation in a squamous carcinoma cell line harboring DCN1 amplification.  Although compd. I exhibits good soly. and permeability, it is rapidly metabolized in microsomal models (CLint = 170 mL/min/kg).  This work lays out the discovery of an orally bioavailable analog, NAcM-OPT (II).  Compd. II retains the favorable biochem. and cellular activity of compd. I but is significantly more stable both in vitro and in vivo.  Compd. II is orally bioavailable, well tolerated in mice, and currently used to study the effects of acute pharmacol. inhibition of the DCN1-UBE2M interaction on the NEDD8/CUL pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4fvhBFy2Ux7Vg90H21EOLACvtfcHk0lh8X1-loGY1kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGkt7c%253D&md5=5775690be4373f8d8a6cb401812363dd</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01282%26sid%3Dliteratum%253Aachs%26aulast%3DHammill%26aufirst%3DJ.%2BT.%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DD.%2BC.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DConnelly%26aufirst%3DM.%2BC.%26aulast%3DHammill%26aufirst%3DC.%26aulast%3DHolbrook%26aufirst%3DG.%26aulast%3DJeffries%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520defective%2520in%2520cullin%2520neddylation%25201%2520%2528DCN1%2529-mediated%2520cullin%2520neddylation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2694%26epage%3D2706%26doi%3D10.1021%2Facs.jmedchem.7b01282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleynet, D. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B. Z.</span></span> <span> </span><span class="NLM_article-title">A general synthesis of unsymmetrical tetrasubstituted ureas</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4158</span>, <span class="refDoi"> DOI: 10.1021/jo962245t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo962245t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlGhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=4155-4158&author=A.+R.+Katritzkyauthor=D.+P.+M.+Pleynetauthor=B.+Z.+Yang&title=A+general+synthesis+of+unsymmetrical+tetrasubstituted+ureas&doi=10.1021%2Fjo962245t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">A General Synthesis of Unsymmetrical Tetrasubstituted Ureas</span></div><div class="casAuthors">Katritzky, Alan R.; Pleynet, David P. M.; Yang, Baozhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4155-4158</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,1'-Carbonylbisbenzotriazole (2), prepd. from benzotriazole and phosgene, is a safe, mild and versatile reagent for the prepn. of unsym. tetrasubstituted ureas, and di- and trisubstituted ureas.  Successive treatments of 2 with a wide variety (arom., aliph., bicyclic) of amines R1R2NH and R3R4NH afford unsym. tetrasubstituted, and di- and trisubstituted ureas R1R2NC(O)NR3R4 in 16-85% yield.  Thus, 2 reacted with aniline for 27 h at room temp. in dry THF under N2.  Then, octylamine was added and the soln. was stirred 27 h.  N-Phenyl-N'-octylurea was isolated in 85% yield.  The carbamoylbenzotriazoles formed from reaction with the first amine were also isolated in some examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkZgfQoHxZ-7Vg90H21EOLACvtfcHk0lh8X1-loGY1kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlGhs78%253D&md5=bfe57ea451edea9fec03dfd2b009d8f5</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjo962245t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo962245t%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DPleynet%26aufirst%3DD.%2BP.%2BM.%26aulast%3DYang%26aufirst%3DB.%2BZ.%26atitle%3DA%2520general%2520synthesis%2520of%2520unsymmetrical%2520tetrasubstituted%2520ureas%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D4155%26epage%3D4158%26doi%3D10.1021%2Fjo962245t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senanayake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, V.</span></span> <span> </span><span class="NLM_article-title">Practical synthesis of unsymmetrical ureas from isopropenyl carbamates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">6960</span>– <span class="NLM_lpage">6963</span>, <span class="refDoi"> DOI: 10.1021/jo0507643</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0507643" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFWntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=6960-6963&author=I.+Gallouauthor=M.+Erikssonauthor=X.+Zengauthor=C.+Senanayakeauthor=V.+Farina&title=Practical+synthesis+of+unsymmetrical+ureas+from+isopropenyl+carbamates&doi=10.1021%2Fjo0507643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Practical Synthesis of Unsymmetrical Ureas from Isopropenyl Carbamates</span></div><div class="casAuthors">Gallou, Isabelle; Eriksson, Magnus; Zeng, Xingzhong; Senanayake, Chris; Farina, Vittorio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6960-6963</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A very convenient method for the synthesis of unsym. ureas from isopropenyl carbamates is described.  The synthetic efficiency of traditional methods for urea formation, such as use of phosgene or alkyl and aryl carbamates, is limited by the formation of sym. urea side products or reaction reversibility.  Isopropenyl carbamates react with amines cleanly and irreversibly and give unsym. ureas in high yield and purity.  This method is ideal for the rapid synthesis of compd. libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrgrCLMCXWp7Vg90H21EOLACvtfcHk0lh8X1-loGY1kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFWntrY%253D&md5=0db13cbc0dd4e98f34fc777501f5397d</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjo0507643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0507643%26sid%3Dliteratum%253Aachs%26aulast%3DGallou%26aufirst%3DI.%26aulast%3DEriksson%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DSenanayake%26aufirst%3DC.%26aulast%3DFarina%26aufirst%3DV.%26atitle%3DPractical%2520synthesis%2520of%2520unsymmetrical%2520ureas%2520from%2520isopropenyl%2520carbamates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D6960%26epage%3D6963%26doi%3D10.1021%2Fjo0507643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voyle, M.</span></span> <span> </span><span class="NLM_article-title">A simple method for the synthesis of unsymmetrical ureas</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1943</span>, <span class="refDoi"> DOI: 10.1080/00397910008087243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F00397910008087243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFSrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=1937-1943&author=J.+Kitteringhamauthor=M.+R.+Shiptonauthor=M.+Voyle&title=A+simple+method+for+the+synthesis+of+unsymmetrical+ureas&doi=10.1080%2F00397910008087243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for the synthesis of unsymmetrical ureas</span></div><div class="casAuthors">Kitteringham, J.; Shipton, M. R.; Voyle, M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1937-1943</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A simple one pot procedure for the synthesis of N,N'-unsym. ureas using Ph chloroformate in THF is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6k4ROnpDNurVg90H21EOLACvtfcHk0lijmct0D5O6RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFSrtbc%253D&md5=3ae947475835e701bc0dc0ac2fe5909e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1080%2F00397910008087243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008087243%26sid%3Dliteratum%253Aachs%26aulast%3DKitteringham%26aufirst%3DJ.%26aulast%3DShipton%26aufirst%3DM.%2BR.%26aulast%3DVoyle%26aufirst%3DM.%26atitle%3DA%2520simple%2520method%2520for%2520the%2520synthesis%2520of%2520unsymmetrical%2520ureas%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D1937%26epage%3D1943%26doi%3D10.1080%2F00397910008087243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span> <span> </span><span class="NLM_article-title">Organic carbamates in drug design and medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2895</span>– <span class="NLM_lpage">2940</span>, <span class="refDoi"> DOI: 10.1021/jm501371s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501371s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2895-2940&author=A.+K.+Ghoshauthor=M.+Brindisi&title=Organic+carbamates+in+drug+design+and+medicinal+chemistry&doi=10.1021%2Fjm501371s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Organic Carbamates in Drug Design and Medicinal Chemistry</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2895-2940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The carbamate group is a key structural motif in many approved drugs and prodrugs.  There is an increasing use of carbamates in medicinal chem. and many derivs. are specifically designed to make drug-target interactions through their carbamate moiety.  In this Perspective, we present properties and stabilities of carbamates, reagents and chem. methodologies for the synthesis of carbamates, and recent applications of carbamates in drug design and medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGollKFyXYJJHLVg90H21EOLACvtfcHk0lijmct0D5O6RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWkuw%253D%253D&md5=e3548247931b74b60e299ada1e27dda5</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm501371s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501371s%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26atitle%3DOrganic%2520carbamates%2520in%2520drug%2520design%2520and%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2895%26epage%3D2940%26doi%3D10.1021%2Fjm501371s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anbazhagan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, A. R. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajappa, S.</span></span> <span> </span><span class="NLM_article-title">Conversion of carbonimidodithioates into unsymmetrical di- and tri-substituted ureas including urea dipeptides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3609</span>– <span class="NLM_lpage">3612</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00561-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2898%2900561-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlSrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=3609-3612&author=M.+Anbazhaganauthor=A.+R.+A.+S.+Deshmukhauthor=S.+Rajappa&title=Conversion+of+carbonimidodithioates+into+unsymmetrical+di-+and+tri-substituted+ureas+including+urea+dipeptides&doi=10.1016%2FS0040-4039%2898%2900561-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of carbonimidodithioates into unsymmetrical di- and tri- substituted ureas including urea dipeptides</span></div><div class="casAuthors">Anbazhagan, Mariappan; Rakeeb, Abdul; Deshmukh, A. S.; Rajappa, Srinivasachari</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3609-3612</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Selective hydrolysis of carbonimidodithioates RN:C(SMe)2 [R = Bu, (S)-CH(CH2Ph)CO2Me] leads to the thiocarbamates R1C(O)SMe (R = BuNH, L-Phe-OMe), which can be easily transformed to the unsym. ureas R2R3NCOR1 by treatment with the appropriate amines.  This constitutes a synthesis of ureas without the use of phosgene or carbon monoxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri7zSh-CDIU7Vg90H21EOLACvtfcHk0lijmct0D5O6RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlSrtrg%253D&md5=f999777b6dd8b0d11ee2acccd6650959</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900561-9%26sid%3Dliteratum%253Aachs%26aulast%3DAnbazhagan%26aufirst%3DM.%26aulast%3DDeshmukh%26aufirst%3DA.%2BR.%2BA.%2BS.%26aulast%3DRajappa%26aufirst%3DS.%26atitle%3DConversion%2520of%2520carbonimidodithioates%2520into%2520unsymmetrical%2520di-%2520and%2520tri-substituted%2520ureas%2520including%2520urea%2520dipeptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D3609%26epage%3D3612%26doi%3D10.1016%2FS0040-4039%2898%2900561-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batey, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhakumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshina-Ishii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. D.</span></span> <span> </span><span class="NLM_article-title">An efficient new protocol for the formation of unsymmetrical tri- and tetrasubstituted ureas</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">6267</span>– <span class="NLM_lpage">6270</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)01330-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2898%2901330-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXltlKnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=6267-6270&author=R.+A.+Bateyauthor=V.+Santhakumarauthor=C.+Yoshina-Ishiiauthor=S.+D.+Taylor&title=An+efficient+new+protocol+for+the+formation+of+unsymmetrical+tri-+and+tetrasubstituted+ureas&doi=10.1016%2FS0040-4039%2898%2901330-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient new protocol for the formation of unsymmetrical tri- and tetrasubstituted ureas</span></div><div class="casAuthors">Batey, Robert A.; Santhakumar, V.; Yoshina-Ishii, Chiaki; Taylor, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">6267-6270</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new method for producing unsym., tetrasubstituted urea from N,N'-carbonyldiimidazole (CDI) is presented.  Carbamoyl imidazolium salts are prepd. from the reaction of CDI with a secondary amine, followed by alkylation with MeI.  Secondary amines add with ease to imidazolium salts at room temp. to give unsym. tetrasubstituted ureas in excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw_66xsjKbfLVg90H21EOLACvtfcHk0lgoffRYSaoYzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlKnurc%253D&md5=4b286c231bf9a2e7e9fbc07e56f4910a</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2901330-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252901330-6%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DR.%2BA.%26aulast%3DSanthakumar%26aufirst%3DV.%26aulast%3DYoshina-Ishii%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DS.%2BD.%26atitle%3DAn%2520efficient%2520new%2520protocol%2520for%2520the%2520formation%2520of%2520unsymmetrical%2520tri-%2520and%2520tetrasubstituted%2520ureas%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D6267%26epage%3D6270%26doi%3D10.1016%2FS0040-4039%2898%2901330-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grzyb, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshina-Ishii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batey, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbamoylimidazolium and thiocarbamoylimidazolium salts: novel reagents for the synthesis of ureas, thioureas, carbamates, thiocarbamates and amides</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7153</span>– <span class="NLM_lpage">7175</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2005.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tet.2005.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVCisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=7153-7175&author=J.+A.+Grzybauthor=M.+Shenauthor=C.+Yoshina-Ishiiauthor=W.+Chiauthor=R.+S.+Brownauthor=R.+A.+Batey&title=Carbamoylimidazolium+and+thiocarbamoylimidazolium+salts%3A+novel+reagents+for+the+synthesis+of+ureas%2C+thioureas%2C+carbamates%2C+thiocarbamates+and+amides&doi=10.1016%2Fj.tet.2005.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoylimidazolium and thiocarbamoylimidazolium salts: novel reagents for the synthesis of ureas, thioureas, carbamates, thiocarbamates and amides</span></div><div class="casAuthors">Grzyb, Justyna A.; Shen, Ming; Yoshina-Ishii, Chiaki; Chi, W.; Brown, R. Stanley; Batey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7153-7175</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Carbamoylimidazolium iodide salts I•I- [R = 1,2,3,4-tetrahydro-1-quinolinyl, 1,2,3,4-tetrahydro-2-isoquinolinyl, PhNMe, PhCH2N(Me2CH), 1-pyrrolidinyl, (S)-2-(benzyloxycarbonyl)pyrrolidinyl, 4-morpholinyl, MeON(Me), 1,4-dioxa-8-azaspiro[4.5]dec-8-yl] are prepd. from secondary amines, carbonyldiimidazole, and Me iodide; I react with amines, alcs., thiols, and carboxylic acids to yield ureas, carbamates, S-thiocarbamate esters, and amides.  I•I- are prepd. by treatment of secondary amines with N,N'-carbonyldiimidazole followed by N-alkylation of the acylimidazoles with iodomethane.  I•I- are more efficient carbamoyl transfer reagents than the corresponding carbamoylimidazoles; base-promoted hydrolysis of I•I- occurs roughly a hundred times more rapidly than hydrolysis of the corresponding acylimidazoles.  Thiocarbonylimidazolium iodide salts are also prepd. using thiocarbonyldiimidazole instead of carbonyldiimidazole and subsequently used in the prepn. of thioureas.  Coupling of diethylphosphonoacetic acid with I•I- (R = 4-morpholinyl) followed by Horner-Wadsworth-Emmons olefination of isobutyraldehyde mediated by lithium chloride and DBU yields (E)-4-(4-methyl-2-pentenoyl)morpholine.  Using the amidation of diethylphosphonoacetic acid with appropriate carbamoylimidazolium iodides and intramol. Horner-Wadsworth-Emmons olefination reactions as key steps, unsatd. lactams II (X = bond, CH2) are prepd. in seven steps from 2-hydroxymethylpiperidine and 2-(2-hydroxyethyl)piperidine, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGparYnzgLy-1rVg90H21EOLACvtfcHk0lgoffRYSaoYzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVCisLk%253D&md5=cb851314c8fa1815b8f87bea9d52c8a5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DGrzyb%26aufirst%3DJ.%2BA.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DYoshina-Ishii%26aufirst%3DC.%26aulast%3DChi%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DR.%2BS.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DCarbamoylimidazolium%2520and%2520thiocarbamoylimidazolium%2520salts%253A%2520novel%2520reagents%2520for%2520the%2520synthesis%2520of%2520ureas%252C%2520thioureas%252C%2520carbamates%252C%2520thiocarbamates%2520and%2520amides%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D7153%26epage%3D7175%26doi%3D10.1016%2Fj.tet.2005.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artuso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fochi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magistris, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of mono-, di-, and trisubstituted ureas by carbonylation of aliphatic amines with <i>S,S</i>-dimethyl dithiocarbonate</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">3497</span>– <span class="NLM_lpage">3506</span>, <span class="refDoi"> DOI: 10.1055/s-2007-990813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-2007-990813" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=3497-3506&author=E.+Artusoauthor=L.+Deganiauthor=R.+Fochiauthor=C.+Magistris&title=Preparation+of+mono-%2C+di-%2C+and+trisubstituted+ureas+by+carbonylation+of+aliphatic+amines+with+S%2CS-dimethyl+dithiocarbonate&doi=10.1055%2Fs-2007-990813"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-990813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-990813%26sid%3Dliteratum%253Aachs%26aulast%3DArtuso%26aufirst%3DE.%26aulast%3DDegani%26aufirst%3DL.%26aulast%3DFochi%26aufirst%3DR.%26aulast%3DMagistris%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520mono-%252C%2520di-%252C%2520and%2520trisubstituted%2520ureas%2520by%2520carbonylation%2520of%2520aliphatic%2520amines%2520with%2520S%252CS-dimethyl%2520dithiocarbonate%26jtitle%3DSynthesis%26date%3D2007%26volume%3D2007%26spage%3D3497%26epage%3D3506%26doi%3D10.1055%2Fs-2007-990813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, Y. J.</span></span> <span> </span><span class="NLM_article-title">Phenyl 4,5-dichloro-6-oxopyridazine-1(6H)-carboxylate as carbonyl source: facile and selective synthesis of carbamates and ureas under mild conditions</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">2809</span>– <span class="NLM_lpage">2814</span>, <span class="refDoi"> DOI: 10.1055/s-0029-1217997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0029-1217997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=2809-2814&author=H.+G.+Leeauthor=M.+J.+Kimauthor=S.+E.+Parkauthor=J.+J.+Kimauthor=B.+R.+Kimauthor=S.+G.+Leeauthor=Y.+J.+Yoon&title=Phenyl+4%2C5-dichloro-6-oxopyridazine-1%286H%29-carboxylate+as+carbonyl+source%3A+facile+and+selective+synthesis+of+carbamates+and+ureas+under+mild+conditions&doi=10.1055%2Fs-0029-1217997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1055%2Fs-0029-1217997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0029-1217997%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DPark%26aufirst%3DS.%2BE.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DYoon%26aufirst%3DY.%2BJ.%26atitle%3DPhenyl%25204%252C5-dichloro-6-oxopyridazine-1%25286H%2529-carboxylate%2520as%2520carbonyl%2520source%253A%2520facile%2520and%2520selective%2520synthesis%2520of%2520carbamates%2520and%2520ureas%2520under%2520mild%2520conditions%26jtitle%3DSynlett%26date%3D2009%26volume%3D2009%26spage%3D2809%26epage%3D2814%26doi%3D10.1055%2Fs-0029-1217997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padiya, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardile, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaware, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurhade, S.</span></span> <span> </span><span class="NLM_article-title">Unprecedented ″in water″ imidazole carbonylation: paradigm shift for preparation of urea and carbamate</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2814</span>– <span class="NLM_lpage">2817</span>, <span class="refDoi"> DOI: 10.1021/ol301009d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol301009d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1ajsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=2814-2817&author=K.+J.+Padiyaauthor=S.+Gavadeauthor=B.+Kardileauthor=M.+Tiwariauthor=S.+Bajareauthor=M.+Maneauthor=V.+Gawareauthor=S.+Vargheseauthor=D.+Harelauthor=S.+Kurhade&title=Unprecedented+%E2%80%B3in+water%E2%80%B3+imidazole+carbonylation%3A+paradigm+shift+for+preparation+of+urea+and+carbamate&doi=10.1021%2Fol301009d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented "In Water" Imidazole Carbonylation: Paradigm Shift for Preparation of Urea and Carbamate</span></div><div class="casAuthors">Padiya, Kamlesh J.; Gavade, Sandip; Kardile, Bhavana; Tiwari, Manojkumar; Bajare, Swapnil; Mane, Madhav; Gaware, Vivek; Varghese, Shaji; Harel, Dipak; Kurhade, Suresh</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2814-2817</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first "in water" imidazolecarbonylation of amine is described.  A one pot reaction of 1,1'-carbonyldiimidazole in water with a nucleophile provides an efficient and general method for the prepn. of urea, carbamates and thiocarbamates.  Use of an anhyd. solvent and an inert atm. could be avoided.  Product ppt. out from the reaction mixt. and can be obtained in high purity by filtration, resulting in a simple and scalable method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQqf3vSGLRcbVg90H21EOLACvtfcHk0ljfZjM-U6CgOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1ajsrk%253D&md5=9c1bd196cb4f8879cfc4bc56423071ad</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fol301009d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301009d%26sid%3Dliteratum%253Aachs%26aulast%3DPadiya%26aufirst%3DK.%2BJ.%26aulast%3DGavade%26aufirst%3DS.%26aulast%3DKardile%26aufirst%3DB.%26aulast%3DTiwari%26aufirst%3DM.%26aulast%3DBajare%26aufirst%3DS.%26aulast%3DMane%26aufirst%3DM.%26aulast%3DGaware%26aufirst%3DV.%26aulast%3DVarghese%26aufirst%3DS.%26aulast%3DHarel%26aufirst%3DD.%26aulast%3DKurhade%26aufirst%3DS.%26atitle%3DUnprecedented%2520%25E2%2580%25B3in%2520water%25E2%2580%25B3%2520imidazole%2520carbonylation%253A%2520paradigm%2520shift%2520for%2520preparation%2520of%2520urea%2520and%2520carbamate%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D2814%26epage%3D2817%26doi%3D10.1021%2Fol301009d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bogolubsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroz, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mykhailiuk, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granat, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipko, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konovets, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroschuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A.</span></span> <span> </span><span class="NLM_article-title">Bis(2,2,2-trifluoroethyl) carbonate as a condensing agent in one-pot parallel synthesis of unsymmetrical aliphatic ureas</span>. <i>ACS Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1021/co500025f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/co500025f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsFKqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=303-308&author=A.+V.+Bogolubskyauthor=Y.+S.+Morozauthor=P.+K.+Mykhailiukauthor=D.+S.+Granatauthor=S.+E.+Pipkoauthor=A.+I.+Konovetsauthor=R.+Doroschukauthor=A.+Tolmachev&title=Bis%282%2C2%2C2-trifluoroethyl%29+carbonate+as+a+condensing+agent+in+one-pot+parallel+synthesis+of+unsymmetrical+aliphatic+ureas&doi=10.1021%2Fco500025f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Bis(2,2,2-trifluoroethyl) Carbonate as a Condensing Agent in One-Pot Parallel Synthesis of Unsymmetrical Aliphatic Ureas</span></div><div class="casAuthors">Bogolubsky, Andrey V.; Moroz, Yurii S.; Mykhailiuk, Pavel K.; Granat, Dmitry S.; Pipko, Sergey E.; Konovets, Anzhelika I.; Doroschuk, Roman; Tolmachev, Andrey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">303-308</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One-pot parallel synthesis of unsym. aliph. ureas was achieved with bis(2,2,2-trifluoroethyl) carbonate.  The procedure worked well for both the monosubstituted and functionalized alkylamines and required no special conditions (temp. control, order, or rate of addn.).  Thus, an acetonitrile soln. of the first alkylamine, N,N-diisopropylethylamine, and bis(2,2,2-trifluoroethyl) carbonate was heated at 75 °C in a sealed tube for 2 h.  After complete removal of bis(2,2,2-trifluoroethyl) carbonate and addn. of DBU, the second alkylaminewas added to the crude trifluoroethyl carbamate to give the unsym. aliph. urea.  A library of 96 diverse ureas was easily synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQIevy9_gSLbVg90H21EOLACvtfcHk0ljfZjM-U6CgOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsFKqt7Y%253D&md5=26ad42a9b0aa35ebee2ce89fff8d2b3d</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fco500025f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco500025f%26sid%3Dliteratum%253Aachs%26aulast%3DBogolubsky%26aufirst%3DA.%2BV.%26aulast%3DMoroz%26aufirst%3DY.%2BS.%26aulast%3DMykhailiuk%26aufirst%3DP.%2BK.%26aulast%3DGranat%26aufirst%3DD.%2BS.%26aulast%3DPipko%26aufirst%3DS.%2BE.%26aulast%3DKonovets%26aufirst%3DA.%2BI.%26aulast%3DDoroschuk%26aufirst%3DR.%26aulast%3DTolmachev%26aufirst%3DA.%26atitle%3DBis%25282%252C2%252C2-trifluoroethyl%2529%2520carbonate%2520as%2520a%2520condensing%2520agent%2520in%2520one-pot%2520parallel%2520synthesis%2520of%2520unsymmetrical%2520aliphatic%2520ureas%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2014%26volume%3D16%26spage%3D303%26epage%3D308%26doi%3D10.1021%2Fco500025f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, Y.</span></span> <span> </span><span class="NLM_article-title">Electrochemically induced Hofmann rearrangement</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">8879</span>– <span class="NLM_lpage">8882</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(97)10324-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2897%2910324-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFCru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=8879-8882&author=Y.+Matsumuraauthor=T.+Makiauthor=Y.+Satoh&title=Electrochemically+induced+Hofmann+rearrangement&doi=10.1016%2FS0040-4039%2897%2910324-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemically induced Hofmann rearrangement</span></div><div class="casAuthors">Matsumura, Yoshihiro; Maki, Toshihide; Satoh, Yuki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">8879-8882</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Electrochem. induced Hofmann rearrangement under new solvent systems contg. a variety of alcs. was developed.  Since the reaction proceeds under mild conditions (neutral), a variety of carbamates possessing various alkoxy moieties could be easily prepd. by this method.  An epoxy functional group in the amide and alc. parts remained intact during the electrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPyRcVi7UaA7Vg90H21EOLACvtfcHk0lgYsT_-74zvmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFCru7Y%253D&md5=052252b269093aab6f0df76b8a05dd49</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2897%2910324-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252897%252910324-0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DMaki%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DY.%26atitle%3DElectrochemically%2520induced%2520Hofmann%2520rearrangement%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D8879%26epage%3D8882%26doi%3D10.1016%2FS0040-4039%2897%2910324-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chany, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuladhar, S. M.</span></span> <span> </span><span class="NLM_article-title">Preparation of methyl carbamates from primary alkylcarboxamides and arylcarboxamides using hypervalent iodine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2478</span>– <span class="NLM_lpage">2482</span>, <span class="refDoi"> DOI: 10.1021/jo00061a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00061a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3sXitlertrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=2478-2482&author=R.+M.+Moriartyauthor=C.+J.+Chanyauthor=R.+K.+Vaidauthor=O.+Prakashauthor=S.+M.+Tuladhar&title=Preparation+of+methyl+carbamates+from+primary+alkylcarboxamides+and+arylcarboxamides+using+hypervalent+iodine&doi=10.1021%2Fjo00061a022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of methyl carbamates from primary alkyl- and arylcarboxamides using hypervalent iodine</span></div><div class="casAuthors">Moriarty, Robert M.; Chany, Calvin J., II; Vaid, Rahde K.; Prakash, Om; Tuladhar, Sudersan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2478-82</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A series of 14 primary alkyl- and arylcarboxamides, e.g., cycloheptenylcarbamate I (R = CONH2) and quinoline II (R = CONH2), were treated with PhI(OAc)2 in KOH-CH3OH at 5-10° to give the corresponding Me carbamates, e.g., I (R = NHCO2Me) and II (R = NHCO2Me), in good to excellent yields.  These conditions avoid the use of elemental bromine or heavy metal reagents (Pb(OAc)4, AgOAc, Hg(OAc)2), while taking advantage of the com. availability of PhI(OAc)2.  The Me carbamates are easily purified via column chromatog. on silica gel.  The isolated yields of the carbamates ranged from 72% for Me N-cyclopropylcarbamate to 97% for Me N-phenylcarbamate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ5ADwJTNivbVg90H21EOLACvtfcHk0lgYsT_-74zvmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitlertrc%253D&md5=370fd7b1b9ac707004cbc020bcc98358</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjo00061a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00061a022%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DR.%2BM.%26aulast%3DChany%26aufirst%3DC.%2BJ.%26aulast%3DVaid%26aufirst%3DR.%2BK.%26aulast%3DPrakash%26aufirst%3DO.%26aulast%3DTuladhar%26aufirst%3DS.%2BM.%26atitle%3DPreparation%2520of%2520methyl%2520carbamates%2520from%2520primary%2520alkylcarboxamides%2520and%2520arylcarboxamides%2520using%2520hypervalent%2520iodine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D2478%26epage%3D2482%26doi%3D10.1021%2Fjo00061a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radlick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L. R.</span></span> <span> </span><span class="NLM_article-title">A versatile modification of the Hofmann rearrangement</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1055/s-1974-23298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-1974-23298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1974&pages=290-292&author=P.+Radlickauthor=L.+R.+Brown&title=A+versatile+modification+of+the+Hofmann+rearrangement&doi=10.1055%2Fs-1974-23298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1055%2Fs-1974-23298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1974-23298%26sid%3Dliteratum%253Aachs%26aulast%3DRadlick%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DL.%2BR.%26atitle%3DA%2520versatile%2520modification%2520of%2520the%2520Hofmann%2520rearrangement%26jtitle%3DSynthesis%26date%3D1974%26volume%3D4%26spage%3D290%26epage%3D292%26doi%3D10.1055%2Fs-1974-23298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keillor, J. W.</span></span> <span> </span><span class="NLM_article-title">Preparation of methyl carbamates via a modified Hofmann rearrangement</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(96)02341-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2896%2902341-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXotFalsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=313-316&author=X.+C.+Huangauthor=J.+W.+Keillor&title=Preparation+of+methyl+carbamates+via+a+modified+Hofmann+rearrangement&doi=10.1016%2FS0040-4039%2896%2902341-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of methyl carbamates via a modified Hofmann rearrangement</span></div><div class="casAuthors">Huang, Xicai; Keillor, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-316</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Treatment of a series of para-substituted arom. and primary aliph. carboxamides with NBS and NaOMe in methanol heated to reflux for ten minutes results in the conversion of the carboxamides to their corresponding primary amino Me carbamates in nearly quant. yields.  The mild oxidative conditions of this modified Hofmann rearrangement are shown to be particularly useful for the prepn. of p-substituted anilines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-ibgIWvmuiLVg90H21EOLACvtfcHk0ljRiVgfOpF2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotFalsQ%253D%253D&md5=f306932e71eee037d3c422d2f027eb72</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2896%2902341-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252896%252902341-6%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BC.%26aulast%3DKeillor%26aufirst%3DJ.%2BW.%26atitle%3DPreparation%2520of%2520methyl%2520carbamates%2520via%2520a%2520modified%2520Hofmann%2520rearrangement%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D313%26epage%3D316%26doi%3D10.1016%2FS0040-4039%2896%2902341-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senanayake, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburgh, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reamer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoeven, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reider, P. J.</span></span> <span> </span><span class="NLM_article-title">Nature of <i>N</i>-bromosuccinimide in basic-media - the true oxidizing species in the Hofmann rearrangement</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">7947</span>– <span class="NLM_lpage">7948</span>, <span class="refDoi"> DOI: 10.1021/ja00096a082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00096a082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2MXksFWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=7947-7948&author=C.+H.+Senanayakeauthor=L.+E.+Fredenburghauthor=R.+A.+Reamerauthor=R.+D.+Larsenauthor=T.+R.+Verhoevenauthor=P.+J.+Reider&title=Nature+of+N-bromosuccinimide+in+basic-media+-+the+true+oxidizing+species+in+the+Hofmann+rearrangement&doi=10.1021%2Fja00096a082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Nature of N-Bromosuccinimide in Basic Media: The True Oxidizing Species in the Hofmann Rearrangement</span></div><div class="casAuthors">Senanayake, Chris H.; Fredenburgh, Laura E.; Reamer, Robert A.; Larsen, Robert D.; Verhoeven, Thomas R.; Reider, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7947-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Dissoln. of NBS in KOH/D2O gave 15% potassium succinimide (I) and 85% N-bromosuccinamic acid, KO2CCH2CH2NKBr (II).  N-bromosuccinamic acid salt II is the oxidizing agent in the Hofmann rearrangement of aminonicotinamide III with NBS in KOH/MeOH.  Hofmann rearrangement of III with NBS in KOH/MeOH at -5° gave only 60% urea IV, along with 30% starting material III and brominated byproducts V and VI.  Optimized reaction conditions, pretreatment of NBS with KOH in MeOH for 16 h at -5° followed by addn. of III at -20° gave 95% urea IV.  Urea formation occurs through transfer of the bromonium ion from oxidizing agent II to the aminonicotinamide; the intermediate N-bromoamide VII then rearranges to the isocyanate VIII, which undergoes intramol. capture to yield the cyclic urea IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV08OvHf6Uu7Vg90H21EOLACvtfcHk0ljRiVgfOpF2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksFWjtw%253D%253D&md5=9e47d9082ee61a9360716615c153bf05</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fja00096a082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00096a082%26sid%3Dliteratum%253Aachs%26aulast%3DSenanayake%26aufirst%3DC.%2BH.%26aulast%3DFredenburgh%26aufirst%3DL.%2BE.%26aulast%3DReamer%26aufirst%3DR.%2BA.%26aulast%3DLarsen%26aufirst%3DR.%2BD.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26atitle%3DNature%2520of%2520N-bromosuccinimide%2520in%2520basic-media%2520-%2520the%2520true%2520oxidizing%2520species%2520in%2520the%2520Hofmann%2520rearrangement%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D7947%26epage%3D7948%26doi%3D10.1021%2Fja00096a082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baumgarten, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staklis, A.</span></span> <span> </span><span class="NLM_article-title">Reactions of amines. XVIII. Oxidative rearrangement of amides with lead tetraacetate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">3554</span>– <span class="NLM_lpage">3561</span>, <span class="refDoi"> DOI: 10.1021/jo00912a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00912a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE28Xks1Wm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=3554-3561&author=H.+E.+Baumgartenauthor=H.+L.+Smithauthor=A.+Staklis&title=Reactions+of+amines.+XVIII.+Oxidative+rearrangement+of+amides+with+lead+tetraacetate&doi=10.1021%2Fjo00912a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of amines.  XVIII.  Oxidative rearrangement of amides with lead tetraacetate</span></div><div class="casAuthors">Baumgarten, Henry E.; Smith, Howard L.; Staklis, Andris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3554-61</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Fourteen primary amides RCONH2 (e.g., R = Ph, PhCH2, cyclobutyl, pyridyl were converted to isocyanates by treatment with Pb(OAc)4.  Generally, the isocyanates were not isolated but were converted to carbamates by using a reaction solvent such as benzyl or, preferably, tert-butyl alc.  Alternatively, the reactions were run in DMF and the isocyanates converted to unsym. ureas by treatment with tert-butylamine.  The carbamates could be easily cleaved to the corresponding amines (as the hydrochlorides) by treatment with HCl in alcohol, ether, or acetic acid.  The title rearrangement proceeded with retention of configuration about the migrating carbon atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfnyJ3G_kqN7Vg90H21EOLACvtfcHk0ljRiVgfOpF2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xks1Wm&md5=943889ff0c9854c22558b05036e72a65</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjo00912a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00912a019%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgarten%26aufirst%3DH.%2BE.%26aulast%3DSmith%26aufirst%3DH.%2BL.%26aulast%3DStaklis%26aufirst%3DA.%26atitle%3DReactions%2520of%2520amines.%2520XVIII.%2520Oxidative%2520rearrangement%2520of%2520amides%2520with%2520lead%2520tetraacetate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D3554%26epage%3D3561%26doi%3D10.1021%2Fjo00912a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kajigaeshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakinami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, T.</span></span> <span> </span><span class="NLM_article-title">Oxidation using quaternary ammonium polyhalides 0.1. An efficient method for the Hofmann degradation of amides by use of benzyltrimethylammonium tribromide</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1246/cl.1989.463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1246%2Fcl.1989.463" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1989&pages=463-464&author=S.+Kajigaeshiauthor=K.+Asanoauthor=S.+Fujisakiauthor=T.+Kakinamiauthor=T.+Okamoto&title=Oxidation+using+quaternary+ammonium+polyhalides+0.1.+An+efficient+method+for+the+Hofmann+degradation+of+amides+by+use+of+benzyltrimethylammonium+tribromide&doi=10.1246%2Fcl.1989.463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1246%2Fcl.1989.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.1989.463%26sid%3Dliteratum%253Aachs%26aulast%3DKajigaeshi%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DFujisaki%26aufirst%3DS.%26aulast%3DKakinami%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DT.%26atitle%3DOxidation%2520using%2520quaternary%2520ammonium%2520polyhalides%25200.1.%2520An%2520efficient%2520method%2520for%2520the%2520Hofmann%2520degradation%2520of%2520amides%2520by%2520use%2520of%2520benzyltrimethylammonium%2520tribromide%26jtitle%3DChem.%2520Lett.%26date%3D1989%26volume%3D18%26spage%3D463%26epage%3D464%26doi%3D10.1246%2Fcl.1989.463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinklin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWolf, W. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraser, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McVean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgis, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtli, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houze, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-pyridylureas as glucokinase activators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8180</span>– <span class="NLM_lpage">8186</span>, <span class="refDoi"> DOI: 10.1021/jm501204z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501204z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8180-8186&author=R.+J.+Hinklinauthor=T.+D.+Aicherauthor=D.+A.+Andersonauthor=B.+R.+Baerauthor=S.+A.+Boydauthor=K.+R.+Condroskiauthor=W.+E.+DeWolfauthor=C.+F.+Kraserauthor=M.+McVeanauthor=S.+P.+Rhodesauthor=H.+L.+Sturgisauthor=W.+C.+Voegtliauthor=L.+Williamsauthor=J.+B.+Houze&title=Discovery+of+2-pyridylureas+as+glucokinase+activators&doi=10.1021%2Fjm501204z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-pyridylureas as glucokinase activators</span></div><div class="casAuthors">Hinklin, Ronald J.; Aicher, Thomas D.; Anderson, Deborah A.; Baer, Brian R.; Boyd, Steven A.; Condroski, Kevin R.; DeWolf, Walter E.; Kraser, Christopher F.; McVean, Maralee; Rhodes, Susan P.; Sturgis, Hillary L.; Voegtli, Walter C.; Williams, Lance; Houze, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8180-8186</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucokinase (GK) is the rate-limiting step for insulin release from the pancreas in response to high levels of glucose.  Flux through GK also contributes to reducing hepatic glucose output.  Since many individuals with type 2 diabetes appear to have an inadequacy or defect in one or both of these processes, identifying compds. that can allosterically activate GK may address this issue.  Herein the authors report the identification and initial optimization of a novel series of glucokinase activators (GKAs).  Optimization led to the identification of I as a compd. that displayed activity in an oral glucose tolerance test (OGTT) in normal and diabetic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xEdxjFsxirVg90H21EOLACvtfcHk0li3bLhWrwhM5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsbfP&md5=6d451b02e7cc78bf7e3a376a2c8c14dd</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm501204z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501204z%26sid%3Dliteratum%253Aachs%26aulast%3DHinklin%26aufirst%3DR.%2BJ.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DD.%2BA.%26aulast%3DBaer%26aufirst%3DB.%2BR.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DKraser%26aufirst%3DC.%2BF.%26aulast%3DMcVean%26aufirst%3DM.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DSturgis%26aufirst%3DH.%2BL.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%25202-pyridylureas%2520as%2520glucokinase%2520activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8180%26epage%3D8186%26doi%3D10.1021%2Fjm501204z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">General route to 2,4,5-trisubstituted piperidines from enantiopure beta-amino esters. Total synthesis of pseudodistomin B triacetate and pseudodistomin F</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">6009</span>– <span class="NLM_lpage">6016</span>, <span class="refDoi"> DOI: 10.1021/jo000447q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo000447q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVaisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=6009-6016&author=D.+Maauthor=H.+Sun&title=General+route+to+2%2C4%2C5-trisubstituted+piperidines+from+enantiopure+beta-amino+esters.+Total+synthesis+of+pseudodistomin+B+triacetate+and+pseudodistomin+F&doi=10.1021%2Fjo000447q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">General Route to 2,4,5-Trisubstituted Piperidines from Enantiopure β-Amino Esters. Total Synthesis of Pseudodistomin B Triacetate and Pseudodistomin F</span></div><div class="casAuthors">Ma, Dawei; Sun, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6009-6016</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Michael addn. reaction of enantiopure β-amino esters with Me acrylate followed by Dieckmann condensation and enol silylation affords enol ethers I (R = BOC), which are hydrogenated with catalysis by Raney-Ni at 80 atm and 80 °C to provide 2,4,5-trisubstituted piperidines with high diastereoselectivity.  In this case Ni-H attacks the C-C double bond from the direction of the 2-alkyl group to provide the products in which the 4-hydroxy group and 5-ester moiety are trans to the 2-alkyl group.  While hydrogenation of enol ether I (R = H, R1 = OTBS) without a N-Boc protecting group gives the product in which 2,4,5-trisubstituted groups are all cis to each other.  By using the diastereoselective hydrogenation products II (R1 = HO(CH2)5) and II (R1 = OH) as key intermediates, pseudodistomin B triacetate and pseudodistomin F are synthesized.  The key steps for these transformations include Curtius rearrangement and Julia olefination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKhi57jVXm_rVg90H21EOLACvtfcHk0li3bLhWrwhM5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVaisbw%253D&md5=b00309dd6023097d3970b3f2fadc328f</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjo000447q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000447q%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DGeneral%2520route%2520to%25202%252C4%252C5-trisubstituted%2520piperidines%2520from%2520enantiopure%2520beta-amino%2520esters.%2520Total%2520synthesis%2520of%2520pseudodistomin%2520B%2520triacetate%2520and%2520pseudodistomin%2520F%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D6009%26epage%3D6016%26doi%3D10.1021%2Fjo000447q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Migawa, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swayze, E. E.</span></span> <span> </span><span class="NLM_article-title">A solid-phase synthesis of <i>N,N’</i>-disubstituted ureas and Perhydroimidazo</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3309</span>– <span class="NLM_lpage">3311</span>, <span class="refDoi"> DOI: 10.1021/ol006383n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006383n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1ShtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3309-3311&author=M.+T.+Migawaauthor=E.+E.+Swayze&title=A+solid-phase+synthesis+of+N%2CN%E2%80%99-disubstituted+ureas+and+Perhydroimidazo&doi=10.1021%2Fol006383n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">A Solid-Phase Synthesis of N,N'-Disubstituted Ureas and Perhydroimidazo[1,5-a]pyrazines via the Curtius Rearrangement</span></div><div class="casAuthors">Migawa, Michael T.; Swayze, Eric E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3309-3311</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method for trapping isocyanates, generated from the Curtius rearrangement, with resin-bound amines is reported.  A com. available carboxylic acid is treated with diphenylphosphoryl azide, followed by thermal rearrangement, cooling, and trapping in one pot.  Cleavage from the resin gives an N,N'-disubstituted urea in excellent purity, as demonstrated with several heterocyclic and aliph. carboxylic acids.  Further utility is shown by prepg. several novel perhydroimidazo[1,5-a]pyrazines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxDALVwThm4LVg90H21EOLACvtfcHk0li3bLhWrwhM5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1ShtL4%253D&md5=89f7b8bf1816f8fb73bfd6674c992a7c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fol006383n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006383n%26sid%3Dliteratum%253Aachs%26aulast%3DMigawa%26aufirst%3DM.%2BT.%26aulast%3DSwayze%26aufirst%3DE.%2BE.%26atitle%3DA%2520solid-phase%2520synthesis%2520of%2520N%252CN%25E2%2580%2599-disubstituted%2520ureas%2520and%2520Perhydroimidazo%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3309%26epage%3D3311%26doi%3D10.1021%2Fol006383n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, A.</span></span> <span> </span><span class="NLM_article-title">The Curtius rearrangement: applications in modern drug discovery and medicinal chemistry</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2373</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fcmdc.201800518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=30187672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVygs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2351-2373&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=A.+Sarkar&title=The+Curtius+rearrangement%3A+applications+in+modern+drug+discovery+and+medicinal+chemistry&doi=10.1002%2Fcmdc.201800518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Sarkar, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2351-2373</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The Curtius rearrangement is the thermal decompn. of an acyl azide derived from carboxylic acid to produce an isocyanate as the initial product.  The isocyanate can undergo further reactions to provide amines and their derivs.  Due to its tolerance for a large variety of functional groups and complete retention of stereochem. during rearrangement, the Curtius rearrangement has been used in the synthesis of a wide variety of medicinal agents with amines and amine-derived functional groups such as ureas and urethanes.  The current review outlines various applications of the Curtius rearrangement in drug discovery and medicinal chem.  In particular, the review highlights some widely used rearrangement methods, syntheses of some key agents for popular drug targets and FDA-approved drugs.  In addn., the review highlights applications of the Curtius rearrangement in continuous-flow protocols for the scale-up of active pharmaceutical ingredients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhw8Uw6o6owLVg90H21EOLACvtfcHk0lh9nXqJ75wjfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVygs7zM&md5=da82f908635028b26540cbe25080ee63</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800518%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DSarkar%26aufirst%3DA.%26atitle%3DThe%2520Curtius%2520rearrangement%253A%2520applications%2520in%2520modern%2520drug%2520discovery%2520and%2520medicinal%2520chemistry%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D2351%26epage%3D2373%26doi%3D10.1002%2Fcmdc.201800518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span> <span> </span><span class="NLM_article-title">The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2006</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1039/C8OB00138C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC8OB00138C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=29479624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlKguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=2006-2027&author=A.+K.+Ghoshauthor=A.+Sarkarauthor=M.+Brindisi&title=The+Curtius+rearrangement%3A+mechanistic+insight+and+recent+applications+in+natural+product+syntheses&doi=10.1039%2FC8OB00138C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses</span></div><div class="casAuthors">Ghosh, Arun K.; Sarkar, Anindya; Brindisi, Margherita</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2006-2027</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The Curtius rearrangement is a versatile reaction in which a carboxylic acid can be converted to an isocyanate through an acyl azide intermediate under mild conditions.  The resulting stable isocyanate can then be readily transformed into a variety of amines and amine derivs. including urethanes and ureas.  There have been wide-ranging applications of the Curtius rearrangement in the synthesis of natural products and their derivs.  Also, this reaction has been extensively utilized in the synthesis and application of a variety of biomols.  In this review, we present mechanistic studies, chem. methodologies and reagents for the synthesis of isocyanates from carboxylic acids, the conversion of isocyanates to amines and amine derivs., and their applications in the synthesis of bioactive natural products and their congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxXsMDCLjtKLVg90H21EOLACvtfcHk0lh9nXqJ75wjfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlKguro%253D&md5=242915726420c02b495c466675f713dc</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1039%2FC8OB00138C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB00138C%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DSarkar%26aufirst%3DA.%26aulast%3DBrindisi%26aufirst%3DM.%26atitle%3DThe%2520Curtius%2520rearrangement%253A%2520mechanistic%2520insight%2520and%2520recent%2520applications%2520in%2520natural%2520product%2520syntheses%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2018%26volume%3D16%26spage%3D2006%26epage%3D2027%26doi%3D10.1039%2FC8OB00138C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. P.</span></span> <span> </span><span class="NLM_article-title">Development of a scalable synthesis of an azaindolyl-pyrimidine inhibitor of influenza virus replication</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.6b00063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.6b00063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Gqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=965-969&author=J.+L.+Liangauthor=J.+E.+Cochranauthor=W.+A.+Dorschauthor=I.+Daviesauthor=M.+P.+Clark&title=Development+of+a+scalable+synthesis+of+an+azaindolyl-pyrimidine+inhibitor+of+influenza+virus+replication&doi=10.1021%2Facs.oprd.6b00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Scalable Synthesis of an Azaindolyl-Pyrimidine Inhibitor of Influenza Virus Replication</span></div><div class="casAuthors">Liang, Jianglin; Cochran, John E.; Dorsch, Warren A.; Davies, Ioana; Clark, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">965-969</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scalable, asym. route for the synthesis of the influenza virus replication inhibitor I is presented.  The key steps include an enzymic desymmetrization of cis-1,3-cyclohexane diester in 99% yield and 96% ee, SNAr displacement of a methanesulfinylpyrimidine, and a Curtius rearrangement to form a morpholinyl urea.  This high-yielding route allowed us to rapidly synthesize hundreds of grams of I in 99% purity to support in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBIFVjisPoRrVg90H21EOLACvtfcHk0lh9nXqJ75wjfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Gqt7s%253D&md5=559465f677ef840c96d7100ea5cc2ad4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.6b00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.6b00063%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%2BL.%26aulast%3DCochran%26aufirst%3DJ.%2BE.%26aulast%3DDorsch%26aufirst%3DW.%2BA.%26aulast%3DDavies%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DM.%2BP.%26atitle%3DDevelopment%2520of%2520a%2520scalable%2520synthesis%2520of%2520an%2520azaindolyl-pyrimidine%2520inhibitor%2520of%2520influenza%2520virus%2520replication%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2016%26volume%3D20%26spage%3D965%26epage%3D969%26doi%3D10.1021%2Facs.oprd.6b00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narendra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennakrishnareddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureshbabu, V. V.</span></span> <span> </span><span class="NLM_article-title">Application of carbodiimide mediated Lossen rearrangement for the synthesis of alpha-ureidopeptides and peptidyl ureas employing N-urethane alpha-amino/peptidyl hydroxamic acids</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3520</span>– <span class="NLM_lpage">3526</span>, <span class="refDoi"> DOI: 10.1039/b905790k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb905790k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19675909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsl2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=3520-3526&author=N.+Narendraauthor=G.+Chennakrishnareddyauthor=V.+V.+Sureshbabu&title=Application+of+carbodiimide+mediated+Lossen+rearrangement+for+the+synthesis+of+alpha-ureidopeptides+and+peptidyl+ureas+employing+N-urethane+alpha-amino%2Fpeptidyl+hydroxamic+acids&doi=10.1039%2Fb905790k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Application of carbodiimide mediated Lossen rearrangement for the synthesis of α-ureidopeptides and peptidyl ureas employing N-urethane α-amino/peptidyl hydroxamic acids</span></div><div class="casAuthors">Narendra, N.; Chennakrishnareddy, Gundala; Sureshbabu, Vommina V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3520-3526</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Application of the Lossen rearrangement to the synthesis of N-urethane protected α-peptidyl ureas and ureidopeptides is reported.  The carbodiimide mediated rearrangement of N-Boc/Z/Fmoc protected α-amino/peptide hydroxamic acids into isocyanates and coupling of the latter with the amino acid esters/peptide esters have been accomplished in a single-pot to obtain good yields of urea products.  Synthesis of the ureidoalanine derivs. via the hydroxamate derivs. of N-protected aspartic acid has also been carried out using the same procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBlImPKeZ5GbVg90H21EOLACvtfcHk0lhQNjRp_5k0KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsl2itro%253D&md5=5200b814eda702317ece792aaf9900b2</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1039%2Fb905790k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905790k%26sid%3Dliteratum%253Aachs%26aulast%3DNarendra%26aufirst%3DN.%26aulast%3DChennakrishnareddy%26aufirst%3DG.%26aulast%3DSureshbabu%26aufirst%3DV.%2BV.%26atitle%3DApplication%2520of%2520carbodiimide%2520mediated%2520Lossen%2520rearrangement%2520for%2520the%2520synthesis%2520of%2520alpha-ureidopeptides%2520and%2520peptidyl%2520ureas%2520employing%2520N-urethane%2520alpha-amino%252Fpeptidyl%2520hydroxamic%2520acids%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D3520%26epage%3D3526%26doi%3D10.1039%2Fb905790k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dube, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathel, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couturier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboussafy, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardink, M.</span></span> <span> </span><span class="NLM_article-title">Carbonyldiimidazole-mediated Lossen rearrangement</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5622</span>– <span class="NLM_lpage">5625</span>, <span class="refDoi"> DOI: 10.1021/ol9023387</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9023387" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=5622-5625&author=P.+Dubeauthor=N.+F.+Nathelauthor=M.+Vetelinoauthor=M.+Couturierauthor=C.+L.+Aboussafyauthor=S.+Pichetteauthor=M.+L.+Jorgensenauthor=M.+Hardink&title=Carbonyldiimidazole-mediated+Lossen+rearrangement&doi=10.1021%2Fol9023387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonyldiimidazole-Mediated Lossen Rearrangement</span></div><div class="casAuthors">Dube, Pascal; Nathel, Noah F. Fine; Vetelino, Michael; Couturier, Michel; Aboussafy, Claude Larrivee; Pichette, Simon; Jorgensen, Matthew L.; Hardink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5622-5625</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbonyldiimidazole (CDI) was found to mediate the Lossen rearrangement of various hydroxamic acids to isocyanates.  This process is exptl. simple and mild, with imidazole and CO2 being the sole stoichiometric byproducts.  Significant for large-scale application, the method avoids the use of hazardous reagents and thus represents a green alternative to std. processing conditions for the Curtius and Hofmann rearrangements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN1ZnlIQT6b7Vg90H21EOLACvtfcHk0lhQNjRp_5k0KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtLvI&md5=84290a969989a97ed2067de0a77512e0</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fol9023387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9023387%26sid%3Dliteratum%253Aachs%26aulast%3DDube%26aufirst%3DP.%26aulast%3DNathel%26aufirst%3DN.%2BF.%26aulast%3DVetelino%26aufirst%3DM.%26aulast%3DCouturier%26aufirst%3DM.%26aulast%3DAboussafy%26aufirst%3DC.%2BL.%26aulast%3DPichette%26aufirst%3DS.%26aulast%3DJorgensen%26aufirst%3DM.%2BL.%26aulast%3DHardink%26aufirst%3DM.%26atitle%3DCarbonyldiimidazole-mediated%2520Lossen%2520rearrangement%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D5622%26epage%3D5625%26doi%3D10.1021%2Fol9023387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vasantha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemantha, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureshbabu, V. V.</span></span> <span> </span><span class="NLM_article-title">1-Propanephosphonic acid cyclic anhydride (T3P) as an efficient promoter for the Lossen rearrangement: application to the synthesis of urea and carbamate derivatives</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span>,  <span class="NLM_fpage">2990</span>– <span class="NLM_lpage">2996</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1258158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0030-1258158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=2990-2996&author=B.+Vasanthaauthor=H.+P.+Hemanthaauthor=V.+V.+Sureshbabu&title=1-Propanephosphonic+acid+cyclic+anhydride+%28T3P%29+as+an+efficient+promoter+for+the+Lossen+rearrangement%3A+application+to+the+synthesis+of+urea+and+carbamate+derivatives&doi=10.1055%2Fs-0030-1258158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1258158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1258158%26sid%3Dliteratum%253Aachs%26aulast%3DVasantha%26aufirst%3DB.%26aulast%3DHemantha%26aufirst%3DH.%2BP.%26aulast%3DSureshbabu%26aufirst%3DV.%2BV.%26atitle%3D1-Propanephosphonic%2520acid%2520cyclic%2520anhydride%2520%2528T3P%2529%2520as%2520an%2520efficient%2520promoter%2520for%2520the%2520Lossen%2520rearrangement%253A%2520application%2520to%2520the%2520synthesis%2520of%2520urea%2520and%2520carbamate%2520derivatives%26jtitle%3DSynthesis%26date%3D2010%26volume%3D2010%26spage%3D2990%26epage%3D2996%26doi%3D10.1055%2Fs-0030-1258158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thalluri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manne, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, B.</span></span> <span> </span><span class="NLM_article-title">Ethyl 2-cyano-2-(4-nitrophenylsulfonyloxyimino)acetate-mediated Lossen rearrangement: single-pot racemization-free synthesis of hydroxamic acids and ureas from carboxylic acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">3765</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1021/jo4026429</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo4026429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=3765-3775&author=K.+Thalluriauthor=S.+R.+Manneauthor=D.+Devauthor=B.+Mandal&title=Ethyl+2-cyano-2-%284-nitrophenylsulfonyloxyimino%29acetate-mediated+Lossen+rearrangement%3A+single-pot+racemization-free+synthesis+of+hydroxamic+acids+and+ureas+from+carboxylic+acids&doi=10.1021%2Fjo4026429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Ethyl 2-Cyano-2-(4-nitrophenylsulfonyloxyimino)acetate-Mediated Lossen Rearrangement: Single-Pot Racemization-Free Synthesis of Hydroxamic Acids and Ureas from Carboxylic Acids</span></div><div class="casAuthors">Thalluri, Kishore; Manne, Srinivasa Rao; Dev, Dharm; Mandal, Bhubaneswar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3765-3775</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Et 2-cyano-2-(4-nitrophenylsulfonyloxyimino)acetate (4-NBsOXY) mediated Lossen rearrangement and its application for the synthesis of ureas is demonstrated.  Required hydroxamic acids for the Lossen rearrangements were synthesized from carboxylic acids using the same reagent.  Finally, reaction of an amine with the produced isocyanate resulted in urea.  Good yields without racemization were achieved under milder and simpler reaction conditions.  Reactions are compatible with common N-protecting groups, such as Boc, Fmoc, Cbz, and benzyl, as well as various OH protecting groups, such as tBu and Bzl.  Conversion from carboxylic acid to urea is achieved in one pot.  Most importantly, byproducts Oxyma [ethyl 2-cyano-2-(hydroxyimino)acetate] and 4-nitrobenzenesulfonic acid can be recovered easily and can be recycled to prep. the reagent.  Thus, the method is environmentally friendly and cost-effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6H0-DKuUJNrVg90H21EOLACvtfcHk0lj5Y-cNkeG9uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsrs%253D&md5=b549f4d579d7234fed518901b1669677</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjo4026429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4026429%26sid%3Dliteratum%253Aachs%26aulast%3DThalluri%26aufirst%3DK.%26aulast%3DManne%26aufirst%3DS.%2BR.%26aulast%3DDev%26aufirst%3DD.%26aulast%3DMandal%26aufirst%3DB.%26atitle%3DEthyl%25202-cyano-2-%25284-nitrophenylsulfonyloxyimino%2529acetate-mediated%2520Lossen%2520rearrangement%253A%2520single-pot%2520racemization-free%2520synthesis%2520of%2520hydroxamic%2520acids%2520and%2520ureas%2520from%2520carboxylic%2520acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D3765%26epage%3D3775%26doi%3D10.1021%2Fjo4026429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leogane, O.</span></span> <span> </span><span class="NLM_article-title">Curtius rearrangement of aromatic carboxylic acids to access protected anilines and aromatic ureas</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5717</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi"> DOI: 10.1021/ol0622920</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0622920" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WhsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=5717-5720&author=H.+Lebelauthor=O.+Leogane&title=Curtius+rearrangement+of+aromatic+carboxylic+acids+to+access+protected+anilines+and+aromatic+ureas&doi=10.1021%2Fol0622920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Curtius rearrangement of aromatic carboxylic acids to access protected anilines and aromatic ureas</span></div><div class="casAuthors">Lebel, Helene; Leogane, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5717-5720</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The reaction of a chloroformate or di-tert-Bu dicarbonate and sodium azide with an arom. carboxylic acid produced the corresponding acyl azide, presumably through the formation of an azidoformate.  The acyl azide underwent a Curtius rearrangement to form an isocyanate deriv. which was trapped either by an alkoxide or by an amine to form the arom. carbamate or urea.  The reaction conditions were compatible with a variety of functional groups and allowed the synthesis of a series of aniline derivs. contg. alkyl, halide, nitro, ketone, ether, and thioether substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTWwUjS6F9LVg90H21EOLACvtfcHk0litaRNKc6hLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WhsLfN&md5=1c09a86ebebdb7d8716dff08614d7436</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fol0622920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0622920%26sid%3Dliteratum%253Aachs%26aulast%3DLebel%26aufirst%3DH.%26aulast%3DLeogane%26aufirst%3DO.%26atitle%3DCurtius%2520rearrangement%2520of%2520aromatic%2520carboxylic%2520acids%2520to%2520access%2520protected%2520anilines%2520and%2520aromatic%2520ureas%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D5717%26epage%3D5720%26doi%3D10.1021%2Fol0622920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hemantha, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennakrishnareddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwanatha, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureshbabu, V. V.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of ureido peptides and urea-tethered glycosylated amino acids employing Deoxo-Fluor and TMSN<sub>3</sub></span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1055/s-0028-1087538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0028-1087538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=407-410&author=H.+P.+Hemanthaauthor=G.+Chennakrishnareddyauthor=T.+M.+Vishwanathaauthor=V.+V.+Sureshbabu&title=One-pot+synthesis+of+ureido+peptides+and+urea-tethered+glycosylated+amino+acids+employing+Deoxo-Fluor+and+TMSN3&doi=10.1055%2Fs-0028-1087538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1087538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1087538%26sid%3Dliteratum%253Aachs%26aulast%3DHemantha%26aufirst%3DH.%2BP.%26aulast%3DChennakrishnareddy%26aufirst%3DG.%26aulast%3DVishwanatha%26aufirst%3DT.%2BM.%26aulast%3DSureshbabu%26aufirst%3DV.%2BV.%26atitle%3DOne-pot%2520synthesis%2520of%2520ureido%2520peptides%2520and%2520urea-tethered%2520glycosylated%2520amino%2520acids%2520employing%2520Deoxo-Fluor%2520and%2520TMSN3%26jtitle%3DSynlett%26date%3D2009%26volume%3D2009%26spage%3D407%26epage%3D410%26doi%3D10.1055%2Fs-0028-1087538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, G. A.</span></span> <span> </span><span class="NLM_article-title">Scalable, one-pot, microwave-accelerated tandem synthesis of unsymmetrical urea derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b02521</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b02521" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2nurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=992-999&author=A.+R.+Kulkarniauthor=S.+Garaiauthor=G.+A.+Thakur&title=Scalable%2C+one-pot%2C+microwave-accelerated+tandem+synthesis+of+unsymmetrical+urea+derivatives&doi=10.1021%2Facs.joc.6b02521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable, One-Pot, Microwave-Accelerated Tandem Synthesis of Unsymmetrical Urea Derivatives</span></div><div class="casAuthors">Kulkarni, Abhijit R.; Garai, Sumanta; Thakur, Ganesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">992-999</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a facile, microwave-accelerated, one-pot tandem synthesis of unsym. ureas via Curtius rearrangement.  In this method, one-pot microwave irradn. of com. available (hetero)arom. acids and amines in presence of diphenylphosphorylazide enabled extremely rapid (1-5 mins) construction of an array of unsym. ureas in good to excellent yields.  We demonstrate the utility of our method in efficient, gram-scale synthesis of key biol. active compds. targeting the cannabinoid 1 and α7 nicotinic acetylcholine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoctWwDicAShbVg90H21EOLACvtfcHk0litaRNKc6hLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2nurbM&md5=4eed27924c955b05fed3b794c96a25f7</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b02521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b02521%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DA.%2BR.%26aulast%3DGarai%26aufirst%3DS.%26aulast%3DThakur%26aufirst%3DG.%2BA.%26atitle%3DScalable%252C%2520one-pot%252C%2520microwave-accelerated%2520tandem%2520synthesis%2520of%2520unsymmetrical%2520urea%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D992%26epage%3D999%26doi%3D10.1021%2Facs.joc.6b02521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. M.</span></span> <span> </span><span class="NLM_article-title">Highly efficient synthesis of ureas and carbamates from amides by iodosylbenzene-induced Hofmann rearrangement</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">1994</span>– <span class="NLM_lpage">2000</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201101784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201101784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1WmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1994-2000&author=P.+Liuauthor=Z.+M.+Wangauthor=X.+M.+Hu&title=Highly+efficient+synthesis+of+ureas+and+carbamates+from+amides+by+iodosylbenzene-induced+Hofmann+rearrangement&doi=10.1002%2Fejoc.201101784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient Synthesis of Ureas and Carbamates from Amides by Iodosylbenzene-Induced Hofmann Rearrangement</span></div><div class="casAuthors">Liu, Peng; Wang, Zhiming; Hu, Xianming</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1994-2000, S1994/1-S1994/38</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A simple and efficient method for the synthesis of 1,3-disubstituted ureas and carbamates from amides by using iodosylbenzene as the oxidant is described.  Sym. and asym. ureas and carbamates can be prepd. by this procedure in up to 98 % yield.  Ureidopeptides can also be prepd. in good yield by this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroQoakyCi6wLVg90H21EOLACvtfcHk0litaRNKc6hLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1WmtLk%253D&md5=f22738c3c3a87bfcb9f4cffb518d3420</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201101784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201101784%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DZ.%2BM.%26aulast%3DHu%26aufirst%3DX.%2BM.%26atitle%3DHighly%2520efficient%2520synthesis%2520of%2520ureas%2520and%2520carbamates%2520from%2520amides%2520by%2520iodosylbenzene-induced%2520Hofmann%2520rearrangement%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D1994%26epage%3D2000%26doi%3D10.1002%2Fejoc.201101784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, T. C.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of <i>N</i>-monosubstituted ureas from nitriles via Tiemann rearrangement</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1823</span>– <span class="NLM_lpage">1826</span>, <span class="refDoi"> DOI: 10.1055/s-0034-1381007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0034-1381007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2rsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=1823-1826&author=C.+H.+Wangauthor=T.+H.+Hsiehauthor=C.+C.+Linauthor=W.+H.+Yehauthor=C.+A.+Linauthor=T.+C.+Chien&title=One-pot+synthesis+of+N-monosubstituted+ureas+from+nitriles+via+Tiemann+rearrangement&doi=10.1055%2Fs-0034-1381007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Synthesis of N-Monosubstituted Ureas from Nitriles via Tiemann Rearrangement</span></div><div class="casAuthors">Wang, Chien-Hong; Hsieh, Tsung-Han; Lin, Chia-Chi; Yeh, Wen-Hsiung; Lin, Chih-An; Chien, Tun-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1823-1826</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Amidoximes, obtained from the reaction of nitriles with hydroxylamine, underwent Tiemann rearrangement in the presence of benzenesulfonyl chlorides (TsCl or o-NsCl) to form the N-substituted cyanamides.  Subsequently, acidic hydrolysis of the cyanamides afforded the corresponding N-monosubstituted ureas.  The synthesis of N-monosubstituted ureas from nitriles was accomplished by three steps in one pot, which provides a direct access to versatile N-monosubstituted urea derivs. from a wide variety of nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1jAs8AXBZc7Vg90H21EOLACvtfcHk0lgGWV8E_MqLbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2rsL3O&md5=40667ce2551cd4d1fa13ec7c3169829d</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1055%2Fs-0034-1381007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0034-1381007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DT.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DYeh%26aufirst%3DW.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BA.%26aulast%3DChien%26aufirst%3DT.%2BC.%26atitle%3DOne-pot%2520synthesis%2520of%2520N-monosubstituted%2520ureas%2520from%2520nitriles%2520via%2520Tiemann%2520rearrangement%26jtitle%3DSynlett%26date%3D2015%26volume%3D26%26spage%3D1823%26epage%3D1826%26doi%3D10.1055%2Fs-0034-1381007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feberero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez-Pantiga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabello, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, R.</span></span> <span> </span><span class="NLM_article-title">1,5-O --> N Carbamoyl Snieckus-Fries-type rearrangement</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2437</span>– <span class="NLM_lpage">2440</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b00782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b00782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVKhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=2437-2440&author=C.+Febereroauthor=S.+Suarez-Pantigaauthor=Z.+Cabelloauthor=R.+Sanz&title=1%2C5-O+%2D%2D%3E+N+Carbamoyl+Snieckus-Fries-type+rearrangement&doi=10.1021%2Facs.orglett.8b00782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-O → N Carbamoyl Snieckus-Fries-Type Rearrangement</span></div><div class="casAuthors">Feberero, Claudia; Suarez-Pantiga, Samuel; Cabello, Zaida; Sanz, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2437-2440</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The reaction of o-lithiated O-aryl N,N-diethylcarbamates with (hetero)arom. nitriles gives rise to functionalized salicylidene urea derivs. in high yields through a new 1,5-O → N carbamoyl migration.  This Snieckus-Fries-type rearrangement nicely complements previously known O → C and O → O related shifts.  In addn., when dimethylmalononitrile is used as the electrophilic partner, the carbamoyl shift is preferred over the expected transnitrilation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_PBxX6Huv3LVg90H21EOLACvtfcHk0lgGWV8E_MqLbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVKhs7g%253D&md5=b88ab257c22364568c9caf10a497c8ce</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b00782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b00782%26sid%3Dliteratum%253Aachs%26aulast%3DFeberero%26aufirst%3DC.%26aulast%3DSuarez-Pantiga%26aufirst%3DS.%26aulast%3DCabello%26aufirst%3DZ.%26aulast%3DSanz%26aufirst%3DR.%26atitle%3D1%252C5-O%2520--%253E%2520N%2520Carbamoyl%2520Snieckus-Fries-type%2520rearrangement%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D2437%26epage%3D2440%26doi%3D10.1021%2Facs.orglett.8b00782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conforti, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccinno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, G.</span></span> <span> </span><span class="NLM_article-title">Clean synthesis in water: uncatalysed preparation of ylidenemalononitriles</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1039/b001246g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb001246g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktV2iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=101-103&author=F.+Bigiauthor=M.+L.+Confortiauthor=R.+Maggiauthor=A.+Piccinnoauthor=G.+Sartori&title=Clean+synthesis+in+water%3A+uncatalysed+preparation+of+ylidenemalononitriles&doi=10.1039%2Fb001246g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Clean synthesis in water: uncatalyzed preparation of ylidenemalononitriles</span></div><div class="casAuthors">Bigi, Franca; Conforti, Maria Lina; Maggi, Raimondo; Piccinno, Annalisa; Sartori, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">101-103</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A simple, efficient and environment-friendly procedure is developed for the condensation of malononitrile with arom., heteroarom. and aliph. aldehydes in water.  The ylidenemalononitriles are synthesized in high yields (84-98%) and selectivities (87-98%) in distd. water at 65° for 1 h, avoiding the addn. of any catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMaclXyT4pI7Vg90H21EOLACvtfcHk0lgGWV8E_MqLbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktV2iurk%253D&md5=ebe400cff5104c68353e8c260a6a7aff</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1039%2Fb001246g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb001246g%26sid%3Dliteratum%253Aachs%26aulast%3DBigi%26aufirst%3DF.%26aulast%3DConforti%26aufirst%3DM.%2BL.%26aulast%3DMaggi%26aufirst%3DR.%26aulast%3DPiccinno%26aufirst%3DA.%26aulast%3DSartori%26aufirst%3DG.%26atitle%3DClean%2520synthesis%2520in%2520water%253A%2520uncatalysed%2520preparation%2520of%2520ylidenemalononitriles%26jtitle%3DGreen%2520Chem.%26date%3D2000%26volume%3D2%26spage%3D101%26epage%3D103%26doi%3D10.1039%2Fb001246g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darko, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElwee-White, L.</span></span> <span> </span><span class="NLM_article-title">Transition metal-catalyzed oxidative carbonylation of amines to ureas</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">4453</span>– <span class="NLM_lpage">4465</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200700148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.200700148" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=4453-4465&author=D.+J.+Diazauthor=A.+K.+Darkoauthor=L.+McElwee-White&title=Transition+metal-catalyzed+oxidative+carbonylation+of+amines+to+ureas&doi=10.1002%2Fejoc.200700148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200700148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200700148%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DD.%2BJ.%26aulast%3DDarko%26aufirst%3DA.%2BK.%26aulast%3DMcElwee-White%26aufirst%3DL.%26atitle%3DTransition%2520metal-catalyzed%2520oxidative%2520carbonylation%2520of%2520amines%2520to%2520ureas%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D4453%26epage%3D4465%26doi%3D10.1002%2Fejoc.200700148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, N.</span></span> <span> </span><span class="NLM_article-title">Organic synthesis by means of noble-metal compounds. Palladium-catalyzed carbonylation of amines</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_fpage">380</span>, <span class="refDoi"> DOI: 10.1039/c19660000380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc19660000380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaF28Xktlyisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=380&author=J.+Tsujiauthor=N.+Iwamoto&title=Organic+synthesis+by+means+of+noble-metal+compounds.+Palladium-catalyzed+carbonylation+of+amines&doi=10.1039%2Fc19660000380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis by means of noble-metal compounds. Palladium-catalyzed carbonylation of amines</span></div><div class="casAuthors">Tsuji, J.; Iwamoto, N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (London)</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">380</span>CODEN:
                <span class="NLM_cas:coden">CCOMA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-241X</span>.
    </div><div class="casAbstract">Primary amines can be carbonylated to form disubstituted ureas and oxamides while H is produced.  Thus, 7.9 g. n-decylamine, 0.5 g. PdCl2, and 30 ml. benzene in a glass vessel was placed in an autoclave.  A CO pressure of 10 kg./cm.2 was applied and the reaction carried out by shaking 20 hrs. at 180°. N,N'-Didecyloxamide (m. 122°) (3.8 g.) and 2.2 g. 1,3-didecylurea (m. 97-8) were obtained.  The H formation was followed by gas chromatography.  Classes and proportions of the products depend mainly on the catalyst form and the amines used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotc-VJZSM-TLVg90H21EOLACvtfcHk0liykd365etEwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28Xktlyisrk%253D&md5=17a63c2ec4d7cb1bb67bc843dcd27ef2</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1039%2Fc19660000380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc19660000380%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DJ.%26aulast%3DIwamoto%26aufirst%3DN.%26atitle%3DOrganic%2520synthesis%2520by%2520means%2520of%2520noble-metal%2520compounds.%2520Palladium-catalyzed%2520carbonylation%2520of%2520amines%26jtitle%3DChem.%2520Commun.%26date%3D1966%26spage%3D380%26doi%3D10.1039%2Fc19660000380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, G.</span></span> <span> </span><span class="NLM_article-title">Oxidative carbonylation as a powerful tool for the direct synthesis of carbonylated heterocycles</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">6825</span>– <span class="NLM_lpage">6839</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201200794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201200794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=6825-6839&author=B.+Gabrieleauthor=R.+Mancusoauthor=G.+Salerno&title=Oxidative+carbonylation+as+a+powerful+tool+for+the+direct+synthesis+of+carbonylated+heterocycles&doi=10.1002%2Fejoc.201200794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative carbonylation as a powerful tool for the direct synthesis of carbonylated heterocycles</span></div><div class="casAuthors">Gabriele, Bartolo; Mancuso, Raffaella; Salerno, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">6825-6839</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Recent advances in the field of oxidative carbonylation reactions leading to carbonylated heterocyclic derivs. were presented (coverage: 2006 to the beginning of 2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCCFM0DpzpBLVg90H21EOLACvtfcHk0liykd365etEwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrnN&md5=bb64a1e3b829b7f2852cc50d798a97d5</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201200794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201200794%26sid%3Dliteratum%253Aachs%26aulast%3DGabriele%26aufirst%3DB.%26aulast%3DMancuso%26aufirst%3DR.%26aulast%3DSalerno%26aufirst%3DG.%26atitle%3DOxidative%2520carbonylation%2520as%2520a%2520powerful%2520tool%2520for%2520the%2520direct%2520synthesis%2520of%2520carbonylated%2520heterocycles%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D6825%26epage%3D6839%26doi%3D10.1002%2Fejoc.201200794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukuoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, M.</span></span> <span> </span><span class="NLM_article-title">A novel catalytic synthesis of carbamates by oxydative alkoxycarbonylation of amines in the presence of palladium and iodide</span>. <i>J. Chem. Soc., Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1039/c39840000399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc39840000399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaL2cXkvFSmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=399-400&author=S.+Fukuokaauthor=M.+Chonoauthor=M.+Kohno&title=A+novel+catalytic+synthesis+of+carbamates+by+oxydative+alkoxycarbonylation+of+amines+in+the+presence+of+palladium+and+iodide&doi=10.1039%2Fc39840000399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">A novel catalytic synthesis of carbamates by oxidative alkoxycarbonylation of amines in the presence of palladium and iodide</span></div><div class="casAuthors">Fukuoka, Shinsuke; Chono, Masazumi; Kohno, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">399-400</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">Oxidative carbonylation of amines by CO, O, and alcs. to give high yields of carbamates was catalyzed by metallic Pd and I-.  A mixt. of PhNH2, EtOH, Pd black, and NaI under 80 kg/cm2 CO was further pressurized to 86 kg/cm2 by O and heated 2 h at 160-170° to give 93% EtO2CNHPh with 98% selectivity and 95% conversion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRHruWd5n6UrVg90H21EOLACvtfcHk0lhVuwixr9RhIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvFSmsbw%253D&md5=c9d4d561144f87771f25849f1db0035a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1039%2Fc39840000399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39840000399%26sid%3Dliteratum%253Aachs%26aulast%3DFukuoka%26aufirst%3DS.%26aulast%3DChono%26aufirst%3DM.%26aulast%3DKohno%26aufirst%3DM.%26atitle%3DA%2520novel%2520catalytic%2520synthesis%2520of%2520carbamates%2520by%2520oxydative%2520alkoxycarbonylation%2520of%2520amines%2520in%2520the%2520presence%2520of%2520palladium%2520and%2520iodide%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1984%26spage%3D399%26epage%3D400%26doi%3D10.1039%2Fc39840000399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolhe, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagasabapathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, R. V.</span></span> <span> </span><span class="NLM_article-title">Selectivity behavior in catalytic oxidative carbonylation of alkylamines</span>. <i>Ind. Eng. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1021/ie00001a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ie00001a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK38XktVyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=172-176&author=A.+A.+Kelkarauthor=D.+S.+Kolheauthor=S.+Kanagasabapathyauthor=R.+V.+Chaudhari&title=Selectivity+behavior+in+catalytic+oxidative+carbonylation+of+alkylamines&doi=10.1021%2Fie00001a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity behavior in catalytic oxidative carbonylation of alkyl amines</span></div><div class="casAuthors">Kelkar, Ashutosh A.; Kolhe, Devidas S.; Kanagasabapathy, Subbareddy; Chaudhari, Raghunath V.</div><div class="citationInfo"><span class="NLM_cas:title">Industrial & Engineering Chemistry Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-6</span>CODEN:
                <span class="NLM_cas:coden">IECRED</span>;
        ISSN:<span class="NLM_cas:issn">0888-5885</span>.
    </div><div class="casAbstract">Alkyl carbamates are prepd. in good yields by oxidative carbonylation of alkylamines using a transition-metal catalyst and sodium iodide promoter.  Various homogeneous and heterogeneous transition-metal catalysts are studied.  Synthesis of Me N-methylcarbamate by oxidative carbonylation of methylamine is reported for the first time using the Pd-NaI catalyst system.  The effects of various process parameters on oxidative carbonylation of methylamine are studied in detail.  It is found that the selectivity pattern is strongly dependent on the type of catalyst used, the concn. of methylamine, the CO:O2 ratio, and the temp.  A possible mechanism based on the results is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPT_1on_doNLVg90H21EOLACvtfcHk0lhVuwixr9RhIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVyrtA%253D%253D&md5=cd7f542aa3ebc2df1bb3bc5437631291</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fie00001a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fie00001a024%26sid%3Dliteratum%253Aachs%26aulast%3DKelkar%26aufirst%3DA.%2BA.%26aulast%3DKolhe%26aufirst%3DD.%2BS.%26aulast%3DKanagasabapathy%26aufirst%3DS.%26aulast%3DChaudhari%26aufirst%3DR.%2BV.%26atitle%3DSelectivity%2520behavior%2520in%2520catalytic%2520oxidative%2520carbonylation%2520of%2520alkylamines%26jtitle%3DInd.%2520Eng.%2520Chem.%2520Res.%26date%3D1992%26volume%3D31%26spage%3D172%26epage%3D176%26doi%3D10.1021%2Fie00001a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiusoli, G. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-oxazolidinones by direct palladium-catalyzed oxidative carbonylation of 2-amino-1-alkanols</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1021/ol9913789</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9913789" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVCrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=625-627&author=B.+Gabrieleauthor=G.+Salernoauthor=D.+Brindisiauthor=M.+Costaauthor=G.+P.+Chiusoli&title=Synthesis+of+2-oxazolidinones+by+direct+palladium-catalyzed+oxidative+carbonylation+of+2-amino-1-alkanols&doi=10.1021%2Fol9913789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-oxazolidinones by direct palladium-catalyzed oxidative carbonylation of 2-amino-1-alkanols</span></div><div class="casAuthors">Gabriele, Bartolo; Salerno, Giuseppe; Brindisi, Donatella; Costa, Mirco; Chiusoli, Gian Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-627</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The oxazolidinones I (R, R1 = H, H; Me, H; Ph, H; H, Me; H, Ph; H, i-Pr; H, benzyl) were obtained in excellent yields (up to 100%) and with unprecedented catalytic efficiencies (up to 2000 mol of product/mol of catalyst used) by direct PdI2/KI-catalyzed oxidative carbonylation of the readily available 2-amino-1-alkanols HOCHRCHR1NH2.  The reactions were carried out in MeOH at 100° using a 1/6/5 CO/O2/air mixt. with 60 atm total pressure at 25°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlv163ZcOY7Vg90H21EOLACvtfcHk0lhVuwixr9RhIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVCrsbs%253D&md5=906c74be10fec588ad9a2c325fff0831</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fol9913789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9913789%26sid%3Dliteratum%253Aachs%26aulast%3DGabriele%26aufirst%3DB.%26aulast%3DSalerno%26aufirst%3DG.%26aulast%3DBrindisi%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DChiusoli%26aufirst%3DG.%2BP.%26atitle%3DSynthesis%2520of%25202-oxazolidinones%2520by%2520direct%2520palladium-catalyzed%2520oxidative%2520carbonylation%2520of%25202-amino-1-alkanols%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D625%26epage%3D627%26doi%3D10.1021%2Fol9913789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enquist, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Super fast cobalt carbonyl-mediated synthesis of ureas</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3335</span>– <span class="NLM_lpage">3339</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2005.03.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tetlet.2005.03.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlKns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=3335-3339&author=P.+A.+Enquistauthor=P.+Nilssonauthor=J.+Edinauthor=M.+Larhed&title=Super+fast+cobalt+carbonyl-mediated+synthesis+of+ureas&doi=10.1016%2Fj.tetlet.2005.03.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Super fast cobalt carbonyl-mediated synthesis of ureas</span></div><div class="casAuthors">Enquist, Per-Anders; Nilsson, Peter; Edin, Johan; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3335-3339</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fast cobalt carbonyl-mediated generation of ureas from primary amines was performed using high-d. microwave irradn.  This enhanced method permitted the prepn. of sym. ureas in good yields and unsym. ureas in moderate yields.  The reaction times varied between 10 s and 40 min.  The proposed mechanism for the reaction includes in situ generation of an intermediate isocyanate that subsequently traps the free amine, producing the urea product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmHUKtF6gnrVg90H21EOLACvtfcHk0lgC1_zmclUtMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlKns7g%253D&md5=6b57d297c781ee2319c923229c64b341</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.03.076%26sid%3Dliteratum%253Aachs%26aulast%3DEnquist%26aufirst%3DP.%2BA.%26aulast%3DNilsson%26aufirst%3DP.%26aulast%3DEdin%26aufirst%3DJ.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DSuper%2520fast%2520cobalt%2520carbonyl-mediated%2520synthesis%2520of%2520ureas%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D3335%26epage%3D3339%26doi%3D10.1016%2Fj.tetlet.2005.03.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tafesh, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiguny, J.</span></span> <span> </span><span class="NLM_article-title">A review of the selective catalytic reduction of aromatic nitro compounds into aromatic amines, isocyanates, carbamates, and ureas using CO</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2035</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.1021/cr950083f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr950083f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XlsFWhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=2035-2052&author=A.+M.+Tafeshauthor=J.+Weiguny&title=A+review+of+the+selective+catalytic+reduction+of+aromatic+nitro+compounds+into+aromatic+amines%2C+isocyanates%2C+carbamates%2C+and+ureas+using+CO&doi=10.1021%2Fcr950083f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of the Selective Catalytic Reduction of Aromatic Nitro Compounds into Aromatic Amines, Isocyanates, Carbamates, and Ureas Using CO</span></div><div class="casAuthors">Tafesh, Ahmed M.; Weiguny, Jens</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2035-2052</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 127 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbq_89gOYUD7Vg90H21EOLACvtfcHk0lgC1_zmclUtMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFWhtrs%253D&md5=039e52fcb03801f48fb22f25968d3ab1</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fcr950083f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950083f%26sid%3Dliteratum%253Aachs%26aulast%3DTafesh%26aufirst%3DA.%2BM.%26aulast%3DWeiguny%26aufirst%3DJ.%26atitle%3DA%2520review%2520of%2520the%2520selective%2520catalytic%2520reduction%2520of%2520aromatic%2520nitro%2520compounds%2520into%2520aromatic%2520amines%252C%2520isocyanates%252C%2520carbamates%252C%2520and%2520ureas%2520using%2520CO%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D2035%26epage%3D2052%26doi%3D10.1021%2Fcr950083f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Pd/C Catalyzed carbonylation of azides in the presence of amines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1736</span>– <span class="NLM_lpage">1739</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVKjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1736-1739&author=J.+Zhaoauthor=Z.+Liauthor=S.+Yanauthor=S.+Xuauthor=M.+A.+Wangauthor=B.+Fuauthor=Z.+Zhang&title=Pd%2FC+Catalyzed+carbonylation+of+azides+in+the+presence+of+amines&doi=10.1021%2Facs.orglett.6b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Pd/C Catalyzed Carbonylation of Azides in the Presence of Amines</span></div><div class="casAuthors">Zhao, Jin; Li, Zongyang; Yan, Shuaihu; Xu, Shiyang; Wang, Ming-An; Fu, Bin; Zhang, Zhenhua</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1736-1739</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile and efficient Pd/C-catalyzed carbonylation of both aliph. and arom. azides in the presence of amines is reported.  Serving as the widely existed fragments in an array of biol. pharmaceuticals, functionalized unsym. ureas were straightforwardly synthesized by using readily available and cheap azides with amines under CO atm., with the extrusion of N2 as the only byproduct.  It was found that not only aryl azides but also benzyl and alkyl azides were suited for this methodol.  Another feature of this procedure was the employment of a highly efficient palladium charcoal catalytic system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjJ3A_jq07d7Vg90H21EOLACvtfcHk0lgC1_zmclUtMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVKjtr8%253D&md5=e62e70633dd94a379bab698809073c06</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b00381%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%2BA.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DPd%252FC%2520Catalyzed%2520carbonylation%2520of%2520azides%2520in%2520the%2520presence%2520of%2520amines%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D1736%26epage%3D1739%26doi%3D10.1021%2Facs.orglett.6b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fors, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling of aryl chlorides and triflates with sodium cyanate: a practical synthesis of unsymmetrical ureas</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">11132</span>– <span class="NLM_lpage">11135</span>, <span class="refDoi"> DOI: 10.1021/ja305212v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja305212v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFartb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=11132-11135&author=E.+V.+Vinogradovaauthor=B.+P.+Forsauthor=S.+L.+Buchwald&title=Palladium-catalyzed+cross-coupling+of+aryl+chlorides+and+triflates+with+sodium+cyanate%3A+a+practical+synthesis+of+unsymmetrical+ureas&doi=10.1021%2Fja305212v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling of Aryl Chlorides and Triflates with Sodium Cyanate: A Practical Synthesis of Unsymmetrical Ureas</span></div><div class="casAuthors">Vinogradova, Ekaterina V.; Fors, Brett P.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">11132-11135</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method for palladium-catalyzed cross-coupling of aryl chlorides and triflates with sodium cyanate is reported.  The protocol allows for the synthesis of unsym. N,N'-di- and N,N,N'-trisubstituted ureas in one pot and is tolerant of a wide range of functional groups.  Insight into the mechanism of aryl isocyanate formation was gleaned through studies of the transmetalation and reductive elimination steps of the reaction, including the first demonstration of reductive elimination from an arylpalladium isocyanate complex to produce an aryl isocyanate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtjsO5TnI5m7Vg90H21EOLACvtfcHk0lgC1_zmclUtMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFartb8%253D&md5=1a59556ae499f90fec8def64025c0a50</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fja305212v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305212v%26sid%3Dliteratum%253Aachs%26aulast%3DVinogradova%26aufirst%3DE.%2BV.%26aulast%3DFors%26aufirst%3DB.%2BP.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520of%2520aryl%2520chlorides%2520and%2520triflates%2520with%2520sodium%2520cyanate%253A%2520a%2520practical%2520synthesis%2520of%2520unsymmetrical%2520ureas%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D11132%26epage%3D11135%26doi%3D10.1021%2Fja305212v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raut, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Ca, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carfagna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, B.</span></span> <span> </span><span class="NLM_article-title">Catalytic oxidative carbonylation of amino moieties to ureas, oxamides, 2-oxazolidinones, and benzoxazolones</span>. <i>ChemSusChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2204</span>– <span class="NLM_lpage">2211</span>, <span class="refDoi"> DOI: 10.1002/cssc.201500343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fcssc.201500343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26089244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVensLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=2204-2211&author=R.+Mancusoauthor=D.+S.+Rautauthor=N.+Della+Caauthor=F.+Finiauthor=C.+Carfagnaauthor=B.+Gabriele&title=Catalytic+oxidative+carbonylation+of+amino+moieties+to+ureas%2C+oxamides%2C+2-oxazolidinones%2C+and+benzoxazolones&doi=10.1002%2Fcssc.201500343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Oxidative Carbonylation of Amino Moieties to Ureas, Oxamides, 2-Oxazolidinones, and Benzoxazolones</span></div><div class="casAuthors">Mancuso, Raffaella; Raut, Dnyaneshwar S.; Della Ca, Nicola; Fini, Francesco; Carfagna, Carla; Gabriele, Bartolo</div><div class="citationInfo"><span class="NLM_cas:title">ChemSusChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2204-2211</span>CODEN:
                <span class="NLM_cas:coden">CHEMIZ</span>;
        ISSN:<span class="NLM_cas:issn">1864-5631</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The direct synthesis of ureas RNHC(O)NHR [R = (CH2)3CH3, 4-ClC6H4, 4-(H3C)2CHC6H4, etc.], oxamides R1C(O)C(O)R1 (R1 = morpholin-4-yl, pyrrolidin-1-yl, diethylamino, butylamino, etc.), 2-oxazolidinones, e.g., I, and benzoxazolones, e.g., II, by the oxidative carbonylation of amines, U+03B2-amino alcs., and 2-aminophenols has been reported.  It is possible to perform these transformations using the PdI2/KI catalytic system in an ionic liq., such as 1-butyl-3-methylimidazolium tetrafluoroborate, as the solvent, the solvent/catalyst system can be recycled several times with only a slight loss of activity, and the product can be recovered easily by crystn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9jcN4xaso_bVg90H21EOLACvtfcHk0lhlxpp4Nbxr4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVensLzK&md5=4952818cca38c025fd84d42cab77b089</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1002%2Fcssc.201500343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcssc.201500343%26sid%3Dliteratum%253Aachs%26aulast%3DMancuso%26aufirst%3DR.%26aulast%3DRaut%26aufirst%3DD.%2BS.%26aulast%3DDella%2BCa%26aufirst%3DN.%26aulast%3DFini%26aufirst%3DF.%26aulast%3DCarfagna%26aufirst%3DC.%26aulast%3DGabriele%26aufirst%3DB.%26atitle%3DCatalytic%2520oxidative%2520carbonylation%2520of%2520amino%2520moieties%2520to%2520ureas%252C%2520oxamides%252C%25202-oxazolidinones%252C%2520and%2520benzoxazolones%26jtitle%3DChemSusChem%26date%3D2015%26volume%3D8%26spage%3D2204%26epage%3D2211%26doi%3D10.1002%2Fcssc.201500343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youn, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Pd(II)/Ag(I)-Promoted one-pot synthesis of cyclic ureas from (hetero)aromatic amines and isocyanates</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6140</span>– <span class="NLM_lpage">6143</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b03151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b03151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWgtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=6140-6143&author=S.+W.+Younauthor=Y.+H.+Kim&title=Pd%28II%29%2FAg%28I%29-Promoted+one-pot+synthesis+of+cyclic+ureas+from+%28hetero%29aromatic+amines+and+isocyanates&doi=10.1021%2Facs.orglett.6b03151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Pd(II)/Ag(I)-Promoted One-Pot Synthesis of Cyclic Ureas from (Hetero)Aromatic Amines and Isocyanates</span></div><div class="casAuthors">Youn, So Won; Kim, Yi Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6140-6143</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple and facile one-pot reaction has been developed to afford a diverse range of N,N'-disubstituted benzimidazolones and imidazopyridinones contg. two differently substituted N atoms.  A cooperative Pd(II)/Ag(I) system promotes the sequential addn./intramol. C-H amidation reaction of (hetero)arom. amines and isocyanates, leading to the formation of two C-N bonds.  A mechanism involving radical intermediates generated by single-electron transfer (SET) in the presence of a Ag2CO3 oxidant and Pd(OAc)2 Lewis acid is proposed.  This protocol offers an operationally easy, simple, and robust approach with the use of readily available starting materials, good functional group tolerance, and high efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu42FGYH-bXbVg90H21EOLACvtfcHk0lhlxpp4Nbxr4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWgtb7J&md5=39bd7a40d5cb59111aa8d14c60a6cee0</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b03151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b03151%26sid%3Dliteratum%253Aachs%26aulast%3DYoun%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DPd%2528II%2529%252FAg%2528I%2529-Promoted%2520one-pot%2520synthesis%2520of%2520cyclic%2520ureas%2520from%2520%2528hetero%2529aromatic%2520amines%2520and%2520isocyanates%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D6140%26epage%3D6143%26doi%3D10.1021%2Facs.orglett.6b03151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient palladium-catalyzed reductive carbonylation of aryl iodides with dual role of formic acid</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5835</span>– <span class="NLM_lpage">5838</span>, <span class="refDoi"> DOI: 10.1002/chem.201600387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.201600387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26934464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlOgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=5835-5838&author=X.+Qiauthor=C.+L.+Liauthor=X.+F.+Wu&title=A+convenient+palladium-catalyzed+reductive+carbonylation+of+aryl+iodides+with+dual+role+of+formic+acid&doi=10.1002%2Fchem.201600387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Palladium-Catalyzed Reductive Carbonylation of Aryl Iodides with Dual Role of Formic Acid</span></div><div class="casAuthors">Qi, Xinxin; Li, Chong-Liang; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5835-5838</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In this communication, palladium catalyzed reductive carbonylation of aryl iodides with formic acid as the formyl source is developed.  As a convenient, practical, and environmental friendly methodol., no addnl. silane or H2 was required.  A variety of arom. aldehydes were isolated in moderate to excellent yields under mild reaction conditions.  Notably, this is the first procedure on using formic acid as the formyl source.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOo36sZw1oubVg90H21EOLACvtfcHk0lhlxpp4Nbxr4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlOgtbc%253D&md5=42de399fa2fff7d54424c0e99a63c729</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1002%2Fchem.201600387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201600387%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520palladium-catalyzed%2520reductive%2520carbonylation%2520of%2520aryl%2520iodides%2520with%2520dual%2520role%2520of%2520formic%2520acid%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2016%26volume%3D22%26spage%3D5835%26epage%3D5838%26doi%3D10.1002%2Fchem.201600387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed one-pot carbonylative Sonogashira reaction employing formic acid as the CO source</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1870</span>– <span class="NLM_lpage">1873</span>, <span class="refDoi"> DOI: 10.1002/asia.201500518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fasia.201500518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26097102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWjtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1870-1873&author=X.+Qiauthor=L.+B.+Jiangauthor=C.+L.+Liauthor=R.+Liauthor=X.+F.+Wu&title=Palladium-catalyzed+one-pot+carbonylative+Sonogashira+reaction+employing+formic+acid+as+the+CO+source&doi=10.1002%2Fasia.201500518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed One-Pot Carbonylative Sonogashira Reaction Employing Formic acid as the CO Source</span></div><div class="casAuthors">Qi, Xinxin; Jiang, Li-Bing; Li, Chong-Liang; Li, Rui; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1870-1873</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A convenient palladium-catalyzed carbonylative coupling of aryl iodides and terminal alkynes with formic acid as the CO precursor was developed.  A variety of alkynones were obtained in good yields in a one-pot manner for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA_5VEFJ4bNbVg90H21EOLACvtfcHk0lgo_-d5BWE9-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWjtr7F&md5=b9569b429aaa9f69505516d67c9f45ac</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1002%2Fasia.201500518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201500518%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%2BB.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPalladium-catalyzed%2520one-pot%2520carbonylative%2520Sonogashira%2520reaction%2520employing%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2015%26volume%3D10%26spage%3D1870%26epage%3D1873%26doi%3D10.1002%2Fasia.201500518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient palladium-catalyzed carbonylative Suzuki coupling of aryl halides with formic acid as the carbon monoxide source</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">17650</span>– <span class="NLM_lpage">17656</span>, <span class="refDoi"> DOI: 10.1002/chem.201502943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.201502943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26486227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSmsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=17650-17656&author=X.+Qiauthor=L.+B.+Jiangauthor=H.+P.+Liauthor=X.+F.+Wu&title=A+convenient+palladium-catalyzed+carbonylative+Suzuki+coupling+of+aryl+halides+with+formic+acid+as+the+carbon+monoxide+source&doi=10.1002%2Fchem.201502943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Palladium-Catalyzed Carbonylative Suzuki Coupling of Aryl Halides with Formic Acid as the Carbon Monoxide Source</span></div><div class="casAuthors">Qi, Xinxin; Jiang, Li-Bing; Li, Hao-Peng; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17650-17656</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A practical palladium-catalyzed carbonylative Suzuki coupling of aryl halides under carbon monoxide gas-free conditions has been developed.  Here, formic acid was utilized as the carbon monoxide source for the first time with acetic anhydride as the additive.  A variety of diarylketones were produced in moderate to excellent yields from the corresponding aryl halides and arylboronic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGCBXUzGuLULVg90H21EOLACvtfcHk0lgo_-d5BWE9-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSmsLvM&md5=e9253458ed142451fe242c5392ae9a0c</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502943%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%2BB.%26aulast%3DLi%26aufirst%3DH.%2BP.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520palladium-catalyzed%2520carbonylative%2520Suzuki%2520coupling%2520of%2520aryl%2520halides%2520with%2520formic%2520acid%2520as%2520the%2520carbon%2520monoxide%2520source%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D17650%26epage%3D17656%26doi%3D10.1002%2Fchem.201502943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed alkoxycarbonylation of aryl halides with phenols employing formic acid as the CO source</span>. <i>Catal. Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3107</span>, <span class="refDoi"> DOI: 10.1039/C5CY01957E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC5CY01957E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKitLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=3099-3107&author=X.+X.+Qiauthor=C.+L.+Liauthor=L.+B.+Jiangauthor=W.+Q.+Zhangauthor=X.+F.+Wu&title=Palladium-catalyzed+alkoxycarbonylation+of+aryl+halides+with+phenols+employing+formic+acid+as+the+CO+source&doi=10.1039%2FC5CY01957E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed alkoxycarbonylation of aryl halides with phenols employing formic acid as the CO source</span></div><div class="casAuthors">Qi, Xinxin; Li, Chong-Liang; Jiang, Li-Bing; Zhang, Wan-Quan; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Catalysis Science & Technology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3099-3107</span>CODEN:
                <span class="NLM_cas:coden">CSTAGD</span>;
        ISSN:<span class="NLM_cas:issn">2044-4753</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">An efficient palladium-catalyzed alkoxycarbonylation of aryl halides with phenols was developed.  Various aryl benzoates were isolated in good to excellent yields with formic acid as the CO source.  The reaction proceeds smoothly under mild conditions and good functional group tolerance was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wOnejx8nFbVg90H21EOLACvtfcHk0lgo_-d5BWE9-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKitLjP&md5=0b1c852351fae1f1e192483cd5c371b7</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1039%2FC5CY01957E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CY01957E%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%2BX.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DJiang%26aufirst%3DL.%2BB.%26aulast%3DZhang%26aufirst%3DW.%2BQ.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPalladium-catalyzed%2520alkoxycarbonylation%2520of%2520aryl%2520halides%2520with%2520phenols%2520employing%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DCatal.%2520Sci.%2520Technol.%26date%3D2016%26volume%3D6%26spage%3D3099%26epage%3D3107%26doi%3D10.1039%2FC5CY01957E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient and efficient palladium-catalyzed carbonylative Sonogashira transformation with formic acid as the CO source</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1434</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201700076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201700076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVWgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1434-1437&author=J.+B.+Pengauthor=F.+P.+Wuauthor=C.+L.+Liauthor=X.+Qiauthor=X.+F.+Wu&title=A+convenient+and+efficient+palladium-catalyzed+carbonylative+Sonogashira+transformation+with+formic+acid+as+the+CO+source&doi=10.1002%2Fejoc.201700076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient and Efficient Palladium-Catalyzed Carbonylative Sonogashira Transformation with Formic Acid as the CO Source</span></div><div class="casAuthors">Peng, Jin-Bao; Wu, Fu-Peng; Li, Chong-Liang; Qi, Xinxin; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1434-1437</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A practical, convenient, and efficient palladium-catalyzed carbonylative Sonogashira reaction of aryl iodides was developed.  With formic acid as the CO source and dicyclohexylcarbodiimide as the activator, various alkynones were produced in good to excellent yields.  Thus, e.g., reaction of iodobenzene with phenylacetylene using HCOOH and DCC as CO source in presence of Pd(OAc)2, PPh3 and Et3N in toluene afforded alkynone I (97% isolated).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhNJP9c7bu8rVg90H21EOLACvtfcHk0liIMn8zVEiEzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVWgt7g%253D&md5=61e3beb392e7bd467daa40c6e654d6c8</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201700076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201700076%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%2BB.%26aulast%3DWu%26aufirst%3DF.%2BP.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520and%2520efficient%2520palladium-catalyzed%2520carbonylative%2520Sonogashira%2520transformation%2520with%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1434%26epage%3D1437%26doi%3D10.1002%2Fejoc.201700076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed carbonylative synthesis of alkynones from aryl iodides and phenylpropiolic acid employing formic acid as the CO source</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>838</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2017.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.jorganchem.2017.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=838&publication_year=2017&pages=9-11&author=C.+L.+Liauthor=W.+Q.+Zhangauthor=X.+X.+Qiauthor=J.+B.+Pengauthor=X.+F.+Wu&title=Palladium-catalyzed+carbonylative+synthesis+of+alkynones+from+aryl+iodides+and+phenylpropiolic+acid+employing+formic+acid+as+the+CO+source&doi=10.1016%2Fj.jorganchem.2017.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed carbonylative synthesis of alkynones from aryl iodides and phenylpropiolic acid employing formic acid as the CO source</span></div><div class="casAuthors">Li, Chong-Liang; Zhang, Wan-Quan; Qi, Xinxin; Peng, Jin-Bao; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">838</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-11</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A palladium-catalyzed procedure for the decarboxylative-carbonylation of phenylpropiolic acid with iodobenzenes to the corresponding alkynones with formic acid as carbon monoxide source was developed.  Various alkynones were produced in moderate to good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11V2fDeC1QbVg90H21EOLACvtfcHk0liIMn8zVEiEzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKqtbY%253D&md5=3db5de2f57bf6fa9ad424ce9c75e1531</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2017.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2017.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DZhang%26aufirst%3DW.%2BQ.%26aulast%3DQi%26aufirst%3DX.%2BX.%26aulast%3DPeng%26aufirst%3DJ.%2BB.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPalladium-catalyzed%2520carbonylative%2520synthesis%2520of%2520alkynones%2520from%2520aryl%2520iodides%2520and%2520phenylpropiolic%2520acid%2520employing%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2017%26volume%3D838%26spage%3D9%26epage%3D11%26doi%3D10.1016%2Fj.jorganchem.2017.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Pd/C-Catalyzed aminocarbonylation of aryl iodides with anthranils in water using Mo(CO)<sub>6</sub> as the CO source</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">15026</span>– <span class="NLM_lpage">15029</span>, <span class="refDoi"> DOI: 10.1002/chem.201703994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.201703994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=28929551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CitLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=15026-15029&author=Z.+Wangauthor=Z.+Yinauthor=X.+F.+Wu&title=Pd%2FC-Catalyzed+aminocarbonylation+of+aryl+iodides+with+anthranils+in+water+using+Mo%28CO%296+as+the+CO+source&doi=10.1002%2Fchem.201703994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Pd/C-Catalyzed Aminocarbonylation of Aryl Iodides with Anthranils in Water Using Mo(CO)6 as the CO Source</span></div><div class="casAuthors">Wang, Zechao; Yin, Zhiping; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">15026-15029</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A convenient procedure for the synthesis of N-(2-carbonylaryl)benzamides was developed.  Through Pd/C-catalyzed aminocarbonylation of anthranils with various hindered and functionalized aryl iodides, the desired amides were afforded in moderate to good yields.  The protocol was advantageous due to the recyclable Pd/C catalyst, safe Mo(CO)6 as the solid CO source, and environmentally benign water as solvent.  No inert atm. protection was needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq474ofE9Dy1rVg90H21EOLACvtfcHk0lgVHphhlOJXdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CitLvO&md5=d1564352314895f44fce99a08c04fa71</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703994%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPd%252FC-Catalyzed%2520aminocarbonylation%2520of%2520aryl%2520iodides%2520with%2520anthranils%2520in%2520water%2520using%2520Mo%2528CO%25296%2520as%2520the%2520CO%2520source%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D15026%26epage%3D15029%26doi%3D10.1002%2Fchem.201703994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient palladium-catalyzed carbonylative synthesis of 4(3H)-quinazolinones from 2-bromoformanilides and organo nitros with Mo(CO)<sub>6</sub> as a multiple promoter</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3763</span>– <span class="NLM_lpage">3767</span>, <span class="refDoi"> DOI: 10.1039/C4GC00801D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC4GC00801D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3763-3767&author=L.+Heauthor=M.+Sharifauthor=H.+Neumannauthor=M.+Bellerauthor=X.+F.+Wu&title=A+convenient+palladium-catalyzed+carbonylative+synthesis+of+4%283H%29-quinazolinones+from+2-bromoformanilides+and+organo+nitros+with+Mo%28CO%296+as+a+multiple+promoter&doi=10.1039%2FC4GC00801D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient palladium-catalyzed carbonylative synthesis of 4(3H)-quinazolinones from 2-bromoformanilides and organo nitros with Mo(CO)6 as a multiple promoter</span></div><div class="casAuthors">He, Lin; Sharif, Muhammad; Neumann, Helfried; Beller, Matthias; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3763-3767</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel and convenient procedure for the synthesis of quinazolinones has been developed.  Using 2-bromoformanilides and organo nitros as substrates and Mo(CO)6 as a multiple promoter, the desired products were isolated in moderate to excellent yields in the presence of a palladium catalyst.  Here, Mo(CO)6 was not only a CO source, but also a nitro compd. reducing reagent and a cyclization promoter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGZFYMBW7M7Vg90H21EOLACvtfcHk0lgVHphhlOJXdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsrvO&md5=0c0fe12a9053fd4ffc3b9a47b0fa37bf</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1039%2FC4GC00801D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4GC00801D%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DSharif%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DH.%26aulast%3DBeller%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520palladium-catalyzed%2520carbonylative%2520synthesis%2520of%25204%25283H%2529-quinazolinones%2520from%25202-bromoformanilides%2520and%2520organo%2520nitros%2520with%2520Mo%2528CO%25296%2520as%2520a%2520multiple%2520promoter%26jtitle%3DGreen%2520Chem.%26date%3D2014%26volume%3D16%26spage%3D3763%26epage%3D3767%26doi%3D10.1039%2FC4GC00801D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oschatz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, P.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed carbonylative synthesis of <i>N</i>-benzoylindoles with Mo(CO)<sub>6</sub> as the carbon monoxide source</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2641</span>– <span class="NLM_lpage">2646</span>, <span class="refDoi"> DOI: 10.1055/s-0034-1380752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0034-1380752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Srsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=2641-2646&author=X.+F.+Wuauthor=S.+Oschatzauthor=M.+Sharifauthor=P.+Langer&title=Palladium-catalyzed+carbonylative+synthesis+of+N-benzoylindoles+with+Mo%28CO%296+as+the+carbon+monoxide+source&doi=10.1055%2Fs-0034-1380752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Carbonylative Synthesis of N-Benzoylindoles with Mo(CO)6 as the Carbon Monoxide Source</span></div><div class="casAuthors">Wu, Xiao-Feng; Oschatz, Stefan; Sharif, Muhammad; Langer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2641-2646</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A mild and carbon monoxide gas-free palladium-catalyzed aminocarbonylation of indole has been developed for the synthesis of N-benzoylindoles.  This method uses Mo(CO)6 as a convenient CO-precursor and BuPAd2 as the ligand.  A no. of substituents on the aryl bromide species is tolerated under the presented conditions and gave the desired products in up to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvDXKuAK-UCbVg90H21EOLACvtfcHk0lgVHphhlOJXdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Srsb8%253D&md5=7674363cbb43cdd633770b94aaba8b6f</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1055%2Fs-0034-1380752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0034-1380752%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%2BF.%26aulast%3DOschatz%26aufirst%3DS.%26aulast%3DSharif%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DP.%26atitle%3DPalladium-catalyzed%2520carbonylative%2520synthesis%2520of%2520N-benzoylindoles%2520with%2520Mo%2528CO%25296%2520as%2520the%2520carbon%2520monoxide%2520source%26jtitle%3DSynthesis%26date%3D2015%26volume%3D47%26spage%3D2641%26epage%3D2646%26doi%3D10.1055%2Fs-0034-1380752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. H.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed urea synthesis using methanol as the C1 source</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.5b03328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b03328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks12jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=212-215&author=S.+H.+Kimauthor=S.+H.+Hong&title=Ruthenium-catalyzed+urea+synthesis+using+methanol+as+the+C1+source&doi=10.1021%2Facs.orglett.5b03328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Urea Synthesis Using Methanol as the C1 Source</span></div><div class="casAuthors">Kim, Seung Hyo; Hong, Soon Hyeok</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-215</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An unprecedented protocol for urea synthesis directly from methanol and amine was accomplished.  The reaction is highly atom-economical, producing hydrogen as the sole byproduct.  Com. available ruthenium pincer complexes were used as catalysts.  In addn., no additive, such as a base, oxidant, or hydrogen acceptor, was required.  Furthermore, unsym. urea derivs. were successfully obtained via a one-pot, two-step reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoYQHFGzkhSLVg90H21EOLACvtfcHk0liLrEXudgRbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks12jsQ%253D%253D&md5=1ee491be22642c34f7b83c955ad035ea</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b03328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b03328%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BH.%26atitle%3DRuthenium-catalyzed%2520urea%2520synthesis%2520using%2520methanol%2520as%2520the%2520C1%2520source%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D212%26epage%3D215%26doi%3D10.1021%2Facs.orglett.5b03328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnakumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunanathan, C.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed urea synthesis by N-H activation of amines</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7278</span>– <span class="NLM_lpage">7284</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b00962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b00962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFWrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=7278-7284&author=V.+Krishnakumarauthor=B.+Chatterjeeauthor=C.+Gunanathan&title=Ruthenium-catalyzed+urea+synthesis+by+N-H+activation+of+amines&doi=10.1021%2Facs.inorgchem.7b00962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Urea Synthesis by N-H Activation of Amines</span></div><div class="casAuthors">Krishnakumar, Varadhan; Chatterjee, Basujit; Gunanathan, Chidambaram</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7278-7284</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the presence of a bis(diphenylphosphinoethyl)amine ruthenium pincer complex and KOt-Bu, primary benzyl- and alkylamines underwent condensation reactions with N,N-dimethylformamide at 130-150° to yield sym. and unsym. N,N'-disubstituted ureas; the method avoids the use of carbon monoxide and stoichiometric activating agents.  Three bis(diphenylphosphinoethyl)amine ruthenium benzylamine complexes were prepd.; the structure of a bis(diphenylphosphinoethyl)amine ruthenium fluorobenzylamine complex was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVnLS9EoKe9rVg90H21EOLACvtfcHk0liLrEXudgRbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFWrs78%253D&md5=3308b761089e529f2ab84ec2797ed2cf</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b00962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b00962%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnakumar%26aufirst%3DV.%26aulast%3DChatterjee%26aufirst%3DB.%26aulast%3DGunanathan%26aufirst%3DC.%26atitle%3DRuthenium-catalyzed%2520urea%2520synthesis%2520by%2520N-H%2520activation%2520of%2520amines%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D7278%26epage%3D7284%26doi%3D10.1021%2Facs.inorgchem.7b00962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darko, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElwee-White, L.</span></span> <span> </span><span class="NLM_article-title">Catalytic oxidative carbonylation of arylamines to ureas with W(CO)(6)/I-2 as catalyst</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">6261</span>– <span class="NLM_lpage">6268</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201100657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201100657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=6261-6268&author=L.+Zhangauthor=A.+K.+Darkoauthor=J.+I.+Johnsauthor=L.+McElwee-White&title=Catalytic+oxidative+carbonylation+of+arylamines+to+ureas+with+W%28CO%29%286%29%2FI-2+as+catalyst&doi=10.1002%2Fejoc.201100657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Oxidative Carbonylation of Arylamines to Ureas with W(CO)6/I2 as Catalyst</span></div><div class="casAuthors">Zhang, Li; Darko, Ampofo K.; Johns, Jennifer I.; McElwee-White, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6261-6268</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The oxidative carbonylation of aniline to N,N'-diphenylurea was carried out by using W(CO)6 as the catalyst, I2 as the oxidant, CO as the carbonyl source and 4-(dimethylamino)pyridine (DMAP) as the base.  The reaction conditions were optimized with respect to different bases, molar ratio of DMAP/iodine, temp., time, and CO pressure.  Various p-substituted arylamines can be converted into the resp. sym. and unsym. N,N'-disubstituted ureas in moderate to good yields.  The reaction demonstrated broad tolerance of functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFZ4XitaupLVg90H21EOLACvtfcHk0liLrEXudgRbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers7rO&md5=374afeee80d837d3d2aaa4e296aeb322</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201100657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201100657%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDarko%26aufirst%3DA.%2BK.%26aulast%3DJohns%26aufirst%3DJ.%2BI.%26aulast%3DMcElwee-White%26aufirst%3DL.%26atitle%3DCatalytic%2520oxidative%2520carbonylation%2520of%2520arylamines%2520to%2520ureas%2520with%2520W%2528CO%2529%25286%2529%252FI-2%2520as%2520catalyst%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2011%26volume%3D2011%26spage%3D6261%26epage%3D6268%26doi%3D10.1002%2Fejoc.201100657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-oxazolidinones by salen-Co-complexes catalyzed oxidative carbonylation of beta-amino alcohols</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tetlet.2006.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=929-932&author=J.+M.+Liuauthor=X.+G.+Pengauthor=J.+H.+Liuauthor=S.+Z.+Zhengauthor=W.+Sunauthor=C.+G.+Xia&title=Synthesis+of+2-oxazolidinones+by+salen-Co-complexes+catalyzed+oxidative+carbonylation+of+beta-amino+alcohols&doi=10.1016%2Fj.tetlet.2006.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-oxazolidinones by salen-Co-complexes catalyzed oxidative carbonylation of β-amino alcohols</span></div><div class="casAuthors">Liu, Jian-Ming; Peng, Xin-Gao; Liu, Jian-Hua; Zheng, Shu-Zhan; Sun, Wei; Xia, Chun-Gu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">2-Oxazolidinones are synthesized in high yield by oxidative carbonylation of β-amino alcs. using salen-Co(II)/NaI or salen-Co(III)-I as a catalyst and using CO as the carbonyl source.  Studies of functional group compatibility using a series of substituted salen-Co(II) or salen-Co(III)-I complexes demonstrate a broad tolerance of functionality during the carbonylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrapiWIquu9DLVg90H21EOLACvtfcHk0ljXsiQUPrivWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFGgsQ%253D%253D&md5=76baffdfa56ef391ddc8f98db86a427c</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26aulast%3DPeng%26aufirst%3DX.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DZheng%26aufirst%3DS.%2BZ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DXia%26aufirst%3DC.%2BG.%26atitle%3DSynthesis%2520of%25202-oxazolidinones%2520by%2520salen-Co-complexes%2520catalyzed%2520oxidative%2520carbonylation%2520of%2520beta-amino%2520alcohols%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D929%26epage%3D932%26doi%3D10.1016%2Fj.tetlet.2006.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C. G.</span></span> <span> </span><span class="NLM_article-title">A novel and efficient (NHC)Cu-I (NHC = N-heterocyclic carbene) catalyst for the oxidative carbonylation of amino compounds</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5883</span>– <span class="NLM_lpage">5886</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tetlet.2007.06.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotV2rt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=5883-5886&author=S.+Z.+Zhengauthor=F.+W.+Liauthor=J.+M.+Liuauthor=C.+G.+Xia&title=A+novel+and+efficient+%28NHC%29Cu-I+%28NHC+%3D+N-heterocyclic+carbene%29+catalyst+for+the+oxidative+carbonylation+of+amino+compounds&doi=10.1016%2Fj.tetlet.2007.06.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and efficient (NHC)CuI (NHC = N-heterocyclic carbene) catalyst for the oxidative carbonylation of amino compounds</span></div><div class="casAuthors">Zheng, Shuzhan; Li, Fuwei; Liu, Jianming; Xia, Chungu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5883-5886</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Oxidative carbonylation of β-amino alcs. and primary amines to prep. corresponding 2-oxazolidinones, ureas, and carbamates selectively in the presence of (NHC)CuI without any additives was achieved for the first time in good yields and selectivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcRcpI0oIs4bVg90H21EOLACvtfcHk0ljXsiQUPrivWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotV2rt7o%253D&md5=1c5810fa152bbaf5df552574768508e9</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%2BZ.%26aulast%3DLi%26aufirst%3DF.%2BW.%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26aulast%3DXia%26aufirst%3DC.%2BG.%26atitle%3DA%2520novel%2520and%2520efficient%2520%2528NHC%2529Cu-I%2520%2528NHC%2520%253D%2520N-heterocyclic%2520carbene%2529%2520catalyst%2520for%2520the%2520oxidative%2520carbonylation%2520of%2520amino%2520compounds%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D5883%26epage%3D5886%26doi%3D10.1016%2Fj.tetlet.2007.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casiello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iannone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotugno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monopoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cioffi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciminale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzeciak, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacci, A.</span></span> <span> </span><span class="NLM_article-title">Copper(II)-catalysed oxidative carbonylation of aminols and amines in water: A direct access to oxazolidinones, ureas and carbamates</span>. <i>J. Mol. Catal. A: Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.molcata.2015.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.molcata.2015.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2015&pages=8-14&author=M.+Casielloauthor=F.+Iannoneauthor=P.+Cotugnoauthor=A.+Monopoliauthor=N.+Cioffiauthor=F.+Ciminaleauthor=A.+M.+Trzeciakauthor=A.+Nacci&title=Copper%28II%29-catalysed+oxidative+carbonylation+of+aminols+and+amines+in+water%3A+A+direct+access+to+oxazolidinones%2C+ureas+and+carbamates&doi=10.1016%2Fj.molcata.2015.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(II)-catalysed oxidative carbonylation of aminols and amines in water: A direct access to oxazolidinones, ureas and carbamates</span></div><div class="casAuthors">Casiello, Michele; Iannone, Francesco; Cotugno, Pietro; Monopoli, Antonio; Cioffi, Nicola; Ciminale, Francesco; Trzeciak, Anna M.; Nacci, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Catalysis A: Chemical</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-14</span>CODEN:
                <span class="NLM_cas:coden">JMCCF2</span>;
        ISSN:<span class="NLM_cas:issn">1381-1169</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Copper(II) chloride catalyzes the oxidative carbonylation of aminols, amine and alcs. to give 2-oxazolidinones, ureas and carbamates.  Reaction proceeds smoothly in water under homogeneous conditions (Ptot = 4 MPa; PO2 = 0.6 MPa, PCO), at 100 °C in relatively short reaction times (4 h) and without using bases or any other additives.  This methodol. represents an economic and environmentally benign non-phosgene alternative for the prepn. of these three important N-contg. carbonyl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukwxc7Mm38bVg90H21EOLACvtfcHk0ljXsiQUPrivWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtrrF&md5=8ee0dcd89ce98eb2ef864e9ca4566b8f</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.molcata.2015.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcata.2015.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DCasiello%26aufirst%3DM.%26aulast%3DIannone%26aufirst%3DF.%26aulast%3DCotugno%26aufirst%3DP.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DCioffi%26aufirst%3DN.%26aulast%3DCiminale%26aufirst%3DF.%26aulast%3DTrzeciak%26aufirst%3DA.%2BM.%26aulast%3DNacci%26aufirst%3DA.%26atitle%3DCopper%2528II%2529-catalysed%2520oxidative%2520carbonylation%2520of%2520aminols%2520and%2520amines%2520in%2520water%253A%2520A%2520direct%2520access%2520to%2520oxazolidinones%252C%2520ureas%2520and%2520carbamates%26jtitle%3DJ.%2520Mol.%2520Catal.%2520A%253A%2520Chem.%26date%3D2015%26volume%3D407%26spage%3D8%26epage%3D14%26doi%3D10.1016%2Fj.molcata.2015.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spyropoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokotos, C. G.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of ureas from Boc-protected amines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">4477</span>– <span class="NLM_lpage">4483</span>, <span class="refDoi"> DOI: 10.1021/jo500492x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo500492x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=4477-4483&author=C.+Spyropoulosauthor=C.+G.+Kokotos&title=One-pot+synthesis+of+ureas+from+Boc-protected+amines&doi=10.1021%2Fjo500492x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Synthesis of Ureas from Boc-Protected Amines</span></div><div class="casAuthors">Spyropoulos, Constantinos; Kokotos, Christoforos G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4477-4483</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical one-pot synthesis of ureas is described.  Boc-protected amines can be transformed into nonsym. and sym. disubstituted and trisubstituted ureas utilizing 2-chloropyridine and trifluoromethanesulfonyl anhydride for the in situ generation of an isocyanate, which reacts with an amine.  A variety of amines can be employed successfully, leading to high yields of isolated ureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZxf9z4HcUZ7Vg90H21EOLACvtfcHk0lg1aAfp8Sts_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtbY%253D&md5=b3528b1ce3b9873117bae9e3bbac0792</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fjo500492x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo500492x%26sid%3Dliteratum%253Aachs%26aulast%3DSpyropoulos%26aufirst%3DC.%26aulast%3DKokotos%26aufirst%3DC.%2BG.%26atitle%3DOne-pot%2520synthesis%2520of%2520ureas%2520from%2520Boc-protected%2520amines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D4477%26epage%3D4483%26doi%3D10.1021%2Fjo500492x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span> <span> </span><span class="NLM_article-title">Facile one-pot synthesis of unsymmetrical ureas, carbamates, and thiocarbamates from Cbz-protected amines</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7345</span>– <span class="NLM_lpage">7353</span>, <span class="refDoi"> DOI: 10.1039/C6OB01290F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC6OB01290F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27406041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaiu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=7345-7353&author=H.+K.+Kimauthor=A.+Lee&title=Facile+one-pot+synthesis+of+unsymmetrical+ureas%2C+carbamates%2C+and+thiocarbamates+from+Cbz-protected+amines&doi=10.1039%2FC6OB01290F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Facile one-pot synthesis of unsymmetrical ureas, carbamates, and thiocarbamates from Cbz-protected amines</span></div><div class="casAuthors">Kim, Hee-Kwon; Lee, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7345-7353</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel one-pot synthesis of unsym. ureas, carbamates and thiocarbamates from Cbz-protected amines has been developed.  In the presence of 2-chloropyridine and trifluoromethanesulfonyl anhydride, isocyanates are generated in situ, which facilitate rapid reaction with amines, alcs., and thiols to afford the corresponding ureas, carbamates and thiocarbamates in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob7iU0BTSo1LVg90H21EOLACvtfcHk0lg1aAfp8Sts_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaiu7nJ&md5=dc0a56279a51cfb486504c70e4bb846b</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1039%2FC6OB01290F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB01290F%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DA.%26atitle%3DFacile%2520one-pot%2520synthesis%2520of%2520unsymmetrical%2520ureas%252C%2520carbamates%252C%2520and%2520thiocarbamates%2520from%2520Cbz-protected%2520amines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D7345%26epage%3D7353%26doi%3D10.1039%2FC6OB01290F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lako, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, N. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szigetvari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis of urea derivatives in two sequential continuous-flow reactors</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.7b00019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.7b00019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=611-622&author=P.+Banaauthor=A.+Lakoauthor=N.+Z.+Kissauthor=Z.+Beniauthor=A.+Szigetvariauthor=J.+Kotiauthor=G.+I.+Turosauthor=J.+Elesauthor=I.+Greiner&title=Synthesis+of+urea+derivatives+in+two+sequential+continuous-flow+reactors&doi=10.1021%2Facs.oprd.7b00019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Urea Derivatives in Two Sequential Continuous-Flow Reactors</span></div><div class="casAuthors">Bana, Peter; Lako, Agnes; Kiss, Nora Zsuzsa; Beni, Zoltan; Szigetvari, Aron; Koti, Janos; Turos, Gyorgy Istvan; Eles, Janos; Greiner, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">611-622</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A continuous-flow system consisting of two sequential microreactors was developed for the synthesis of non-sym. substituted ureas starting from tert-butoxycarbonyl protected amines.  Short reaction times could be achieved under mild conditions.  In-line FT-IR anal. technique was used to monitor the reaction, including the formation of the isocyanate intermediate, thus allowing optimization of the reagent ratios.  The mechanistic role of the applied base was also clarified.  The set-up was successfully utilized for the synthesis of several urea derivs. including the active pharmaceutical ingredient cariprazine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCjBLF8PCb7Vg90H21EOLACvtfcHk0lg1aAfp8Sts_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVagtbk%253D&md5=b6e1ffb930915b7df9ea51e444df4336</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.7b00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.7b00019%26sid%3Dliteratum%253Aachs%26aulast%3DBana%26aufirst%3DP.%26aulast%3DLako%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DN.%2BZ.%26aulast%3DBeni%26aufirst%3DZ.%26aulast%3DSzigetvari%26aufirst%3DA.%26aulast%3DKoti%26aufirst%3DJ.%26aulast%3DTuros%26aufirst%3DG.%2BI.%26aulast%3DEles%26aufirst%3DJ.%26aulast%3DGreiner%26aufirst%3DI.%26atitle%3DSynthesis%2520of%2520urea%2520derivatives%2520in%2520two%2520sequential%2520continuous-flow%2520reactors%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2017%26volume%3D21%26spage%3D611%26epage%3D622%26doi%3D10.1021%2Facs.oprd.7b00019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riesco-Dominguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Ania, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutjes, F. P. J. T.</span></span> <span> </span><span class="NLM_article-title">Continuous flow synthesis of urea-containing compound libraries based on the piperidin-4-one scaffold</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">1312</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201701539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201701539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=1312-1320&author=A.+Riesco-Dominguezauthor=D.+Blanco-Aniaauthor=F.+P.+J.+T.+Rutjes&title=Continuous+flow+synthesis+of+urea-containing+compound+libraries+based+on+the+piperidin-4-one+scaffold&doi=10.1002%2Fejoc.201701539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Flow Synthesis of Urea-Containing Compound Libraries Based on the Piperidin-4-one Scaffold</span></div><div class="casAuthors">Riesco-Dominguez, Alejandra; Blanco-Ania, Daniel; Rutjes, Floris P. J. T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1312-1320</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The advantages of performing reactions in continuous flow vs. the classic batch processes render flow chem. a suitable technique for library synthesis.  Inspired by the authors' recent work to create fluorine-contg. nitrogen heterocycles and by the potential of the urea group in drug design, the authors herewith describe the combination of both aspects in the continuous flow synthesis of two libraries of urea derivs. based on the piperidin-4-one scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI-sR426easLVg90H21EOLACvtfcHk0lgfoVZShP-Agg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOmurw%253D&md5=9dfb037331a94c43df5bdb66e2ba637f</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201701539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201701539%26sid%3Dliteratum%253Aachs%26aulast%3DRiesco-Dominguez%26aufirst%3DA.%26aulast%3DBlanco-Ania%26aufirst%3DD.%26aulast%3DRutjes%26aufirst%3DF.%2BP.%2BJ.%2BT.%26atitle%3DContinuous%2520flow%2520synthesis%2520of%2520urea-containing%2520compound%2520libraries%2520based%2520on%2520the%2520piperidin-4-one%2520scaffold%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D2018%26spage%3D1312%26epage%3D1320%26doi%3D10.1002%2Fejoc.201701539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganem, B.</span></span> <span> </span><span class="NLM_article-title">Trifluoroacetic anhydride-catalyzed oxidation of isonitriles by DMSO: a rapid, convenient synthesis of isocyanates</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2585</span>, <span class="refDoi"> DOI: 10.1021/ol200695y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol200695y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslemtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=2584-2585&author=H.+V.+Leauthor=B.+Ganem&title=Trifluoroacetic+anhydride-catalyzed+oxidation+of+isonitriles+by+DMSO%3A+a+rapid%2C+convenient+synthesis+of+isocyanates&doi=10.1021%2Fol200695y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroacetic Anhydride-Catalyzed Oxidation of Isonitriles by DMSO: A Rapid, Convenient Synthesis of Isocyanates</span></div><div class="casAuthors">Le, Hoang V.; Ganem, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2584-2585</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A smooth and efficient oxidn. of isonitriles to isocyanates by sulfoxides is catalyzed by trifluoroacetic anhydride.  With use of DMSO as the oxidant and 5 mol % TFAA (dichloromethane, -60 to 0 °C), the process is complete in a few minutes, forming di-Me sulfide as the only byproduct.  The newly formed isocyanates may be used directly or isolated in high purity by solvent evapn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOFugvTQiSpbVg90H21EOLACvtfcHk0lgfoVZShP-Agg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslemtLk%253D&md5=6a50018388a2c936d7f675ebe56937ad</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1021%2Fol200695y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol200695y%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DGanem%26aufirst%3DB.%26atitle%3DTrifluoroacetic%2520anhydride-catalyzed%2520oxidation%2520of%2520isonitriles%2520by%2520DMSO%253A%2520a%2520rapid%252C%2520convenient%2520synthesis%2520of%2520isocyanates%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D2584%26epage%3D2585%26doi%3D10.1021%2Fol200695y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senadi, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutra, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. J.</span></span> <span> </span><span class="NLM_article-title">Oximes as reusable templates for the synthesis of ureas and carbamates by an in situ generation of carbamoyl oximes</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4272</span>– <span class="NLM_lpage">4277</span>, <span class="refDoi"> DOI: 10.1039/C7GC01449J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC7GC01449J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OjsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=4272-4277&author=G.+C.+Senadiauthor=M.+R.+Mutraauthor=T.+Y.+Luauthor=J.+J.+Wang&title=Oximes+as+reusable+templates+for+the+synthesis+of+ureas+and+carbamates+by+an+in+situ+generation+of+carbamoyl+oximes&doi=10.1039%2FC7GC01449J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Oximes as reusable templates for the synthesis of ureas and carbamates by an in situ generation of carbamoyl oximes</span></div><div class="casAuthors">Senadi, Gopal Chandru; Mutra, Mohana Reddy; Lu, Ting-Yi; Wang, Jeh-Jeng</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4272-4277</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Oximes have been identified as reusable templates for the synthesis of ureas and carbamates by an in situ generation of carbamoyl oximes under metal-free conditions.  The recovered oxime has been utilized for three trials in the synthesis of urea derivs. without any loss in the yield and efficiency.  In addn., this template approach could override the usage of hazardous and less stable isocyanates as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLWKuHi_Io1LVg90H21EOLACvtfcHk0lgfoVZShP-Agg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OjsLjK&md5=72965362050b03fddc2a2557501bcad0</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1039%2FC7GC01449J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7GC01449J%26sid%3Dliteratum%253Aachs%26aulast%3DSenadi%26aufirst%3DG.%2BC.%26aulast%3DMutra%26aufirst%3DM.%2BR.%26aulast%3DLu%26aufirst%3DT.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26atitle%3DOximes%2520as%2520reusable%2520templates%2520for%2520the%2520synthesis%2520of%2520ureas%2520and%2520carbamates%2520by%2520an%2520in%2520situ%2520generation%2520of%2520carbamoyl%2520oximes%26jtitle%3DGreen%2520Chem.%26date%3D2017%26volume%3D19%26spage%3D4272%26epage%3D4277%26doi%3D10.1039%2FC7GC01449J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stucka, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span> <span> </span><span class="NLM_article-title">Parallel synthesis of ureas and carbamates from amines and CO2 under mild conditions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/ol100259j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100259j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Cltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1340-1343&author=S.+L.+Petersonauthor=S.+M.+Stuckaauthor=C.+J.+Dinsmore&title=Parallel+synthesis+of+ureas+and+carbamates+from+amines+and+CO2+under+mild+conditions&doi=10.1021%2Fol100259j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel Synthesis of Ureas and Carbamates from Amines and CO2 under Mild Conditions</span></div><div class="casAuthors">Peterson, Scott L.; Stucka, Sabrina M.; Dinsmore, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1340-1343</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild and efficient library synthesis technique has been developed for the synthesis of ureas and carbamates from carbamic acids derived from the DBU-catalyzed reaction of amines and gaseous carbon dioxide.  Carbamic acids derived from primary amines reacted with Mitsunobu reagents to generate isocyanates in situ which were condensed with primary and secondary amines to afford the desired ureas.  Similarly, carbamic acids from secondary amines reacted with alcs. activated with Mitsunobu reagents to form carbamates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDbIeFW48qMrVg90H21EOLACvtfcHk0li3aIEspg6RQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Cltb4%253D&md5=8103430c5a397ea2b8efb4286846e0ad</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1021%2Fol100259j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100259j%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DS.%2BL.%26aulast%3DStucka%26aufirst%3DS.%2BM.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26atitle%3DParallel%2520synthesis%2520of%2520ureas%2520and%2520carbamates%2520from%2520amines%2520and%2520CO2%2520under%2520mild%2520conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1340%26epage%3D1343%26doi%3D10.1021%2Fol100259j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aversa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geuna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdembri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montemurro, F.</span></span> <span> </span><span class="NLM_article-title">Linifanib: current status and future potential in cancer therapy</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1586/14737140.2015.1042369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1586%2F14737140.2015.1042369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25936222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=677-687&author=C.+Aversaauthor=F.+Leoneauthor=G.+Zucchiniauthor=G.+Seriniauthor=E.+Geunaauthor=A.+Milaniauthor=D.+Valdembriauthor=R.+Martinelloauthor=F.+Montemurro&title=Linifanib%3A+current+status+and+future+potential+in+cancer+therapy&doi=10.1586%2F14737140.2015.1042369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Linifanib: current status and future potential in cancer therapy</span></div><div class="casAuthors">Aversa, Caterina; Leone, Francesco; Zucchini, Giorgia; Serini, Guido; Geuna, Elena; Milani, Andrea; Valdembri, Donatella; Martinello, Rossella; Montemurro, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">677-687</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is one of the major mechanisms controlling tumor proliferation and metastatic spreading.  Targeting of pro-angiogenic factors and their downstream effectors represents an appealing therapeutic option in the treatment of different cancer types.  Linifanib (ABT-869) is a novel tyrosine-kinase inhibitor (TKI) inhibitor and its anti-angiogenic activity has been explored in numerous clin. trials.  Here, we review preclin. development of linifanib focusing on its pharmacodynamic and pharmacokinetic characteristics and briefly summarize its evaluation in clin. trials.  Linifanib selectively targets VEGFR and PDGFR and has low off-target inhibitory activity.  Preclin. and early-phase trials have been showing promising efficacy results However, although signals of anti-tumor activity have been proven in some malignancies, linifanib late-phase development has been facing some challenges due to limited efficacy and increased toxicities.  New strategies aimed at finding biomarkers of response and minimizing toxicities are needed to allow the further development of a promising compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVwBBHC7UrqLVg90H21EOLACvtfcHk0li3aIEspg6RQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1KktL8%253D&md5=246812e3151d49c64fdbb953c8dc9d99</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1586%2F14737140.2015.1042369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.2015.1042369%26sid%3Dliteratum%253Aachs%26aulast%3DAversa%26aufirst%3DC.%26aulast%3DLeone%26aufirst%3DF.%26aulast%3DZucchini%26aufirst%3DG.%26aulast%3DSerini%26aufirst%3DG.%26aulast%3DGeuna%26aufirst%3DE.%26aulast%3DMilani%26aufirst%3DA.%26aulast%3DValdembri%26aufirst%3DD.%26aulast%3DMartinello%26aufirst%3DR.%26aulast%3DMontemurro%26aufirst%3DF.%26atitle%3DLinifanib%253A%2520current%2520status%2520and%2520future%2520potential%2520in%2520cancer%2520therapy%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2015%26volume%3D15%26spage%3D677%26epage%3D687%26doi%3D10.1586%2F14737140.2015.1042369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratain, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowinsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruzzese, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simantov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dwyer, P. J.</span></span> <span> </span><span class="NLM_article-title">Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2505</span>– <span class="NLM_lpage">2512</span>, <span class="refDoi"> DOI: 10.1200/JCO.2005.03.6723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1200%2FJCO.2005.03.6723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16636341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVOmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2505-2512&author=M.+J.+Ratainauthor=T.+Eisenauthor=W.+M.+Stadlerauthor=K.+T.+Flahertyauthor=S.+B.+Kayeauthor=G.+L.+Rosnerauthor=M.+Goreauthor=A.+A.+Desaiauthor=A.+Patnaikauthor=H.+Q.+Xiongauthor=E.+Rowinskyauthor=J.+L.+Abbruzzeseauthor=C.+Xiaauthor=R.+Simantovauthor=B.+Schwartzauthor=P.+J.+O%E2%80%99Dwyer&title=Phase+II+placebo-controlled+randomized+discontinuation+trial+of+sorafenib+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1200%2FJCO.2005.03.6723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Ratain, Mark J.; Eisen, Tim; Stadler, Walter M.; Flaherty, Keith T.; Kaye, Stan B.; Rosner, Gary L.; Gore, Martin; Desai, Apurva A.; Patnaik, Amita; Xiong, Henry Q.; Rowinsky, Eric; Abbruzzese, James L.; Xia, Chenghua; Simantov, Ronit; Schwartz, Brian; O'Dwyer, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2505-2512</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This phase II randomized discontinuation trial evaluated the effects of sorafenib (BAY 43-9006), an oral multikinase inhibitor targeting the tumor and vasculature, on tumor growth in patients with metastatic renal cell carcinoma.  Patients and Methods: Patients initially received oral sorafenib 400 mg twice daily during the initial run-in period.  After 12 wk, patients with changes in bidimensional tumor measurements that were less than 25% from baseline were randomly assigned to sorafenib or placebo for an addnl. 12 wk; patients with ≥25% tumor shrinkage continued open-label sorafenib; patients with ≥25% tumor growth discontinued treatment.  The primary end point was the percentage of randomly assigned patients remaining progression free at 24 wk after the initiation of sorafenib.  Results: Of 202 patients treated during the run-in period, 73 patients had tumor shrinkage of ≥25%.  Sixty-five patients with stable disease at 12 wk were randomly assigned to sorafenib (n = 32) or placebo (n = 33).  At 24 wk, 50% of the sorafenib-treated patients were progression free vs. 18% of the placebo-treated patients (P = .0077).  Median progression-free survival (PFS) from randomization was significantly longer with sorafenib (24 wk) than placebo (6 wk; P = .0087).  Median overall PFS was 29 wk for the entire renal cell carcinoma population (n = 202).  Sorafenib was readministered in 28 patients whose disease progressed on placebo; these patients continued on sorafenib until further progression, for a median of 24 wk.  Common adverse events were skin rash/desquamation, hand-foot skin reaction, and fatigue; 9% of patients discontinued therapy, and no patients died from toxicity.  Conclusion: Sorafenib has significant disease-stabilizing activity in metastatic renal cell carcinoma and is tolerable with chronic daily therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUM2n0Jl3GurVg90H21EOLACvtfcHk0lhB3-Hu6H-G9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVOmtrk%253D&md5=9c0c7184c9681c9e354e48e5582aa431</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.6723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.6723%26sid%3Dliteratum%253Aachs%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26aulast%3DEisen%26aufirst%3DT.%26aulast%3DStadler%26aufirst%3DW.%2BM.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DRosner%26aufirst%3DG.%2BL.%26aulast%3DGore%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DA.%2BA.%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DXiong%26aufirst%3DH.%2BQ.%26aulast%3DRowinsky%26aufirst%3DE.%26aulast%3DAbbruzzese%26aufirst%3DJ.%2BL.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DP.%2BJ.%26atitle%3DPhase%2520II%2520placebo-controlled%2520randomized%2520discontinuation%2520trial%2520of%2520sorafenib%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2505%26epage%3D2512%26doi%3D10.1200%2FJCO.2005.03.6723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukowski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreicer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. A.</span></span> <span> </span><span class="NLM_article-title">A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1007/s10637-010-9516-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs10637-010-9516-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20711630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=364-367&author=D.+R.+Shepardauthor=M.+M.+Cooneyauthor=P.+Elsonauthor=R.+M.+Bukowskiauthor=R.+Dreicerauthor=B.+I.+Riniauthor=J.+A.+Garcia&title=A+phase+II+study+of+tandutinib+%28MLN518%29%2C+a+selective+inhibitor+of+type+III+tyrosine+receptor+kinases%2C+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1007%2Fs10637-010-9516-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Shepard, Dale R.; Cooney, Matthew M.; Elson, Paul; Bukowski, Ronald M.; Dreicer, Robert; Rini, Brian I.; Garcia, Jorge A.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">364-367</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Therapies which target VEGF and mTOR are now available for patients with metastatic renal cell carcinoma, but there is a continued need to develop agents for patients who become refractory to these initial agents.  Tandutinib is a relatively selective inhibitor of type III tyrosine kinase receptor kinases with promising activity in some tumors.  In this trial, 10 patients with metastatic renal cell carcinoma refractory to previous therapy with sunitinib or sorafenib (median age 61 years, 80% performance status 0, 60% intermediate MSKCC risk classification) received tandutinib 500 mg bid daily with RECIST-defined response as the primary endpoint and progression-free survival (PFS) and overall survival (OS) as secondary endpoints.  No patient had more than 2 cycles of therapy and 50% of patients only received 1 cycle with 70% of patients discontinuing for progressive disease and 30% for toxicity.  Tandutinib was not well tolerated with dose redn. in 60% of patients due to adverse events.  The most common grade 3 toxicity was fatigue (30%).  Tandutinib had no clin. activity and due to the excessive toxicity should not be developed further in patients with sunitinib or sorafenib-refractory metastatic renal cell carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiUZspSDA4LrVg90H21EOLACvtfcHk0lhB3-Hu6H-G9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVWisQ%253D%253D&md5=2909607b7c96ffa157c3d072d9242a1d</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1007%2Fs10637-010-9516-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-010-9516-1%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DD.%2BR.%26aulast%3DCooney%26aufirst%3DM.%2BM.%26aulast%3DElson%26aufirst%3DP.%26aulast%3DBukowski%26aufirst%3DR.%2BM.%26aulast%3DDreicer%26aufirst%3DR.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DGarcia%26aufirst%3DJ.%2BA.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520tandutinib%2520%2528MLN518%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520type%2520III%2520tyrosine%2520receptor%2520kinases%252C%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D364%26epage%3D367%26doi%3D10.1007%2Fs10637-010-9516-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimer, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klisovic, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligiuri, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecerf, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karol, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. C.</span></span> <span> </span><span class="NLM_article-title">Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">3674</span>– <span class="NLM_lpage">3681</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-02-005702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1182%2Fblood-2006-02-005702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16902153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Kgs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=3674-3681&author=D.+J.+DeAngeloauthor=R.+M.+Stoneauthor=M.+L.+Heaneyauthor=S.+D.+Nimerauthor=R.+L.+Paquetteauthor=R.+B.+Klisovicauthor=M.+A.+Caligiuriauthor=M.+R.+Cooperauthor=J.+M.+Lecerfauthor=M.+D.+Karolauthor=S.+Shengauthor=N.+Holfordauthor=P.+T.+Curtinauthor=B.+J.+Drukerauthor=M.+C.+Heinrich&title=Phase+1+clinical+results+with+tandutinib+%28MLN518%29%2C+a+novel+FLT3+antagonist%2C+in+patients+with+acute+myelogenous+leukemia+or+high-risk+myelodysplastic+syndrome%3A+safety%2C+pharmacokinetics%2C+and+pharmacodynamics&doi=10.1182%2Fblood-2006-02-005702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics</span></div><div class="casAuthors">DeAngelo, Daniel J.; Stone, Richard M.; Heaney, Mark L.; Nimer, Stephen D.; Paquette, Ronald L.; Klisovic, Rebecca B.; Caligiuri, Michael A.; Cooper, Michael R.; Lecerf, Jean-Michel; Karol, Michael D.; Sheng, Shihong; Holford, Nick; Curtin, Peter T.; Druker, Brian J.; Heinrich, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3674-3681</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Tandutinib (MLN518/CT53518) is a novel quinazoline-based inhibitor of the type III receptor tyrosine kinases: FMS-like tyrosine kinase 3 (FLT3), platelet-derived growth factor receptor (PDGFR), and KIT.  Because of the correlation between FLT3 internal tandem duplication (ITD) mutations and poor prognosis in acute myelogenous leukemia (AML), we conducted a phase 1 trial of tandutinib in 40 patients with either AML or high-risk myelodysplastic syndrome (MDS).  Tandutinib was given orally in doses ranging from 50 mg to 700 mg twice daily The principal dose-limiting toxicity (DLT) of tandutinib was reversible generalized muscular weakness, fatigue, or both, occurring at doses of 525 mg and 700 mg twice daily.  Tandutinib's pharmacokinetics were characterized by slow elimination, with achievement of steady-state plasma concns. requiring greater than 1 wk of dosing.  Western blotting showed that tandutinib inhibited phosphorylation of FLT3 in circulating leukemic blasts.  Eight patients had FLT3-ITD mutations; 5 of these were evaluable for assessment of tandutinib's antileukemic effect.  Two of the 5 patients, treated at 525 mg and 700 mg twice daily, showed evidence of antileukemic activity, with decreases in both peripheral and bone marrow blasts.  Tandutinib at the MTD (525 mg twice daily) should be evaluated more extensively in patients with AML with FLT3-ITD mutations to better define its antileukemic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraXRBv_Gv-TLVg90H21EOLACvtfcHk0ljwm6wiHJ69yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Kgs7%252FM&md5=42c0b5a4c193955023198d6c6d12c463</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-02-005702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-02-005702%26sid%3Dliteratum%253Aachs%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DHeaney%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DPaquette%26aufirst%3DR.%2BL.%26aulast%3DKlisovic%26aufirst%3DR.%2BB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DLecerf%26aufirst%3DJ.%2BM.%26aulast%3DKarol%26aufirst%3DM.%2BD.%26aulast%3DSheng%26aufirst%3DS.%26aulast%3DHolford%26aufirst%3DN.%26aulast%3DCurtin%26aufirst%3DP.%2BT.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26atitle%3DPhase%25201%2520clinical%2520results%2520with%2520tandutinib%2520%2528MLN518%2529%252C%2520a%2520novel%2520FLT3%2520antagonist%252C%2520in%2520patients%2520with%2520acute%2520myelogenous%2520leukemia%2520or%2520high-risk%2520myelodysplastic%2520syndrome%253A%2520safety%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26spage%3D3674%26epage%3D3681%26doi%3D10.1182%2Fblood-2006-02-005702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><a href="https://www.clinicaltrials.gov/ct2/show/NCT02438761" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02438761</a> (accessed April 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02438761+%28accessed+April+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W. J.</span></span> <span> </span><span class="NLM_article-title">The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1006/excr.1999.4706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1006%2Fexcr.1999.4706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10579913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1MXnsF2itL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=78-87&author=H.+Kimauthor=W.+J.+Muller&title=The+role+of+the+epidermal+growth+factor+receptor+family+in+mammary+tumorigenesis+and+metastasis&doi=10.1006%2Fexcr.1999.4706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis</span></div><div class="casAuthors">Kim, Harold; Muller, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-87</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 109 refs.  A no. of receptor systems have been implicated to play an important role in the development and progression of many human cancers.  The epidermal growth factor (EGF) receptor tyrosine kinase family has been found to consistently play a leading role in tumor progression.  Indeed, in human breast cancer cases the prognosis of a patient is inversely correlated with the overexpression and/or amplification of this receptor family.  Furthermore, downstream signaling components such as the Src kinases, PI3'K, and the Ras pathway display evidence of deregulation that can accelerate tumor progression.  The transgenic mouse system has been ideal in elucidating the biol. significance of this receptor family in mammary tumorigenesis.  Mol. events involved in mammary tumorigenesis such as ligand binding, receptor dimerization, and the activation of downstream pathways have been addressed using this system.  Although there are many mol. steps that appear to drive each stage of tumor development, the EGF receptor family appears to play a causal role in the progression to a transformed phenotype.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptCmIjyIHglrVg90H21EOLACvtfcHk0ljwm6wiHJ69yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsF2itL8%253D&md5=fd74f320166f00185f17af2f372cddf0</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4706%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520role%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520in%2520mammary%2520tumorigenesis%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D78%26epage%3D87%26doi%3D10.1006%2Fexcr.1999.4706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarden, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwkowski, M. X.</span></span> <span> </span><span class="NLM_article-title">Untangling the ErbB signalling network</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1038/35052073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2F35052073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11252954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=127-137&author=Y.+Yardenauthor=M.+X.+Sliwkowski&title=Untangling+the+ErbB+signalling+network&doi=10.1038%2F35052073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Untangling the ErbB signalling network</span></div><div class="casAuthors">Yarden, Yosef; Sliwkowski, Mark X.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 112 refs.  When epidermal growth factor and its relatives bind the ErbB family of receptors, they trigger a rich network of signaling pathways, culminating in responses ranging from cell division to death, motility to adhesion.  The network is often dysregulated in cancer and lends credence to the mantra that mol. understanding yields clin. benefit: over 25,000 women with breast cancer have now been treated with Herceptin, a recombinant antibody designed to block the receptor ErbB2.  Likewise, small-mol. enzyme inhibitors and monoclonal antibodies to ErbB1 are in advanced phases of clin. testing.  What can this pathway teach us about translating basic science into clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovhWL1HObvNrVg90H21EOLACvtfcHk0ljEhegsnAhdjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVWnt7k%253D&md5=1561a9666f77fce888be821399870cd6</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1038%2F35052073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35052073%26sid%3Dliteratum%253Aachs%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26atitle%3DUntangling%2520the%2520ErbB%2520signalling%2520network%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2001%26volume%3D2%26spage%3D127%26epage%3D137%26doi%3D10.1038%2F35052073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A.</span></span> <span> </span><span class="NLM_article-title">ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1002/med.20209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fmed.20209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22183797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ehurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=166-215&author=R.+Saxenaauthor=A.+Dwivedi&title=ErbB+family+receptor+inhibitors+as+therapeutic+agents+in+breast+cancer%3A+current+status+and+future+clinical+perspective&doi=10.1002%2Fmed.20209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective</span></div><div class="casAuthors">Saxena, Ruchi; Dwivedi, Anila</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">166-215</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Breast cancer is the most common cancer diagnosed in women and the second most common cause of female cancer-related deaths, with more than one million new cases diagnosed per yr throughout the world.  With the recent advances in the knowledge of cellular processes and signaling pathways involved in the pathogenesis of breast cancer, the current focus of researchers and clinicians is to develop novel treatment strategies that can be included in the armamentarium against breast cancer.  With the failure of endocrine-targeted therapy and the development of resistance to existing chemotherapy, the most explored pathway as next generation target for breast cancer therapy has been the epidermal growth factor receptor (EGFR) (ErbB-1)/herceptin-2 (HER-2) (ErbB-2) pathway.  This review focuses on the rationale for targeting members of ErbB receptor family and numerous agents that are in use for inhibiting the pathway.  The mechanism of action, preclin. and clin. trial data of the agents that are in use for targeting the EGFR/HER-2 pathway and the current status, thereof, have been discussed in detail.  In addn., the future clin. trial promises these agents hold either as monotherapy or as combination therapy with conventional agents or with other antisignaling agents have been pondered, so as to provide better and more efficacious treatment strategies for breast cancer patients. © 2010 Wiley Periodicals, Inc.  Med Res Rev 32:166-215, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmiIlr-zXabVg90H21EOLACvtfcHk0ljEhegsnAhdjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ehurfL&md5=5a5b35fb0b1c8da860119a53689c3711</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1002%2Fmed.20209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20209%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DDwivedi%26aufirst%3DA.%26atitle%3DErbB%2520family%2520receptor%2520inhibitors%2520as%2520therapeutic%2520agents%2520in%2520breast%2520cancer%253A%2520current%2520status%2520and%2520future%2520clinical%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D166%26epage%3D215%26doi%3D10.1002%2Fmed.20209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mowafy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farag, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouzid, K. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2012.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23142066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Kjsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=132-145&author=S.+Mowafyauthor=N.+A.+Faragauthor=K.+A.+Abouzid&title=Design%2C+synthesis+and+in+vitro+anti-proliferative+activity+of+4%2C6-quinazolinediamines+as+potent+EGFR-TK+inhibitors&doi=10.1016%2Fj.ejmech.2012.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors</span></div><div class="casAuthors">Mowafy, Samar; Farag, Nahla A.; Abouzid, Khaled A. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-145</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Anilino-6-substituted-quinazolines were designed, synthesized and evaluated for EGFR-TK and tumor growth inhibitory activities.  The target compds. were designed with enamine ester or urea moieties appended at the C-6 of quinazoline as addnl. hydrogen bond acceptor functions.  Most of the synthesized compds. displayed potent EGFR-TK inhibitory activity at 10 μM and the 6-ureido-anilinoquinazoline deriv. (I) showed IC50 value of 0.061 μM.  Moreover, six compds. were tested by National Cancer Institute (NCI), USA for their anti-proliferative activity at 10 μM in full NCI 60 cell panel.  Compd. I was further assayed for five dose molar ranges in full NCI 60 cell panel and exhibited remarkable growth inhibitory activity pattern against Non-Small Cell Lung Cancer EKVX (GI50 = 0.37 μM), NCI-H322M (GI50 = 0.36 μM), Renal Cancer A498 (GI50 = 0.46 μM), TK-10 (GI50 = 0.99 μM) and Breast Cancer MDA-MB-468 (GI50 = 1.096 μM) which are of high EGFR expression.  Docking study was performed for the active compds. into ATP binding site of EGFR-TK which showed similar binding mode to gefitinib and addnl. binding with Cys-773 at the gatekeeper of EGFR-TK enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ6Ian6C596LVg90H21EOLACvtfcHk0ljEhegsnAhdjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Kjsb3E&md5=e74abcf0e7ff68497f022ac4e1400ab1</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DMowafy%26aufirst%3DS.%26aulast%3DFarag%26aufirst%3DN.%2BA.%26aulast%3DAbouzid%26aufirst%3DK.%2BA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520anti-proliferative%2520activity%2520of%25204%252C6-quinazolinediamines%2520as%2520potent%2520EGFR-TK%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D61%26spage%3D132%26epage%3D145%26doi%3D10.1016%2Fj.ejmech.2012.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7988</span>– <span class="NLM_lpage">7998</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmc.2013.09.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24183742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSlsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7988-7998&author=X.+Zhangauthor=T.+Pengauthor=X.+Jiauthor=J.+Liauthor=L.+Tongauthor=Z.+Liauthor=W.+Yangauthor=Y.+Xuauthor=M.+Liauthor=J.+Dingauthor=H.+Jiangauthor=H.+Xieauthor=H.+Liu&title=Design%2C+synthesis+and+biological+evaluation+of+novel+4-anilinoquinazolines+with+C-6+urea-linked+side+chains+as+inhibitors+of+the+epidermal+growth+factor+receptor&doi=10.1016%2Fj.bmc.2013.09.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor</span></div><div class="casAuthors">Zhang, Xu; Peng, Ting; Ji, Xun; Li, Jian; Tong, Linjiang; Li, Zeng; Yang, Wei; Xu, Yungen; Li, Mengyuan; Ding, Jian; Jiang, Hualiang; Xie, Hua; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7988-7998</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of anilinoquinazoline compds. with C-6 urea-linked side chains was designed and synthesized as reversible inhibitors of epidermal growth factor receptor (EGFR) based on the structure-activity relationships (SARs) of anilinoquinazoline inhibitors.  All compds. demonstrated good inhibition of EGFR wild type (EGFR wt) and inhibited proliferation of A431cell line.  Compds. (I) and (II) almost completely blocked the phosphorylation of EGFR in A431 cell line at 0.01 μM.  Interestingly, all of the compds. also demonstrated moderate inhibition of EGFR/T790M/L858R.  In addn., compds. (III) and (IV) blocked the autophosphorylation of EGFR in NCI-H1975 cells at high concn. (10 μM), and compd. 8f was confirmed to be an irreversible inhibitor through the diln. method.  Importantly, the compds. with C-6 urea-linked side chains which did not contain Michael acceptors demonstrated moderate to strong irreversible EGFR inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm9A3kxR7nTbVg90H21EOLACvtfcHk0lgwIg57QgfEzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSlsLrI&md5=30a7a86cd500a9073efe50cd1660bf4b</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.049%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25204-anilinoquinazolines%2520with%2520C-6%2520urea-linked%2520side%2520chains%2520as%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7988%26epage%3D7998%26doi%3D10.1016%2Fj.bmc.2013.09.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. Y.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1039/c3md00096f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc3md00096f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotleqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=979-986&author=Q.+W.+Zhangauthor=Y.+Y.+Diaoauthor=F.+Wangauthor=Y.+Fuauthor=F.+Tangauthor=Q.+D.+Youauthor=H.+Y.+Zhou&title=Design+and+discovery+of+4-anilinoquinazoline+ureas+as+multikinase+inhibitors+targeting+BRAF%2C+VEGFR-2+and+EGFR&doi=10.1039%2Fc3md00096f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR</span></div><div class="casAuthors">Zhang, Qingwen; Diao, Yuanyuan; Wang, Fei; Fu, Ying; Tang, Fei; You, Qidong; Zhou, Houyuan</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">979-986</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">4-Anilinoquinazoline ureas were envisaged according to the hybrid-design approach based upon two privileged pharmacophores in kinase drug discovery, i.e. 4-anilinoquinazoline and unsym. diaryl urea.  In our structure-activity relationships (SAR) campaign, title compds. were synthesized and profiled in biochem. assay for their kinase inhibitory activity.  Title compds. 18-20 were found to be multikinase inhibitors with profound activity against BRAF, BRAF V600E, VEGFR-2 and EGFR.  Mol. docking into DFG-out conformations of BRAF and VEGFR-2 suggested that they might be type II inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNq-LAIAB3urVg90H21EOLACvtfcHk0lgwIg57QgfEzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotleqsr0%253D&md5=8749fa7cffe96ef37e379bf205010499</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1039%2Fc3md00096f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00096f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%2BW.%26aulast%3DDiao%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DZhou%26aufirst%3DH.%2BY.%26atitle%3DDesign%2520and%2520discovery%2520of%25204-anilinoquinazoline%2520ureas%2520as%2520multikinase%2520inhibitors%2520targeting%2520BRAF%252C%2520VEGFR-2%2520and%2520EGFR%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D979%26epage%3D986%26doi%3D10.1039%2Fc3md00096f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. P.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2016.09.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27688180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFymsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=245-254&author=H.+Q.+Zhangauthor=F.+H.+Gongauthor=J.+Q.+Yeauthor=C.+Zhangauthor=X.+H.+Yueauthor=C.+G.+Liauthor=Y.+G.+Xuauthor=L.+P.+Sun&title=Design+and+discovery+of+4-anilinoquinazoline-urea+derivatives+as+dual+TK+inhibitors+of+EGFR+and+VEGFR-2&doi=10.1016%2Fj.ejmech.2016.09.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2</span></div><div class="casAuthors">Zhang, Hai-Qi; Gong, Fei-Hu; Ye, Ji-Qing; Zhang, Chi; Yue, Xiao-Hong; Li, Chuan-Gui; Xu, Yun-Gen; Sun, Li-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-254</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">EGFR and VEGFR-2 are involved in pathol. disorders and the progression of different kinds of tumors, the combined blockade of EGFR and VEGFR signaling pathways appears to be an attractive approach to cancer therapy.  In this work, a series of 4-anilinoquinazoline derivs. contg. substituted diaryl urea or glycine Me ester moiety were designed and identified as EGFR and VEGFR-2 dual inhibitors.  Compds. I, II and III exhibited the most potent inhibitory activities against EGFR (IC50 = 1 nM, 78 nM and 51 nM, resp.) and VEGFR-2 (IC50 = 79 nM, 14 nM and 14 nM, resp.), they showed good antiproliferative activities as well.  Mol. docking established the interaction of I with the DFG-out conformation of VEGFR-2, suggesting that they might be type II kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyAsg6-6mJ5LVg90H21EOLACvtfcHk0lgDPGNb9ry2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFymsb3N&md5=f97387e248ed7557360b9cf4d496c4d6</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BQ.%26aulast%3DGong%26aufirst%3DF.%2BH.%26aulast%3DYe%26aufirst%3DJ.%2BQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DYue%26aufirst%3DX.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DY.%2BG.%26aulast%3DSun%26aufirst%3DL.%2BP.%26atitle%3DDesign%2520and%2520discovery%2520of%25204-anilinoquinazoline-urea%2520derivatives%2520as%2520dual%2520TK%2520inhibitors%2520of%2520EGFR%2520and%2520VEGFR-2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D245%26epage%3D254%26doi%3D10.1016%2Fj.ejmech.2016.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">The hallmarks of cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81683-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer&doi=10.1016%2FS0092-8674%2800%2981683-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lgDPGNb9ry2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70%26doi%3D10.1016%2FS0092-8674%2800%2981683-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pralhad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhusudan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendrakumar, K.</span></span> <span> </span><span class="NLM_article-title">Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1211/0022357021819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1211%2F0022357021819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12956893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=1045-1053&author=T.+Pralhadauthor=S.+Madhusudanauthor=K.+Rajendrakumar&title=Concept%2C+mechanisms+and+therapeutics+of+angiogenesis+in+cancer+and+other+diseases&doi=10.1211%2F0022357021819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Pralhad, Tayade; Madhusudan, Saraf; Rajendrakumar, Kale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1045-1053</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  Angiogenesis supports normal physiol. as well as contributing to the progression of various diseases including cancer.  Detn. of the key role of angiogenesis in cancer has led to much optimism for the development of targeted drugs without cytotoxic side-effects.  Currently, research in angiogenesis therapy is robust, with the discovery of a growing no. of pro- and anti-angiogenic mols.  More time, however, is required to be able to elucidate the complex interactions among these mols., how they affect vasculature, and their functions in different environments.  As more is learned about the mol. mechanisms of angiogenesis, a no. of effective methods to treat cancer and other diseases will be developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuQLA1HzTRkrVg90H21EOLACvtfcHk0lgDPGNb9ry2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGnsb8%253D&md5=7051a61be69e134ad9d427feff2f3648</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1211%2F0022357021819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357021819%26sid%3Dliteratum%253Aachs%26aulast%3DPralhad%26aufirst%3DT.%26aulast%3DMadhusudan%26aufirst%3DS.%26aulast%3DRajendrakumar%26aufirst%3DK.%26atitle%3DConcept%252C%2520mechanisms%2520and%2520therapeutics%2520of%2520angiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2003%26volume%3D55%26spage%3D1045%26epage%3D1053%26doi%3D10.1211%2F0022357021819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span> <span> </span><span class="NLM_article-title">Development and strategies of VEGFR-2/KDR inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1839</span>– <span class="NLM_lpage">1852</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.4155%2Ffmc.12.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23043480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOhsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1839-1852&author=L.+Huangauthor=Z.+Huangauthor=Z.+Baiauthor=R.+Xieauthor=L.+Sunauthor=K.+Lin&title=Development+and+strategies+of+VEGFR-2%2FKDR+inhibitors&doi=10.4155%2Ffmc.12.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Development and strategies of VEGFR-2/KDR inhibitors</span></div><div class="casAuthors">Huang, Lingyi; Huang, Zhengui; Bai, Zhiqiang; Xie, Rui; Sun, Liping; Lin, Kejiang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1839-1852</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  VEGF is an important signaling protein involved in both vasculogenesis and angiogenesis.  As an essential receptor protein tyrosine kinase propagating cellular signal transduction processes, VEGFR-2 is a central target for drug discovery against tumor-assocd. angiogenesis.  Since the autophosphorylation of VEGFR-2 represents a key step in this signal pathway that contributes to angiogenesis, the discovery of small mol. inhibitors that block this reaction has attracted great interest for novel drugs research and development.  Advances in the understanding of catalytic cleft and the conformational changes of DFG motif have resulted in the development of small mol. inhibitors known as type I and type II.  High-resoln. crystal structures of various inhibitors in complex with the receptor offer an insight into the relationship among binding modes, inhibition mechanisms, activity, selectivity and resistance.  To control selectivity, improve activity and introduce intellectual property novelty, the strategies for the further development are discussed through structural and conformational anal. in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMgCdblpbQc7Vg90H21EOLACvtfcHk0lh1QcWGjHO1ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOhsb3O&md5=96cc54622cc92d45a8549eb88d551a7f</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.121%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DK.%26atitle%3DDevelopment%2520and%2520strategies%2520of%2520VEGFR-2%252FKDR%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1839%26epage%3D1852%26doi%3D10.4155%2Ffmc.12.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldehna, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aly, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abou-Seri, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aziz, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abou El Ella, D. A.</span></span> <span> </span><span class="NLM_article-title">Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2015.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26071861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=89-97&author=W.+M.+Eldehnaauthor=M.+Faresauthor=H.+S.+Ibrahimauthor=M.+H.+Alyauthor=S.+Zadaauthor=M.+M.+Aliauthor=S.+M.+Abou-Seriauthor=H.+A.+Abdel-Azizauthor=D.+A.+Abou+El+Ella&title=Indoline+ureas+as+potential+anti-hepatocellular+carcinoma+agents+targeting+VEGFR-2%3A+Synthesis%2C+in+vitro+biological+evaluation+and+molecular+docking&doi=10.1016%2Fj.ejmech.2015.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking</span></div><div class="casAuthors">Eldehna, Wagdy M.; Fares, Mohamed; Ibrahim, Hany S.; Aly, Mohamed H.; Zada, Suher; Ali, Mamdouh M.; Abou-Seri, Sahar M.; Abdel-Aziz, Hatem A.; Abou El Ella, Dalal A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In our effort to develop potent and effective agents with anti-proliferative activity towards HepG2 hepatocellular carcinoma cells with potential inhibitory activity against VEGFR-2, a novel series of 1-(4-((2-oxoindolin-3-ylidene)amino)phenyl)-3-arylureas was designed and synthesized.  All the newly prepd. ureas were evaluated in vitro for their anti-proliferative activity against HepG2 hepatocellular carcinoma cell line.  Some compds. exhibited good activity against HepG2 cancer cells (IC50 = 1.22 ± 0.11-8.37 ± 0.85 μM) comparable to that of doxorubicin and sorafinib (IC50 = 2.90 ± 0.36 and 3.40 ± 0.25 μM, resp.).  These compds. were further evaluated for their inhibitory activity against VEGFR-2.  Compd. I emerged as the most active counterpart against VEGFR-2 with IC50 value of 0.31 ± 0.04 μM.  Furthermore, a mol. docking of the tested compds. was carried out in order to investigate their binding pattern with the prospective target, VEGFR-2 (PDB-code: 4ASD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDlQoeELeaMLVg90H21EOLACvtfcHk0lh1QcWGjHO1ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjM&md5=7d81fe853234fa7009fe39266c767ad0</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DEldehna%26aufirst%3DW.%2BM.%26aulast%3DFares%26aufirst%3DM.%26aulast%3DIbrahim%26aufirst%3DH.%2BS.%26aulast%3DAly%26aufirst%3DM.%2BH.%26aulast%3DZada%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DM.%2BM.%26aulast%3DAbou-Seri%26aufirst%3DS.%2BM.%26aulast%3DAbdel-Aziz%26aufirst%3DH.%2BA.%26aulast%3DAbou%2BEl%2BElla%26aufirst%3DD.%2BA.%26atitle%3DIndoline%2520ureas%2520as%2520potential%2520anti-hepatocellular%2520carcinoma%2520agents%2520targeting%2520VEGFR-2%253A%2520Synthesis%252C%2520in%2520vitro%2520biological%2520evaluation%2520and%2520molecular%2520docking%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D100%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.ejmech.2015.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Six, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofalo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depreux, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24747748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=369-381&author=S.+Ravezauthor=A.+Barczykauthor=P.+Sixauthor=A.+Cagnonauthor=A.+Garofaloauthor=L.+Goossensauthor=P.+Depreux&title=Inhibition+of+tumor+cell+growth+and+angiogenesis+by+7-aminoalkoxy-4-aryloxy-quinazoline+ureas%2C+a+novel+series+of+multi-tyrosine+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2014.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor cell growth and angiogenesis by 7-Aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors</span></div><div class="casAuthors">Ravez, Severine; Barczyk, Amelie; Six, Perrine; Cagnon, Aurelie; Garofalo, Antonio; Goossens, Laurence; Depreux, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-381</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Several regulatory and signaling mols. governing angiogenesis are targets of interest for the development of drugs in the cancer, including growth factors such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF).  A series of 4-aryloxy-6,7-dimethoxyquinazolines, previously synthesized in our lab., has shown a nanomolar inhibition of kinase enzymic activity of VEGFR, PDGFR and c-Kit.  We have therefore studied the impact of the variation in the 7-position substitution of the quinazoline core.  Substitution by aminoalkoxy chains led to new highly potent ATP-competitive inhibitors of VEGFR, PDGFR and c-Kit enzyme with IC50 values in the nanomolar range and this substitution has increased greatly antiproliferative activity on cancer cell lines (PC3, MCF7, HT29) and HUVEC (human umbilical vein endothelial cells).  One of the most promising compds. (36) was assessed for its ability to limit the induction of web like network of capillary tubes by the human umbilical vascular endothelial cells (HUVEC) and for its ability to inhibit invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eAoR7W7m1rVg90H21EOLACvtfcHk0lhHZ1cQgLu5SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWgurY%253D&md5=b0e3b6efa1cf399a29c8715c310f7a4b</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DRavez%26aufirst%3DS.%26aulast%3DBarczyk%26aufirst%3DA.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DCagnon%26aufirst%3DA.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%2520and%2520angiogenesis%2520by%25207-aminoalkoxy-4-aryloxy-quinazoline%2520ureas%252C%2520a%2520novel%2520series%2520of%2520multi-tyrosine%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D369%26epage%3D381%26doi%3D10.1016%2Fj.ejmech.2014.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peyssonnaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eychene, A.</span></span> <span> </span><span class="NLM_article-title">The Raf/MEK/ERK pathway: new concepts of activation</span>. <i>Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/S0248-4900(01)01125-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0248-4900%2801%2901125-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11730323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=53-62&author=C.+Peyssonnauxauthor=A.+Eychene&title=The+Raf%2FMEK%2FERK+pathway%3A+new+concepts+of+activation&doi=10.1016%2FS0248-4900%2801%2901125-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">The Raf/MEK/ERK pathway: New concepts of activation</span></div><div class="casAuthors">Peyssonnaux, Carole; Eychene, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Biology of the Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BCELDF</span>;
        ISSN:<span class="NLM_cas:issn">0248-4900</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review.  The Raf/MEK/ERK signaling was the first MAP kinase cascade to be characterized.  It is probably one of the most well known signal transduction pathways among biologists because of its implication in a wide variety of cellular functions as diverse -and occasionally contradictory- as cell proliferation, cell-cycle arrest, terminal differentiation and apoptosis.  Discovery and understanding of this pathway have benefited from the combination of both genetic studies in worms and flies and biochem. studies in mammalian cells.  However, ten years after, this field is still under debate and new mol. partners in the cascade continue to increase the complexity of its regulation.  This review deals with the emergence of new concepts in the activation and regulation of the Raf/MEK/ERK module.  In particular, the preponderant role of B-Raf is underlined, and the role of novel regulators such as KSR is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyjiXSFlBQ6rVg90H21EOLACvtfcHk0lhHZ1cQgLu5SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D&md5=cde3db5b205a1305dc2e6262deea65ec</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2FS0248-4900%2801%2901125-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0248-4900%252801%252901125-X%26sid%3Dliteratum%253Aachs%26aulast%3DPeyssonnaux%26aufirst%3DC.%26aulast%3DEychene%26aufirst%3DA.%26atitle%3DThe%2520Raf%252FMEK%252FERK%2520pathway%253A%2520new%2520concepts%2520of%2520activation%26jtitle%3DBiol.%2520Cell%26date%3D2001%26volume%3D93%26spage%3D53%26epage%3D62%26doi%3D10.1016%2FS0248-4900%2801%2901125-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C.</span></span> <span> </span><span class="NLM_article-title">Targeted cancer therapy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1038/nature03095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnature03095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15549090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=294-297&author=C.+Sawyers&title=Targeted+cancer+therapy&doi=10.1038%2Fnature03095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy</span></div><div class="casAuthors">Sawyers, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">294-297</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer.  Complex networks of regulatory factors, the tumor microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.  Recent progress in understanding the mol. changes that underlie cancer development offer the prospect of specifically targeting malfunctioning mols. and pathways to achieve more effective and rational cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAGMTW2TYsubVg90H21EOLACvtfcHk0lhHZ1cQgLu5SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D&md5=5bd377d2c9ddcffc136d5cf181facd02</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1038%2Fnature03095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03095%26sid%3Dliteratum%253Aachs%26aulast%3DSawyers%26aufirst%3DC.%26atitle%3DTargeted%2520cancer%2520therapy%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D294%26epage%3D297%26doi%3D10.1038%2Fnature03095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu-Duvaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marais, R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">867</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(04)00215-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0092-8674%2804%2900215-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15035987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=855-867&author=P.+T.+Wanauthor=M.+J.+Garnettauthor=S.+M.+Roeauthor=S.+Leeauthor=D.+Niculescu-Duvazauthor=V.+M.+Goodauthor=C.+M.+Jonesauthor=C.+J.+Marshallauthor=C.+J.+Springerauthor=D.+Barfordauthor=R.+Marais&title=Mechanism+of+activation+of+the+RAF-ERK+signaling+pathway+by+oncogenic+mutations+of+B-RAF&doi=10.1016%2FS0092-8674%2804%2900215-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF</span></div><div class="casAuthors">Wan, Paul T. C.; Garnett, Mathew J.; Roe, S. Mark; Lee, Sharlene; Niculescu-Duvaz, Dan; Good, Valerie M.; Project, Cancer Genome; Jones, C. Michael; Marshall, Christopher J.; Springer, Caroline J.; Barford, David; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">855-867</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Over 30 mutations of the B-RAF gene assocd. with human cancers have been identified, the majority of which are located within the kinase domain.  Here the authors show that of 22 B-RAF mutants analyzed, 18 have elevated kinase activity and signal to ERK in vivo.  Surprisingly, three mutants have reduced kinase activity towards MEK in vitro but, by activating C-RAF in vivo, signal to ERK in cells.  The structures of wild type and oncogenic V599EB-RAF kinase domains in complex with the RAF inhibitor BAY43-9006 show that the activation segment is held in an inactive conformation by assocn. with the P loop.  The clustering of most mutations to these two regions suggests that disruption of this interaction converts B-RAF into its active conformation.  The high activity mutants signal to ERK by directly phosphorylating MEK, whereas the impaired activity mutants stimulate MEK by activating endogenous C-RAF, possibly via an allosteric or transphosphorylation mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYiQicwc1xVLVg90H21EOLACvtfcHk0liB9w3gBSUd_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D&md5=4cc020056c64e514286c000666da1972</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900215-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900215-6%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DP.%2BT.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DNiculescu-Duvaz%26aufirst%3DD.%26aulast%3DGood%26aufirst%3DV.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BM.%26aulast%3DMarshall%26aufirst%3DC.%2BJ.%26aulast%3DSpringer%26aufirst%3DC.%2BJ.%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DMechanism%2520of%2520activation%2520of%2520the%2520RAF-ERK%2520signaling%2520pathway%2520by%2520oncogenic%2520mutations%2520of%2520B-RAF%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D855%26epage%3D867%26doi%3D10.1016%2FS0092-8674%2804%2900215-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mambo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trink, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westra, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladenson, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, D.</span></span> <span> </span><span class="NLM_article-title">BRAF mutation in papillary thyroid carcinoma</span>. <i>J. Natl. Cancer Inst</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1093/jnci/95.8.625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1093%2Fjnci%2F95.8.625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12697856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=625-627&author=Y.+Cohenauthor=M.+Xingauthor=E.+Mamboauthor=Z.+Guoauthor=G.+Wuauthor=B.+Trinkauthor=U.+Bellerauthor=W.+H.+Westraauthor=P.+W.+Ladensonauthor=D.+Sidransky&title=BRAF+mutation+in+papillary+thyroid+carcinoma&doi=10.1093%2Fjnci%2F95.8.625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF Mutation in Papillary Thyroid Carcinoma</span></div><div class="casAuthors">Cohen, Yoram; Xing, Mingzhao; Mambo, Elizabeth; Guo, Zhongmin; Wu, Guogun; Trink, Barry; Beller, Uziel; Westra, William H.; Ladenson, Paul W.; Sidransky, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">625-627</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The BRAF gene has been found to be activated by mutation in human cancers, predominantly in malignant melanoma.  We tested 476 primary tumors, including 214 lung, 126 head and neck, 54 thyroid, 27 bladder, 38 cervical, and 17 prostate cancers, for the BRAF T1796A mutation by polymerase chain reaction (PCR)-restriction enzyme anal. of BRAF exon 15.  In 24 (69%) of the 35 papillary thyroid carcinomas examd., we found a missense thymine (T) adenine (A) transversion at nucleotide 1796 in the BRAF gene (T1796A).  The T1796A mutation was detected in four lung cancers and in six head and neck cancers but not in bladder, cervical, or prostate cancers.  Our data suggest that activating BRAF mutations may be an important event in the development of papillary thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_OIrIo68gtLVg90H21EOLACvtfcHk0liB9w3gBSUd_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWqsbw%253D&md5=a28b118adbca62616d62ab88bc94dff6</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.8.625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.8.625%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DM.%26aulast%3DMambo%26aufirst%3DE.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DTrink%26aufirst%3DB.%26aulast%3DBeller%26aufirst%3DU.%26aulast%3DWestra%26aufirst%3DW.%2BH.%26aulast%3DLadenson%26aufirst%3DP.%2BW.%26aulast%3DSidransky%26aufirst%3DD.%26atitle%3DBRAF%2520mutation%2520in%2520papillary%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst%26date%3D2003%26volume%3D95%26spage%3D625%26epage%3D627%26doi%3D10.1093%2Fjnci%2F95.8.625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25462267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOjtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=581-596&author=W.+Yangauthor=Y.+Chenauthor=X.+Zhouauthor=Y.+Guauthor=W.+Qianauthor=F.+Zhangauthor=W.+Hanauthor=T.+Luauthor=W.+Tang&title=Design%2C+synthesis+and+biological+evaluation+of+bis-aryl+ureas+and+amides+based+on+2-amino-3-purinylpyridine+scaffold+as+DFG-out+B-Raf+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2014.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors</span></div><div class="casAuthors">Yang, Weimin; Chen, Yadong; Zhou, Xiang; Gu, Yazhou; Qian, Wenqi; Zhang, Fan; Han, Wei; Lu, Tao; Tang, Weifang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">581-596</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">By combining the scaffolds of UI-125 and Sorafenib, a series of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine moiety were designed and synthesized as novel DFG-out B-RafV600E inhibitors.  Several of these compds. displayed potent antiproliferative activities against melanoma A375 (B-RafV600E) cell lines with IC50 values of 3.190, 2.276, 1.856, 1.632 μM and 1.839 μM, resp., comparable with the pos. control Vemurafenib (IC50 = 3.32 μM).  Selected compds. were tested for the ERK inhibition in human melanoma A375 (B-RafV600E) and SK-MEL-2 (B-RafWT) cell lines by Western blot.  The results revealed that our compds. inhibited the proliferation of melanoma A375 cells (B-RafV600E) through ERK pathway, without paradoxical activation of ERK in melanoma SK-MEL-2 cells (B-RafWT).  Eventually, two compds. were selected to confirm their inhibitory effects on tumor growth in A375 xenograft models in mice.  Compd. I exhibited equiv. antitumor efficacy in vivo (T/C = 44.37%), compared to Sorafenib (T/C = 37.35%), by 23-day repetitive administration of a single dose of 50 mg/kg without significant body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq84bBDYugz1bVg90H21EOLACvtfcHk0lj9kuVI9QR9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOjtL7I&md5=6a65e09b0121c8f2f32facbfeae8f86b</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520bis-aryl%2520ureas%2520and%2520amides%2520based%2520on%25202-amino-3-purinylpyridine%2520scaffold%2520as%2520DFG-out%2520B-Raf%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D581%26epage%3D596%26doi%3D10.1016%2Fj.ejmech.2014.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Damasy, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, G.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2016.02.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27017549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVymu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=201-216&author=A.+K.+El-Damasyauthor=J.+H.+Leeauthor=S.+H.+Seoauthor=N.+C.+Choauthor=A.+N.+Paeauthor=G.+Keum&title=Design+and+synthesis+of+new+potent+anticancer+benzothiazole+amides+and+ureas+featuring+pyridylamide+moiety+and+possessing+dual+B-Raf%28V600E%29+and+C-Raf+kinase+inhibitory+activities&doi=10.1016%2Fj.ejmech.2016.02.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities</span></div><div class="casAuthors">El-Damasy, Ashraf Kareem; Lee, Ju-Hyeon; Seo, Seon Hee; Cho, Nam-Chul; Pae, Ae Nim; Keum, Gyochang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-216</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new series of benzothiazole amide and urea derivs. tethered with the privileged pyridylamide moiety by ether linkage at the 6-position of benzothiazole (22 final compds.) has been designed and synthesized as potent anticancer sorafenib analogs.  A selected group of twelve derivs. was appraised for its antiproliferative activity over a panel of 60 human cancer cell lines at a single dose concn. of 10 μM at National Cancer Institute (NCI, USA).  Some compds. exhibited promising growth inhibitions and thus were further tested in advanced 5-dose testing assay to det. their GI50 values.  The cellular based assay results revealed that 3,5-bis-trifluoromethylphenyl urea deriv. I is the best deriv. with superior potency and efficacy compared to sorafenib as well as notable extended spectrum activity covering 57 human cancer cell lines.  Kinase screening of compd. I showed its kinase inhibitory effect against both B-RafV600E and C-Raf.  Moreover, the most potent derivs. in cells were investigated for their RAF inhibitory activities, and the results were rationalized with the mol. docking study.  Profiling of CYP450 and hERG channel inhibitory effects for the active compds. revealed their low possibilities to exhibit undesirable drug-drug interactions and cardiac side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrZG_38JUm7Vg90H21EOLACvtfcHk0lj9kuVI9QR9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVymu7c%253D&md5=1b8d482241d0f75e6df8f518b7fc3bbc</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.039%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Damasy%26aufirst%3DA.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSeo%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DN.%2BC.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DKeum%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520potent%2520anticancer%2520benzothiazole%2520amides%2520and%2520ureas%2520featuring%2520pyridylamide%2520moiety%2520and%2520possessing%2520dual%2520B-Raf%2528V600E%2529%2520and%2520C-Raf%2520kinase%2520inhibitory%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D201%26epage%3D216%26doi%3D10.1016%2Fj.ejmech.2016.02.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogeti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telikepalli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutkoski, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogeti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kays, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipskind, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobleski, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobb, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clay, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walgren, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clawson, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglicmot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groshong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starling, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, D. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3- d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4165</span>– <span class="NLM_lpage">4179</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlCisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4165-4179&author=J.+R.+Henryauthor=M.+D.+Kaufmanauthor=S.+B.+Pengauthor=Y.+M.+Ahnauthor=T.+M.+Caldwellauthor=L.+Vogetiauthor=H.+Telikepalliauthor=W.+P.+Luauthor=M.+M.+Hoodauthor=T.+J.+Rutkoskiauthor=B.+D.+Smithauthor=S.+Vogetiauthor=D.+Millerauthor=S.+C.+Wiseauthor=L.+Chunauthor=X.+Zhangauthor=Y.+Zhangauthor=L.+Kaysauthor=P.+A.+Hipskindauthor=A.+D.+Wrobleskiauthor=K.+L.+Lobbauthor=J.+M.+Clayauthor=J.+D.+Cohenauthor=J.+L.+Walgrenauthor=D.+McCannauthor=P.+Patelauthor=D.+K.+Clawsonauthor=S.+Guoauthor=D.+Manglicmotauthor=C.+Groshongauthor=C.+Loganauthor=J.+J.+Starlingauthor=D.+L.+Flynn&title=Discovery+of+1-%283%2C3-dimethylbutyl%29-3-%282-fluoro-4-methyl-5-%287-methyl-2-%28methylamino%29pyrido%5B2%2C3-+d%5Dpyrimidin-6-yl%29phenyl%29urea+%28LY3009120%29+as+a+pan-RAF+inhibitor+with+minimal+paradoxical+activation+and+activity+against+BRAF+or+RAS+mutant+tumor+cells&doi=10.1021%2Facs.jmedchem.5b00067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells</span></div><div class="casAuthors">Henry, James R.; Kaufman, Michael D.; Peng, Sheng-Bin; Ahn, Yu Mi; Caldwell, Timothy M.; Vogeti, Lakshminarayana; Telikepalli, Hanumaiah; Lu, Wei-Ping; Hood, Molly M.; Rutkoski, Thomas J.; Smith, Bryan D.; Vogeti, Subha; Miller, David; Wise, Scott C.; Chun, Lawrence; Zhang, Xiaoyi; Zhang, Youyan; Kays, Lisa; Hipskind, Philip A.; Wrobleski, Aaron D.; Lobb, Karen L.; Clay, Julia M.; Cohen, Jeffrey D.; Walgren, Jennie L.; McCann, Denis; Patel, Phenil; Clawson, David K.; Guo, Sherry; Manglicmot, Danalyn; Groshong, Chris; Logan, Cheyenne; Starling, James J.; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4165-4179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The RAS-RAF-MEK-MAPK cascade is an essential signaling pathway, with activation typically mediated through cell surface receptors.  The kinase inhibitors vemurafenib and dabrafenib, which target oncogenic BRAF V600E, have shown significant clin. efficacy in melanoma patients harboring this mutation.  Because of paradoxical pathway activation, both agents were demonstrated to promote growth and metastasis of tumor cells with RAS mutations in preclin. models and are contraindicated for treatment of cancer patients with BRAF WT background, including patients with KRAS or NRAS mutations.  To eliminate the issues assocd. with paradoxical MAPK pathway activation and to provide therapeutic benefit to patients with RAS mutant cancers, we sought to identify a compd. not only active against BRAF V600E but also wild type BRAF and CRAF.  On the basis of its superior in vitro and in vivo profile, compd. 13 was selected for further development and is currently being evaluated in phase I clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXIUwbnhct2rVg90H21EOLACvtfcHk0lj9kuVI9QR9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlCisL0%253D&md5=9e5bc7ee7f45d238e2fa40e1d5cfc739</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00067%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DCaldwell%26aufirst%3DT.%2BM.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DTelikepalli%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DRutkoski%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DVogeti%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKays%26aufirst%3DL.%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26aulast%3DWrobleski%26aufirst%3DA.%2BD.%26aulast%3DLobb%26aufirst%3DK.%2BL.%26aulast%3DClay%26aufirst%3DJ.%2BM.%26aulast%3DCohen%26aufirst%3DJ.%2BD.%26aulast%3DWalgren%26aufirst%3DJ.%2BL.%26aulast%3DMcCann%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DClawson%26aufirst%3DD.%2BK.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DManglicmot%26aufirst%3DD.%26aulast%3DGroshong%26aufirst%3DC.%26aulast%3DLogan%26aufirst%3DC.%26aulast%3DStarling%26aufirst%3DJ.%2BJ.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DDiscovery%2520of%25201-%25283%252C3-dimethylbutyl%2529-3-%25282-fluoro-4-methyl-5-%25287-methyl-2-%2528methylamino%2529pyrido%255B2%252C3-%2520d%255Dpyrimidin-6-yl%2529phenyl%2529urea%2520%2528LY3009120%2529%2520as%2520a%2520pan-RAF%2520inhibitor%2520with%2520minimal%2520paradoxical%2520activation%2520and%2520activity%2520against%2520BRAF%2520or%2520RAS%2520mutant%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4165%26epage%3D4179%26doi%3D10.1021%2Facs.jmedchem.5b00067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vakana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blosser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowless, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancato, L. F.</span></span> <span> </span><span class="NLM_article-title">LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">9251</span>– <span class="NLM_lpage">9266</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.14002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.18632%2Foncotarget.14002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27999210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FmvFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=9251-9266&author=E.+Vakanaauthor=S.+Prattauthor=W.+Blosserauthor=M.+Dowlessauthor=N.+Simpsonauthor=X.+J.+Yuanauthor=S.+Jakenauthor=J.+Manroauthor=J.+Stephensauthor=Y.+Zhangauthor=L.+Huberauthor=S.+B.+Pengauthor=L.+F.+Stancato&title=LY3009120%2C+a+panRAF+inhibitor%2C+has+significant+anti-tumor+activity+in+BRAF+and+KRAS+mutant+preclinical+models+of+colorectal+cancer&doi=10.18632%2Foncotarget.14002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer</span></div><div class="casAuthors">Vakana Eliza; Pratt Susan; Blosser Wayne; Dowless Michele; Stephens Jennifer; Zhang Youyan; Huber Lysiane; Peng Sheng-Bin; Stancato Louis F; Simpson Nicholas; Yuan Xiu-Juan; Jaken Susan; Manro Jason</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">9251-9266</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Activating mutations in the KRAS and BRAF genes, leading to hyperactivation of the RAS/RAF/MAPK oncogenic signaling cascade, are common in patients with colorectal cancer (CRC).  While selective BRAF inhibitors are efficacious in BRAFmut melanoma, they have limited efficacy in BRAFmut CRC patients.  In a RASmut background, selective BRAF inhibitors are contraindicated due to paradoxical activation of the MAPK pathway through potentiation of CRAF kinase activity.  A way to overcome such paradoxical activation is through concurrent inhibition of the kinase activity of both RAF isoforms.  Here, we further examined the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of CRC with various mutational backgrounds.  We demonstrate that LY3009120 induced anti-proliferative effects in BRAFmut and KRASmut CRC cell lines through G1-cell cycle arrest.  The anti-proliferative effects of LY3009120 in KRASmut CRC cell lines phenocopied molecular inhibition of RAF isoforms by simultaneous siRNA-mediated knockdown of ARAF, BRAF and CRAF.  Additionally, LY3009120 displayed significant activity in in vivo BRAFmut and KRASmut CRC xenograft models.  Examination of potential resistance to LY3009120 demonstrated RAF-independent ERK and AKT activation in the KRASmut CRC cell line HCT 116.  These findings describe the preclinical activity of a panRAF inhibitor in a BRAFmut and KRASmut CRC setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6nK1jxnNjuvh3YQQtAhNufW6udTcc2eaJwuafpAsg0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FmvFamuw%253D%253D&md5=d995e803ce26baeff079855005acddac</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.14002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.14002%26sid%3Dliteratum%253Aachs%26aulast%3DVakana%26aufirst%3DE.%26aulast%3DPratt%26aufirst%3DS.%26aulast%3DBlosser%26aufirst%3DW.%26aulast%3DDowless%26aufirst%3DM.%26aulast%3DSimpson%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DX.%2BJ.%26aulast%3DJaken%26aufirst%3DS.%26aulast%3DManro%26aufirst%3DJ.%26aulast%3DStephens%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DStancato%26aufirst%3DL.%2BF.%26atitle%3DLY3009120%252C%2520a%2520panRAF%2520inhibitor%252C%2520has%2520significant%2520anti-tumor%2520activity%2520in%2520BRAF%2520and%2520KRAS%2520mutant%2520preclinical%2520models%2520of%2520colorectal%2520cancer%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D9251%26epage%3D9266%26doi%3D10.18632%2Foncotarget.14002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, H. G.</span></span> <span> </span><span class="NLM_article-title">Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8618433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaK283gtV2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=588-599&author=H.+G.+Drexler&title=Expression+of+FLT3+receptor+and+response+to+FLT3+ligand+by+leukemic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells</span></div><div class="casAuthors">Drexler H G</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">588-99</span>
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    </div><div class="casAbstract">The novel hematopoietic growth factor FLT3 ligand (FL) is the cognate ligand for the FLT3, tyrosine kinase receptor (R), also referred to as FLK-2 and STK-1.  The FLT3R belongs to a family of receptor tyrosine kinases involved in hematopoiesis that also includes KIT, the receptor for SCF (stem cell factor), and FMS. the receptor for M-CSF (macrophage colony- stimulating factor).  Restricted FLT3R expression was seen on human and murine hematopoietic progenitor cells.  In functional assays recombinant FL stimulated the proliferation and colony formation of human hematopoietic progenitor cells, i.e.  CD34+ cord and peripheral blood, bone marrow and fetal liver cells.  Synergy was reported for co-stimulation with G-CSF (granulocyte-CSF).  GM-CSF (granulocyte-macrophage CSF), M-CSF, interleukin-3 (IL-3), PIXY-321 (an IL-3/GM-CSF fusion protein) and SCF.  In the mouse, FL potently enhanced growth of various types of progenitor/precursor cells in synergy with G-CSF, GM-CSF, M-CSF, IL-3, IL-6, IL-7, IL-11, IL-12 and SCF.  The well-documented involvement of this ligand-receptor pair in physiological hematopoiesis brought forth the question whether FLT3R and FL might also have a role in the pathobiology of leukemia.  At the mRNA level FLT3R was expressed by most (80-100%) cases of AML (acute myeloid leukemia) throughout the different morphological subtypes (MO-M7), of ALL(acute lymphoblastic leukemia) of the immunological subtypes T-ALL and BCP-ALL (B cell precursor ALL including pre-pre B-ALL, cALL and pre B-ALL), of AMLL (acute mixed-lineage leukemia), and of CML (chronic myeloid leukemia) in lymphoid or mixed blast crisis.  Analysis of cell surface expression of FLT3R by flow cytometry confirmed these observations for AML (66% positivity when the data from all studies are combined), BCP-ALL (64%) and CML lymphoid blast crisis (86%) whereas less than 30% of T-ALL were FLT3R+.  The myeloid, monocytic and pre B cell type categories also contained the highest proportions of FLT3R+ leukemia cell lines .  In contrast to the selective expression of the receptor, FL expression was detected in 90-100% of the various cell types of leukemia cell lines from all hematopoietic cell lineages.  The potential of FL to induce proliferation of leukemia cells in vitro was also examined in primary and continuously cultured leukemia cells.  The data on FL-stimulated leukemia cell growth underline the extensive heterogeneity of primary AML and ALL samples in terms of cytokine-inducible DNA synthesis that has been seen with other effective cytokines.  While the majority of T-ALL (0-33% of the cases responded proliferatively; mean 11%) and BCP-ALL (0-30%; mean 20%) failed to proliferate in the presence of FL despite strong expression of surface FLT3R, FL caused a proliferative response in a significantly higher percentage of AML cases (22-90%; mean 53%).  In the panel of leukemia cell lines examined only myeloid and monocytic growth factor- dependent cell lines increased their proliferation upon incubation with FL, whereas all growth factor-independent cell lines were refractory to stimulation.  Combinations of FL with G-CSF, GM-CSF, M-CSF, IL-3, PIXY- 321 or SCF and FL with IL-3 or IL-7 had synergistic or additive mitogenic effects on primary AML and ALL cells, respectively.  The potent stimulation of the myelomonocytic cell lines was further augmented by addition of bFGF (basic fibroblast growth factor), GM-CSF, IL-3 or SCF.  The inhibitory effects of TGF-beta 1 (transforming growth factor-beta 1) on FL- supported proliferation were abrogated by bFGF.  Taken together, these results demonstrate the expression of functional FLT3R capable of mediating FL- dependent mitogenic signaling in a subset of AML and ALL cases further underline the heterogeneity of AML and ALL samples in their proliferative response to cytokine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_MDUZMlgnZlm8bhe6roZYfW6udTcc2eaJwuafpAsg0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283gtV2qsA%253D%253D&md5=d9d427a65fa9b8b1b279c442d353f18f</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrexler%26aufirst%3DH.%2BG.%26atitle%3DExpression%2520of%2520FLT3%2520receptor%2520and%2520response%2520to%2520FLT3%2520ligand%2520by%2520leukemic%2520cells%26jtitle%3DLeukemia%26date%3D1996%26volume%3D10%26spage%3D588%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. C.</span></span> <span> </span><span class="NLM_article-title">Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.2174/1389557043487394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F1389557043487394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15032673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=255-271&author=M.+C.+Heinrich&title=Targeting+FLT3+kinase+in+acute+myelogenous+leukemia%3A+progress%2C+perils%2C+and+prospects&doi=10.2174%2F1389557043487394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects</span></div><div class="casAuthors">Heinrich, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-271</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Activating mutations of the FLT3 receptor tyrosine kinase are the most common recurring genetic abnormality in acute myelogenous leukemia (AM).  Inhibition of FLT3 kinase activity by small mol. inhibitors has been proposed as a novel therapeutic approach AML.  The pre-clin. and clin. development of candidate FLT3 inhibitors will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpymzaJRL2RMLVg90H21EOLACvtfcHk0lhax6H5ZEfb5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKhtbc%253D&md5=9894e760a02d0a6c81a507124dac3f50</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.2174%2F1389557043487394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557043487394%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26atitle%3DTargeting%2520FLT3%2520kinase%2520in%2520acute%2520myelogenous%2520leukemia%253A%2520progress%252C%2520perils%252C%2520and%2520prospects%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D255%26epage%3D271%26doi%3D10.2174%2F1389557043487394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprankle, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardane, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, S. S.</span></span> <span> </span><span class="NLM_article-title">Identification of N-(5-tert-butyl-isoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1, 3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7808</span>– <span class="NLM_lpage">7816</span>, <span class="refDoi"> DOI: 10.1021/jm9007533</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9007533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7808-7816&author=Q.+Chaoauthor=K.+G.+Sprankleauthor=R.+M.+Grotzfeldauthor=A.+G.+Laiauthor=T.+A.+Carterauthor=A.+M.+Velascoauthor=R.+N.+Gunawardaneauthor=M.+D.+Cramerauthor=M.+F.+Gardnerauthor=J.+Jamesauthor=P.+P.+Zarrinkarauthor=H.+K.+Patelauthor=S.+S.+Bhagwat&title=Identification+of+N-%285-tert-butyl-isoxazol-3-yl%29-N%E2%80%99-%7B4-%5B7-%282-morpholin-4-yl-ethoxy%29imidazo%5B2%2C1-b%5D%5B1%2C+3%5Dbenzothiazol-2-yl%5Dphenyl%7Durea+dihydrochloride+%28AC220%29%2C+a+uniquely+potent%2C+selective%2C+and+efficacious+FMS-like+tyrosine+kinase-3+%28FLT3%29+inhibitor&doi=10.1021%2Fjm9007533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor</span></div><div class="casAuthors">Chao, Qi; Sprankle, Kelly G.; Grotzfeld, Robert M.; Lai, Andiliy G.; Carter, Todd A.; Velasco, Anne Marie; Gunawardane, Ruwanthi N.; Cramer, Merryl D.; Gardner, Michael F.; James, Joyce; Zarrinkar, Patrick P.; Patel, Hitesh K.; Bhagwat, Shripad S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7808-7816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of AML patients with small mol. inhibitors of FLT3 kinase has been explored as a viable therapy.  However, these agents are found to be less than optimal for the treatment of AML because of lack of sufficient potency or suboptimal oral pharmacokinetics (PK) or lack of adequate tolerability at efficacious doses.  We have developed a series of extremely potent and highly selective FLT3 inhibitors with good oral PK properties.  The first series of compds. represented by 1 (AB530) was found to be a potent and selective FLT3 kinase inhibitor with good PK properties.  The aq. soly. and oral PK properties at higher doses in rodents were found to be less than optimal for clin. development.  A novel series of compds. were designed lacking the carboxamide group of 1 with an added water solubilizing group.  Compd. 7 (AC220) was identified from this series to be the most potent and selective FLT3 inhibitor with good pharmaceutical properties, excellent PK profile, and superior efficacy and tolerability in tumor xenograft models.  Compd. 7 has demonstrated a desirable safety and PK profile in humans and is currently in phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAtNhT4frlQ7Vg90H21EOLACvtfcHk0lhax6H5ZEfb5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7zK&md5=1b64254428a51c637da0ff647ac8d567</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1021%2Fjm9007533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9007533%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DQ.%26aulast%3DSprankle%26aufirst%3DK.%2BG.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DGunawardane%26aufirst%3DR.%2BN.%26aulast%3DCramer%26aufirst%3DM.%2BD.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DJ.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26atitle%3DIdentification%2520of%2520N-%25285-tert-butyl-isoxazol-3-yl%2529-N%25E2%2580%2599-%257B4-%255B7-%25282-morpholin-4-yl-ethoxy%2529imidazo%255B2%252C1-b%255D%255B1%252C%25203%255Dbenzothiazol-2-yl%255Dphenyl%257Durea%2520dihydrochloride%2520%2528AC220%2529%252C%2520a%2520uniquely%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520FMS-like%2520tyrosine%2520kinase-3%2520%2528FLT3%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7808%26epage%3D7816%26doi%3D10.1021%2Fjm9007533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><a href="https://clinicaltrials.gov/ct2/results?term=quizartinib&amp;Search=Search" class="extLink">https://clinicaltrials.gov/ct2/results?term=quizartinib&Search=Search</a> (accessed April 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fterm%3Dquizartinib%26Search%3DSearch+%28accessed+April+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Accumulation of FLT3(+) CD11c (+) dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor</span>. <i>Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1007/s12026-014-8521-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs12026-014-8521-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24895100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFelt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=112-126&author=H.+X.+Yanauthor=W.+W.+Liauthor=Y.+Zhangauthor=X.+W.+Weiauthor=L.+X.+Fuauthor=G.+B.+Shenauthor=T.+Yinauthor=X.+Y.+Liauthor=H.+S.+Shiauthor=Y.+Wanauthor=Q.+Y.+Zhangauthor=J.+Liauthor=S.+Y.+Yangauthor=Y.+Q.+Wei&title=Accumulation+of+FLT3%28%2B%29+CD11c+%28%2B%29+dendritic+cells+in+psoriatic+lesions+and+the+anti-psoriatic+effect+of+a+selective+FLT3+inhibitor&doi=10.1007%2Fs12026-014-8521-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of FLT3+ CD11c+ dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor</span></div><div class="casAuthors">Yan, Heng-Xiu; Li, Wei-Wei; Zhang, Yan; Wei, Xia-Wei; Fu, Li-Xin; Shen, Guo-Bo; Yin, Tao; Li, Xiu-Ying; Shi, Hua-Shan; Wan, Yang; Zhang, Qing-Yin; Li, Jiong; Yang, Sheng-Yong; Wei, Yu-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Immunologic Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-126</span>CODEN:
                <span class="NLM_cas:coden">IMRSEB</span>;
        ISSN:<span class="NLM_cas:issn">0257-277X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Psoriasis is a common chronic T-cell-mediated autoimmune skin disease, and traditional immunotherapies for psoriasis have focused on the direct inhibition of T cells, which often causes toxicity and lacks long-term effectiveness.  Safe and effective therapeutic strategies are strongly needed for psoriasis.  In this study, we show for the first time a significant accumulation of FLT3+ CD11c+ dendritic cells (DCs) in human psoriatic lesions and in the skin of exptl. preclin. K14-VEGF transgenic homozygous mice, our animal model, although not an exact match for human psoriasis, displays many characteristics of inflammatory skin inflammation.  SKLB4771, a potent and selective FLT3 inhibitor that we designed and synthesized, was used to treat cutaneous inflammation and psoriasis-like symptoms of disease in mice and almost completely cured the psoriasis-like disease without obvious toxicity.  Mechanistic studies indicated that SKLB4771 treatment significantly decreased the no. and activation of pDCs and mDCs in vitro and in vivo, and subsequent T-cell cascade reactions mediated by Th1/Th17 pathways.  These findings show that targeted inhibition of FLT3, and hence direct interference with DCs, may be a novel therapeutic approach for the treatment of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-pjgFK0m2irVg90H21EOLACvtfcHk0liP5e3ZJimhdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFelt7g%253D&md5=cccc42ce83e27f8d222d9f3087481a1a</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1007%2Fs12026-014-8521-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12026-014-8521-4%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%2BX.%26aulast%3DLi%26aufirst%3DW.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DX.%2BW.%26aulast%3DFu%26aufirst%3DL.%2BX.%26aulast%3DShen%26aufirst%3DG.%2BB.%26aulast%3DYin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DShi%26aufirst%3DH.%2BS.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DWei%26aufirst%3DY.%2BQ.%26atitle%3DAccumulation%2520of%2520FLT3%2528%252B%2529%2520CD11c%2520%2528%252B%2529%2520dendritic%2520cells%2520in%2520psoriatic%2520lesions%2520and%2520the%2520anti-psoriatic%2520effect%2520of%2520a%2520selective%2520FLT3%2520inhibitor%26jtitle%3DImmunol.%2520Res.%26date%3D2014%26volume%3D60%26spage%3D112%26epage%3D126%26doi%3D10.1007%2Fs12026-014-8521-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Drug discovery against psoriasis: identification of a new potent FMS-like tyrosine kinase 3 (FLT3) inhibitor, 1-(4-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)iso xazol-3-yl)urea, that showed potent activity in a psoriatic animal model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8293</span>– <span class="NLM_lpage">8305</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOgt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8293-8305&author=G.+B.+Liauthor=S.+Maauthor=L.+L.+Yangauthor=S.+Jiauthor=Z.+Fangauthor=G.+Zhangauthor=L.+J.+Wangauthor=J.+M.+Zhongauthor=Y.+Xiongauthor=J.+H.+Wangauthor=S.+Z.+Huangauthor=L.+L.+Liauthor=R.+Xiangauthor=D.+Niuauthor=Y.+C.+Chenauthor=S.+Y.+Yang&title=Drug+discovery+against+psoriasis%3A+identification+of+a+new+potent+FMS-like+tyrosine+kinase+3+%28FLT3%29+inhibitor%2C+1-%284-%28%281H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-yl%29oxy%29-3-fluorophenyl%29-3-%285-%28tert-butyl%29iso+xazol-3-yl%29urea%2C+that+showed+potent+activity+in+a+psoriatic+animal+model&doi=10.1021%2Facs.jmedchem.6b00604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model</span></div><div class="casAuthors">Li, Guo-Bo; Ma, Shuang; Yang, Ling-Ling; Ji, Sen; Fang, Zhen; Zhang, Guo; Wang, Li-Jiao; Zhong, Jie-Min; Xiong, Yu; Wang, Jiang-Hong; Huang, Shen-Zhen; Li, Lin-Li; Xiang, Rong; Niu, Dawen; Chen, Ying-Chun; Yang, Sheng-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8293-8305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Psoriasis is a chronic T-cell-mediated autoimmune disease, and FMS-like tyrosine kinase 3 (FLT3) has been considered as a potential mol. target for the treatment of psoriasis.  In this investigation, structural optimization was performed on a lead compd., 1-(4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl)-3-(4-chloro-3- (trifluoromethyl)phenyl)urea, which showed a moderate inhibitory activity against FLT3.  A series of pyrazolo[3,4-d]pyrimidine derivs. were synthesized, and structure-activity relationship anal. led to the discovery of a no. of potent FLT3 inhibitors.  One of the most active compds., 1-(4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-3-fluorophenyl)-3-(5-tert-butylisoxazol-3-yl)urea (I), was then chosen for in-depth anti-psoriasis studies because this compd. displayed the highest potency in a preliminary anti-psoriasis test.  Compd. I exhibited significant anti-psoriatic effects in the K14-VEGF transgenic mouse model of psoriasis, and no recurrence was found 15 days later after the last administration.  Detailed mechanisms of action of compd. I were also investigated.  Collectively, compd. I could be a potential drug candidate for psoriasis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbj6cxXp78VbVg90H21EOLACvtfcHk0liP5e3ZJimhdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOgt73L&md5=82b107175f8c3b7a2e1fc3e5db6d488e</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00604%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BB.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%2BL.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DZhong%26aufirst%3DJ.%2BM.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DHuang%26aufirst%3DS.%2BZ.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DDrug%2520discovery%2520against%2520psoriasis%253A%2520identification%2520of%2520a%2520new%2520potent%2520FMS-like%2520tyrosine%2520kinase%25203%2520%2528FLT3%2529%2520inhibitor%252C%25201-%25284-%2528%25281H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-yl%2529oxy%2529-3-fluorophenyl%2529-3-%25285-%2528tert-butyl%2529iso%2520xazol-3-yl%2529urea%252C%2520that%2520showed%2520potent%2520activity%2520in%2520a%2520psoriatic%2520animal%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8293%26epage%3D8305%26doi%3D10.1021%2Facs.jmedchem.6b00604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhmanova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, M. O.</span></span> <span> </span><span class="NLM_article-title">Control of microtubule organization and dynamics: two ends in the limelight</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1038/nrm4084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnrm4084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26562752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=711-726&author=A.+Akhmanovaauthor=M.+O.+Steinmetz&title=Control+of+microtubule+organization+and+dynamics%3A+two+ends+in+the+limelight&doi=10.1038%2Fnrm4084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Control of microtubule organization and dynamics: two ends in the limelight</span></div><div class="casAuthors">Akhmanova, Anna; Steinmetz, Michel O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">711-726</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules have fundamental roles in many essential biol. processes, including cell division and intracellular transport.  They assemble and disassemble from their two ends, denoted the plus end and the minus end.  Significant advances have been made in our understanding of microtubule plus-end-tracking proteins (+TIPs) such as end-binding protein 1 (EB1), XMAP215, selected kinesins and dynein.  By contrast, information on microtubule minus-end-targeting proteins (-TIPs), such as the calmodulin-regulated spectrin-assocd. proteins (CAMSAPs) and Patronin, has only recently started to emerge.  Here, we review our current knowledge of factors, including microtubule-targeting agents, that assoc. with microtubule ends to control the dynamics and function of microtubules during the cell cycle and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps4xzvh0o6PbVg90H21EOLACvtfcHk0liRWvLn2_I1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7%252FI&md5=7c941bcce8d5d51aef6a8deb140356d3</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1038%2Fnrm4084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm4084%26sid%3Dliteratum%253Aachs%26aulast%3DAkhmanova%26aufirst%3DA.%26aulast%3DSteinmetz%26aufirst%3DM.%2BO.%26atitle%3DControl%2520of%2520microtubule%2520organization%2520and%2520dynamics%253A%2520two%2520ends%2520in%2520the%2520limelight%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D711%26epage%3D726%26doi%3D10.1038%2Fnrm4084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kueh, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span> <span> </span><span class="NLM_article-title">Structural plasticity in actin and tubulin polymer dynamics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">960</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1126/science.1168823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1126%2Fscience.1168823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19696342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtValsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=960-963&author=H.+Y.+Kuehauthor=T.+J.+Mitchison&title=Structural+plasticity+in+actin+and+tubulin+polymer+dynamics&doi=10.1126%2Fscience.1168823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Structural plasticity in actin and tubulin polymer dynamics</span></div><div class="casAuthors">Kueh, Hao Yuan; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5943</span>),
    <span class="NLM_cas:pages">960-963</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Actin filaments and microtubules polymerize and depolymerize by adding and removing subunits.  Since A. Wegner (1976) proposed the treadmilling theory for actin, it has largely been assumed that the chem. state of the bound nucleotide dets. the rates of subunit addn. and removal.  This chem. kinetics view is difficult to reconcile with observations revealing multiple structural states of the polymer that influence polymn. dynamics but that are not strictly coupled to the bound nucleotide state.  The authors refer to these phenomena as "structural plasticity" and discuss emerging evidence that they play a central role in polymer dynamics and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraIvJeoXqOabVg90H21EOLACvtfcHk0liRWvLn2_I1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtValsrnN&md5=bbb2322ee14296739eff093d66e3ae71</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168823%26sid%3Dliteratum%253Aachs%26aulast%3DKueh%26aufirst%3DH.%2BY.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DStructural%2520plasticity%2520in%2520actin%2520and%2520tubulin%2520polymer%2520dynamics%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D960%26epage%3D963%26doi%3D10.1126%2Fscience.1168823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span> <span> </span><span class="NLM_article-title">Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3094</span>– <span class="NLM_lpage">3103</span>, <span class="refDoi"> DOI: 10.1021/jm070890u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070890u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3094-3103&author=D.+Q.+Songauthor=Y.+Wangauthor=L.+Z.+Wuauthor=P.+Yangauthor=Y.+M.+Wangauthor=L.+M.+Gaoauthor=Y.+Liauthor=J.+R.+Quauthor=Y.+H.+Wangauthor=Y.+H.+Liauthor=N.+N.+Duauthor=Y.+X.+Hanauthor=Z.+P.+Zhangauthor=J.+D.+Jiang&title=Benzoylurea+derivatives+as+a+novel+class+of+antimitotic+agents%3A+synthesis%2C+anticancer+activity%2C+and+structure-activity+relationships&doi=10.1021%2Fjm070890u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoylurea Derivatives as a Novel Class of Antimitotic Agents: Synthesis, Anticancer Activity, and Structure-Activity Relationships</span></div><div class="casAuthors">Song, Dan-Qing; Wang, Yan; Wu, Lian-Zong; Yang, Peng; Wang, Yue-Ming; Gao, Li-Mei; Li, Yan; Qu, Jing-Rong; Wang, Yong-Hong; Li, Ying-Hong; Du, Na-Na; Han, Yan-Xing; Zhang, Zhi-Ping; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3094-3103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Forty-six new compds. I (R1 = H, 2-Me, 4-MeO, 6-Br, 5-COOMe, etc.; R2 = CH2Br, CH2Cl, CH2I, CHBrMe, CHClMe) and II (X = O, S) were synthesized as 3-haloacylamino benzoylurea analogs and their anticancer activity has been studied.  Structure-activity relationship (SAR) anal. indicated that (i) the configuration of the chiral center in I (R1 = H; R2 = CHBrMe) is not indispensable for the activity, (ii) the Ph ring is essential, and (iii) a substitution at the 6-position of the Ph ring with a halogen enhances the activity.  Among the analogs, I (R1 = 6-F; R2 = CH2Br, CH2I) bearing 6-fluoro substituent showed potent activities against nine human tumor cell lines, including CEM (leukemia), Daudi (lymphoma), MCF-7 (breast cancer), Bel-7402 (hepatoma), DU-145 (prostate cancer), PC-3 (prostate cancer), DND-1A (melanoma), LOVO (colon cancer), and MIA Paca (pancreatic cancer) with IC50 values between 0.01 and 0.30 μM.  I (R1 = 6-F; R2 = CH2I) inhibited human hepatocarcinoma by 86% in vol. in nude mice.  The mechanism of action for this compd. is to inhibit microtubule assembly, followed by the M-phase arrest, bcl-2 inactivation, and then apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ3kIz_0cP4LVg90H21EOLACvtfcHk0liRWvLn2_I1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVKntLg%253D&md5=a9e11b26f34c21b844ebe435857f6a7c</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1021%2Fjm070890u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070890u%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.%2BQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%2BZ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DGao%26aufirst%3DL.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DLi%26aufirst%3DY.%2BH.%26aulast%3DDu%26aufirst%3DN.%2BN.%26aulast%3DHan%26aufirst%3DY.%2BX.%26aulast%3DZhang%26aufirst%3DZ.%2BP.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26atitle%3DBenzoylurea%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520antimitotic%2520agents%253A%2520synthesis%252C%2520anticancer%2520activity%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3094%26epage%3D3103%26doi%3D10.1021%2Fjm070890u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1007/s10637-010-9577-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs10637-010-9577-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21080210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=490-507&author=J.+Zhangauthor=J.+Zhouauthor=X.+Renauthor=Y.+Diaoauthor=H.+Liauthor=H.+Jiangauthor=K.+Dingauthor=D.+Pei&title=A+new+diaryl+urea+compound%2C+D181%2C+induces+cell+cycle+arrest+in+the+G1+and+M+phases+by+targeting+receptor+tyrosine+kinases+and+the+microtubule+skeleton&doi=10.1007%2Fs10637-010-9577-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton</span></div><div class="casAuthors">Zhang, Jin; Zhou, Jing; Ren, Xiaomei; Diao, Yanyan; Li, Honglin; Jiang, Hualiang; Ding, Ke; Pei, Duanqing</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">490-507</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Receptor tyrosine kinases (RTKs) modulate a variety of cellular events, including cell proliferation, differentiation, mobility and apoptosis.  In addn., RTKs have been validated as targets for cancer therapies.  Microtubules are another class of proven targets for many clin. anticancer drugs.  Here, we report that 1-(4-chloro-3-(trifluoromethyl) phenyl)-3-(2-cyano-4-hydroxyphenyl)urea (D181) functions as both a receptor tyrosine kinase inhibitor and a tubulin polymn. enhancer.  D181 displayed potent inhibitory activities against a panel of RTKs, including Flt3, VEGFR, cKit, FGFR1 and PDGFRβ.  D181 also enhanced tubulin polymn. and modified the secondary structure of tubulin proteins to disrupt their dynamic instability.  Because of synergistic cooperation, D181 strongly inhibited the proliferation of various cancer cell lines, induced LoVo cell cycle arrest in the G1 and M phases and suppressed tumor growth in nude mice bearing human LoVo and HT29 xenografts.  Our studies have provided a new, promising lead compd. and novel clues for multi-target anticancer drug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyanTqNl3fSrVg90H21EOLACvtfcHk0lh_eiCDcwmZhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGmsbc%253D&md5=b410c9d24274f9b50f60093efeb80032</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1007%2Fs10637-010-9577-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-010-9577-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DDiao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DA%2520new%2520diaryl%2520urea%2520compound%252C%2520D181%252C%2520induces%2520cell%2520cycle%2520arrest%2520in%2520the%2520G1%2520and%2520M%2520phases%2520by%2520targeting%2520receptor%2520tyrosine%2520kinases%2520and%2520the%2520microtubule%2520skeleton%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D490%26epage%3D507%26doi%3D10.1007%2Fs10637-010-9577-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leggans, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleicher, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20’ urea derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1021/jm3015684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3015684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=628-639&author=E.+K.+Leggansauthor=K.+K.+Duncanauthor=T.+J.+Barkerauthor=K.+D.+Schleicherauthor=D.+L.+Boger&title=A+remarkable+series+of+vinblastine+analogues+displaying+enhanced+activity+and+an+unprecedented+tubulin+binding+steric+tolerance%3A+C20%E2%80%99+urea+derivatives&doi=10.1021%2Fjm3015684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">A Remarkable Series of Vinblastine Analogues Displaying Enhanced Activity and an Unprecedented Tubulin Binding Steric Tolerance: C20' Urea Derivatives</span></div><div class="casAuthors">Leggans, Erick K.; Duncan, Katharine K.; Barker, Timothy J.; Schleicher, Kristin D.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">628-639</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A systematic series of previously inaccessible key C20' urea and thiourea derivs. of vinblastine were prepd. from 20'-aminovinblastine that was made accessible through a unique Fe(III)/NaBH4-mediated alkene functionalization reaction of anhydrovinblastine.  Their examn. defined key structural features of the urea-based analogs that contribute to their properties and provided derivs. that match or exceed the potency of vinblastine by as much as 10-fold in cell-based functional assays, which is directly related to their relative tubulin binding affinity.  In contrast to expectations based on apparent steric constraints of the tubulin binding site surrounding the vinblastine C20' center depicted in an X-ray cocrystal structure, remarkably large C20' urea derivs. are accommodated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyFGNDiwuMM7Vg90H21EOLACvtfcHk0lh_eiCDcwmZhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqs7fJ&md5=3af29fd43a2de5b0d6bcc7f79f5ce280</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1021%2Fjm3015684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3015684%26sid%3Dliteratum%253Aachs%26aulast%3DLeggans%26aufirst%3DE.%2BK.%26aulast%3DDuncan%26aufirst%3DK.%2BK.%26aulast%3DBarker%26aufirst%3DT.%2BJ.%26aulast%3DSchleicher%26aufirst%3DK.%2BD.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DA%2520remarkable%2520series%2520of%2520vinblastine%2520analogues%2520displaying%2520enhanced%2520activity%2520and%2520an%2520unprecedented%2520tubulin%2520binding%2520steric%2520tolerance%253A%2520C20%25E2%2580%2599%2520urea%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D628%26epage%3D639%26doi%3D10.1021%2Fjm3015684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gagne-Boulet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacroix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">R, C. G.</span></span> <span> </span><span class="NLM_article-title">Styryl-N-phenyl-N’-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26069928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=34-43&author=M.+Gagne-Bouletauthor=S.+Fortinauthor=J.+Lacroixauthor=C.+A.+Lefebvreauthor=M.+F.+Coteauthor=C.+G.+R&title=Styryl-N-phenyl-N%E2%80%99-%282-chloroethyl%29ureas+and+styrylphenylimidazolidin-2-ones+as+new+potent+microtubule-disrupting+agents+using+combretastatin+A-4+as+model&doi=10.1016%2Fj.ejmech.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model</span></div><div class="casAuthors">Gagne-Boulet, Mathieu; Fortin, Sebastien; Lacroix, Jacques; Lefebvre, Carole-Anne; Cote, Marie-France; C.-Gaudreault, Rene</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Combretastatin A-4 (CA-4) is a well-studied and attractive mol. template to develop new antimitotics.  Several thousand of modifications were performed on the ring B and the ethenyl bridge of CA-4 but only a few involved the trimethoxyphenyl moiety (TMP, ring A) often considered essential to the antiproliferative and antimicrotubule activities.  In this study, the authors described the design, the prepn., the characterization and the biol. evaluation of three new series of CA-4 analogs namely styryl-N-phenyl-N'-ethylureas (SEUs), styryl-N-phenyl-N'-(2-chloroethyl)ureas I [R = 3-Cl; 3,5-Me; 3,4,5-MeO] (SCEUs) and styrylphenylimidazolidin-2-ones (SIMZs) II [R = 3-Cl; 3,5-Me; 3,4,5-MeO].  All SCEU and SIMZ Z-isomers were active in the high and the low nanomolar range, resp.  Conversely to SEUs and their E-isomers that were significantly less active or inactive.  Interestingly, the TMP moiety is giving rise to derivs. exhibiting the lowest antiproliferative activity in the SCEU series I [R = 3,4,5-MeO] and the most active compd. in the SIMZ series II [R = 3,4,5-MeO].  Moreover, Z-isomers of II [R = 3-Cl] or II [R = 3,5-Me] exhibited antiproliferative activities that are also in the same order of magnitude as II [R = 3,4,5-MeO].  All SCEU and SIMZ Z-isomers also arrested the cell cycle progression in G2/M phase, bound to the colchicine-binding site and disrupted the cytoskeleton of cancer cells.  In addn. to the promising and innovative microtubule-disrupting properties of SCEUs and SIMZs, these results show that the TMP moiety is not essential for the cytocidal activity of these new CA-4 analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2U9fMsB49q7Vg90H21EOLACvtfcHk0ljPWY6jOEOAkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjO&md5=ea36725803d74dc3fbbd99a44565c1a9</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DGagne-Boulet%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DS.%26aulast%3DLacroix%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DC.%2BA.%26aulast%3DCote%26aufirst%3DM.%2BF.%26aulast%3DR%26aufirst%3DC.%2BG.%26atitle%3DStyryl-N-phenyl-N%25E2%2580%2599-%25282-chloroethyl%2529ureas%2520and%2520styrylphenylimidazolidin-2-ones%2520as%2520new%2520potent%2520microtubule-disrupting%2520agents%2520using%2520combretastatin%2520A-4%2520as%2520model%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D100%26spage%3D34%26epage%3D43%26doi%3D10.1016%2Fj.ejmech.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peserico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, C.</span></span> <span> </span><span class="NLM_article-title">Physical and functional HAT/HDAC interplay regulates protein acetylation balance</span>. <i>J. Biomed. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">371832</span>, <span class="refDoi"> DOI: 10.1155/2011/371832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1155%2F2011%2F371832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21151613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1Wjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=371832&author=A.+Pesericoauthor=C.+Simone&title=Physical+and+functional+HAT%2FHDAC+interplay+regulates+protein+acetylation+balance&doi=10.1155%2F2011%2F371832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Physical and functional HAT/HDAC interplay regulates protein acetylation balance</span></div><div class="casAuthors">Peserico Alessia; Simone Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedicine & biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371832</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The balance between protein acetylation and deacetylation controls several physiological and pathological cellular processes, and the enzymes involved in the maintenance of this equilibrium-acetyltransferases (HATs) and deacetylases (HDACs)-have been widely studied.  Presently, the evidences obtained in this field suggest that the dynamic acetylation equilibrium is mostly maintained through the physical and functional interplay between HAT and HDAC activities.  This model overcomes the classical vision in which the epigenetic marks of acetylation have only an activating function whereas deacetylation marks have a repressing activity.  Given the existence of several players involved in the preservation of this equilibrium, the identification of these complex networks of interacting proteins will likely foster our understanding of how cells regulate intracellular processes and respond to the extracellular environment and will offer the rationale for new therapeutic approaches based on epigenetic drugs in human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRprtziIe4zZApJitSxOdIlfW6udTcc2ebI4X_LCJBLE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1Wjtw%253D%253D&md5=f0530de3d94caae16715b232b30d3c65</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1155%2F2011%2F371832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F371832%26sid%3Dliteratum%253Aachs%26aulast%3DPeserico%26aufirst%3DA.%26aulast%3DSimone%26aufirst%3DC.%26atitle%3DPhysical%2520and%2520functional%2520HAT%252FHDAC%2520interplay%2520regulates%2520protein%2520acetylation%2520balance%26jtitle%3DJ.%2520Biomed.%2520Biotechnol.%26date%3D2011%26volume%3D2011%26spage%3D371832%26doi%3D10.1155%2F2011%2F371832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5310</span>– <span class="NLM_lpage">5318</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fsj.onc.1210599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17694074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5310-5318&author=X.+J.+Yangauthor=E.+Seto&title=HATs+and+HDACs%3A+from+structure%2C+function+and+regulation+to+novel+strategies+for+therapy+and+prevention&doi=10.1038%2Fsj.onc.1210599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span></div><div class="casAuthors">Yang, X.-J.; Seto, E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5310-5318</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The acetylation of the ε-NH2 group of a Lys residue was 1st discovered with histones in 1968, but the responsible enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs), were not identified until the mid-1990s.  In the past decade, knowledge about this modification has exploded, with targets rapidly expanding from histones to transcription factors and other nuclear proteins, and then to the cytoskeleton, metabolic enzymes, and signaling regulators in the cytoplasm.  Thus, protein Lys acetylation has emerged as a major post-translational modification to rival phosphorylation.  Here, various aspects of the enzymes governing Lys acetylation, esp. about their intimate links to cancer are reviewed.  For central themes are highlighted: (1) multisubunit enzymic complexes; (2) non-histone substrates in diverse cellular processes; (3) interplay of Lys acetylation with other regulatory mechanisms, such as noncoding RNA-mediated gene silencing and activation; and (4) novel therapeutic strategies and preventive measures to combat cancer and other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuGSkc-b3umrVg90H21EOLACvtfcHk0ljPWY6jOEOAkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D&md5=de49d71791356a55d90fd797cbecaf4b</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210599%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BJ.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHATs%2520and%2520HDACs%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520novel%2520strategies%2520for%2520therapy%2520and%2520prevention%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5310%26epage%3D5318%26doi%3D10.1038%2Fsj.onc.1210599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9891</span>– <span class="NLM_lpage">9899</span>, <span class="refDoi"> DOI: 10.1021/jm301098e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9891-9899&author=J.+A.+Bergmanauthor=K.+Woanauthor=P.+Perez-Villarroelauthor=A.+Villagraauthor=E.+M.+Sotomayorauthor=A.+P.+Kozikowski&title=Selective+histone+deacetylase+6+inhibitors+bearing+substituted+urea+linkers+inhibit+melanoma+cell+growth&doi=10.1021%2Fjm301098e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span></div><div class="casAuthors">Bergman, Joel A.; Woan, Karrune; Perez-Villarroel, Patricio; Villagra, Alejandro; Sotomayor, Eduardo M.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9891-9899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incidence of malignant melanoma has dramatically increased in recent years thus requiring the need for improved therapeutic strategies.  In our efforts to design selective histone deactylase inhibitors (HDACI), we discovered that the aryl urea 1 is a modestly potent yet nonselective inhibitor.  Structure-activity relationship studies revealed that adding substituents to the nitrogen atom of the urea so as to generate compds. bearing a branched linker group results in increased potency and selectivity for HDAC6.  Compd. 5g shows low nanomolar inhibitory potency against HDAC6 and a selectivity of ∼600-fold relative to the inhibition of HDAC1.  These HDACIs were evaluated for their ability to inhibit the growth of B16 melanoma cells with the most potent and selective HDAC6I being found to decrease tumor cell growth.  To the best of our knowledge, this work constitutes the first report of HDAC6-selective inhibitors that possess antiproliferative effects against melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkTtPLqvwsrVg90H21EOLACvtfcHk0ljPWY6jOEOAkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ&md5=d6be4c0efb3922fc35d814ba00ae9ed1</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1021%2Fjm301098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301098e%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DWoan%26aufirst%3DK.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DVillagra%26aufirst%3DA.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%2520histone%2520deacetylase%25206%2520inhibitors%2520bearing%2520substituted%2520urea%2520linkers%2520inhibit%2520melanoma%2520cell%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9891%26epage%3D9899%26doi%3D10.1021%2Fjm301098e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnekenburger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazumder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogister, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouider, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefranc, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklos, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Tullio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of R/S-N-3-cyanophenyl-N’-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1- benzopyran-4-yl)urea, a new histone deacetylase class III inhibitor exerting antiproliferative activity against cancer cell lines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4714</span>– <span class="NLM_lpage">4733</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00533</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1Cgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4714-4733&author=M.+Schnekenburgerauthor=E.+Goffinauthor=J.+Y.+Leeauthor=J.+Y.+Jangauthor=A.+Mazumderauthor=S.+Jiauthor=B.+Rogisterauthor=N.+Bouiderauthor=F.+Lefrancauthor=W.+Miklosauthor=V.+Mathieuauthor=P.+de+Tullioauthor=K.+W.+Kimauthor=M.+Dicatoauthor=W.+Bergerauthor=B.+W.+Hanauthor=R.+Kissauthor=B.+Pirotteauthor=M.+Diederich&title=Discovery+and+characterization+of+R%2FS-N-3-cyanophenyl-N%E2%80%99-%286-tert-butoxycarbonylamino-3%2C4-dihydro-2%2C2-dimethyl-2H-1-+benzopyran-4-yl%29urea%2C+a+new+histone+deacetylase+class+III+inhibitor+exerting+antiproliferative+activity+against+cancer+cell+lines&doi=10.1021%2Facs.jmedchem.7b00533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines</span></div><div class="casAuthors">Schnekenburger, Michael; Goffin, Eric; Lee, Jin-Young; Jang, Jun Young; Mazumder, Aloran; Ji, Seungwon; Rogister, Bernard; Bouider, Nafila; Lefranc, Florence; Miklos, Walter; Mathieu, Veronique; de Tullio, Pascal; Kim, Kyu-Won; Dicato, Mario; Berger, Walter; Han, Byung Woo; Kiss, Robert; Pirotte, Bernard; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4714-4733</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of (N-aryl-N'-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examd. as putative anticancer agents targeting sirtuins in glioma cells.  On the basis of computational docking combined to in vitro sirtuin 1/2 inhibition assays, we selected compd. I [R/S-N-3-cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea] which displays a potent antiproliferative activity on various glioma cell types, assessed by quant. video microscopy, eventually triggering senescence.  The impact on normal glial cells was lower with a selectivity index of >10.  Furthermore, human U373 and Hs683 glioblastoma cell lines served to demonstrate the inhibitory activity of I against histone deacetylase (HDAC) class III sirtuins 1 and 2 (SIRT1/2) by quantifying acetylation levels of histone and non-histone proteins.  The translational potential of I was validated by an NCI-60 cell line screen and validation of growth inhibition of drug resistant cancer cell models.  Eventually, the anticancer potential of I was validated in 3D glioblastoma spheroids and in vivo by zebrafish xenografts.  In summary, compd. I is the first representative of a new class of SIRT inhibitors opening new perspectives in the medicinal chem. of HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyMh16OaJ1hrVg90H21EOLACvtfcHk0lh6vhMhAi-ahQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1Cgsro%253D&md5=812f2ad6ed54dd8fd1e10ca7151562ab</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00533%26sid%3Dliteratum%253Aachs%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DJang%26aufirst%3DJ.%2BY.%26aulast%3DMazumder%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DRogister%26aufirst%3DB.%26aulast%3DBouider%26aufirst%3DN.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DMiklos%26aufirst%3DW.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DB.%2BW.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520R%252FS-N-3-cyanophenyl-N%25E2%2580%2599-%25286-tert-butoxycarbonylamino-3%252C4-dihydro-2%252C2-dimethyl-2H-1-%2520benzopyran-4-yl%2529urea%252C%2520a%2520new%2520histone%2520deacetylase%2520class%2520III%2520inhibitor%2520exerting%2520antiproliferative%2520activity%2520against%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4714%26epage%3D4733%26doi%3D10.1021%2Facs.jmedchem.7b00533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barinka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomper, M.</span></span> <span> </span><span class="NLM_article-title">Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.2174/092986712799034888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F092986712799034888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22214450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=856-870&author=C.+Barinkaauthor=C.+Rojasauthor=B.+Slusherauthor=M.+Pomper&title=Glutamate+carboxypeptidase+II+in+diagnosis+and+treatment+of+neurologic+disorders+and+prostate+cancer&doi=10.2174%2F092986712799034888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer</span></div><div class="casAuthors">Barinka, C.; Rojas, C.; Slusher, B.; Pomper, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">856-870</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate carboxypeptidase II (GCPII) is a membrane-bound binuclear zinc metallopeptidase with the highest expression levels found in the nervous and prostatic tissue.  Throughout the nervous system, glia-bound GCPII is intimately involved in the neuronneuron and neuron-glia signaling via the hydrolysis of N-acetylaspartylglutamate (NAAG), the most abundant mammalian peptidic neurotransmitter.  The inhibition of the GCPII-controlled NAAG catabolism has been shown to attenuate neurotoxicity assocd. with enhanced glutamate transmission and GCPII-specific inhibitors demonstrate efficacy in multiple preclin. models including traumatic brain injury, stroke, neuropathic and inflammatory pain, amyotrophic lateral sclerosis, and schizophrenia.  The second major area of pharmacol. interventions targeting GCPII focuses on prostate carcinoma; GCPII expression levels are highly increased in androgen-independent and metastatic disease.  Consequently, the enzyme serves as a potential target for imaging and therapy.  This review offers a summary of GCPII structure, physiol. functions in healthy tissues, and its assocn. with various pathologies.  The review also outlines the development of GCPII-specific small-mol. compds. and their use in preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyUBiL7cpnjrVg90H21EOLACvtfcHk0lh6vhMhAi-ahQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D&md5=1d4a526d7ecd78b11f6b405112d6220a</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.2174%2F092986712799034888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799034888%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGlutamate%2520carboxypeptidase%2520II%2520in%2520diagnosis%2520and%2520treatment%2520of%2520neurologic%2520disorders%2520and%2520prostate%2520cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D856%26epage%3D870%26doi%3D10.2174%2F092986712799034888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silver, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellicer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fair, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heston, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordon-Cardo, C.</span></span> <span> </span><span class="NLM_article-title">Prostate-specific membrane antigen expression in normal and malignant human tissues</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9815541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=81-85&author=D.+A.+Silverauthor=I.+Pellicerauthor=W.+R.+Fairauthor=W.+D.+Hestonauthor=C.+Cordon-Cardo&title=Prostate-specific+membrane+antigen+expression+in+normal+and+malignant+human+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen expression in normal and malignant human tissues</span></div><div class="casAuthors">Silver D A; Pellicer I; Fair W R; Heston W D; Cordon-Cardo C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-5</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">Prostate-specific membrane antigen is a type II membrane protein with folate hydrolase activity produced by prostatic epithelium.  The expression of this molecule has also been documented in extraprostatic tissues, including small bowel and brain.  In the present study, an extensive immunohistochemical analysis was performed on a panel of well-characterized normal and malignant human tissues to further define the pattern of prostate-specific membrane antigen (PSMA) expression.  Detectable PSMA levels were identified in prostatic epithelium, duodenal mucosa, and a subset of proximal renal tubules.  A subpopulation of neuroendocrine cells in the colonic crypts also exhibited PSMA immunoreactivity.  All other normal tissues, including cerebral cortex and cerebellum, had undetectable levels of PSMA.  Thirty-three of 35 primary prostate adenocarcinomas and 7 of 8 lymph node metastases displayed tumor cell PSMA immunostaining.  Eight of 18 prostate tumors metastatic to bone expressed PSMA.  All of the other nonprostatic primary tumors studied had undetectable PSMA levels.  However, intense staining was observed in endothelial cells of capillary vessels in peritumoral and endotumoral areas of certain malignancies, including 8 of 17 renal cell carcinomas, 7 of 13 transitional cell carcinomas, and 3 of 19 colon carcinomas.  Extraprostatic PSMA expression appears to be highly restricted.  Nevertheless, its diverse anatomical distribution implies a broader functional significance than previously suspected.  The decrease in PSMA immunoreactivity noted in advanced prostate cancer suggests that expression of this molecule may be linked to the degree of tumor differentiation.  The neoexpression of PSMA in endothelial cells of capillary beds in certain tumors may be related to tumor angiogenesis and suggests a potential mechanism for specific targeting of tumor neovasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa3hRIf6mlYUcLvDNbOD4DfW6udTcc2eYiRtSvstAI27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D&md5=06fb3a1b21fc371a5e42843ed558e5eb</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DD.%2BA.%26aulast%3DPellicer%26aufirst%3DI.%26aulast%3DFair%26aufirst%3DW.%2BR.%26aulast%3DHeston%26aufirst%3DW.%2BD.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520expression%2520in%2520normal%2520and%2520malignant%2520human%2520tissues%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saji, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7890</span>– <span class="NLM_lpage">7901</span>, <span class="refDoi"> DOI: 10.1021/jm400895s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400895s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7890-7901&author=N.+Haradaauthor=H.+Kimuraauthor=M.+Onoauthor=H.+Saji&title=Preparation+of+asymmetric+urea+derivatives+that+target+prostate-specific+membrane+antigen+for+SPECT+imaging&doi=10.1021%2Fjm400895s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging</span></div><div class="casAuthors">Harada, Naoya; Kimura, Hiroyuki; Ono, Masahiro; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7890-7901</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA) has been identified as a diagnostic and therapeutic target for prostate cancer.  (S)-2-[3-[(R)-1-Carboxy-2-mercaptoethyl]ureido]pentanedioic acid (Cys-CO-Glu) were used to design novel PSMA targeting probes by nucleophilic conjugate addn. between cysteine and maleimide based reagents.  [123I]I ([123I]-IGLCE) was synthesized by this strategy and showed high affinity for PSMA.  Results of binding inhibition assays of these derivs. suggested the importance of an arom. group and succinimide moiety for high affinity.  [123I]I was evaluated in vivo with PSMA pos. LNCaP and PSMA neg. PC-3 human prostate cancer xenograft bearing mice.  [125I]I accumulated in LNCaP tumors but not in PC-3 tumors, and the accumulation was inhibited by 2-(phosphonomethyl)-pentanedioic acid (2-PMPA).  Use of [123I]I provided pos. images of LNCaP tumors in single photon emission tomog. scans.  These results warrant further evaluation of [123I]I and its derivs. as radiolabeled probes for the diagnosis of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWMd3vED-FxrVg90H21EOLACvtfcHk0lgtjMOJ9Iql6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbJ&md5=db971b6cfcf9a0a8f333f43a67822f4d</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1021%2Fjm400895s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400895s%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520asymmetric%2520urea%2520derivatives%2520that%2520target%2520prostate-specific%2520membrane%2520antigen%2520for%2520SPECT%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7890%26epage%3D7901%26doi%3D10.1021%2Fjm400895s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beliveau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasioukhin, V.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1352</span>– <span class="NLM_lpage">1362</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.18632%2Foncotarget.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24657880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC2crmtlensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1352-1362&author=X.+Tangauthor=S.+S.+Mahajanauthor=L.+T.+Nguyenauthor=F.+Beliveauauthor=R.+Leducauthor=J.+A.+Simonauthor=V.+Vasioukhin&title=Targeted+inhibition+of+cell-surface+serine+protease+Hepsin+blocks+prostate+cancer+bone+metastasis&doi=10.18632%2Foncotarget.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis</span></div><div class="casAuthors">Tang Xi; Mahajan Sumit S; Nguyen Liem T; Beliveau Francois; Leduc Richard; Simon Julian A; Vasioukhin Valeri</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1352-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of effective therapies inhibiting prostate cancer progression and metastasis may substantially impact prostate cancer mortality and potentially reduce the rates of invasive treatments by enhancing the safety of active surveillance strategies.  Hepsin (HPN) is a cell surface serine protease amplified in a subset of human sarcomas (7.2%), as well as in ovarian (10%), lung adeno (5.4%), lung squamous cell (4.5%), adenoid cystic (5%), breast (2.6%), uterine (1.7%) and colon (1.4%) carcinomas.  While HPN is not amplified in prostate cancer, it is one of the most prominently overexpressed genes in the majority of human prostate tumors and genetic experiments in mice indicate that Hepsin promotes prostate cancer metastasis, particularly metastasis to the bone marrow.  We report here the development, analysis and animal trial of the small-molecule Hepsin inhibitor HepIn-13.  Long-term exposure to HepIn-13 inhibited bone, liver and lung metastasis in a murine model of metastatic prostate cancer.  These findings indicate that inhibition of Hepsin with small-molecule compounds could provide an effective tool for attenuation of prostate cancer progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ4F7N8tAxh9LIORRPd5lbfW6udTcc2eYiRtSvstAI27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmtlensw%253D%253D&md5=8d1079ed49024e41ce122f378e1ab87d</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1817%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DNguyen%26aufirst%3DL.%2BT.%26aulast%3DBeliveau%26aufirst%3DF.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DVasioukhin%26aufirst%3DV.%26atitle%3DTargeted%2520inhibition%2520of%2520cell-surface%2520serine%2520protease%2520Hepsin%2520blocks%2520prostate%2520cancer%2520bone%2520metastasis%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D1352%26epage%3D1362%26doi%3D10.18632%2Foncotarget.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ok, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomper, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2016.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27128184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslWquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=208-218&author=M.+Subediauthor=I.+Minnauthor=J.+Chenauthor=Y.+Kimauthor=K.+Okauthor=Y.+W.+Jungauthor=M.+G.+Pomperauthor=Y.+Byun&title=Design%2C+synthesis+and+biological+evaluation+of+PSMA%2Fhepsin-targeted+heterobivalent+ligands&doi=10.1016%2Fj.ejmech.2016.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands</span></div><div class="casAuthors">Subedi, Milan; Minn, Il; Chen, Jianbo; Kim, YunHye; Ok, Kiwon; Jung, Yong Woo; Pomper, Martin G.; Byun, Youngjoo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">208-218</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cell surface biomarkers such as prostate-specific membrane antigen (PSMA) and hepsin have received considerable attention as targets for imaging prostate cancer (PCa) due to their high cell surface expression in such tumors and easy access for imaging probes.  Novel amidine-contg. indole analogs as hepsin inhibitors were designed and synthesized.  These compds. showed in vitro inhibitory activity against hepsin with IC50 values from 5.9 to 70 μM.  Based on the SAR of amidine-derived analogs, the novel heterobivalent compd. , targeting both hepsin and PSMA, was synthesized by linking compd. 2-[40-(Aminomethyl)-4-hydroxy[1,10-biphenyl]-3-yl]-1H-indole-5-carboximidamide with Lys-urea-Glu, the key scaffold for the specific binding to PSMA, followed by the conjugation of the optical dye SulfoCy7.  Prepd. compd. exhibited inhibitory activities against PSMA and hepsin, with IC50 values of 28 nM and 2.8 μM, resp.  In vitro cell uptake and preliminary in vivo optical imaging studies of 30 showed selective binding and retention in both PSMA and hepsin high-expressing PC3/ML-PSMA-HPN cells as compared with low-expressing PC3/ML cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokdqUSbkjI1bVg90H21EOLACvtfcHk0ligdiyUG2pfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslWquro%253D&md5=2e2bc57f314721f5a8fb3f7135c96502</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DSubedi%26aufirst%3DM.%26aulast%3DMinn%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DOk%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DY.%2BW.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DByun%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520PSMA%252Fhepsin-targeted%2520heterobivalent%2520ligands%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D208%26epage%3D218%26doi%3D10.1016%2Fj.ejmech.2016.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkskas, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3889</span>– <span class="NLM_lpage">3897</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2009.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19447524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlersLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=3889-3897&author=F.+Azamauthor=I.+A.+Alkskasauthor=M.+A.+Ahmed&title=Synthesis+of+some+urea+and+thiourea+derivatives+of+3-phenyl%2Fethyl-2-thioxo-2%2C3-dihydrothiazolo%5B4%2C5-d%5Dpyrimidine+and+their+antagonistic+effects+on+haloperidol-induced+catalepsy+and+oxidative+stress+in+mice&doi=10.1016%2Fj.ejmech.2009.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice</span></div><div class="casAuthors">Azam, Faizul; Alkskas, Ismail A.; Ahmed, Musa A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3889-3897</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7-yl urea and thiourea derivs. were designed and synthesized.  All the compds. have been evaluated for their antiparkinsonian activity in catalepsy induced by haloperidol in mice.  A majority of the compds. exhibited significant antiparkinsonian activity after i.p. administration.  The most active compd. carries methoxy group at 2-position of the Ph ring.  Some of the potent compds. I (R1 = Ph, Et; R2 = O, S) were selected for biochem. estns. of malondialdehyde, glutathione, superoxide dismutase and glutathione peroxidase from brain homogenate to highlight the neuroprotective properties assocd. with them.  The results obtained in the present study may lead to the development of a suitable approach to the treatment of Parkinson's disease and may be the starting point for the future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM371dHezPJrVg90H21EOLACvtfcHk0ligdiyUG2pfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlersLk%253D&md5=2f0ff8303c1ea1da6ffa0343d29f1f73</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DF.%26aulast%3DAlkskas%26aufirst%3DI.%2BA.%26aulast%3DAhmed%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%2520of%2520some%2520urea%2520and%2520thiourea%2520derivatives%2520of%25203-phenyl%252Fethyl-2-thioxo-2%252C3-dihydrothiazolo%255B4%252C5-d%255Dpyrimidine%2520and%2520their%2520antagonistic%2520effects%2520on%2520haloperidol-induced%2520catalepsy%2520and%2520oxidative%2520stress%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D3889%26epage%3D3897%26doi%3D10.1016%2Fj.ejmech.2009.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettinetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bothmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rosa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncarati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valacchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanaletti, R.</span></span> <span> </span><span class="NLM_article-title">SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5247</span>– <span class="NLM_lpage">5258</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmc.2009.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19515567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5247-5258&author=S.+N.+Haydarauthor=C.+Ghironauthor=L.+Bettinettiauthor=H.+Bothmannauthor=T.+A.+Comeryauthor=J.+Dunlopauthor=S.+La+Rosaauthor=I.+Miccoauthor=M.+Pollastriniauthor=J.+Quinnauthor=R.+Roncaratiauthor=C.+Scaliauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanaletti&title=SAR+and+biological+evaluation+of+SEN12333%2FWAY-317538%3A+Novel+alpha+7+nicotinic+acetylcholine+receptor+agonist&doi=10.1016%2Fj.bmc.2009.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist</span></div><div class="casAuthors">Haydar, Simon N.; Ghiron, Chiara; Bettinetti, Laura; Bothmann, Hendrick; Comery, Thomas A.; Dunlop, John; La Rosa, Salvatore; Micco, Iolanda; Pollastrini, Martina; Quinn, Joanna; Roncarati, Renza; Scali, Carla; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5247-5258</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alpha 7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment assocd. with a variety of disorders including Alzheimer's disease and schizophrenia.  Alpha 7 nAChRs are expressed in brain regions assocd. with cognitive function, regulate cholinergic neurotransmission and have been shown to be down regulated in both schizophrenia and Alzheimer's disease.  Herein we report a novel, potent small mol. agonist of the alpha 7 nAChR, SEN12333/WAY-317538.  This compd. is a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, excellent brain penetration and oral bioavailability, and demonstrates in vivo efficacy in multiple behavioral cognition models.  The SAR and biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyFjYGluXw3bVg90H21EOLACvtfcHk0ligdiyUG2pfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D&md5=293ee7e518e64386330cfde5ca72c584</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26atitle%3DSAR%2520and%2520biological%2520evaluation%2520of%2520SEN12333%252FWAY-317538%253A%2520Novel%2520alpha%25207%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5247%26epage%3D5258%26doi%3D10.1016%2Fj.bmc.2009.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghiron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aschmies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bothmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocconcelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jow, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rosa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncarati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terstappen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turlizzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valacchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanaletti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanelli, U.</span></span> <span> </span><span class="NLM_article-title">Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4379</span>– <span class="NLM_lpage">4389</span>, <span class="refDoi"> DOI: 10.1021/jm901692q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901692q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4379-4389&author=C.+Ghironauthor=S.+N.+Haydarauthor=S.+Aschmiesauthor=H.+Bothmannauthor=C.+Castaldoauthor=G.+Cocconcelliauthor=T.+A.+Comeryauthor=L.+Diauthor=J.+Dunlopauthor=T.+Lockauthor=A.+Kramerauthor=D.+Kowalauthor=F.+Jowauthor=S.+Grauerauthor=B.+Harrisonauthor=S.+La+Rosaauthor=L.+Maccariauthor=K.+L.+Marquisauthor=I.+Miccoauthor=A.+Nenciniauthor=J.+Quinnauthor=A.+J.+Robichaudauthor=R.+Roncaratiauthor=C.+Scaliauthor=G.+C.+Terstappenauthor=E.+Turlizziauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanalettiauthor=U.+Zanelli&title=Novel+alpha-7+nicotinic+acetylcholine+receptor+agonists+containing+a+urea+moiety%3A+identification+and+characterization+of+the+potent%2C+selective%2C+and+orally+efficacious+agonist+1-%5B6-%284-fluorophenyl%29pyridin-3-yl%5D-3-%284-piperidin-1-ylbutyl%29+urea+%28SEN34625%2FWYE-103914%29&doi=10.1021%2Fjm901692q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonists Containing a Urea Moiety: Identification and Characterization of the Potent, Selective, and Orally Efficacious Agonist 1-[6-(4-Fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) Urea (SEN34625/WYE-103914)</span></div><div class="casAuthors">Ghiron, Chiara; Haydar, Simon N.; Aschmies, Suzan; Bothmann, Hendrick; Castaldo, Cristiana; Cocconcelli, Giuseppe; Comery, Thomas A.; Di, Li; Dunlop, John; Lock, Tim; Kramer, Angela; Kowal, Dianne; Jow, Flora; Grauer, Steve; Harrison, Boyd; La Rosa, Salvatore; Maccari, Laura; Marquis, Karen L.; Micco, Iolanda; Nencini, Arianna; Quinn, Joanna; Robichaud, Albert J.; Roncarati, Renza; Scali, Carla; Terstappen, Georg C.; Turlizzi, Elisa; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo; Zanelli, Ugo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4379-4389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alpha-7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment.  We report a series of novel, potent small mol. agonists (4-18) of the α7 nAChR deriving from our continuing efforts in the areas of Alzheimer's disease and schizophrenia.  One of the compds. of the series contg. a urea moiety (16)(I) was further shown to be a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, brain penetration, and oral bioavailability and demonstrated in vivo efficacy in multiple behavioral cognition models.  Structural modifications leading to the improved selectivity profile and the biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlg-l6HJigrrVg90H21EOLACvtfcHk0lgDBJQdjPvZiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D&md5=f15ad80636d6ba345752ce1ddc7be15b</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1021%2Fjm901692q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901692q%26sid%3Dliteratum%253Aachs%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DCastaldo%26aufirst%3DC.%26aulast%3DCocconcelli%26aufirst%3DG.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMaccari%26aufirst%3DL.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DTurlizzi%26aufirst%3DE.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26aulast%3DZanelli%26aufirst%3DU.%26atitle%3DNovel%2520alpha-7%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520containing%2520a%2520urea%2520moiety%253A%2520identification%2520and%2520characterization%2520of%2520the%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520agonist%25201-%255B6-%25284-fluorophenyl%2529pyridin-3-yl%255D-3-%25284-piperidin-1-ylbutyl%2529%2520urea%2520%2528SEN34625%252FWYE-103914%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4379%26epage%3D4389%26doi%3D10.1021%2Fjm901692q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genesio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turlizzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanaletti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a hybrid series of potent and selective agonists of alpha7 nicotinic acetylcholine receptor</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24704613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=401-418&author=A.+Nenciniauthor=C.+Castaldoauthor=T.+A.+Comeryauthor=J.+Dunlopauthor=E.+Genesioauthor=C.+Ghironauthor=S.+Haydarauthor=L.+Maccariauthor=I.+Miccoauthor=E.+Turlizziauthor=R.+Zanalettiauthor=J.+Zhang&title=Design+and+synthesis+of+a+hybrid+series+of+potent+and+selective+agonists+of+alpha7+nicotinic+acetylcholine+receptor&doi=10.1016%2Fj.ejmech.2014.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor</span></div><div class="casAuthors">Nencini, Arianna; Castaldo, Cristiana; Comery, Thomas A.; Dunlop, John; Genesio, Eva; Ghiron, Chiara; Haydar, Simon; Maccari, Laura; Micco, Iolanda; Turlizzi, Elisa; Zanaletti, Riccardo; Zhang, Jean</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401-418</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">α7 Nicotinic acetylcholine receptor agonists are promising therapeutic candidates for the treatment of cognitive impairment.  As a follow up of our internal medicinal chem. program we investigated a novel series of α7 nAChR agonists.  Starting from mol. docking studies on two series of mols. recently developed in our labs., an alternative scaffold was designed attempting to combine the optimal features of these previously identified urea and pyrazole compds.  Based on our previous SAR knowledge and on predicted drug-like properties, a small library was synthesized in parallel manner, affording compds. with excellent α7 nAChR activity, selectivity and preliminary ADME profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfIXbX0n7YLVg90H21EOLACvtfcHk0lgDBJQdjPvZiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWntLo%253D&md5=3b5fc8e8eead70d1c6dc8310f4ad39f4</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DCastaldo%26aufirst%3DC.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DGenesio%26aufirst%3DE.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%26aulast%3DMaccari%26aufirst%3DL.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DTurlizzi%26aufirst%3DE.%26aulast%3DZanaletti%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520hybrid%2520series%2520of%2520potent%2520and%2520selective%2520agonists%2520of%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D78%26spage%3D401%26epage%3D418%26doi%3D10.1016%2Fj.ejmech.2014.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkamhawy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, E. J.</span></span> <span> </span><span class="NLM_article-title">Novel quinazoline-urea analogues as modulators for Abeta-induced mitochondrial dysfunction: design, synthesis, and molecular docking study</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.07.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25050879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=466-475&author=A.+Elkamhawyauthor=J.+Leeauthor=B.+G.+Parkauthor=I.+Parkauthor=A.+N.+Paeauthor=E.+J.+Roh&title=Novel+quinazoline-urea+analogues+as+modulators+for+Abeta-induced+mitochondrial+dysfunction%3A+design%2C+synthesis%2C+and+molecular+docking+study&doi=10.1016%2Fj.ejmech.2014.07.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Novel quinazoline-urea analogues as modulators for Aβ-induced mitochondrial dysfunction: Design, synthesis, and molecular docking study</span></div><div class="casAuthors">Elkamhawy, Ahmed; Lee, Jiyoun; Park, Beoung-Geon; Park, Insun; Pae, Ae Nim; Roh, Eun Joo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">466-475</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A novel series of twenty-six quinazoline-urea derivs. was designed and synthesized.  Their blocking activities against β-amyloid peptide (Aβ) induced mitochondrial permeability transition pore (mPTP) opening were evaluated by JC-1 assay which measured the change of mitochondrial membrane potential.  Seven compds. showed better inhibitory activities than the std. Cyclosporin A (CsA).  The most active analogs were tested by MTT assay to evaluate their toxicity on the cellular survival; they revealed excellent cellular viability.  To explain the difference in inhibitory activity, mol. docking study using (GOLD) program was performed for selected sets of the most active and inactive compds. on cyclophilin D (CypD) receptor as a major component of mPTP.  Moreover, ADME profiling, in silico toxicity, drug-likeness, and drug-score studies were discussed.  From these results, we report compd. I as the most active nonpeptidyl mPTP blocker possessing quinazoline-urea scaffold; 2 folds of CsA activity, which would constitute a new direction for the design of novel mPTP modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow1rB8rasuJLVg90H21EOLACvtfcHk0lh5uIfKKo4ntg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL%252FP&md5=d6ef5366cbb4e47bf261ce7afd61d3bc</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DElkamhawy%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DB.%2BG.%26aulast%3DPark%26aufirst%3DI.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DRoh%26aufirst%3DE.%2BJ.%26atitle%3DNovel%2520quinazoline-urea%2520analogues%2520as%2520modulators%2520for%2520Abeta-induced%2520mitochondrial%2520dysfunction%253A%2520design%252C%2520synthesis%252C%2520and%2520molecular%2520docking%2520study%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D466%26epage%3D475%26doi%3D10.1016%2Fj.ejmech.2014.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macalino, S. J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of conformationally restricted human glutaminyl cyclase inhibitors as potent anti-Alzheimer’s agents by structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8027</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8011-8027&author=V.+H.+Hoangauthor=V.+T.+H.+Ngoauthor=M.+Cuiauthor=N.+V.+Manhauthor=P.+T.+Tranauthor=J.+Annauthor=H.+J.+Haauthor=H.+Kimauthor=K.+Choiauthor=Y.+H.+Kimauthor=H.+Changauthor=S.+J.+Y.+Macalinoauthor=J.+Leeauthor=S.+Choi&title=Discovery+of+conformationally+restricted+human+glutaminyl+cyclase+inhibitors+as+potent+anti-Alzheimer%E2%80%99s+agents+by+structure-based+design&doi=10.1021%2Facs.jmedchem.9b00751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design</span></div><div class="casAuthors">Hoang, Van-Hai; Ngo, Van T. H.; Cui, Minghua; Manh, Nguyen Van; Tran, Phuong-Thao; Ann, Jihyae; Ha, Hee-Jin; Kim, Hee; Choi, Kwanghyun; Kim, Young-Ho; Chang, Hyerim; Macalino, Stephani Joy Y.; Lee, Jiyoun; Choi, Sun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8011-8027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD.  Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of β-amyloid in the brains of AD patients.  On the basis of a putative active conformation of the prototype inhibitor 1, a series of N-substituted thiourea, urea, and α-substituted amide derivs. were developed.  The structure-activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogs, and several selected compds. demonstrated desirable therapeutic activity in an AD mouse model.  The conformational anal. of a representative inhibitor indicated that the inhibitor appeared to maintain the Z-E conformation at the active site, as it is crit. for its potent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKWajqMIkJrVg90H21EOLACvtfcHk0lh5uIfKKo4ntg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP&md5=5830439908c727943bfc534ff1030308</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00751%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DNgo%26aufirst%3DV.%2BT.%2BH.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DManh%26aufirst%3DN.%2BV.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DMacalino%26aufirst%3DS.%2BJ.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520conformationally%2520restricted%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520potent%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8011%26epage%3D8027%26doi%3D10.1021%2Facs.jmedchem.9b00751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaiser, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcher-Rorsted, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropke Jorgensen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frykman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brauner-Osborne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiesen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejer Pedersen, D.</span></span> <span> </span><span class="NLM_article-title">Probing the existence of a metastable binding site at the beta2-adrenergic receptor with homobivalent bitopic ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7806</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlOhu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7806-7839&author=B.+I.+Gaiserauthor=M.+Danielsenauthor=E.+Marcher-Rorstedauthor=K.+Ropke+Jorgensenauthor=T.+M.+Wrobelauthor=M.+Frykmanauthor=H.+Johanssonauthor=H.+Brauner-Osborneauthor=D.+E.+Gloriamauthor=J.+M.+Mathiesenauthor=D.+Sejer+Pedersen&title=Probing+the+existence+of+a+metastable+binding+site+at+the+beta2-adrenergic+receptor+with+homobivalent+bitopic+ligands&doi=10.1021%2Facs.jmedchem.9b00595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Existence of a Metastable Binding Site at the β2-Adrenergic Receptor with Homobivalent Bitopic Ligands</span></div><div class="casAuthors">Gaiser, Birgit I.; Danielsen, Mia; Marcher-Roersted, Emil; Roepke Joergensen, Kira; Wrobel, Tomasz M.; Frykman, Mikael; Johansson, Henrik; Brauner-Osborne, Hans; Gloriam, David E.; Mathiesen, Jesper Mosolff; Sejer Pedersen, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7806-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we report the development of bitopic ligands aimed at targeting the orthosteric binding site (OBS) and a metastable binding site (MBS) within the same receptor unit.  Previous mol. dynamics studies on ligand binding to the β2-adrenergic receptor (β2AR) suggested that ligands pause at transient, less-conserved MBSs.  We envisioned that MBSs can be regarded as allosteric binding sites and targeted by homobivalent bitopic ligands linking two identical pharmacophores.  Such ligands were designed based on docking of the antagonist (S)-alprenolol into the OBS and an MBS and synthesized.  Pharmacol. characterization revealed ligands with similar potency and affinity, slightly increased β2/β1AR-selectivity, and/or substantially slower β2AR off-rates compared to (S)-alprenolol.  Truncated bitopic ligands suggested the major contribution of the metastable pharmacophore to be a hydrophobic interaction with the β2AR, while the linkers alone decreased the potency of the orthosteric fragment.  Altogether, the study underlines the potential of targeting MBSs for improving the pharmacol. profiles of ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt_nqROQHIBrVg90H21EOLACvtfcHk0liyNdcrlDgZqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlOhu7%252FI&md5=411f11f6df72b940f3919b21510adf0b</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00595%26sid%3Dliteratum%253Aachs%26aulast%3DGaiser%26aufirst%3DB.%2BI.%26aulast%3DDanielsen%26aufirst%3DM.%26aulast%3DMarcher-Rorsted%26aufirst%3DE.%26aulast%3DRopke%2BJorgensen%26aufirst%3DK.%26aulast%3DWrobel%26aufirst%3DT.%2BM.%26aulast%3DFrykman%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DH.%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26aulast%3DSejer%2BPedersen%26aufirst%3DD.%26atitle%3DProbing%2520the%2520existence%2520of%2520a%2520metastable%2520binding%2520site%2520at%2520the%2520beta2-adrenergic%2520receptor%2520with%2520homobivalent%2520bitopic%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7806%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.9b00595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurt, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazioglu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basile, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonmez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucukislamoglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guccione, S.</span></span> <span> </span><span class="NLM_article-title">Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2015.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26244990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Ogs7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2015&pages=80-92&author=B.+Z.+Kurtauthor=I.+Gaziogluauthor=L.+Basileauthor=F.+Sonmezauthor=T.+Ginexauthor=M.+Kucukislamogluauthor=S.+Guccione&title=Potential+of+aryl-urea-benzofuranylthiazoles+hybrids+as+multitasking+agents+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease</span></div><div class="casAuthors">Kurt, Belma Zengin; Gazioglu, Isil; Basile, Livia; Sonmez, Fatih; Ginex, Tiziana; Kucukislamoglu, Mustafa; Guccione, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80-92</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The new benzofuranylthiazole derivs. contg. the aryl-urea I [R = H, Br, NO2; R1 = H, 2-NO2, 3-OCH3, 4-CH3, etc.] moiety were synthesized and evaluated in vitro as dual acetylcholinesterase (AChE)-butyrylcholinesterase (BuChE) inhibitors.  In addn., the cupric reducing antioxidant capacities (CUPRAC) and ABTS cation radical scavenging abilities of the synthesized compds. I were assayed.  The result showed that all the synthesized compds. I exhibited inhibitory activity on both AChE and BuChE with I [R = Br; R1 = 2-F] (IC50 value of 3.85 μM) and I [R = NO2; R1 = 4-I] (IC50 value of 2.03 μM) as the strongest inhibitors against AChE and BuChE, resp.  The compd. I [R = NO2; R1 = 4-I] was 8.5-fold more potent than galanthamine.  The selectivity index of I [R = Br, NO2; R1 = 2-F, 4-I] was 2.40 and 0.37 against AChE and BuChE, resp.  The compd. I [R = H; R1 = 3-OCH3, 4-CH3, 4-F] (IC50 = 0.2, 0.5 and 1.13 μM, resp.) showed a better ABTS cation radical scavenging ability than the std. quercetin (IC50 = 1.18 μM).  Best poses of compds. I [R = NO2; R1 = 4-I] on BuChE and I [R = Br; R1 = 2-F] on AChE indicate that the thiazole ring and the amidic moiety are important sites of interaction with both ChEs.  In addn., the benzofuran ring and Ph ring are anchored to the side chains of both enzymes by π-π interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxx3fVuauPmbVg90H21EOLACvtfcHk0liyNdcrlDgZqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Ogs7zK&md5=a7d6c69966904dc7626f5e53d41356f2</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DKurt%26aufirst%3DB.%2BZ.%26aulast%3DGazioglu%26aufirst%3DI.%26aulast%3DBasile%26aufirst%3DL.%26aulast%3DSonmez%26aufirst%3DF.%26aulast%3DGinex%26aufirst%3DT.%26aulast%3DKucukislamoglu%26aufirst%3DM.%26aulast%3DGuccione%26aufirst%3DS.%26atitle%3DPotential%2520of%2520aryl-urea-benzofuranylthiazoles%2520hybrids%2520as%2520multitasking%2520agents%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D102%26spage%3D80%26epage%3D92%26doi%3D10.1016%2Fj.ejmech.2015.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and antiepileptic properties of novel 1-(substituted benzylidene)-3-(1-(morpholino/piperidino methyl)-2,3-dioxoindolin-5-yl)urea derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6057</span>– <span class="NLM_lpage">6065</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2011.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22037252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKqtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=6057-6065&author=C.+R.+Prakashauthor=S.+Raja&title=Design%2C+synthesis+and+antiepileptic+properties+of+novel+1-%28substituted+benzylidene%29-3-%281-%28morpholino%2Fpiperidino+methyl%29-2%2C3-dioxoindolin-5-yl%29urea+derivatives&doi=10.1016%2Fj.ejmech.2011.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and antiepileptic properties of novel 1-(substituted benzylidene)-3-(1-(morpholino/piperidino methyl)-2,3-dioxoindolin-5-yl)urea derivatives</span></div><div class="casAuthors">Prakash, Chinnasamy Rajaram; Raja, Sundararajan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6057-6065</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Twenty new 1-(substituted benzylidene)-3-(1-(morpholino/piperidinomethyl)-2,3-dioxoindolin-5-yl)urea derivs. were designed and synthesized.  Antiepileptic screening was performed using MES and scPTZ seizures tests.  The neurotoxicity was detd. by rotorod test.  In the preliminary screening, several compds. were found active in the MES model, while one compd. showed significant antiepileptic activity in the scPTZ model.  Five compds. were administered orally to rats, and they showed better activity than Phenytoin in the oral route.  Among these compds., compd. I revealed protection in MES at a dose of 30 mg/kg and 100 mg/kg 0.5 h and 4 h after i.p. administration resp.  This mol. provided also protection in the scPTZ at a dose of 300 mg/kg in both time intervals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9C_z8OoAatbVg90H21EOLACvtfcHk0ljY5FKaR6QPGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKqtb7P&md5=32ebdb5f18c0e0399008abc9868d9625</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DC.%2BR.%26aulast%3DRaja%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antiepileptic%2520properties%2520of%2520novel%25201-%2528substituted%2520benzylidene%2529-3-%25281-%2528morpholino%252Fpiperidino%2520methyl%2529-2%252C3-dioxoindolin-5-yl%2529urea%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D6057%26epage%3D6065%26doi%3D10.1016%2Fj.ejmech.2011.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2236</span>– <span class="NLM_lpage">2242</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2011.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21435751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2236-2242&author=N.+Siddiquiauthor=M.+S.+Alamauthor=J.+P.+Stables&title=Synthesis+and+anticonvulsant+properties+of+1-%28amino-N-arylmethanethio%29-3-%281-substituted+benzyl-2%2C+3-dioxoindolin-5-yl%29+urea+derivatives&doi=10.1016%2Fj.ejmech.2011.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives</span></div><div class="casAuthors">Siddiqui, Nadeem; Alam, M. Shamsher; Stables, James P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2236-2242</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Various 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea were designed keeping in view the structural requirements suggested in the pharmacophore model for anticonvulsant activity.  Their in vivo anticonvulsant screenings were performed by two most adopted seizure models, maximal electroshock seizure (MES) and s.c. pentylenetetrazole (scPTZ).  Compd. I (R = Ph, R' = 2-OMePh) was found active in MES screening while compds. I (R = Ph, R' = 4-OMePh; R = 2-ClPh, R' = Ph, 2-MePh, and 4-MePh)showed significant anticonvulsant activity in both the screenings and were devoid of any neurotoxicity.  Compd. I (R = Ph, R' = 4-OMePh; R = 2-ClPh, R' = Ph) showed marked protection at 300 mg/kg against MES and scPTZ screening.  Compd. I (R = 2-ClPh, R' = Ph) also showed protection against MES screening at the dose of 100 mg/kg.  In 6 Hz screening these two compds. showed significant protection and emerged as lead compds. for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPIplz9F2CCbVg90H21EOLACvtfcHk0ljY5FKaR6QPGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCnt7k%253D&md5=0aeaa69ccddc22809dd325a6debe2695</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DN.%26aulast%3DAlam%26aufirst%3DM.%2BS.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26atitle%3DSynthesis%2520and%2520anticonvulsant%2520properties%2520of%25201-%2528amino-N-arylmethanethio%2529-3-%25281-substituted%2520benzyl-2%252C%25203-dioxoindolin-5-yl%2529%2520urea%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2236%26epage%3D2242%26doi%3D10.1016%2Fj.ejmech.2011.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Substituted 1-Phenyl-3-(pyridin-2-yl)urea negative allosteric modulators of mGlu5: discovery of a new tool compound VU0463841 with activity in rat models of cocaine addiction</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1021/cn400070k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400070k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1217-1228&author=R.+J.+Amatoauthor=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=D.+F.+Venableauthor=R.+D.+Morrisonauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jonesauthor=K.+A.+Emmitte&title=Substituted+1-Phenyl-3-%28pyridin-2-yl%29urea+negative+allosteric+modulators+of+mGlu5%3A+discovery+of+a+new+tool+compound+VU0463841+with+activity+in+rat+models+of+cocaine+addiction&doi=10.1021%2Fcn400070k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu5: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction</span></div><div class="casAuthors">Amato, Russell J.; Felts, Andrew S.; Rodriguez, Alice L.; Venable, Daryl F.; Morrison, Ryan D.; Byers, Frank W.; Daniels, J. Scott; Niswender, Colleen M.; Conn, P. Jeffrey; Lindsley, Craig W.; Jones, Carrie K.; Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1217-1228</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cocaine is a powerful and highly addictive stimulant that disrupts the normal reward circuitry in the central nervous system (CNS), producing euphoric effects.  Cocaine use can lead to acute and life threatening emergencies, and abuse is assocd. with increased risk for contracting infectious diseases.  Though certain types of behavioral therapy have proven effective for treatment of cocaine addiction, relapse remains high, and there are currently no approved medications for the treatment of cocaine abuse.  Evidence has continued to accumulate that indicates a crit. role for the metabotropic glutamate receptor subtype 5 (mGlu5) in the modulation of neural circuitry assocd. with the addictive properties of cocaine.  While the small mol. mGlu5 neg. allosteric modulator (NAM) field is relatively advanced, investigation into the potential of small mol. mGlu5 NAMs for the treatment of cocaine addiction remains an area of high interest.  Herein the authors describe the discovery and characterization of a potent and selective compd. 29 (VU0463841) with good CNS exposure in rats.  The utility of compd. 29 (VU0463841) was demonstrated by its ability to attenuate drug seeking behaviors in relevant rat models of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7d7-mYwmD5LVg90H21EOLACvtfcHk0liUl5i0NJpFzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGhs74%253D&md5=393278d7d07d3316ebee0e6759b065bf</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1021%2Fcn400070k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400070k%26sid%3Dliteratum%253Aachs%26aulast%3DAmato%26aufirst%3DR.%2BJ.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DSubstituted%25201-Phenyl-3-%2528pyridin-2-yl%2529urea%2520negative%2520allosteric%2520modulators%2520of%2520mGlu5%253A%2520discovery%2520of%2520a%2520new%2520tool%2520compound%2520VU0463841%2520with%2520activity%2520in%2520rat%2520models%2520of%2520cocaine%2520addiction%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1217%26epage%3D1228%26doi%3D10.1021%2Fcn400070k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of CNS penetrant CXCR2 antagonists for the potential treatment of CNS demyelinating disorders</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00489</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00489" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Ojsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=397-402&author=H.+Xuauthor=H.+Luauthor=Z.+Xuauthor=L.+Luanauthor=C.+Liauthor=Y.+Xuauthor=K.+Dongauthor=J.+Zhangauthor=X.+Liauthor=Y.+Liauthor=G.+Liuauthor=S.+Gongauthor=Y.+G.+Zhaoauthor=A.+Liuauthor=Y.+Zhangauthor=W.+Zhangauthor=X.+Caiauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=X.+Lin&title=Discovery+of+CNS+penetrant+CXCR2+antagonists+for+the+potential+treatment+of+CNS+demyelinating+disorders&doi=10.1021%2Facsmedchemlett.5b00489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders</span></div><div class="casAuthors">Xu, Heng; Lu, Hongfu; Xu, Zhongmiao; Luan, Linbo; Li, Chengyong; Xu, Yan; Dong, Kelly; Zhang, Jinqiang; Li, Xiong; Li, Yvonne; Liu, Gentao; Gong, Sophie; Zhao, Yong-Gang; Liu, Ailian; Zhang, Yueting; Zhang, Wei; Cai, Xin; Xiang, Jia-Ning; Elliott, John D.; Lin, Xichen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-402</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationship exploration of the historical biarylurea series led to the identification of novel CNS penetrant CXCR2 antagonists with nanomolar potency, favorable PK profile, and good developability potentials.  More importantly, the key compd. I showed efficacy in a cuprizone-induced demyelination model with twice daily oral administration, thereby supporting CXCR2 to be a potential therapeutic target for the treatment of demyelinating diseases such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKTCTsJmbuwrVg90H21EOLACvtfcHk0liUl5i0NJpFzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Ojsr4%253D&md5=8ee345c1bd7f4f840cb516a02a558481</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00489%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLuan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGong%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%2BG.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520CNS%2520penetrant%2520CXCR2%2520antagonists%2520for%2520the%2520potential%2520treatment%2520of%2520CNS%2520demyelinating%2520disorders%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D397%26epage%3D402%26doi%3D10.1021%2Facsmedchemlett.5b00489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref255"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref255'); return false;" data-citation="" class="refNumLink">255</a></strong><div class="NLM_citation" id="cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of cyclic urea as potent CCR5 antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6381</span>– <span class="NLM_lpage">6385</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2011.08.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21930378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6381-6385&author=M.+Duanauthor=W.+M.+Kazmierskiauthor=M.+Tallantauthor=J.+H.+Junauthor=M.+Edelsteinauthor=R.+Ferrisauthor=D.+Toddauthor=P.+Wheelanauthor=Z.+Xiong&title=Discovery+of+a+novel+series+of+cyclic+urea+as+potent+CCR5+antagonists&doi=10.1016%2Fj.bmcl.2011.08.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel series of cyclic urea as potent CCR5 antagonists</span></div><div class="casAuthors">Duan, Mao-Sheng; Kazmierski, Wieslaw M.; Tallant, Matt; Jun, Jung-Ho; Edelstein, Mark; Ferris, Rob; Todd, Dan; Wheelan, Pat; Xiong, Zhi-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6381-6385</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of cyclic urea-based CCR5 antagonists was designed aiming to resolve instability issue in the fasted simulated intestinal fluid (FSIF) assocd. with the acyclic urea moiety in 1 (I).  This class of CCR5 compds. demonstrated high antiviral activities against HIV-1 infection in both HOS and PBL assays.  Further evaluation of these compds. indicated that the I analog 16-R not only substantially enhanced its stability, but also exhibited excellent pharmacokinetics properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx6ist8zyP47Vg90H21EOLACvtfcHk0lj-msYGtH6r9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FF&md5=52accac06c1550e1e0fc17c7f8395470</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.096%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DTallant%26aufirst%3DM.%26aulast%3DJun%26aufirst%3DJ.%2BH.%26aulast%3DEdelstein%26aufirst%3DM.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DTodd%26aufirst%3DD.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520cyclic%2520urea%2520as%2520potent%2520CCR5%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6381%26epage%3D6385%26doi%3D10.1016%2Fj.bmcl.2011.08.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref256"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref256'); return false;" data-citation="" class="refNumLink">256</a></strong><div class="NLM_citation" id="cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamatake, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvest, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3021</span>– <span class="NLM_lpage">3026</span>, <span class="refDoi"> DOI: 10.1021/jm201278q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201278q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3021-3026&author=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.+J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wangauthor=X.+Liauthor=S.+Zhangauthor=Y.+K.+Zhangauthor=Y.+Liuauthor=C.+Z.+Dingauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liu&title=Discovery+of+novel+urea-based+hepatitis+C+protease+inhibitors+with+high+potency+against+protease-inhibitor-resistant+mutants&doi=10.1021%2Fjm201278q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Hamatake, Robert; Duan, Maosheng; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Wang, Amy; Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3021-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors were prepd. and characterized in replicase HCV protease-resistant mutants assay.  Several compds., exemplified by I, were found to be more potent in HCV replicon assays than leading second generation inhibitors such as danoprevir and TMC-435350.  Addnl., following oral administration, inhibitor I was found in rat liver in significantly higher concns. than those reported for both danoprevir and TMC-435350, suggesting that inhibitor I has the combination of anti-HCV and pharmacokinetic properties that warrants further development of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZf8snkMwqSrVg90H21EOLACvtfcHk0lj-msYGtH6r9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D&md5=43f9016626357a5fea8d6d1e9784e2d8</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1021%2Fjm201278q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201278q%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520urea-based%2520hepatitis%2520C%2520protease%2520inhibitors%2520with%2520high%2520potency%2520against%2520protease-inhibitor-resistant%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3021%26epage%3D3026%26doi%3D10.1021%2Fjm201278q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref257"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref257'); return false;" data-citation="" class="refNumLink">257</a></strong><div class="NLM_citation" id="cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drlica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span> <span> </span><span class="NLM_article-title">DNA gyrase, topoisomerase IV, and the 4-quinolones</span>. <i>Microbiol Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1128%2F.61.3.377-392.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9293187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1yhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=377-392&author=K.+Drlicaauthor=X.+Zhao&title=DNA+gyrase%2C+topoisomerase+IV%2C+and+the+4-quinolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">DNA gyrase, topoisomerase IV, and the 4-quinolones</span></div><div class="casAuthors">Drlica, Karl; Zhao, Xilin</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-392</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review with 214 refs. on the antibacterial action of 4-quinolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpePsktP7PDhrVg90H21EOLACvtfcHk0li-R8ND2qbB2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1yhsL0%253D&md5=a8c0f1314b8a568873bd1fc8d044b72a</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1128%2F.61.3.377-392.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252F.61.3.377-392.1997%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DDNA%2520gyrase%252C%2520topoisomerase%2520IV%252C%2520and%2520the%25204-quinolones%26jtitle%3DMicrobiol%2520Mol.%2520Biol.%2520Rev.%26date%3D1997%26volume%3D61%26spage%3D377%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref258"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref258'); return false;" data-citation="" class="refNumLink">258</a></strong><div class="NLM_citation" id="cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases: structure, function, and mechanism</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.70.1.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1146%2Fannurev.biochem.70.1.369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11395412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=369-413&author=J.+J.+Champoux&title=DNA+topoisomerases%3A+structure%2C+function%2C+and+mechanism&doi=10.1146%2Fannurev.biochem.70.1.369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases: structure, function, and mechanism</span></div><div class="casAuthors">Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-413</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 196 refs.  DNA topoisomerases solve the topol. problems assocd. with DNA replication, transcription, recombination, and chromatin remodeling by introducing temporary single- or double-strand breaks in the DNA.  In addn., these enzymes fine-tune the steady-state level of DNA supercoiling both to facilitate protein interactions with the DNA and to prevent excessive supercoiling that is deleterious.  In recent years, the crystal structures of a no. of topoisomerase fragments, representing nearly all of the known classes of enzymes, have been solved.  These structures provide remarkable insights into the mechanisms of these enzymes and complement previous conclusions based on biochem. analyses.  Surprisingly, despite little or no sequence homol., both type IA and type IIA topoisomerases from prokaryotes and the type IIA enzymes from eukaryotes share structural folds that appear to reflect functional motifs within crit. regions of the enzymes.  The type IB enzymes are structurally distinct from all other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases.  The structural themes common to all topoisomerases include hinged clamps that open and close to bind DNA, the presence of DNA binding cavities for temporary storage of DNA segments, and the coupling of protein conformational changes to DNA rotation or DNA movement.  For the type II topoisomerases, the binding and hydrolysis of ATP further modulate conformational changes in the enzymes to effect changes in DNA topol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4rDyIYy17Vg90H21EOLACvtfcHk0li-R8ND2qbB2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D&md5=67c3e38eb4fcb85527b33d7077309482</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.369%26sid%3Dliteratum%253Aachs%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DDNA%2520topoisomerases%253A%2520structure%252C%2520function%252C%2520and%2520mechanism%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D369%26epage%3D413%26doi%3D10.1146%2Fannurev.biochem.70.1.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref259"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref259'); return false;" data-citation="" class="refNumLink">259</a></strong><div class="NLM_citation" id="cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, D. M.</span></span> <span> </span><span class="NLM_article-title">The ATP-binding site of type II topoisomerases as a target for antibacterial drugs</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.2174/1568026033452500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F1568026033452500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12570764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Cluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=283-303&author=A.+Maxwellauthor=D.+M.+Lawson&title=The+ATP-binding+site+of+type+II+topoisomerases+as+a+target+for+antibacterial+drugs&doi=10.2174%2F1568026033452500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">The ATP-binding site of type II topoisomerases as a target for antibacterial drugs</span></div><div class="casAuthors">Maxwell, Anthony; Lawson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-303</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are essential enzymes in all cell types and have been valuable drug targets both for antibacterial and anti-cancer chemotherapy.  Type II topoisomerases possess a binding site for ATP, which can be exploited as a target for chemo-therapeutic agents.  High-resoln. structures of protein fragments contg. this site complexed with antibiotics or an ATP analog have provided vital information for the understanding of the action of existing drugs and for the potential development of novel anti-bacterial agents.  In this article we have reviewed the structure and function of the ATPase domain of DNA gyrase (bacterial topoisomerase II), particularly highlighting novel information that has been revealed by structural studies.  We discuss the efficacy and mode of action of existing drugs and consider the prospects for the development of novel agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooHh_snP6iBbVg90H21EOLACvtfcHk0li-R8ND2qbB2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Cluw%253D%253D&md5=9b3d6e867a5d29e523842811f3d4b046</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.2174%2F1568026033452500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452500%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DLawson%26aufirst%3DD.%2BM.%26atitle%3DThe%2520ATP-binding%2520site%2520of%2520type%2520II%2520topoisomerases%2520as%2520a%2520target%2520for%2520antibacterial%2520drugs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D283%26epage%3D303%26doi%3D10.2174%2F1568026033452500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref260"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref260'); return false;" data-citation="" class="refNumLink">260</a></strong><div class="NLM_citation" id="cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drumm, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeTiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessier, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5243</span>– <span class="NLM_lpage">5263</span>, <span class="refDoi"> DOI: 10.1021/jm800318d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800318d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5243-5263&author=P.+S.+Charifsonauthor=A.+L.+Grillotauthor=T.+H.+Grossmanauthor=J.+D.+Parsonsauthor=M.+Badiaauthor=S.+Bellonauthor=D.+D.+Deiningerauthor=J.+E.+Drummauthor=C.+H.+Grossauthor=A.+LeTiranauthor=Y.+Liaoauthor=N.+Maniauthor=D.+P.+Nicolauauthor=E.+Perolaauthor=S.+Ronkinauthor=D.+Shannonauthor=L.+L.+Swensonauthor=Q.+Tangauthor=P.+R.+Tessierauthor=S.+K.+Tianauthor=M.+Trudeauauthor=T.+Wangauthor=Y.+Weiauthor=H.+Zhangauthor=D.+Stamos&title=Novel+dual-targeting+benzimidazole+urea+inhibitors+of+DNA+gyrase+and+topoisomerase+IV+possessing+potent+antibacterial+activity%3A+intelligent+design+and+evolution+through+the+judicious+use+of+structure-guided+design+and+structure-activity+relationships&doi=10.1021%2Fjm800318d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Structure-Activity Relationships</span></div><div class="casAuthors">Charifson, Paul S.; Grillot, Anne-Laure; Grossman, Trudy H.; Parsons, Jonathan D.; Badia, Michael; Bellon, Steve; Deininger, David D.; Drumm, Joseph E.; Gross, Christian H.; LeTiran, Arnaud; Liao, Yusheng; Mani, Nagraj; Nicolau, David P.; Perola, Emanuele; Ronkin, Steven; Shannon, Dean; Swenson, Lora L.; Tang, Qing; Tessier, Pamela R.; Tian, Ski-Kai; Trudeau, Martin; Wang, Tiansheng; Wei, Yunyi; Zhang, Hong; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5243-5263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new antibacterial agents with novel mechanisms of action is necessary to overcome the problem of bacterial resistance that affects all currently used classes of antibiotics.  Bacterial DNA gyrase and topoisomerase IV are well-characterized clin. validated targets of the fluoroquinolone antibiotics which exert their antibacterial activity through inhibition of the catalytic subunits.  Inhibition of these targets through interaction with their ATP sites has been less clin. successful.  The discovery and characterization of a new class of low mol. wt., synthetic inhibitors of gyrase and topoisomerase IV that bind to the ATP sites are presented.  The benzimidazole ureas are dual targeting inhibitors of both enzymes and possess potent antibacterial activity against a wide spectrum of relevant pathogens responsible for hospital- and community-acquired infections.  The discovery and optimization of this novel class of antibacterials by the use of structure-guided design, modeling, and structure-activity relationships are described.  Data are presented for enzyme inhibition, antibacterial activity, and in vivo efficacy by oral and i.v. administration in two rodent infection models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSg-NiMYqXebVg90H21EOLACvtfcHk0ljfBteGYmXrSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D&md5=284d19912422bcadd38d9c021cd71ef8</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Fjm800318d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800318d%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrillot%26aufirst%3DA.%2BL.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DBadia%26aufirst%3DM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DTian%26aufirst%3DS.%2BK.%26aulast%3DTrudeau%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DNovel%2520dual-targeting%2520benzimidazole%2520urea%2520inhibitors%2520of%2520DNA%2520gyrase%2520and%2520topoisomerase%2520IV%2520possessing%2520potent%2520antibacterial%2520activity%253A%2520intelligent%2520design%2520and%2520evolution%2520through%2520the%2520judicious%2520use%2520of%2520structure-guided%2520design%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5243%26epage%3D5263%26doi%3D10.1021%2Fjm800318d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref261"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref261'); return false;" data-citation="" class="refNumLink">261</a></strong><div class="NLM_citation" id="cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzelka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8792</span>– <span class="NLM_lpage">8816</span>, <span class="refDoi"> DOI: 10.1021/jm500563g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500563g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8792-8816&author=A.+L.+Grillotauthor=A.+Le+Tiranauthor=D.+Shannonauthor=E.+Kruegerauthor=Y.+Liaoauthor=H.+O%E2%80%99Dowdauthor=Q.+Tangauthor=S.+Ronkinauthor=T.+Wangauthor=N.+Waalauthor=P.+Liauthor=D.+Laufferauthor=E.+Sizenskyauthor=J.+Tanouryauthor=E.+Perolaauthor=T.+H.+Grossmanauthor=T.+Doyleauthor=B.+Hanzelkaauthor=S.+Jonesauthor=V.+Dixitauthor=N.+Ewingauthor=S.+Liaoauthor=B.+Boucherauthor=M.+Jacobsauthor=Y.+Bennaniauthor=P.+S.+Charifson&title=Second-generation+antibacterial+benzimidazole+ureas%3A+discovery+of+a+preclinical+candidate+with+reduced+metabolic+liability&doi=10.1021%2Fjm500563g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span></div><div class="casAuthors">Grillot, Anne-Laure; Tiran, Arnaud Le; Shannon, Dean; Krueger, Elaine; Liao, Yusheng; O'Dowd, Hardwin; Tang, Qing; Ronkin, Steve; Wang, Tiansheng; Waal, Nathan; Li, Pan; Lauffer, David; Sizensky, Emmanuelle; Tanoury, Jerry; Perola, Emanuele; Grossman, Trudy H.; Doyle, Tim; Hanzelka, Brian; Jones, Steven; Dixit, Vaishali; Ewing, Nigel; Liao, Shengkai; Boucher, Brian; Jacobs, Marc; Bennani, Youssef; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8792-8816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. 3 is a potent aminobenzimidazole urea with broad-spectrum Gram-pos. antibacterial activity resulting from dual inhibition of bacterial gyrase (GyrB) and topoisomerase IV (ParE), and it demonstrates efficacy in rodent models of bacterial infection.  Preclin. in vitro and in vivo studies showed that compd. 3 covalently labels liver proteins, presumably via formation of a reactive metabolite, and hence presented a potential safety liability.  The urea moiety in compd. 3 was identified as being potentially responsible for reactive metabolite formation, but its replacement resulted in loss of antibacterial activity and/or oral exposure due to poor physicochem. parameters.  To identify second-generation aminobenzimidazole ureas devoid of reactive metabolite formation potential, we implemented a metabolic shift strategy, which focused on shifting metab. away from the urea moiety by introducing metabolic soft spots elsewhere in the mol.  Aminobenzimidazole urea 34, identified through this strategy, exhibits similar antibacterial activity as that of 3 and did not label liver proteins in vivo, indicating reduced/no potential for reactive metabolite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1TXw5pd6rXbVg90H21EOLACvtfcHk0ljfBteGYmXrSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J&md5=493a19ab7eaa9997f836228e25fe3125</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1021%2Fjm500563g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500563g%26sid%3Dliteratum%253Aachs%26aulast%3DGrillot%26aufirst%3DA.%2BL.%26aulast%3DLe%2BTiran%26aufirst%3DA.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DKrueger%26aufirst%3DE.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLauffer%26aufirst%3DD.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%26aulast%3DEwing%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSecond-generation%2520antibacterial%2520benzimidazole%2520ureas%253A%2520discovery%2520of%2520a%2520preclinical%2520candidate%2520with%2520reduced%2520metabolic%2520liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8792%26epage%3D8816%26doi%3D10.1021%2Fjm500563g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref262"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref262'); return false;" data-citation="" class="refNumLink">262</a></strong><div class="NLM_citation" id="cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomaides-Brears, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaplewski, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunniss, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peasley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydon, D. J.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5977</span>– <span class="NLM_lpage">5986</span>, <span class="refDoi"> DOI: 10.1128/AAC.00719-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1128%2FAAC.00719-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24041906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5977-5986&author=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=S.+Barkerauthor=J.+M.+Bennettauthor=J.+Berryauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=V.+Gambleauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=H.+Peasleyauthor=S.+Pommierauthor=D.+Priceauthor=C.+Smeeauthor=D.+J.+Haydon&title=Biological+evaluation+of+benzothiazole+ethyl+urea+inhibitors+of+bacterial+type+II+topoisomerases&doi=10.1128%2FAAC.00719-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span></div><div class="casAuthors">Stokes Neil R; Thomaides-Brears Helena B; Barker Stephanie; Bennett James M; Berry Joanne; Collins Ian; Czaplewski Lloyd G; Gamble Vicki; Lancett Paul; Logan Alastair; Lunniss Christopher J; Peasley Hilary; Pommier Stephanie; Price Daniel; Smee Carol; Haydon David J</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5977-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The type II topoisomerases DNA gyrase (GyrA/GyrB) and topoisomerase IV (ParC/ParE) are well-validated targets for antibacterial drug discovery.  Because of their structural and functional homology, these enzymes are amenable to dual targeting by a single ligand.  In this study, two novel benzothiazole ethyl urea-based small molecules, designated compound A and compound B, were evaluated for their biochemical, antibacterial, and pharmacokinetic properties.  The two compounds inhibited the ATPase activity of GyrB and ParE with 50% inhibitory concentrations of <0.1 μg/ml.  Prevention of DNA supercoiling by DNA gyrase was also observed.  Both compounds potently inhibited the growth of a range of bacterial organisms, including staphylococci, streptococci, enterococci, Clostridium difficile, and selected Gram-negative respiratory pathogens.  MIC90s against clinical isolates ranged from 0.015 μg/ml for Streptococcus pneumoniae to 0.25 μg/ml for Staphylococcus aureus.  No cross-resistance with common drug resistance phenotypes was observed.  In addition, no synergistic or antagonistic interactions between compound A or compound B and other antibiotics, including the topoisomerase inhibitors novobiocin and levofloxacin, were detected in checkerboard experiments.  The frequencies of spontaneous resistance for S. aureus were <2.3 × 10(-10) with compound A and <5.8 × 10(-11) with compound B at concentrations equivalent to 8× the MICs.  These values indicate a multitargeting mechanism of action.  The pharmacokinetic properties of both compounds were profiled in rats.  Following intravenous administration, compound B showed approximately 3-fold improvement over compound A in terms of both clearance and the area under the concentration-time curve.  The measured oral bioavailability of compound B was 47.7%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB7u8-ATVsmBFwe7cAcrfPfW6udTcc2eY79Dvbqfboh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D&md5=6ede7459b1d20c528f016a29446253c4</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1128%2FAAC.00719-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00719-13%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBerry%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DGamble%26aufirst%3DV.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DPeasley%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DSmee%26aufirst%3DC.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DBiological%2520evaluation%2520of%2520benzothiazole%2520ethyl%2520urea%2520inhibitors%2520of%2520bacterial%2520type%2520II%2520topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5977%26epage%3D5986%26doi%3D10.1128%2FAAC.00719-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref263"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref263'); return false;" data-citation="" class="refNumLink">263</a></strong><div class="NLM_citation" id="cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yule, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaplewski, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narramore, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span> <span> </span><span class="NLM_article-title">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25137573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=31-38&author=I.+A.+Yuleauthor=L.+G.+Czaplewskiauthor=S.+Pommierauthor=D.+T.+Daviesauthor=S.+K.+Narramoreauthor=C.+W.+Fishwick&title=Pyridine-3-carboxamide-6-yl-ureas+as+novel+inhibitors+of+bacterial+DNA+gyrase%3A+structure+based+design%2C+synthesis%2C+SAR+and+antimicrobial+activity&doi=10.1016%2Fj.ejmech.2014.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity</span></div><div class="casAuthors">Yule, Ian A.; Czaplewski, Lloyd G.; Pommier, Stephanie; Davies, David T.; Narramore, Sarah K.; Fishwick, Colin W. G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of antibacterial drugs based on novel chemotypes is essential to the future management of serious drug resistant infections.  We herein report the design, synthesis and SAR of a novel series of N-ethylurea inhibitors based on a pyridine-3-carboxamide scaffold targeting the ATPase sub-unit of DNA gyrase.  Consideration of structural aspects of the GyrB ATPase site has aided the development of this series resulting in derivs. that demonstrate excellent enzyme inhibitory activity coupled to potent Gram pos. antibacterial efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa7ay8GaYorVg90H21EOLACvtfcHk0ljKEaOxnPFpHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL&md5=0b6959bec14a8d28d3321db46b33b4fa</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DYule%26aufirst%3DI.%2BA.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%2BT.%26aulast%3DNarramore%26aufirst%3DS.%2BK.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26atitle%3DPyridine-3-carboxamide-6-yl-ureas%2520as%2520novel%2520inhibitors%2520of%2520bacterial%2520DNA%2520gyrase%253A%2520structure%2520based%2520design%252C%2520synthesis%252C%2520SAR%2520and%2520antimicrobial%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D31%26epage%3D38%26doi%3D10.1016%2Fj.ejmech.2014.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref264"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref264'); return false;" data-citation="" class="refNumLink">264</a></strong><div class="NLM_citation" id="cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. C.</span></span> <span> </span><span class="NLM_article-title">Linezolid: the first oxazolidinone antimicrobial</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-138-2-200301210-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.7326%2F0003-4819-138-2-200301210-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12529096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=135-142&author=R.+C.+Moellering&title=Linezolid%3A+the+first+oxazolidinone+antimicrobial&doi=10.7326%2F0003-4819-138-2-200301210-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid: the first oxazolidinone antimicrobial</span></div><div class="casAuthors">Moellering, Robert C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-142</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians-American Society of Internal Medicine</span>)
        </div><div class="casAbstract">A review.  Linezolid is the first of a new class of antimicrobial agents, the oxazolidinones, to be approved for clin. use in the United States and elsewhere.  The drug is a totally synthetic compd., which lessens the likelihood of naturally occurring resistance mechanisms.  It has excellent activity against virtually all important gram-pos. pathogens, including methicillin-resistant staphylococci, penicillin-resistant pneumococci, macrolide-resistant streptococci, and vancomycin-resistant enterococci.  Development of resistance to the compd. has been infrequent thus far.  Linezolid is 100% bioavailable, so it can be given in equal doses orally or parenterally.  Its elimination half-life allows dosing twice per day, and alteration of drug dosage is not required in patients with impaired renal or hepatic function.  Linezolid has approved indications for skin and soft tissue infections; lower respiratory tract infections; and vancomycin-resistant Enterococcus faecium infections, including cases with concurrent bacteremia.  The drug has an acceptable profile of adverse events, but reversible myelosuppression has occurred in patients receiving high doses for more than 2 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj72PaeTyuRLVg90H21EOLACvtfcHk0ljKEaOxnPFpHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVWks78%253D&md5=0a1217e18504e1d8ad2a0fc98cc4c89e</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-138-2-200301210-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-138-2-200301210-00015%26sid%3Dliteratum%253Aachs%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26atitle%3DLinezolid%253A%2520the%2520first%2520oxazolidinone%2520antimicrobial%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2003%26volume%3D138%26spage%3D135%26epage%3D142%26doi%3D10.7326%2F0003-4819-138-2-200301210-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref265"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref265'); return false;" data-citation="" class="refNumLink">265</a></strong><div class="NLM_citation" id="cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsiodras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoulas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliopoulos, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennersten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, M. J.</span></span> <span> </span><span class="NLM_article-title">Linezolid resistance in a clinical isolate of Staphylococcus aureus</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(01)05410-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0140-6736%2801%2905410-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11476839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=207-208&author=S.+Tsiodrasauthor=H.+S.+Goldauthor=G.+Sakoulasauthor=G.+M.+Eliopoulosauthor=C.+Wennerstenauthor=L.+Venkataramanauthor=R.+C.+Moelleringauthor=M.+J.+Ferraro&title=Linezolid+resistance+in+a+clinical+isolate+of+Staphylococcus+aureus&doi=10.1016%2FS0140-6736%2801%2905410-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in a clinical isolate of Staphylococcus aureus</span></div><div class="casAuthors">Tsiodras, S.; Gold, H. S.; Sakoulas, G.; Eliopoulos, G. M.; Wennersten, C.; Venkataraman, L.; Moellering, R. C.; Ferraro, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">9277</span>),
    <span class="NLM_cas:pages">207-208</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various Gram-pos. bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).  Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clin. isolates of S aureus.  The authors have characterized an MRSA isolate resistant to linezolid that was recovered from a patient treated with this agent for dialysis-assocd. peritonitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRryTK5F9tc7Vg90H21EOLACvtfcHk0lhfA7O9XE-xnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D&md5=d8574bd50d0f1129cbc8d5dae0ac8127</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2801%2905410-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252801%252905410-1%26sid%3Dliteratum%253Aachs%26aulast%3DTsiodras%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DH.%2BS.%26aulast%3DSakoulas%26aufirst%3DG.%26aulast%3DEliopoulos%26aufirst%3DG.%2BM.%26aulast%3DWennersten%26aufirst%3DC.%26aulast%3DVenkataraman%26aufirst%3DL.%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26aulast%3DFerraro%26aufirst%3DM.%2BJ.%26atitle%3DLinezolid%2520resistance%2520in%2520a%2520clinical%2520isolate%2520of%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D207%26epage%3D208%26doi%3D10.1016%2FS0140-6736%2801%2905410-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref266"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref266'); return false;" data-citation="" class="refNumLink">266</a></strong><div class="NLM_citation" id="cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreckenberger, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DenBesten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. P.</span></span> <span> </span><span class="NLM_article-title">Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1179</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(00)04376-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0140-6736%2800%2904376-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11323048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFaqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1179&author=R.+D.+Gonzalesauthor=P.+C.+Schreckenbergerauthor=M.+B.+Grahamauthor=S.+Kelkarauthor=K.+DenBestenauthor=J.+P.+Quinn&title=Infections+due+to+vancomycin-resistant+Enterococcus+faecium+resistant+to+linezolid&doi=10.1016%2FS0140-6736%2800%2904376-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid</span></div><div class="casAuthors">Gonzales, R. D.; Schreckenberger, P. C.; Graham, M. B.; Kelkar, S.; DenBesten, K.; Quinn, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9263</span>),
    <span class="NLM_cas:pages">1179</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">Linezolid is a new oxazolidinone antibiotic used to treat infections caused by vancomycin-resistant enterococci (VRE).  In early clin. trials, emergence of resistance occurred rarely.  The authors report clin. details and antibiotic susceptibility from 5 patients treated with linezolid for VRE infections who had resistant organisms isolated during therapy.  Four were transplant patients receiving protracted courses of the drug; 3 cases were assocd. with treatment failure.  One of 45 linezolid-treated patients developed resistance during therapy.  Susceptibility testing should be done in all cases on starting therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdnzIal5XYyLVg90H21EOLACvtfcHk0lhfA7O9XE-xnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFaqsb0%253D&md5=accd02388931411eaa373b9b69a01347</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2904376-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252904376-2%26sid%3Dliteratum%253Aachs%26aulast%3DGonzales%26aufirst%3DR.%2BD.%26aulast%3DSchreckenberger%26aufirst%3DP.%2BC.%26aulast%3DGraham%26aufirst%3DM.%2BB.%26aulast%3DKelkar%26aufirst%3DS.%26aulast%3DDenBesten%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DJ.%2BP.%26atitle%3DInfections%2520due%2520to%2520vancomycin-resistant%2520Enterococcus%2520faecium%2520resistant%2520to%2520linezolid%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1179%26doi%3D10.1016%2FS0140-6736%2800%2904376-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref267"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref267'); return false;" data-citation="" class="refNumLink">267</a></strong><div class="NLM_citation" id="cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toh, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villegas, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankin, A. S.</span></span> <span> </span><span class="NLM_article-title">Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1506</span>– <span class="NLM_lpage">1514</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2007.05744.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1111%2Fj.1365-2958.2007.05744.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17555436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1506-1514&author=S.+M.+Tohauthor=L.+Xiongauthor=C.+A.+Ariasauthor=M.+V.+Villegasauthor=K.+Lolansauthor=J.+Quinnauthor=A.+S.+Mankin&title=Acquisition+of+a+natural+resistance+gene+renders+a+clinical+strain+of+methicillin-resistant+Staphylococcus+aureus+resistant+to+the+synthetic+antibiotic+linezolid&doi=10.1111%2Fj.1365-2958.2007.05744.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid</span></div><div class="casAuthors">Toh, Seok-Ming; Xiong, Liqun; Arias, Cesar A.; Villegas, Maria V.; Lolans, Karen; Quinn, John; Mankin, Alexander S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1506-1514</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Linezolid, which targets the ribosome, is a new synthetic antibiotic that is used for treatment of infections caused by Gram-pos. pathogens.  Clin. resistance to linezolid, so far, has been developing only slowly and has involved exclusively target site mutations.  We have discovered that linezolid resistance in a methicillin-resistant Staphylococcus aureus hospital strain from Colombia is detd. by the presence of the cfr gene whose product, Cfr methyltransferase, modifies adenosine at position 2503 in 23S rRNA in the large ribosomal subunit.  The mol. model of the linezolid-ribosome complex reveals localization of A2503 within the drug binding site.  The natural function of cfr likely involves protection against natural antibiotics whose site of action overlaps that of linezolid.  In the chromosome of the clin. strain, cfr is linked to ermB, a gene responsible for dimethylation of A2058 in 23S rRNA.  Coexpression of these two genes confers resistance to all the clin. relevant antibiotics that target the large ribosomal subunit.  The assocn. of the ermB/cfr operon with transposon and plasmid genetic elements indicates its possible mobile nature.  This is the first example of clin. resistance to the synthetic drug linezolid which involves a natural resistance gene with the capability of disseminating among Gram-pos. pathogenic strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBz3CL3GnHirVg90H21EOLACvtfcHk0liqmSnjWrnWfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvVaisLk%253D&md5=0d2e6ae18e8e638530a0ad6191ba0677</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2007.05744.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2007.05744.x%26sid%3Dliteratum%253Aachs%26aulast%3DToh%26aufirst%3DS.%2BM.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DArias%26aufirst%3DC.%2BA.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DLolans%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DMankin%26aufirst%3DA.%2BS.%26atitle%3DAcquisition%2520of%2520a%2520natural%2520resistance%2520gene%2520renders%2520a%2520clinical%2520strain%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520resistant%2520to%2520the%2520synthetic%2520antibiotic%2520linezolid%26jtitle%3DMol.%2520Microbiol.%26date%3D2007%26volume%3D64%26spage%3D1506%26epage%3D1514%26doi%3D10.1111%2Fj.1365-2958.2007.05744.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref268"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref268'); return false;" data-citation="" class="refNumLink">268</a></strong><div class="NLM_citation" id="cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsunomiya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasukata, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2013.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24044938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaqs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=262-277&author=H.+Suzukiauthor=I.+Utsunomiyaauthor=K.+Shudoauthor=N.+Fukuharaauthor=T.+Iwakiauthor=T.+Yasukata&title=Synthesis+and+in+vitro%2Fin+vivo+antibacterial+activity+of+oxazolidinones+having+thiocarbamate+at+C-5+on+the+A-ring+and+an+amide-+or+urea-substituted+%5B1%2C2%2C5%5Dtriazepane+or+%5B1%2C2%2C5%5Doxadiazepane+as+the+C-ring&doi=10.1016%2Fj.ejmech.2013.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring</span></div><div class="casAuthors">Suzuki, Hideyuki; Utsunomiya, Iwao; Shudo, Koichi; Fukuhara, Norio; Iwaki, Tsutomu; Yasukata, Tatsuro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">262-277</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Oxazolidinones (e.g., I) bearing a seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane heterocycle substituted with an amide or urea functionality as the C-ring and having a [1,2,3]triazole, a thiocarbamate, an isoxazole-3-ylamino, or a thioacetamide C-5 side chain unit on the A-ring instead of the typical acetamide were synthesized and their in vitro antibacterial activities towards various pathogens were evaluated.  Several derivs. exhibited potent in vitro antibacterial activity toward not only Gram-pos., but also Gram-neg. and linezolid-resistant pathogens.  The in vivo therapeutic effects of amide 11a and ureas 16e, 17a were 2- to 3-fold greater than that of linezolid in a systemic mouse infection model treated by i.v. administration.  Furthermore, compds. 11a and 17a showed lower monoamine oxidase (MAO)-inhibitory activity than our previously reported potent oxazolidinone antibacterials 3a and 3b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQG9zCkR5umLVg90H21EOLACvtfcHk0liqmSnjWrnWfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaqs7%252FP&md5=aba5a71f79c670f5f917cdac48a0d44d</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DUtsunomiya%26aufirst%3DI.%26aulast%3DShudo%26aufirst%3DK.%26aulast%3DFukuhara%26aufirst%3DN.%26aulast%3DIwaki%26aufirst%3DT.%26aulast%3DYasukata%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in%2520vitro%252Fin%2520vivo%2520antibacterial%2520activity%2520of%2520oxazolidinones%2520having%2520thiocarbamate%2520at%2520C-5%2520on%2520the%2520A-ring%2520and%2520an%2520amide-%2520or%2520urea-substituted%2520%255B1%252C2%252C5%255Dtriazepane%2520or%2520%255B1%252C2%252C5%255Doxadiazepane%2520as%2520the%2520C-ring%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D262%26epage%3D277%26doi%3D10.1016%2Fj.ejmech.2013.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref269"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref269'); return false;" data-citation="" class="refNumLink">269</a></strong><div class="NLM_citation" id="cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanfardino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notomista, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichelhaus, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saturnino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varcamonti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriente, A.</span></span> <span> </span><span class="NLM_article-title">Novel promising linezolid analogues: rational design, synthesis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2013.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24099997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=779-785&author=M.+De+Rosaauthor=A.+Zanfardinoauthor=E.+Notomistaauthor=T.+A.+Wichelhausauthor=C.+Saturninoauthor=M.+Varcamontiauthor=A.+Soriente&title=Novel+promising+linezolid+analogues%3A+rational+design%2C+synthesis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2013.09.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Novel promising linezolid analogues: Rational design, synthesis and biological evaluation</span></div><div class="casAuthors">De Rosa, Margherita; Zanfardino, Anna; Notomista, Eugenio; Wichelhaus, Thomas A.; Saturnino, Carmela; Varcamonti, Mario; Soriente, Annunziata</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">779-785</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new series of 5-substituted oxazolidinones derived from linezolid, having urea and thiourea moieties at the C-5 side chain of the oxazolidinone ring, were prepd. and their in vitro antibacterial activity was evaluated.  The compd. 10f demonstrated high antimicrobial activity, comparable to that of linezolid against Staphylococcus aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxz-aHlAQN7Vg90H21EOLACvtfcHk0liqmSnjWrnWfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartLnM&md5=d67d6e7184e3bcb04a2264a3f221993f</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DZanfardino%26aufirst%3DA.%26aulast%3DNotomista%26aufirst%3DE.%26aulast%3DWichelhaus%26aufirst%3DT.%2BA.%26aulast%3DSaturnino%26aufirst%3DC.%26aulast%3DVarcamonti%26aufirst%3DM.%26aulast%3DSoriente%26aufirst%3DA.%26atitle%3DNovel%2520promising%2520linezolid%2520analogues%253A%2520rational%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D779%26epage%3D785%26doi%3D10.1016%2Fj.ejmech.2013.09.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref270"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref270'); return false;" data-citation="" class="refNumLink">270</a></strong><div class="NLM_citation" id="cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanpithakpong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhasivanon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindegardh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Socheat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin resistance in Plasmodium falciparum malaria</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0808859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1056%2FNEJMoa0808859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19641202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=455-467&author=A.+M.+Dondorpauthor=F.+Nostenauthor=P.+Yiauthor=D.+Dasauthor=A.+P.+Phyoauthor=J.+Tarningauthor=K.+M.+Lwinauthor=F.+Arieyauthor=W.+Hanpithakpongauthor=S.+J.+Leeauthor=P.+Ringwaldauthor=K.+Silamutauthor=M.+Imwongauthor=K.+Chotivanichauthor=P.+Limauthor=T.+Herdmanauthor=S.+S.+Anauthor=S.+Yeungauthor=P.+Singhasivanonauthor=N.+P.+Dayauthor=N.+Lindegardhauthor=D.+Socheatauthor=N.+J.+White&title=Artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa0808859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Dondorp, Arjen M.; Nosten, Francois; Yi, Poravuth; Das, Debashish; Phyo, Aung Phae; Tarning, Joel; Lwin, Khin Maung; Ariey, Frederic; Hanpithakpong, Warunee; Lee, Sue J.; Ringwald, Pascal; Silamut, Kamolrat; Imwong, Mallika; Chotivanich, Kesinee; Lim, Pharath; Herdman, Trent; Sam An, Sen; Yeung, Shunmay; Singhasivanon, Pratap; Day, Nicholas P. J.; Lindegardh, Niklas; Socheat, Duong; White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-467</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease.  There are recent concerns that the efficacy of such therapies has declined on the Thai-Cambodian border, historically a site of emerging antimalarial-drug resistance.  METHODS: In two open-label, randomized trials, we compared the efficacies of two treatments for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, northwestern Thailand: oral artesunate given at a dose of 2 mg per kg of body wt. per day, for 7 days, and artesunate given at a dose of 4 mg per kg per day, for 3 days, followed by mefloqine at two doses totaling 25 mg per kg.  We assessed in vitro and in vivo Plasmodium-falciparum susceptibility, artesunate pharmacokinetics, and mol. markers of resistance.  RESULTS: We studied 40 patients in each of the two locations.  The overall median parasite clearance times were 84 h (interquartile range, 60 to 96) in Pailin and 48 h (interquartile range, 36 to 66) in Wang Pha (P < 0.001).  Recrudescence confirmed by means of polymerase-chain-reaction assay occurred in 6 of 20 patients (30%) receiving artesunate monotherapy and 1 of 20 (5%) receiving artesunate-mefloqine therapy in Pailin, as compared with 2 of 20 (10%) and 1 of 20 (5%), resp., in Wang Pha (P = 0.31).  These markedly different parasitol. responses were not explained by differences in age, artesunate or dihydroartemisinin pharmacokinetics, results of isotopic in vitro sensitivity tests, or putative mol. correlates of P.falciparum drug resistance (mutations or amplifications of the gene encoding a multidrug resistance protein [PfMDR1] or mutations in the gene encoding sarco-endoplasmic reticulum calcium ATPase6 [PfSERCA]).  Adverse events were mild and did not differ significantly between the two treatment groups.  CONCLUSIONS: P.falciparum has reduced in vivo susceptibility to artesunate in western Cambodia as compared with northwestern Thailand.  Resistance is characterized by slow parasite clearance in vivo without corresponding redns. on conventional in vitro susceptibility testing.  Containment measures are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfVvi4ozTDSLVg90H21EOLACvtfcHk0lgVLJ6SGkU2Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D&md5=ae3098a15e9fb82c80fa0ddd05378220</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808859%26sid%3Dliteratum%253Aachs%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DLwin%26aufirst%3DK.%2BM.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DHanpithakpong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DHerdman%26aufirst%3DT.%26aulast%3DAn%26aufirst%3DS.%2BS.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DSinghasivanon%26aufirst%3DP.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DLindegardh%26aufirst%3DN.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DArtemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D455%26epage%3D467%26doi%3D10.1056%2FNEJMoa0808859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref271"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref271'); return false;" data-citation="" class="refNumLink">271</a></strong><div class="NLM_citation" id="cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wongsrichanalai, C.</span></span> <span> </span><span class="NLM_article-title">Artemisinin resistance or artemisinin-based combination therapy resistance?</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(12)70349-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS1473-3099%2812%2970349-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23347632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Git7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=114-115&author=C.+Wongsrichanalai&title=Artemisinin+resistance+or+artemisinin-based+combination+therapy+resistance%3F&doi=10.1016%2FS1473-3099%2812%2970349-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance or artemisinin-based combination therapy resistance?</span></div><div class="casAuthors">Wongsrichanalai, Chansuda</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">114-115</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The research of Breman (2012) entitled 'Resistance to artemisinin-based combination therapy' and of Amaratunga et al. (2012) entitled 'Artemisinin-resistant Plasmodium falciparum malaria in Pursat province, western Cambodia: a parasite-clearance-rate study' are reviewed with commentary and refs.  Breman discussed parasite resistance to artemisinin-based combination therapy (ACT) and the heritability of this resistance.  The differences between artemisinin resistance and resistance to ACT merit further clarification.  Amaratunga et al. delayed mefloquine administration to exclude the contribution of mefloquine in parasite clearance during the first 72 h - the period most relevant to artemisinin action.  This approach deviates from the std. treatment schedule for the purpose of their study, i.e., to investigate the genetic basis of artemisinin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv8REl73iD67Vg90H21EOLACvtfcHk0lgVLJ6SGkU2Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Git7s%253D&md5=12e10152d71f896e6bfdf20f920b240f</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2812%2970349-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252812%252970349-3%26sid%3Dliteratum%253Aachs%26aulast%3DWongsrichanalai%26aufirst%3DC.%26atitle%3DArtemisinin%2520resistance%2520or%2520artemisinin-based%2520combination%2520therapy%2520resistance%253F%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2013%26volume%3D13%26spage%3D114%26epage%3D115%26doi%3D10.1016%2FS1473-3099%2812%2970349-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref272"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref272'); return false;" data-citation="" class="refNumLink">272</a></strong><div class="NLM_citation" id="cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, C. H.</span></span> <span> </span><span class="NLM_article-title">Tracking artemisinin resistance in Plasmodium falciparum</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">999</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(13)70260-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS1473-3099%2813%2970260-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24035557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOntr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=999-1000&author=C.+H.+Sibley&title=Tracking+artemisinin+resistance+in+Plasmodium+falciparum&doi=10.1016%2FS1473-3099%2813%2970260-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking artemisinin resistance in Plasmodium falciparum</span></div><div class="casAuthors">Sibley, Carol Hopkins</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">999-1000</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This article reports the tracking artemisinin resistance in Plasmodium falciparum.  The important artemisinin combination therapies are described in this article.  The adapted parasites from individual patients and tested them in their short-pulse assay.  After an initial 3 h pulse of drug, parasites from slow clearing patients showed significantly better survival than those from patients whose parasites cleared rapidly.  This made a direct link between the clearance phenotype in patients and the response of those parasites in the assay.  The response of Plasmodium falciparum fresh parasite isolates from the peripheral blood was tested with no synchronization step, and showed that this simple assay also clearly identified parasites with the slow clearance phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOQiM3NeHqRrVg90H21EOLACvtfcHk0lh097CWCknBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOntr7O&md5=783aff4a7de213debdc11df30e359f9c</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2813%2970260-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252813%252970260-3%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DC.%2BH.%26atitle%3DTracking%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2013%26volume%3D13%26spage%3D999%26epage%3D1000%26doi%3D10.1016%2FS1473-3099%2813%2970260-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref273"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref273'); return false;" data-citation="" class="refNumLink">273</a></strong><div class="NLM_citation" id="cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verlinden, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woster, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel alkylated (bis)urea and (bis)thiourea polyamine analogues with potent antimalarial activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6624</span>– <span class="NLM_lpage">6633</span>, <span class="refDoi"> DOI: 10.1021/jm200463z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200463z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOmsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6624-6633&author=B.+K.+Verlindenauthor=J.+Niemandauthor=J.+Snymanauthor=S.+K.+Sharmaauthor=R.+J.+Beattieauthor=P.+M.+Wosterauthor=L.+M.+Birkholtz&title=Discovery+of+novel+alkylated+%28bis%29urea+and+%28bis%29thiourea+polyamine+analogues+with+potent+antimalarial+activities&doi=10.1021%2Fjm200463z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Alkylated (bis)Urea and (bis)Thiourea Polyamine Analogues with Potent Antimalarial Activities</span></div><div class="casAuthors">Verlinden, Bianca K.; Niemand, Jandeli; Snyman, Janette; Sharma, Shiv K.; Beattie, Ross J.; Woster, Patrick M.; Birkholtz, Lyn-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6624-6633</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of alkylated (bis)urea and (bis)thiourea polyamine analogs were synthesized and screened for antimalarial activity against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro.  All analogs showed growth inhibitory activity against P. falciparum at less than 3 μM, with the majority having effective IC50 values in the 100-650 nM range.  Analogs arrested parasitic growth within 24 h of exposure due to a block in nuclear division and therefore asexual development.  Moreover, this effect appears to be cytotoxic and highly selective to malaria parasites (>7000-fold lower IC50 against P. falciparum) and is not reversible by the exogenous addn. of polyamines.  With this first report of potent antimalarial activity of polyamine analogs contg. 3-7-3 or 3-6-3 carbon backbones and substituted terminal urea- or thiourea moieties, we propose that these compds. represent a structurally novel class of antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULINvA9vpULVg90H21EOLACvtfcHk0lh097CWCknBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOmsbbI&md5=fbf96c2f4250c133624b37f998800a9d</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1021%2Fjm200463z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200463z%26sid%3Dliteratum%253Aachs%26aulast%3DVerlinden%26aufirst%3DB.%2BK.%26aulast%3DNiemand%26aufirst%3DJ.%26aulast%3DSnyman%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DBeattie%26aufirst%3DR.%2BJ.%26aulast%3DWoster%26aufirst%3DP.%2BM.%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26atitle%3DDiscovery%2520of%2520novel%2520alkylated%2520%2528bis%2529urea%2520and%2520%2528bis%2529thiourea%2520polyamine%2520analogues%2520with%2520potent%2520antimalarial%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6624%26epage%3D6633%26doi%3D10.1021%2Fjm200463z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref274"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref274'); return false;" data-citation="" class="refNumLink">274</a></strong><div class="NLM_citation" id="cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span> <span> </span><span class="NLM_article-title">Urea/oxalamide tethered beta-lactam-7-chloroquinoline conjugates: synthesis and in vitro antimalarial evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.10.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2013.10.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24287561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=128-134&author=P.+Singhauthor=R.+Rajauthor=J.+Gutauthor=P.+J.+Rosenthalauthor=V.+Kumar&title=Urea%2Foxalamide+tethered+beta-lactam-7-chloroquinoline+conjugates%3A+synthesis+and+in+vitro+antimalarial+evaluation&doi=10.1016%2Fj.ejmech.2013.10.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit274R"><div class="casContent"><span class="casTitleNuber">274</span><div class="casTitle"><span class="NLM_cas:atitle">Urea/oxalamide tethered β-lactam-7-chloroquinoline conjugates: Synthesis and in vitro antimalarial evaluation</span></div><div class="casAuthors">Singh, Pardeep; Raj, Raghu; Singh, Parvesh; Gut, Jiri; Rosenthal, Philip J.; Kumar, Vipan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The manuscript pertains to the synthesis of urea/oxalamide tethered β-lactam-7-chloroquinoline conjugates, e.g., I (R = C6H11, n = 2, 3, 4, 6; R = 4-MeC6H4, n = 2, 3, 4, 6), with well modulated chain lengths and their antimalarial evaluation.  The results reveal the dependence of activity profiles on the N-1 substituent of the β-lactam ring, the nature of the linker as well as the length of the alkyl chain.  The most potent of the tested compds. showed an IC50 of 34.97 nM against chloroquine resistant W2 strain of Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-C47BUed9qrVg90H21EOLACvtfcHk0lh097CWCknBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGrtro%253D&md5=ca2f6d8942c4f62854e507239aa431cf</span></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.10.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.10.079%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DRaj%26aufirst%3DR.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DUrea%252Foxalamide%2520tethered%2520beta-lactam-7-chloroquinoline%2520conjugates%253A%2520synthesis%2520and%2520in%2520vitro%2520antimalarial%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D71%26spage%3D128%26epage%3D134%26doi%3D10.1016%2Fj.ejmech.2013.10.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref275"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref275'); return false;" data-citation="" class="refNumLink">275</a></strong><div class="NLM_citation" id="cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coster, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouwer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healy, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1558</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1039/C4OB01849D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC4OB01849D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25490858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2jur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=1558-1570&author=B.+D.+Schwartzauthor=T.+S.+Skinner-Adamsauthor=K.+T.+Andrewsauthor=M.+J.+Costerauthor=M.+D.+Edsteinauthor=D.+MacKenzieauthor=S.+A.+Charmanauthor=M.+Koltunauthor=S.+Blundellauthor=A.+Campbellauthor=R.+H.+Pouwerauthor=R.+J.+Quinnauthor=K.+D.+Beattieauthor=P.+C.+Healyauthor=R.+A.+Davis&title=Synthesis+and+antimalarial+evaluation+of+amide+and+urea+derivatives+based+on+the+thiaplakortone+A+natural+product+scaffold&doi=10.1039%2FC4OB01849D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold</span></div><div class="casAuthors">Schwartz, Brett D.; Skinner-Adams, Tina S.; Andrews, Katherine T.; Coster, Mark J.; Edstein, Michael D.; MacKenzie, Donna; Charman, Susan A.; Koltun, Maria; Blundell, Scott; Campbell, Anna; Pouwer, Rebecca H.; Quinn, Ronald J.; Beattie, Karren D.; Healy, Peter C.; Davis, Rohan A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1558-1570</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of amide and urea analogs I (R = Me, Et, cyclopropyl, furan-3-yl, Ph, NHBu, NMeOMe ,etc., R1 = H; R = Me, R1 = Me, cyclopentyl, PhCH2, etc.) based on the thiaplakortone A natural product scaffold were synthesized and screened for in vitro antimalarial activity against chloroquine-sensitive (3D7) and chloroquine- and mefloquine-resistant (Dd2) Plasmodium falciparum parasite lines.  Several analogs displayed potent inhibition of P. falciparum growth (IC50 <500 nM) and good selectivity for P. falciparum vs. human neonatal foreskin fibroblast cells (selectivity index >100).  Two of these compds., I (R = Me, NHBu, R1 = H), exhibited good aq. soly. and metabolic stability, and when administered s.c. to mice (32 mg kg-1), plasma concns. remained above 0.2 μM for at least 8 h.  Both I (R = Me, NHBu, R1 = H) were well tolerated in mice after s.c. administration of 32 mg kg-1 twice daily for 4 days.  Using this regimen blood stage P. berghei was suppressed by 52% for I (R = Me, R1 = H) and 26% for I (R = NHBu, R1 = H), relative to the vehicle control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5UgQDexwzrVg90H21EOLACvtfcHk0lhM4HHhGAAjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2jur3I&md5=42668d6a4e4146424e142e2b75ce0d62</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1039%2FC4OB01849D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01849D%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DB.%2BD.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCoster%26aufirst%3DM.%2BJ.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DMacKenzie%26aufirst%3DD.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DBlundell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DPouwer%26aufirst%3DR.%2BH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26aulast%3DBeattie%26aufirst%3DK.%2BD.%26aulast%3DHealy%26aufirst%3DP.%2BC.%26aulast%3DDavis%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520antimalarial%2520evaluation%2520of%2520amide%2520and%2520urea%2520derivatives%2520based%2520on%2520the%2520thiaplakortone%2520A%2520natural%2520product%2520scaffold%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D1558%26epage%3D1570%26doi%3D10.1039%2FC4OB01849D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref276"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref276'); return false;" data-citation="" class="refNumLink">276</a></strong><div class="NLM_citation" id="cit276"><span><a href="http://www.who.int/mediacentre/factsheets/fs259/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs259/en/</a> (accessed April 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs259%2Fen%2F+%28accessed+April+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref277"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref277'); return false;" data-citation="" class="refNumLink">277</a></strong><div class="NLM_citation" id="cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2451</span>– <span class="NLM_lpage">2465</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmc.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27102161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2451-2465&author=D.+A.+Patrickauthor=T.+Wenzlerauthor=S.+Yangauthor=P.+T.+Weiserauthor=M.+Z.+Wangauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+of+novel+amide+and+urea+derivatives+of+thiazol-2-ethylamines+and+their+activity+against+Trypanosoma+brucei+rhodesiense&doi=10.1016%2Fj.bmc.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense</span></div><div class="casAuthors">Patrick, Donald A.; Wenzler, Tanja; Yang, Sihyung; Weiser, Patrick T.; Wang, Michael Zhuo; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2451-2465</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-(2-Benzamido)ethyl-4-phenylthiazole I was one of 1035 mols. (grouped into 115 distinct scaffolds) found to be inhibitory to Trypanosoma brucei, the pathogen causing human African trypanosomiasis, at concns. below 3.6 μM and nontoxic to mammalian (Huh7) cells in a phenotypic high-throughput screen of a 700,000 compd. library performed by the Genomics Institute of the Novartis Research Foundation (GNF).  Compd. I and 72 analogs were synthesized in this lab. by one of two general pathways.  These plus 10 com. available analogs were tested against T. brucei rhodesiense STIB900 and L6 rat myoblast cells (for cytotoxicity) in vitro.  Forty-four derivs. were more potent than I, including eight with IC50 values below 100 nM.  The most potent and most selective for the parasite was the urea analog 2-(2-piperidin-1-ylamido)ethyl-4-(3-fluorophenyl)thiazole II (IC50 = 9 nM, SI > 18,000).  None of 33 compds. tested were able to cure mice infected with the parasite; however, seven compds. caused temporary redns. of parasitemia (≥97%) but with subsequent relapses.  The lack of in vivo efficacy was at least partially due to their poor metabolic stability, as demonstrated by the short half-lives of 15 analogs against mouse and human liver microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV78D13zDrJ7Vg90H21EOLACvtfcHk0lhM4HHhGAAjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D&md5=d371dc632576f40e4002cd96b67c5a77</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWeiser%26aufirst%3DP.%2BT.%26aulast%3DWang%26aufirst%3DM.%2BZ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520of%2520novel%2520amide%2520and%2520urea%2520derivatives%2520of%2520thiazol-2-ethylamines%2520and%2520their%2520activity%2520against%2520Trypanosoma%2520brucei%2520rhodesiense%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2451%26epage%3D2465%26doi%3D10.1016%2Fj.bmc.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref278"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref278'); return false;" data-citation="" class="refNumLink">278</a></strong><div class="NLM_citation" id="cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laydbak, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucker, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span> <span> </span><span class="NLM_article-title">Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6342</span>– <span class="NLM_lpage">6351</span>, <span class="refDoi"> DOI: 10.1021/jm300303e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300303e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6342-6351&author=S.+Shibataauthor=J.+R.+Gillespieauthor=R.+M.+Ranadeauthor=C.+Y.+Kohauthor=J.+E.+Kimauthor=J.+U.+Laydbakauthor=F.+H.+Zuckerauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=F.+S.+Bucknerauthor=E.+Fan&title=Urea-based+inhibitors+of+Trypanosoma+brucei+methionyl-tRNA+synthetase%3A+selectivity+and+in+vivo+characterization&doi=10.1021%2Fjm300303e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Urea-Based Inhibitors of Trypanosoma brucei Methionyl-tRNA Synthetase: Selectivity and in Vivo Characterization</span></div><div class="casAuthors">Shibata, Sayaka; Gillespie, J. Robert; Ranade, Ranae M.; Koh, Cho Yeow; Kim, Jessica E.; Laydbak, Joy U.; Zucker, Frank H.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Fan, Erkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6342-6351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based methionyl-tRNA synthetase inhibitors were designed, synthesized, and evaluated for their potential toward treating human African trypanosomiasis (HAT).  With the aid of a homol. model and a structure-activity-relationship approach, low nM inhibitors were discovered that show high selectivity toward the parasite enzyme over the closest human homolog.  These compds. inhibit parasite growth with EC50 values as low as 0.15 μM while having low toxicity to mammalian cells.  Two compds. (2 and 26) showed excellent membrane permeation in the MDR1-MDCKII model and encouraging oral pharmacokinetic properties in mice.  Compd. 2 (I) was confirmed to enter the CNS in mice.  Compd. 26 had modest suppressive activity against Trpanosoma brucei rhodesiense in the mouse model, suggesting that more potent analogs or compds. with higher exposures need to be developed.  The urea-based inhibitors are thus a promising starting point for further optimization toward the discovery of orally available and CNS active drugs to treat HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobDMlz2d57bLVg90H21EOLACvtfcHk0lhM4HHhGAAjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D&md5=a7029357bdc79d52992a4b6eeff53e80</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1021%2Fjm300303e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300303e%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DKoh%26aufirst%3DC.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLaydbak%26aufirst%3DJ.%2BU.%26aulast%3DZucker%26aufirst%3DF.%2BH.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DFan%26aufirst%3DE.%26atitle%3DUrea-based%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520methionyl-tRNA%2520synthetase%253A%2520selectivity%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6342%26epage%3D6351%26doi%3D10.1021%2Fjm300303e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref63':['cit63'],'ref62':['cit62'],'ref61':['cit61'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254'],'ref255':['cit255'],'ref256':['cit256'],'ref257':['cit257'],'ref258':['cit258'],'ref259':['cit259'],'ref260':['cit260'],'ref261':['cit261'],'ref262':['cit262'],'ref263':['cit263'],'ref264':['cit264'],'ref265':['cit265'],'ref266':['cit266'],'ref267':['cit267'],'ref268':['cit268'],'ref269':['cit269'],'ref270':['cit270'],'ref271':['cit271'],'ref272':['cit272'],'ref273':['cit273'],'ref274':['cit274'],'ref275':['cit275'],'ref276':['cit276'],'ref277':['cit277'],'ref278':['cit278']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 37 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Subhro Mandal, <span class="NLM_string-name hlFld-ContribAuthor">Animesh Pramanik</span>. </span><span class="cited-content_cbyCitation_article-title">Three-Component Synthesis of Pyrrolo/indolo[1,2-a]quinoxalines Substituted with o-Biphenylester/N-arylcarbamate/N-arylurea: A Domino Approach Involving Spirocyclic Ring Opening. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (7)
                                     , 5047-5064. <a href="https://doi.org/10.1021/acs.joc.0c02973" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02973%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThree-Component%252BSynthesis%252Bof%252BPyrrolo%25252Findolo%25255B1%25252C2-a%25255Dquinoxalines%252BSubstituted%252Bwith%252Bo-Biphenylester%25252FN-arylcarbamate%25252FN-arylurea%25253A%252BA%252BDomino%252BApproach%252BInvolving%252BSpirocyclic%252BRing%252BOpening%26aulast%3DMandal%26aufirst%3DSubhro%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D18122020%26date%3D12032021%26volume%3D86%26issue%3D7%26spage%3D5047%26epage%3D5064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rebecca B. Watson, Todd W. Butler, <span class="NLM_string-name hlFld-ContribAuthor">Jacob C. DeForest</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of Carbamates, Esters, Amides, and Unsymmetrical Ureas via Brønsted Acid-Activated N-Acyl Imidazoliums. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (3)
                                     , 500-506. <a href="https://doi.org/10.1021/acs.oprd.0c00445" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00445%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPreparation%252Bof%252BCarbamates%25252C%252BEsters%25252C%252BAmides%25252C%252Band%252BUnsymmetrical%252BUreas%252Bvia%252BBr%2525C3%2525B8nsted%252BAcid-Activated%252BN-Acyl%252BImidazoliums%26aulast%3DWatson%26aufirst%3DRebecca%2BB.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01102020%26date%3D15122020%26volume%3D25%26issue%3D3%26spage%3D500%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chengwei Li, Jialiang Zhong, Baohu Liu, Tao Yang, Binhua Lv, <span class="NLM_string-name hlFld-ContribAuthor">Youfu Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Study on Typical Diarylurea Drugs or Derivatives in Cocrystallizing with Strong H-Bond Acceptor DMSO. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (8)
                                     , 5532-5547. <a href="https://doi.org/10.1021/acsomega.0c05908" title="DOI URL">https://doi.org/10.1021/acsomega.0c05908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c05908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c05908%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DStudy%252Bon%252BTypical%252BDiarylurea%252BDrugs%252Bor%252BDerivatives%252Bin%252BCocrystallizing%252Bwith%252BStrong%252BH-Bond%252BAcceptor%252BDMSO%26aulast%3DLi%26aufirst%3DChengwei%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D04122020%26date%3D11022021%26date%3D19022021%26volume%3D6%26issue%3D8%26spage%3D5532%26epage%3D5547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kai Xu, Yan Zheng, Yong Ye, Delong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Wanbin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Desymmetrization of meso-Dicarbonatecyclohexene with β-Hydrazino Carboxylic Esters via a Pd-Catalyzed Allylic Substitution Cascade. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (22)
                                     , 8836-8841. <a href="https://doi.org/10.1021/acs.orglett.0c03211" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03211%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDesymmetrization%252Bof%252Bmeso-Dicarbonatecyclohexene%252Bwith%252B%2525CE%2525B2-Hydrazino%252BCarboxylic%252BEsters%252Bvia%252Ba%252BPd-Catalyzed%252BAllylic%252BSubstitution%252BCascade%26aulast%3DXu%26aufirst%3DKai%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24092020%26date%3D10112020%26volume%3D22%26issue%3D22%26spage%3D8836%26epage%3D8841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shikha Kumari, Angelica V. Carmona, Amit K. Tiwari, <span class="NLM_string-name hlFld-ContribAuthor">Paul C. Trippier</span>. </span><span class="cited-content_cbyCitation_article-title">Amide Bond Bioisosteres: Strategies, Synthesis, and Successes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12290-12358. <a href="https://doi.org/10.1021/acs.jmedchem.0c00530" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00530%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmide%252BBond%252BBioisosteres%25253A%252BStrategies%25252C%252BSynthesis%25252C%252Band%252BSuccesses%26aulast%3DKumari%26aufirst%3DShikha%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31032020%26date%3D04082020%26date%3D20072020%26volume%3D63%26issue%3D21%26spage%3D12290%26epage%3D12358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michelina Soccio, Rita Mazzoni, Carlo Lucarelli, Silvia Quattrosoldi, Andrea Cingolani, Maurizio Fiorini, Nadia Lotti, <span class="NLM_string-name hlFld-ContribAuthor">Tommaso Tabanelli</span>. </span><span class="cited-content_cbyCitation_article-title">Urea and Polyurea Production: An Innovative Solvent- and Catalyst-Free Approach through Catechol Carbonate. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2020,</strong> <em>8 </em>
                                    (41)
                                     , 15640-15650. <a href="https://doi.org/10.1021/acssuschemeng.0c05177" title="DOI URL">https://doi.org/10.1021/acssuschemeng.0c05177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.0c05177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.0c05177%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DUrea%252Band%252BPolyurea%252BProduction%25253A%252BAn%252BInnovative%252BSolvent-%252Band%252BCatalyst-Free%252BApproach%252Bthrough%252BCatechol%252BCarbonate%26aulast%3DSoccio%26aufirst%3DMichelina%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14072020%26date%3D15092020%26date%3D02102020%26date%3D28092020%26volume%3D8%26issue%3D41%26spage%3D15640%26epage%3D15650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mookda Pattarawarapan, Dolnapa Yamano, Nittaya Wiriya, Saranphong Yimklan, <span class="NLM_string-name hlFld-ContribAuthor">Wong Phakhodee</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous Formation and Functionalization of Aryliminophosphoranes Using 1,3-Dihydro-1H-benzimidazol-2-ones as Precursors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (20)
                                     , 13330-13338. <a href="https://doi.org/10.1021/acs.joc.0c01979" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01979%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSimultaneous%252BFormation%252Band%252BFunctionalization%252Bof%252BAryliminophosphoranes%252BUsing%252B1%25252C3-Dihydro-1H-benzimidazol-2-ones%252Bas%252BPrecursors%26aulast%3DPattarawarapan%26aufirst%3DMookda%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17082020%26date%3D02102020%26volume%3D85%26issue%3D20%26spage%3D13330%26epage%3D13338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rohitesh Kumar, Charles L. Bidgood, Claire Levrier, Jennifer H. Gunter, Colleen C. Nelson, Martin C. Sadowski, <span class="NLM_string-name hlFld-ContribAuthor">Rohan A. Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Unique Psammaplysin F Library and Functional Evaluation in Prostate Cancer Cells by Multiparametric Quantitative Single Cell Imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (8)
                                     , 2357-2366. <a href="https://doi.org/10.1021/acs.jnatprod.0c00121" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00121%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DSynthesis%252Bof%252Ba%252BUnique%252BPsammaplysin%252BF%252BLibrary%252Band%252BFunctional%252BEvaluation%252Bin%252BProstate%252BCancer%252BCells%252Bby%252BMultiparametric%252BQuantitative%252BSingle%252BCell%252BImaging%26aulast%3DKumar%26aufirst%3DRohitesh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01022020%26date%3D21072020%26volume%3D83%26issue%3D8%26spage%3D2357%26epage%3D2366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qian Wang, Jesse Tuinhof, Kumchok C. Mgimpatsang, Katarzyna Kurpiewska, Justyna Kalinowska-Tluscik, <span class="NLM_string-name hlFld-ContribAuthor">Alexander Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Modular Assembly of Polyheterocycles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (15)
                                     , 9915-9927. <a href="https://doi.org/10.1021/acs.joc.0c01238" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01238%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BModular%252BAssembly%252Bof%252BPolyheterocycles%26aulast%3DWang%26aufirst%3DQian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22052020%26date%3D13072020%26date%3D03072020%26volume%3D85%26issue%3D15%26spage%3D9915%26epage%3D9927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">James P. Driscoll, Corinne M. Sadlowski, Nina R. Shah, <span class="NLM_string-name hlFld-ContribAuthor">Antonio Feula</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism and Bioactivation: It’s Time to Expect the Unexpected. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6303-6314. <a href="https://doi.org/10.1021/acs.jmedchem.0c00026" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetabolism%252Band%252BBioactivation%25253A%252BIt%2525E2%252580%252599s%252BTime%252Bto%252BExpect%252Bthe%252BUnexpected%26aulast%3DDriscoll%26aufirst%3DJames%2BP.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07012020%26date%3D21042020%26date%3D08042020%26volume%3D63%26issue%3D12%26spage%3D6303%26epage%3D6314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Leila Terrab, Christopher J. Rosenker, Lisa Johnstone, Linh K. Ngo, Li Zhang, Nathaniel F. Ware, Bettina Miller, Andrea Z. Topacio, Sara Sannino, Jeffrey L. Brodsky, <span class="NLM_string-name hlFld-ContribAuthor">Peter Wipf</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Selective Functionalization of Thiadiazine 1,1-Dioxides with Efficacy in a Model of Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 984-990. <a href="https://doi.org/10.1021/acsmedchemlett.0c00018" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00018%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSelective%252BFunctionalization%252Bof%252BThiadiazine%252B1%25252C1-Dioxides%252Bwith%252BEfficacy%252Bin%252Ba%252BModel%252Bof%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DTerrab%26aufirst%3DLeila%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13012020%26date%3D19022020%26date%3D24022020%26date%3D20022020%26volume%3D11%26issue%3D5%26spage%3D984%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fares Hezam  Al-Ostoot</span>, <span class="hlFld-ContribAuthor ">Zabiulla</span>, <span class="hlFld-ContribAuthor ">Salma  Salah</span>, <span class="hlFld-ContribAuthor ">Shaukath Ara  Khanum</span>. </span><span class="cited-content_cbyCitation_article-title">Recent investigations into synthesis and pharmacological activities of phenoxy acetamide and its derivatives (chalcone, indole and quinoline) as possible therapeutic candidates. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2021,</strong> <em>18 </em>
                                    (8)
                                     , 1839-1875. <a href="https://doi.org/10.1007/s13738-021-02172-5" title="DOI URL">https://doi.org/10.1007/s13738-021-02172-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-021-02172-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-021-02172-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DRecent%252Binvestigations%252Binto%252Bsynthesis%252Band%252Bpharmacological%252Bactivities%252Bof%252Bphenoxy%252Bacetamide%252Band%252Bits%252Bderivatives%252B%252528chalcone%25252C%252Bindole%252Band%252Bquinoline%252529%252Bas%252Bpossible%252Btherapeutic%252Bcandidates%26aulast%3DAl-Ostoot%26aufirst%3DFares%2BHezam%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D8%26spage%3D1839%26epage%3D1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Ronchetti</span>, <span class="hlFld-ContribAuthor ">Giada  Moroni</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Antimo  Gioiello</span>, <span class="hlFld-ContribAuthor ">Emidio  Camaioni</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1046-1064. <a href="https://doi.org/10.1039/D1MD00058F" title="DOI URL">https://doi.org/10.1039/D1MD00058F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00058F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00058F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Burea-%252Band%252Bthiourea-containing%252Bcompounds%25253A%252Bfocus%252Bon%252Binnovative%252Bapproaches%252Bin%252Bmedicinal%252Bchemistry%252Band%252Borganic%252Bsynthesis%26aulast%3DRonchetti%26aufirst%3DRiccardo%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D1046%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula A.  Rodríguez-Huerto</span>, <span class="hlFld-ContribAuthor ">Diana  Peña-Solórzano</span>, <span class="hlFld-ContribAuthor ">Cristian  Ochoa-Puentes</span>. </span><span class="cited-content_cbyCitation_article-title">Nitroarenes as versatile building blocks for the synthesis of unsymmetrical urea derivatives and N-Arylmethyl-2-substituted benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2021,</strong> <em>34 </em><a href="https://doi.org/10.1007/s11696-021-01785-7" title="DOI URL">https://doi.org/10.1007/s11696-021-01785-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-021-01785-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-021-01785-7%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DNitroarenes%252Bas%252Bversatile%252Bbuilding%252Bblocks%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bunsymmetrical%252Burea%252Bderivatives%252Band%252BN-Arylmethyl-2-substituted%252Bbenzimidazoles%26aulast%3DRodr%25C3%25ADguez-Huerto%26aufirst%3DPaula%2BA.%26date%3D2021%26date%3D2021%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimmy E.  Jakobsson</span>, <span class="hlFld-ContribAuthor ">Sanjay  Telu</span>, <span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Susovan  Jana</span>, <span class="hlFld-ContribAuthor ">Victor W.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">Broad Scope and High‐Yield Access to Unsymmetrical Acyclic [
              11
              C]Ureas for Biomedical Imaging from [
              11
              C]Carbonyl Difluoride. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (40)
                                     , 10369-10376. <a href="https://doi.org/10.1002/chem.202100690" title="DOI URL">https://doi.org/10.1002/chem.202100690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100690%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DBroad%252BScope%252Band%252BHigh%2525E2%252580%252590Yield%252BAccess%252Bto%252BUnsymmetrical%252BAcyclic%252B%25255B%252B11%252BC%25255DUreas%252Bfor%252BBiomedical%252BImaging%252Bfrom%252B%25255B%252B11%252BC%25255DCarbonyl%252BDifluoride%26aulast%3DJakobsson%26aufirst%3DJimmy%2BE.%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D40%26spage%3D10369%26epage%3D10376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor  Babin</span>, <span class="hlFld-ContribAuthor ">Antoine  Sallustrau</span>, <span class="hlFld-ContribAuthor ">Olivier  Loreau</span>, <span class="hlFld-ContribAuthor ">Fabien  Caillé</span>, <span class="hlFld-ContribAuthor ">Amélie  Goudet</span>, <span class="hlFld-ContribAuthor ">Héloïse  Cahuzac</span>, <span class="hlFld-ContribAuthor ">Antonio  Del Vecchio</span>, <span class="hlFld-ContribAuthor ">Frédéric  Taran</span>, <span class="hlFld-ContribAuthor ">Davide  Audisio</span>. </span><span class="cited-content_cbyCitation_article-title">A general procedure for carbon isotope labeling of linear urea derivatives with carbon dioxide. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (54)
                                     , 6680-6683. <a href="https://doi.org/10.1039/D1CC02665H" title="DOI URL">https://doi.org/10.1039/D1CC02665H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC02665H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC02665H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bgeneral%252Bprocedure%252Bfor%252Bcarbon%252Bisotope%252Blabeling%252Bof%252Blinear%252Burea%252Bderivatives%252Bwith%252Bcarbon%252Bdioxide%26aulast%3DBabin%26aufirst%3DVictor%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D54%26spage%3D6680%26epage%3D6683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pascale  Crochet</span>, <span class="hlFld-ContribAuthor ">Victorio  Cadierno</span>. </span><span class="cited-content_cbyCitation_article-title">Access to
              α
              ‐ and
              β
              ‐Hydroxyamides and Ureas through Metal‐Catalyzed C≡N Bond Hydration and Transfer Hydration Reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Inorganic Chemistry</span><span> <strong>2021,</strong> <em>4 </em><a href="https://doi.org/10.1002/ejic.202100413" title="DOI URL">https://doi.org/10.1002/ejic.202100413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejic.202100413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejic.202100413%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Inorganic%2520Chemistry%26atitle%3DAccess%252Bto%252B%2525CE%2525B1%252B%2525E2%252580%252590%252Band%252B%2525CE%2525B2%252B%2525E2%252580%252590Hydroxyamides%252Band%252BUreas%252Bthrough%252BMetal%2525E2%252580%252590Catalyzed%252BC%2525E2%252589%2525A1N%252BBond%252BHydration%252Band%252BTransfer%252BHydration%252BReactions%26aulast%3DCrochet%26aufirst%3DPascale%26date%3D2021%26date%3D2021%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babita  Kushwaha</span>, <span class="hlFld-ContribAuthor ">Narva Deshwar  Kushwaha</span>, <span class="hlFld-ContribAuthor ">Tanya  Parish</span>, <span class="hlFld-ContribAuthor ">Junitta  Guzman</span>, <span class="hlFld-ContribAuthor ">Afsana  Kajee</span>, <span class="hlFld-ContribAuthor ">Mahamadhanif S.  Shaikh</span>, <span class="hlFld-ContribAuthor ">Idowu  Kehinde</span>, <span class="hlFld-ContribAuthor ">Vincent A.  Obakachi</span>, <span class="hlFld-ContribAuthor ">Tabasum Khan  Pathan</span>, <span class="hlFld-ContribAuthor ">Suraj Raosaheb  Shinde</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>. </span><span class="cited-content_cbyCitation_article-title">A New Class of Linezolid‐Based Molecules as Potential Antimicrobial and Antitubercular Agents: A Rational Approach. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (13)
                                     , 3065-3074. <a href="https://doi.org/10.1002/slct.202100493" title="DOI URL">https://doi.org/10.1002/slct.202100493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100493%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DA%252BNew%252BClass%252Bof%252BLinezolid%2525E2%252580%252590Based%252BMolecules%252Bas%252BPotential%252BAntimicrobial%252Band%252BAntitubercular%252BAgents%25253A%252BA%252BRational%252BApproach%26aulast%3DKushwaha%26aufirst%3DBabita%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D13%26spage%3D3065%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya. P.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">E. K.  Degtyarenko</span>, <span class="hlFld-ContribAuthor ">V. V.  Burmistrov</span>, <span class="hlFld-ContribAuthor ">M. H. Abbas  Saeef</span>, <span class="hlFld-ContribAuthor ">D. A.  Pitushkin</span>, <span class="hlFld-ContribAuthor ">A. A.  Vernigora</span>, <span class="hlFld-ContribAuthor ">G. M.  Butov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Properties of N,N′-Disubstituted Ureas and Their Isosteric Analogs Containing Polycyclic Fragments: IX. N-(1,7,7-Trimethylbicyclo[2.2.1]heptan-2-yl) Ureas and Thioureas. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>57 </em>
                                    (4)
                                     , 515-523. <a href="https://doi.org/10.1134/S1070428021040035" title="DOI URL">https://doi.org/10.1134/S1070428021040035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428021040035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428021040035%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BProperties%252Bof%252BN%25252CN%2525E2%252580%2525B2-Disubstituted%252BUreas%252Band%252BTheir%252BIsosteric%252BAnalogs%252BContaining%252BPolycyclic%252BFragments%25253A%252BIX.%252BN-%2525281%25252C7%25252C7-Trimethylbicyclo%25255B2.2.1%25255Dheptan-2-yl%252529%252BUreas%252Band%252BThioureas%26aulast%3DKuznetsov%26aufirst%3DYa.%2BP.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D4%26spage%3D515%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Varun  Chahal</span>, <span class="hlFld-ContribAuthor ">Rita  Kakkar</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical investigation of the structural and electronic features of SLC-0111, a novel inhibitor of human carbonic anhydrase IX, and its anion. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2021,</strong> <em>63 </em><a href="https://doi.org/10.1007/s11224-021-01741-x" title="DOI URL">https://doi.org/10.1007/s11224-021-01741-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-021-01741-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-021-01741-x%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DTheoretical%252Binvestigation%252Bof%252Bthe%252Bstructural%252Band%252Belectronic%252Bfeatures%252Bof%252BSLC-0111%25252C%252Ba%252Bnovel%252Binhibitor%252Bof%252Bhuman%252Bcarbonic%252Banhydrase%252BIX%25252C%252Band%252Bits%252Banion%26aulast%3DChahal%26aufirst%3DVarun%26date%3D2021%26date%3D2021%26volume%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ozlem  Akgul</span>, <span class="hlFld-ContribAuthor ">Srishti  Singh</span>, <span class="hlFld-ContribAuthor ">Jacob T.  Andring</span>, <span class="hlFld-ContribAuthor ">Robert  McKenna</span>, <span class="hlFld-ContribAuthor ">Silvia  Selleri</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Handling drug-target selectivity: A study on ureido containing Carbonic Anhydrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113035. <a href="https://doi.org/10.1016/j.ejmech.2020.113035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHandling%252Bdrug-target%252Bselectivity%25253A%252BA%252Bstudy%252Bon%252Bureido%252Bcontaining%252BCarbonic%252BAnhydrase%252Binhibitors%26aulast%3DAkgul%26aufirst%3DOzlem%26date%3D2021%26volume%3D212%26spage%3D113035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yipin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xia  Ge</span>, <span class="hlFld-ContribAuthor ">Hongjian  Lu</span>, <span class="hlFld-ContribAuthor ">Guigen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Decarboxylative C−N Formation to Generate Alkyl, Alkenyl, and Aryl Amines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (4)
                                     , 1873-1880. <a href="https://doi.org/10.1002/ange.202010974" title="DOI URL">https://doi.org/10.1002/ange.202010974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202010974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202010974%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCatalytic%252BDecarboxylative%252BC%2525E2%252588%252592N%252BFormation%252Bto%252BGenerate%252BAlkyl%25252C%252BAlkenyl%25252C%252Band%252BAryl%252BAmines%26aulast%3DZhang%26aufirst%3DYipin%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D4%26spage%3D1873%26epage%3D1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yipin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xia  Ge</span>, <span class="hlFld-ContribAuthor ">Hongjian  Lu</span>, <span class="hlFld-ContribAuthor ">Guigen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Decarboxylative C−N Formation to Generate Alkyl, Alkenyl, and Aryl Amines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (4)
                                     , 1845-1852. <a href="https://doi.org/10.1002/anie.202010974" title="DOI URL">https://doi.org/10.1002/anie.202010974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202010974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202010974%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCatalytic%252BDecarboxylative%252BC%2525E2%252588%252592N%252BFormation%252Bto%252BGenerate%252BAlkyl%25252C%252BAlkenyl%25252C%252Band%252BAryl%252BAmines%26aulast%3DZhang%26aufirst%3DYipin%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D4%26spage%3D1845%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamada H.H.  Mohammed</span>, <span class="hlFld-ContribAuthor ">Samar H.  Abbas</span>, <span class="hlFld-ContribAuthor ">Alaa M.  Hayallah</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>, <span class="hlFld-ContribAuthor ">Yaser A.  Mostafa</span>. </span><span class="cited-content_cbyCitation_article-title">Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>106 </em>, 104422. <a href="https://doi.org/10.1016/j.bioorg.2020.104422" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104422%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Burea%252Blinked%252Bciprofloxacin-chalcone%252Bhybrids%252Bhaving%252Bantiproliferative%252Btopoisomerases%252BI%25252FII%252Binhibitory%252Bactivities%252Band%252Bcaspases-mediated%252Bapoptosis%26aulast%3DMohammed%26aufirst%3DHamada%2BH.H.%26date%3D2021%26volume%3D106%26spage%3D104422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md  Ashraf-Uz-Zaman</span>, <span class="hlFld-ContribAuthor ">Sadisna  Shahi</span>, <span class="hlFld-ContribAuthor ">Racheal  Akwii</span>, <span class="hlFld-ContribAuthor ">Md Sanaullah  Sajib</span>, <span class="hlFld-ContribAuthor ">Mohammad Jodeiri  Farshbaf</span>, <span class="hlFld-ContribAuthor ">Raja Reddy  Kallem</span>, <span class="hlFld-ContribAuthor ">William  Putnam</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ruiwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Karina  Alvina</span>, <span class="hlFld-ContribAuthor ">Paul C.  Trippier</span>, <span class="hlFld-ContribAuthor ">Constantinos M.  Mikelis</span>, <span class="hlFld-ContribAuthor ">Nadezhda A.  German</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112866. <a href="https://doi.org/10.1016/j.ejmech.2020.112866" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112866</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112866%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252Bnovel%252Burea%252Bcompounds%252Bas%252BFGFR1%252Binhibitors%252Bto%252Btreat%252Bmetastatic%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DAshraf-Uz-Zaman%26aufirst%3DMd%26date%3D2021%26volume%3D209%26spage%3D112866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoshun  Luo</span>, <span class="hlFld-ContribAuthor ">Xin  Lin</span>, <span class="hlFld-ContribAuthor ">Zhenbang  Li</span>, <span class="hlFld-ContribAuthor ">Maoxu  Xiao</span>, <span class="hlFld-ContribAuthor ">Xinyu  Li</span>, <span class="hlFld-ContribAuthor ">Dayong  Zhang</span>, <span class="hlFld-ContribAuthor ">Hua  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112910. <a href="https://doi.org/10.1016/j.ejmech.2020.112910" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112910%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-guided%252Bmodification%252Bof%252Bisoxazole-type%252BFXR%252Bagonists%25253A%252BIdentification%252Bof%252Ba%252Bpotent%252Band%252Borally%252Bbioavailable%252BFXR%252Bmodulator%26aulast%3DLuo%26aufirst%3DGuoshun%26date%3D2021%26volume%3D209%26spage%3D112910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessia  Catalano</span>, <span class="hlFld-ContribAuthor ">Domenico  Iacopetta</span>, <span class="hlFld-ContribAuthor ">Maria Stefania  Sinicropi</span>, <span class="hlFld-ContribAuthor ">Carlo  Franchini</span>. </span><span class="cited-content_cbyCitation_article-title">Diarylureas as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 374. <a href="https://doi.org/10.3390/app11010374" title="DOI URL">https://doi.org/10.3390/app11010374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app11010374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp11010374%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DDiarylureas%252Bas%252BAntitumor%252BAgents%26aulast%3DCatalano%26aufirst%3DAlessia%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  He</span>, <span class="hlFld-ContribAuthor ">Dan  Wu</span>, <span class="hlFld-ContribAuthor ">Esmail  Vessally</span>. </span><span class="cited-content_cbyCitation_article-title">Cross-dehydrogenative Coupling Reactions Between Formamidic C(sp2)–H and X–H (X = C, O, N) Bonds. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2020,</strong> <em>378 </em>
                                    (6)
                                     <a href="https://doi.org/10.1007/s41061-020-00309-3" title="DOI URL">https://doi.org/10.1007/s41061-020-00309-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00309-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00309-3%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DCross-dehydrogenative%252BCoupling%252BReactions%252BBetween%252BFormamidic%252BC%252528sp2%252529%2525E2%252580%252593H%252Band%252BX%2525E2%252580%252593H%252B%252528X%2525E2%252580%252589%25253D%2525E2%252580%252589C%25252C%252BO%25252C%252BN%252529%252BBonds%26aulast%3DHe%26aufirst%3DZhe%26date%3D2020%26date%3D2020%26volume%3D378%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaqi  Xiao</span>, <span class="hlFld-ContribAuthor ">Meixiang  Gao</span>, <span class="hlFld-ContribAuthor ">Zhou  Sun</span>, <span class="hlFld-ContribAuthor ">Qiang  Diao</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112830. <a href="https://doi.org/10.1016/j.ejmech.2020.112830" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112830%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bpodophyllotoxin%25252Fepipodophyllotoxin%252Bhybrids%252Bin%252Banticancer%252Bactivity%25252C%252Bmode%252Bof%252Baction%25252C%252Band%252Bstructure-activity%252Brelationship%25253A%252BAn%252Bupdate%252B%2525282010%2525E2%252580%2525932020%252529%26aulast%3DXiao%26aufirst%3DJiaqi%26date%3D2020%26volume%3D208%26spage%3D112830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. A.  Pitushkin</span>, <span class="hlFld-ContribAuthor ">V. V.  Burmistrov</span>, <span class="hlFld-ContribAuthor ">Ya. P.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">O. M.  Ivankina</span>, <span class="hlFld-ContribAuthor ">G. M.  Butov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Properties of N,N′-Disubstituted Ureas and Their
			Isosteric Analogs Containing Polycyclic Fragments: VI. N-[Fluoro(chloro)phenyl]-N′-(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptan-1-yl)ureas. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>56 </em>
                                    (12)
                                     , 2057-2066. <a href="https://doi.org/10.1134/S1070428020120027" title="DOI URL">https://doi.org/10.1134/S1070428020120027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428020120027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428020120027%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BProperties%252Bof%252BN%25252CN%2525E2%252580%2525B2-Disubstituted%252BUreas%252Band%252BTheir%252BIsosteric%252BAnalogs%252BContaining%252BPolycyclic%252BFragments%25253A%252BVI.%252BN-%25255BFluoro%252528chloro%252529phenyl%25255D-N%2525E2%252580%2525B2-%2525284%25252C7%25252C7-trimethyl-3-oxo-2-oxabicyclo%25255B2.2.1%25255Dheptan-1-yl%252529ureas%26aulast%3DPitushkin%26aufirst%3DD.%2BA.%26date%3D2020%26date%3D2021%26volume%3D56%26issue%3D12%26spage%3D2057%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Matošević</span>, <span class="hlFld-ContribAuthor ">Anita  Bosak</span>. </span><span class="cited-content_cbyCitation_article-title">Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Archives of Industrial Hygiene and Toxicology</span><span> <strong>2020,</strong> <em>71 </em>
                                    (4)
                                     , 285-299. <a href="https://doi.org/10.2478/aiht-2020-71-3466" title="DOI URL">https://doi.org/10.2478/aiht-2020-71-3466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2478/aiht-2020-71-3466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2478%2Faiht-2020-71-3466%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Industrial%2520Hygiene%2520and%2520Toxicology%26atitle%3DCarbamate%252Bgroup%252Bas%252Bstructural%252Bmotif%252Bin%252Bdrugs%25253A%252Ba%252Breview%252Bof%252Bcarbamate%252Bderivatives%252Bused%252Bas%252Btherapeutic%252Bagents%26aulast%3DMato%25C5%25A1evi%25C4%2587%26aufirst%3DAna%26date%3D2020%26date%3D2020%26volume%3D71%26issue%3D4%26spage%3D285%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. A.  Pitushkin</span>, <span class="hlFld-ContribAuthor ">V. V.  Burmistrov</span>, <span class="hlFld-ContribAuthor ">M. H. Abbas  Saeef</span>, <span class="hlFld-ContribAuthor ">A. A.  Vernigora</span>, <span class="hlFld-ContribAuthor ">G. M.  Butov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Properties of 1,3-Disubstituted Ureas and Their
			Isosteric Analogs Containing Polycyclic Fragments: V. 1-(Bicyclo[2.2.1]heptan-2-yl)-3-R-
			and 1-(1,7,7-Tricyclo[2.2.1]heptan-2-yl)-3-R-ureas. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>56 </em>
                                    (11)
                                     , 1893-1904. <a href="https://doi.org/10.1134/S1070428020110020" title="DOI URL">https://doi.org/10.1134/S1070428020110020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428020110020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428020110020%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BProperties%252Bof%252B1%25252C3-Disubstituted%252BUreas%252Band%252BTheir%252BIsosteric%252BAnalogs%252BContaining%252BPolycyclic%252BFragments%25253A%252BV.%252B1-%252528Bicyclo%25255B2.2.1%25255Dheptan-2-yl%252529-3-R-%252Band%252B1-%2525281%25252C7%25252C7-Tricyclo%25255B2.2.1%25255Dheptan-2-yl%252529-3-R-ureas%26aulast%3DPitushkin%26aufirst%3DD.%2BA.%26date%3D2020%26date%3D2021%26volume%3D56%26issue%3D11%26spage%3D1893%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed Karam  Farag</span>, <span class="hlFld-ContribAuthor ">Ahmed H.E.  Hassan</span>, <span class="hlFld-ContribAuthor ">Kyung-Sook  Chung</span>, <span class="hlFld-ContribAuthor ">Jeong-Hun  Lee</span>, <span class="hlFld-ContribAuthor ">Hyo-Sun  Gil</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Lee</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Roh</span>. </span><span class="cited-content_cbyCitation_article-title">Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104121. <a href="https://doi.org/10.1016/j.bioorg.2020.104121" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104121%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiarylurea%252Bderivatives%252Bcomprising%252B2%25252C4-diarylpyrimidines%25253A%252BDiscovery%252Bof%252Bnovel%252Bpotential%252Banticancer%252Bagents%252Bvia%252Bcombined%252Bfailed-ligands%252Brepurposing%252Band%252Bmolecular%252Bhybridization%252Bapproaches%26aulast%3DFarag%26aufirst%3DAhmed%2BKaram%26date%3D2020%26volume%3D103%26spage%3D104121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgios  Rotas</span>, <span class="hlFld-ContribAuthor ">George  Varvounis</span>. </span><span class="cited-content_cbyCitation_article-title">Tunable reactivity of triphosgene-triethylamine: A study on the synthesis of pyrrole-based tricyclics. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (43)
                                     , 131527. <a href="https://doi.org/10.1016/j.tet.2020.131527" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131527%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DTunable%252Breactivity%252Bof%252Btriphosgene-triethylamine%25253A%252BA%252Bstudy%252Bon%252Bthe%252Bsynthesis%252Bof%252Bpyrrole-based%252Btricyclics%26aulast%3DRotas%26aufirst%3DGeorgios%26date%3D2020%26volume%3D76%26issue%3D43%26spage%3D131527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Yafei  Huang</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yunpeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Ji-An  Chen</span>, <span class="hlFld-ContribAuthor ">Chenyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Meiqi  Song</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112536. <a href="https://doi.org/10.1016/j.ejmech.2020.112536" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112536%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcarboxyl-containing%252Bbiaryl%252Bureas%252Bas%252Bpotent%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%26aulast%3DSun%26aufirst%3DNannan%26date%3D2020%26volume%3D202%26spage%3D112536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengxian  Zhao</span>, <span class="hlFld-ContribAuthor ">Yin  Cao</span>, <span class="hlFld-ContribAuthor ">Zhenzhen  Cui</span>, <span class="hlFld-ContribAuthor ">Jiayun  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Pan</span>, <span class="hlFld-ContribAuthor ">Hongyu  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activity of 2-Arylidene-
              N
              -(quinolin-6-yl)hydrazine-1-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>, 1-9. <a href="https://doi.org/10.1155/2020/2189743" title="DOI URL">https://doi.org/10.1155/2020/2189743</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/2189743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F2189743%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BActivity%252Bof%252B2-Arylidene-%252BN%252B-%252528quinolin-6-yl%252529hydrazine-1-carboxamides%26aulast%3DZhao%26aufirst%3DShengxian%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sadashivamurthy  Shamanth</span>, <span class="hlFld-ContribAuthor ">Nagaraju  Chaithra</span>, <span class="hlFld-ContribAuthor ">Mahesha  Gurukiran</span>, <span class="hlFld-ContribAuthor ">Mahesha  Mamatha</span>, <span class="hlFld-ContribAuthor ">N. K.  Lokanath</span>, <span class="hlFld-ContribAuthor ">Kanchugarakoppal S.  Rangappa</span>, <span class="hlFld-ContribAuthor ">Kempegowda  Mantelingu</span>. </span><span class="cited-content_cbyCitation_article-title">I
              2
              -Catalyzed transformation of
              o
              -aminobenzamide to
              o
              -ureidobenzonitrile using isothiocyanates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (14)
                                     , 2678-2684. <a href="https://doi.org/10.1039/D0OB00118J" title="DOI URL">https://doi.org/10.1039/D0OB00118J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00118J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00118J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DI%252B2%252B-Catalyzed%252Btransformation%252Bof%252Bo%252B-aminobenzamide%252Bto%252Bo%252B-ureidobenzonitrile%252Busing%252Bisothiocyanates%26aulast%3DShamanth%26aufirst%3DSadashivamurthy%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D14%26spage%3D2678%26epage%3D2684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0074.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0074.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of urea and selected urea derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Possible resonance structures for the urea moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conformations of <i>N,N′</i>-diphenyl urea, <i>N</i>-methyl-<i>N,N′</i>-diphenyl urea, and <i>N,N′</i>-dimethyl-<i>N,N′</i>-diphenyl urea.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. HOMO and LUMO overlap in substituted diarylureas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Formation of π-stacked aromatic arrays using substituted diarylureas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stereoselective reduction of acylurea <b>11</b> containing a chiral sulfinyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Association pattern of <i>N</i>,<i>N</i>′-disubstituted ureas; (B) proposed association pattern for DIPPU (<b>14</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Construction of pseudoring systems exploiting intramolecular hydrogen bonding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Disruption of the planarity of urea derivatives through urea alkylation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Disruption of urea planarity by introduction of <i>ortho</i>-substituents at the aryl urea system.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Representation of the stacking interaction between Trp6 and urea; (B) NH−π interaction between the tryptophan 6 side-chain and urea. Part of the Trp-cage miniprotein is shown in magenta; carbon atoms, nitrogen, and hydrogen atoms are shown in green, blue, and yellow, respectively. The figure is modified based upon published structures.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(61)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structure of HIV-1 protease inhibitor <b>23</b> and highlight of the interaction with protease. Hydrogen bonding interactions are shown by blue dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. X-ray structure of urea derivative <b>24</b> and HIV-1 protease complex (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMP">1DMP</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. X-ray structure of sorafenib (<b>25</b>) and VEGFR2 complex (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ASD">4ASD</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. X-ray structure of lenvatinib (<b>26</b>) and VEGFR2 complex (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WZD">3WZD</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. X-ray structure of MAP kinase inhibitor BIRB 796 (<b>27</b>) with human p38 MAP kinase (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KV2">1KV2</a>). Hydrogen bonding interactions are shown by black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. (A) Transition state for sEH-catalyzed oxirane ring opening; (B) Interaction of inhibitor <b>28</b> in the enzyme active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Mechanism of FAAH inhibition by urea derivative PF-04457845 (<b>29</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of urea containing FDA approved drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0036.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Traditional Methodologies for the Synthesis of Ureas</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0037.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Formation of Urea-Containing MAGL Inhibitor <b>43</b> Using Phosgene</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0038.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Formation of the Urea Derivative <b>47</b> Using Triphosgene</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0039.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Formation of Urea Derivative <b>51</b> Using CDI (<b>50</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0040.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Formation of Urea Derivatives Using 1,l′-Carbonylbisbenzotriazole (<b>53</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0041.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Formation of Urea Derivatives through Aminolysis of Carbamates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0042.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Urea Derivatives Using Carbamoylimidazolium Salts</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0043.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Urea Derivatives Using <i>S</i>,<i>S</i>-Dimethyl Dithiocarbonate (<b>63</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0044.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Urea Derivatives Using Phenyl 4,5-Dichloro-6-oxopyridazine-1(6<i>H</i>)-carboxylate (<b>68</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0045.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Urea Derivatives <b>71–73</b> Using CDI in Water Medium</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch11" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0046.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Urea Derivatives Using <i>Bis</i>(2,2,2-trifluoroethyl) Carbonate <b>76</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch12" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0047.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Formation of the Urea Derivative <b>81</b> Using a Key Hofmann Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch13" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0048.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Formation of Urea Derivative <b>83</b> Using the Curtius Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch14" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0049.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Formation of Urea Derivative <b>86</b> Using the Lossen Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch15" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0050.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Synthesis of Urea Derivatives Using CDI-Mediated Lossen Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch16" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0051.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 16. Synthesis of Urea Derivatives Using a Lossen Rearrangement Mediated by 1-Propanephosphonic Acid Cyclic Anhydride (<b>87</b>, T3P)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch17" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0052.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 17. Synthesis of Urea Derivatives Using a Lossen Rearrangement Mediated by 2-Cyano-2-(4-nitrophenylsulfonyloxyimino)acetate (<b>88</b>, 4-NBsOXY)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch18" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0053.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 18. Synthesis of Urea Derivatives Using Curtius Rearrangement via Formation of the Azidoformate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch19" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Scheme 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0054.jpeg" id="rightTab-gr38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 19. Synthesis of Urea Derivatives <b>91</b> and <b>93</b> Using Curtius Rearrangement under Ultrasonication Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch20" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Scheme 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0055.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0055.jpeg" id="rightTab-gr39" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 20. Synthesis of Urea Derivatives Using Curtius Rearrangement under Microwave Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0055.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch21" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Scheme 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0056.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0056.jpeg" id="rightTab-gr40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 21. PhIO-Induced Hofmann Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0056.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch22" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Scheme 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0057.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0057.jpeg" id="rightTab-gr41" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 22. Synthesis of Urea Derivatives Using Tienmann Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0057.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch23" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Scheme 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0058.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0058.jpeg" id="rightTab-gr42" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 23. Synthesis of Urea Derivatives Using Snieckus–Fries-Type Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0058.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch24" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Scheme 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0059.jpeg" id="rightTab-gr43" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 24. Dicobalt Octacarbonyl Promoted Generation of Urea Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch25" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Scheme 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0060.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0060.jpeg" id="rightTab-gr44" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 25. Generation of Urea Derivatives from Nitroarenes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0060.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch26" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Scheme 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0061.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0061.jpeg" id="rightTab-gr45" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 26. Synthesis of Urea Derivatives Using Cross Coupling of Aryl Chlorides and Triflates with Sodium Cyanate in the Presence of Ligand <b>101</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0061.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch27" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Scheme 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0062.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0062.jpeg" id="rightTab-gr46" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 27. Pd-Catalyzed Reductive Alkylation of Urea Derivatives with Aldehydes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0062.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch27"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Solvent free conditions.</p></p></figure><figure data-id="sch28" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Scheme 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0063.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0063.jpeg" id="rightTab-gr47" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 28. Pd/C-Catalyzed Carbonylation of Benzyl, Alkyl, and Aryl Azides with XPhos</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0063.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch28"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>PhMe, 60 °C, 12 h.</p><p class="last"><span class="fn-label"><sup>b</sup></span>5% <i>n</i>Bu<sub>4</sub>NCl, H<sub>2</sub>O/PhMe 20:1, rt, 24 h.</p></p></figure><figure data-id="sch29" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Scheme 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0064.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0064.jpeg" id="rightTab-gr48" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 29. Synthesis of Urea Derivatives by Oxidative Carbonylation Using PdI<sub>2</sub> and KI</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0064.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch30" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Scheme 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0065.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0065.jpeg" id="rightTab-gr49" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 30. Synthesis of Urea Derivatives by Carbonylation with Mo(CO)<sub>6</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0065.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch31" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Scheme 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0066.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0066.jpeg" id="rightTab-gr50" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 31. Synthesis of Urea Derivatives Using Ruthenium Pincer Complex (<b>104</b>, Ru-MACHO-BH) as the Precatalyst</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0066.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch32" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Scheme 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0067.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0067.jpeg" id="rightTab-gr51" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 32. Synthesis of Urea Derivatives Using Ruthenium Pincer Complex <b>105</b> and DMF</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0067.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch33" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Scheme 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0068.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0068.jpeg" id="rightTab-gr52" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 33. Synthesis of Urea Derivatives Using a Copper-Catalyzed Reaction</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0068.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch34" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Scheme 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0069.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0069.jpeg" id="rightTab-gr53" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 34. One-Pot Synthesis of Urea Derivatives from Boc-Amines and Cbz-Amines</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0069.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch35" data-index="54" class="article__inlineFigure"><h2 class="fig-label">Scheme 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0070.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0070.jpeg" id="rightTab-gr54" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 35. Synthesis of Urea Derivatives by a Continuous-Flow Process</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0070.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch36" data-index="55" class="article__inlineFigure"><h2 class="fig-label">Scheme 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0071.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0071.jpeg" id="rightTab-gr55" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 36. Synthesis of Ureas from Isonitriles via the Intermediate Isocyanates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0071.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch37" data-index="56" class="article__inlineFigure"><h2 class="fig-label">Scheme 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0072.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0072.jpeg" id="rightTab-gr56" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 37. Synthesis of Urea Derivatives Using Oximes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0072.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch38" data-index="57" class="article__inlineFigure"><h2 class="fig-label">Scheme 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0073.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0073.jpeg" id="rightTab-gr57" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 38. Synthesis of Urea Derivatives via Carbamic Acids</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0073.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=sch38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="58" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0020.jpeg" id="rightTab-gr58" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. EGFR inhibitor <b>108</b> and urea-containing EGFR inhibitors <b>109</b> and <b>110</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="59" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0021.jpeg" id="rightTab-gr59" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Urea-containing multikinase inhibitors <b>111</b>–<b>113</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="60" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0022.jpeg" id="rightTab-gr60" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Urea-containing VEGFR-2 inhibitors <b>114</b>–<b>116</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="61" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0023.jpeg" id="rightTab-gr61" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Urea-containing kinase inhibitors as antitumor agents <b>117</b>–<b>120</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="62" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0024.jpeg" id="rightTab-gr62" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Urea derivatives as kinase inhibitors <b>121</b>–<b>123</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="63" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0025.jpeg" id="rightTab-gr63" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Urea-containing microtubule targeting agents <b>124</b>–<b>127</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="64" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0026.jpeg" id="rightTab-gr64" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Urea containing anticancer agents <b>128</b>–<b>131</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="65" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0027.jpeg" id="rightTab-gr65" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Urea derivatives <b>132</b>–<b>134</b> for neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="66" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0028.jpeg" id="rightTab-gr66" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Urea derivatives <b>135</b>–<b>137</b> for neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="67" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0029.jpeg" id="rightTab-gr67" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Urea derivatives <b>138</b>–<b>140</b> for neurobiological and neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="68" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0030.jpeg" id="rightTab-gr68" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Urea derivatives <b>141</b> and <b>142</b> for neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="69" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0031.jpeg" id="rightTab-gr69" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Urea-containing antiviral agents <b>143</b> and <b>144</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="70" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0032.jpeg" id="rightTab-gr70" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Urea-derivatives <b>145</b>–<b>147</b> as antibacterial agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="71" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0033.jpeg" id="rightTab-gr71" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Urea-containing antibacterial agents <b>148</b>–<b>150</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="72" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0034.jpeg" id="rightTab-gr72" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Urea-containing antimalarial agents <b>151</b>–<b>153</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="73" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/medium/jm9b01541_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0035.jpeg" id="rightTab-gr73" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Urea-containing antitripanosomal agents <b>47</b>, <b>154</b>, and <b>155</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01541/20200323/images/large/jm9b01541_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01541&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 278 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wöhler, F.</span></span> <span> </span><span class="NLM_article-title">Ueber künstliche bildung des harnstoffs</span>. <i>Ann. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1828</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1002/andp.18280880206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fandp.18280880206" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1828&pages=253-256&author=F.+W%C3%B6hler&title=Ueber+k%C3%BCnstliche+bildung+des+harnstoffs&doi=10.1002%2Fandp.18280880206"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fandp.18280880206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fandp.18280880206%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6hler%26aufirst%3DF.%26atitle%3DUeber%2520k%25C3%25BCnstliche%2520bildung%2520des%2520harnstoffs%26jtitle%3DAnn.%2520Phys.%26date%3D1828%26volume%3D88%26spage%3D253%26epage%3D256%26doi%3D10.1002%2Fandp.18280880206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramberg, P. J.</span></span> <span> </span><span class="NLM_article-title">The death of vitalism and the birth of organic chemistry: Wohler’s urea synthesis and the disciplinary identity of organic chemistry</span>. <i>Ambix</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1179/amb.2000.47.3.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1179%2Famb.2000.47.3.170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11640223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXoslClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2000&pages=170-195&author=P.+J.+Ramberg&title=The+death+of+vitalism+and+the+birth+of+organic+chemistry%3A+Wohler%E2%80%99s+urea+synthesis+and+the+disciplinary+identity+of+organic+chemistry&doi=10.1179%2Famb.2000.47.3.170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The death of vitalism and the birth of organic chemistry: Wohler's urea synthesis and the disciplinary identity of organic chemistry</span></div><div class="casAuthors">Ramberg, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Ambix</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-195</span>CODEN:
                <span class="NLM_cas:coden">AMBXAO</span>;
        ISSN:<span class="NLM_cas:issn">0002-6980</span>.
    
            (<span class="NLM_cas:orgname">Black Bear Press Ltd.</span>)
        </div><div class="casAbstract">The Wohler myth is the story concerning the impact of Wohler's synthesis of urea from inorg. compds., thereby destroying the concept of vitalism and establishing the science of org. chem.  An exploratory study was conducted on the origins and history of the Wohler myth, its incorporation into the popular and textbook literature of org. chem., and the important role it played in establishing and maintaining the disciplinary identity of org. chem.  The origins of the Wohler myth during the first half of the 19th century are first examd.  Then, the dissemination of the myth by means of chem. lectures, textbooks, and popular and scholarly histories from the late 19th century to the present, is outlined.  Finally, some ways in which the Wohler myth created and still maintains a disciplinary identity for org. chem., are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodUYz11RUjrVg90H21EOLACvtfcHk0lhXhnVxoGti3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXoslClsw%253D%253D&md5=35e11c54f654274b1b297513671e1ee7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1179%2Famb.2000.47.3.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252Famb.2000.47.3.170%26sid%3Dliteratum%253Aachs%26aulast%3DRamberg%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520death%2520of%2520vitalism%2520and%2520the%2520birth%2520of%2520organic%2520chemistry%253A%2520Wohler%25E2%2580%2599s%2520urea%2520synthesis%2520and%2520the%2520disciplinary%2520identity%2520of%2520organic%2520chemistry%26jtitle%3DAmbix%26date%3D2000%26volume%3D47%26spage%3D170%26epage%3D195%26doi%3D10.1179%2Famb.2000.47.3.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, A.</span></span> <span> </span><span class="NLM_article-title">History and Economics of Medicinal Chemistry</span> In  <i>Medicinal Chemistry</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, A.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">1970</span>; Vol  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">19</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&pages=4-19&author=A.+Burgerauthor=A.+Burger&title=Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DA.%26atitle%3DHistory%2520and%2520Economics%2520of%2520Medicinal%2520Chemistry%26btitle%3DMedicinal%2520Chemistry%26aulast%3DBurger%26aufirst%3DA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1970%26volume%3D1%26spage%3D4%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lombardino, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, J. A.,  3rd</span></span> <span> </span><span class="NLM_article-title">The role of the medicinal chemist in drug discovery--then and now</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">853</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/nrd1523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnrd1523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15459676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVSmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=853-862&author=J.+G.+Lombardinoauthor=J.+A.+Lowe&title=The+role+of+the+medicinal+chemist+in+drug+discovery%2D%2Dthen+and+now&doi=10.1038%2Fnrd1523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A guide to drug discovery: The role of the medicinal chemist in drug discovery - then and now</span></div><div class="casAuthors">Lombardino, Joseph G.; Lowe, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">853-862</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The role of the medicinal chemist in drug discovery has undergone major changes in the past 25 yr, mainly because of the introduction of technologies such as combinatorial chem. and structure-based drug design.  As medicinal chemists with more than 50 yr of combined experience spanning the past four decades, we discuss this changing role using examples from our own and others' experience.  This historical perspective could provide insights in to how to improve the current model for drug discovery by helping the medicinal chemist regain the creative role that contributed to past successes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-y0ocbJ2mAbVg90H21EOLACvtfcHk0lhXhnVxoGti3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVSmtbk%253D&md5=aaddf4af21f9c38a92dcc970456aae93</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1523%26sid%3Dliteratum%253Aachs%26aulast%3DLombardino%26aufirst%3DJ.%2BG.%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520the%2520medicinal%2520chemist%2520in%2520drug%2520discovery--then%2520and%2520now%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D853%26epage%3D862%26doi%3D10.1038%2Fnrd1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallou, I.</span></span> <span> </span><span class="NLM_article-title">Unsymmetrical ureas. Synthetic methodologies and application in drug design</span>. <i>Org. Prep. Proced. Int.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1080/00304940709458592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F00304940709458592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Ois7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=355-383&author=I.+Gallou&title=Unsymmetrical+ureas.+Synthetic+methodologies+and+application+in+drug+design&doi=10.1080%2F00304940709458592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Unsymmetrical ureas. Synthetic methodologies and application in drug design</span></div><div class="casAuthors">Gallou, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-383</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">A review on synthetic methodologies for unsym. ureas and their application in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdRgmvCIn2LbVg90H21EOLACvtfcHk0ljCxu60lh_jfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Ois7w%253D&md5=d89da174b8ae87b13e80bcf7ce6ed3c0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F00304940709458592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304940709458592%26sid%3Dliteratum%253Aachs%26aulast%3DGallou%26aufirst%3DI.%26atitle%3DUnsymmetrical%2520ureas.%2520Synthetic%2520methodologies%2520and%2520application%2520in%2520drug%2520design%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2007%26volume%3D39%26spage%3D355%26epage%3D383%26doi%3D10.1080%2F00304940709458592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitfelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirillo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madwed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pargellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pav, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinamer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torcellini, C.</span></span> <span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2994</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1021/jm020057r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate&doi=10.1021%2Fjm020057r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0ljCxu60lh_jfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008%26doi%3D10.1021%2Fjm020057r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span>; <span class="NLM_string-name">Gemma, S.</span></span> <i>Structure-Based Design of Drugs and Other Bioactive Molecules: Tools and Strategies</i>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2F9783527665211" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+K.+Ghosh&author=S.+Gemma&title=Structure-Based+Design+of+Drugs+and+Other+Bioactive+Molecules%3A+Tools+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F9783527665211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527665211%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26btitle%3DStructure-Based%2520Design%2520of%2520Drugs%2520and%2520Other%2520Bioactive%2520Molecules%253A%2520Tools%2520and%2520Strategies%26pub%3DWiley-VCH%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span> <i>Structure-Based Drug Discovery: An overview</i>; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">London, England</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2F9781847552549" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=R.+E.+Hubbard&title=Structure-Based+Drug+Discovery%3A+An+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2F9781847552549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781847552549%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26btitle%3DStructure-Based%2520Drug%2520Discovery%253A%2520An%2520overview%26pub%3DRSC%2520Publishing%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span> <span> </span><span class="NLM_article-title">The development of drugs for treatment of sleeping sickness: a historical review</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">15</span>, <span class="refDoi"> DOI: 10.1186/1756-3305-3-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1186%2F1756-3305-3-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20219092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC3c3hs1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=15&author=D.+Steverding&title=The+development+of+drugs+for+treatment+of+sleeping+sickness%3A+a+historical+review&doi=10.1186%2F1756-3305-3-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The development of drugs for treatment of sleeping sickness: a historical review</span></div><div class="casAuthors">Steverding Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & vectors</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Only four drugs are available for the chemotherapy of human African trypanosomiasis or sleeping sickness; Suramin, pentamidine, melarsoprol and eflornithine.  The history of the development of these drugs is well known and documented. suramin, pentamidine and melarsoprol were developed in the first half of the last century by the then recently established methods of medicinal chemistry.  Eflornithine, originally developed in the 1970s as an anti-cancer drug, became a treatment of sleeping sickness largely by accident.  This review summarises the developmental processes which led to these chemotherapies from the discovery of the first bioactive lead compounds to the identification of the final drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAQwn8t9l1f7P3FVUi_gf8fW6udTcc2ebvImggHl_iQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3hs1ehug%253D%253D&md5=66fb9be5250960500c4a7ae5296baf5a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1756-3305-3-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-3305-3-15%26sid%3Dliteratum%253Aachs%26aulast%3DSteverding%26aufirst%3DD.%26atitle%3DThe%2520development%2520of%2520drugs%2520for%2520treatment%2520of%2520sleeping%2520sickness%253A%2520a%2520historical%2520review%26jtitle%3DParasites%2520Vectors%26date%3D2010%26volume%3D3%26spage%3D15%26doi%3D10.1186%2F1756-3305-3-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, J.</span></span> In  <i>Review of Chemotherapeutic and Chemoprophylactic Agents. The African trypanosomiasis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, H. W.</span></span>, Ed.; <span class="NLM_publisher-name">Allen & Unwin</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">1970</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&author=J.+Williamsonauthor=H.+W.+Mulligan&title=Review+of+Chemotherapeutic+and+Chemoprophylactic+Agents.+The+African+trypanosomiasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%26btitle%3DReview%2520of%2520Chemotherapeutic%2520and%2520Chemoprophylactic%2520Agents.%2520The%2520African%2520trypanosomiasis%26aulast%3DMulligan%26aufirst%3DH.%2BW.%26pub%3DAllen%2520%2526%2520Unwin%26date%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsilambros, N.</span>; <span class="NLM_string-name">Diakoumopoulou, E.</span>; <span class="NLM_string-name">Ioannidis, I.</span>; <span class="NLM_string-name">Liatis, S.</span>; <span class="NLM_string-name">Makrilakis, K.</span>; <span class="NLM_string-name">Tentolouris, N.</span>; <span class="NLM_string-name">Tsapogas, P.</span></span> <i>Diabetes in Clinical Practice: Questions and Answers from Case Studies</i>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2007</span>; p  <span class="NLM_fpage">342</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=342&author=N.+Katsilambros&author=E.+Diakoumopoulou&author=I.+Ioannidis&author=S.+Liatis&author=K.+Makrilakis&author=N.+Tentolouris&author=P.+Tsapogas&title=Diabetes+in+Clinical+Practice%3A+Questions+and+Answers+from+Case+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKatsilambros%26aufirst%3DN.%26btitle%3DDiabetes%2520in%2520Clinical%2520Practice%253A%2520Questions%2520and%2520Answers%2520from%2520Case%2520Studies%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2007%26spage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelias, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lh6C5SSYunraA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreef, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span> <span> </span><span class="NLM_article-title">Potential role of sorafenib in the treatment of acute myeloid leukemia</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2246</span>– <span class="NLM_lpage">2255</span>, <span class="refDoi"> DOI: 10.1080/10428190802510349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F10428190802510349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19052971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKjsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=2246-2255&author=S.+Moriauthor=J.+Cortesauthor=H.+Kantarjianauthor=W.+Zhangauthor=M.+Andreefauthor=F.+Ravandi&title=Potential+role+of+sorafenib+in+the+treatment+of+acute+myeloid+leukemia&doi=10.1080%2F10428190802510349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of sorafenib in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Mori, Shahram; Cortes, Jorge; Kantarjian, Hagop; Zhang, Weiguo; Andreef, Michael; Ravandi, Farhad</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2246-2255</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The identification of aberrant cellular pathways and dysfunctional mols. important in neoplastic transformation has begun to provide us with a no. of targets for drug development.  It is likely that many of these agents will be incorporated into our existing treatment strategies that include cytotoxic agents.  Sorafenib, a multi-kinase inhibitor has been approved in the United States for the treatment of renal cell carcinoma as well as hepatocellular cancer.  Its potential role in hematol. malignancies, particularly acute myeloid leukemia (AML) is under evaluation.  Here we describe the biol. pathways in AML that are the potential targets of sorafenib action and discuss the early clin. data with the agent in solid tumors and AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEcMC8shxmbVg90H21EOLACvtfcHk0liUBeycOMISmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKjsr%252FN&md5=0fb05e7866581d2f4f5c4f70204756c5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F10428190802510349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190802510349%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DS.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DAndreef%26aufirst%3DM.%26aulast%3DRavandi%26aufirst%3DF.%26atitle%3DPotential%2520role%2520of%2520sorafenib%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2008%26volume%3D49%26spage%3D2246%26epage%3D2255%26doi%3D10.1080%2F10428190802510349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheyas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1128/AAC.50.3.1013-1020.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1128%2FAAC.50.3.1013-1020.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16495264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells&doi=10.1128%2FAAC.50.3.1013-1020.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span></div><div class="casAuthors">Malcolm, B. A.; Liu, R.; Lahser, F.; Agrawal, S.; Belanger, B.; Butkiewicz, N.; Chase, R.; Gheyas, F.; Hart, A.; Hesk, D.; Ingravallo, P.; Jiang, C.; Kong, R.; Lu, J.; Pichardo, J.; Prongay, A.; Skelton, A.; Tong, X.; Venkatraman, S.; Xia, E.; Girijavallabhan, V.; Njoroge, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1013-1020</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cleavage of the hepatitis C virus (HCV) polyprotein by the viral NS3 protease releases functional viral proteins essential for viral replication.  Recent studies by Foy and coworkers strongly suggest that NS3-mediated cleavage of host factors may abrogate cellular response to alpha interferon (IFN-α).  Blockage of NS3 protease activity therefore is expected to inhibit HCV replication by both direct suppression of viral protein prodn. as well as by restoring host responsiveness to IFN.  Using structure-assisted design, a ketoamide inhibitor, SCH 503034, was generated which demonstrated potent (overall inhibition const., 14 nM) time-dependent inhibition of the NS3 protease in cell-free enzyme assays as well as robust in vitro activity in the HCV replicon system, as monitored by immunofluorescence and real-time PCR anal.  Continuous exposure of replicon-bearing cell lines to six times the 90% effective concn. of SCH 503034 for 15 days resulted in a greater than 4-log redn. in replicon RNA.  The combination of SCH 503034 with IFN was more effective in suppressing replicon synthesis than either compd. alone, supporting the suggestion of Foy and coworkers that combinations of IFN with protease inhibitors would lead to enhanced therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpEpdwyo4a_bVg90H21EOLACvtfcHk0liJ_GQg30cH9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D&md5=c21551e6d306f85039888211b1d07479</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.3.1013-1020.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.3.1013-1020.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020%26doi%3D10.1128%2FAAC.50.3.1013-1020.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, D. M.</span></span> <span> </span><span class="NLM_article-title">A new era of hepatitis C therapy begins</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1272</span>– <span class="NLM_lpage">1274</span>, <span class="refDoi"> DOI: 10.1056/NEJMe1100829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1056%2FNEJMe1100829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21449791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Cgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1272-1274&author=D.+M.+Jensen&title=A+new+era+of+hepatitis+C+therapy+begins&doi=10.1056%2FNEJMe1100829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A new era of hepatitis C therapy begins</span></div><div class="casAuthors">Jensen, Donald M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1272-1274</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYuRehu2WKbVg90H21EOLACvtfcHk0liJ_GQg30cH9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Cgs70%253D&md5=c519565d43b89d8a918a283a5e5f4fcc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1100829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1100829%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DD.%2BM.%26atitle%3DA%2520new%2520era%2520of%2520hepatitis%2520C%2520therapy%2520begins%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1272%26epage%3D1274%26doi%3D10.1056%2FNEJMe1100829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahrus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziller, J. W.</span></span> <span> </span><span class="NLM_article-title">Triurea derivatives of diethylenetriamine as potential templates for the formation of artificial beta-sheets</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1021/ja9536072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9536072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28Xks12gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=1066-1072&author=J.+S.+Nowickauthor=S.+Mahrusauthor=E.+M.+Smithauthor=J.+W.+Ziller&title=Triurea+derivatives+of+diethylenetriamine+as+potential+templates+for+the+formation+of+artificial+beta-sheets&doi=10.1021%2Fja9536072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Triurea Derivatives of Diethylenetriamine as Potential Templates for the Formation of Artificial β-Sheets</span></div><div class="casAuthors">Nowick, James S.; Mahrus, Sami; Smith, Eric M.; Ziller, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1066-72</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes synthetic and structural studies of triurea derivs. of an N,N"-disubstituted diethylenetriamine.  Diethylenetriamine triureas I (R = Me, Ph) and II are efficiently prepd. in 5 or 6 steps from N-phenylethylenediamine.  IR, 1H NMR, and x-ray crystallog. indicate that triureas I and II adopt intramolecularly hydrogen-bonded conformations, both in chloroform soln. and in the solid state.  The three urea groups form a hydrogen-bonded network.  The three R groups are aligned along the triurea backbone, pointing in roughly the same direction, like three fingers on a hand.  Mol. modeling suggests that the triurea backbone will be a suitable template for the creation of artificial β-sheets.  When mol. mechanics energy minimization calcns. are performed upon a triurea bearing three N-terminally linked peptide strands, a parallel β-sheet is formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJDqezUHMy-LVg90H21EOLACvtfcHk0liJ_GQg30cH9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks12gsQ%253D%253D&md5=eb9d481f07f6ab21513087493fe16844</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja9536072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9536072%26sid%3Dliteratum%253Aachs%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26aulast%3DMahrus%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DZiller%26aufirst%3DJ.%2BW.%26atitle%3DTriurea%2520derivatives%2520of%2520diethylenetriamine%2520as%2520potential%2520templates%2520for%2520the%2520formation%2520of%2520artificial%2520beta-sheets%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D1066%26epage%3D1072%26doi%3D10.1021%2Fja9536072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of artificial beta-sheets</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">7665</span>– <span class="NLM_lpage">7669</span>, <span class="refDoi"> DOI: 10.1021/ja9710971</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9710971" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1ykt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=7665-7669&author=D.+L.+Holmesauthor=E.+M.+Smithauthor=J.+S.+Nowick&title=Solid-phase+synthesis+of+artificial+beta-sheets&doi=10.1021%2Fja9710971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Synthesis of Artificial β-Sheets</span></div><div class="casAuthors">Holmes, Darren L.; Smith, Eric M.; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7665-7669</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The solid-phase syntheses of artificial β-sheets, e.g. I, which mimic the structure and hydrogen-bonding patterns of protein β-sheets is described.  In these compds., mol. templates induce β-sheet structures in attached peptide strands.  The templates consist of di- and triurea derivs., which hold peptide and peptidomimetic strands in proximity, and β-strand mimics, which hydrogen bond to the peptide strands.  The syntheses involve constructing the "lower" peptide strand on Merrifield resin, attaching the di- or triamine portions of the di- or triurea templates, connecting the "upper" peptide and peptidomimetic strands, and cleaving the resulting artificial β-sheets from the resin.  The artificial β-sheets were prepd. in 8-13 steps from leucine Merrifield in 33-67% overall yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs7bpgTUK17bVg90H21EOLACvtfcHk0lhpwnxhjwQcBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1ykt78%253D&md5=b13d10d98e0e45a9af8c40d4654f975d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja9710971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9710971%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DSolid-phase%2520synthesis%2520of%2520artificial%2520beta-sheets%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D7665%26epage%3D7669%26doi%3D10.1021%2Fja9710971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claudon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamour, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decossas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heurtault, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mely, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamart-Gregoire, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averlant-Petit, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briand, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duportail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, G.</span></span> <span> </span><span class="NLM_article-title">Consequences of isostructural main-chain modifications for the design of antimicrobial foldamers: helical mimics of host-defense peptides based on a heterogeneous amide/urea backbone</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1002/anie.200905591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fanie.200905591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsFWl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=333-336&author=P.+Claudonauthor=A.+Violetteauthor=K.+Lamourauthor=M.+Decossasauthor=S.+Fournelauthor=B.+Heurtaultauthor=J.+Godetauthor=Y.+Melyauthor=B.+Jamart-Gregoireauthor=M.+C.+Averlant-Petitauthor=J.+P.+Briandauthor=G.+Duportailauthor=H.+Monteilauthor=G.+Guichard&title=Consequences+of+isostructural+main-chain+modifications+for+the+design+of+antimicrobial+foldamers%3A+helical+mimics+of+host-defense+peptides+based+on+a+heterogeneous+amide%2Furea+backbone&doi=10.1002%2Fanie.200905591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Consequences of Isostructural Main-Chain Modifications for the Design of Antimicrobial Foldamers: Helical Mimics of Host-Defense Peptides Based on a Heterogeneous Amide/Urea Backbone</span></div><div class="casAuthors">Claudon, Paul; Violette, Aude; Lamour, Karen; Decossas, Marion; Fournel, Sylvie; Heurtault, Beatrice; Godet, Julien; Mely, Yves; Jamart-Gregoire, Brigitte; Averlant-Petit, Marie-Christine; Briand, Jean-Paul; Duportail, Guy; Monteil, Henri; Guichard, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-336, S333/1-S333/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The design of unnatural oligomers with predictable folding patterns (i.e., foldamers) and function has attracted considerable attention over the last ten years.  Applications in biol. include the development of antimicrobial agents, cell-penetrating agents, and inhibitors of protein-protein interactions.  Non-natural oligoamides built from α-amino acid residues (e.g., peptoids) and higher homologs (e.g., β-, γ-, and δ-peptides) are the epitomes of peptidomimetic foldamers.  A substantial increase in the no. of backbones with folding propensity came from the exploration of the β- and γ-peptide families (i.e., by introduction of isosteric or isoelectronic backbone modifications).  The substitution of a urea moiety for the CH2-CO-NH units in the γ4-peptide backbone is an interesting case of quasi-isostructural replacement.  High-resoln. structural studies in soln. and in the solid state have shown that the oligourea backbone adopts a remarkably stable helical fold reminiscent of the 14-helix described for the cognate γ-peptides.  How such quasi-isostructural backbones compare in mol. recognition is presently unknown.  It was reported previously that oligoureas designed to mimic globally amphiphilic α-helical host-defense peptides display broad antibacterial activity with selectivity for prokaryotic vs. mammalian red blood cell membranes.  To better understand structure-property relationships and to gain insight into the mechanisms of membrane disruption, the authors have now undertaken detailed comparative studies of oligoureas, their γ-peptide counterparts, and various mixed amide/urea congeners bearing identical side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAqZoUQ54clbVg90H21EOLACvtfcHk0lhpwnxhjwQcBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsFWl&md5=e38503875b65760a3e7d767e3046a1c5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.200905591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200905591%26sid%3Dliteratum%253Aachs%26aulast%3DClaudon%26aufirst%3DP.%26aulast%3DViolette%26aufirst%3DA.%26aulast%3DLamour%26aufirst%3DK.%26aulast%3DDecossas%26aufirst%3DM.%26aulast%3DFournel%26aufirst%3DS.%26aulast%3DHeurtault%26aufirst%3DB.%26aulast%3DGodet%26aufirst%3DJ.%26aulast%3DMely%26aufirst%3DY.%26aulast%3DJamart-Gregoire%26aufirst%3DB.%26aulast%3DAverlant-Petit%26aufirst%3DM.%2BC.%26aulast%3DBriand%26aufirst%3DJ.%2BP.%26aulast%3DDuportail%26aufirst%3DG.%26aulast%3DMonteil%26aufirst%3DH.%26aulast%3DGuichard%26aufirst%3DG.%26atitle%3DConsequences%2520of%2520isostructural%2520main-chain%2520modifications%2520for%2520the%2520design%2520of%2520antimicrobial%2520foldamers%253A%2520helical%2520mimics%2520of%2520host-defense%2520peptides%2520based%2520on%2520a%2520heterogeneous%2520amide%252Furea%2520backbone%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D333%26epage%3D336%26doi%3D10.1002%2Fanie.200905591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claudon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendem, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miclet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierjean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ennifar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, G.</span></span> <span> </span><span class="NLM_article-title">The canonical helix of urea oligomers at atomic resolution: insights into folding-induced axial organization</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1002/anie.200905592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fanie.200905592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1067-1070&author=L.+Fischerauthor=P.+Claudonauthor=N.+Pendemauthor=E.+Micletauthor=C.+Didierjeanauthor=E.+Ennifarauthor=G.+Guichard&title=The+canonical+helix+of+urea+oligomers+at+atomic+resolution%3A+insights+into+folding-induced+axial+organization&doi=10.1002%2Fanie.200905592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The canonical helix of urea oligomers at atomic resolution: Insights into folding-induced axial organization</span></div><div class="casAuthors">Fischer, Lucile; Claudon, Paul; Pendem, Nagendar; Miclet, Emeric; Didierjean, Claude; Ennifar, Eric; Guichard, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1067-1070, S1067/1-S1067/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Oligoureas (I) (n = 4, 5), (II) and (III) have been prepd. in soln. by stepwise assembly of N-Boc (Boc = tert-butoxycarbonyl) protected monomers.  All four oligoureas, including short tetramer I, are fully helical in the solid state.  The canonical 2.5 helical structure of oligoureas has been characterized at at. resoln.  The similarity between the structures reported herein and those deduced earlier from NMR studies in soln. is striking and underlines the excellent complementarities of the two techniques to analyze urea-based foldamers.  The study also demonstrates the robustness of the folding process: four acyclic residue are sufficient to drive complete helix formation with all complementary. H-bonding sites being satisfied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVGWR08q9frVg90H21EOLACvtfcHk0liK0epxSN9CoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbw%253D&md5=b7e362c2dc5a973ee66d2cc34279e7e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.200905592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200905592%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DL.%26aulast%3DClaudon%26aufirst%3DP.%26aulast%3DPendem%26aufirst%3DN.%26aulast%3DMiclet%26aufirst%3DE.%26aulast%3DDidierjean%26aufirst%3DC.%26aulast%3DEnnifar%26aufirst%3DE.%26aulast%3DGuichard%26aufirst%3DG.%26atitle%3DThe%2520canonical%2520helix%2520of%2520urea%2520oligomers%2520at%2520atomic%2520resolution%253A%2520insights%2520into%2520folding-induced%2520axial%2520organization%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1067%26epage%3D1070%26doi%3D10.1002%2Fanie.200905592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L. W.</span></span> <span> </span><span class="NLM_article-title">Fast and facile synthesis of 4-nitrophenyl 2-azidoethylcarbamate derivatives from N-Fmoc-protected alpha-amino acids as activated building blocks for urea moiety-containing compound library</span>. <i>ACS Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1021/acscombsci.6b00160</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscombsci.6b00160" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=131-136&author=Y.+Y.+Chenauthor=L.+T.+Changauthor=H.+W.+Chenauthor=C.+Y.+Yangauthor=L.+W.+Hsin&title=Fast+and+facile+synthesis+of+4-nitrophenyl+2-azidoethylcarbamate+derivatives+from+N-Fmoc-protected+alpha-amino+acids+as+activated+building+blocks+for+urea+moiety-containing+compound+library&doi=10.1021%2Facscombsci.6b00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Fast and Facile Synthesis of 4-Nitrophenyl 2-Azidoethylcarbamate Derivatives from N-Fmoc-Protected α-Amino Acids as Activated Building Blocks for Urea Moiety-Containing Compound Library</span></div><div class="casAuthors">Chen, Ying-Ying; Chang, Li-Te; Chen, Hung-Wei; Yang, Chia-Ying; Hsin, Ling-Wei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-136</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fast and facile synthesis of a series of 4-nitrophenyl 2-azidoethylcarbamate derivs. as activated urea building blocks was developed.  The N-Fmoc-protected 2-aminoethyl mesylates derived from various com. available N-Fmoc-protected α-amino acids, including those having functionalized side chains with acid-labile protective groups, were directly transformed into 4-nitrophenyl 2-azidoethylcarbamate derivs. in 1 h via a one-pot two-step reaction.  These urea building blocks were utilized for the prepn. of a series of urea moiety-contg. mitoxantrone-amino acid conjugates in 75-92% yields and parallel soln.-phase synthesis of a urea compd. library consisted of 30 members in 38-70% total yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoraI1-6JXBVrVg90H21EOLACvtfcHk0liK0epxSN9CoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslWktA%253D%253D&md5=929d1c7f7f293c74a263d44a8b6a9765</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facscombsci.6b00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscombsci.6b00160%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BY.%26aulast%3DChang%26aufirst%3DL.%2BT.%26aulast%3DChen%26aufirst%3DH.%2BW.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26atitle%3DFast%2520and%2520facile%2520synthesis%2520of%25204-nitrophenyl%25202-azidoethylcarbamate%2520derivatives%2520from%2520N-Fmoc-protected%2520alpha-amino%2520acids%2520as%2520activated%2520building%2520blocks%2520for%2520urea%2520moiety-containing%2520compound%2520library%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2017%26volume%3D19%26spage%3D131%26epage%3D136%26doi%3D10.1021%2Facscombsci.6b00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linthicum, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. W.</span></span> <span> </span><span class="NLM_article-title">Solid-phase syntheses of unnatural biopolymers containing repeating urea units</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">909</span>, <span class="refDoi"> DOI: 10.1002/anie.199509071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fanie.199509071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2MXlsV2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=907-909&author=K.+Burgessauthor=D.+S.+Linthicumauthor=H.+W.+Shin&title=Solid-phase+syntheses+of+unnatural+biopolymers+containing+repeating+urea+units&doi=10.1002%2Fanie.199509071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-phase syntheses of unnatural biopolymers containing repeating urea units</span></div><div class="casAuthors">Burgess, Kevin; Linthicum, D. Scott; Shin, Hunwoo</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition in English</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">907-9</span>CODEN:
                <span class="NLM_cas:coden">ACIEAY</span>;
        ISSN:<span class="NLM_cas:issn">0570-0833</span>.
    
            (<span class="NLM_cas:orgname">VCH</span>)
        </div><div class="casAbstract">Oligourea compds. CH2Gu.CH2Fu.CH2Fu.CH2Au.A-amide and YG.CH2Gu.CH2Fu.L-amide, where CH2Xu denotes a urea analog of an amino acid X (e.g., CH2Au = NHCH2CHMeNHCO), were prepd. by solid-phase coupling of isocyanate intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv8eA-IXd_0LVg90H21EOLACvtfcHk0liK0epxSN9CoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsV2jtbk%253D&md5=12eac1470aa3b371a5fea31456febefe</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fanie.199509071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199509071%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DK.%26aulast%3DLinthicum%26aufirst%3DD.%2BS.%26aulast%3DShin%26aufirst%3DH.%2BW.%26atitle%3DSolid-phase%2520syntheses%2520of%2520unnatural%2520biopolymers%2520containing%2520repeating%2520urea%2520units%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D907%26epage%3D909%26doi%3D10.1002%2Fanie.199509071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, P. R.</span></span> <span> </span><span class="NLM_article-title">(Thio)urea organocatalysis-what can be learnt from anion recognition?</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1039/b801793j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb801793j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19421588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFaju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2009&pages=1187-1198&author=Z.+Zhangauthor=P.+R.+Schreiner&title=%28Thio%29urea+organocatalysis-what+can+be+learnt+from+anion+recognition%3F&doi=10.1039%2Fb801793j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">(Thio)urea organocatalysis - What can be learnt from anion recognition?</span></div><div class="casAuthors">Zhang, Zhiguo; Schreiner, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1187-1198</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The present crit. review outlines the close relationship and mutual interplay between mol. recognition, active site considerations in enzyme catalysis involving anions, and organocatalysis utilizing explicit hydrogen bonding.  These interconnections are generally not made although, as we demonstrate, they are quite apparent as exemplified with pertinent examples in the field of (thio)urea organocatalysis.  Indeed, the concepts of anion binding or binding with neg. (partially) charged heteroatoms is key for designing new organocatalytic transformations.  Utilizing anions through recognition with hydrogen-bonding organocatalysts is still in its infancy but bears great potential.  In turn, the discovery and mechanistic elucidation of such reactions is likely to improve the understanding of enzyme active sites (108 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvm5E0Zun2trVg90H21EOLACvtfcHk0lgrUV8Z7QbGgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFaju7o%253D&md5=02c138763c1f2d7d38991f34c5a2541d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2Fb801793j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb801793j%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26atitle%3D%2528Thio%2529urea%2520organocatalysis-what%2520can%2520be%2520learnt%2520from%2520anion%2520recognition%253F%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2009%26volume%3D38%26spage%3D1187%26epage%3D1198%26doi%3D10.1039%2Fb801793j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serdyuk, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsogoeva, S. B.</span></span> <span> </span><span class="NLM_article-title">Bifunctional primary amine-thioureas in asymmetric organocatalysis</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">7051</span>– <span class="NLM_lpage">7071</span>, <span class="refDoi"> DOI: 10.1039/c3ob41403e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc3ob41403e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24057617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOis7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=7051-7071&author=O.+V.+Serdyukauthor=C.+M.+Heckelauthor=S.+B.+Tsogoeva&title=Bifunctional+primary+amine-thioureas+in+asymmetric+organocatalysis&doi=10.1039%2Fc3ob41403e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional primary amine-thioureas in asymmetric organocatalysis</span></div><div class="casAuthors">Serdyuk, Olga V.; Heckel, Christina M.; Tsogoeva, Svetlana B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7051-7071</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Research disclosed since the demonstration of the first examples of primary amine-thiourea organocatalysis in 2006 has shown that primary amine-based thioureas can successfully catalyze a diverse variety of highly enantioselective transformations providing a wide range of versatile org. compds.  Recent remarkable progress with these new chiral catalysts (such as primary amine-thiourea-based on tert-Bu esters of S-amino acids) is summarized in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1OR6ECsmTfbVg90H21EOLACvtfcHk0lgrUV8Z7QbGgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOis7jP&md5=decc07248246a5fde1f72f5d0d7a4349</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc3ob41403e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob41403e%26sid%3Dliteratum%253Aachs%26aulast%3DSerdyuk%26aufirst%3DO.%2BV.%26aulast%3DHeckel%26aufirst%3DC.%2BM.%26aulast%3DTsogoeva%26aufirst%3DS.%2BB.%26atitle%3DBifunctional%2520primary%2520amine-thioureas%2520in%2520asymmetric%2520organocatalysis%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D7051%26epage%3D7071%26doi%3D10.1039%2Fc3ob41403e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis of urea derivatives from amines and CO<sub>2</sub> in the absence of catalyst and solvent</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1811</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1039/c0gc00059k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc0gc00059k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gjs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1811-1816&author=C.+Y.+Wuauthor=H.+Y.+Chengauthor=R.+X.+Liuauthor=Q.+A.+Wangauthor=Y.+F.+Haoauthor=Y.+C.+Yuauthor=F.+Y.+Zhao&title=Synthesis+of+urea+derivatives+from+amines+and+CO2+in+the+absence+of+catalyst+and+solvent&doi=10.1039%2Fc0gc00059k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of urea derivatives from amines and CO2 in the absence of catalyst and solvent</span></div><div class="casAuthors">Wu, Chaoyong; Cheng, Haiyang; Liu, Ruixia; Wang, Qiang; Hao, Yufen; Yu, Yancun; Zhao, Fengyu</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1811-1816</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Urea derivs. are obtained in mild to good yield from the reactions of primary aliph. amines with CO2 in the absence of any catalysts, org. solvents or other additives.  To optimize reaction conditions, exptl. variables including temp., pressure, the concn. of amine, reaction time etc. were studied.  Satisfactory yields were obtained at the optimized conditions that are comparable to the presence of catalyst and solvent.  The preliminary investigation of the reaction mechanism showed that alkyl ammonium alkyl carbamate was quickly formed as the intermediate, and then the final product was formed by the intramol. dehydration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTZFpcu6NtbVg90H21EOLACvtfcHk0lgrUV8Z7QbGgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gjs7zF&md5=5bb3d88fd204652204e3575de387a232</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc0gc00059k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0gc00059k%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DR.%2BX.%26aulast%3DWang%26aufirst%3DQ.%2BA.%26aulast%3DHao%26aufirst%3DY.%2BF.%26aulast%3DYu%26aufirst%3DY.%2BC.%26aulast%3DZhao%26aufirst%3DF.%2BY.%26atitle%3DSynthesis%2520of%2520urea%2520derivatives%2520from%2520amines%2520and%2520CO2%2520in%2520the%2520absence%2520of%2520catalyst%2520and%2520solvent%26jtitle%3DGreen%2520Chem.%26date%3D2010%26volume%3D12%26spage%3D1811%26epage%3D1816%26doi%3D10.1039%2Fc0gc00059k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondekar, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadani, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chern, J. W.</span></span> <span> </span><span class="NLM_article-title">Ureas: applications in drug design</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.2174/0929867323666161129124915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F0929867323666161129124915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27897114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVChurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=622-651&author=A.+D.+Jagtapauthor=N.+B.+Kondekarauthor=A.+A.+Sadaniauthor=J.+W.+Chern&title=Ureas%3A+applications+in+drug+design&doi=10.2174%2F0929867323666161129124915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ureas: Applications in Drug Design</span></div><div class="casAuthors">Jagtap, Ajit Dhananjay; Kondekar, Nagendra Bharatrao; Sadani, Amit A.; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">622-651</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The unique hydrogen binding capabilities of ureas make them an important functional group to make drug-target interactions and thus incorporated in small mols. displaying broad range of bioactivities.  The related research and numerous excellent achievements of ureas applicability in drug design for the modulation of selectivity, stability, toxicity and pharmacokinetic profile of lead mols. have become active topic.  This review aims to provide insights in to the significance of urea in drug design by summarizing successful studies of various urea derivs. as modulators biol. targets (viz. kinases, NAMPT, sol. epoxide hydrolases, mTOR, proteases, gyrB/parE, and epigenetic enzymes such as HDAC, PRMT or DOT1L etc.).  The findings of this review confirm the importance of urea moiety in medicinal chem. and stimulate its use as a structural motif with rational decision making approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql4bGowxpMbbVg90H21EOLACvtfcHk0ljOQm15gsClFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVChurg%253D&md5=a3b883c65d950d7e698b40bb71a7f938</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F0929867323666161129124915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666161129124915%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DA.%2BD.%26aulast%3DKondekar%26aufirst%3DN.%2BB.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DChern%26aufirst%3DJ.%2BW.%26atitle%3DUreas%253A%2520applications%2520in%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D622%26epage%3D651%26doi%3D10.2174%2F0929867323666161129124915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sikka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashim, S. R.</span></span> <span> </span><span class="NLM_article-title">Role of aryl urea containing compounds in medicinal chemistry</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.4172/2161-0444.1000305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.4172%2F2161-0444.1000305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=479-483&author=P.+Sikkaauthor=J.+K.+Sahuauthor=A.+K.+Mishraauthor=S.+R.+Hashim&title=Role+of+aryl+urea+containing+compounds+in+medicinal+chemistry&doi=10.4172%2F2161-0444.1000305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4172%2F2161-0444.1000305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2161-0444.1000305%26sid%3Dliteratum%253Aachs%26aulast%3DSikka%26aufirst%3DP.%26aulast%3DSahu%26aufirst%3DJ.%2BK.%26aulast%3DMishra%26aufirst%3DA.%2BK.%26aulast%3DHashim%26aufirst%3DS.%2BR.%26atitle%3DRole%2520of%2520aryl%2520urea%2520containing%2520compounds%2520in%2520medicinal%2520chemistry%26jtitle%3DMed.%2520Chem.%26date%3D2015%26volume%3D5%26spage%3D479%26epage%3D483%26doi%3D10.4172%2F2161-0444.1000305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avitabile, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M.</span></span> <span> </span><span class="NLM_article-title">Crystal and molecular structure of <i>N,N’</i>-diethyl- <i>N,N’</i>-diphenylurea</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1073/pnas.67.1.426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.67.1.426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16591865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE3cXlt1Cmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1970&pages=426-433&author=P.+Ganisauthor=G.+Avitabileauthor=E.+Benedettiauthor=C.+Pedoneauthor=M.+Goodman&title=Crystal+and+molecular+structure+of+N%2CN%E2%80%99-diethyl-+N%2CN%E2%80%99-diphenylurea&doi=10.1073%2Fpnas.67.1.426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal and molecular structure of N,N'-diethyl-N,N'-diphenylurea</span></div><div class="casAuthors">Ganis, Paolo; Avitabile, Gustavo; Benedetti, Ettore; Pedone, Carlo; Goodman, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">426-33</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">N,N'-diphenyl-N,N'-diethylurea (C17H20N2O) crystallizes in the space group P21/c.  The unit cell consts. are:  a 10.42 ± 0.01, b 16.86 ± 0.02, c 10.66 ± 0.01 Å, β 125°16' ± 5'; Z = 4, d. (calcd.) = 1.16, d. (measured) = 1.16 ± 0.01.  Data for 1392 reflections were collected at room temp. on a Picker automated diffractometer.  The crystal structure was solved by direct methods and refined by block-diagonalized matrix least-squares calcns.  The mol. is characterized by a pseudo C2 symmetry; both Ph groups are trans with respect to the O atom.  The hybridization of the 2 N atoms is intermediate between trigonal and tetrahedral; the nonplanar distortion of the amide groups is ∼30°.  The amide C-N bond lengths are 1.37 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXOKgbCUdaLVg90H21EOLACvtfcHk0lhP01vKIBiFZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXlt1Cmur0%253D&md5=c4eb0e51192817caec0677824486bc21</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.67.1.426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.67.1.426%26sid%3Dliteratum%253Aachs%26aulast%3DGanis%26aufirst%3DP.%26aulast%3DAvitabile%26aufirst%3DG.%26aulast%3DBenedetti%26aufirst%3DE.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DCrystal%2520and%2520molecular%2520structure%2520of%2520N%252CN%25E2%2580%2599-diethyl-%2520N%252CN%25E2%2580%2599-diphenylurea%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1970%26volume%3D67%26spage%3D426%26epage%3D433%26doi%3D10.1073%2Fpnas.67.1.426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanatani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azumaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, M.</span></span> <span> </span><span class="NLM_article-title">Unusual conformational preference of an aromatic secondary urea: solvent-dependent open-closed conformational switching of N,N’-bis(porphyrinyl)urea</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2290</span>– <span class="NLM_lpage">2292</span>, <span class="refDoi"> DOI: 10.1039/C2CC37583D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC2CC37583D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23198285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVOjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2290-2292&author=M.+Matsumuraauthor=A.+Tanataniauthor=I.+Azumayaauthor=H.+Masuauthor=D.+Hashizumeauthor=H.+Kagechikaauthor=A.+Muranakaauthor=M.+Uchiyama&title=Unusual+conformational+preference+of+an+aromatic+secondary+urea%3A+solvent-dependent+open-closed+conformational+switching+of+N%2CN%E2%80%99-bis%28porphyrinyl%29urea&doi=10.1039%2FC2CC37583D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual conformational preference of an aromatic secondary urea: solvent-dependent open-closed conformational switching of N,N'-bis(porphyrinyl)urea</span></div><div class="casAuthors">Matsumura, Mio; Tanatani, Aya; Azumaya, Isao; Masu, Hyuma; Hashizume, Daisuke; Kagechika, Hiroyuki; Muranaka, Atsuya; Uchiyama, Masanobu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2290-2292</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N,N'-Bis(2,3,7,8,12,13,17,18-octaethylporphyrin-5-yl)urea (3) exhibits cis-trans conformational switching depending on the solvent properties, and can adopt the cofacial porphyrin dimer structure under certain conditions.  The conformational preference can be switched by electrochem. stimulus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu1XuJhSKr2LVg90H21EOLACvtfcHk0lhP01vKIBiFZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVOjs7o%253D&md5=7834fb599dd399decabf4dfca347453f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC2CC37583D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2CC37583D%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DM.%26aulast%3DTanatani%26aufirst%3DA.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DMasu%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DD.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DMuranaka%26aufirst%3DA.%26aulast%3DUchiyama%26aufirst%3DM.%26atitle%3DUnusual%2520conformational%2520preference%2520of%2520an%2520aromatic%2520secondary%2520urea%253A%2520solvent-dependent%2520open-closed%2520conformational%2520switching%2520of%2520N%252CN%25E2%2580%2599-bis%2528porphyrinyl%2529urea%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2013%26volume%3D49%26spage%3D2290%26epage%3D2292%26doi%3D10.1039%2FC2CC37583D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohmer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshcheryakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thondorf, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolte, M.</span></span> <span> </span><span class="NLM_article-title">3-oxa-6,8-diaza-1,2:4,5-dibenzo-cycloocta-1,4-dien-7-one: a three-dimensional network assembled by hydrogen-bonding, pi-pi and edge-to-face interactions</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">O136</span>– <span class="NLM_lpage">O139</span>, <span class="refDoi"> DOI: 10.1107/S0108270103027586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1107%2FS0108270103027586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=14767138" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=O136-O139&author=V.+Bohmerauthor=D.+Meshcheryakovauthor=I.+Thondorfauthor=M.+Bolte&title=3-oxa-6%2C8-diaza-1%2C2%3A4%2C5-dibenzo-cycloocta-1%2C4-dien-7-one%3A+a+three-dimensional+network+assembled+by+hydrogen-bonding%2C+pi-pi+and+edge-to-face+interactions&doi=10.1107%2FS0108270103027586"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0108270103027586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270103027586%26sid%3Dliteratum%253Aachs%26aulast%3DBohmer%26aufirst%3DV.%26aulast%3DMeshcheryakov%26aufirst%3DD.%26aulast%3DThondorf%26aufirst%3DI.%26aulast%3DBolte%26aufirst%3DM.%26atitle%3D3-oxa-6%252C8-diaza-1%252C2%253A4%252C5-dibenzo-cycloocta-1%252C4-dien-7-one%253A%2520a%2520three-dimensional%2520network%2520assembled%2520by%2520hydrogen-bonding%252C%2520pi-pi%2520and%2520edge-to-face%2520interactions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D2004%26volume%3D60%26spage%3DO136%26epage%3DO139%26doi%3D10.1107%2FS0108270103027586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meshcheryakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud-Neu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohmer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubscher-Bruder, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thondorf, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span></span> <span> </span><span class="NLM_article-title">Cyclic triureas-synthesis, crystal structures and properties</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1039/b718114k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb718114k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18327325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVCjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1004-1014&author=D.+Meshcheryakovauthor=F.+Arnaud-Neuauthor=V.+Bohmerauthor=M.+Bolteauthor=V.+Hubscher-Bruderauthor=E.+Jobinauthor=I.+Thondorfauthor=S.+Werner&title=Cyclic+triureas-synthesis%2C+crystal+structures+and+properties&doi=10.1039%2Fb718114k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic triureas-synthesis, crystal structures and properties</span></div><div class="casAuthors">Meshcheryakov, Denys; Arnaud-Neu, Francoise; Boehmer, Volker; Bolte, Michael; Hubscher-Bruder, Veronique; Jobin, Emilie; Thondorf, Iris; Werner, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1004-1014</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of 24-membered macrocycles is described, in which rigid xanthene units (X) and/or di-Ph ether units (D) as flexible analogs are linked via urea groups.  All four possible combinations (XXX, XXD, XDD, DDD) have been obtained with yields of 40-72% for the cyclization step.  In two cases, the resp. cyclic hexamers (XXDXXD, XXXXXX) were also isolated.  Two compds. have been characterized by a single crystal X-ray anal. of the free triurea (XXD, XDD) and one example (DDD) by its complex with tetrabutylammonium chloride.  It shows the chloride anion in the center of the macrocycle, held by six NH···Cl- hydrogen bonds.  The interaction with various other anions has been studied by 1H NMR.  Complexation consts. for chloride, bromide and acetate have been measured for all trimers by UV spectrophotometry.  Mol. dynamics simulations have been carried out to det. the conformation of the free receptors in chloroform and acetonitrile.  They show that in chloroform, intramol. hydrogen bonding occasionally facilitated by trans → cis isomerization of an amide bond dominates the conformation of the macrocycles while in acetonitrile (the solvent used for complexation measurements), the ligating urea NH protons are properly arranged for the complexation of anions, however, their strong solvation is counteractive to the complexation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbwTQgNHYxL7Vg90H21EOLACvtfcHk0liSdkkHdqcFoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVCjurg%253D&md5=88b2040a3e51d360e7e8fc394c21c18b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fb718114k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb718114k%26sid%3Dliteratum%253Aachs%26aulast%3DMeshcheryakov%26aufirst%3DD.%26aulast%3DArnaud-Neu%26aufirst%3DF.%26aulast%3DBohmer%26aufirst%3DV.%26aulast%3DBolte%26aufirst%3DM.%26aulast%3DHubscher-Bruder%26aufirst%3DV.%26aulast%3DJobin%26aufirst%3DE.%26aulast%3DThondorf%26aufirst%3DI.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DCyclic%2520triureas-synthesis%252C%2520crystal%2520structures%2520and%2520properties%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D1004%26epage%3D1014%26doi%3D10.1039%2Fb718114k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migdal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagdon, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M.</span></span> <span> </span><span class="NLM_article-title">Conformations of substituted arylureas in solution</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2590</span>– <span class="NLM_lpage">2594</span>, <span class="refDoi"> DOI: 10.1021/jo00955a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00955a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE3sXks1GlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=2590-2594&author=G.+Leporeauthor=S.+Migdalauthor=D.+E.+Blagdonauthor=M.+Goodman&title=Conformations+of+substituted+arylureas+in+solution&doi=10.1021%2Fjo00955a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Conformations of substituted arylureas in solution</span></div><div class="casAuthors">Lepore, Giuseppina; Migdal, Samuel; Blagdon, Douglas E.; Goodman, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2590-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The conformation of N,N'-diaryl ureas in soln. is studied to obtain information about stacking interactions between arom. rings.  The only isomer which appears to exist has both arom. rings in an anti relationship to the O of the urea.  Anal. of NMR and uv spectra suggests that there is a charge-transfer interaction between the two rings, esp. when they are substituted with electron-withdrawing and electron-donating groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmciSt_ZCE27Vg90H21EOLACvtfcHk0li4VyRin5nHdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXks1GlsLc%253D&md5=5a62eadc7f677c2a1418acd58beedede</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00955a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00955a003%26sid%3Dliteratum%253Aachs%26aulast%3DLepore%26aufirst%3DG.%26aulast%3DMigdal%26aufirst%3DS.%26aulast%3DBlagdon%26aufirst%3DD.%2BE.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DConformations%2520of%2520substituted%2520arylureas%2520in%2520solution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D2590%26epage%3D2594%26doi%3D10.1021%2Fjo00955a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castronuovo Lepore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M.</span></span> <span> </span><span class="NLM_article-title">Conformation of substituted arylureas. Crystal structures of <i>N,N</i>’-dimethyl-<i>N,N</i>’-di(<i>p</i>-nitrophenyl)urea and <i>N,N’</i>-dimethyl-<i>N,N</i>’-di(2,4-dinitrophenyl)urea</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2134</span>– <span class="NLM_lpage">2137</span>, <span class="refDoi"> DOI: 10.1021/jo00874a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00874a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE28Xkt1Sntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1976&pages=2134-2137&author=U.+Leporeauthor=G.+Castronuovo+Leporeauthor=P.+Ganisauthor=G.+Germainauthor=M.+Goodman&title=Conformation+of+substituted+arylureas.+Crystal+structures+of+N%2CN%E2%80%99-dimethyl-N%2CN%E2%80%99-di%28p-nitrophenyl%29urea+and+N%2CN%E2%80%99-dimethyl-N%2CN%E2%80%99-di%282%2C4-dinitrophenyl%29urea&doi=10.1021%2Fjo00874a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation of substituted arylureas.  Crystal structures of N,N'-dimethyl-N,N'-di(p-nitrophenyl)urea and N,N'-dimethyl-N,N'-di(2,4-dinitrophenyl)urea</span></div><div class="casAuthors">Lepore, U.; Castronuovo Lepore, G.; Ganis, P.; Germain, G.; Goodman, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2134-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The x-ray crystal and mol. structure of (p-O2NC6H4NMe)2CO (I) and the [2,4-(O2N)2C6H3NMe]2CO (II) were detd.  The benzene rings in I were anti to the carbonyl O atom and the benzene rings in II were syn to the carbonyl O atom.  The 200 MHz PMR of II in CO3CN or (CO3)2CO at -30 to +35° indicated that the crystal conformation existed as the only soln. stable conformation.  The soln. conformation of I was also the same as the crystal conformation.  I, II, and (PhNEt)2CO existed in both soln. and cryst. phases as the conformation in which the amide groups were distorted from planarity with concomitant dehydrocyclization of the N atoms from the trigonal to the tetrahedral shape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWCgpQMC60krVg90H21EOLACvtfcHk0li4VyRin5nHdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xkt1Sntbg%253D&md5=b27a2d3f5e01e9fbcbdae58815bdc861</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00874a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00874a014%26sid%3Dliteratum%253Aachs%26aulast%3DLepore%26aufirst%3DU.%26aulast%3DCastronuovo%2BLepore%26aufirst%3DG.%26aulast%3DGanis%26aufirst%3DP.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DConformation%2520of%2520substituted%2520arylureas.%2520Crystal%2520structures%2520of%2520N%252CN%25E2%2580%2599-dimethyl-N%252CN%25E2%2580%2599-di%2528p-nitrophenyl%2529urea%2520and%2520N%252CN%25E2%2580%2599-dimethyl-N%252CN%25E2%2580%2599-di%25282%252C4-dinitrophenyl%2529urea%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1976%26volume%3D41%26spage%3D2134%26epage%3D2137%26doi%3D10.1021%2Fjo00874a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germany, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinato, M. G.</span></span> <span> </span><span class="NLM_article-title">Theoretical and spectroscopic analysis of <i>N,N</i>’-diphenylurea and <i>N,N’</i>-dimethyl-<i>N,N’</i>-diphenylurea conformations</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">5304</span>– <span class="NLM_lpage">5315</span>, <span class="refDoi"> DOI: 10.1021/jp503539m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp503539m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=5304-5315&author=J.+F.+Galanauthor=E.+Germanyauthor=A.+Pawlowskiauthor=L.+Stricklandauthor=M.+G.+Galinato&title=Theoretical+and+spectroscopic+analysis+of+N%2CN%E2%80%99-diphenylurea+and+N%2CN%E2%80%99-dimethyl-N%2CN%E2%80%99-diphenylurea+conformations&doi=10.1021%2Fjp503539m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical and Spectroscopic Analysis of N,N'-Diphenylurea and N,N'-Dimethyl-N,N'-diphenylurea Conformations</span></div><div class="casAuthors">Galan, Jhenny F.; Germany, Edward; Pawlowski, Amanda; Strickland, Lynette; Galinato, Mary Grace I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">5304-5315</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural organization of macromols. is highly dependent on the conformational propensity of the monomer units.  Goal is to systematically quantify differences in the conformational propensities of arom. oligourea foldamer units.  Specifically, the authors study the conformational propensities of N,N'-diphenylurea and N,N'-dimethyl-N,N'-diphenylurea in different media using a combination of theor. methods, and IR and NMR spectroscopies.  Results show variation in the conformational behavior upon adding Me substituents on N,N'-diphenylurea, and varying the environments surrounding the compds.  Energetic analyses and conformational distributions in the gas phase show predominance of the cis-trans and trans-trans conformations for N,N'-diphenylurea, while cis-cis conformation is favored for N,N'-dimethyl-N,N'-diphenylurea.  In soln., results support the trans-trans conformer as the predominant conformer for N,N'-diphenylurea, whereas the cis-cis and cis-trans forms are favored in N,N'-dimethyl-N,N'-diphenylurea.  N,N'-Dimethyl-N,N'-diphenylurea also exhibits a more dynamic conformational behavior in soln., with const. fluctuations between cis-cis and cis-trans conformations.  Detailed quant. analyses are an important aspect in fine-tuning desired conformations and dynamic properties of this class of oligomers by providing a mol. basis for the behavior at the monomeric level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxlFL5HQOuJrVg90H21EOLACvtfcHk0ljcDear99l2RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbbK&md5=08d228d4ee94a93d698fe7f16a37b79c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjp503539m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp503539m%26sid%3Dliteratum%253Aachs%26aulast%3DGalan%26aufirst%3DJ.%2BF.%26aulast%3DGermany%26aufirst%3DE.%26aulast%3DPawlowski%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DL.%26aulast%3DGalinato%26aufirst%3DM.%2BG.%26atitle%3DTheoretical%2520and%2520spectroscopic%2520analysis%2520of%2520N%252CN%25E2%2580%2599-diphenylurea%2520and%2520N%252CN%25E2%2580%2599-dimethyl-N%252CN%25E2%2580%2599-diphenylurea%2520conformations%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2014%26volume%3D118%26spage%3D5304%26epage%3D5315%26doi%3D10.1021%2Fjp503539m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennecke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helliwell, M.</span></span> <span> </span><span class="NLM_article-title">The origin of the conformational preference of <i>N,N’</i>-diaryl-<i>N,N’</i>-dimethyl ureas</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">15056</span>– <span class="NLM_lpage">15064</span>, <span class="refDoi"> DOI: 10.1039/c0cp00571a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc0cp00571a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20953510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2gu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=15056-15064&author=J.+Claydenauthor=U.+Henneckeauthor=M.+A.+Vincentauthor=I.+H.+Hillierauthor=M.+Helliwell&title=The+origin+of+the+conformational+preference+of+N%2CN%E2%80%99-diaryl-N%2CN%E2%80%99-dimethyl+ureas&doi=10.1039%2Fc0cp00571a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The origin of the conformational preference of N,N'-diaryl-N,N'-dimethylureas</span></div><div class="casAuthors">Clayden, Jonathan; Hennecke, Ulrich; Vincent, Mark A.; Hillier, Ian H.; Helliwell, Madeleine</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">15056-15064</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Poly arom. ureas and poly arom. amides are important classes of foldamers-oligomers with well defined conformations.  We have explored the origins of the conformational preference of some N,N'-diaryl-N,N'-dimethyl ureas by a combination of NMR spectroscopy and electronic structure calcns. using both a recently developed d. functional (M06-2X) and a DFT approach (DFT-D) having empirical corrections for dispersive interactions.  We have validated the DFT-D approach for structures of this type using high level wavefunction calcns., (CCSD(T)), of the unsubstituted N,N'-diphenyl-N,N'-dimethyl urea.  For the N,N'-diaryl-N,N'-dimethyl ureas we have identified a no. of endo' conformers (i.e. having an E,E geometrical conformation about the two urea C-N bonds), both π- and tert-butyl-stacked, as well as 'exo' structures (having a Z geometrical conformation about at least one of the C-N bonds), and have computed the relative energies of these conformers as well as the barriers for their interconversion.  We find that the relative energies of the endo' structures closely follow the relative values of the dispersive interactions.  The calcns. have allowed us to assoc. different conformers with the various peaks in the NMR spectra, which point to relatively small differences in energy between the conformers.  Somewhat larger energy differences are predicted by the two computational approaches, with the M06-2X functional performing the better of the two.  It is suggested that the continuum model employed may not be sufficiently accurate to reflect the solvation of the various conformers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2J4ff-ZKva7Vg90H21EOLACvtfcHk0ljcDear99l2RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2gu7fK&md5=75bc72ab6e889345901662356d89e7ae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fc0cp00571a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cp00571a%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DHennecke%26aufirst%3DU.%26aulast%3DVincent%26aufirst%3DM.%2BA.%26aulast%3DHillier%26aufirst%3DI.%2BH.%26aulast%3DHelliwell%26aufirst%3DM.%26atitle%3DThe%2520origin%2520of%2520the%2520conformational%2520preference%2520of%2520N%252CN%25E2%2580%2599-diaryl-N%252CN%25E2%2580%2599-dimethyl%2520ureas%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2010%26volume%3D12%26spage%3D15056%26epage%3D15064%26doi%3D10.1039%2Fc0cp00571a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span> <span> </span><span class="NLM_article-title">Crystallographic studies on urea cytokinins</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1021/jf00004a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf00004a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXhsF2jt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=793-796&author=K.+Yamaguchiauthor=K.+Shudo&title=Crystallographic+studies+on+urea+cytokinins&doi=10.1021%2Fjf00004a036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic studies on urea cytokinins</span></div><div class="casAuthors">Yamaguchi, Kentaro; Shudo, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">793-6</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    </div><div class="casAbstract">Some heteroarom. ureas, such as N-(2-chloro-4-pyridyl)-N'-phenylurea (I) and N-(4-pyridyl)-N'-phenylurea (II), exhibit strong cytokinin activity.  However, the structure-activity relationship of urea cytokinins remains unclear.  To elucidate this problem, x-ray crystal structure anal. of I and II were performed.  All the free urea mols. take an extended trans conformation, whereas a N-methylurea mol. which is completely inactive takes a folded cis conformation in the cryst. state.  Apparently, the trans extended conformation is required for cytokinin activity in 4-pyridyl urea derivs.  However, the difference between the potent cytokinin activities of I and II as compared with the much weaker activities of related compds. could not be explained in terms of the steric structures around the urea moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUdPq2rkyR8LVg90H21EOLACvtfcHk0lj9Eltfa67ryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsF2jt74%253D&md5=4e1555c0ee3d5c432422b7971423df8a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjf00004a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf00004a036%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DShudo%26aufirst%3DK.%26atitle%3DCrystallographic%2520studies%2520on%2520urea%2520cytokinins%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D1991%26volume%3D39%26spage%3D793%26epage%3D796%26doi%3D10.1021%2Fjf00004a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azumaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span> <span> </span><span class="NLM_article-title">Aromatic architecture - use of the <i>N</i>-methylamide structure as a molecular splint</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">5474</span>– <span class="NLM_lpage">5475</span>, <span class="refDoi"> DOI: 10.1021/ja00014a060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00014a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXkslWjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=5474-5475&author=K.+Yamaguchiauthor=G.+Matsumuraauthor=H.+Kagechikaauthor=I.+Azumayaauthor=Y.+Itoauthor=A.+Itaiauthor=K.+Shudo&title=Aromatic+architecture+-+use+of+the+N-methylamide+structure+as+a+molecular+splint&doi=10.1021%2Fja00014a060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic architecture.  Use of the N-methylamide structure as a molecular splint</span></div><div class="casAuthors">Yamaguchi, Kentaro; Matsumura, Go; Kagechika, Hiroyuki; Azumaya, Isao; Ito, Yuji; Itai, Akiko; Shudo, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5474-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Crystal and soln. structures of methylamides I (R, R1 = H, CONMePh) and II were analyzed.  The N-methylamide structure in every compd. was revealed to exist in cis amide conformation in crystal and soln.  These examples show the intrinsic stability of the cis amide structure, and suggest the usefulness of the N-methylamide moiety in constructing mol. structures of various types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHtCresRdsrVg90H21EOLACvtfcHk0lj9Eltfa67ryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkslWjtLw%253D&md5=ea47be4f72a1be82a3d1388242528103</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja00014a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00014a060%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DG.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DItai%26aufirst%3DA.%26aulast%3DShudo%26aufirst%3DK.%26atitle%3DAromatic%2520architecture%2520-%2520use%2520of%2520the%2520N-methylamide%2520structure%2520as%2520a%2520molecular%2520splint%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D5474%26epage%3D5475%26doi%3D10.1021%2Fja00014a060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. S.</span></span> <span> </span><span class="NLM_article-title">A field guide to foldamers</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3893</span>– <span class="NLM_lpage">4012</span>, <span class="refDoi"> DOI: 10.1021/cr990120t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr990120t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFagtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=3893-4012&author=D.+J.+Hillauthor=M.+J.+Mioauthor=R.+B.+Princeauthor=T.+S.+Hughesauthor=J.+S.+Moore&title=A+field+guide+to+foldamers&doi=10.1021%2Fcr990120t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A Field Guide to Foldamers</span></div><div class="casAuthors">Hill, David J.; Mio, Matthew J.; Prince, Ryan B.; Hughes, Thomas S.; Moore, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3893-4011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review that surveyed the field of foldamers-the study of conformational in synthetic chain mols.  The products of this field are new oligomeric backbones that adopt a particular type of secondary structure through noncovalent interactions.  When one looks deeper into the chem. details making up these secondary structures, what emerges to date is that only a relatively small no. of "good folders" have as of yet been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_SHY0A3KTzbVg90H21EOLACvtfcHk0lj02Zk5InOiow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFagtrk%253D&md5=0e26cf01f9d4baf210aa49f3b79d348f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr990120t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr990120t%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DD.%2BJ.%26aulast%3DMio%26aufirst%3DM.%2BJ.%26aulast%3DPrince%26aufirst%3DR.%2BB.%26aulast%3DHughes%26aufirst%3DT.%2BS.%26aulast%3DMoore%26aufirst%3DJ.%2BS.%26atitle%3DA%2520field%2520guide%2520to%2520foldamers%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D3893%26epage%3D4012%26doi%3D10.1021%2Fcr990120t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span> <span> </span><span class="NLM_article-title">Relaying stereochemistry through aromatic ureas: 1,9 and 1,15 remote stereocontrol</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1039/B817527F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FB817527F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19283286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=547-549&author=J.+Claydenauthor=M.+Pickworthauthor=L.+H.+Jones&title=Relaying+stereochemistry+through+aromatic+ureas%3A+1%2C9+and+1%2C15+remote+stereocontrol&doi=10.1039%2FB817527F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Relaying stereochemistry through aromatic ureas: 1,9 and 1,15 remote stereocontrol</span></div><div class="casAuthors">Clayden, Jonathan; Pickworth, Mark; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-549</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The well-defined conformation of an N,N'-diarylurea allows a chiral sulfinyl substituent to influence diastereoselectivity in the formation of new stereogenic centers up to 14 bond lengths away.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzov9aKCBqoLVg90H21EOLACvtfcHk0lju9ViTO2mdVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVOntA%253D%253D&md5=8e08ce4a832c9bcccc2807f45eb67147</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FB817527F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB817527F%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DPickworth%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DRelaying%2520stereochemistry%2520through%2520aromatic%2520ureas%253A%25201%252C9%2520and%25201%252C15%2520remote%2520stereocontrol%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2009%26spage%3D547%26epage%3D549%26doi%3D10.1039%2FB817527F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, C. D.</span></span> <span> </span><span class="NLM_article-title">Polyaryl anion radicals via alkali metal reduction of arylurea oligomers</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1021/ol0496069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0496069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1aitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1605-1608&author=F.+D.+Lewisauthor=T.+L.+Kurthauthor=C.+M.+Hattanauthor=R.+C.+Reiterauthor=C.+D.+Stevenson&title=Polyaryl+anion+radicals+via+alkali+metal+reduction+of+arylurea+oligomers&doi=10.1021%2Fol0496069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Polyaryl Anion Radicals via Alkali Metal Reduction of Arylurea Oligomers</span></div><div class="casAuthors">Lewis, Frederick D.; Kurth, Todd L.; Hattan, Chris M.; Reiter, Richard C.; Stevenson, Cheryl D.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1605-1608</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N-methylated polyarylurea oligomers has been reduced with potassium metal in HMPA.  These redns. result in the transient formation of arylurea anion radicals, which undergo reductive elimination of the urea linkages.  The aryl moieties appear in the products as the anion radicals of oligoaryl systems.  The reaction is intramol., and the sequencing in the polyaryl anion radical remains the same as in the polyarylureas due to the urea-enforced π-π stacking interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxcDllphLyjbVg90H21EOLACvtfcHk0lju9ViTO2mdVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1aitLw%253D&md5=03259d6c3fc7e260ef378de1cb189531</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fol0496069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0496069%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DF.%2BD.%26aulast%3DKurth%26aufirst%3DT.%2BL.%26aulast%3DHattan%26aufirst%3DC.%2BM.%26aulast%3DReiter%26aufirst%3DR.%2BC.%26aulast%3DStevenson%26aufirst%3DC.%2BD.%26atitle%3DPolyaryl%2520anion%2520radicals%2520via%2520alkali%2520metal%2520reduction%2520of%2520arylurea%2520oligomers%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D1605%26epage%3D1608%26doi%3D10.1021%2Fol0496069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azumaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanatani, A.</span></span> <span> </span><span class="NLM_article-title">Identification of absolute helical structures of aromatic multilayered oligo(m-phenylurea)s in solution</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">8154</span>– <span class="NLM_lpage">8163</span>, <span class="refDoi"> DOI: 10.1021/jo901934r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo901934r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cjs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=8154-8163&author=M.+Kudoauthor=T.+Hanashimaauthor=A.+Muranakaauthor=H.+Satoauthor=M.+Uchiyamaauthor=I.+Azumayaauthor=T.+Hiranoauthor=H.+Kagechikaauthor=A.+Tanatani&title=Identification+of+absolute+helical+structures+of+aromatic+multilayered+oligo%28m-phenylurea%29s+in+solution&doi=10.1021%2Fjo901934r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Absolute Helical Structures of Aromatic Multilayered Oligo(m-phenylurea)s in Solution</span></div><div class="casAuthors">Kudo, Mayumi; Hanashima, Takayuki; Muranaka, Atsuya; Sato, Hisako; Uchiyama, Masanobu; Azumaya, Isao; Hirano, Tomoya; Kagechika, Hiroyuki; Tanatani, Aya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8154-8163</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The oligomeric arom. ureas bearing N,N'-dimethylated urea bonds such as 3 (I, R1 = R2 = Me) have arom. multilayered structure, based on the (cis,cis)-urea structure, and also have dynamic helical structure (all-R or all-S axis chirality) when the benzene rings are connected at the meta positions.  The abs. helical structure of oligo(m-phenylurea)s were identified by the empirical and theor. studies on the CD and vibrational CD (VCD) spectra.  Thus, each enantiomer of oligo(m-phenylurea)s 4 (I, R1 = n-Pr) bearing a chiral ((S)- for 4a and (R)- for 4b) N-2-(methoxyethoxyethoxy)propyl group (R2) were synthesized.  Intense dispersion-type CD spectra of 4 were obsd., which indicated the induction of handedness in the helical structure.  In the VCD spectra of 4 in the film state, the signals due to the carbonyl and arom. ring vibrations were seen with neg. and pos. values for compds. 4a and 4b, resp.  The calcns. of both CD and VCD spectra of oligo(m-phenylurea)s without any chiral N-substituent gave the same assignment about the axis chirality of 4.  Thus, the abs. configurations of 4a and 4b are all-R and all-S structures, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaRTpSfN-eurVg90H21EOLACvtfcHk0lhcYddM_jl9TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cjs73P&md5=fa734200c2e15e833380243a60daa7be</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo901934r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901934r%26sid%3Dliteratum%253Aachs%26aulast%3DKudo%26aufirst%3DM.%26aulast%3DHanashima%26aufirst%3DT.%26aulast%3DMuranaka%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DM.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DTanatani%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520absolute%2520helical%2520structures%2520of%2520aromatic%2520multilayered%2520oligo%2528m-phenylurea%2529s%2520in%2520solution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D8154%26epage%3D8163%26doi%3D10.1021%2Fjo901934r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span> <i>Fundamentals of Medicinal Chemistry</i>; <span class="NLM_publisher-name">John Wiley and Sons, Ltd.</span>: <span class="NLM_publisher-loc">West Sussex, U.K</span>., <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">70</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=56-70&author=G.+Thomas&title=Fundamentals+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DG.%26btitle%3DFundamentals%2520of%2520Medicinal%2520Chemistry%26pub%3DJohn%2520Wiley%2520and%2520Sons%252C%2520Ltd%26date%3D2003%26spage%3D56%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G. R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eaHtVCSTkRv5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouritsen, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, K.</span></span> <span> </span><span class="NLM_article-title">A new look at lipid-membrane structure in relation to drug research</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1023/A:1011986613392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1023%2FA%3A1011986613392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9794491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Ghtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=1507-1519&author=O.+G.+Mouritsenauthor=K.+Jorgensen&title=A+new+look+at+lipid-membrane+structure+in+relation+to+drug+research&doi=10.1023%2FA%3A1011986613392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A new look at lipid-membrane structure in relation to drug research</span></div><div class="casAuthors">Mouritsen, Ole G.; Jorgensen, Kent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1507-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">A review with 131 refs.  Lipid-bilayer membranes are key objects in drug research in relation to (i) interaction of drugs with membrane-bound receptors, (ii) drug targeting, penetration, and permeation of cell membranes, and (iii) use of liposomes in micro-encapsulation technologies for drug delivery.  Rational design of new drugs and drug-delivery systems therefore requires insight into the phys. properties of lipid-bilayer membranes.  This mini-review provides a perspective on the current view of lipid-bilayer structure and dynamics based on information obtained from a variety of recent exptl. and theor. studies.  Special attention is paid to trans-bilayer structure, lateral mol. organization of the lipid bilayer, lipid-mediated protein assembly, and lipid-bilayer permeability.  It is argued that lipids play a major role in lipid membrane-organization and functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6YGOBjQ5P-bVg90H21EOLACvtfcHk0lieUM6_0Kzzzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Ghtbg%253D&md5=870fe751a4442a586b2734eeb3470995</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011986613392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011986613392%26sid%3Dliteratum%253Aachs%26aulast%3DMouritsen%26aufirst%3DO.%2BG.%26aulast%3DJorgensen%26aufirst%3DK.%26atitle%3DA%2520new%2520look%2520at%2520lipid-membrane%2520structure%2520in%2520relation%2520to%2520drug%2520research%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D1507%26epage%3D1519%26doi%3D10.1023%2FA%3A1011986613392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span> <i>Urea: Synthesis, Properties and Uses</i>; <span class="NLM_publisher-name">Nova
Science Publishers, Inc.</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Urea%3A+Synthesis%2C+Properties+and+Uses%3B+Nova%0AScience+Publishers%2C+Inc.%3A+New+York%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DUrea%253A%2520Synthesis%252C%2520Properties%2520and%2520Uses%26pub%3DNova%250AScience%2520Publishers%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herbig, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, D. H.</span></span> <span> </span><span class="NLM_article-title">Correlation of hydrotropic solubilization by urea with logD of drug molecules and utilization of this effect for topical formulations</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2013.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejpb.2013.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23958327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWhurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=158-160&author=M.+E.+Herbigauthor=D.+H.+Evers&title=Correlation+of+hydrotropic+solubilization+by+urea+with+logD+of+drug+molecules+and+utilization+of+this+effect+for+topical+formulations&doi=10.1016%2Fj.ejpb.2013.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of hydrotropic solubilization by urea with log D of drug molecules and utilization of this effect for topical formulations</span></div><div class="casAuthors">Herbig, Michael E.; Evers, Dirk-Heinrich</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">158-160</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Solubilization of drugs in aq. phases of liq. and semisolid environment is typically achieved by co-solvents or surfactants.  On contrast, solubilization by means of hydrotropic agents, i.e., small hydrophilic org. compds. like urea or citric acid, is little explored in the context of pharmaceutical formulations.  Esp., with regard to topical dosage forms, however, hydrotropic solubilization can provide valuable alternatives to establish solubilization approaches.  A difficulty of employing hydrotropic solubilization was that its extent could not be predicted for different drug mols.  Using a chem. heterogeneous set of 12 compds. relevant for dermatol. (with overall 16 different log D values tested), we were able to demonstrate that hydrotropic effects of urea can be predicted by log D values of drugs.  All compds. with log D values between 2 and 4.5 showed a soly. enhancement factor (EF) of >5 in 40% aq. solns. of urea.  For log D values below 2 or above 5, only EF < 5 were found.  For some compds., e.g., diclofenac (pH 4) and prednicarbate could achieved only EF > 5 at 5% urea and EF > 250 at 20% urea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYqAZk_MiPLVg90H21EOLACvtfcHk0lhloKxRGIpspw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWhurvJ&md5=6d70255b3c710baf2123f51a49187ebe</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2013.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2013.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DHerbig%26aufirst%3DM.%2BE.%26aulast%3DEvers%26aufirst%3DD.%2BH.%26atitle%3DCorrelation%2520of%2520hydrotropic%2520solubilization%2520by%2520urea%2520with%2520logD%2520of%2520drug%2520molecules%2520and%2520utilization%2520of%2520this%2520effect%2520for%2520topical%2520formulations%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2013%26volume%3D85%26spage%3D158%26epage%3D160%26doi%3D10.1016%2Fj.ejpb.2013.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span> <span> </span><span class="NLM_article-title">Hydrotropic solubilization by urea derivatives: a molecular dynamics simulation study</span>. <i>J. Pharm. (N. Y., NY, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">791370</span>, <span class="refDoi"> DOI: 10.1155/2013/791370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1155%2F2013%2F791370" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=791370&author=Y.+Cui&title=Hydrotropic+solubilization+by+urea+derivatives%3A+a+molecular+dynamics+simulation+study&doi=10.1155%2F2013%2F791370"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1155%2F2013%2F791370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F791370%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DY.%26atitle%3DHydrotropic%2520solubilization%2520by%2520urea%2520derivatives%253A%2520a%2520molecular%2520dynamics%2520simulation%2520study%26jtitle%3DJ.%2520Pharm.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2013%26volume%3D2013%26spage%3D791370%26doi%3D10.1155%2F2013%2F791370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boileau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouteiller, L.</span></span> <span> </span><span class="NLM_article-title"><i>N,N</i>’-disubstituted ureas: influence of substituents on the formation of supramolecular polymers</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3008</span>– <span class="NLM_lpage">3014</span>, <span class="refDoi"> DOI: 10.1002/chem.200304801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.200304801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12833282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Kgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=3008-3014&author=F.+Lortieauthor=S.+Boileauauthor=L.+Bouteiller&title=N%2CN%E2%80%99-disubstituted+ureas%3A+influence+of+substituents+on+the+formation+of+supramolecular+polymers&doi=10.1002%2Fchem.200304801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">N,N'-disubstituted ureas: Influence of substituents on the formation of supramolecular polymers</span></div><div class="casAuthors">Lortie, Frederic; Boileau, Sylvie; Bouteiller, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3008-3014</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sym. N,N'-disubstituted ureas have been synthesized and characterized.  Among them, the branched dialkylureas prepd. are highly sol. in org. media.  Moreover, the solns. obtained are very viscous in heptane, if the branched alkyl groups are not too bulky (i.e. a Me group on the α carbon, or an Et group on the β carbon).  Due to the strong, bifurcated hydrogen bonds between the urea moieties, linear supramol. polymers are formed.  The degree of assocn. of these supramol. polymers has been detd. by FTIR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLS01Bxqv2LVg90H21EOLACvtfcHk0lhloKxRGIpspw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Kgurs%253D&md5=20f64d39a74fe34a646a484e502da289</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fchem.200304801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200304801%26sid%3Dliteratum%253Aachs%26aulast%3DLortie%26aufirst%3DF.%26aulast%3DBoileau%26aufirst%3DS.%26aulast%3DBouteiller%26aufirst%3DL.%26atitle%3DN%252CN%25E2%2580%2599-disubstituted%2520ureas%253A%2520influence%2520of%2520substituents%2520on%2520the%2520formation%2520of%2520supramolecular%2520polymers%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2003%26volume%3D9%26spage%3D3008%26epage%3D3014%26doi%3D10.1002%2Fchem.200304801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1039/c1md00093d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space&doi=10.1039%2Fc1md00093d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span></div><div class="casAuthors">Alex, Alexander; Millan, David S.; Perez, Manuel; Wakenhut, Florian; Whitlock, Gavin A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">669-674</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Utilizing 'beyond rule of five' chem. space is becoming increasingly important in drug design, but is usually at odds with good oral absorption.  The formation of intramol. hydrogen bonds in drug mols. is hypothesised to shield polarity facilitating improved membrane permeability and intestinal absorption.  NMR based evidence for intramol. hydrogen bonding in several 'beyond rule of five' oral drugs is described.  Furthermore, the propensity for these drugs to form intramol. hydrogen bonds could be predicted for through modeling the lowest energy conformation in the gas phase.  The modulation of apparent lipophilicity through intramol. hydrogen bonding in these mols. is supported by intrinsic cell permeability and intestinal absorption data in rat and human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp93l2KJMdB2bVg90H21EOLACvtfcHk0lhEqLZspP2R2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D&md5=3effbdd29832ac7b57eabbc26c66217b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674%26doi%3D10.1039%2Fc1md00093d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0liKE1KcnlFWeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guagnano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span> <span> </span><span class="NLM_article-title">Entry into a new class of protein kinase inhibitors by pseudo ring design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2007.12.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18248988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=897-900&author=P.+Furetauthor=G.+Caravattiauthor=V.+Guagnanoauthor=M.+Langauthor=T.+Meyerauthor=J.+Schoepfer&title=Entry+into+a+new+class+of+protein+kinase+inhibitors+by+pseudo+ring+design&doi=10.1016%2Fj.bmcl.2007.12.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Entry into a new class of protein kinase inhibitors by pseudo ring design</span></div><div class="casAuthors">Furet, Pascal; Caravatti, Giorgio; Guagnano, Vito; Lang, Marc; Meyer, Thomas; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">897-900</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A pyrimidin-4-yl-urea motif forming a pseudo ring by intramol. hydrogen bonding has been designed to mimic the pyrido[2,3-d]pyrimidin-7-one core structure of a well-established class of protein kinase inhibitors.  Potent inhibition of a no. of protein kinases was obtained with the first prototype compd. synthesized to probe the design concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5MZZKS4I03LVg90H21EOLACvtfcHk0liKE1KcnlFWeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D&md5=989b4bb7f1d5177be45d4edf31290de5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.041%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520inhibitors%2520by%2520pseudo%2520ring%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D897%26epage%3D900%26doi%3D10.1016%2Fj.bmcl.2007.12.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1021/jm101356p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry&doi=10.1021%2Fjm101356p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0ljmGoi4Ii_a5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554%26doi%3D10.1021%2Fjm101356p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dax, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheatham, W. W.</span></span> <span> </span><span class="NLM_article-title">Nonsymmetrically substituted cyclic urea HIV protease inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4079</span>– <span class="NLM_lpage">4088</span>, <span class="refDoi"> DOI: 10.1021/jm970288b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970288b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1Ogtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4079-4088&author=W.+W.+Wilkersonauthor=S.+Daxauthor=W.+W.+Cheatham&title=Nonsymmetrically+substituted+cyclic+urea+HIV+protease+inhibitors&doi=10.1021%2Fjm970288b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsymmetrically substituted cyclic urea HIV protease inhibitors</span></div><div class="casAuthors">Wilkerson, Wendell W.; Dax, Scott; Cheatham, Walter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4079-4088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of nonsym. substituted cyclic urea carboxamides was synthesized and evaluated for antiviral activity as a function of the inhibition of HIV-protease.  Selected protease inhibitors were also evaluated for oral bioavailability.  The synthesis, pharmacol., quant. structure-activity relationship (QSAR), and pharmacokinetics for the series will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfX0NHWdHBrVg90H21EOLACvtfcHk0ljmGoi4Ii_a5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1Ogtbg%253D&md5=823aa7f272a2e9f22d13550148916615</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm970288b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970288b%26sid%3Dliteratum%253Aachs%26aulast%3DWilkerson%26aufirst%3DW.%2BW.%26aulast%3DDax%26aufirst%3DS.%26aulast%3DCheatham%26aufirst%3DW.%2BW.%26atitle%3DNonsymmetrically%2520substituted%2520cyclic%2520urea%2520HIV%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4079%26epage%3D4088%26doi%3D10.1021%2Fjm970288b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scully, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of cytokine-mediated STAT1 signal transduction in beta-cells with improved aqueous solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4125</span>– <span class="NLM_lpage">4129</span>, <span class="refDoi"> DOI: 10.1021/jm400397x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400397x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Wis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4125-4129&author=S.+S.+Scullyauthor=A.+J.+Tangauthor=M.+Lundhauthor=C.+M.+Mosherauthor=K.+M.+Perkinsauthor=B.+K.+Wagner&title=Small-molecule+inhibitors+of+cytokine-mediated+STAT1+signal+transduction+in+beta-cells+with+improved+aqueous+solubility&doi=10.1021%2Fjm400397x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of cytokine-mediated STAT1 signal transduction in β-cells with improved aqueous solubility</span></div><div class="casAuthors">Scully, Stephen S.; Tang, Alicia J.; Lundh, Morten; Mosher, Carrie M.; Perkins, Kedar M.; Wagner, Bridget K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4125-4129</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported the discovery of BRD0476 I, a small mol. generated by diversity-oriented synthesis that suppresses cytokine-induced β-cell apoptosis.  Herein, we report the synthesis and biol. evaluation of I and analogs with improved aq. soly.  By replacing naphthyl with quinoline moieties, we prepd. active analogs with up to a 1400-fold increase in soly. from I.  In addn., we demonstrated that I and analogs inhibit STAT1 signal transduction induced by IFN-γ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8w_RnDRGu37Vg90H21EOLACvtfcHk0lio9jDj0uTzYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Wis78%253D&md5=4444398e6aa75eadcaaed87ef4a093b7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm400397x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400397x%26sid%3Dliteratum%253Aachs%26aulast%3DScully%26aufirst%3DS.%2BS.%26aulast%3DTang%26aufirst%3DA.%2BJ.%26aulast%3DLundh%26aufirst%3DM.%26aulast%3DMosher%26aufirst%3DC.%2BM.%26aulast%3DPerkins%26aufirst%3DK.%2BM.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520cytokine-mediated%2520STAT1%2520signal%2520transduction%2520in%2520beta-cells%2520with%2520improved%2520aqueous%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4125%26epage%3D4129%26doi%3D10.1021%2Fjm400397x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eid, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span> <span> </span><span class="NLM_article-title">Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1021/jm501680m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501680m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1846-1861&author=Y.+Yinauthor=K.+Zhengauthor=N.+Eidauthor=S.+Howardauthor=J.+H.+Jeongauthor=F.+Yiauthor=J.+Guoauthor=C.+M.+Parkauthor=M.+Bibianauthor=W.+Wuauthor=P.+Hernandezauthor=H.+Parkauthor=Y.+Wuauthor=J.+L.+Luoauthor=P.+V.+LoGrassoauthor=Y.+Feng&title=Bis-aryl+urea+derivatives+as+potent+and+selective+LIM+kinase+%28Limk%29+inhibitors&doi=10.1021%2Fjm501680m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Bis-aryl Urea Derivatives as Potent and Selective LIM Kinase (Limk) Inhibitors</span></div><div class="casAuthors">Yin, Yan; Zheng, Ke; Eid, Nibal; Howard, Shannon; Jeong, Ji-Hak; Yi, Fei; Guo, Jia; Park, Chul Min; Bibian, Mathieu; Wu, Weilin; Hernandez, Pamela; Park, HaJeung; Wu, Yuntao; Luo, Jun-Li; LoGrasso, Philip V.; Feng, Yangbo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1846-1861</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery/optimization of bis-aryl ureas as Limk inhibitors to obtain high potency and selectivity and appropriate pharmacokinetic properties through systematic SAR studies is reported.  Docking studies supported the obsd. SAR.  Optimized Limk inhibitors had high biochem. potency (IC50 < 25 nM), excellent selectivity against ROCK and JNK kinases (>400-fold), potent inhibition of cofilin phosphorylation in A7r5, PC-3, and CEM-SS T cells (IC50 < 1 μM), and good in vitro and in vivo pharmacokinetic properties.  In the profiling against a panel of 61 kinases, compd. I at 1 μM inhibited only Limk1 and STK16 with ≥80% inhibition.  Compds. I and II were highly efficient in inhibiting cell-invasion/migration in PC-3 cells.  In addn., compd. III was demonstrated to be effective on reducing intraocular pressure on rat eyes.  Taken together, these data demonstrated that the authors had developed a novel class of bis-aryl urea derived potent and selective Limk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6gl5J5n9-HrVg90H21EOLACvtfcHk0lhZjQ9XkeMH3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWgtb4%253D&md5=67352d15ab435e75f561552f283b29b9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm501680m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501680m%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DEid%26aufirst%3DN.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DJ.%2BH.%26aulast%3DYi%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBibian%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DHernandez%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DFeng%26aufirst%3DY.%26atitle%3DBis-aryl%2520urea%2520derivatives%2520as%2520potent%2520and%2520selective%2520LIM%2520kinase%2520%2528Limk%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1846%26epage%3D1861%26doi%3D10.1021%2Fjm501680m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannicchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouvelet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalla Cort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouteiller, L.</span></span> <span> </span><span class="NLM_article-title">Orthohalogen substituents dramatically enhance hydrogen bonding of aromatic ureas in solution</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1039/C3CC47447J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC3CC47447J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24280764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=611-613&author=I.+Giannicchiauthor=B.+Jouveletauthor=B.+Isareauthor=M.+Linaresauthor=A.+Dalla+Cortauthor=L.+Bouteiller&title=Orthohalogen+substituents+dramatically+enhance+hydrogen+bonding+of+aromatic+ureas+in+solution&doi=10.1039%2FC3CC47447J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Orthohalogen substituents dramatically enhance hydrogen bonding of aromatic ureas in solution</span></div><div class="casAuthors">Giannicchi, Ilaria; Jouvelet, Benjamin; Isare, Benjamin; Linares, Mathieu; Dalla Cort, Antonella; Bouteiller, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">611-613</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The phenylurea moiety is a ubiquitous synthon in supramol. chem.  Here we report that the introduction of chlorine or bromine atoms in the ortho positions to the urea unit is a simple and very efficient way to improve its intermol. hydrogen bond (HB) donor character.  This effect was demonstrated in soln. both in the context of self-assocn. of bis-ureas and hydrogen bonding of mono-ureas to strong HB acceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry1IyEbp2gjbVg90H21EOLACvtfcHk0lhZjQ9XkeMH3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt77F&md5=e40de965ff4043092d8a4d4e63eeb0f6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC3CC47447J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CC47447J%26sid%3Dliteratum%253Aachs%26aulast%3DGiannicchi%26aufirst%3DI.%26aulast%3DJouvelet%26aufirst%3DB.%26aulast%3DIsare%26aufirst%3DB.%26aulast%3DLinares%26aufirst%3DM.%26aulast%3DDalla%2BCort%26aufirst%3DA.%26aulast%3DBouteiller%26aufirst%3DL.%26atitle%3DOrthohalogen%2520substituents%2520dramatically%2520enhance%2520hydrogen%2520bonding%2520of%2520aromatic%2520ureas%2520in%2520solution%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2014%26volume%3D50%26spage%3D611%26epage%3D613%26doi%3D10.1039%2FC3CC47447J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creighton, T. E.</span></span> <span> </span><span class="NLM_article-title">Stability of folded conformations</span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/0959-440X(91)90004-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2F0959-440X%2891%2990004-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXkvVOmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1991&pages=5-16&author=T.+E.+Creighton&title=Stability+of+folded+conformations&doi=10.1016%2F0959-440X%2891%2990004-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Stability of folded conformations</span></div><div class="casAuthors">Creighton, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-16</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    </div><div class="casAbstract">A review with 80 refs.  Significant advances have been made in understanding the thermodn. of the hydrophobic effect and of the reversible unfolding of proteins, although there is still considerable controversy.  Recent analyses suggest that the predominant factor in stabilizing the folded states of proteins is intramol. hydrogen bonding, even though in the unfolded state the polar groups form intermol. hydrogen bonds with water.  Van der Waals interactions between non-polar groups also contribute substantially, but perhaps not as much as might have been expected if protein interiors were perfectly close-packed.  The role of the solvent seems to be primarily destabilizing, and involves the favorable solvation of both polar and non-polar groups.  The effects of added stabilizers and denaturants can be understood on the basis of their alterations of the properties of water and of their interactions with the surfaces of folded and unfolded proteins.  Also, the electrostatic interactions between groups involved in salt bridges in folded proteins can be substantial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqja09cHX-Z9LVg90H21EOLACvtfcHk0li7sQL4Wx1--A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvVOmtb8%253D&md5=d38fde90fbdd2858755bff520b2a04ac</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0959-440X%2891%2990004-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0959-440X%252891%252990004-D%26sid%3Dliteratum%253Aachs%26aulast%3DCreighton%26aufirst%3DT.%2BE.%26atitle%3DStability%2520of%2520folded%2520conformations%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D1991%26volume%3D1%26spage%3D5%26epage%3D16%26doi%3D10.1016%2F0959-440X%2891%2990004-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clopton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downing, M.</span></span> <span> </span><span class="NLM_article-title">Solubility of diketopiperazine in aqueous solutions of urea</span>. <i>J. Phys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1435</span>, <span class="refDoi"> DOI: 10.1021/j100826a037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/j100826a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaF3MXht1yktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1961&pages=1432-1435&author=S.+J.+Gillauthor=J.+Hutsonauthor=J.+R.+Cloptonauthor=M.+Downing&title=Solubility+of+diketopiperazine+in+aqueous+solutions+of+urea&doi=10.1021%2Fj100826a037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Solubility of diketopiperazine in aqueous solutions of urea</span></div><div class="casAuthors">Gill, S. J.; Hutson, J.; Clopton, J. R.; Downing, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1432-5</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">The soly. was measured in aq. urea solns. as a function of temp. and urea concn. and followed a simple exponential dependence on 1/T.  The heats of soln. obtained from this temp. relation served to evaluate the H-bond interaction of diketopiperazine with urea.  The fraction of peptide-urea interactions was estd. by simple equil. considerations.  The heat of assocn. of urea with a cis peptide bond was evaluated from exptl. data as -3.4 ± 0.5 kcal.  An equil. const. was 0.096 for the assocn. of urea with the peptide bond in aq. soln.  The strong H-bond interaction between urea and peptides was further illustrated by the discovery of a 2 urea: 1 diketopiperazine solid complex which was formed in 8M urea below 30°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHG7P9fxlP7Vg90H21EOLACvtfcHk0lg4RosYU0JrBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1yktrw%253D&md5=6c0a06c68f229dd153019629b91bc1a5</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fj100826a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100826a037%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DS.%2BJ.%26aulast%3DHutson%26aufirst%3DJ.%26aulast%3DClopton%26aufirst%3DJ.%2BR.%26aulast%3DDowning%26aufirst%3DM.%26atitle%3DSolubility%2520of%2520diketopiperazine%2520in%2520aqueous%2520solutions%2520of%2520urea%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1961%26volume%3D65%26spage%3D1432%26epage%3D1435%26doi%3D10.1021%2Fj100826a037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sliwoski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kothiwale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E. W.</span></span> <span> </span><span class="NLM_article-title">Computational methods in drug discovery</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1124/pr.112.007336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fpr.112.007336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24381236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=334-395&author=G.+Sliwoskiauthor=S.+Kothiwaleauthor=J.+Meilerauthor=E.+W.+Lowe&title=Computational+methods+in+drug+discovery&doi=10.1124%2Fpr.112.007336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Computational methods in drug discovery</span></div><div class="casAuthors">Sliwoski, Gregory; Kothiwale, Sandeepkumar; Meiler, Jens; Lowe Edward, W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">334-395, 62 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Computer-aided drug discovery/design methods have played a major role in the development of therapeutically important small mols. for over three decades.  These methods are broadly classified as either structure-based or ligand-based methods.  Structure-based methods are in principle analogous to high-throughput screening in that both target and ligand structure information is imperative.  Structure-based approaches include ligand docking, pharmacophore, and ligand design methods.  The article discusses theory behind the most important methods and recent successful applications.  Ligand-based methods use only ligand information for predicting activity depending on its similarity/dissimilarity to previously known active ligands.  We review widely used ligand-based methods such as ligand-based pharmacophores, mol. descriptors, and quant. structure-activity relationships.  In addn., important tools such as target/ligand data bases, homol. modeling, ligand fingerprint methods, etc., necessary for successful implementation of various computer-aided drug discovery/design methods in a drug discovery campaign are discussed.  Finally, computational methods for toxicity prediction and optimization for favorable physiol. properties are discussed with successful examples from literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL4miiF8oaQrVg90H21EOLACvtfcHk0lg4RosYU0JrBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu7nL&md5=3dde38a0b60c583f832c688c2d27819f</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.007336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.007336%26sid%3Dliteratum%253Aachs%26aulast%3DSliwoski%26aufirst%3DG.%26aulast%3DKothiwale%26aufirst%3DS.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DE.%2BW.%26atitle%3DComputational%2520methods%2520in%2520drug%2520discovery%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26spage%3D334%26epage%3D395%26doi%3D10.1124%2Fpr.112.007336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fradera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosfield, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynands, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haunsø, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C.</span></span> <span> </span><span class="NLM_article-title">X-ray structures of the LXR-alpha LBD in its homodimeric form and implications for heterodimer signaling</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.jmb.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20382159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVSkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=2010&pages=120-132&author=X.+Fraderaauthor=D.+Vuauthor=O.+Nimzauthor=R.+Skeneauthor=D.+Hosfieldauthor=R.+Wynandsauthor=A.+J.+Cookeauthor=A.+Hauns%C3%B8author=A.+Kingauthor=D.+J.+Bennettauthor=R.+McGuireauthor=J.+C.+Uitdehaag&title=X-ray+structures+of+the+LXR-alpha+LBD+in+its+homodimeric+form+and+implications+for+heterodimer+signaling&doi=10.1016%2Fj.jmb.2010.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">X-Ray Structures of the LXRα LBD in Its Homodimeric Form and Implications for Heterodimer Signaling</span></div><div class="casAuthors">Fradera, Xavier; Vu, Diep; Nimz, Olaf; Skene, Robert; Hosfield, David; Wynands, Robert; Cooke, Andrew J.; Haunso, Anders; King, Angela; Bennett, D. Jonathan; McGuire, Ross; Uitdehaag, Joost C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-132</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Liver X receptors (LXRs) are nuclear receptors that are central regulators of cholesterol homeostasis, and synthetic LXR agonists have shown promise as promoters of reverse cholesterol transport and anti-inflammatory agents.  Here, we present three X-ray structures of three different agonists bound to the ligand binding domain of LXRα.  These compds. are GW3965, F3methylAA, and a benzisoxazole urea, and we show that these diverse chem. scaffolds address common structural themes, leading to high binding affinity for LXR.  Our structures show the LXRα ligand binding domain in its homodimeric form, an arrangement previously thought to be stereochem. difficult.  A comparison with existing structures of the LXRβ homodimer and LXRα:RXR (retinoid X receptor) heterodimers explains differences in dimer affinity and leads us to propose a model for allosteric activation in nuclear receptor dimers, in which an unactivated RXR partner provides an inhibitory tail wrap to the cofactor binding pocket of LXR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMF30Ry-u9e7Vg90H21EOLACvtfcHk0lhcR_zn8Bxasg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVSkt7c%253D&md5=3d00f9b0e694c994fce9d8e2ee85e008</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DFradera%26aufirst%3DX.%26aulast%3DVu%26aufirst%3DD.%26aulast%3DNimz%26aufirst%3DO.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DHosfield%26aufirst%3DD.%26aulast%3DWynands%26aufirst%3DR.%26aulast%3DCooke%26aufirst%3DA.%2BJ.%26aulast%3DHauns%25C3%25B8%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DD.%2BJ.%26aulast%3DMcGuire%26aufirst%3DR.%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%26atitle%3DX-ray%2520structures%2520of%2520the%2520LXR-alpha%2520LBD%2520in%2520its%2520homodimeric%2520form%2520and%2520implications%2520for%2520heterodimer%2520signaling%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D399%26spage%3D120%26epage%3D132%26doi%3D10.1016%2Fj.jmb.2010.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madej, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanczycki, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiessen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geer, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchler-Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S. H.</span></span> <span> </span><span class="NLM_article-title">MMDB and VAST+: tracking structural similarities between macromolecular complexes</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">D297</span>– <span class="NLM_lpage">D303</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1093%2Fnar%2Fgkt1208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24319143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=D297-D303&author=T.+Madejauthor=C.+J.+Lanczyckiauthor=D.+Zhangauthor=P.+A.+Thiessenauthor=R.+C.+Geerauthor=A.+Marchler-Bauerauthor=S.+H.+Bryant&title=MMDB+and+VAST%2B%3A+tracking+structural+similarities+between+macromolecular+complexes&doi=10.1093%2Fnar%2Fgkt1208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">MMDB and VAST+: tracking structural similarities between macromolecular complexes</span></div><div class="casAuthors">Madej, Thomas; Lanczycki, Christopher J.; Zhang, Dachuan; Thiessen, Paul A.; Geer, Renata C.; Marchler-Bauer, Aron; Bryant, Stephen H.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D297-D303</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The computational detection of similarities between protein 3D structures has become an indispensable tool for the detection of homologous relationships, the classification of protein families and functional inference.  Consequently, numerous algorithms have been developed that facilitate structure comparison, including rapid searches against a steadily growing collection of protein structures.  To this end, NCBI's Mol. Modeling Database (MMDB), which is based on the Protein Data Bank (PDB), maintains a comprehensive and up-to-date archive of protein structure similarities computed with the Vector Alignment Search Tool (VAST).  These similarities have been recorded on the level of single proteins and protein domains, comprising in excess of 1.5 billion pairwise alignments.  Here we present VAST+, an extension to the existing VAST service, which summarizes and presents structural similarity on the level of biol. assemblies or macromol. complexes.  VAST+ simplifies structure neighboring results and shows, for macromol. complexes tracked in MMDB, lists of similar complexes ranked by the extent of similarity.  VAST+ replaces the previous VAST service as the default presentation of structure neighboring data in NCBI's Entrez query and retrieval system.  MMDB and VAST+ can be accessed via http://www.ncbi.nlm.nih.gov/Structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiNDUHdKvRr7Vg90H21EOLACvtfcHk0lhcR_zn8Bxasg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cl&md5=6fe50e4abc811a3c32c8cc25ecfe734d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1208%26sid%3Dliteratum%253Aachs%26aulast%3DMadej%26aufirst%3DT.%26aulast%3DLanczycki%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DThiessen%26aufirst%3DP.%2BA.%26aulast%3DGeer%26aufirst%3DR.%2BC.%26aulast%3DMarchler-Bauer%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DS.%2BH.%26atitle%3DMMDB%2520and%2520VAST%252B%253A%2520tracking%2520structural%2520similarities%2520between%2520macromolecular%2520complexes%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3DD297%26epage%3DD303%26doi%3D10.1093%2Fnar%2Fgkt1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span> <span> </span><span class="NLM_article-title">Urea–aromatic stacking and concerted urea transport: conserved mechanisms in urea transporters revealed by molecular dynamics</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5190</span>– <span class="NLM_lpage">5200</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.6b00602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.6b00602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeht7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=5190-5200&author=S.+Padhiauthor=U.+D.+Priyakumar&title=Urea%E2%80%93aromatic+stacking+and+concerted+urea+transport%3A+conserved+mechanisms+in+urea+transporters+revealed+by+molecular+dynamics&doi=10.1021%2Facs.jctc.6b00602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Urea-Aromatic Stacking and Concerted Urea Transport: Conserved Mechanisms in Urea Transporters Revealed by Molecular Dynamics</span></div><div class="casAuthors">Padhi, Siladitya; Priyakumar, U. Deva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5190-5200</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea transporters are membrane proteins that selectively allow urea mols. to pass through.  It is not clear how these transporters allow rapid conduction of urea, a polar mol., in spite of the presence of a hydrophobic constriction lined by arom. rings.  The current study elucidates the mechanism that is responsible for this rapid conduction by performing free energy calcns. on transporter dvUT with a cumulative sampling time of ∼1.3 μs.  A parallel arrangement of arom. rings in the pore enables stacking of urea with these rings, which, in turn, lowers the energy barrier for urea transport.  Such interaction of the rings with urea is proposed to be a conserved mechanism across all urea-conducting proteins.  The free energy landscape for the permeation of multiple urea mols. reveals an interplay between inter-urea interaction and solvation state of the urea mols.  This is the 1st time that multiple mol. permeation through any small mol. transporter has been modeled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHuZSJkM5sSLVg90H21EOLACvtfcHk0lhogcLXdMXDsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeht7zF&md5=df00959601b9c02095949e7913592641</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.6b00602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.6b00602%26sid%3Dliteratum%253Aachs%26aulast%3DPadhi%26aufirst%3DS.%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26atitle%3DUrea%25E2%2580%2593aromatic%2520stacking%2520and%2520concerted%2520urea%2520transport%253A%2520conserved%2520mechanisms%2520in%2520urea%2520transporters%2520revealed%2520by%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D5190%26epage%3D5200%26doi%3D10.1021%2Facs.jctc.6b00602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasavajhala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span> <span> </span><span class="NLM_article-title">Role of urea–aromatic stacking interactions in stabilizing the aromatic residues of the protein in urea-induced denatured state</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">14931</span>– <span class="NLM_lpage">14946</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b05463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b05463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sks73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=14931-14946&author=S.+Goyalauthor=A.+Chattopadhyayauthor=K.+Kasavajhalaauthor=U.+D.+Priyakumar&title=Role+of+urea%E2%80%93aromatic+stacking+interactions+in+stabilizing+the+aromatic+residues+of+the+protein+in+urea-induced+denatured+state&doi=10.1021%2Fjacs.7b05463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Urea-Aromatic Stacking Interactions in Stabilizing the Aromatic Residues of the Protein in Urea-Induced Denatured State</span></div><div class="casAuthors">Goyal, Siddharth; Chattopadhyay, Aditya; Kasavajhala, Koushik; Priyakumar, U. Deva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14931-14946</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A delicate balance of different types of intramol. interactions makes the folded states of proteins marginally more stable than the unfolded states.  Expts. use thermal, chem., or mech. stress to perturb the folding equil. for examg. protein stability and protein folding processes.  The elucidation of the mechanism by which chem. denaturants unfold proteins is crucial; this study explores the nature of urea-arom. interactions relevant in urea-assisted protein denaturation.  Free energy profiles corresponding to the unfolding of Trp-cage mini-protein in the presence and absence of urea at 3 different temps. demonstrated the distortion of the hydrophobic core to be a crucial step.  Exposure of the Trp-6 residue to the solvent was found to be favored in the presence of urea.  Previous expts. showed that urea had high affinity for arom. groups of proteins.  We showed here that this was due to the remarkable ability of urea to form stacking and NH-π interactions with arom. groups of proteins.  Urea-nucleobase stacking interactions have been shown to be crucial in urea-assisted RNA unfolding.  An examn. of these interactions using microsecond-long unrestrained simulations showed that urea-arom. stacking interactions were stabilizing and long lasting.  Further mol. dynamics simulations, thermodn. integration and quantum mech. calcns. on arom. model systems revealed that such interactions are possible for all the arom. amino acid side-chains.  Finally, we validated the ubiquitous nature of urea-arom. stacking interactions by analyzing exptl. structures of urea transporters and proteins crystd. in presence of urea or urea derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_nKDBTuumrVg90H21EOLACvtfcHk0lhKL0ynmsIS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sks73F&md5=0b8890b9b5d9d480d100ce979aecb9db</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b05463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b05463%26sid%3Dliteratum%253Aachs%26aulast%3DGoyal%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26atitle%3DRole%2520of%2520urea%25E2%2580%2593aromatic%2520stacking%2520interactions%2520in%2520stabilizing%2520the%2520aromatic%2520residues%2520of%2520the%2520protein%2520in%2520urea-induced%2520denatured%2520state%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D14931%26epage%3D14946%26doi%3D10.1021%2Fjacs.7b05463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esteva-Font, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkman, A. S.</span></span> <span> </span><span class="NLM_article-title">Urea transporter proteins as targets for small-molecule diuretics</span>. <i>Nat. Rev. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1038/nrneph.2014.219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnrneph.2014.219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25488859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=113-123&author=C.+Esteva-Fontauthor=M.+O.+Andersonauthor=A.+S.+Verkman&title=Urea+transporter+proteins+as+targets+for+small-molecule+diuretics&doi=10.1038%2Fnrneph.2014.219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Urea transporter proteins as targets for small-molecule diuretics</span></div><div class="casAuthors">Esteva-Font, Cristina; Anderson, Marc O.; Verkman, Alan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Nephrology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-123</span>CODEN:
                <span class="NLM_cas:coden">NRNABO</span>;
        ISSN:<span class="NLM_cas:issn">1759-5061</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Conventional diuretics such as furosemide and thiazides target salt transporters in kidney tubules, but urea transporters (UTs) have emerged as alternative targets.  UTs are a family of transmembrane channels expressed in a variety of mammalian tissues, in particular the kidney.  UT knockout mice and humans with UT mutations exhibit reduced maximal urinary osmolality, demonstrating that UTs are necessary for the concn. of urine.  Small-mol. screening has identified potent and selective inhibitors of UT-A, the UT protein expressed in renal tubule epithelial cells, and UT-B, the UT protein expressed in vasa recta endothelial cells.  Data from UT knockout mice and from rodents administered UT inhibitors support the diuretic action of UT inhibition.  The kidney-specific expression of UT-A1, together with high selectivity of the small-mol. inhibitors, means that off-target effects of such small-mol. drugs should be minimal.  This Review summarizes the structure, expression and function of UTs, and looks at the evidence supporting the validity of UTs as targets for the development of salt-sparing diuretics with a unique mechanism of action.  UT-targeted inhibitors may be useful alone or in combination with conventional diuretics for therapy of various edemas and hyponatremias, potentially including those refractory to treatment with current diuretics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8QvCDHRPMp7Vg90H21EOLACvtfcHk0lhKL0ynmsIS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKksrjI&md5=ff85fb1acbbcd754235594556be3135d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnrneph.2014.219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneph.2014.219%26sid%3Dliteratum%253Aachs%26aulast%3DEsteva-Font%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DM.%2BO.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26atitle%3DUrea%2520transporter%2520proteins%2520as%2520targets%2520for%2520small-molecule%2520diuretics%26jtitle%3DNat.%2520Rev.%2520Nephrol.%26date%3D2015%26volume%3D11%26spage%3D113%26epage%3D123%26doi%3D10.1038%2Fnrneph.2014.219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaganade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazhayam, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span> <span> </span><span class="NLM_article-title">Energetic, structural and dynamic properties of nucleobase-urea interactions that aid in urea assisted RNA unfolding</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">8805</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-45010-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fs41598-019-45010-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=31217494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BB3M3osFOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=8805&author=T.+Jaganadeauthor=A.+Chattopadhyayauthor=N.+M.+Pazhayamauthor=U.+D.+Priyakumar&title=Energetic%2C+structural+and+dynamic+properties+of+nucleobase-urea+interactions+that+aid+in+urea+assisted+RNA+unfolding&doi=10.1038%2Fs41598-019-45010-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Energetic, Structural and Dynamic Properties of Nucleobase-Urea Interactions that Aid in Urea Assisted RNA Unfolding</span></div><div class="casAuthors">Jaganade Tanashree; Chattopadhyay Aditya; Pazhayam Nila M; Priyakumar U Deva</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8805</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Understanding the structure-function relationships of RNA has become increasingly important given the realization of its functional role in various cellular processes.  Chemical denaturation of RNA by urea has been shown to be beneficial in investigating RNA stability and folding.  Elucidation of the mechanism of unfolding of RNA by urea is important for understanding the folding pathways.  In addition to studying denaturation of RNA in aqueous urea, it is important to understand the nature and strength of interactions of the building blocks of RNA.  In this study, a systematic examination of the structural features and energetic factors involving interactions between nucleobases and urea is presented.  Results from molecular dynamics (MD) simulations on each of the five DNA/RNA bases in water and eight different concentrations of aqueous urea, and free energy calculations using the thermodynamic integration method are presented.  The interaction energies between all the nucleobases with the solvent environment and the transfer free energies become more favorable with respect to increase in the concentration of urea.  Preferential interactions of urea versus water molecules with all model systems determined using Kirkwood-Buff integrals and two-domain models indicate preference of urea by nucleobases in comparison to water.  The modes of interaction between urea and the nucleobases were analyzed in detail.  In addition to the previously identified hydrogen bonding and stacking interactions between urea and nucleobases that stabilize the unfolded states of RNA in aqueous solution, NH-π interactions are proposed to be important.  Dynamic properties of each of these three modes of interactions have been presented.  The study provides fundamental insights into the nature of interaction of urea molecules with nucleobases and how it disrupts nucleic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSguW6ydoBgS70AGQpJZWpJfW6udTcc2eYD_8d0jMVzA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3osFOgtQ%253D%253D&md5=26182c34deec65109392b691895ec47d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-45010-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-45010-8%26sid%3Dliteratum%253Aachs%26aulast%3DJaganade%26aufirst%3DT.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3DPazhayam%26aufirst%3DN.%2BM.%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26atitle%3DEnergetic%252C%2520structural%2520and%2520dynamic%2520properties%2520of%2520nucleobase-urea%2520interactions%2520that%2520aid%2520in%2520urea%2520assisted%2520RNA%2520unfolding%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D8805%26doi%3D10.1038%2Fs41598-019-45010-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyakumar, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyeon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirumalai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKerell, A. D.</span></span> <span> </span><span class="NLM_article-title">Urea destabilizes RNA by forming stacking interactions and multiple hydrogen bonds with nucleic acid bases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">17759</span>– <span class="NLM_lpage">17761</span>, <span class="refDoi"> DOI: 10.1021/ja905795v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja905795v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17759-17761&author=U.+D.+Priyakumarauthor=C.+Hyeonauthor=D.+Thirumalaiauthor=A.+D.+MacKerell&title=Urea+destabilizes+RNA+by+forming+stacking+interactions+and+multiple+hydrogen+bonds+with+nucleic+acid+bases&doi=10.1021%2Fja905795v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Urea Destabilizes RNA by Forming Stacking Interactions and Multiple Hydrogen Bonds with Nucleic Acid Bases</span></div><div class="casAuthors">Priyakumar, U. Deva; Hyeon, Changbong; Thirumalai, D.; MacKerell, Alexander D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17759-17761</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea titrn. of RNA by urea is an effective approach to investigate the forces stabilizing this biol. important mol.  We used all atom mol. dynamics simulations using two urea force fields and two RNA constructs to elucidate in at. detail the destabilization mechanism of folded RNA in aq. urea solns.  Urea denatures RNA by forming multiple hydrogen bonds with the RNA bases and has little influence on the phosphodiester backbone.  Most significantly we discovered that urea engages in stacking interactions with the bases.  We also est., for the first time, the m-value for RNA, which is a measure of the strength of urea-RNA interactions.  Our work provides a conceptual understanding of the mechanism by which urea enhances RNA folding rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq2g7vhPmRr7Vg90H21EOLACvtfcHk0lhr8UtkCWmLew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValur7M&md5=6eb803e34d185d39afb7cda8889a5ca1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja905795v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja905795v%26sid%3Dliteratum%253Aachs%26aulast%3DPriyakumar%26aufirst%3DU.%2BD.%26aulast%3DHyeon%26aufirst%3DC.%26aulast%3DThirumalai%26aufirst%3DD.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26atitle%3DUrea%2520destabilizes%2520RNA%2520by%2520forming%2520stacking%2520interactions%2520and%2520multiple%2520hydrogen%2520bonds%2520with%2520nucleic%2520acid%2520bases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17759%26epage%3D17761%26doi%3D10.1021%2Fja905795v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. J.</span>; <span class="NLM_string-name">Johson, D. A.</span></span> <span> </span><span class="NLM_article-title">Receptors and Drug Action</span> In  <i>Foye’s Principles of Medicinal Chemistry</i>; <span class="NLM_publisher-name">Lippincott Williams and Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+J.+Maher&author=D.+A.+Johson&title=Foye%E2%80%99s+Principles+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DT.%2BJ.%26atitle%3DReceptors%2520and%2520Drug%2520Action%26btitle%3DFoye%25E2%2580%2599s%2520Principles%2520of%2520Medicinal%2520Chemistry%26pub%3DLippincott%2520Williams%2520and%2520Wilkins%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Getman, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCrescenzo, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heintz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talley, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallings, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegeman, R. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1021/jm00054a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00054a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1egtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=288-291&author=D.+P.+Getmanauthor=G.+A.+DeCrescenzoauthor=R.+M.+Heintzauthor=K.+L.+Reedauthor=J.+J.+Talleyauthor=M.+L.+Bryantauthor=M.+Clareauthor=K.+A.+Housemanauthor=J.+J.+Marrauthor=R.+A.+Muellerauthor=M.+L.+Vazquezauthor=H.-S.+Shiehauthor=W.+C.+Stallingsauthor=R.+A.+Stegeman&title=Discovery+of+a+novel+class+of+potent+HIV-1+protease+inhibitors+containing+the+%28R%29-%28hydroxyethyl%29urea+isostere&doi=10.1021%2Fjm00054a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere</span></div><div class="casAuthors">Getman, Daniel P.; DeCrescenzo, Gary A.; Heintz, Robert M.; Reed, Kathryn L.; Talley, John J.; Bryant, Martin L.; Clare, Michael; Houseman, Kathryn A.; Marr, J. Joseph; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-91</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A novel series of HIV-1 protease inhibitors is described which incorporate the hydroxyethylurea isostere.  Contrasting the hydroxyethylurea isostere with the well-known hydroxyethylene isostere, one sees that the P1' chiral α-carbon has been replaced by a trigonal nitrogen.  The inhibitors reported herein are potent and selective inhibitors of the HIV-1 protease and show excellent antiviral properties in tissue culture.  The preferred stereochem. for the key hydroxyl group is R.  As detd. by x-ray diffraction studies, these inhibitors bind to the enzyme in a previously unreported manner wherein the expected P1' and P2' substituents actually reside in the S2' and S1' subsites of the enzyme resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3NCLik_xTrrVg90H21EOLACvtfcHk0liN2x17raKPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1egtLo%253D&md5=c75fb6abf68208fda73824977c7b2091</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm00054a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00054a014%26sid%3Dliteratum%253Aachs%26aulast%3DGetman%26aufirst%3DD.%2BP.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DHeintz%26aufirst%3DR.%2BM.%26aulast%3DReed%26aufirst%3DK.%2BL.%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26aulast%3DBryant%26aufirst%3DM.%2BL.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DHouseman%26aufirst%3DK.%2BA.%26aulast%3DMarr%26aufirst%3DJ.%2BJ.%26aulast%3DMueller%26aufirst%3DR.%2BA.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DShieh%26aufirst%3DH.-S.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520potent%2520HIV-1%2520protease%2520inhibitors%2520containing%2520the%2520%2528R%2529-%2528hydroxyethyl%2529urea%2520isostere%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D288%26epage%3D291%26doi%3D10.1021%2Fjm00054a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyermann, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodge, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ru, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacheler, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Viitanen, S.</span></span> <span> </span><span class="NLM_article-title">Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1126/science.8278812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1126%2Fscience.8278812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8278812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2cXitVOqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=380-384&author=P.+Y.+Lamauthor=P.+K.+Jadhavauthor=C.+J.+Eyermannauthor=C.+N.+Hodgeauthor=Y.+Ruauthor=L.+T.+Bachelerauthor=J.+L.+Meekauthor=M.+J.+Ottoauthor=M.+M.+Raynerauthor=Y.+N.+Wongauthor=C.-H.+Changauthor=P.+C.+Weberauthor=D.+A.+Jacksonauthor=T.+R.+Sharpeauthor=S.+Erickson-Viitanen&title=Rational+design+of+potent%2C+bioavailable%2C+nonpeptide+cyclic+ureas+as+HIV+protease+inhibitors&doi=10.1126%2Fscience.8278812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors</span></div><div class="casAuthors">Lam, Patrick Y. S.; Jadhav, Prabhakar K.; Eyermann, Charles J.; Hodge, C. Nicholas; Ru, Yu; Bacheler, Lee T.; Meek, Otto, Michael J.; Rayner, Marlene M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">5145</span>),
    <span class="NLM_cas:pages">380-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Mechanistic information and structure-based design methods have been used to design a series of nonpeptide cyclic ureas that are potent inhibitors of human immunodeficiency virus (HIV) protease and HIV replication.  A fundamental feature of these inhibitors is the cyclic urea carbonyl oxygen that mimics the hydrogen-bonding features of a key structural water mol.  The success of the design in both displacing and mimicking the structural water mol. was confirmed by x-ray crystallog. studies.  Highly selective, preorganized inhibitors with relatively low mol. wt. and high oral bioavailability were synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuSQfJfsq8LVg90H21EOLACvtfcHk0ljgGi4xp5weMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitVOqtLg%253D&md5=e5c975858e1dd98d8115fd3129d74344</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1126%2Fscience.8278812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8278812%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DHodge%26aufirst%3DC.%2BN.%26aulast%3DRu%26aufirst%3DY.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DMeek%26aufirst%3DJ.%2BL.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DRayner%26aufirst%3DM.%2BM.%26aulast%3DWong%26aufirst%3DY.%2BN.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DJackson%26aufirst%3DD.%2BA.%26aulast%3DSharpe%26aufirst%3DT.%2BR.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26atitle%3DRational%2520design%2520of%2520potent%252C%2520bioavailable%252C%2520nonpeptide%2520cyclic%2520ureas%2520as%2520HIV%2520protease%2520inhibitors%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D380%26epage%3D384%26doi%3D10.1126%2Fscience.8278812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodge, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacheler, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyermann, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winslow, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Viitanen, S.</span></span> <span> </span><span class="NLM_article-title">Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(96)90110-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS1074-5521%2896%2990110-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8807858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XjtVKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=301-314&author=C.+N.+Hodgeauthor=P.+E.+Aldrichauthor=L.+T.+Bachelerauthor=C.+H.+Changauthor=C.+J.+Eyermannauthor=S.+Garberauthor=M.+Grubbauthor=D.+A.+Jacksonauthor=P.+K.+Jadhavauthor=B.+Korantauthor=P.+Y.+Lamauthor=M.+B.+Maurinauthor=J.+L.+Meekauthor=M.+J.+Ottoauthor=M.+M.+Raynerauthor=C.+Reidauthor=T.+R.+Sharpeauthor=L.+Shumauthor=D.+L.+Winslowauthor=S.+Erickson-Viitanen&title=Improved+cyclic+urea+inhibitors+of+the+HIV-1+protease%3A+synthesis%2C+potency%2C+resistance+profile%2C+human+pharmacokinetics+and+X-ray+crystal+structure+of+DMP+450&doi=10.1016%2FS1074-5521%2896%2990110-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and x-ray crystal structure of DMP 450</span></div><div class="casAuthors">Hodge, C. Nicholas; Aldrich, Paul E.; Bacheler, Lee T.; Chang, Chong-Hwan; Eyermann, Charles J.; Garber, Sena; Grubb, Mary; Jackson, David A.; Jadhav, Prabharkar K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-314</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Effective HIV protease inhibitors must combine potency towards wild-type and mutant variants of HIV with oral bioavailability such that drug levels in relevant tissues continuously exceed that required for inhibition of virus replication.  Computer-aided design led to the discovery of cyclic urea inhibitors of the HIV protease.  We set out to improve the phys. properties and oral bioavailability of these compds.  We have synthesized DMP 450 (bis-methanesulfonic acid salt), a water-sol. cyclic urea compd. and a potent inhibitor of HIV replication in cell culture that also inhibits variants of HIV with single amino acid substitutions in the protease.  DMP 450 is highly selective for HIV protease, consistent with displacement of the retrovirus-specific structural water mol.  Single doses of 10 mg kg-1 DMP 450 result in plasma levels in man in excess of that required to inhibit wild-type and several mutant HIVs.  A plasmid-based, in vivo assay model suggests that maintenance of plasma levels of DMP 450 near the antiviral IC90 suppresses HIV protease activity in the animal.  We did identify mutants that are resistant to DMP 450, however; multiple mutations within the protease gene caused a significant redn. in the antiviral response.  DMP 450 is a significant advance within the cyclic urea class of HIV protease inhibitors due to its exceptional oral bioavailability.  The data presented here suggest that an optimal cyclic urea will provide clin. benefit in treating AIDS if it combines favorable pharmacokinetics with potent activity against not only single mutants of HIV, but also multiply-mutant variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB7tjY-v76kLVg90H21EOLACvtfcHk0liPS5SW9yJpUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVKhtrs%253D&md5=950677362347d0025040bb67d9d76e53</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2896%2990110-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252896%252990110-6%26sid%3Dliteratum%253Aachs%26aulast%3DHodge%26aufirst%3DC.%2BN.%26aulast%3DAldrich%26aufirst%3DP.%2BE.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DGarber%26aufirst%3DS.%26aulast%3DGrubb%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DD.%2BA.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26aulast%3DKorant%26aufirst%3DB.%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DMaurin%26aufirst%3DM.%2BB.%26aulast%3DMeek%26aufirst%3DJ.%2BL.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DRayner%26aufirst%3DM.%2BM.%26aulast%3DReid%26aufirst%3DC.%26aulast%3DSharpe%26aufirst%3DT.%2BR.%26aulast%3DShum%26aufirst%3DL.%26aulast%3DWinslow%26aufirst%3DD.%2BL.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26atitle%3DImproved%2520cyclic%2520urea%2520inhibitors%2520of%2520the%2520HIV-1%2520protease%253A%2520synthesis%252C%2520potency%252C%2520resistance%2520profile%252C%2520human%2520pharmacokinetics%2520and%2520X-ray%2520crystal%2520structure%2520of%2520DMP%2520450%26jtitle%3DChem.%2520Biol.%26date%3D1996%26volume%3D3%26spage%3D301%26epage%3D314%26doi%3D10.1016%2FS1074-5521%2896%2990110-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemori-Kawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jestel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Konig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, J.</span></span> <span> </span><span class="NLM_article-title">Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1021/ml500394m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500394m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=89-94&author=K.+Okamotoauthor=M.+Ikemori-Kawadaauthor=A.+Jestelauthor=K.+von+Konigauthor=Y.+Funahashiauthor=T.+Matsushimaauthor=A.+Tsuruokaauthor=A.+Inoueauthor=J.+Matsui&title=Distinct+binding+mode+of+multikinase+inhibitor+lenvatinib+revealed+by+biochemical+characterization&doi=10.1021%2Fml500394m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization</span></div><div class="casAuthors">Okamoto, Kiyoshi; Ikemori-Kawada, Megumi; Jestel, Anja; von Konig, Konstanze; Funahashi, Yasuhiro; Matsushima, Tomohiro; Tsuruoka, Akihiko; Inoue, Atsushi; Matsui, Junji</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-94</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lenvatinib is an oral multikinase inhibitor that selectively inhibits vascular endothelial growth factor (VEGF) receptors 1 to 3 and other proangiogenic and oncogenic pathway-related receptor tyrosine kinases.  To elucidate the origin of the potency of lenvatinib in VEGF receptor 2 (VEGFR2) inhibition, we conducted a kinetic interaction anal. of lenvatinib with VEGFR2 and x-ray anal. of the crystal structure of VEGFR2-lenvatinib complexes.  Kinetic anal. revealed that lenvatinib had a rapid assocn. rate const. and a relatively slow dissocn. rate const. in complex with VEGFR2.  Co-crystal structure anal. demonstrated that lenvatinib binds at its ATP mimetic quinoline moiety to the ATP binding site and to the neighboring region via a cyclopropane ring, adopting an Asp-Phe-Gly (DFG)-"in" conformation.  These results suggest that lenvatinib is very distinct in its binding mode of interaction compared to the several approved VEGFR2 kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUysiHRGw3P7Vg90H21EOLACvtfcHk0lgMrbJTvINiuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtb7E&md5=5461832fad0577f2ea93b47521b4bbdc</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fml500394m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500394m%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DIkemori-Kawada%26aufirst%3DM.%26aulast%3DJestel%26aufirst%3DA.%26aulast%3Dvon%2BKonig%26aufirst%3DK.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DMatsushima%26aufirst%3DT.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DMatsui%26aufirst%3DJ.%26atitle%3DDistinct%2520binding%2520mode%2520of%2520multikinase%2520inhibitor%2520lenvatinib%2520revealed%2520by%2520biochemical%2520characterization%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D89%26epage%3D94%26doi%3D10.1021%2Fml500394m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheek, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nm0597-562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnm0597-562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9142128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXivFOltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=562-566&author=M.+F.+Moghaddamauthor=D.+F.+Grantauthor=J.+M.+Cheekauthor=J.+F.+Greeneauthor=K.+C.+Williamsonauthor=B.+D.+Hammock&title=Bioactivation+of+leukotoxins+to+their+toxic+diols+by+epoxide+hydrolase&doi=10.1038%2Fnm0597-562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase</span></div><div class="casAuthors">Moghaddam, Mehran F.; Grant, David F.; Cheek, Jeffrey M.; Greene, Jessica F.; Williamson, Kristin C.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">562-566</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Leukotoxin is a linoleic acid oxide produced by leukocytes and has been assocd. with the multiple organ failure and adult respiratory distress syndrome seen in some severe burn patients.  Leukotoxin has been reported to be toxic when injected into animals i.v.  Herein, the authors report that this lipid is not directly cytotoxic in at least two in vitro systems.  Using a baculovirus expression system the authors demonstrate that leukotoxin is only cytotoxic in the presence of epoxide hydrolases.  In addn., it is the diol metabolite that proves toxic to pulmonary alveolar epithelial cells, suggesting a crit. role for the diol in leukotoxin-assocd. respiratory disease.  In vivo data also support the toxicity of leukotoxin diol.  For the first time the authors demonstrate that sol. epoxide hydrolase can bioactivate epoxides to diols that are apparently cytotoxic.  Thus, leukotoxin should be regarded as a protoxin corresponding to the more toxic diol.  This clearly has implications for designing new clin. interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr92m-hf2QxLVg90H21EOLACvtfcHk0lhwT56yfo_FTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFOltLs%253D&md5=89d85fa2acc478a04ee3b5b21378c2e9</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnm0597-562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0597-562%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DGrant%26aufirst%3DD.%2BF.%26aulast%3DCheek%26aufirst%3DJ.%2BM.%26aulast%3DGreene%26aufirst%3DJ.%2BF.%26aulast%3DWilliamson%26aufirst%3DK.%2BC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DBioactivation%2520of%2520leukotoxins%2520to%2520their%2520toxic%2520diols%2520by%2520epoxide%2520hydrolase%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D562%26epage%3D566%26doi%3D10.1038%2Fnm0597-562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable potent soluble epoxide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1021/jm070270t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070270t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3825-3840&author=S.+H.+Hwangauthor=H.+J.+Tsaiauthor=J.+Y.+Liuauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Orally+bioavailable+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm070270t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors</span></div><div class="casAuthors">Hwang, Sung Hee; Tsai, Hsing-Ju; Liu, Jun-Yan; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3825-3840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepd. and tested as sol. epoxide hydrolase (sEH) inhibitors.  This series of compds. showed low nanomolar to picomolar activities against recombinant human sEH.  Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human hepatic microsomes.  Furthermore, these new potent inhibitors show a greater metabolic stability in vivo than previously described sEH inhibitors.  Trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (I, t-AUCB, IC50 = 1.3 ± 0.05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVS4Wx8hrt_bVg90H21EOLACvtfcHk0lhwT56yfo_FTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D&md5=ad2116c2671dc36d35b44ff93d55863d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm070270t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070270t%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOrally%2520bioavailable%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3825%26epage%3D3840%26doi%3D10.1021%2Fjm070270t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasagami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5217</span>– <span class="NLM_lpage">5226</span>, <span class="refDoi"> DOI: 10.1021/jm070705c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070705c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOlur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5217-5226&author=I.+H.+Kimauthor=H.+J.+Tsaiauthor=K.+Nishiauthor=T.+Kasagamiauthor=C.+Morisseauauthor=B.+D.+Hammock&title=1%2C3-disubstituted+ureas+functionalized+with+ether+groups+are+potent+inhibitors+of+the+soluble+epoxide+hydrolase+with+improved+pharmacokinetic+properties&doi=10.1021%2Fjm070705c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Disubstituted Ureas Functionalized with Ether Groups are Potent Inhibitors of the Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties</span></div><div class="casAuthors">Kim, In-Hae; Tsai, Hsing-Ju; Nishi, Kosuke; Kasagami, Takeo; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5217-5226</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is a therapeutic target for treating hypertension and inflammation.  1,3-Disubstituted ureas functionalized with an ether group are potent sEH inhibitors.  However, their relatively low metabolic stability leads to poor pharmacokinetic properties.  To improve their bioavailability, we investigated the effect of incorporating various polar groups on the ether function on the inhibition potencies, phys. properties, in vitro metabolic stability, and pharmacokinetic properties.  The structure-activity relationship studies showed that a hydrophobic linker between the urea group and the ether function is necessary to keep their potency.  In addn., urea-ether inhibitors having a polar group such as diethylene glycol or morpholine significantly improved their phys. properties and metabolic stability without any loss of inhibitory potency.  Furthermore, improved pharmacokinetic properties in murine and canine models were obtained with the resulting inhibitors.  These findings will facilitate the usage of sEH inhibitors in animal models of hypertension and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE4y2_2Aw6YLVg90H21EOLACvtfcHk0lhwT56yfo_FTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOlur7J&md5=73026ff3639b8ff905e7f79091cc8c31</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm070705c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070705c%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DNishi%26aufirst%3DK.%26aulast%3DKasagami%26aufirst%3DT.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1%252C3-disubstituted%2520ureas%2520functionalized%2520with%2520ether%2520groups%2520are%2520potent%2520inhibitors%2520of%2520the%2520soluble%2520epoxide%2520hydrolase%2520with%2520improved%2520pharmacokinetic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5217%26epage%3D5226%26doi%3D10.1021%2Fjm070705c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shihadih, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2197</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2014.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24685540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2193-2197&author=V.+Burmistrovauthor=C.+Morisseauauthor=K.+S.+Leeauthor=D.+S.+Shihadihauthor=T.+R.+Harrisauthor=G.+M.+Butovauthor=B.+D.+Hammock&title=Symmetric+adamantyl-diureas+as+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Lee, Kin Sing Stephen; Shihadih, Diyala S.; Harris, Todd R.; Butov, Gennady M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2193-2197</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of inhibitors of the sol. epoxide hydrolase (sEH) contg. two urea groups has been developed.  Inhibition potency of the described compds. ranges from 2.0 μM to 0.4 nM. 1,6-(hexamethylene)bis[(adamant-1-yl)urea] was found to be a potent slow tight binding inhibitor (IC50 = 0.5 nM) with a strong binding to sEH (Ki = 3.1 nM) and a moderately long residence time on the enzyme (koff = 1.05 × 10-3 s-1; t1/2 = 11 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi-gy0pevlO7Vg90H21EOLACvtfcHk0lgxtR5Kl0uUiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOntL0%253D&md5=35625299d7d4e014cb446bd7ec1838a5</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DShihadih%26aufirst%3DD.%2BS.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSymmetric%2520adamantyl-diureas%2520as%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2193%26epage%3D2197%26doi%3D10.1016%2Fj.bmcl.2014.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1039/c2md00288d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc2md00288d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25225606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=379-384&author=S.+X.+Huangauthor=B.+Caoauthor=C.+Morisseauauthor=Y.+Tinauthor=B.+D.+Hammockauthor=Y.+Q.+Long&title=Structure-based+optimization+of+the+piperazino-containing+1%2C3-disubstituted+ureas+affording+sub-nanomolar+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1039%2Fc2md00288d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Huang, Shao-Xu; Cao, Bin; Morisseau, Christophe; Jin, Yi; Hammock, Bruce D.; Long, Ya-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The inhibition of the sol. epoxide hydrolase (sEH) is a promising new therapy in the treatment of cardiovascular, inflammation and other disorders.  A piperazino functionality as the tertiary pharmacophore remarkably improved the drug-like profile of the 1,3-disubstituted urea sEH inhibitors.  However, the potency was more dependent on the overall best balance of the hydrophilicity and lipophilicity.  Based on the sEH-inhibitor complex structure, further structural optimization on the piperazino-contg. 1,3-disubstituted urea scaffold was conducted for an improved potency.  The 1-adamantylacetamide and para-phenylcarbonyl group were identified to be an optimal primary pharmacophore and secondary pharmacophore motif, resp., generating sub-nanomolar sEH inhibitors with favorable water soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4KGERQTtSKrVg90H21EOLACvtfcHk0lgxtR5Kl0uUiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOqu7o%253D&md5=7517438f79da7538eec4dd028dd2b063</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1039%2Fc2md00288d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md00288d%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BX.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DTin%26aufirst%3DY.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DStructure-based%2520optimization%2520of%2520the%2520piperazino-containing%25201%252C3-disubstituted%2520ureas%2520affording%2520sub-nanomolar%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D379%26epage%3D384%26doi%3D10.1039%2Fc2md00288d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1110/ps.051720206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1110%2Fps.051720206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16322563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=58-64&author=G.+A.+Gomezauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Christianson&title=Human+soluble+epoxide+hydrolase%3A+structural+basis+of+inhibition+by+4-%283-cyclohexylureido%29-carboxylic+acids&doi=10.1110%2Fps.051720206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span></div><div class="casAuthors">Gomez, German A.; Morisseau, Christophe; Hammock, Bruce D.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">X-ray crystal structures of human sol. epoxide hydrolase (sEH) complexed with four different dialkylurea inhibitors bearing pendant carboxylate "tails" of varying length have been detd. at 2.3-3.0 Å resoln.  Similarities among inhibitor binding modes reinforce the proposed roles of Y381 and/or Y465 as general acids that protonate the epoxide ring of the substrate in concert with nucleophilic attack of D333 at the electrophilic epoxide carbon.  Addnl., the binding of these inhibitors allows us to model the binding mode of the endogenous substrate 14,15-epoxyeicosatrienoic acid.  Contrasts among inhibitor binding modes include opposite orientations of inhibitor binding in the active-site hydrophobic tunnel.  Alternative binding orientations obsd. for this series of inhibitors to human sEH, as well as the binding of certain dialkylurea inhibitors to human sEH and murine sEH, complicate the structure-based design of human sEH inhibitors with potential pharmaceutical applications in the treatment of hypertension.  Thus, with regard to the optimization of inhibitor designs targeting human sEH, it is crit. that human sEH and not murine sEH be utilized for inhibitor screening, and it is crit. that structures of human sEH-inhibitor complexes be detd. to verify inhibitor binding orientations that correlate with measured affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrqO7mSzRPrVg90H21EOLACvtfcHk0lhBbvIdnz9hag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D&md5=b16bb0c99a177acc885cbbb789374f2b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1110%2Fps.051720206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.051720206%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DG.%2BA.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHuman%2520soluble%2520epoxide%2520hydrolase%253A%2520structural%2520basis%2520of%2520inhibition%2520by%25204-%25283-cyclohexylureido%2529-carboxylic%2520acids%26jtitle%3DProtein%2520Sci.%26date%3D2006%26volume%3D15%26spage%3D58%26epage%3D64%26doi%3D10.1110%2Fps.051720206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8854</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.16.8849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.96.16.8849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10430859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8849-8854&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=D.+Dowdyauthor=J.+Zhengauthor=J.+F.+Greeneauthor=J.+R.+Sanbornauthor=B.+D.+Hammock&title=Potent+urea+and+carbamate+inhibitors+of+soluble+epoxide+hydrolases&doi=10.1073%2Fpnas.96.16.8849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Dowdy, Deanna; Zheng, Jiang; Greene, Jessica F.; Sanborn, James R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8849-8854</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) plays a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformations.  Herein, the authors report the discovery of substituted ureas and carbamates as potent inhibitors of sEH.  Some of these selective, competitive tight-binding inhibitors with nanomolar Ki values interacted stoichiometrically with the homogeneous recombinant murine and human sEHs.  These inhibitors enhance cytotoxicity of trans-stilbene oxide, which is active as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to its toxic diol.  They also reduce toxicity of leukotoxin in vivo in mice and prevent symptoms suggestive of acute respiratory distress syndrome.  These potent inhibitors may be valuable tools for testing hypotheses of involvement of diol and epoxide lipids in chem. mediation in vitro or in vivo systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOIwuI01SYLVg90H21EOLACvtfcHk0lhBbvIdnz9hag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D&md5=eeff85f27c1a33e2da6fb7f8f2ae91de</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.16.8849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.16.8849%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DDowdy%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DJ.%2BF.%26aulast%3DSanborn%26aufirst%3DJ.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPotent%2520urea%2520and%2520carbamate%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8849%26epage%3D8854%26doi%3D10.1073%2Fpnas.96.16.8849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lonsdale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grey, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulholland, A. J.</span></span> <span> </span><span class="NLM_article-title">Determinants of reactivity and selectivity in soluble epoxide hydrolase from quantum mechanics/molecular mechanics modeling</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1774</span>– <span class="NLM_lpage">1786</span>, <span class="refDoi"> DOI: 10.1021/bi201722j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201722j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Oitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1774-1786&author=R.+Lonsdaleauthor=S.+Hoyleauthor=D.+T.+Greyauthor=L.+Ridderauthor=A.+J.+Mulholland&title=Determinants+of+reactivity+and+selectivity+in+soluble+epoxide+hydrolase+from+quantum+mechanics%2Fmolecular+mechanics+modeling&doi=10.1021%2Fbi201722j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of Reactivity and Selectivity in Soluble Epoxide Hydrolase from Quantum Mechanics/Molecular Mechanics Modeling</span></div><div class="casAuthors">Lonsdale, Richard; Hoyle, Simon; Grey, Daniel T.; Ridder, Lars; Mulholland, Adrian J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1774-1786</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an enzyme involved in drug metab. that catalyzes the hydrolysis of epoxides to form their corresponding diols. sEH has a broad substrate range and shows high regio- and enantioselectivity for nucleophilic ring opening by Asp333.  Epoxide hydrolases therefore have potential synthetic applications.  We have used combined quantum mechanics/mol. mechanics (QM/MM) umbrella sampling mol. dynamics (MD) simulations (at the AM1/CHARMM22 level) and high-level ab initio (SCS-MP2) QM/MM calcns. to analyze the reactions, and determinants of selectivity, for two substrates: trans-stilbene oxide (t-SO) and trans-diphenylpropene oxide (t-DPPO).  The calcd. free energy barriers from the QM/MM (AM1/CHARMM22) umbrella sampling MD simulations show a lower barrier for Ph attack in t-DPPO, compared with that for benzylic attack, in agreement with expt.  Activation barriers in agreement with exptl. rate consts. are obtained only with the highest level of QM theory (SCS-MP2) used.  Our results show that the selectivity of the ring-opening reaction is influenced by several factors, including proximity to the nucleophile, electronic stabilization of the transition state (TS), and hydrogen bonding to two active site tyrosine residues.  The protonation state of His523 during nucleophilic attack has also been investigated, and our results show that the protonated form is most consistent with exptl. findings.  The work presented here illustrates how determinants of selectivity can be identified from QM/MM simulations.  These insights may also provide useful information for the design of novel catalysts for use in the synthesis of enantiopure compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozsUe7betCxrVg90H21EOLACvtfcHk0lhBbvIdnz9hag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Oitrc%253D&md5=928a0010368479451f4ea9dc1b39c20a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fbi201722j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201722j%26sid%3Dliteratum%253Aachs%26aulast%3DLonsdale%26aufirst%3DR.%26aulast%3DHoyle%26aufirst%3DS.%26aulast%3DGrey%26aufirst%3DD.%2BT.%26aulast%3DRidder%26aufirst%3DL.%26aulast%3DMulholland%26aufirst%3DA.%2BJ.%26atitle%3DDeterminants%2520of%2520reactivity%2520and%2520selectivity%2520in%2520soluble%2520epoxide%2520hydrolase%2520from%2520quantum%2520mechanics%252Fmolecular%2520mechanics%2520modeling%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D1774%26epage%3D1786%26doi%3D10.1021%2Fbi201722j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazerwith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesten, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beidler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattachar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesten, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomanbhoy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1021/ml100190t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor&doi=10.1021%2Fml100190t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0ljqm7KDHCgGdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96%26doi%3D10.1021%2Fml100190t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayfield, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilula, N. B.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1038/384083a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2F384083a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8900284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=83-87&author=B.+F.+Cravattauthor=D.+K.+Giangauthor=S.+P.+Mayfieldauthor=D.+L.+Bogerauthor=R.+A.+Lernerauthor=N.+B.+Gilula&title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&doi=10.1038%2F384083a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span></div><div class="casAuthors">Cravatt, Benjamin F.; Giang, Dan K.; Mayfield, Stephen P.; Boger, Dale L.; Lerner, Richard A.; Gilula, Norton B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604</span>),
    <span class="NLM_cas:pages">83-87</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Endogenous neuromodulatory mols.. are commonly couples to specific metabolic enzymes to ensure rapid signal inactivation.  Thus, acetylcholine is hydrolyzed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases.  Previously, we reported the structure and sleep-deproved cats.  Cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results).  We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid.  We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes.  We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling mols., the fatty-acid amides.  Therefore we will hereafter refer to oelamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhJfsk7jdmLVg90H21EOLACvtfcHk0ljqm7KDHCgGdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D&md5=155095116ad61669c06c4b6dcc25e28a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2F384083a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384083a0%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DMayfield%26aufirst%3DS.%2BP.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DLerner%26aufirst%3DR.%2BA.%26aulast%3DGilula%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520characterization%2520of%2520an%2520enzyme%2520that%2520degrades%2520neuromodulatory%2520fatty-acid%2520amides%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D83%26epage%3D87%26doi%3D10.1038%2F384083a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kathuria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaetani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fegley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Modulation of anxiety through blockade of anandamide hydrolysis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1038/nm803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnm803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12461523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivF2l" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=76-81&author=S.+Kathuriaauthor=S.+Gaetaniauthor=D.+Fegleyauthor=F.+Valinoauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=G.+La+Ranaauthor=A.+Calignanoauthor=A.+Giustinoauthor=M.+Tattoliauthor=M.+Palmeryauthor=V.+Cuomoauthor=D.+Piomelli&title=Modulation+of+anxiety+through+blockade+of+anandamide+hydrolysis&doi=10.1038%2Fnm803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of anxiety through blockade of anandamide hydrolysis</span></div><div class="casAuthors">Kathuria, Satish; Gaetani, Silvana; Fegley, Darren; Valino, Fernando; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; La Rana, Giovanna; Calignano, Antonio; Giustino, Arcangela; Tattoli, Maria; Palmery, Maura; Cuomo, Vincenzo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-81</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The psychoactive constituent of cannabis, Δ9-tetrahydrocannabinol, produces in humans subjective responses mediated by CB1 cannabinoid receptors, indicating that endogenous cannabinoids may contribute to the control of emotion.  But the variable effects of Δ9-tetrahydrocannabinol obscure the interpretation of these results and limit the therapeutic potential of direct cannabinoid agonists.  An alternative approach may be to develop drugs that amplify the effects of endogenous cannabinoids by preventing their inactivation.  Here, the authors describe a class of potent, selective, and systemically active inhibitors of fatty acid amide hydrolase, the enzyme responsible for the degrdn. of the endogenous cannabinoid anandamide.  Like clin. used anti-anxiety drugs, in rats the inhibitors exhibit benzodiazepine-like properties in the elevated zero-maze test and suppress isolation-induced vocalizations.  These effects are accompanied by augmented brain levels of anandamide and are prevented by CB1 receptor blockade.  Apparently, anandamide participates in the modulation of emotional states and fatty acid amide hydrolase inhibition is an innovative approach to anti-anxiety therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbjKypjqxPcrVg90H21EOLACvtfcHk0lhLK7t4Ak0MdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivF2l&md5=350c8a5af97b6ea4e41e9f0c821231e4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnm803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm803%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DValino%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGiustino%26aufirst%3DA.%26aulast%3DTattoli%26aufirst%3DM.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DModulation%2520of%2520anxiety%2520through%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D76%26epage%3D81%26doi%3D10.1038%2Fnm803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghatelian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardouin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1124/jpet.104.069401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fjpet.104.069401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15229230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=441-448&author=A.+H.+Lichtmanauthor=D.+Leungauthor=C.+C.+Sheltonauthor=A.+Saghatelianauthor=C.+Hardouinauthor=D.+L.+Bogerauthor=B.+F.+Cravatt&title=Reversible+inhibitors+of+fatty+acid+amide+hydrolase+that+promote+analgesia%3A+evidence+for+an+unprecedented+combination+of+potency+and+selectivity&doi=10.1124%2Fjpet.104.069401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: Evidence for an unprecedented combination of potency and selectivity</span></div><div class="casAuthors">Lichtman, Aron H.; Leung, Donmienne; Shelton, Christopher C.; Saghatelian, Alan; Hardouin, Christophe; Boger, Dale L.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-448</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is the primary catabolic regulator of several bioactive lipid amides in vivo, including the endogenous cannabinoid anandamide and the sleep-inducing substance oleamide.  Inhibitors of FAAH are considered a potential therapeutic approach for the treatment of several nervous system disorders, including pain, anxiety, and insomnia.  However, for FAAH inhibitors to achieve clin. utility, they must not only display efficacy in vivo but also selectivity for this enzyme relative to the numerous other serine hydrolases present in mammalian proteomes.  Here, we report a general strategy for evaluating the pharmacol. activity and target specificity of FAAH inhibitors and its implementation to develop the first class of selective reversible inhibitors of this enzyme that are highly efficacious in vivo.  Using a series of functional proteomics, anal. chem., and behavioral pharmacol. assays, we have identified a class of α-keto-heterocycles that show unprecedented selectivity for FAAH relative to other mammalian hydrolases, and, when administered to rodents, raise central nervous system levels of anandamide and promote cannabinoid receptor 1-dependent analgesia in several assays of pain sensation.  These studies provide further evidence that FAAH may represent an attractive therapeutic target and describe a general route by which inhibitors of this enzyme can be optimized to achieve exceptional potency, selectivity, and efficacy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-2yWRQoneprVg90H21EOLACvtfcHk0lhLK7t4Ak0MdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKrt7k%253D&md5=53e5c721cde0d43d07413d4563ded313</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.069401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.069401%26sid%3Dliteratum%253Aachs%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DShelton%26aufirst%3DC.%2BC.%26aulast%3DSaghatelian%26aufirst%3DA.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DReversible%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520that%2520promote%2520analgesia%253A%2520evidence%2520for%2520an%2520unprecedented%2520combination%2520of%2520potency%2520and%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D441%26epage%3D448%26doi%3D10.1124%2Fjpet.104.069401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beidler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazerwith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=M.+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+characterization+of+a+highly+selective+FAAH+inhibitor+that+reduces+inflammatory+pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0lgWXN1U-Explw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520selective%2520FAAH%2520inhibitor%2520that%2520reduces%2520inflammatory%2520pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everdeen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">12820</span>– <span class="NLM_lpage">12824</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806121105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.0806121105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18753625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=12820-12824&author=M.+Mileniauthor=D.+S.+Johnsonauthor=Z.+Wangauthor=D.+S.+Everdeenauthor=M.+Liimattaauthor=B.+Pabstauthor=K.+Bhattacharyaauthor=R.+A.+Nugentauthor=S.+Kamtekarauthor=B.+F.+Cravattauthor=K.+Ahnauthor=R.+C.+Stevens&title=Structure-guided+inhibitor+design+for+human+FAAH+by+interspecies+active+site+conversion&doi=10.1073%2Fpnas.0806121105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span></div><div class="casAuthors">Mileni, Mauro; Johnson, Douglas S.; Wang, Zhigang; Everdeen, Daniel S.; Liimatta, Marya; Pabst, Brandon; Bhattacharya, Keshab; Nugent, Richard A.; Kamtekar, Satwik; Cravatt, Benjamin F.; Ahn, Kay; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12820-12824</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The integral membrane enzyme fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and related amidated signaling lipids.  Genetic or pharmacol. inactivation of FAAH produces analgesic, anxiolytic, and antiinflammatory phenotypes but not the undesirable side effects of direct cannabinoid receptor agonists, indicating that FAAH may be a promising therapeutic target.  Structure-based inhibitor design has, however, been hampered by difficulties in expressing the human FAAH enzyme.  Here, we address this problem by interconverting the active sites of rat and human FAAH using site-directed mutagenesis.  The resulting humanized rat (h/r) FAAH protein exhibits the inhibitor sensitivity profiles of human FAAH but maintains the high-expression yield of the rat enzyme.  We report a 2.75-Å crystal structure of h/rFAAH complexed with an inhibitor, N-phenyl-4- (quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750), that shows strong preference for human FAAH.  This structure offers compelling insights to explain the species selectivity of FAAH inhibitors, which should guide future drug design programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq16BzSUEI2DbVg90H21EOLACvtfcHk0lgWXN1U-Explw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP&md5=bebc9409a5e71734f651c5ab89303fad</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806121105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806121105%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEverdeen%26aufirst%3DD.%2BS.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520for%2520human%2520FAAH%2520by%2520interspecies%2520active%2520site%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D12820%26epage%3D12824%26doi%3D10.1073%2Fpnas.0806121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes-Briones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creatura, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurnauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherif, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skosnik, P. D.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial</span>. <i>Lancet Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/S2215-0366(18)30427-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS2215-0366%2818%2930427-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=30528676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BB3crpvFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=35-45&author=D.+C.+D%E2%80%99Souzaauthor=J.+Cortes-Brionesauthor=G.+Creaturaauthor=G.+Bluezauthor=H.+Thurnauerauthor=E.+Deasoauthor=K.+Bielenauthor=T.+Surtiauthor=R.+Radhakrishnanauthor=A.+Guptaauthor=S.+Guptaauthor=J.+Cahillauthor=M.+A.+Sherifauthor=A.+Makriyannisauthor=P.+T.+Morganauthor=M.+Ranganathanauthor=P.+D.+Skosnik&title=Efficacy+and+safety+of+a+fatty+acid+amide+hydrolase+inhibitor+%28PF-04457845%29+in+the+treatment+of+cannabis+withdrawal+and+dependence+in+men%3A+a+double-blind%2C+placebo-controlled%2C+parallel+group%2C+phase+2a+single-site+randomised+controlled+trial&doi=10.1016%2FS2215-0366%2818%2930427-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial</span></div><div class="casAuthors">D'Souza Deepak Cyril; Cortes-Briones Jose; Creatura Gina; Bluez Grai; Thurnauer Halle; Deaso Emma; Bielen Kim; Surti Toral; Radhakrishnan Rajiv; Gupta Aarti; Gupta Swapnil; Cahill John; Sherif Mohamed A; Morgan Peter T; Ranganathan Mohini; Skosnik Patrick D; Makriyannis Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">The lancet. Psychiatry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Cannabis is one of the most widely used drugs worldwide.  Cannabis use disorder is characterised by recurrent use of cannabis that causes significant clinical and functional impairment.  There are no approved pharmacological treatments for cannabis use disorder.  One approach is to potentiate endocannabinoid signalling by inhibiting fatty acid amide hydrolase (FAAH), the enzyme that degrades the endocannabinoid anandamide.  We aimed to test the efficacy and safety of the FAAH-inhibitor PF-04457845 in reduction of cannabis withdrawal and cannabis use in men who were daily cannabis users.  METHODS:  We did a double-blind, placebo-controlled, parallel group phase 2a trial at one site in men aged 18-55 years with cannabis dependence according to DSM-IV criteria (equivalent to cannabis use disorder in DSM-5).  After baseline assessments, participants were randomly assigned (2:1) to receive PF-04457845 (4 mg per day) or placebo using a fixed block size of six participants, stratified by severity of cannabis use and desire to quit.  Participants were admitted to hospital for 5 days (maximum 8 days) to achieve abstinence and precipitate cannabis withdrawal, after which they were discharged to continue the remaining 3 weeks of treatment as outpatients.  The primary endpoints were treatment-related differences in cannabis withdrawal symptoms during hospital admission, and week 4 (end of treatment) self-reported cannabis use and urine THC-COOH concentrations in the intention-to-treat population.  The study is registered at ClinicalTrials.gov, number NCT01618656.  FINDINGS:  Between Sept 12, 2012, and Jan 18, 2016, 46 men were randomly assigned to PF-04457845 and 24 to placebo.  Adherence to study medication was 88%, as confirmed by video-calling and pill count, and corroborated by corresponding drug and anandamide concentrations in blood.  Relative to placebo, treatment with PF-04457845 was associated with reduced symptoms of cannabis withdrawal (first day of treatment mean symptom score 11·00 [95% CI 7·78-15·57] vs 6·04 [4·43-8·24]; difference 4·96 [0·71-9·21]; padj=0·048; second day of treatment 11·74 [8·28-16·66] vs 6·02 [4·28-8·47]; difference 5·73 [1·13-10·32]; padj=0·035) and related mood symptoms during the inpatient phase.  Additionally, treatment with PF-04457845 was associated with lower self-reported cannabis use at 4 weeks (mean 1·27 joints per day [95% CI 0·82-1·97] vs 0·40 [0·25-0·62]; difference 0·88 [0·29-1·46]; p=0·0003) and lower urinary THC-COOH concentrations (mean 657·92 ng/mL [95% CI 381·60-1134·30] vs 265·55 [175·60-401·57]; difference 392·37 [17·55-767·18)]; p=0·009).  Eight (17%) patients in the PF-04457845 group and four (17%) in the placebo group discontinued during the treatment period.  During the 4-week treatment phase, 20 (43%) of 46 participants in the PF-04457845 group and 11 (46%) of 24 participants in the placebo group had an adverse event.  There were no serious adverse events.  INTERPRETATION:  PF-04457845, a novel FAAH inhibitor, reduced cannabis withdrawal symptoms and cannabis use in men, and might represent an effective and safe approach for the treatment of cannabis use disorder.  FUNDING:  United States National Institute of Drug Abuse (NIDA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuFJfQq81sAy6Ufuk_1xoTfW6udTcc2eaG2TO6TFxc8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crpvFWrtg%253D%253D&md5=dd9bcc6470045275e5a977d175d70cbf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS2215-0366%2818%2930427-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2215-0366%252818%252930427-9%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BC.%26aulast%3DCortes-Briones%26aufirst%3DJ.%26aulast%3DCreatura%26aufirst%3DG.%26aulast%3DBluez%26aufirst%3DG.%26aulast%3DThurnauer%26aufirst%3DH.%26aulast%3DDeaso%26aufirst%3DE.%26aulast%3DBielen%26aufirst%3DK.%26aulast%3DSurti%26aufirst%3DT.%26aulast%3DRadhakrishnan%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DCahill%26aufirst%3DJ.%26aulast%3DSherif%26aufirst%3DM.%2BA.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DP.%2BT.%26aulast%3DRanganathan%26aufirst%3DM.%26aulast%3DSkosnik%26aufirst%3DP.%2BD.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520a%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520%2528PF-04457845%2529%2520in%2520the%2520treatment%2520of%2520cannabis%2520withdrawal%2520and%2520dependence%2520in%2520men%253A%2520a%2520double-blind%252C%2520placebo-controlled%252C%2520parallel%2520group%252C%2520phase%25202a%2520single-site%2520randomised%2520controlled%2520trial%26jtitle%3DLancet%2520Psychiatry%26date%3D2019%26volume%3D6%26spage%3D35%26epage%3D45%26doi%3D10.1016%2FS2215-0366%2818%2930427-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. L.</span></span> <span> </span><span class="NLM_article-title">Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives</span>. <i>J. Hepatocell Carcinoma</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.2147/JHC.S45040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2147%2FJHC.S45040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27508178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ptlWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=85-99&author=C.+H.+Hsuauthor=Y.+C.+Shenauthor=Y.+Y.+Shaoauthor=C.+Hsuauthor=A.+L.+Cheng&title=Sorafenib+in+advanced+hepatocellular+carcinoma%3A+current+status+and+future+perspectives&doi=10.2147%2FJHC.S45040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives</span></div><div class="casAuthors">Hsu Chih-Hung; Shao Yu-Yun; Hsu Chiun; Shen Ying-Chun; Cheng Ann-Lii</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatocellular carcinoma</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-99</span>
        ISSN:<span class="NLM_cas:issn">2253-5969</span>.
    </div><div class="casAbstract">The approval of sorafenib, a multikinase inhibitor targeting primarily Raf kinase and the vascular endothelial growth factor receptor, in 2007 for treating advanced hepatocellular carcinoma (HCC) has generated considerable enthusiasm in drug development for this difficult-to-treat disease.  However, because several randomized Phase III studies testing new multikinase inhibitors failed, sorafenib remains the standard of first-line systemic therapy for patients with advanced HCC.  Field practice studies worldwide have suggested that in daily practice, physicians are adopting either a preemptive dose modification or a ramp-up strategy to improve the compliance of their patients.  In addition, accumulating data have suggested that patients with Child-Pugh class B liver function can tolerate sorafenib as well as patients with Child-Pugh class A liver function, although the actual benefit of sorafenib in patients with Child-Pugh class B liver function has yet to be confirmed.  Whether sorafenib can be used as an adjunctive therapy to improve the outcomes of intermediate-stage HCC patients treated with transcatheter arterial chemoembolization or early-stage HCC patients after curative therapies is being investigated in several ongoing randomized Phase III studies.  An increasing number of studies have reported that sorafenib exerts "off-target" effects, including the modulation of signaling pathways other than Raf/MEK/ERK pathway, nonapoptotic cell death mechanisms, and even immune modulation.  Finally, although sorafenib in combination with chemotherapy or other targeted therapies has the potential to improve therapeutic efficacy in treating HCC, it also increases toxicity.  Additional clinical studies are warranted to determine useful sorafenib-based combinations for the treatment of advanced HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRayDb-rrwA1Ob6AVA-44PTfW6udTcc2eaG2TO6TFxc8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ptlWhtg%253D%253D&md5=a86929d85c76bfc22bbdc1b3c2725c1c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2147%2FJHC.S45040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJHC.S45040%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DC.%2BH.%26aulast%3DShen%26aufirst%3DY.%2BC.%26aulast%3DShao%26aufirst%3DY.%2BY.%26aulast%3DHsu%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DA.%2BL.%26atitle%3DSorafenib%2520in%2520advanced%2520hepatocellular%2520carcinoma%253A%2520current%2520status%2520and%2520future%2520perspectives%26jtitle%3DJ.%2520Hepatocell%2520Carcinoma%26date%3D2014%26volume%3D1%26spage%3D85%26epage%3D99%26doi%3D10.2147%2FJHC.S45040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lathia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lettieri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallentine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaresan, P.</span></span> <span> </span><span class="NLM_article-title">Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1007/s00280-005-0068-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs00280-005-0068-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16133532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1KktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2006&pages=685-692&author=C.+Lathiaauthor=J.+Lettieriauthor=F.+Cihonauthor=M.+Gallentineauthor=M.+Radtkeauthor=P.+Sundaresan&title=Lack+of+effect+of+ketoconazole-mediated+CYP3A+inhibition+on+sorafenib+clinical+pharmacokinetics&doi=10.1007%2Fs00280-005-0068-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics</span></div><div class="casAuthors">Lathia, Chetan; Lettieri, John; Cihon, Frank; Gallentine, Martha; Radtke, Martin; Sundaresan, Pavur</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Sorafenib is a novel, small-mol. anticancer compd. that inhibits tumor cell proliferation by targeting Raf in the Raf/MEK/ERK signaling pathway, and inhibits angiogenesis by targeting tyrosine kinases such as vascular-endothelial growth factor receptor (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor (PDGFR).  In vitro microsomal data indicate that sorafenib is metabolized by two pathways: phase I oxidn. mediated by cytochrome P 450 (CYP) 3A4; and phase II conjugation mediated by UGT1A9.  Approx. 50% of an orally administered dose is recovered as unchanged drug in the feces, due to either biliary excretion or lack of absorption.  The aim of this study was to evaluate the effect of CYP3A inhibition by ketoconazole on sorafenib pharmacokinetics.  This was an open-label, non-randomized, 2-period, one-way crossover study in sixteen healthy male subjects.  A single 50 mg dose of sorafenib was administered alone (period 1) and in combination with ketoconazole 400 mg once daily (period 2) (ketoconazole was given for 7 days, and a single 50 mg sorafenib dose was administered concomitantly on day 4).  No clin. relevant change in pharmacokinetics of sorafenib and no clin. relevant adverse events or lab. abnormalities were obsd. in this study upon co-administration of the two drugs.  Plasma concns. of the main CYP3A4 generated metabolite, sorafenib N-oxide, decreased considerably upon ketoconazole co-administration.  This effect is in accordance with the in vitro finding that CYP3A4 is the primary enzyme for sorafenib N-oxide formation.  Further, these data indicate that blocking sorafenib metab. by the CYP3A4 pathway will not lead to an increase in sorafenib exposure.  This is consistent with data from a clin. mass-balance study that showed 15% of the administered dose was eliminated by glucuronidation, compared to less than 5% eliminated as oxidative metabolites.  Since there was no increase in sorafenib exposure following concomitant administration of the highly potent CYP3A4 inhibitor ketoconazole with low dose sorafenib, it is postulated that higher therapeutic doses of sorafenib may be safely co-administered with ketoconazole, as well as with other inhibitors of CYP3A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV-01_MtXZH7Vg90H21EOLACvtfcHk0lhjWeQ7Pwy_ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1KktLk%253D&md5=7d13ee0c45f5280fcdaf9d6982339dec</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-0068-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-0068-6%26sid%3Dliteratum%253Aachs%26aulast%3DLathia%26aufirst%3DC.%26aulast%3DLettieri%26aufirst%3DJ.%26aulast%3DCihon%26aufirst%3DF.%26aulast%3DGallentine%26aufirst%3DM.%26aulast%3DRadtke%26aufirst%3DM.%26aulast%3DSundaresan%26aufirst%3DP.%26atitle%3DLack%2520of%2520effect%2520of%2520ketoconazole-mediated%2520CYP3A%2520inhibition%2520on%2520sorafenib%2520clinical%2520pharmacokinetics%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2006%26volume%3D57%26spage%3D685%26epage%3D692%26doi%3D10.1007%2Fs00280-005-0068-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sissung, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federspiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venzon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarchoan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widemann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span> <span> </span><span class="NLM_article-title">Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2099</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-2484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1158%2F1078-0432.CCR-11-2484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22307138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2099-2107&author=C.+J.+Peerauthor=T.+M.+Sissungauthor=A.+Kimauthor=L.+Jainauthor=S.+Wooauthor=E.+R.+Gardnerauthor=C.+T.+Kirklandauthor=S.+M.+Troutmanauthor=B.+C.+Englishauthor=E.+D.+Richardsonauthor=J.+Federspielauthor=D.+Venzonauthor=W.+Dahutauthor=E.+Kohnauthor=S.+Kummarauthor=R.+Yarchoanauthor=G.+Giacconeauthor=B.+Widemannauthor=W.+D.+Figg&title=Sorafenib+is+an+inhibitor+of+UGT1A1+but+is+metabolized+by+UGT1A9%3A+implications+of+genetic+variants+on+pharmacokinetics+and+hyperbilirubinemia&doi=10.1158%2F1078-0432.CCR-11-2484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia</span></div><div class="casAuthors">Peer, Cody J.; Sissung, Tristan M.; Kim, Ae Rang; Jain, Lokesh; Woo, Sukyung; Gardner, Erin R.; Kirkland, C. Tyler; Troutman, Sarah M.; English, Bevin C.; Richardson, Emily D.; Federspiel, Joel; Venzon, David; Dahut, William; Kohn, Elise; Kummar, Shivaani; Yarchoan, Robert; Giaccone, Giuseppe; Widemann, Brigitte; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2099-2107</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Several case reports suggest sorafenib exposure and sorafenib-induced hyperbilirubinemia may be related to a (TA)5/6/7 repeat polymorphism in UGT1A1*28 (UGT, uridine glucuronosyl transferase).  We hypothesized that sorafenib inhibits UGT1A1 and individuals carrying UGT1A1*28 and/or UGT1A9 variants experience greater sorafenib exposure and greater increase in sorafenib-induced plasma bilirubin concn.  Exptl. Design: Inhibition of UGT1A1-mediated bilirubin glucuronidation by sorafenib was assessed in vitro.  UGT1A1*28 and UGT1A9*3 genotypes were ascertained with fragment anal. or direct sequencing in 120 cancer patients receiving sorafenib on five different clin. trials.  Total bilirubin measurements were collected in prostate cancer patients before receiving sorafenib (n = 41) and 19 to 30 days following treatment and were compared with UGT1A1*28 genotype.  RESULTS: Sorafenib exhibited mixed-mode inhibition of UGT1A1-mediated bilirubin glucuronidation (IC50 = 18 μmol/L; Ki = 11.7 μmol/L) in vitro.  Five patients carrying UGT1A1*28/*28 (n = 4) or UGT1A9*3/*3 (n = 1) genotypes had first dose, dose-normalized areas under the sorafenib plasma concn. vs. time curve (AUC) that were in the 93rd percentile, whereas three patients carrying UGT1A1*28/*28 had AUCs in the bottom quartile of all genotyped patients.  The Drug Metabolizing Enzymes and Transporters genotyping platform was applied to DNA obtained from six patients, which revealed the ABCC2-24C>T genotype cosegregated with sorafenib AUC phenotype.  Sorafenib exposure was related to plasma bilirubin increases in patients carrying 1 or 2 copies of UGT1A1*28 alleles (n = 12 and n = 5; R2 = 0.38 and R2 = 0.77; P = 0.032 and P = 0.051, resp.).  UGT1A1*28 carriers showed two distinct phenotypes that could be explained by ABCC2-24C>T genotype and are more likely to experience plasma bilirubin increases following sorafenib if they had high sorafenib exposure.  CONCLUSIONS: This pilot study indicates that genotype status of UGT1A1, UGT1A9, and ABCC2 and serum bilirubin concn. increases reflect abnormally high AUC in patients treated with sorafenib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFsvwIshxcLVg90H21EOLACvtfcHk0lhpSaUcs9GLxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOls7o%253D&md5=896671fb72062ce112c85551b5b33834</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2484%26sid%3Dliteratum%253Aachs%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DSissung%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DL.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DGardner%26aufirst%3DE.%2BR.%26aulast%3DKirkland%26aufirst%3DC.%2BT.%26aulast%3DTroutman%26aufirst%3DS.%2BM.%26aulast%3DEnglish%26aufirst%3DB.%2BC.%26aulast%3DRichardson%26aufirst%3DE.%2BD.%26aulast%3DFederspiel%26aufirst%3DJ.%26aulast%3DVenzon%26aufirst%3DD.%26aulast%3DDahut%26aufirst%3DW.%26aulast%3DKohn%26aufirst%3DE.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DYarchoan%26aufirst%3DR.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DWidemann%26aufirst%3DB.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DSorafenib%2520is%2520an%2520inhibitor%2520of%2520UGT1A1%2520but%2520is%2520metabolized%2520by%2520UGT1A9%253A%2520implications%2520of%2520genetic%2520variants%2520on%2520pharmacokinetics%2520and%2520hyperbilirubinemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D2099%26epage%3D2107%26doi%3D10.1158%2F1078-0432.CCR-11-2484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishnani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.036996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fdmd.110.036996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21123164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVWiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=510-521&author=A.+Ghosalauthor=Y.+Yuanauthor=W.+Tongauthor=A.+D.+Suauthor=C.+Guauthor=S.+K.+Chowdhuryauthor=N.+S.+Kishnaniauthor=K.+B.+Alton&title=Characterization+of+human+liver+enzymes+involved+in+the+biotransformation+of+boceprevir%2C+a+hepatitis+C+virus+protease+inhibitor&doi=10.1124%2Fdmd.110.036996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor</span></div><div class="casAuthors">Ghosal, Anima; Yuan, Yuan; Tong, Wei; Su, Ai-Duen; Gu, Chunyan; Chowdhury, Swapan K.; Kishnani, Narendra S.; Alton, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">510-521</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Boceprevir (SCH 503034), a protease inhibitor, is under clin. development for the treatment of human hepatitis C virus infections.  In human liver microsomes, formation of oxidative metabolites after incubations with [14C]boceprevir was catalyzed by CYP3A4 and CYP3A5.  In addn., the highest turnover was obsd. in recombinant CYP3A4 and CYP3A5.  After a single radiolabeled dose to human, boceprevir was subjected to two distinct pathways, namely cytochrome P 450-mediated oxidn. and ketone redn.  Therefore, attempts were made to identify the enzymes responsible for the formation of carbonyl-reduced metabolites.  Human liver S9 and cytosol converted ∼28 and ∼68% of boceprevir to M28, resp., in the presence of an NADPH-generating system.  Screening of boceprevir with recombinant human aldo-keto reductases (AKRs) revealed that AKR1C2 and AKR1C3 exhibited catalytic activity with respect to the formation of M+2 metabolites (M28 and M31).  The formation of M28 was inhibited by 100 μM flufenamic acid (80.3%), 200 μM mefenamic acid (83.7%), and 100 μM phenolphthalein (86.1%), known inhibitors of AKRs, suggesting its formation through carbonyl redn. pathway.  Formation of M28 was also inhibited by 100 μM diazepam (75.1%), 1 mM ibuprofen (70%), and 200 μM diflunisal (89.4%).  These data demonstrated that CYP3A4 and CYP3A5 are primarily responsible for the formation of oxidative metabolites and the formation of M28 and M31, the keto-reduced metabolites, are most likely mediated by AKR1C2 and AKR1C3.  Because the biotransformation and clearance of boceprevir involves two different enzymic pathways, boceprevir is less likely to be a victim of significant drug-drug interaction with concomitant medication affecting either of these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWIBhV6dK5Z7Vg90H21EOLACvtfcHk0lhpSaUcs9GLxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVWiur0%253D&md5=71b72850630971fe3e274f91172dfa1f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.036996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.036996%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DW.%26aulast%3DSu%26aufirst%3DA.%2BD.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DChowdhury%26aufirst%3DS.%2BK.%26aulast%3DKishnani%26aufirst%3DN.%2BS.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26atitle%3DCharacterization%2520of%2520human%2520liver%2520enzymes%2520involved%2520in%2520the%2520biotransformation%2520of%2520boceprevir%252C%2520a%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D510%26epage%3D521%26doi%3D10.1124%2Fdmd.110.036996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span> </span><span class="NLM_article-title">New drugs-reports of new drugs recently approved by the FDA. Ritonavir</span>.  <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume">5</span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">462</span>.<span class="refDoi"> DOI: 10.1016/S0968-0896(96)00260-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0968-0896%2896%2900260-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9113321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXit1yrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+drugs-reports+of+new+drugs+recently+approved+by+the+FDA.+Ritonavir.+Bioorg.+Med.+Chem.+1997%2C+5%2C+461%E2%80%93462.+10.1016%2FS0968-0896%2896%2900260-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">New drugs - Reports of new drugs recently approved by the FDA: ritonavir</span></div><div class="casAuthors">Ohta, Yukari; Shinkai, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-462</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ritonavir (Norvir, A 84538, or ABT 538) is a peptidomimetic inhibitor of both HIV-1 and HIV-2 proteases.  The concn. of drug that inhibits 50% of viral replication (EC50) ranged from 3.8 to 153 nM depending upon the HIV-1 isolate and the cells employed.  The av. EC50 for low passage clin. isolates was 22 nM.  In a 1090-patient study, 1.2 g of the drug used concomitantly with existing nucleoside therapy, produced a significant decrease in mean viral RNA levels of placebo and an increase in av. change of CD4 count over the first 16 wk.  After seven months the mortality rate was 4.8% for ritonavir patients and 8.4% for placebo.  Ritonavir demonstrated additive effects against HIV-1 in combination with either zidovudine (ZDV) or didanosine (ddI).  Genotypic anal. of HIV-1 isolates with reduced susceptibility to ritonavir showed mutations in the HIV protease gene at amino acid positions 84 (Ile to Val), 82 (Val to Phe), 71 (Ala to Val), and 46 (Met to Ile).  Phenotypic and genotypic changes in HIV isolates from selected patients treated with ritonavir were monitored in phase I/II trials over a period of 3-32 wk.  Mutation appeared to occur in a stepwise and ordered fashion.  The potential for HIV cross-resistance between protease inhibitors has not been fully explored.  The abs. bioavailability of ritonavir has not been detd.  After a 600 mg dose of oral soln., peak concns. of ritonavir were achieved approx. 2 and 4 h after dosing under fasting and nonfasting conditions, resp.  The isopropylthiazole oxidn. metabolite (M-2) is the major metabolite.  Studies utilizing human liver microsome have demonstrated that cytochrome P 450 3A (CYP3A) is the major isoform involved in ritonavir metab., although CYP2D6 also contributes to the formation of M-2.  Agents that increase CYP3A activity would be expected to increase the clearance of ritonavir resulting in decrease of ritonavir plasma concn.  Ritonavir can produce a large increase in plasma concns. of certain highly metabolized drugs.  Ritonavir prevents fast metab. of saquinavir allowing increased blood levels.  Addn. of saquinavir is not expected to accelerate resistance to ritonavir due to the distinct mutation profiles of both drugs.  Norvir capsules are available for oral administration in a strength of 100 mg ritonavir.  Norvir oral soln. is also available for oral administration as 80 mg/mL of ritonavir in a flavored vehicle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-nZFEUWiDMbVg90H21EOLACvtfcHk0litVL8UB06IDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1yrsLs%253D&md5=4522919bc7f11f511eeac80cf8863882</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2896%2900260-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252896%252900260-X%26sid%3Dliteratum%253Aachs%26atitle%3DNew%2520drugs-reports%2520of%2520new%2520drugs%2520recently%2520approved%2520by%2520the%2520FDA.%2520Ritonavir%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1997%26volume%3D5%26spage%3D461%26epage%3D462%26doi%3D10.1016%2FS0968-0896%2896%2900260-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sevrioukova, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span> <span> </span><span class="NLM_article-title">Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">18422</span>– <span class="NLM_lpage">18427</span>, <span class="refDoi"> DOI: 10.1073/pnas.1010693107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1073%2Fpnas.1010693107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20937904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2ktr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=18422-18427&author=I.+F.+Sevrioukovaauthor=T.+L.+Poulos&title=Structure+and+mechanism+of+the+complex+between+cytochrome+P4503A4+and+ritonavir&doi=10.1073%2Fpnas.1010693107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir</span></div><div class="casAuthors">Sevrioukova, Irina F.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">18422-18427, S18422/1-S18422/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ritonavir is a HIV protease inhibitor routinely prescribed to HIV patients that also potently inactivates cytochrome P 4503A4 (CYP3A4), the major human drug-metabolizing enzyme.  By inhibiting CYP3A4, ritonavir increases plasma concns. of other anti-HIV drugs oxidized by CYP3A4 thereby improving clin. efficacy.  Despite the importance and wide use of ritonavir in anti-HIV therapy, the precise mechanism of CYP3A4 inhibition remains unclear.  The available data are inconsistent and suggest that ritonavir acts as a mechanism-based, competitive or mixed competitive-noncompetitive CYP3A4 inactivator.  To resolve this controversy and gain functional and structural insights into the mechanism of CYP3A4 inhibition, we investigated the ritonavir binding reaction by kinetic and equil. anal., elucidated how the drug affects redox properties of the hemoprotein, and detd. the 2.0 Å X-ray structure of the CYP3A4:ritonavir complex.  Our results show that ritonavir is a type II ligand that perfectly fits into the CYP3A4 active site cavity and irreversibly binds to the heme iron via the thiazole nitrogen, which decreases the redox potential of the protein arid precludes its redn. with the redox partner, cytochrome P 450 reductase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmlxyeZQWYLVg90H21EOLACvtfcHk0litVL8UB06IDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2ktr3J&md5=e279ebcfb188677e389807e73a00e1b9</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1010693107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1010693107%26sid%3Dliteratum%253Aachs%26aulast%3DSevrioukova%26aufirst%3DI.%2BF.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520complex%2520between%2520cytochrome%2520P4503A4%2520and%2520ritonavir%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D18422%26epage%3D18427%26doi%3D10.1073%2Fpnas.1010693107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertz, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnichen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latte, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurad, B.</span></span> <span> </span><span class="NLM_article-title">Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis</span>. <i>Clin. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1097/00002826-200603000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1097%2F00002826-200603000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16614540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=80-86&author=C.+Hofmannauthor=U.+Pennerauthor=R.+Dorowauthor=H.+H.+Pertzauthor=S.+Jahnichenauthor=R.+Horowskiauthor=K.+P.+Latteauthor=D.+Pallaauthor=B.+Schurad&title=Lisuride%2C+a+dopamine+receptor+agonist+with+5-HT2B+receptor+antagonist+properties%3A+absence+of+cardiac+valvulopathy+adverse+drug+reaction+reports+supports+the+concept+of+a+crucial+role+for+5-HT2B+receptor+agonism+in+cardiac+valvular+fibrosis&doi=10.1097%2F00002826-200603000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis</span></div><div class="casAuthors">Hofmann, C.; Penner, U.; Dorow, R.; Pertz, H. H.; Jaehnichen, S.; Horowski, R.; Latte, K. P.; Palla, D.; Schurad, B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Neuropharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">80-86</span>CODEN:
                <span class="NLM_cas:coden">CLNEDB</span>;
        ISSN:<span class="NLM_cas:issn">0362-5664</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Objectives: The high incidence of fibrotic cardiac valvulopathies reported in assocn. with the 8β-ergoline dopamine (DA) agonist, pergolide, and also case reports for cabergoline and bromocriptine have made it necessary to review the theor. basis and actual findings in the case of another DA agonist, the 8α-ergoline lisuride (used since the 1970s for migraine prophylaxis as well as since the 1980s for its prolactin-lowering and anti-Parkinson activity).  Methods: We have reviewed the pharmacol. of lisuride in relation to other DA agonists, and we have performed a throughout literature search as well as a search of our own and other adverse drug reaction databases for a possible relationship of lisuride with cardiac valvulopathy or for any reports of fibrosis in other locations.  Results: Our review of the pharmacol. and the literature strongly suggests that drug-induced cardiac valvulopathies are always related to a stimulatory drug effect on trophic 5-HT2B receptors.  As lisuride is devoid of such an effect, but on the contrary is an extremely potent 5-HT2B antagonist, an assocn. of lisuride therapy with cardiac valvulopathies seems to be highly unlikely.  In agreement with this hypothesis, not a single report of a cardiac valvulopathy assocd. with lisuride therapy has been identified in any database so far.Furthermore, against a background of an estd. 360,000 patient years, we have found only a very small no. of cases of any other form of fibrosis (1× retroperitoneal, 2× pleural, 2× pulmonary, 1× interstitial pulmonary changes), in part combined with other risk factors and confounding variables.  This closely matches 4 reports available from WHO (1× retroperitoneal, 3× pleural fibrosis).  In addn., only 5 other possibly related conditions (3× pleural effusion, 1× pleuritis, 1× pericarditis) were identified in the lisuride adverse drug reaction database of Schering, Berlin.  Conclusions: No link has been found between lisuride use and fibrotic cardiac valvulopathy, in agreement with the 5-HT2B receptor antagonist effect of this drug.  The very low incidence of spontaneous reports of any other fibrosis could be even compatible with an assocn. by chance in the population exposed to lisuride.  Although close monitoring for this kind of side effects is still to be recommended in the therapy with lisuride, our data do not support the concept of a class effect suggesting that all ergot-derived drugs and esp. DA receptor agonists with some chem. similarity to the ergot structure will cause or facilitate cardiac valvulopathies as obsd. with pergolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO6Rsrw9jtzLVg90H21EOLACvtfcHk0litVL8UB06IDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVersr4%253D&md5=a12de38613de4f88bf099762849ef0df</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1097%2F00002826-200603000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002826-200603000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DC.%26aulast%3DPenner%26aufirst%3DU.%26aulast%3DDorow%26aufirst%3DR.%26aulast%3DPertz%26aufirst%3DH.%2BH.%26aulast%3DJahnichen%26aufirst%3DS.%26aulast%3DHorowski%26aufirst%3DR.%26aulast%3DLatte%26aufirst%3DK.%2BP.%26aulast%3DPalla%26aufirst%3DD.%26aulast%3DSchurad%26aufirst%3DB.%26atitle%3DLisuride%252C%2520a%2520dopamine%2520receptor%2520agonist%2520with%25205-HT2B%2520receptor%2520antagonist%2520properties%253A%2520absence%2520of%2520cardiac%2520valvulopathy%2520adverse%2520drug%2520reaction%2520reports%2520supports%2520the%2520concept%2520of%2520a%2520crucial%2520role%2520for%25205-HT2B%2520receptor%2520agonism%2520in%2520cardiac%2520valvular%2520fibrosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2006%26volume%3D29%26spage%3D80%26epage%3D86%26doi%3D10.1097%2F00002826-200603000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humpel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommerenke, G.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1007/BF03189685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2FBF03189685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=6532807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaL2M7nvFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1984&pages=347-357&author=M.+Humpelauthor=W.+Krauseauthor=G.+A.+Hoyerauthor=H.+Wendtauthor=G.+Pommerenke&title=The+pharmacokinetics+and+biotransformation+of+14C-lisuride+hydrogen+maleate+in+rhesus+monkey+and+in+man&doi=10.1007%2FBF03189685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man</span></div><div class="casAuthors">Humpel M; Krause W; Hoyer G A; Wendt H; Pommerenke G</div><div class="citationInfo"><span class="NLM_cas:title">European journal of drug metabolism and pharmacokinetics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-57</span>
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    </div><div class="casAbstract">14C-labelled lisuride hydrogen maleate was administered intravenously (25 micrograms) and orally (200 micrograms) to three male and three female elderly volunteers.  Following i.v. injection radioimmunologically determined plasma levels of unchanged lisuride showed a three-phasic decline with half-lives of 3 minutes, 16 minutes and 2.9 hours.  The total clearance was 16 +/- 9 ml/min/kg.  Bioavailability was estimated to be 14% of oral dose.  Determination of 14C-radioactivity did not show any specific enrichment of lisuride metabolites in cellular components of blood.  The drug was almost totally metabolized and its degradation products were eliminated equally via the kidney and liver.  Total recovery was about 90% of dose.  The elimination half-life was 10 hours.  Small parts of the dose administered were renally excreted with a half-life of 23 hours.  Lisuride is metabolized extensively.  HPLC radiochromatograms of freely extractable metabolites from urine did not show marked differences between both routes of administration.  More than 15 compounds were freely extractable, only one of them represented more than 5% of dose.  Phase II reactions were quantitatively unimportant.  From rhesus monkey urine 6 metabolites were isolated.  Chemical structures were proposed for 5 of them.  They were assigned to the pattern of freely extractable human urinary metabolites and covered about 50% of radiolabel corresponding to about 13% of dose.  The main freely extractable urinary metabolite was thought to be the 2-keto-3-hydroxy-lisuride derivative.  Structures of the other four metabolites and earlier observations on the stability of the N'-ethyl-3H label led to the interpretation of independent changes of lisuride by different enzymatic processes such as oxidative N-deethylation, hydroxylation of the benzene system, monooxygenation at C2 and C9, and oxidation of double bonds at C2/C3 and C9/C10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTakQ8dVGXEZmxpATR2EQURfW6udTcc2eaxGOUiClPd5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7nvFKisw%253D%253D&md5=e73cc4aeab00fe072a6f1ab84dfd936d</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2FBF03189685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03189685%26sid%3Dliteratum%253Aachs%26aulast%3DHumpel%26aufirst%3DM.%26aulast%3DKrause%26aufirst%3DW.%26aulast%3DHoyer%26aufirst%3DG.%2BA.%26aulast%3DWendt%26aufirst%3DH.%26aulast%3DPommerenke%26aufirst%3DG.%26atitle%3DThe%2520pharmacokinetics%2520and%2520biotransformation%2520of%252014C-lisuride%2520hydrogen%2520maleate%2520in%2520rhesus%2520monkey%2520and%2520in%2520man%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1984%26volume%3D9%26spage%3D347%26epage%3D357%26doi%3D10.1007%2FBF03189685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agai-Csongor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domany, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogradi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galambos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vago, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlovszky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vastag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tihanyi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyertyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zajer-Balazs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemesi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szombathelyi, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3437</span>– <span class="NLM_lpage">3440</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.03.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2012.03.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22537450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFeksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3437-3440&author=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Nogradiauthor=J.+Galambosauthor=I.+Vagoauthor=G.+M.+Keseruauthor=I.+Greinerauthor=I.+Laszlovszkyauthor=A.+Gereauthor=E.+Schmidtauthor=B.+Kissauthor=M.+Vastagauthor=K.+Tihanyiauthor=K.+Saghyauthor=J.+Laszyauthor=I.+Gyertyanauthor=M.+Zajer-Balazsauthor=L.+Gemesiauthor=M.+Kapasauthor=Z.+Szombathelyi&title=Discovery+of+cariprazine+%28RGH-188%29%3A+a+novel+antipsychotic+acting+on+dopamine+D3%2FD2+receptors&doi=10.1016%2Fj.bmcl.2012.03.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors</span></div><div class="casAuthors">Agai-Csongor, Eva; Domany, Gyorgy; Nogradi, Katalin; Galambos, Janos; Vago, Istvan; Keseru, Gyorgy Miklos; Greiner, Istvan; Laszlovszky, Istvan; Gere, Aniko; Schmidt, Eva; Kiss, Bela; Vastag, Monika; Tihanyi, Karoly; Saghy, Katalin; Laszy, Judit; Gyertyan, Istvan; Zajer-Balazs, Maria; Gemesi, Larisza; Kapas, Margit; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3437-3440</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Medicinal chem. optimization of an impurity isolated during the scale-up synthesis of a pyridylsulfonamide type dopamine D3/D2 compd. (1, I) led to a series of new piperazine derivs. having affinity to both dopamine D3 and D2 receptors.  Several members of this group showed excellent pharmacokinetic and pharmacodynamic properties as demonstrated by outstanding activities in different antipsychotic tests.  The most promising representative, 2m (cariprazine) had good absorption, excellent brain penetration and advantageous safety profile.  Based on its successful clin. development we are looking forward to the NDA filing of cariprazine in 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgEXo42Fb5i7Vg90H21EOLACvtfcHk0lgJsJI_y9xVpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFeksLY%253D&md5=c70cd98791c4d5c2da5ac1f3904a8b98</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.104%26sid%3Dliteratum%253Aachs%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DNogradi%26aufirst%3DK.%26aulast%3DGalambos%26aufirst%3DJ.%26aulast%3DVago%26aufirst%3DI.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DGreiner%26aufirst%3DI.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DGere%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DVastag%26aufirst%3DM.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DSaghy%26aufirst%3DK.%26aulast%3DLaszy%26aufirst%3DJ.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DZajer-Balazs%26aufirst%3DM.%26aulast%3DGemesi%26aufirst%3DL.%26aulast%3DKapas%26aufirst%3DM.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520cariprazine%2520%2528RGH-188%2529%253A%2520a%2520novel%2520antipsychotic%2520acting%2520on%2520dopamine%2520D3%252FD2%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3437%26epage%3D3440%26doi%3D10.1016%2Fj.bmcl.2012.03.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemethy, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlovszky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugovics, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazekas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornok, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orosz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyertyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agai-Csongor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domany, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tihanyi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adham, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szombathelyi, Z.</span></span> <span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.160432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horvathauthor=Z.+Nemethyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyertyanauthor=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+dopamine+D%283%29+receptor-preferring%2C+D%283%29%2FD%282%29+dopamine+receptor+antagonist-partial+agonist+antipsychotic+candidate%3A+in+vitro+and+neurochemical+profile&doi=10.1124%2Fjpet.109.160432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0ljfwuYI2Ok0_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DNemethy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520dopamine%2520D%25283%2529%2520receptor-preferring%252C%2520D%25283%2529%252FD%25282%2529%2520dopamine%2520receptor%2520antagonist-partial%2520agonist%2520antipsychotic%2520candidate%253A%2520in%2520vitro%2520and%2520neurochemical%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340%26doi%3D10.1124%2Fjpet.109.160432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Invernizzi, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasina, L.</span></span> <span> </span><span class="NLM_article-title">A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia</span>. <i>Ther. Clin. Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.2147/TCRM.S35137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2147%2FTCRM.S35137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23966785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGjtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=319-328&author=S.+Cacciaauthor=R.+W.+Invernizziauthor=A.+Nobiliauthor=L.+Pasina&title=A+new+generation+of+antipsychotics%3A+pharmacology+and+clinical+utility+of+cariprazine+in+schizophrenia&doi=10.2147%2FTCRM.S35137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia</span></div><div class="casAuthors">Caccia, Silvio; Invernizzi, Roberto William; Nobili, Alessandro; Pasina, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">319-328</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1178-203X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Cariprazine is a potential antipsychotic awaiting approval from the US Food and Drug Administration.  It is a dopamine D2- and D3-receptor partial agonist, with higher affinity for D3 receptors, as opposed to the D2 antagonism of most older antipsychotic agents.  Like most lipophilic antipsychotics, it undergoes extensive hepatic metab. by cytochrome P 450 (CYP), mainly the highly variable 3A4, with the formation of active metabolites.  However, the parent compd. - particularly its active didesmethyl deriv. - is cleared very slowly, with elimination half-lives in schizophrenic patients ranging from 2-5 days for cariprazine to 2-3 wk for didesmethyl-cariprazine.  Exposure to the latter was several times that for cariprazine, although didesmethyl-cariprazine did not reach steady state within the 3 wk of 12.5 mg/day dosing.  Preliminary information on its therapeutic role comes from press releases and a few abstrs. presented at scientific meetings.  In short-term controlled trials, it was more effective than placebo in reducing pos. and neg. symptoms of schizophrenia, with an ED range of 1.5-12 mg/day.  Although cariprazine was assocd. with a higher incidence of akathisia and extrapyramidal side effects than placebo, it did not cause wt. gain, metabolic abnormalities, prolactin increase or cor. QT prolongation.  Similarly, cariprazine's efficacy and tolerability for the treatment of bipolar disorder (manic/mixed and depressive episodes) was established in the dose range of 3-12 mg/day, although again no long-term data are available.  Well-designed clin. trials, mainly direct "head-to-head" comparisons with other second-generation antipsychotic agents, are needed to define the therapeutic role and safety profile of cariprazine in schizophrenia and bipolar mania.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskxYb8cxgErVg90H21EOLACvtfcHk0ljfwuYI2Ok0_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGjtb%252FM&md5=0f8ad133c73e50a93dd99bdb40f4124f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.2147%2FTCRM.S35137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FTCRM.S35137%26sid%3Dliteratum%253Aachs%26aulast%3DCaccia%26aufirst%3DS.%26aulast%3DInvernizzi%26aufirst%3DR.%2BW.%26aulast%3DNobili%26aufirst%3DA.%26aulast%3DPasina%26aufirst%3DL.%26atitle%3DA%2520new%2520generation%2520of%2520antipsychotics%253A%2520pharmacology%2520and%2520clinical%2520utility%2520of%2520cariprazine%2520in%2520schizophrenia%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2013%26volume%3D9%26spage%3D319%26epage%3D328%26doi%3D10.2147%2FTCRM.S35137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Citrome, L.</span></span> <span> </span><span class="NLM_article-title">Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1517/17425255.2013.759211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1517%2F17425255.2013.759211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23320989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=193-206&author=L.+Citrome&title=Cariprazine%3A+chemistry%2C+pharmacodynamics%2C+pharmacokinetics%2C+and+metabolism%2C+clinical+efficacy%2C+safety%2C+and+tolerability&doi=10.1517%2F17425255.2013.759211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability</span></div><div class="casAuthors">Citrome, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-206</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: is an atypical antipsychotic in clin. development for the treatment of schizophrenia and bipolar mania/mixed episodes.Areas covered: The purpose of this review is to describe the chem., pharmacodynamic profile, pharmacokinetics, and clin. profile of cariprazine.Expert opinion: Cariprazine is a dopamine D3-preferring D3/D2 receptor partial agonist.  Doses ≥ 1.5 mg/d yielded 69 - 75% D2/D3 receptor occupancy as measured in positron emission tomog. scans.  Mean half-life for cariprazine was 2 - 5 d over a dose range of 1.5 - 12.5 mg.  Cariprazine produces two clin. relevant metabolites: desmethyl-cariprazine and didesmethyl-cariprazine, the latter having a longer half-life than cariprazine.  Exposure to didesmethyl-cariprazine exceeded that of the parent drug.  Cariprazine is metabolized by CYP3A4 and to a lesser extent by CYP2D6.  The efficacy and safety of cariprazine have been so far investigated only in a few short-term (unpublished) clin. trials; however, three studies in schizophrenia and three studies in bipolar mania/mixed episodes evidenced a statistically significant therapeutic effect compared to placebo for cariprazine at doses ranging from 1.5 to 12 mg/d.  There does not appear to be clin. relevant adverse effects of cariprazine on metabolic variables.  Commonly encountered adverse events assocd. with cariprazine include insomnia, extrapyramidal symptoms, akathisia, sedation, nausea, dizziness, and constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWppq7db6U-7Vg90H21EOLACvtfcHk0lirAG6lvKkAWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt7c%253D&md5=1614e35696a45f228020448bd0698e0b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.759211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.759211%26sid%3Dliteratum%253Aachs%26aulast%3DCitrome%26aufirst%3DL.%26atitle%3DCariprazine%253A%2520chemistry%252C%2520pharmacodynamics%252C%2520pharmacokinetics%252C%2520and%2520metabolism%252C%2520clinical%2520efficacy%252C%2520safety%252C%2520and%2520tolerability%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26spage%3D193%26epage%3D206%26doi%3D10.1517%2F17425255.2013.759211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodick, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibensperger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assaid, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lines, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winner, P. K.</span></span> <span> </span><span class="NLM_article-title">Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">2115</span>– <span class="NLM_lpage">2123</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(08)61626-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0140-6736%2808%2961626-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19036425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Ojtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=2115-2123&author=T.+W.+Hoauthor=M.+D.+Ferrariauthor=D.+W.+Dodickauthor=V.+Galetauthor=J.+Kostauthor=X.+Fanauthor=H.+Leibenspergerauthor=S.+Fromanauthor=C.+Assaidauthor=C.+Linesauthor=H.+Koppenauthor=P.+K.+Winner&title=Efficacy+and+tolerability+of+MK-0974+%28telcagepant%29%2C+a+new+oral+antagonist+of+calcitonin+gene-related+peptide+receptor%2C+compared+with+zolmitriptan+for+acute+migraine%3A+a+randomised%2C+placebo-controlled%2C+parallel-treatment+trial&doi=10.1016%2FS0140-6736%2808%2961626-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial</span></div><div class="casAuthors">Ho Tony W; Ferrari Michel D; Dodick David W; Galet Vince; Kost James; Fan Xiaoyin; Leibensperger Heather; Froman Samar; Assaid Christopher; Lines Christopher; Koppen Hille; Winner Paul K</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9656</span>),
    <span class="NLM_cas:pages">2115-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Calcitonin gene-related peptide (CGRP) probably has a role in migraine pathophysiology, and antagonism of its receptors might provide treatment without the vasoconstrictor effects of triptans.  We aimed to assess the clinical profile of MK-0974 (telcagepant), an orally bioavailable antagonist of CGRP receptor.  METHODS:  In a randomised, parallel-treatment, placebo-controlled, double-blind, trial at 81 sites in the Europe and the USA, adults with migraine diagnosed by International Headache Society criteria treated moderate or severe attacks with either oral telcagepant 150 mg or 300 mg, zolmitriptan 5 mg, or placebo.  The five co-primary endpoints were pain freedom, pain relief, or absence of photophobia, phonophobia, or nausea at 2 h after treatment.  Analysis was by the full analysis set and multiplicity was controlled for with a step-down closed-testing procedure.  This trial is registered with ClinicalTrials.gov, number NCT00442936.  FINDINGS:  1380 patients were randomly assigned to receive telcagepant 150 mg (n=333) or 300 mg (354), zolmitriptan (345), or placebo (348).  Telcagepant 300 mg was more effective than placebo for pain freedom (95 [27%] of 353 patients vs 33 [10%] of 343 [p<0.0001]), pain relief (194 [55%] of 353 vs 95 [28%] of 343 [p<0.0001]), and absences of phonophobia (204 [58%] of 353 vs 126 [37%] of 342 [p<0.0001]), photophobia (180 [51%] of 353 vs 99 [29%] of 342 [p<0.0001]), and nausea (229 [65%] of 352 vs 189 [55%] of 342 [p=0.0061]).  Efficacy of telcagepant 300 mg and zolmitriptan 5 mg were much the same, and both were more effective than telcagepant 150 mg.  Adverse events were recorded for 31% taking telcagepant 150 mg, 37% taking telcagepant 300 mg, 51% taking zolmitriptan 5 mg, and 32% taking placebo.  INTERPRETATION:  Telcagepant 300 mg is effective as an acute treatment for migraine with efficacy comparable to that of zolmitriptan 5 mg, but with fewer associated adverse effects.  FUNDING:  Merck Research Laboratories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKtuWEUmAWlc-crCu0nI_sfW6udTcc2eaMZEeVTxfvHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Ojtw%253D%253D&md5=48be09dccd58a3a37069d88f5f8142f8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2808%2961626-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252808%252961626-8%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DT.%2BW.%26aulast%3DFerrari%26aufirst%3DM.%2BD.%26aulast%3DDodick%26aufirst%3DD.%2BW.%26aulast%3DGalet%26aufirst%3DV.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DLeibensperger%26aufirst%3DH.%26aulast%3DFroman%26aufirst%3DS.%26aulast%3DAssaid%26aufirst%3DC.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DKoppen%26aufirst%3DH.%26aulast%3DWinner%26aufirst%3DP.%2BK.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520MK-0974%2520%2528telcagepant%2529%252C%2520a%2520new%2520oral%2520antagonist%2520of%2520calcitonin%2520gene-related%2520peptide%2520receptor%252C%2520compared%2520with%2520zolmitriptan%2520for%2520acute%2520migraine%253A%2520a%2520randomised%252C%2520placebo-controlled%252C%2520parallel-treatment%2520trial%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D2115%26epage%3D2123%26doi%3D10.1016%2FS0140-6736%2808%2961626-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearlman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppenhaver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lines, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvinsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goadsby, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000000771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1212%2FWNL.0000000000000771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25107879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFert7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=958-966&author=T.+W.+Hoauthor=K.+M.+Connorauthor=Y.+Zhangauthor=E.+Pearlmanauthor=J.+Koppenhaverauthor=X.+Fanauthor=C.+Linesauthor=L.+Edvinssonauthor=P.+J.+Goadsbyauthor=D.+Michelson&title=Randomized+controlled+trial+of+the+CGRP+receptor+antagonist+telcagepant+for+migraine+prevention&doi=10.1212%2FWNL.0000000000000771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention</span></div><div class="casAuthors">Ho, Tony W.; Connor, Kathryn M.; Zhang, Ying; Pearlman, Eric; Koppenhaver, Janelle; Fan, Xiaoyin; Lines, Christopher; Edvinsson, Lars; Goadsby, Peter J.; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">958-966</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To evaluate whether the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant might be effective for migraine prevention.  Methods: In this randomized, double-blind, placebo-controlled, multicenter trial (ClinicalTrials.gov NCT00797667), patients experiencing 3-14 migraine days during a 4-wk baseline were randomized to telcagepant 140 mg, telcagepant 280 mg, or placebo twice daily for 12 wk.  Efficacy was assessed by mean monthly headache days and migraine/probable migraine days (headache plus ≥1 assocd. symptom).  Results: The trial was terminated following a recommendation from the Safety Monitoring Board due to hepatotoxicity concerns.  At termination, the planned 660 patients had been randomized, 656 had been treated with ≥1 dose of study medication, and 14 had completed the trial.  The mean treatment duration was 48-50 days.  Thirteen patients, all in the telcagepant groups, had an alanine aminotransferase (ALT) elevation ≥3× the upper limit of normal and 7 of these also had an aspartate aminotransferase elevation ≥3× the upper limit of normal.  Two patients had very high symptomatic transaminase elevations that occurred within 2-6 wk of treatment initiation and resolved after treatment discontinuation.  The originally planned efficacy anal. over 12 wk was not performed due to limited data at later time points, but there was evidence that telcagepant resulted in a larger redn. from baseline than placebo for mean monthly headache days (month 1: 140 mg = -2.9, 280 mg = -3.1, placebo = -1.7; p < 0.05) and migraine/probable migraine days (month 1: 140 mg = -2.7, 280 mg = -3.0, placebo = -1.6; p < 0.05).  Conclusions: These data suggest a potential role for CGRP receptor antagonism in migraine prophylaxis.  However, the obsd. aminotransferase elevations do not support the use of telcagepant for daily administration.  Classification of evidence: This study provides Class II evidence that in patients with migraine, telcagepant taken daily reduces headache days by 1.4 days per mo compared to placebo and causes 2.5% of patients to have elevations of serum ALT levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNEH1T2nja2bVg90H21EOLACvtfcHk0lh2L2DPWbkv7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFert7bJ&md5=66d4abf9a3373373a1f18c3bd56487f5</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000000771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000000771%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DT.%2BW.%26aulast%3DConnor%26aufirst%3DK.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPearlman%26aufirst%3DE.%26aulast%3DKoppenhaver%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DEdvinsson%26aufirst%3DL.%26aulast%3DGoadsby%26aufirst%3DP.%2BJ.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520controlled%2520trial%2520of%2520the%2520CGRP%2520receptor%2520antagonist%2520telcagepant%2520for%2520migraine%2520prevention%26jtitle%3DNeurology%26date%3D2014%26volume%3D83%26spage%3D958%26epage%3D966%26doi%3D10.1212%2FWNL.0000000000000771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laspina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Stein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prueksaritanont, T.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1080/00498250802546861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F00498250802546861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19219746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=33-45&author=S.+Rollerauthor=D.+Cuiauthor=C.+Laspinaauthor=C.+Miller-Steinauthor=J.+Roweauthor=B.+Wongauthor=T.+Prueksaritanont&title=Preclinical+pharmacokinetics+of+MK-0974%2C+an+orally+active+calcitonin-gene+related+peptide+%28CGRP%29-receptor+antagonist%2C+mechanism+of+dose+dependency+and+species+differences&doi=10.1080%2F00498250802546861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span></div><div class="casAuthors">Roller, S.; Cui, D.; Laspina, C.; Miller-Stein, C.; Rowe, J.; Wong, B.; Prueksaritanont, T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The underlying mechanism for low oral bioavailability of MK-0974, a potent calcitonin-gene related peptide (CGRP)-receptor antagonist, in monkeys and for species-dependent non-linear pharmacokinetics in monkeys and rats were investigated.  In monkeys, MK-0974 displayed moderate clearance (14-20 mL min-1 kg-1), while oral bioavailability was 6%.  The pharmacokinetics of MK-0974 remained linear across 0.5-10 mg kg-1 i.v. dose in monkeys, but the oral area under the blood plasma concn.-time curve (AUC) increase (5-30 mg kg-1) was 15-fold over dose-proportional.  Based on a comparison of AUC following hepatic portal vein administration and cephalic vein infusion, MK-0974 exhibited a low-to-moderate hepatic extn. ratio (36%) in monkeys.  Following oral dose of [14C]MK-0974 to monkeys, the hepatic portal AUC ratio of MK-0974 vs. total radioactivity was 0.32, and the total radioactivity recovered in bile and urine was 45-83%.  MK-0974 undergoes significant oxidative metab. (cytochrome P 450 (CYP) 3A) in monkey intestinal microsomes.  In contrast, oral AUC of MK-0974 in rats was near dose-proportional (15-100 mg kg-1).  Following oral administration of [14C]MK-0974 to rats, the hepatic portal AUC ratio of MK-0974 to total radioactivity (0.67) was higher than in monkeys.  Addnl., the metabolic rate of MK-0974 was slower in rat than in monkey intestinal microsomes.  Collectively, intestinal 1st-pass metab. played a significant role in the low oral bioavailability in monkeys and contributed to the species-dependent non-linear oral pharmacokinetics in rats and monkeys of MK-0974.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSGwTRkl7ECrVg90H21EOLACvtfcHk0lh2L2DPWbkv7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D&md5=4b3039fc4abdf2cfca46a7e0f1fceb53</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1080%2F00498250802546861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250802546861%26sid%3Dliteratum%253Aachs%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DLaspina%26aufirst%3DC.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DRowe%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26atitle%3DPreclinical%2520pharmacokinetics%2520of%2520MK-0974%252C%2520an%2520orally%2520active%2520calcitonin-gene%2520related%2520peptide%2520%2528CGRP%2529-receptor%2520antagonist%252C%2520mechanism%2520of%2520dose%2520dependency%2520and%2520species%2520differences%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26spage%3D33%26epage%3D45%26doi%3D10.1080%2F00498250802546861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters-Golden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, W. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Leukotrienes</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.1056/NEJMra071371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1056%2FNEJMra071371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17978293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=1841-1854&author=M.+Peters-Goldenauthor=W.+R.+Henderson&title=Leukotrienes&doi=10.1056%2FNEJMra071371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotrienes</span></div><div class="casAuthors">Peters-Golden, Marc; Henderson, William R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1841-1854</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Leukotrienes comprise a family of products of the 5-lipoxygenase pathway of arachidonic acid metab.  The cysteinyl leukotrienes C4, D4, and E4 account for the biol. activity that was previously termed "slow-reacting substance of anaphylaxis", and the efficacy of antagonists to type 1 cysteinyl leukotriene receptor (CysLT1) in asthma validates the importance of cysteinyl leukotrienes and CysLT1 in this disease.  Here, the authors discuss: synthesis of leukotrienes; leukotriene receptors; blockade of leukotriene synthesis and leukotriene receptors; leukotrienes in disease; and leukotrienes in antimicrobial defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjehKHMPz2p7Vg90H21EOLACvtfcHk0lgokX-FI_BlQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM&md5=4e617e65cf4b1f55f595bc03344fdb55</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1056%2FNEJMra071371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra071371%26sid%3Dliteratum%253Aachs%26aulast%3DPeters-Golden%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DW.%2BR.%26atitle%3DLeukotrienes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D1841%26epage%3D1854%26doi%3D10.1056%2FNEJMra071371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeberle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bramanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautebin, L.</span></span> <span> </span><span class="NLM_article-title">The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00930.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1111%2Fj.1476-5381.2010.00930.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20880396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kju73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=555-570&author=A.+Rossiauthor=C.+Pergolaauthor=A.+Koeberleauthor=M.+Hoffmannauthor=F.+Dehmauthor=P.+Bramantiauthor=S.+Cuzzocreaauthor=O.+Werzauthor=L.+Sautebin&title=The+5-lipoxygenase+inhibitor%2C+zileuton%2C+suppresses+prostaglandin+biosynthesis+by+inhibition+of+arachidonic+acid+release+in+macrophages&doi=10.1111%2Fj.1476-5381.2010.00930.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages</span></div><div class="casAuthors">Rossi, A.; Pergola, C.; Koeberle, A.; Hoffmann, M.; Dehm, F.; Bramanti, P.; Cuzzocrea, S.; Werz, O.; Sautebin, L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">555-570</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Zileuton is the only 5-lipoxygenase (5-LOX) inhibitor marketed as a treatment for asthma, and is often utilized as a selective tool to evaluate the role of 5-LOX and leukotrienes.  The aim of this study was to investigate the effect of zileuton on prostaglandin (PG) prodn. in vitro and in vivo.  Peritoneal macrophages activated with lipopolysaccharide (LPS)/interferon γ (LPS/IFNγ), J774 macrophages and human whole blood stimulated with LPS were used as in vitro models and rat carrageenan-induced pleurisy as an in vivo model.  Zileuton suppressed PG biosynthesis by interference with arachidonic acid (AA) release in macrophages.  We found that zileuton significantly reduced PGE2 and 6-keto prostaglandin F1α (PGF1α) levels in activated mouse peritoneal macrophages and in J774 macrophages.  This effect was not related to 5-LOX inhibition, because it was also obsd. in macrophages from 5-LOX knockout mice.  Notably, zileuton inhibited PGE2 prodn. in LPS-stimulated human whole blood and suppressed PGE2 and 6-keto PGF1α pleural levels in rat carrageenan-induced pleurisy.  Interestingly, zileuton failed to inhibit the activity of microsomal PGE2 synthase1 and of cyclooxygenase (COX)-2 and did not affect COX-2 expression.  However, zileuton significantly decreased AA release in macrophages accompanied by inhibition of phospholipase A2 translocation to cellular membranes.  Zileuton inhibited PG prodn. by interfering at the level of AA release.  Its mechanism of action, as well as its use as a pharmacol. tool, in exptl. models of inflammation should be reassessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpReUkH6DqnSrVg90H21EOLACvtfcHk0lgokX-FI_BlQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kju73I&md5=2897ff2b1c5f6c13bec864e0ba210ff6</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00930.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00930.x%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DPergola%26aufirst%3DC.%26aulast%3DKoeberle%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DDehm%26aufirst%3DF.%26aulast%3DBramanti%26aufirst%3DP.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DSautebin%26aufirst%3DL.%26atitle%3DThe%25205-lipoxygenase%2520inhibitor%252C%2520zileuton%252C%2520suppresses%2520prostaglandin%2520biosynthesis%2520by%2520inhibition%2520of%2520arachidonic%2520acid%2520release%2520in%2520macrophages%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D555%26epage%3D570%26doi%3D10.1111%2Fj.1476-5381.2010.00930.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Machinist, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulka, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, B. A.</span></span> <span> </span><span class="NLM_article-title">In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">Suppl 2</span>),  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.2165/00003088-199500292-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2165%2F00003088-199500292-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8620669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XnsVSguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1995&pages=34-41&issue=Suppl+2&author=J.+M.+Machinistauthor=M.+J.+Kukulkaauthor=B.+A.+Bopp&title=In+vitro+plasma+protein+binding+of+zileuton+and+its+N-dehydroxylated+metabolite&doi=10.2165%2F00003088-199500292-00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite</span></div><div class="casAuthors">Machinist, Joseph M.; Kukulka, Michael J.; Bopp, Barbara A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis</span>)
        </div><div class="casAbstract">An ultrafiltration technique or equil. dialysis has been used to study the in vitro human plasma protein binding of racemic zileuton, its individual enantiomers, and its pharmacol. inactive metabolite N-dehydroxyzileuton.  The plasma protein binding of zileuton and N-dehydroxyzileuton over the concn. range of 0.1 to 100 mg/L averaged 93.1 ± 0.22 and 92.0 ± 0.12%, resp.  However, there appeared to be a stereoselective effect, with the R(+) enantiomer of zileuton demonstrating greater binding to plasma proteins than the S(-) enantiomer (96 vs 88%, resp.).  Zileuton was bound to both human serum albumin (40 g/L) and α1-acid glycoprotein (1 g/L), although binding affinity to albumin was approx. 3-fold greater.  Displacement interactions of zileuton with warfarin, salicylate, theophylline, naproxen, ibuprofen, prednisone, and terfenadine were minimal.  The blood to plasma concn. ratio for zileuton and N-dehydroxyzileuton ranged from 0.65 to 0.68, indicating that these compds. were mainly distributed in the plasma.  Thus, zileuton is approx. 93% bound to plasma proteins at expected therapeutic concns. in vitro, and this figure is largely unaffected by several commonly prescribed agents with which the drug may be coadministered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOdIGeCC8EI7Vg90H21EOLACvtfcHk0litxMdWiLm-Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsVSguw%253D%253D&md5=fcde7d7485075ba79f9c34efca05c3ee</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.2165%2F00003088-199500292-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199500292-00006%26sid%3Dliteratum%253Aachs%26aulast%3DMachinist%26aufirst%3DJ.%2BM.%26aulast%3DKukulka%26aufirst%3DM.%2BJ.%26aulast%3DBopp%26aufirst%3DB.%2BA.%26atitle%3DIn%2520vitro%2520plasma%2520protein%2520binding%2520of%2520zileuton%2520and%2520its%2520N-dehydroxylated%2520metabolite%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1995%26volume%3D29%26issue%3DSuppl%25202%26spage%3D34%26epage%3D41%26doi%3D10.2165%2F00003088-199500292-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J. A.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator</span>. <i>Am. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">683</span>, <span class="refDoi"> DOI: 10.1016/0002-8703(91)90445-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2F0002-8703%2891%2990445-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1671187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1Wgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1991&pages=677-683&author=M.+H.+Perroneauthor=J.+A.+Barrett&title=Preclinical+pharmacology+of+celiprolol%3A+a+cardioselective+beta-adrenergic+antagonist+and+mild+vasodilator&doi=10.1016%2F0002-8703%2891%2990445-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of celiprolol:  a cardioselective β-adrenergic antagonist and mild vasodilator</span></div><div class="casAuthors">Perrone, Mark H.; Barrett, John A.</div><div class="citationInfo"><span class="NLM_cas:title">American Heart Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">677-83</span>CODEN:
                <span class="NLM_cas:coden">AHJOA2</span>;
        ISSN:<span class="NLM_cas:issn">0002-8703</span>.
    </div><div class="casAbstract">A review with 13 refs.  Celiprolol is a new antihypertensive agent that represents a new generation of β-blockers.  Celiprolol distinguishes itself from other β-blockers by virtue of its cardioselectivity, vasorelaxation via β2-agonism, and the lack of bronchoconstriction and cardiodepression.  These properties obsd. in animal studies have also been documented in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIlnKMgXsLo7Vg90H21EOLACvtfcHk0litxMdWiLm-Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1Wgu7k%253D&md5=3715722498270b8d6b06a42560755daa</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0002-8703%2891%2990445-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-8703%252891%252990445-N%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DM.%2BH.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26atitle%3DPreclinical%2520pharmacology%2520of%2520celiprolol%253A%2520a%2520cardioselective%2520beta-adrenergic%2520antagonist%2520and%2520mild%2520vasodilator%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1991%26volume%3D121%26spage%3D677%26epage%3D683%26doi%3D10.1016%2F0002-8703%2891%2990445-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nawarskas, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng-Lai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frishman, W. H.</span></span> <span> </span><span class="NLM_article-title">Celiprolol: a unique selective adrenoceptor modulator</span>. <i>Cardiol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1097/CRD.0000000000000159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1097%2FCRD.0000000000000159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=28742547" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=247-253&author=J.+J.+Nawarskasauthor=A.+Cheng-Laiauthor=W.+H.+Frishman&title=Celiprolol%3A+a+unique+selective+adrenoceptor+modulator&doi=10.1097%2FCRD.0000000000000159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1097%2FCRD.0000000000000159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCRD.0000000000000159%26sid%3Dliteratum%253Aachs%26aulast%3DNawarskas%26aufirst%3DJ.%2BJ.%26aulast%3DCheng-Lai%26aufirst%3DA.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3DCeliprolol%253A%2520a%2520unique%2520selective%2520adrenoceptor%2520modulator%26jtitle%3DCardiol%2520Rev.%26date%3D2017%26volume%3D25%26spage%3D247%26epage%3D253%26doi%3D10.1097%2FCRD.0000000000000159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doshan, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiss, E. S.</span></span> <span> </span><span class="NLM_article-title">Celiprolol: pharmacokinetics and duration of pharmacodynamic activity</span>. <i>Br J. Clin Pract Suppl</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=2864056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaL28%252FgtVelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1985&pages=12-16&author=F.+S.+Carusoauthor=H.+D.+Doshanauthor=P.+H.+Hernandezauthor=R.+Costelloauthor=W.+Applinauthor=E.+S.+Neiss&title=Celiprolol%3A+pharmacokinetics+and+duration+of+pharmacodynamic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Celiprolol: pharmacokinetics and duration of pharmacodynamic activity</span></div><div class="casAuthors">Caruso F S; Doshan H D; Hernandez P H; Costello R; Applin W; Neiss E S</div><div class="citationInfo"><span class="NLM_cas:title">British journal of clinical practice. Supplement</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-6</span>
        ISSN:<span class="NLM_cas:issn">0262-8767</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGCOXYK4OUDLxanA7vODO6fW6udTcc2eYOME1Q2Dz-cLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28%252FgtVelug%253D%253D&md5=face8cddca1ff41083d0b64b56ccedb8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DF.%2BS.%26aulast%3DDoshan%26aufirst%3DH.%2BD.%26aulast%3DHernandez%26aufirst%3DP.%2BH.%26aulast%3DCostello%26aufirst%3DR.%26aulast%3DApplin%26aufirst%3DW.%26aulast%3DNeiss%26aufirst%3DE.%2BS.%26atitle%3DCeliprolol%253A%2520pharmacokinetics%2520and%2520duration%2520of%2520pharmacodynamic%2520activity%26jtitle%3DBr%2520J.%2520Clin%2520Pract%2520Suppl%26date%3D1985%26volume%3D40%26spage%3D12%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span> <span> </span><span class="NLM_article-title">Efficacy of oral anticancer agents for colorectal cancer</span>. <i>Dis. Colon Rectum</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">S82</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1007/s10350-006-0601-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs10350-006-0601-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17106820" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=S82-91&author=J.+Sakamotoauthor=K.+Obaauthor=T.+Matsuiauthor=M.+Kobayashi&title=Efficacy+of+oral+anticancer+agents+for+colorectal+cancer&doi=10.1007%2Fs10350-006-0601-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1007%2Fs10350-006-0601-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10350-006-0601-7%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DOba%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26atitle%3DEfficacy%2520of%2520oral%2520anticancer%2520agents%2520for%2520colorectal%2520cancer%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D2006%26volume%3D49%26spage%3DS82%26epage%3D91%26doi%3D10.1007%2Fs10350-006-0601-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbaugh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">14379</span>– <span class="NLM_lpage">14455</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWgtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=14379-14455&author=J.+Sheltonauthor=X.+Luauthor=J.+A.+Hollenbaughauthor=J.+H.+Choauthor=F.+Amblardauthor=R.+F.+Schinazi&title=Metabolism%2C+biochemical+actions%2C+and+chemical+synthesis+of+anticancer+nucleosides%2C+nucleotides%2C+and+base+analogs&doi=10.1021%2Facs.chemrev.6b00209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs</span></div><div class="casAuthors">Shelton, Jadd; Lu, Xiao; Hollenbaugh, Joseph A.; Cho, Jong Hyun; Amblard, Franck; Schinazi, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">14379-14455</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Nucleoside, nucleotide, and base analogs have been in the clinic for decades to treat both viral pathogens and neoplasms.  More than 20% of patients on anticancer chemotherapy have been treated with one or more of these analogs.  This review focuses on the chem. synthesis and biol. of anticancer nucleoside, nucleotide, and base analogs that are FDA-approved and in clin. development since 2000.  The authors highlight the cellular biol. and clin. biol. of analogs, drug resistance mechanisms, and compd. specificity towards different cancer types.  Furthermore, the authors explore analog syntheses as well as improved and scale-up syntheses.  The authors conclude with a discussion on what might lie ahead for medicinal chemists, biologists, and physicians as they try to improve analog efficacy through prodrug strategies and drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK6JmQ8iMPQrVg90H21EOLACvtfcHk0lhTJK8bpjyYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWgtL3J&md5=84cbe9e13e6bdaff88a9d49caea2f99a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00209%26sid%3Dliteratum%253Aachs%26aulast%3DShelton%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DHollenbaugh%26aufirst%3DJ.%2BA.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DMetabolism%252C%2520biochemical%2520actions%252C%2520and%2520chemical%2520synthesis%2520of%2520anticancer%2520nucleosides%252C%2520nucleotides%252C%2520and%2520base%2520analogs%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D14379%26epage%3D14455%26doi%3D10.1021%2Facs.chemrev.6b00209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobe, T.</span></span> <span> </span><span class="NLM_article-title">Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma</span>. <i>Br. J. Surg.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1002/bjs.1800830313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fbjs.1800830313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8665186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaK283ks1amtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1996&pages=336-340&author=M.+Yamamotoauthor=S.+Ariiauthor=K.+Sugaharaauthor=T.+Tobe&title=Adjuvant+oral+chemotherapy+to+prevent+recurrence+after+curative+resection+for+hepatocellular+carcinoma&doi=10.1002%2Fbjs.1800830313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma</span></div><div class="casAuthors">Yamamoto M; Arii S; Sugahara K; Tobe T</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of surgery</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">336-40</span>
        ISSN:<span class="NLM_cas:issn">0007-1323</span>.
    </div><div class="casAbstract">Adjuvant oral chemotherapy was studied in 67 patients with stage II hepatocellular carcinoma who underwent curative resection between May 1988 and December 1990.  Patients were stratified into two groups according to preoperative liver dysfunction: 55 had stage I disease (mild dysfunction) and 12 had stage II (moderate dysfunction).  A randomized controlled study of postoperative oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) was conducted in each group.  From October 1994 HCFU administration was suspended because of side-effects in nine patients with stage I liver dysfunction and in three with stage II dysfunction who had received the drug for more than 4 weeks.  Cumulative survival and recurrence-free survival rates of patients with stage I disease in the treatment group were higher (P = 0.08 and P = 0.04 respectively) than those in the control group.  However, in patients with stage II disease no significant difference was observed (P = 0.77 and P = 1.0 respectively).  This study suggests that the potential benefits of HCFU on tumour recurrence should be weighed against the risk of adverse reactions in patients with mild liver dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQk5ElLzb1pE75XHngOXiV_fW6udTcc2ea_u0hsJ7H_Rbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283ks1amtw%253D%253D&md5=82ca69f493676a19e4ebc82b6e16366c</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1002%2Fbjs.1800830313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbjs.1800830313%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DArii%26aufirst%3DS.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DTobe%26aufirst%3DT.%26atitle%3DAdjuvant%2520oral%2520chemotherapy%2520to%2520prevent%2520recurrence%2520after%2520curative%2520resection%2520for%2520hepatocellular%2520carcinoma%26jtitle%3DBr.%2520J.%2520Surg.%26date%3D1996%26volume%3D83%26spage%3D336%26epage%3D340%26doi%3D10.1002%2Fbjs.1800830313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uenaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, M.</span></span> <span> </span><span class="NLM_article-title">Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5459</span>– <span class="NLM_lpage">5465</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-5270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1158%2F1078-0432.CCR-07-5270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=18765537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5459-5465&author=J.+Matsuiauthor=Y.+Funahashiauthor=T.+Uenakaauthor=T.+Watanabeauthor=A.+Tsuruokaauthor=M.+Asada&title=Multi-kinase+inhibitor+E7080+suppresses+lymph+node+and+lung+metastases+of+human+mammary+breast+tumor+MDA-MB-231+via+inhibition+of+vascular+endothelial+growth+factor-receptor+%28VEGF-R%29+2+and+VEGF-R3+kinase&doi=10.1158%2F1078-0432.CCR-07-5270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase</span></div><div class="casAuthors">Matsui, Junji; Funahashi, Yasuhiro; Uenaka, Toshimitsu; Watanabe, Tatsuo; Tsuruoka, Akihiko; Asada, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5459-5465</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Vascular endothelial growth factor (VEGF)-C/VEGF-receptor 3 (VEGF-R3) signal plays a significant role in lymphangiogenesis and tumor metastasis based on its effects on lymphatic vessels.  However, little is known about the effect of inhibiting VEGF-R3 on lymphangiogenesis and lymph node metastases using a small-mol. kinase inhibitor.  Exptl. Design: We evaluated the effect of E7080, a potent inhibitor of both VEGF-R2 and VEGF-R3 kinase, and bevacizumab on lymphangiogenesis and angiogenesis in a mammary fat pad xenograft model of human breast cancer using MDA-MB-231 cells that express excessive amts. of VEGF-C.  Lymphangiogenesis was detd. by lymphatic vessel d. (LVD) and angiogenesis by microvessel d. (MVD).  RESULTS: In contrast to MDA-MB-435 cells, which expressed a similar amt. of VEGF to MDA-MB-231 cells with an undetectable amt. of VEGF-C, only MDA-MB-231 exhibited lymphangiogenesis in the primary tumor.  E7080 but not bevacizumab significantly decreased LVD within the MDA-MB-231 tumor.  E7080 and bevacizumab decreased MVD in both the MDA-MB-231 and MDA-MB-435 models.  E7080 significantly suppressed regional lymph nodes and distant lung metastases of MDA-MB-231, whereas bevacizumab significantly inhibited only lung metastases.  E7080 also decreased both MVD and LVD within the metastatic nodules at lymph nodes after resection of the primary tumor.  CONCLUSIONS: Inhibition of VEGF-R3 kinase with E7080 effectively decreased LVD within MDA-MB-231 tumors, which express VEGF-C.  Simultaneous inhibition of both VEGF-R2 and VEGF-R3 kinases by E7080 may be a promising new strategy to control regional lymph node and distant lung metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrBisu80xI7Vg90H21EOLACvtfcHk0lhTJK8bpjyYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsbjP&md5=0a73511c46d0f668f09f84d89c718417</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-5270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-5270%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DUenaka%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DAsada%26aufirst%3DM.%26atitle%3DMulti-kinase%2520inhibitor%2520E7080%2520suppresses%2520lymph%2520node%2520and%2520lung%2520metastases%2520of%2520human%2520mammary%2520breast%2520tumor%2520MDA-MB-231%2520via%2520inhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor-receptor%2520%2528VEGF-R%2529%25202%2520and%2520VEGF-R3%2520kinase%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5459%26epage%3D5465%26doi%3D10.1158%2F1078-0432.CCR-07-5270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uenaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, M.</span></span> <span> </span><span class="NLM_article-title">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">671</span>, <span class="refDoi"> DOI: 10.1002/ijc.23131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fijc.23131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17943726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=664-671&author=J.+Matsuiauthor=Y.+Yamamotoauthor=Y.+Funahashiauthor=A.+Tsuruokaauthor=T.+Watanabeauthor=T.+Wakabayashiauthor=T.+Uenakaauthor=M.+Asada&title=E7080%2C+a+novel+inhibitor+that+targets+multiple+kinases%2C+has+potent+antitumor+activities+against+stem+cell+factor+producing+human+small+cell+lung+cancer+H146%2C+based+on+angiogenesis+inhibition&doi=10.1002%2Fijc.23131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span></div><div class="casAuthors">Matsui Junji; Yamamoto Yuji; Funahashi Yasuhiro; Tsuruoka Akihiko; Watanabe Tatsuo; Wakabayashi Toshiaki; Uenaka Toshimitsu; Asada Makoto</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">664-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">E7080 is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.  In this study, we show the inhibitory activity of E7080 against SCF-induced angiogenesis in vitro and tumor growth of SCF-producing human small cell lung carcinoma H146 cells in vivo.  E7080 inhibits SCF-driven tube formation of HUVEC, which express SCF receptor, KIT at the IC(50) value of 5.2 nM and it was almost identical for VEGF-driven one (IC(50) = 5.1 nM).  To assess the role of SCF/KIT signaling in tumor angiogenesis, we evaluated the effect of imatinib, a selective KIT kinase inhibitor, on tumor growth of H146 cells in nude mice.  Imatinib did not show the potent antitumor activity in vitro (IC(50) = 2,200 nM), because H146 cells did not express KIT.  However, oral administration of imatinib at 160 mg/kg clearly slowed tumor growth of H146 cells in nude mice, accompanied by decreased microvessel density.  Oral administration of E7080 inhibited tumor growth of H146 cells at doses of 30 and 100 mg/kg in a dose-dependent manner and caused tumor regression at 100 mg/kg.  While anti-VEGF antibody also slowed tumor growth, it did not cause tumor regression.  These results indicate that KIT signaling has a role in tumor angiogenesis of SCF-producing H146 cells, and E7080 causes regression of H146 tumors as a result of antiangiogenic activity mediated by inhibition of both KIT and VEGF receptor signaling.  E7080 may provide therapeutic benefits in the treatment of SCF-producing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxatmtwSKaDe98rul4nhSdfW6udTcc2eaEjbcM4jTsBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhvVGnsA%253D%253D&md5=cfa467e773fd98d6f95b0dded62d31ef</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fijc.23131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23131%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DT.%26aulast%3DUenaka%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DM.%26atitle%3DE7080%252C%2520a%2520novel%2520inhibitor%2520that%2520targets%2520multiple%2520kinases%252C%2520has%2520potent%2520antitumor%2520activities%2520against%2520stem%2520cell%2520factor%2520producing%2520human%2520small%2520cell%2520lung%2520cancer%2520H146%252C%2520based%2520on%2520angiogenesis%2520inhibition%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2008%26volume%3D122%26spage%3D664%26epage%3D671%26doi%3D10.1002%2Fijc.23131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugi, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, A.</span></span> <span> </span><span class="NLM_article-title">Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.canlet.2013.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23856031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=97-103&author=K.+Okamotoauthor=K.+Kodamaauthor=K.+Takaseauthor=N.+H.+Sugiauthor=Y.+Yamamotoauthor=M.+Iwataauthor=A.+Tsuruoka&title=Antitumor+activities+of+the+targeted+multi-tyrosine+kinase+inhibitor+lenvatinib+%28E7080%29+against+RET+gene+fusion-driven+tumor+models&doi=10.1016%2Fj.canlet.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models</span></div><div class="casAuthors">Okamoto, Kiyoshi; Kodama, Kotaro; Takase, Kazuma; Sugi, Naoko Hata; Yamamoto, Yuji; Iwata, Masao; Tsuruoka, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">RET gene fusions are recurrent oncogenes identified in thyroid and lung carcinomas.  Lenvatinib is a multi-tyrosine kinase inhibitor currently under evaluation in several clin. trials.  Here we evaluated lenvatinib in RET gene fusion-driven preclin. models.  In cellular assays, lenvatinib inhibited auto-phosphorylation of KIF5B-RET, CCDC6-RET, and NcoA4-RET.  Lenvatinib suppressed the growth of CCDC6-RET human thyroid and lung cancer cell lines, and as well, suppressed anchorage-independent growth and tumorigenicity of RET gene fusion-transformed NIH3T3 cells.  These results demonstrate that lenvatinib can exert antitumor activity against RET gene fusion-driven tumor models by inhibiting oncogenic RET gene fusion signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr151nVk6WXn7Vg90H21EOLACvtfcHk0li2NWtXtkrdfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygtb7M&md5=e2399184aae74ae2c4b18997a6b7273b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DTakase%26aufirst%3DK.%26aulast%3DSugi%26aufirst%3DN.%2BH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DTsuruoka%26aufirst%3DA.%26atitle%3DAntitumor%2520activities%2520of%2520the%2520targeted%2520multi-tyrosine%2520kinase%2520inhibitor%2520lenvatinib%2520%2528E7080%2529%2520against%2520RET%2520gene%2520fusion-driven%2520tumor%2520models%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D340%26spage%3D97%26epage%3D103%26doi%3D10.1016%2Fj.canlet.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabanillas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habra, M. A.</span></span> <span> </span><span class="NLM_article-title">Lenvatinib: Role in thyroid cancer and other solid tumors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2015.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ctrv.2015.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26678514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyqu77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2016&pages=47-55&author=M.+E.+Cabanillasauthor=M.+A.+Habra&title=Lenvatinib%3A+Role+in+thyroid+cancer+and+other+solid+tumors&doi=10.1016%2Fj.ctrv.2015.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Lenvatinib: Role in thyroid cancer and other solid tumors</span></div><div class="casAuthors">Cabanillas, Maria E.; Habra, Mouhammed Amir</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite recent breakthroughs in treatment of advanced thyroid cancers, prognoses remain poor.  Treatment of advanced, progressive disease remains challenging, with limited treatment options.  Small-mol. tyrosine kinase inhibitors, including vandetanib, cabozantinib, sorafenib, and lenvatinib, which are now FDA-approved for thyroid cancer, have shown clin. benefit in advanced thyroid cancer.  Lenvatinib is approved for treatment of locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC).  It has been studied in phase II and III trials for treatment of advanced RAI-refractory DTC, and in a phase II trial for medullary thyroid cancer (MTC).  Lenvatinib targets vascular endothelial growth factor receptors 1-3 (VEGFR1-3), fibroblast growth factor receptors 1-4 (FGFR-1-4), RET, c-kit, and platelet-derived growth factor receptor α (PDGFRα).  Its antitumor activity may be due to antiangiogenic properties and direct antitumor effects.  Lenvatinib has demonstrated antitumor activity in a variety of solid tumors, including MTC, in phase I and II clin. trials.  In a phase II study in advanced RAI-refractory DTC, lenvatinib-treated patients achieved a 50% response rate (RR), with median progression-free survival (PFS) of 12.6 mo.  In a phase III trial in RAI-refractory DTC, median PFS in lenvatinib-treated patients was 18.3 mo, with a 65% overall RR, vs. 3.6 mo in placebo-treated patients, with a 2% RR.  Adverse events occurring in >50% of patients included hypertension, diarrhea, fatigue/asthenia, and decreased appetite.  Lenvatinib is a promising new agent for treatment of patients with advanced thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiDKE0T_lhrLVg90H21EOLACvtfcHk0lh4bV8bU8OvgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyqu77M&md5=21c6f2d9a05bb312ea31f66ea4c56599</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2015.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DCabanillas%26aufirst%3DM.%2BE.%26aulast%3DHabra%26aufirst%3DM.%2BA.%26atitle%3DLenvatinib%253A%2520Role%2520in%2520thyroid%2520cancer%2520and%2520other%2520solid%2520tumors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2016%26volume%3D42%26spage%3D47%26epage%3D55%26doi%3D10.1016%2Fj.ctrv.2015.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubbelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosing, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebretensae, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumaker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span> <span> </span><span class="NLM_article-title">Development and validation of LC-MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>887–888</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.jchromb.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22309776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1aku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=887%E2%80%93888&publication_year=2012&pages=25-34&author=A.+C.+Dubbelmanauthor=H.+Rosingauthor=B.+Thijssenauthor=A.+Gebretensaeauthor=L.+Lucasauthor=H.+Chenauthor=R.+Shumakerauthor=J.+H.+Schellensauthor=J.+H.+Beijnen&title=Development+and+validation+of+LC-MS%2FMS+assays+for+the+quantification+of+E7080+and+metabolites+in+various+human+biological+matrices&doi=10.1016%2Fj.jchromb.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of LC-MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices</span></div><div class="casAuthors">Dubbelman, A. C.; Rosing, H.; Thijssen, B.; Gebretensae, A.; Lucas, L.; Chen, H.; Shumaker, R.; Schellens, J. H. M.; Beijnen, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">887-888</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To support clin. pharmacokinetic studies with the anticancer agent E7080 (lenvatinib), liq. chromatog. tandem mass spectrometry (LC-MS/MS) methods were developed for the quantification of E7080 and four of its metabolites in human plasma, urine and feces and of E7080 in whole blood.  Cross-analyte interferences between metabolites and parent compd. were expected and therefore accounted for early in the method development.  Plasma, urine and feces samples were extd. with acetonitrile.  Chromatog. sepn. was achieved on a 50 mm × 2.1 mm I.D.  XTerra MS C18 column, with a 0.2 mL/min flow and gradient elution starting with 100% formic acid in water, followed by an increasing percentage of acetonitrile.  Whole blood samples were extd. with di-Et ether and exts. were injected on a 150 mm × 2.1 mm I.D. Symmetry Shield RP8 column.  Detection was performed using an API3000 triple quadrupole mass spectrometer, with a turbo ion spray interface, operating in pos. ion mode.  Using 250 μL of plasma, E7080 and its metabolites could be quantified between 0.25 and 50.0 ng/mL.  The quantifiable ranges of E7080 in whole blood, urine and feces were 0.25-500 ng/mL, 1.00-500 ng/mL and 0.1-25 μg/g, using sample vols. of 250 μL, 200 μL and 250 mg, resp.  Calibration curves in all matrixes were linear with a correlation coeff. (r 2) of 0.994 or better.  At the lower limit of quantification, accuracies were within ±20% of the nominal concn. with CV values less than 20%.  At the other concns. the accuracies were within ±15% of the nominal concn. with CV values below 15%.  The developed methods have successfully been applied in a mass balance study of E7080.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34hsZv1FitLVg90H21EOLACvtfcHk0lh4bV8bU8OvgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1aku74%253D&md5=0f128b8d0c1725246403921cd0c941c6</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DDubbelman%26aufirst%3DA.%2BC.%26aulast%3DRosing%26aufirst%3DH.%26aulast%3DThijssen%26aufirst%3DB.%26aulast%3DGebretensae%26aufirst%3DA.%26aulast%3DLucas%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DShumaker%26aufirst%3DR.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520LC-MS%252FMS%2520assays%2520for%2520the%2520quantification%2520of%2520E7080%2520and%2520metabolites%2520in%2520various%2520human%2520biological%2520matrices%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2012%26volume%3D887%25E2%2580%2593888%26spage%3D25%26epage%3D34%26doi%3D10.1016%2Fj.jchromb.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumaker, R.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacokinetic and pharmacodynamic profile of lenvatinib, an orally active, small-molecule, multitargeted tyrosine kinase inhibitor</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1007/s13318-017-0403-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs13318-017-0403-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=28236116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=903-914&author=Z.+Husseinauthor=H.+Mizuoauthor=S.+Hayatoauthor=M.+Namikiauthor=R.+Shumaker&title=Clinical+pharmacokinetic+and+pharmacodynamic+profile+of+lenvatinib%2C+an+orally+active%2C+small-molecule%2C+multitargeted+tyrosine+kinase+inhibitor&doi=10.1007%2Fs13318-017-0403-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor</span></div><div class="casAuthors">Hussein, Ziad; Mizuo, Hitoshi; Hayato, Seiichi; Namiki, Masayuki; Shumaker, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">903-914</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Lenvatinib is a multikinase inhibitor that targets vascular endothelial growth factor (VEGF) receptors 1-3, fibroblast growth factor receptors 1-4, platelet-derived growth factor receptor-alpha, and RET and KIT proto-oncogenes.  Lenvatinib is approved for the treatment of radioiodine-refractory differentiated thyroid cancer in the United States (US), European Union (EU), Canada, Japan, and Switzerland.  It is also approved in combination with everolimus for the treatment of advanced renal cell carcinoma following ≥1 VEGF-targeted treatment in the US and EU.  In addn., lenvatinib is under investigation for the treatment of hepatocellular carcinoma.  As lenvatinib becomes more widely available, a better understanding of its pharmacokinetic profile has become increasingly important.  Following oral administration, lenvatinib is absorbed rapidly and is metabolized extensively prior to excretion.  This metab. is mediated by multiple pathways, and several metabolites of lenvatinib have been identified.  The effect of food intake on lenvatinib exposure has also been studied and was found to not significantly influence overall exposure to the drug.  Exposure to lenvatinib is increased in patients with severe hepatic impairment, indicating that dose redn. must be considered for those patients.  The findings summarized here indicate that the clin. pharmacokinetic and pharmacodynamic profile for lenvatinib are predictable, with a dose-independent absorption and elimination profile that supports once-daily administration, and has minimal effects due to mild or moderate renal or hepatic impairment or drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN-mhaZ-ys8bVg90H21EOLACvtfcHk0ljR50E03pbLlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2htL4%253D&md5=8dad52dfd3d856a6d94f7a99c7c18cab</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1007%2Fs13318-017-0403-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-017-0403-4%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DZ.%26aulast%3DMizuo%26aufirst%3DH.%26aulast%3DHayato%26aufirst%3DS.%26aulast%3DNamiki%26aufirst%3DM.%26aulast%3DShumaker%26aufirst%3DR.%26atitle%3DClinical%2520pharmacokinetic%2520and%2520pharmacodynamic%2520profile%2520of%2520lenvatinib%252C%2520an%2520orally%2520active%252C%2520small-molecule%252C%2520multitargeted%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2017%26volume%3D42%26spage%3D903%26epage%3D914%26doi%3D10.1007%2Fs13318-017-0403-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wovkulich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzolato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassilev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of RG7112: a small-molecule MDM2 inhibitor in clinical development</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1021/ml4000657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4000657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=466-469&author=B.+Vuauthor=P.+Wovkulichauthor=G.+Pizzolatoauthor=A.+Loveyauthor=Q.+Dingauthor=N.+Jiangauthor=J.+J.+Liuauthor=C.+Zhaoauthor=K.+Glennauthor=Y.+Wenauthor=C.+Tovarauthor=K.+Packmanauthor=L.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7112%3A+a+small-molecule+MDM2+inhibitor+in+clinical+development&doi=10.1021%2Fml4000657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Vu, Binh; Wovkulich, Peter; Pizzolato, Giacomo; Lovey, Allen; Ding, Qingjie; Jiang, Nan; Liu, Jin-Jun; Zhao, Chunlin; Glenn, Kelli; Wen, Yang; Tovar, Christian; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-469</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress.  It is controlled by its neg. regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity.  MDM2 also targets p53 for degrdn. by the proteasome.  Many tumors produce high levels of MDM2, thereby impairing p53 function.  Restoration of p53 activity by inhibiting the p53-MDM2 interaction may represent a novel approach to cancer treatment.  RG7112 (2g) is the first clin. small-mol. MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.  In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZDyQMojUKIrVg90H21EOLACvtfcHk0ljR50E03pbLlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D&md5=3965eb84198ff25eb9bc5f4c3823e850</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fml4000657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000657%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DPizzolato%26aufirst%3DG.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7112%253A%2520a%2520small-molecule%2520MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D466%26epage%3D469%26doi%3D10.1021%2Fml4000657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andreeff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assouline, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strair, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popplewell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruvolo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blotner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jukofsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, K.</span></span> <span> </span><span class="NLM_article-title">Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">876</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-0481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1158%2F1078-0432.CCR-15-0481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26459177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFGmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=868-876&author=M.+Andreeffauthor=K.+R.+Kellyauthor=K.+Yeeauthor=S.+Assoulineauthor=R.+Strairauthor=L.+Popplewellauthor=D.+Bowenauthor=G.+Martinelliauthor=M.+W.+Drummondauthor=P.+Vyasauthor=M.+Kirschbaumauthor=S.+P.+Iyerauthor=V.+Ruvoloauthor=G.+M.+Gonzalezauthor=X.+Huangauthor=G.+Chenauthor=B.+Gravesauthor=S.+Blotnerauthor=P.+Bridgeauthor=L.+Jukofskyauthor=S.+Middletonauthor=M.+Recknerauthor=R.+Ruegerauthor=J.+Zhiauthor=G.+Nicholsauthor=K.+Kojima&title=Results+of+the+phase+I+trial+of+RG7112%2C+a+small-molecule+MDM2+antagonist+in+leukemia&doi=10.1158%2F1078-0432.CCR-15-0481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia</span></div><div class="casAuthors">Andreeff, Michael; Kelly, Kevin R.; Yee, Karen; Assouline, Sarit; Strair, Roger; Popplewell, Leslie; Bowen, David; Martinelli, Giovanni; Drummond, Mark W.; Vyas, Paresh; Kirschbaum, Mark; Iyer, Swaminathan Padmanabhan; Ruvolo, Vivian; Gonzalez, Graciela M. Nogueras; Huang, Xuelin; Chen, Gong; Graves, Bradford; Blotner, Steven; Bridge, Peter; Jukofsky, Lori; Middleton, Steve; Reckner, Monica; Rueger, Ruediger; Zhi, Jianguo; Nichols, Gwen; Kojima, Kensuke</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">868-876</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: RG7112 is a small-mol. MDM2 antagonist.  MDM2 is a neg. regulator of the tumor suppressor p53 and frequently overexpressed in leukemias.  Thus, a phase I study of RG7112 in patients with hematol. malignancies was conducted.  Exptl. Design: Primary study objectives included detn. of the dose and safety profile of RG7112.  Secondary objectives included evaluation of pharmacokinetics; pharmacodynamics, such as TP53-mutation status and MDM2 expression; and preliminary clin. activity.  Patients were divided into two cohorts: Stratum A [relapsed/refractory acute myeloid leukemia (AML; except acute promyelocytic leukemia), acute lymphoblastic leukemia, and chronic myelogenous leukemia] and Stratum B (relapsed/refractory chronic lymphocytic leukemia/small cell lymphocytic leukemia; CLL/sCLL).  Some Stratum A patients were treated at the MTD to assess clin. activity.  Results: RG7112 was administered to 116 patients (96 patients in Stratum A and 20 patients in Stratum B).  All patients experienced at least 1 adverse event, and 3 dose-limiting toxicities were reported.  Pharmacokinetic anal. indicated that twice-daily dosing enhanced daily exposure.  Antileukemia activity was obsd. in the 30 patients with AML assessed at the MTD, including 5 patients who met International Working Group (IWG) criteria for response.  Exploratory anal. revealed TP53 mutations in 14% of Stratum A patients and in 40% of Stratum B patients.  Two patients with TP53 mutations exhibited clin. activity. p53 target genes were induced only in TP53 wild-type leukemic cells.  Baseline expression levels of MDM2 correlated pos. with clin. response.  Conclusions: RG7112 demonstrated clin. activity against relapsed/refractory AML and CLL/sCLL.  MDM2 inhibition resulted in p53 stabilization and transcriptional activation of p53-target genes.  We provide proof-of-concept that MDM2 inhibition restores p53 function and generates clin. responses in hematol. malignancies.  Clin Cancer Res; 22(4); 868-76. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRuwfqK8jXXrVg90H21EOLACvtfcHk0lgpy-pUkMGOCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFGmtrs%253D&md5=9fd607f309a6327c163738291413048a</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0481%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DK.%2BR.%26aulast%3DYee%26aufirst%3DK.%26aulast%3DAssouline%26aufirst%3DS.%26aulast%3DStrair%26aufirst%3DR.%26aulast%3DPopplewell%26aufirst%3DL.%26aulast%3DBowen%26aufirst%3DD.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DDrummond%26aufirst%3DM.%2BW.%26aulast%3DVyas%26aufirst%3DP.%26aulast%3DKirschbaum%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DS.%2BP.%26aulast%3DRuvolo%26aufirst%3DV.%26aulast%3DGonzalez%26aufirst%3DG.%2BM.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DBlotner%26aufirst%3DS.%26aulast%3DBridge%26aufirst%3DP.%26aulast%3DJukofsky%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DReckner%26aufirst%3DM.%26aulast%3DRueger%26aufirst%3DR.%26aulast%3DZhi%26aufirst%3DJ.%26aulast%3DNichols%26aufirst%3DG.%26aulast%3DKojima%26aufirst%3DK.%26atitle%3DResults%2520of%2520the%2520phase%2520I%2520trial%2520of%2520RG7112%252C%2520a%2520small-molecule%2520MDM2%2520antagonist%2520in%2520leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D868%26epage%3D876%26doi%3D10.1158%2F1078-0432.CCR-15-0481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolcher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemunaitis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarapa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, J.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1007/s00280-015-2830-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs00280-015-2830-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26210682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1amtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2015&pages=587-595&author=A.+Patnaikauthor=A.+Tolcherauthor=M.+Beeramauthor=J.+Nemunaitisauthor=G.+J.+Weissauthor=K.+Bhallaauthor=M.+Agrawalauthor=G.+Nicholsauthor=S.+Middletonauthor=A.+Beryozkinaauthor=N.+Sarapaauthor=R.+Peckauthor=J.+Zhi&title=Clinical+pharmacology+characterization+of+RG7112%2C+an+MDM2+antagonist%2C+in+patients+with+advanced+solid+tumors&doi=10.1007%2Fs00280-015-2830-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors</span></div><div class="casAuthors">Patnaik, Amita; Tolcher, Anthony; Beeram, Murali; Nemunaitis, John; Weiss, Glen J.; Bhalla, Kapil; Agrawal, Manish; Nichols, Gwen; Middleton, Steven; Beryozkina, Anna; Sarapa, Nenad; Peck, Richard; Zhi, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">587-595</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: RG7112, the first selective small-mol. MDM2 antagonist in clin. testing, is a non-genotoxic oral p53 activator.  To optimize its dose and schedule, a no. of clin. pharmacol. characteristics were explored in this multicenter trial in patients with advanced solid tumors.  Method: In part 1, the impact of high-energy/high-fat meal and formulations (cryst. and amorphous) on relative bioavailability was examd. in single-dose crossover designs.  In part 2, schedule optimization (4 schedules of drug administration under fasting condition and 2 cohorts with liq. supplementation) was investigated in parallel, dose escalation designs.  Clin. endpoints were pharmacokinetics (PK), pharmacodynamics (PD) including MIC-1 elevation and platelet redn., and safety/tolerability.  Results: With a single-dose treatment, a high-fat/high-energy meal and a new formulation under fasting condition, resp., enhanced overall bioavailability of RG7112 slightly over twofold.  Following multiple-dose administrations, all four schedules yielded the comparable per-cycle (28-d) exposure (AUC), as designed; liq. supplements also enhanced bioavailability.  High-dose treatments of consecutive daily dosing for 5 and 3 days resulted in higher on-treatment-day exposure to RG7112 than both weekly and low-dose/long-duration (20-day) daily schedules.  Serum MIC-1 and blood platelet profiles showed similar patterns to those of PK when the clin. pharmacol. conditions were varied, suggesting the relative importance of treatment-day exposure than overall per-cycle AUC.  Conclusion: Food (both high-fat and low-fat meals) and new formulation enhanced bioavailability.  High-dose consecutive daily treatment for 3-5 days is superior to weekly and low-dose/long-duration (20-day) daily schedules in yielding the sufficiently high drug exposure and PD effects potentially required for cancer treatment efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0X7kDb-ao7Vg90H21EOLACvtfcHk0lgpy-pUkMGOCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1amtb%252FM&md5=1c6b7aff4b25e12c8e8b92ca966ed95f</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs00280-015-2830-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-015-2830-8%26sid%3Dliteratum%253Aachs%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DTolcher%26aufirst%3DA.%26aulast%3DBeeram%26aufirst%3DM.%26aulast%3DNemunaitis%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DAgrawal%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DG.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DBeryozkina%26aufirst%3DA.%26aulast%3DSarapa%26aufirst%3DN.%26aulast%3DPeck%26aufirst%3DR.%26aulast%3DZhi%26aufirst%3DJ.%26atitle%3DClinical%2520pharmacology%2520characterization%2520of%2520RG7112%252C%2520an%2520MDM2%2520antagonist%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2015%26volume%3D76%26spage%3D587%26epage%3D595%26doi%3D10.1007%2Fs00280-015-2830-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noronha, G.</span></span> <span> </span><span class="NLM_article-title">An improved method for the synthesis of enantiomerically pure amino-acid ester isocyanates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7364</span>– <span class="NLM_lpage">7366</span>, <span class="refDoi"> DOI: 10.1021/jo00052a069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00052a069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=7364-7366&author=J.+S.+Nowickauthor=N.+A.+Powellauthor=T.+M.+Nguyenauthor=G.+Noronha&title=An+improved+method+for+the+synthesis+of+enantiomerically+pure+amino-acid+ester+isocyanates&doi=10.1021%2Fjo00052a069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the synthesis of enantiomerically pure amino acid ester isocyanates</span></div><div class="casAuthors">Nowick, James S.; Powell, Noel A.; Nguyen, Tram M.; Noronha, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7364-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Enantiomerically pure amino acid ester isocyanates OCNCHRCOOR1 (R = Me, CH2CH2CO2Et, R1 = Et; R = CHMe2, iso-Bu, sec-Bu, CH2Ph, CH2CH2SMe, CH2OCMe3, R 1 = Me) were prepd. in excellent yield (72-95%) from the corresponding amino acid ester hydrochlorides.  The reaction procedure involves addn. of a soln. of phosgene in toluene (1.3 equiv) to a mixt. of the amino acid ester hydrochloride and pyridine (4.0 equiv) in dry methylene chloride at 0°.  After 2 h, the isocyanate is isolated by rapid aq. workup at 0°, and is then purified by kugelrohr distn.  The isocyanates were detd. to be enantiomerically pure (>99% ee) by 1H NMR anal. of the urea adducts with (R)-1-phenylethylamine.  The mild reaction conditions permit the prepn. of amino acid ester isocyanates contg. acid-sensitive functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQL1Lj7C_frVg90H21EOLACvtfcHk0lg-MyLO9qhNKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Grtw%253D%253D&md5=43f57607f0621ef10b032544dfdca193</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjo00052a069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00052a069%26sid%3Dliteratum%253Aachs%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DNguyen%26aufirst%3DT.%2BM.%26aulast%3DNoronha%26aufirst%3DG.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520synthesis%2520of%2520enantiomerically%2520pure%2520amino-acid%2520ester%2520isocyanates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D7364%26epage%3D7366%26doi%3D10.1021%2Fjo00052a069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groszek, G.</span></span> <span> </span><span class="NLM_article-title">A convenient method of synthesis of unsymmetrical urea derivatives</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1021/op020055g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op020055g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1WmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=759-761&author=G.+Groszek&title=A+convenient+method+of+synthesis+of+unsymmetrical+urea+derivatives&doi=10.1021%2Fop020055g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Method of Synthesis of Unsymmetrical Urea Derivatives</span></div><div class="casAuthors">Groszek, Grazyna</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">759-761</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method for the prepn. of unsym. urea derivs. that may contain functional groups such as hydroxyl, amine, amide, and carboxyl is described.  The method consists of a one-pot modified Curtius rearrangement starting with appropriate arom. acid chloride and carried out in a nonaq. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZDiuzMhT63rVg90H21EOLACvtfcHk0lg-MyLO9qhNKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1WmtL8%253D&md5=8e508af629d9b6ae6f9a35472a0e88a4</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fop020055g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop020055g%26sid%3Dliteratum%253Aachs%26aulast%3DGroszek%26aufirst%3DG.%26atitle%3DA%2520convenient%2520method%2520of%2520synthesis%2520of%2520unsymmetrical%2520urea%2520derivatives%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D759%26epage%3D761%26doi%3D10.1021%2Fop020055g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maramai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabellieri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonfiglio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittaluga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span> <span> </span><span class="NLM_article-title">Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2612</span>– <span class="NLM_lpage">2632</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01812</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01812" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XislOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2612-2632&author=M.+Brindisiauthor=S.+Maramaiauthor=S.+Gemmaauthor=S.+Brogiauthor=A.+Grilloauthor=L.+Di+Cesare+Mannelliauthor=E.+Gabellieriauthor=S.+Lamponiauthor=S.+Saponaraauthor=B.+Gorelliauthor=D.+Tedescoauthor=T.+Bonfiglioauthor=C.+Landryauthor=K.+M.+Jungauthor=A.+Armirottiauthor=L.+Luongoauthor=A.+Ligrestiauthor=F.+Piscitelliauthor=C.+Bertucciauthor=M.+P.+Dehouckauthor=G.+Campianiauthor=S.+Maioneauthor=C.+Ghelardiniauthor=A.+Pittalugaauthor=D.+Piomelliauthor=V.+Di+Marzoauthor=S.+Butini&title=Development+and+pharmacological+characterization+of+selective+blockers+of+2-arachidonoyl+glycerol+degradation+with+efficacy+in+rodent+models+of+multiple+sclerosis+and+pain&doi=10.1021%2Facs.jmedchem.5b01812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain</span></div><div class="casAuthors">Brindisi, Margherita; Maramai, Samuele; Gemma, Sandra; Brogi, Simone; Grillo, Alessandro; Di Cesare Mannelli, Lorenzo; Gabellieri, Emanuele; Lamponi, Stefania; Saponara, Simona; Gorelli, Beatrice; Tedesco, Daniele; Bonfiglio, Tommaso; Landry, Christophe; Jung, Kwang-Mook; Armirotti, Andrea; Luongo, Livio; Ligresti, Alessia; Piscitelli, Fabiana; Bertucci, Carlo; Dehouck, Marie-Pierre; Campiani, Giuseppe; Maione, Sabatino; Ghelardini, Carla; Pittaluga, Anna; Piomelli, Daniele; Di Marzo, Vincenzo; Butini, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2612-2632</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of compd. I, a potent β-lactam-based monoacylglycerol lipase (MGL) inhibitor characterized by an irreversible and stereoselective mechanism of action, high membrane permeability, high brain penetration evaluated using a human in vitro blood-brain barrier model, high selectivity in binding and affinity-based proteomic profiling assays, and low in vitro toxicity.  Mode-of-action studies demonstrate that I, by blocking MGL, increases 2-arachidonoylglycerol and behaves as a cannabinoid (CB1/CB2) receptor indirect agonist.  Administration of I in mice suffering from exptl. autoimmune encephalitis ameliorates the severity of the clin. symptoms in a CB1/CB2-dependent manner.  Moreover, I produced analgesic effects in a rodent model of acute inflammatory pain, which was antagonized by CB1 and CB2 receptor antagonists/inverse agonists. 4a also relieves the neuropathic hypersensitivity induced by oxaliplatin.  Given these evidence, I, as MGL selective inhibitor, could represent a valuable lead for the future development of therapeutic options for multiple sclerosis and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1V_wJf1i3LrVg90H21EOLACvtfcHk0liqpvCHRU4z2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislOnsbw%253D&md5=ff512d8a6ccec5ee5dcd606643797ddc</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01812%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DGrillo%26aufirst%3DA.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DSaponara%26aufirst%3DS.%26aulast%3DGorelli%26aufirst%3DB.%26aulast%3DTedesco%26aufirst%3DD.%26aulast%3DBonfiglio%26aufirst%3DT.%26aulast%3DLandry%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DDehouck%26aufirst%3DM.%2BP.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DPittaluga%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DButini%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520pharmacological%2520characterization%2520of%2520selective%2520blockers%2520of%25202-arachidonoyl%2520glycerol%2520degradation%2520with%2520efficacy%2520in%2520rodent%2520models%2520of%2520multiple%2520sclerosis%2520and%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2612%26epage%3D2632%26doi%3D10.1021%2Facs.jmedchem.5b01812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cotarca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasi, J.</span></span> <span> </span><span class="NLM_article-title">Bis(trichloromethyl)carbonate (BTC, triphosgene): a safer alternative to phosgene?</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1439</span>– <span class="NLM_lpage">1446</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.7b00220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.7b00220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlehtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=1439-1446&author=L.+Cotarcaauthor=T.+Gellerauthor=J.+Repasi&title=Bis%28trichloromethyl%29carbonate+%28BTC%2C+triphosgene%29%3A+a+safer+alternative+to+phosgene%3F&doi=10.1021%2Facs.oprd.7b00220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Bis(trichloromethyl)carbonate (BTC, Triphosgene): A Safer Alternative to Phosgene?</span></div><div class="casAuthors">Cotarca, Livius; Geller, Thomas; Repasi, Jozsef</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1439-1446</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bis(trichloromethyl)carbonate (BTC, triphosgene) is a versatile compd. which enables highly efficient syntheses.  Also, due to its solid state, it is a very convenient compd. for small-scale phosgenation.  Consequently, this compd. is favored as a phosgene substitute in research and development and small-scale prodn.  Although BTC is highly toxic, safe handling is possible as long as its properties and chem. reactivity are understood and considered; however, branding as "safe phosgene" or "safer phosgene" is misleading.  The BTC solid state leads to the misconception there is no significant exposure; however, its vapor pressure is sufficiently high to easily result in toxic concns.  Also, proper monitoring is not yet possible.  Proper BTC use could be more complex than handling phosgene itself; however, handling BTC is normally always assocd. with phosgene and it has its own toxicity.  Hence, BTC use will become more regulated in the future, directly increasing responsibility in route selection during process development.  A stringent safety concept for phosgenation using BTC is necessary.  Due to its interconnection with phosgene, BTC safety concepts will likely be an extended version of the safety concept for phosgene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Jo9CuBcfYLVg90H21EOLACvtfcHk0liqpvCHRU4z2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlehtb7J&md5=81fba7be0c64ea6a4ce32c59144ad211</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.7b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.7b00220%26sid%3Dliteratum%253Aachs%26aulast%3DCotarca%26aufirst%3DL.%26aulast%3DGeller%26aufirst%3DT.%26aulast%3DRepasi%26aufirst%3DJ.%26atitle%3DBis%2528trichloromethyl%2529carbonate%2520%2528BTC%252C%2520triphosgene%2529%253A%2520a%2520safer%2520alternative%2520to%2520phosgene%253F%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2017%26volume%3D21%26spage%3D1439%26epage%3D1446%26doi%3D10.1021%2Facs.oprd.7b00220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randad, R. S.</span></span> <span> </span><span class="NLM_article-title">A safe and efficient method for preparation of <i>N,N’</i>-unsymmetrically disubstituted ureas utilizing triphosgene</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1021/jo00086a061</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00086a061" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2cXjt1Citrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=1937-1938&author=P.+Majerauthor=R.+S.+Randad&title=A+safe+and+efficient+method+for+preparation+of+N%2CN%E2%80%99-unsymmetrically+disubstituted+ureas+utilizing+triphosgene&doi=10.1021%2Fjo00086a061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A Safe and Efficient Method for Preparation of N,N'-Unsymmetrically Disubstituted Ureas Utilizing Triphosgene</span></div><div class="casAuthors">Majer, Pavel; Randad, Ramnarayan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1937-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A convenient, one-pot procedure for the synthesis of N,N'-unsym. disubstituted ureas utilizing com. available triphosgene was described.  The reaction is operationally simple, offers high yields, short reaction time, and high selectivity toward nitrogen nucleophiles.  The isolation of reactive intermediate, the isocyanate, is unnecessary.  Application of this method to the synthesis of various HIV-protease inhibitors is currently under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEq-cTk15G4rVg90H21EOLACvtfcHk0lhbvjoauce0DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjt1Citrg%253D&md5=b100e65453cd7bf70498fa2ccd201fea</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjo00086a061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00086a061%26sid%3Dliteratum%253Aachs%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DRandad%26aufirst%3DR.%2BS.%26atitle%3DA%2520safe%2520and%2520efficient%2520method%2520for%2520preparation%2520of%2520N%252CN%25E2%2580%2599-unsymmetrically%2520disubstituted%2520ureas%2520utilizing%2520triphosgene%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D1937%26epage%3D1938%26doi%3D10.1021%2Fjo00086a061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creason, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R. R.</span></span> <span> </span><span class="NLM_article-title">Urea derivatives of 2-aryl-benzothiazol-5-amines: a new class of potential drugs for human African trypanosomiasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">971</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2lt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=957-971&author=D.+A.+Patrickauthor=J.+R.+Gillespieauthor=J.+McQueenauthor=M.+A.+Hulversonauthor=R.+M.+Ranadeauthor=S.+A.+Creasonauthor=Z.+M.+Herbstauthor=M.+H.+Gelbauthor=F.+S.+Bucknerauthor=R.+R.+Tidwell&title=Urea+derivatives+of+2-aryl-benzothiazol-5-amines%3A+a+new+class+of+potential+drugs+for+human+African+trypanosomiasis&doi=10.1021%2Facs.jmedchem.6b01163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African Trypanosomiasis</span></div><div class="casAuthors">Patrick, Donald A.; Gillespie, J. Robert; McQueen, Joshua; Hulverson, Matthew A.; Ranade, Ranae M.; Creason, Sharon A.; Herbst, Zackary M.; Gelb, Michael H.; Buckner, Frederick S.; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">957-971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A previous publication from this lab explored the antitrypanosomal activities of novel derivs. of 2-(2-benzamido)ethyl-4-phenylthiazole, which had been identified as a hit against Trypanosoma brucei, the causative agent of human African trypanosomiasis.  While a no. of these compds., particularly the urea analogs, were quite potent, these mols. as a whole exhibited poor metabolic stability.  The present work describes the synthesis of 65 new analogs arising from medicinal chem. optimization at different sites on the mol.  The most promising compds. were the urea derivs. of 2-aryl-benzothiazol-5-amines.  One such analog, (S)-2-(3,4-difluorophenyl)-5-(3-fluoro-N-pyrrolidylamido)benzothiazole (I) was chosen for in vivo efficacy studies based upon in vitro activity, metabolic stability, and brain penetration.  This compd. attained 5/5 cures in murine models of both early and late stage human African trypanosomiasis, representing a new lead for the development of drugs to combat this neglected disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOeaBymSHTgLVg90H21EOLACvtfcHk0lhbvjoauce0DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2lt7nN&md5=aaf065ffbba4f4e702119f9c4c81d822</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01163%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DMcQueen%26aufirst%3DJ.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DCreason%26aufirst%3DS.%2BA.%26aulast%3DHerbst%26aufirst%3DZ.%2BM.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DUrea%2520derivatives%2520of%25202-aryl-benzothiazol-5-amines%253A%2520a%2520new%2520class%2520of%2520potential%2520drugs%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D957%26epage%3D971%26doi%3D10.1021%2Facs.jmedchem.6b01163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaltenbach, R. F.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugiel, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, R. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacheler, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordova, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klabe, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Viitanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, S. P.</span></span> <span> </span><span class="NLM_article-title">The synthesis of symmetrical and unsymmetrical P1/P1’ cyclic ureas as HIV protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(98)00175-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0960-894X%2898%2900175-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9871711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlSntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1077-1082&author=M.+Patelauthor=R.+F.+Kaltenbachauthor=D.+A.+Nugielauthor=R.+J.+McHughauthor=P.+K.+Jadhavauthor=L.+T.+Bachelerauthor=B.+C.+Cordovaauthor=R.+M.+Klabeauthor=S.+Erickson-Viitanenauthor=S.+Garberauthor=C.+Reidauthor=S.+P.+Seitz&title=The+synthesis+of+symmetrical+and+unsymmetrical+P1%2FP1%E2%80%99+cyclic+ureas+as+HIV+protease+inhibitors&doi=10.1016%2FS0960-894X%2898%2900175-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitors</span></div><div class="casAuthors">Patel, Mona; Kaltenbach, Robert F., III; Nugiel, David A.; Mchugh, Robert J., Jr.; Jadhay, Prabhakar K.; Bacheler, Lee T.; Cordova, Beverly C.; Klabe, Ronald M.; Erickson-Viitanen, Susan; Garber, Sena; Reid, Carol; Seitz, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1077-1082</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Cyclic urea SD146 (I, R = R1 = benzyl), a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor soly. and bioavailability, which precluded further development of the compd.  In an effort to improve upon the pharmacokinetic profile of the compd., several analogs modified at the P1/P1' residues, e.g., I (R = R1 = Et, hexyl, cyclohexyl, para-substituted benzyl; R = Et, iso-Bu, hexyl, R1 = benzyl), were prepd. and evaluated.  Several of these compds. displayed significant improvement of phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv1Fo8Td9Ma7Vg90H21EOLACvtfcHk0liLv3X3NC_OBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlSntbo%253D&md5=f893f08c99e11b2406077f59988dc386</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900175-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900175-9%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DKaltenbach%26aufirst%3DR.%2BF.%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DMcHugh%26aufirst%3DR.%2BJ.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DCordova%26aufirst%3DB.%2BC.%26aulast%3DKlabe%26aufirst%3DR.%2BM.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DGarber%26aufirst%3DS.%26aulast%3DReid%26aufirst%3DC.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26atitle%3DThe%2520synthesis%2520of%2520symmetrical%2520and%2520unsymmetrical%2520P1%252FP1%25E2%2580%2599%2520cyclic%2520ureas%2520as%2520HIV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1077%26epage%3D1082%26doi%3D10.1016%2FS0960-894X%2898%2900175-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matzen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Amsterdam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautenberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyfried, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottcher, H.</span></span> <span> </span><span class="NLM_article-title">5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1157</span>, <span class="refDoi"> DOI: 10.1021/jm9811054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9811054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1149-1157&author=L.+Matzenauthor=C.+van+Amsterdamauthor=W.+Rautenbergauthor=H.+E.+Greinerauthor=J.+Hartingauthor=C.+A.+Seyfriedauthor=H.+Bottcher&title=5-HT+reuptake+inhibitors+with+5-HT%281B%2F1D%29+antagonistic+activity%3A+a+new+approach+toward+efficient+antidepressants&doi=10.1021%2Fjm9811054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activity: a new approach toward efficient antidepressants</span></div><div class="casAuthors">Matzen, Lisa; Van Amsterdam, Christoph; Rautenberg, Wilfried; Greiner, Hartmut E.; Harting, Juergen; Seyfried, Christoph A.; Boettcher, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1149-1157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of the authors' research program toward new, potential antidepressants, a series of unsym. ureas has been prepd. and evaluated as 5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activities.  The design of these compds. was based on coupling of various indole derivs., previously shown to inhibit 5-HT reuptake, to three different aniline moieties, which are part of known 5-HT1B/1D ligands.  Binding expts. in rat frontal cortex using [125I]iodocyanopindolol, in calf striatum using [3H]5-HT, and in rat hippocampus using [3H]8-OH-DPAT as radioligands, resp., revealed significantly higher affinity at the 5-HT1B receptor as compared to the affinities for the 5-HT1A and 5-HT1D receptors for a no. of compds., among them 4-(5-fluoro-1H-indol-3-yl)piperidine-1-carboxylic acid [4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]amide I (R = R2 = H; R1 = F), the corresponding 4-fluoro-1H-indol-3-yl analog I (R = F; R1 = R2 = H), and the corresponding 6-fluoro-1H-indol-3-yl analog I (R = R1 = H; R2 = F).  Conformational restriction of the aniline moiety in I only slightly enhanced the 5-HT1B affinity, whereas introduction of an aniline moiety with higher conformational flexibility resulted in a less potent 5-HT1B receptor ligand as compared to I.  The functional 5-HT1B/1D antagonistic activity was investigated using the rabbit saphenous vein model as well as the [3H]5-HT release from guinea pig cortical slices.  All new compds. tested in the rabbit saphenous vein model were shown to antagonize the sumatriptan-evoked contractile responses with pA2 values ranging from 7.3 to 8.7.  These observations were consistent with the results of the cortical slice model, in which the ureas were found to block the sumatriptan-induced inhibition of potassium-evoked [3H]5-HT release.  The 5-HT reuptake inhibition of the ureas detd. in rat brain synaptosomes was found to be either increased or decreased as compared to the uncoupled indole derivs. indicating that the reuptake inhibition shown by the ureas is not only due to the indole part but also affected by the aniline moiety of the mol.  Among this series of compds. described the ureas I seem to be the most interesting candidates showing both 5-HT reuptake inhibition and 5-HT1B/1D antagonism in vitro.  This dual pharmacol. profile should in theory lead to a pronounced enhancement in serotonergic neurotransmission and consequently to a more efficient treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPoXyqYo-xI7Vg90H21EOLACvtfcHk0liLv3X3NC_OBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D&md5=339f7c7e7c49ff88559984852971fdd2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm9811054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9811054%26sid%3Dliteratum%253Aachs%26aulast%3DMatzen%26aufirst%3DL.%26aulast%3Dvan%2BAmsterdam%26aufirst%3DC.%26aulast%3DRautenberg%26aufirst%3DW.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3DHarting%26aufirst%3DJ.%26aulast%3DSeyfried%26aufirst%3DC.%2BA.%26aulast%3DBottcher%26aufirst%3DH.%26atitle%3D5-HT%2520reuptake%2520inhibitors%2520with%25205-HT%25281B%252F1D%2529%2520antagonistic%2520activity%253A%2520a%2520new%2520approach%2520toward%2520efficient%2520antidepressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1149%26epage%3D1157%26doi%3D10.1021%2Fjm9811054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammill, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhasin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable inhibitor of defective in cullin neddylation 1 (DCN1)-mediated cullin neddylation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2694</span>– <span class="NLM_lpage">2706</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2694-2706&author=J.+T.+Hammillauthor=D.+Bhasinauthor=D.+C.+Scottauthor=J.+Minauthor=Y.+Chenauthor=Y.+Luauthor=L.+Yangauthor=H.+S.+Kimauthor=M.+C.+Connellyauthor=C.+Hammillauthor=G.+Holbrookauthor=C.+Jeffriesauthor=B.+Singhauthor=B.+A.+Schulmanauthor=R.+K.+Guy&title=Discovery+of+an+orally+bioavailable+inhibitor+of+defective+in+cullin+neddylation+1+%28DCN1%29-mediated+cullin+neddylation&doi=10.1021%2Facs.jmedchem.7b01282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation</span></div><div class="casAuthors">Hammill, Jared T.; Bhasin, Deepak; Scott, Daniel C.; Min, Jaeki; Chen, Yizhe; Lu, Yan; Yang, Lei; Kim, Ho Shin; Connelly, Michele C.; Hammill, Courtney; Holbrook, Gloria; Jeffries, Cynthia; Singh, Bhuvanesh; Schulman, Brenda A.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2694-2706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the discovery, validation, and structure-activity relationships of a series of piperidinyl ureas that potently inhibit the DCN1-UBE2M interaction.  The authors demonstrated that compd. I inhibits both the DCN1-UBE2M protein-protein interaction and DCN1-mediated cullin neddylation in biochem. assays and reduces levels of steady-state cullin neddylation in a squamous carcinoma cell line harboring DCN1 amplification.  Although compd. I exhibits good soly. and permeability, it is rapidly metabolized in microsomal models (CLint = 170 mL/min/kg).  This work lays out the discovery of an orally bioavailable analog, NAcM-OPT (II).  Compd. II retains the favorable biochem. and cellular activity of compd. I but is significantly more stable both in vitro and in vivo.  Compd. II is orally bioavailable, well tolerated in mice, and currently used to study the effects of acute pharmacol. inhibition of the DCN1-UBE2M interaction on the NEDD8/CUL pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4fvhBFy2Ux7Vg90H21EOLACvtfcHk0lgD8WWxLLltYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGkt7c%253D&md5=5775690be4373f8d8a6cb401812363dd</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01282%26sid%3Dliteratum%253Aachs%26aulast%3DHammill%26aufirst%3DJ.%2BT.%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DD.%2BC.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DConnelly%26aufirst%3DM.%2BC.%26aulast%3DHammill%26aufirst%3DC.%26aulast%3DHolbrook%26aufirst%3DG.%26aulast%3DJeffries%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520defective%2520in%2520cullin%2520neddylation%25201%2520%2528DCN1%2529-mediated%2520cullin%2520neddylation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2694%26epage%3D2706%26doi%3D10.1021%2Facs.jmedchem.7b01282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleynet, D. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B. Z.</span></span> <span> </span><span class="NLM_article-title">A general synthesis of unsymmetrical tetrasubstituted ureas</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4158</span>, <span class="refDoi"> DOI: 10.1021/jo962245t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo962245t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlGhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=4155-4158&author=A.+R.+Katritzkyauthor=D.+P.+M.+Pleynetauthor=B.+Z.+Yang&title=A+general+synthesis+of+unsymmetrical+tetrasubstituted+ureas&doi=10.1021%2Fjo962245t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">A General Synthesis of Unsymmetrical Tetrasubstituted Ureas</span></div><div class="casAuthors">Katritzky, Alan R.; Pleynet, David P. M.; Yang, Baozhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4155-4158</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,1'-Carbonylbisbenzotriazole (2), prepd. from benzotriazole and phosgene, is a safe, mild and versatile reagent for the prepn. of unsym. tetrasubstituted ureas, and di- and trisubstituted ureas.  Successive treatments of 2 with a wide variety (arom., aliph., bicyclic) of amines R1R2NH and R3R4NH afford unsym. tetrasubstituted, and di- and trisubstituted ureas R1R2NC(O)NR3R4 in 16-85% yield.  Thus, 2 reacted with aniline for 27 h at room temp. in dry THF under N2.  Then, octylamine was added and the soln. was stirred 27 h.  N-Phenyl-N'-octylurea was isolated in 85% yield.  The carbamoylbenzotriazoles formed from reaction with the first amine were also isolated in some examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkZgfQoHxZ-7Vg90H21EOLACvtfcHk0lgD8WWxLLltYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlGhs78%253D&md5=bfe57ea451edea9fec03dfd2b009d8f5</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjo962245t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo962245t%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DPleynet%26aufirst%3DD.%2BP.%2BM.%26aulast%3DYang%26aufirst%3DB.%2BZ.%26atitle%3DA%2520general%2520synthesis%2520of%2520unsymmetrical%2520tetrasubstituted%2520ureas%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D4155%26epage%3D4158%26doi%3D10.1021%2Fjo962245t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senanayake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, V.</span></span> <span> </span><span class="NLM_article-title">Practical synthesis of unsymmetrical ureas from isopropenyl carbamates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">6960</span>– <span class="NLM_lpage">6963</span>, <span class="refDoi"> DOI: 10.1021/jo0507643</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0507643" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFWntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=6960-6963&author=I.+Gallouauthor=M.+Erikssonauthor=X.+Zengauthor=C.+Senanayakeauthor=V.+Farina&title=Practical+synthesis+of+unsymmetrical+ureas+from+isopropenyl+carbamates&doi=10.1021%2Fjo0507643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Practical Synthesis of Unsymmetrical Ureas from Isopropenyl Carbamates</span></div><div class="casAuthors">Gallou, Isabelle; Eriksson, Magnus; Zeng, Xingzhong; Senanayake, Chris; Farina, Vittorio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6960-6963</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A very convenient method for the synthesis of unsym. ureas from isopropenyl carbamates is described.  The synthetic efficiency of traditional methods for urea formation, such as use of phosgene or alkyl and aryl carbamates, is limited by the formation of sym. urea side products or reaction reversibility.  Isopropenyl carbamates react with amines cleanly and irreversibly and give unsym. ureas in high yield and purity.  This method is ideal for the rapid synthesis of compd. libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrgrCLMCXWp7Vg90H21EOLACvtfcHk0ljojPSRp8YIMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFWntrY%253D&md5=0db13cbc0dd4e98f34fc777501f5397d</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjo0507643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0507643%26sid%3Dliteratum%253Aachs%26aulast%3DGallou%26aufirst%3DI.%26aulast%3DEriksson%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DSenanayake%26aufirst%3DC.%26aulast%3DFarina%26aufirst%3DV.%26atitle%3DPractical%2520synthesis%2520of%2520unsymmetrical%2520ureas%2520from%2520isopropenyl%2520carbamates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D6960%26epage%3D6963%26doi%3D10.1021%2Fjo0507643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voyle, M.</span></span> <span> </span><span class="NLM_article-title">A simple method for the synthesis of unsymmetrical ureas</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1943</span>, <span class="refDoi"> DOI: 10.1080/00397910008087243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1080%2F00397910008087243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFSrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=1937-1943&author=J.+Kitteringhamauthor=M.+R.+Shiptonauthor=M.+Voyle&title=A+simple+method+for+the+synthesis+of+unsymmetrical+ureas&doi=10.1080%2F00397910008087243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for the synthesis of unsymmetrical ureas</span></div><div class="casAuthors">Kitteringham, J.; Shipton, M. R.; Voyle, M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1937-1943</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A simple one pot procedure for the synthesis of N,N'-unsym. ureas using Ph chloroformate in THF is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6k4ROnpDNurVg90H21EOLACvtfcHk0ljojPSRp8YIMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFSrtbc%253D&md5=3ae947475835e701bc0dc0ac2fe5909e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1080%2F00397910008087243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008087243%26sid%3Dliteratum%253Aachs%26aulast%3DKitteringham%26aufirst%3DJ.%26aulast%3DShipton%26aufirst%3DM.%2BR.%26aulast%3DVoyle%26aufirst%3DM.%26atitle%3DA%2520simple%2520method%2520for%2520the%2520synthesis%2520of%2520unsymmetrical%2520ureas%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D1937%26epage%3D1943%26doi%3D10.1080%2F00397910008087243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span> <span> </span><span class="NLM_article-title">Organic carbamates in drug design and medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2895</span>– <span class="NLM_lpage">2940</span>, <span class="refDoi"> DOI: 10.1021/jm501371s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501371s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2895-2940&author=A.+K.+Ghoshauthor=M.+Brindisi&title=Organic+carbamates+in+drug+design+and+medicinal+chemistry&doi=10.1021%2Fjm501371s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Organic Carbamates in Drug Design and Medicinal Chemistry</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2895-2940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The carbamate group is a key structural motif in many approved drugs and prodrugs.  There is an increasing use of carbamates in medicinal chem. and many derivs. are specifically designed to make drug-target interactions through their carbamate moiety.  In this Perspective, we present properties and stabilities of carbamates, reagents and chem. methodologies for the synthesis of carbamates, and recent applications of carbamates in drug design and medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGollKFyXYJJHLVg90H21EOLACvtfcHk0ljojPSRp8YIMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWkuw%253D%253D&md5=e3548247931b74b60e299ada1e27dda5</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm501371s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501371s%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26atitle%3DOrganic%2520carbamates%2520in%2520drug%2520design%2520and%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2895%26epage%3D2940%26doi%3D10.1021%2Fjm501371s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anbazhagan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, A. R. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajappa, S.</span></span> <span> </span><span class="NLM_article-title">Conversion of carbonimidodithioates into unsymmetrical di- and tri-substituted ureas including urea dipeptides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3609</span>– <span class="NLM_lpage">3612</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00561-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2898%2900561-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlSrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=3609-3612&author=M.+Anbazhaganauthor=A.+R.+A.+S.+Deshmukhauthor=S.+Rajappa&title=Conversion+of+carbonimidodithioates+into+unsymmetrical+di-+and+tri-substituted+ureas+including+urea+dipeptides&doi=10.1016%2FS0040-4039%2898%2900561-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of carbonimidodithioates into unsymmetrical di- and tri- substituted ureas including urea dipeptides</span></div><div class="casAuthors">Anbazhagan, Mariappan; Rakeeb, Abdul; Deshmukh, A. S.; Rajappa, Srinivasachari</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3609-3612</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Selective hydrolysis of carbonimidodithioates RN:C(SMe)2 [R = Bu, (S)-CH(CH2Ph)CO2Me] leads to the thiocarbamates R1C(O)SMe (R = BuNH, L-Phe-OMe), which can be easily transformed to the unsym. ureas R2R3NCOR1 by treatment with the appropriate amines.  This constitutes a synthesis of ureas without the use of phosgene or carbon monoxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri7zSh-CDIU7Vg90H21EOLACvtfcHk0liNPIIY2dJxvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlSrtrg%253D&md5=f999777b6dd8b0d11ee2acccd6650959</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900561-9%26sid%3Dliteratum%253Aachs%26aulast%3DAnbazhagan%26aufirst%3DM.%26aulast%3DDeshmukh%26aufirst%3DA.%2BR.%2BA.%2BS.%26aulast%3DRajappa%26aufirst%3DS.%26atitle%3DConversion%2520of%2520carbonimidodithioates%2520into%2520unsymmetrical%2520di-%2520and%2520tri-substituted%2520ureas%2520including%2520urea%2520dipeptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D3609%26epage%3D3612%26doi%3D10.1016%2FS0040-4039%2898%2900561-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batey, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhakumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshina-Ishii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. D.</span></span> <span> </span><span class="NLM_article-title">An efficient new protocol for the formation of unsymmetrical tri- and tetrasubstituted ureas</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">6267</span>– <span class="NLM_lpage">6270</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)01330-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2898%2901330-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1cXltlKnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=6267-6270&author=R.+A.+Bateyauthor=V.+Santhakumarauthor=C.+Yoshina-Ishiiauthor=S.+D.+Taylor&title=An+efficient+new+protocol+for+the+formation+of+unsymmetrical+tri-+and+tetrasubstituted+ureas&doi=10.1016%2FS0040-4039%2898%2901330-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient new protocol for the formation of unsymmetrical tri- and tetrasubstituted ureas</span></div><div class="casAuthors">Batey, Robert A.; Santhakumar, V.; Yoshina-Ishii, Chiaki; Taylor, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">6267-6270</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new method for producing unsym., tetrasubstituted urea from N,N'-carbonyldiimidazole (CDI) is presented.  Carbamoyl imidazolium salts are prepd. from the reaction of CDI with a secondary amine, followed by alkylation with MeI.  Secondary amines add with ease to imidazolium salts at room temp. to give unsym. tetrasubstituted ureas in excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw_66xsjKbfLVg90H21EOLACvtfcHk0liNPIIY2dJxvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlKnurc%253D&md5=4b286c231bf9a2e7e9fbc07e56f4910a</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2901330-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252901330-6%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DR.%2BA.%26aulast%3DSanthakumar%26aufirst%3DV.%26aulast%3DYoshina-Ishii%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DS.%2BD.%26atitle%3DAn%2520efficient%2520new%2520protocol%2520for%2520the%2520formation%2520of%2520unsymmetrical%2520tri-%2520and%2520tetrasubstituted%2520ureas%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D6267%26epage%3D6270%26doi%3D10.1016%2FS0040-4039%2898%2901330-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grzyb, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshina-Ishii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batey, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbamoylimidazolium and thiocarbamoylimidazolium salts: novel reagents for the synthesis of ureas, thioureas, carbamates, thiocarbamates and amides</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7153</span>– <span class="NLM_lpage">7175</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2005.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tet.2005.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVCisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=7153-7175&author=J.+A.+Grzybauthor=M.+Shenauthor=C.+Yoshina-Ishiiauthor=W.+Chiauthor=R.+S.+Brownauthor=R.+A.+Batey&title=Carbamoylimidazolium+and+thiocarbamoylimidazolium+salts%3A+novel+reagents+for+the+synthesis+of+ureas%2C+thioureas%2C+carbamates%2C+thiocarbamates+and+amides&doi=10.1016%2Fj.tet.2005.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoylimidazolium and thiocarbamoylimidazolium salts: novel reagents for the synthesis of ureas, thioureas, carbamates, thiocarbamates and amides</span></div><div class="casAuthors">Grzyb, Justyna A.; Shen, Ming; Yoshina-Ishii, Chiaki; Chi, W.; Brown, R. Stanley; Batey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7153-7175</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Carbamoylimidazolium iodide salts I•I- [R = 1,2,3,4-tetrahydro-1-quinolinyl, 1,2,3,4-tetrahydro-2-isoquinolinyl, PhNMe, PhCH2N(Me2CH), 1-pyrrolidinyl, (S)-2-(benzyloxycarbonyl)pyrrolidinyl, 4-morpholinyl, MeON(Me), 1,4-dioxa-8-azaspiro[4.5]dec-8-yl] are prepd. from secondary amines, carbonyldiimidazole, and Me iodide; I react with amines, alcs., thiols, and carboxylic acids to yield ureas, carbamates, S-thiocarbamate esters, and amides.  I•I- are prepd. by treatment of secondary amines with N,N'-carbonyldiimidazole followed by N-alkylation of the acylimidazoles with iodomethane.  I•I- are more efficient carbamoyl transfer reagents than the corresponding carbamoylimidazoles; base-promoted hydrolysis of I•I- occurs roughly a hundred times more rapidly than hydrolysis of the corresponding acylimidazoles.  Thiocarbonylimidazolium iodide salts are also prepd. using thiocarbonyldiimidazole instead of carbonyldiimidazole and subsequently used in the prepn. of thioureas.  Coupling of diethylphosphonoacetic acid with I•I- (R = 4-morpholinyl) followed by Horner-Wadsworth-Emmons olefination of isobutyraldehyde mediated by lithium chloride and DBU yields (E)-4-(4-methyl-2-pentenoyl)morpholine.  Using the amidation of diethylphosphonoacetic acid with appropriate carbamoylimidazolium iodides and intramol. Horner-Wadsworth-Emmons olefination reactions as key steps, unsatd. lactams II (X = bond, CH2) are prepd. in seven steps from 2-hydroxymethylpiperidine and 2-(2-hydroxyethyl)piperidine, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGparYnzgLy-1rVg90H21EOLACvtfcHk0liug7kWYNSMWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVCisLk%253D&md5=cb851314c8fa1815b8f87bea9d52c8a5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DGrzyb%26aufirst%3DJ.%2BA.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DYoshina-Ishii%26aufirst%3DC.%26aulast%3DChi%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DR.%2BS.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DCarbamoylimidazolium%2520and%2520thiocarbamoylimidazolium%2520salts%253A%2520novel%2520reagents%2520for%2520the%2520synthesis%2520of%2520ureas%252C%2520thioureas%252C%2520carbamates%252C%2520thiocarbamates%2520and%2520amides%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D7153%26epage%3D7175%26doi%3D10.1016%2Fj.tet.2005.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artuso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fochi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magistris, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of mono-, di-, and trisubstituted ureas by carbonylation of aliphatic amines with <i>S,S</i>-dimethyl dithiocarbonate</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">3497</span>– <span class="NLM_lpage">3506</span>, <span class="refDoi"> DOI: 10.1055/s-2007-990813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-2007-990813" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=3497-3506&author=E.+Artusoauthor=L.+Deganiauthor=R.+Fochiauthor=C.+Magistris&title=Preparation+of+mono-%2C+di-%2C+and+trisubstituted+ureas+by+carbonylation+of+aliphatic+amines+with+S%2CS-dimethyl+dithiocarbonate&doi=10.1055%2Fs-2007-990813"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-990813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-990813%26sid%3Dliteratum%253Aachs%26aulast%3DArtuso%26aufirst%3DE.%26aulast%3DDegani%26aufirst%3DL.%26aulast%3DFochi%26aufirst%3DR.%26aulast%3DMagistris%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520mono-%252C%2520di-%252C%2520and%2520trisubstituted%2520ureas%2520by%2520carbonylation%2520of%2520aliphatic%2520amines%2520with%2520S%252CS-dimethyl%2520dithiocarbonate%26jtitle%3DSynthesis%26date%3D2007%26volume%3D2007%26spage%3D3497%26epage%3D3506%26doi%3D10.1055%2Fs-2007-990813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, Y. J.</span></span> <span> </span><span class="NLM_article-title">Phenyl 4,5-dichloro-6-oxopyridazine-1(6H)-carboxylate as carbonyl source: facile and selective synthesis of carbamates and ureas under mild conditions</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">2809</span>– <span class="NLM_lpage">2814</span>, <span class="refDoi"> DOI: 10.1055/s-0029-1217997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0029-1217997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=2809-2814&author=H.+G.+Leeauthor=M.+J.+Kimauthor=S.+E.+Parkauthor=J.+J.+Kimauthor=B.+R.+Kimauthor=S.+G.+Leeauthor=Y.+J.+Yoon&title=Phenyl+4%2C5-dichloro-6-oxopyridazine-1%286H%29-carboxylate+as+carbonyl+source%3A+facile+and+selective+synthesis+of+carbamates+and+ureas+under+mild+conditions&doi=10.1055%2Fs-0029-1217997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1055%2Fs-0029-1217997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0029-1217997%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DPark%26aufirst%3DS.%2BE.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DYoon%26aufirst%3DY.%2BJ.%26atitle%3DPhenyl%25204%252C5-dichloro-6-oxopyridazine-1%25286H%2529-carboxylate%2520as%2520carbonyl%2520source%253A%2520facile%2520and%2520selective%2520synthesis%2520of%2520carbamates%2520and%2520ureas%2520under%2520mild%2520conditions%26jtitle%3DSynlett%26date%3D2009%26volume%3D2009%26spage%3D2809%26epage%3D2814%26doi%3D10.1055%2Fs-0029-1217997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padiya, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardile, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaware, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurhade, S.</span></span> <span> </span><span class="NLM_article-title">Unprecedented ″in water″ imidazole carbonylation: paradigm shift for preparation of urea and carbamate</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2814</span>– <span class="NLM_lpage">2817</span>, <span class="refDoi"> DOI: 10.1021/ol301009d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol301009d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1ajsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=2814-2817&author=K.+J.+Padiyaauthor=S.+Gavadeauthor=B.+Kardileauthor=M.+Tiwariauthor=S.+Bajareauthor=M.+Maneauthor=V.+Gawareauthor=S.+Vargheseauthor=D.+Harelauthor=S.+Kurhade&title=Unprecedented+%E2%80%B3in+water%E2%80%B3+imidazole+carbonylation%3A+paradigm+shift+for+preparation+of+urea+and+carbamate&doi=10.1021%2Fol301009d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented "In Water" Imidazole Carbonylation: Paradigm Shift for Preparation of Urea and Carbamate</span></div><div class="casAuthors">Padiya, Kamlesh J.; Gavade, Sandip; Kardile, Bhavana; Tiwari, Manojkumar; Bajare, Swapnil; Mane, Madhav; Gaware, Vivek; Varghese, Shaji; Harel, Dipak; Kurhade, Suresh</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2814-2817</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first "in water" imidazolecarbonylation of amine is described.  A one pot reaction of 1,1'-carbonyldiimidazole in water with a nucleophile provides an efficient and general method for the prepn. of urea, carbamates and thiocarbamates.  Use of an anhyd. solvent and an inert atm. could be avoided.  Product ppt. out from the reaction mixt. and can be obtained in high purity by filtration, resulting in a simple and scalable method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQqf3vSGLRcbVg90H21EOLACvtfcHk0lhA_AEZsEbexg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1ajsrk%253D&md5=9c1bd196cb4f8879cfc4bc56423071ad</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fol301009d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301009d%26sid%3Dliteratum%253Aachs%26aulast%3DPadiya%26aufirst%3DK.%2BJ.%26aulast%3DGavade%26aufirst%3DS.%26aulast%3DKardile%26aufirst%3DB.%26aulast%3DTiwari%26aufirst%3DM.%26aulast%3DBajare%26aufirst%3DS.%26aulast%3DMane%26aufirst%3DM.%26aulast%3DGaware%26aufirst%3DV.%26aulast%3DVarghese%26aufirst%3DS.%26aulast%3DHarel%26aufirst%3DD.%26aulast%3DKurhade%26aufirst%3DS.%26atitle%3DUnprecedented%2520%25E2%2580%25B3in%2520water%25E2%2580%25B3%2520imidazole%2520carbonylation%253A%2520paradigm%2520shift%2520for%2520preparation%2520of%2520urea%2520and%2520carbamate%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D2814%26epage%3D2817%26doi%3D10.1021%2Fol301009d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bogolubsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroz, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mykhailiuk, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granat, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipko, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konovets, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroschuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A.</span></span> <span> </span><span class="NLM_article-title">Bis(2,2,2-trifluoroethyl) carbonate as a condensing agent in one-pot parallel synthesis of unsymmetrical aliphatic ureas</span>. <i>ACS Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1021/co500025f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/co500025f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsFKqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=303-308&author=A.+V.+Bogolubskyauthor=Y.+S.+Morozauthor=P.+K.+Mykhailiukauthor=D.+S.+Granatauthor=S.+E.+Pipkoauthor=A.+I.+Konovetsauthor=R.+Doroschukauthor=A.+Tolmachev&title=Bis%282%2C2%2C2-trifluoroethyl%29+carbonate+as+a+condensing+agent+in+one-pot+parallel+synthesis+of+unsymmetrical+aliphatic+ureas&doi=10.1021%2Fco500025f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Bis(2,2,2-trifluoroethyl) Carbonate as a Condensing Agent in One-Pot Parallel Synthesis of Unsymmetrical Aliphatic Ureas</span></div><div class="casAuthors">Bogolubsky, Andrey V.; Moroz, Yurii S.; Mykhailiuk, Pavel K.; Granat, Dmitry S.; Pipko, Sergey E.; Konovets, Anzhelika I.; Doroschuk, Roman; Tolmachev, Andrey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">303-308</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One-pot parallel synthesis of unsym. aliph. ureas was achieved with bis(2,2,2-trifluoroethyl) carbonate.  The procedure worked well for both the monosubstituted and functionalized alkylamines and required no special conditions (temp. control, order, or rate of addn.).  Thus, an acetonitrile soln. of the first alkylamine, N,N-diisopropylethylamine, and bis(2,2,2-trifluoroethyl) carbonate was heated at 75 °C in a sealed tube for 2 h.  After complete removal of bis(2,2,2-trifluoroethyl) carbonate and addn. of DBU, the second alkylaminewas added to the crude trifluoroethyl carbamate to give the unsym. aliph. urea.  A library of 96 diverse ureas was easily synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQIevy9_gSLbVg90H21EOLACvtfcHk0lhA_AEZsEbexg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsFKqt7Y%253D&md5=26ad42a9b0aa35ebee2ce89fff8d2b3d</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fco500025f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco500025f%26sid%3Dliteratum%253Aachs%26aulast%3DBogolubsky%26aufirst%3DA.%2BV.%26aulast%3DMoroz%26aufirst%3DY.%2BS.%26aulast%3DMykhailiuk%26aufirst%3DP.%2BK.%26aulast%3DGranat%26aufirst%3DD.%2BS.%26aulast%3DPipko%26aufirst%3DS.%2BE.%26aulast%3DKonovets%26aufirst%3DA.%2BI.%26aulast%3DDoroschuk%26aufirst%3DR.%26aulast%3DTolmachev%26aufirst%3DA.%26atitle%3DBis%25282%252C2%252C2-trifluoroethyl%2529%2520carbonate%2520as%2520a%2520condensing%2520agent%2520in%2520one-pot%2520parallel%2520synthesis%2520of%2520unsymmetrical%2520aliphatic%2520ureas%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2014%26volume%3D16%26spage%3D303%26epage%3D308%26doi%3D10.1021%2Fco500025f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, Y.</span></span> <span> </span><span class="NLM_article-title">Electrochemically induced Hofmann rearrangement</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">8879</span>– <span class="NLM_lpage">8882</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(97)10324-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2897%2910324-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFCru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=8879-8882&author=Y.+Matsumuraauthor=T.+Makiauthor=Y.+Satoh&title=Electrochemically+induced+Hofmann+rearrangement&doi=10.1016%2FS0040-4039%2897%2910324-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemically induced Hofmann rearrangement</span></div><div class="casAuthors">Matsumura, Yoshihiro; Maki, Toshihide; Satoh, Yuki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">8879-8882</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Electrochem. induced Hofmann rearrangement under new solvent systems contg. a variety of alcs. was developed.  Since the reaction proceeds under mild conditions (neutral), a variety of carbamates possessing various alkoxy moieties could be easily prepd. by this method.  An epoxy functional group in the amide and alc. parts remained intact during the electrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPyRcVi7UaA7Vg90H21EOLACvtfcHk0lhA_AEZsEbexg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFCru7Y%253D&md5=052252b269093aab6f0df76b8a05dd49</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2897%2910324-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252897%252910324-0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DMaki%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DY.%26atitle%3DElectrochemically%2520induced%2520Hofmann%2520rearrangement%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D8879%26epage%3D8882%26doi%3D10.1016%2FS0040-4039%2897%2910324-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chany, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuladhar, S. M.</span></span> <span> </span><span class="NLM_article-title">Preparation of methyl carbamates from primary alkylcarboxamides and arylcarboxamides using hypervalent iodine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2478</span>– <span class="NLM_lpage">2482</span>, <span class="refDoi"> DOI: 10.1021/jo00061a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00061a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK3sXitlertrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=2478-2482&author=R.+M.+Moriartyauthor=C.+J.+Chanyauthor=R.+K.+Vaidauthor=O.+Prakashauthor=S.+M.+Tuladhar&title=Preparation+of+methyl+carbamates+from+primary+alkylcarboxamides+and+arylcarboxamides+using+hypervalent+iodine&doi=10.1021%2Fjo00061a022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of methyl carbamates from primary alkyl- and arylcarboxamides using hypervalent iodine</span></div><div class="casAuthors">Moriarty, Robert M.; Chany, Calvin J., II; Vaid, Rahde K.; Prakash, Om; Tuladhar, Sudersan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2478-82</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A series of 14 primary alkyl- and arylcarboxamides, e.g., cycloheptenylcarbamate I (R = CONH2) and quinoline II (R = CONH2), were treated with PhI(OAc)2 in KOH-CH3OH at 5-10° to give the corresponding Me carbamates, e.g., I (R = NHCO2Me) and II (R = NHCO2Me), in good to excellent yields.  These conditions avoid the use of elemental bromine or heavy metal reagents (Pb(OAc)4, AgOAc, Hg(OAc)2), while taking advantage of the com. availability of PhI(OAc)2.  The Me carbamates are easily purified via column chromatog. on silica gel.  The isolated yields of the carbamates ranged from 72% for Me N-cyclopropylcarbamate to 97% for Me N-phenylcarbamate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ5ADwJTNivbVg90H21EOLACvtfcHk0ljsmyICKR0Z4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitlertrc%253D&md5=370fd7b1b9ac707004cbc020bcc98358</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjo00061a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00061a022%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DR.%2BM.%26aulast%3DChany%26aufirst%3DC.%2BJ.%26aulast%3DVaid%26aufirst%3DR.%2BK.%26aulast%3DPrakash%26aufirst%3DO.%26aulast%3DTuladhar%26aufirst%3DS.%2BM.%26atitle%3DPreparation%2520of%2520methyl%2520carbamates%2520from%2520primary%2520alkylcarboxamides%2520and%2520arylcarboxamides%2520using%2520hypervalent%2520iodine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D2478%26epage%3D2482%26doi%3D10.1021%2Fjo00061a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radlick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L. R.</span></span> <span> </span><span class="NLM_article-title">A versatile modification of the Hofmann rearrangement</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1055/s-1974-23298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-1974-23298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1974&pages=290-292&author=P.+Radlickauthor=L.+R.+Brown&title=A+versatile+modification+of+the+Hofmann+rearrangement&doi=10.1055%2Fs-1974-23298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1055%2Fs-1974-23298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1974-23298%26sid%3Dliteratum%253Aachs%26aulast%3DRadlick%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DL.%2BR.%26atitle%3DA%2520versatile%2520modification%2520of%2520the%2520Hofmann%2520rearrangement%26jtitle%3DSynthesis%26date%3D1974%26volume%3D4%26spage%3D290%26epage%3D292%26doi%3D10.1055%2Fs-1974-23298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keillor, J. W.</span></span> <span> </span><span class="NLM_article-title">Preparation of methyl carbamates via a modified Hofmann rearrangement</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(96)02341-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0040-4039%2896%2902341-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXotFalsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=313-316&author=X.+C.+Huangauthor=J.+W.+Keillor&title=Preparation+of+methyl+carbamates+via+a+modified+Hofmann+rearrangement&doi=10.1016%2FS0040-4039%2896%2902341-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of methyl carbamates via a modified Hofmann rearrangement</span></div><div class="casAuthors">Huang, Xicai; Keillor, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-316</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Treatment of a series of para-substituted arom. and primary aliph. carboxamides with NBS and NaOMe in methanol heated to reflux for ten minutes results in the conversion of the carboxamides to their corresponding primary amino Me carbamates in nearly quant. yields.  The mild oxidative conditions of this modified Hofmann rearrangement are shown to be particularly useful for the prepn. of p-substituted anilines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-ibgIWvmuiLVg90H21EOLACvtfcHk0lh3GiItcgzafg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotFalsQ%253D%253D&md5=f306932e71eee037d3c422d2f027eb72</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2896%2902341-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252896%252902341-6%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BC.%26aulast%3DKeillor%26aufirst%3DJ.%2BW.%26atitle%3DPreparation%2520of%2520methyl%2520carbamates%2520via%2520a%2520modified%2520Hofmann%2520rearrangement%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D313%26epage%3D316%26doi%3D10.1016%2FS0040-4039%2896%2902341-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senanayake, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburgh, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reamer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoeven, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reider, P. J.</span></span> <span> </span><span class="NLM_article-title">Nature of <i>N</i>-bromosuccinimide in basic-media - the true oxidizing species in the Hofmann rearrangement</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">7947</span>– <span class="NLM_lpage">7948</span>, <span class="refDoi"> DOI: 10.1021/ja00096a082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00096a082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2MXksFWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=7947-7948&author=C.+H.+Senanayakeauthor=L.+E.+Fredenburghauthor=R.+A.+Reamerauthor=R.+D.+Larsenauthor=T.+R.+Verhoevenauthor=P.+J.+Reider&title=Nature+of+N-bromosuccinimide+in+basic-media+-+the+true+oxidizing+species+in+the+Hofmann+rearrangement&doi=10.1021%2Fja00096a082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Nature of N-Bromosuccinimide in Basic Media: The True Oxidizing Species in the Hofmann Rearrangement</span></div><div class="casAuthors">Senanayake, Chris H.; Fredenburgh, Laura E.; Reamer, Robert A.; Larsen, Robert D.; Verhoeven, Thomas R.; Reider, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7947-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Dissoln. of NBS in KOH/D2O gave 15% potassium succinimide (I) and 85% N-bromosuccinamic acid, KO2CCH2CH2NKBr (II).  N-bromosuccinamic acid salt II is the oxidizing agent in the Hofmann rearrangement of aminonicotinamide III with NBS in KOH/MeOH.  Hofmann rearrangement of III with NBS in KOH/MeOH at -5° gave only 60% urea IV, along with 30% starting material III and brominated byproducts V and VI.  Optimized reaction conditions, pretreatment of NBS with KOH in MeOH for 16 h at -5° followed by addn. of III at -20° gave 95% urea IV.  Urea formation occurs through transfer of the bromonium ion from oxidizing agent II to the aminonicotinamide; the intermediate N-bromoamide VII then rearranges to the isocyanate VIII, which undergoes intramol. capture to yield the cyclic urea IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV08OvHf6Uu7Vg90H21EOLACvtfcHk0lh3GiItcgzafg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksFWjtw%253D%253D&md5=9e47d9082ee61a9360716615c153bf05</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fja00096a082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00096a082%26sid%3Dliteratum%253Aachs%26aulast%3DSenanayake%26aufirst%3DC.%2BH.%26aulast%3DFredenburgh%26aufirst%3DL.%2BE.%26aulast%3DReamer%26aufirst%3DR.%2BA.%26aulast%3DLarsen%26aufirst%3DR.%2BD.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26atitle%3DNature%2520of%2520N-bromosuccinimide%2520in%2520basic-media%2520-%2520the%2520true%2520oxidizing%2520species%2520in%2520the%2520Hofmann%2520rearrangement%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D7947%26epage%3D7948%26doi%3D10.1021%2Fja00096a082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baumgarten, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staklis, A.</span></span> <span> </span><span class="NLM_article-title">Reactions of amines. XVIII. Oxidative rearrangement of amides with lead tetraacetate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">3554</span>– <span class="NLM_lpage">3561</span>, <span class="refDoi"> DOI: 10.1021/jo00912a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00912a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaE28Xks1Wm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=3554-3561&author=H.+E.+Baumgartenauthor=H.+L.+Smithauthor=A.+Staklis&title=Reactions+of+amines.+XVIII.+Oxidative+rearrangement+of+amides+with+lead+tetraacetate&doi=10.1021%2Fjo00912a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of amines.  XVIII.  Oxidative rearrangement of amides with lead tetraacetate</span></div><div class="casAuthors">Baumgarten, Henry E.; Smith, Howard L.; Staklis, Andris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3554-61</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Fourteen primary amides RCONH2 (e.g., R = Ph, PhCH2, cyclobutyl, pyridyl were converted to isocyanates by treatment with Pb(OAc)4.  Generally, the isocyanates were not isolated but were converted to carbamates by using a reaction solvent such as benzyl or, preferably, tert-butyl alc.  Alternatively, the reactions were run in DMF and the isocyanates converted to unsym. ureas by treatment with tert-butylamine.  The carbamates could be easily cleaved to the corresponding amines (as the hydrochlorides) by treatment with HCl in alcohol, ether, or acetic acid.  The title rearrangement proceeded with retention of configuration about the migrating carbon atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfnyJ3G_kqN7Vg90H21EOLACvtfcHk0lh3GiItcgzafg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xks1Wm&md5=943889ff0c9854c22558b05036e72a65</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjo00912a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00912a019%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgarten%26aufirst%3DH.%2BE.%26aulast%3DSmith%26aufirst%3DH.%2BL.%26aulast%3DStaklis%26aufirst%3DA.%26atitle%3DReactions%2520of%2520amines.%2520XVIII.%2520Oxidative%2520rearrangement%2520of%2520amides%2520with%2520lead%2520tetraacetate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D3554%26epage%3D3561%26doi%3D10.1021%2Fjo00912a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kajigaeshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakinami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, T.</span></span> <span> </span><span class="NLM_article-title">Oxidation using quaternary ammonium polyhalides 0.1. An efficient method for the Hofmann degradation of amides by use of benzyltrimethylammonium tribromide</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1246/cl.1989.463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1246%2Fcl.1989.463" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1989&pages=463-464&author=S.+Kajigaeshiauthor=K.+Asanoauthor=S.+Fujisakiauthor=T.+Kakinamiauthor=T.+Okamoto&title=Oxidation+using+quaternary+ammonium+polyhalides+0.1.+An+efficient+method+for+the+Hofmann+degradation+of+amides+by+use+of+benzyltrimethylammonium+tribromide&doi=10.1246%2Fcl.1989.463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1246%2Fcl.1989.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.1989.463%26sid%3Dliteratum%253Aachs%26aulast%3DKajigaeshi%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DFujisaki%26aufirst%3DS.%26aulast%3DKakinami%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DT.%26atitle%3DOxidation%2520using%2520quaternary%2520ammonium%2520polyhalides%25200.1.%2520An%2520efficient%2520method%2520for%2520the%2520Hofmann%2520degradation%2520of%2520amides%2520by%2520use%2520of%2520benzyltrimethylammonium%2520tribromide%26jtitle%3DChem.%2520Lett.%26date%3D1989%26volume%3D18%26spage%3D463%26epage%3D464%26doi%3D10.1246%2Fcl.1989.463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinklin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWolf, W. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraser, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McVean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgis, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtli, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houze, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-pyridylureas as glucokinase activators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8180</span>– <span class="NLM_lpage">8186</span>, <span class="refDoi"> DOI: 10.1021/jm501204z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501204z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8180-8186&author=R.+J.+Hinklinauthor=T.+D.+Aicherauthor=D.+A.+Andersonauthor=B.+R.+Baerauthor=S.+A.+Boydauthor=K.+R.+Condroskiauthor=W.+E.+DeWolfauthor=C.+F.+Kraserauthor=M.+McVeanauthor=S.+P.+Rhodesauthor=H.+L.+Sturgisauthor=W.+C.+Voegtliauthor=L.+Williamsauthor=J.+B.+Houze&title=Discovery+of+2-pyridylureas+as+glucokinase+activators&doi=10.1021%2Fjm501204z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-pyridylureas as glucokinase activators</span></div><div class="casAuthors">Hinklin, Ronald J.; Aicher, Thomas D.; Anderson, Deborah A.; Baer, Brian R.; Boyd, Steven A.; Condroski, Kevin R.; DeWolf, Walter E.; Kraser, Christopher F.; McVean, Maralee; Rhodes, Susan P.; Sturgis, Hillary L.; Voegtli, Walter C.; Williams, Lance; Houze, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8180-8186</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucokinase (GK) is the rate-limiting step for insulin release from the pancreas in response to high levels of glucose.  Flux through GK also contributes to reducing hepatic glucose output.  Since many individuals with type 2 diabetes appear to have an inadequacy or defect in one or both of these processes, identifying compds. that can allosterically activate GK may address this issue.  Herein the authors report the identification and initial optimization of a novel series of glucokinase activators (GKAs).  Optimization led to the identification of I as a compd. that displayed activity in an oral glucose tolerance test (OGTT) in normal and diabetic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xEdxjFsxirVg90H21EOLACvtfcHk0lhah4m9GP4KZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsbfP&md5=6d451b02e7cc78bf7e3a376a2c8c14dd</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm501204z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501204z%26sid%3Dliteratum%253Aachs%26aulast%3DHinklin%26aufirst%3DR.%2BJ.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DD.%2BA.%26aulast%3DBaer%26aufirst%3DB.%2BR.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DKraser%26aufirst%3DC.%2BF.%26aulast%3DMcVean%26aufirst%3DM.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DSturgis%26aufirst%3DH.%2BL.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%25202-pyridylureas%2520as%2520glucokinase%2520activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8180%26epage%3D8186%26doi%3D10.1021%2Fjm501204z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">General route to 2,4,5-trisubstituted piperidines from enantiopure beta-amino esters. Total synthesis of pseudodistomin B triacetate and pseudodistomin F</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">6009</span>– <span class="NLM_lpage">6016</span>, <span class="refDoi"> DOI: 10.1021/jo000447q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo000447q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVaisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=6009-6016&author=D.+Maauthor=H.+Sun&title=General+route+to+2%2C4%2C5-trisubstituted+piperidines+from+enantiopure+beta-amino+esters.+Total+synthesis+of+pseudodistomin+B+triacetate+and+pseudodistomin+F&doi=10.1021%2Fjo000447q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">General Route to 2,4,5-Trisubstituted Piperidines from Enantiopure β-Amino Esters. Total Synthesis of Pseudodistomin B Triacetate and Pseudodistomin F</span></div><div class="casAuthors">Ma, Dawei; Sun, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6009-6016</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Michael addn. reaction of enantiopure β-amino esters with Me acrylate followed by Dieckmann condensation and enol silylation affords enol ethers I (R = BOC), which are hydrogenated with catalysis by Raney-Ni at 80 atm and 80 °C to provide 2,4,5-trisubstituted piperidines with high diastereoselectivity.  In this case Ni-H attacks the C-C double bond from the direction of the 2-alkyl group to provide the products in which the 4-hydroxy group and 5-ester moiety are trans to the 2-alkyl group.  While hydrogenation of enol ether I (R = H, R1 = OTBS) without a N-Boc protecting group gives the product in which 2,4,5-trisubstituted groups are all cis to each other.  By using the diastereoselective hydrogenation products II (R1 = HO(CH2)5) and II (R1 = OH) as key intermediates, pseudodistomin B triacetate and pseudodistomin F are synthesized.  The key steps for these transformations include Curtius rearrangement and Julia olefination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKhi57jVXm_rVg90H21EOLACvtfcHk0liwzVbcpolrQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVaisbw%253D&md5=b00309dd6023097d3970b3f2fadc328f</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjo000447q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000447q%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DGeneral%2520route%2520to%25202%252C4%252C5-trisubstituted%2520piperidines%2520from%2520enantiopure%2520beta-amino%2520esters.%2520Total%2520synthesis%2520of%2520pseudodistomin%2520B%2520triacetate%2520and%2520pseudodistomin%2520F%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D6009%26epage%3D6016%26doi%3D10.1021%2Fjo000447q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Migawa, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swayze, E. E.</span></span> <span> </span><span class="NLM_article-title">A solid-phase synthesis of <i>N,N’</i>-disubstituted ureas and Perhydroimidazo</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3309</span>– <span class="NLM_lpage">3311</span>, <span class="refDoi"> DOI: 10.1021/ol006383n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006383n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1ShtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3309-3311&author=M.+T.+Migawaauthor=E.+E.+Swayze&title=A+solid-phase+synthesis+of+N%2CN%E2%80%99-disubstituted+ureas+and+Perhydroimidazo&doi=10.1021%2Fol006383n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">A Solid-Phase Synthesis of N,N'-Disubstituted Ureas and Perhydroimidazo[1,5-a]pyrazines via the Curtius Rearrangement</span></div><div class="casAuthors">Migawa, Michael T.; Swayze, Eric E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3309-3311</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method for trapping isocyanates, generated from the Curtius rearrangement, with resin-bound amines is reported.  A com. available carboxylic acid is treated with diphenylphosphoryl azide, followed by thermal rearrangement, cooling, and trapping in one pot.  Cleavage from the resin gives an N,N'-disubstituted urea in excellent purity, as demonstrated with several heterocyclic and aliph. carboxylic acids.  Further utility is shown by prepg. several novel perhydroimidazo[1,5-a]pyrazines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxDALVwThm4LVg90H21EOLACvtfcHk0liwzVbcpolrQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1ShtL4%253D&md5=89f7b8bf1816f8fb73bfd6674c992a7c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fol006383n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006383n%26sid%3Dliteratum%253Aachs%26aulast%3DMigawa%26aufirst%3DM.%2BT.%26aulast%3DSwayze%26aufirst%3DE.%2BE.%26atitle%3DA%2520solid-phase%2520synthesis%2520of%2520N%252CN%25E2%2580%2599-disubstituted%2520ureas%2520and%2520Perhydroimidazo%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3309%26epage%3D3311%26doi%3D10.1021%2Fol006383n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, A.</span></span> <span> </span><span class="NLM_article-title">The Curtius rearrangement: applications in modern drug discovery and medicinal chemistry</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2373</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fcmdc.201800518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=30187672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVygs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2351-2373&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=A.+Sarkar&title=The+Curtius+rearrangement%3A+applications+in+modern+drug+discovery+and+medicinal+chemistry&doi=10.1002%2Fcmdc.201800518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Sarkar, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2351-2373</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The Curtius rearrangement is the thermal decompn. of an acyl azide derived from carboxylic acid to produce an isocyanate as the initial product.  The isocyanate can undergo further reactions to provide amines and their derivs.  Due to its tolerance for a large variety of functional groups and complete retention of stereochem. during rearrangement, the Curtius rearrangement has been used in the synthesis of a wide variety of medicinal agents with amines and amine-derived functional groups such as ureas and urethanes.  The current review outlines various applications of the Curtius rearrangement in drug discovery and medicinal chem.  In particular, the review highlights some widely used rearrangement methods, syntheses of some key agents for popular drug targets and FDA-approved drugs.  In addn., the review highlights applications of the Curtius rearrangement in continuous-flow protocols for the scale-up of active pharmaceutical ingredients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhw8Uw6o6owLVg90H21EOLACvtfcHk0liwzVbcpolrQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVygs7zM&md5=da82f908635028b26540cbe25080ee63</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800518%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DSarkar%26aufirst%3DA.%26atitle%3DThe%2520Curtius%2520rearrangement%253A%2520applications%2520in%2520modern%2520drug%2520discovery%2520and%2520medicinal%2520chemistry%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D2351%26epage%3D2373%26doi%3D10.1002%2Fcmdc.201800518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span> <span> </span><span class="NLM_article-title">The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2006</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1039/C8OB00138C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC8OB00138C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=29479624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlKguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=2006-2027&author=A.+K.+Ghoshauthor=A.+Sarkarauthor=M.+Brindisi&title=The+Curtius+rearrangement%3A+mechanistic+insight+and+recent+applications+in+natural+product+syntheses&doi=10.1039%2FC8OB00138C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses</span></div><div class="casAuthors">Ghosh, Arun K.; Sarkar, Anindya; Brindisi, Margherita</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2006-2027</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The Curtius rearrangement is a versatile reaction in which a carboxylic acid can be converted to an isocyanate through an acyl azide intermediate under mild conditions.  The resulting stable isocyanate can then be readily transformed into a variety of amines and amine derivs. including urethanes and ureas.  There have been wide-ranging applications of the Curtius rearrangement in the synthesis of natural products and their derivs.  Also, this reaction has been extensively utilized in the synthesis and application of a variety of biomols.  In this review, we present mechanistic studies, chem. methodologies and reagents for the synthesis of isocyanates from carboxylic acids, the conversion of isocyanates to amines and amine derivs., and their applications in the synthesis of bioactive natural products and their congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxXsMDCLjtKLVg90H21EOLACvtfcHk0lgjh6ArJbtdsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlKguro%253D&md5=242915726420c02b495c466675f713dc</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1039%2FC8OB00138C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB00138C%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DSarkar%26aufirst%3DA.%26aulast%3DBrindisi%26aufirst%3DM.%26atitle%3DThe%2520Curtius%2520rearrangement%253A%2520mechanistic%2520insight%2520and%2520recent%2520applications%2520in%2520natural%2520product%2520syntheses%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2018%26volume%3D16%26spage%3D2006%26epage%3D2027%26doi%3D10.1039%2FC8OB00138C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. P.</span></span> <span> </span><span class="NLM_article-title">Development of a scalable synthesis of an azaindolyl-pyrimidine inhibitor of influenza virus replication</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.6b00063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.6b00063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Gqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=965-969&author=J.+L.+Liangauthor=J.+E.+Cochranauthor=W.+A.+Dorschauthor=I.+Daviesauthor=M.+P.+Clark&title=Development+of+a+scalable+synthesis+of+an+azaindolyl-pyrimidine+inhibitor+of+influenza+virus+replication&doi=10.1021%2Facs.oprd.6b00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Scalable Synthesis of an Azaindolyl-Pyrimidine Inhibitor of Influenza Virus Replication</span></div><div class="casAuthors">Liang, Jianglin; Cochran, John E.; Dorsch, Warren A.; Davies, Ioana; Clark, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">965-969</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scalable, asym. route for the synthesis of the influenza virus replication inhibitor I is presented.  The key steps include an enzymic desymmetrization of cis-1,3-cyclohexane diester in 99% yield and 96% ee, SNAr displacement of a methanesulfinylpyrimidine, and a Curtius rearrangement to form a morpholinyl urea.  This high-yielding route allowed us to rapidly synthesize hundreds of grams of I in 99% purity to support in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBIFVjisPoRrVg90H21EOLACvtfcHk0lgjh6ArJbtdsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Gqt7s%253D&md5=559465f677ef840c96d7100ea5cc2ad4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.6b00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.6b00063%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%2BL.%26aulast%3DCochran%26aufirst%3DJ.%2BE.%26aulast%3DDorsch%26aufirst%3DW.%2BA.%26aulast%3DDavies%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DM.%2BP.%26atitle%3DDevelopment%2520of%2520a%2520scalable%2520synthesis%2520of%2520an%2520azaindolyl-pyrimidine%2520inhibitor%2520of%2520influenza%2520virus%2520replication%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2016%26volume%3D20%26spage%3D965%26epage%3D969%26doi%3D10.1021%2Facs.oprd.6b00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narendra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennakrishnareddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureshbabu, V. V.</span></span> <span> </span><span class="NLM_article-title">Application of carbodiimide mediated Lossen rearrangement for the synthesis of alpha-ureidopeptides and peptidyl ureas employing N-urethane alpha-amino/peptidyl hydroxamic acids</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3520</span>– <span class="NLM_lpage">3526</span>, <span class="refDoi"> DOI: 10.1039/b905790k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb905790k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19675909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsl2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=3520-3526&author=N.+Narendraauthor=G.+Chennakrishnareddyauthor=V.+V.+Sureshbabu&title=Application+of+carbodiimide+mediated+Lossen+rearrangement+for+the+synthesis+of+alpha-ureidopeptides+and+peptidyl+ureas+employing+N-urethane+alpha-amino%2Fpeptidyl+hydroxamic+acids&doi=10.1039%2Fb905790k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Application of carbodiimide mediated Lossen rearrangement for the synthesis of α-ureidopeptides and peptidyl ureas employing N-urethane α-amino/peptidyl hydroxamic acids</span></div><div class="casAuthors">Narendra, N.; Chennakrishnareddy, Gundala; Sureshbabu, Vommina V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3520-3526</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Application of the Lossen rearrangement to the synthesis of N-urethane protected α-peptidyl ureas and ureidopeptides is reported.  The carbodiimide mediated rearrangement of N-Boc/Z/Fmoc protected α-amino/peptide hydroxamic acids into isocyanates and coupling of the latter with the amino acid esters/peptide esters have been accomplished in a single-pot to obtain good yields of urea products.  Synthesis of the ureidoalanine derivs. via the hydroxamate derivs. of N-protected aspartic acid has also been carried out using the same procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBlImPKeZ5GbVg90H21EOLACvtfcHk0lin5qtBeYlnsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsl2itro%253D&md5=5200b814eda702317ece792aaf9900b2</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1039%2Fb905790k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905790k%26sid%3Dliteratum%253Aachs%26aulast%3DNarendra%26aufirst%3DN.%26aulast%3DChennakrishnareddy%26aufirst%3DG.%26aulast%3DSureshbabu%26aufirst%3DV.%2BV.%26atitle%3DApplication%2520of%2520carbodiimide%2520mediated%2520Lossen%2520rearrangement%2520for%2520the%2520synthesis%2520of%2520alpha-ureidopeptides%2520and%2520peptidyl%2520ureas%2520employing%2520N-urethane%2520alpha-amino%252Fpeptidyl%2520hydroxamic%2520acids%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D3520%26epage%3D3526%26doi%3D10.1039%2Fb905790k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dube, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathel, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couturier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboussafy, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardink, M.</span></span> <span> </span><span class="NLM_article-title">Carbonyldiimidazole-mediated Lossen rearrangement</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5622</span>– <span class="NLM_lpage">5625</span>, <span class="refDoi"> DOI: 10.1021/ol9023387</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9023387" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=5622-5625&author=P.+Dubeauthor=N.+F.+Nathelauthor=M.+Vetelinoauthor=M.+Couturierauthor=C.+L.+Aboussafyauthor=S.+Pichetteauthor=M.+L.+Jorgensenauthor=M.+Hardink&title=Carbonyldiimidazole-mediated+Lossen+rearrangement&doi=10.1021%2Fol9023387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonyldiimidazole-Mediated Lossen Rearrangement</span></div><div class="casAuthors">Dube, Pascal; Nathel, Noah F. Fine; Vetelino, Michael; Couturier, Michel; Aboussafy, Claude Larrivee; Pichette, Simon; Jorgensen, Matthew L.; Hardink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5622-5625</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbonyldiimidazole (CDI) was found to mediate the Lossen rearrangement of various hydroxamic acids to isocyanates.  This process is exptl. simple and mild, with imidazole and CO2 being the sole stoichiometric byproducts.  Significant for large-scale application, the method avoids the use of hazardous reagents and thus represents a green alternative to std. processing conditions for the Curtius and Hofmann rearrangements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN1ZnlIQT6b7Vg90H21EOLACvtfcHk0lin5qtBeYlnsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtLvI&md5=84290a969989a97ed2067de0a77512e0</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fol9023387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9023387%26sid%3Dliteratum%253Aachs%26aulast%3DDube%26aufirst%3DP.%26aulast%3DNathel%26aufirst%3DN.%2BF.%26aulast%3DVetelino%26aufirst%3DM.%26aulast%3DCouturier%26aufirst%3DM.%26aulast%3DAboussafy%26aufirst%3DC.%2BL.%26aulast%3DPichette%26aufirst%3DS.%26aulast%3DJorgensen%26aufirst%3DM.%2BL.%26aulast%3DHardink%26aufirst%3DM.%26atitle%3DCarbonyldiimidazole-mediated%2520Lossen%2520rearrangement%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D5622%26epage%3D5625%26doi%3D10.1021%2Fol9023387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vasantha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemantha, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureshbabu, V. V.</span></span> <span> </span><span class="NLM_article-title">1-Propanephosphonic acid cyclic anhydride (T3P) as an efficient promoter for the Lossen rearrangement: application to the synthesis of urea and carbamate derivatives</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span>,  <span class="NLM_fpage">2990</span>– <span class="NLM_lpage">2996</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1258158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0030-1258158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=2990-2996&author=B.+Vasanthaauthor=H.+P.+Hemanthaauthor=V.+V.+Sureshbabu&title=1-Propanephosphonic+acid+cyclic+anhydride+%28T3P%29+as+an+efficient+promoter+for+the+Lossen+rearrangement%3A+application+to+the+synthesis+of+urea+and+carbamate+derivatives&doi=10.1055%2Fs-0030-1258158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1258158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1258158%26sid%3Dliteratum%253Aachs%26aulast%3DVasantha%26aufirst%3DB.%26aulast%3DHemantha%26aufirst%3DH.%2BP.%26aulast%3DSureshbabu%26aufirst%3DV.%2BV.%26atitle%3D1-Propanephosphonic%2520acid%2520cyclic%2520anhydride%2520%2528T3P%2529%2520as%2520an%2520efficient%2520promoter%2520for%2520the%2520Lossen%2520rearrangement%253A%2520application%2520to%2520the%2520synthesis%2520of%2520urea%2520and%2520carbamate%2520derivatives%26jtitle%3DSynthesis%26date%3D2010%26volume%3D2010%26spage%3D2990%26epage%3D2996%26doi%3D10.1055%2Fs-0030-1258158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thalluri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manne, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, B.</span></span> <span> </span><span class="NLM_article-title">Ethyl 2-cyano-2-(4-nitrophenylsulfonyloxyimino)acetate-mediated Lossen rearrangement: single-pot racemization-free synthesis of hydroxamic acids and ureas from carboxylic acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">3765</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1021/jo4026429</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo4026429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=3765-3775&author=K.+Thalluriauthor=S.+R.+Manneauthor=D.+Devauthor=B.+Mandal&title=Ethyl+2-cyano-2-%284-nitrophenylsulfonyloxyimino%29acetate-mediated+Lossen+rearrangement%3A+single-pot+racemization-free+synthesis+of+hydroxamic+acids+and+ureas+from+carboxylic+acids&doi=10.1021%2Fjo4026429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Ethyl 2-Cyano-2-(4-nitrophenylsulfonyloxyimino)acetate-Mediated Lossen Rearrangement: Single-Pot Racemization-Free Synthesis of Hydroxamic Acids and Ureas from Carboxylic Acids</span></div><div class="casAuthors">Thalluri, Kishore; Manne, Srinivasa Rao; Dev, Dharm; Mandal, Bhubaneswar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3765-3775</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Et 2-cyano-2-(4-nitrophenylsulfonyloxyimino)acetate (4-NBsOXY) mediated Lossen rearrangement and its application for the synthesis of ureas is demonstrated.  Required hydroxamic acids for the Lossen rearrangements were synthesized from carboxylic acids using the same reagent.  Finally, reaction of an amine with the produced isocyanate resulted in urea.  Good yields without racemization were achieved under milder and simpler reaction conditions.  Reactions are compatible with common N-protecting groups, such as Boc, Fmoc, Cbz, and benzyl, as well as various OH protecting groups, such as tBu and Bzl.  Conversion from carboxylic acid to urea is achieved in one pot.  Most importantly, byproducts Oxyma [ethyl 2-cyano-2-(hydroxyimino)acetate] and 4-nitrobenzenesulfonic acid can be recovered easily and can be recycled to prep. the reagent.  Thus, the method is environmentally friendly and cost-effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6H0-DKuUJNrVg90H21EOLACvtfcHk0ljnK2j5jtsuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsrs%253D&md5=b549f4d579d7234fed518901b1669677</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjo4026429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4026429%26sid%3Dliteratum%253Aachs%26aulast%3DThalluri%26aufirst%3DK.%26aulast%3DManne%26aufirst%3DS.%2BR.%26aulast%3DDev%26aufirst%3DD.%26aulast%3DMandal%26aufirst%3DB.%26atitle%3DEthyl%25202-cyano-2-%25284-nitrophenylsulfonyloxyimino%2529acetate-mediated%2520Lossen%2520rearrangement%253A%2520single-pot%2520racemization-free%2520synthesis%2520of%2520hydroxamic%2520acids%2520and%2520ureas%2520from%2520carboxylic%2520acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D3765%26epage%3D3775%26doi%3D10.1021%2Fjo4026429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leogane, O.</span></span> <span> </span><span class="NLM_article-title">Curtius rearrangement of aromatic carboxylic acids to access protected anilines and aromatic ureas</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5717</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi"> DOI: 10.1021/ol0622920</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0622920" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WhsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=5717-5720&author=H.+Lebelauthor=O.+Leogane&title=Curtius+rearrangement+of+aromatic+carboxylic+acids+to+access+protected+anilines+and+aromatic+ureas&doi=10.1021%2Fol0622920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Curtius rearrangement of aromatic carboxylic acids to access protected anilines and aromatic ureas</span></div><div class="casAuthors">Lebel, Helene; Leogane, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5717-5720</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The reaction of a chloroformate or di-tert-Bu dicarbonate and sodium azide with an arom. carboxylic acid produced the corresponding acyl azide, presumably through the formation of an azidoformate.  The acyl azide underwent a Curtius rearrangement to form an isocyanate deriv. which was trapped either by an alkoxide or by an amine to form the arom. carbamate or urea.  The reaction conditions were compatible with a variety of functional groups and allowed the synthesis of a series of aniline derivs. contg. alkyl, halide, nitro, ketone, ether, and thioether substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTWwUjS6F9LVg90H21EOLACvtfcHk0ljnK2j5jtsuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WhsLfN&md5=1c09a86ebebdb7d8716dff08614d7436</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fol0622920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0622920%26sid%3Dliteratum%253Aachs%26aulast%3DLebel%26aufirst%3DH.%26aulast%3DLeogane%26aufirst%3DO.%26atitle%3DCurtius%2520rearrangement%2520of%2520aromatic%2520carboxylic%2520acids%2520to%2520access%2520protected%2520anilines%2520and%2520aromatic%2520ureas%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D5717%26epage%3D5720%26doi%3D10.1021%2Fol0622920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hemantha, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennakrishnareddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwanatha, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureshbabu, V. V.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of ureido peptides and urea-tethered glycosylated amino acids employing Deoxo-Fluor and TMSN<sub>3</sub></span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1055/s-0028-1087538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0028-1087538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=407-410&author=H.+P.+Hemanthaauthor=G.+Chennakrishnareddyauthor=T.+M.+Vishwanathaauthor=V.+V.+Sureshbabu&title=One-pot+synthesis+of+ureido+peptides+and+urea-tethered+glycosylated+amino+acids+employing+Deoxo-Fluor+and+TMSN3&doi=10.1055%2Fs-0028-1087538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1087538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1087538%26sid%3Dliteratum%253Aachs%26aulast%3DHemantha%26aufirst%3DH.%2BP.%26aulast%3DChennakrishnareddy%26aufirst%3DG.%26aulast%3DVishwanatha%26aufirst%3DT.%2BM.%26aulast%3DSureshbabu%26aufirst%3DV.%2BV.%26atitle%3DOne-pot%2520synthesis%2520of%2520ureido%2520peptides%2520and%2520urea-tethered%2520glycosylated%2520amino%2520acids%2520employing%2520Deoxo-Fluor%2520and%2520TMSN3%26jtitle%3DSynlett%26date%3D2009%26volume%3D2009%26spage%3D407%26epage%3D410%26doi%3D10.1055%2Fs-0028-1087538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, G. A.</span></span> <span> </span><span class="NLM_article-title">Scalable, one-pot, microwave-accelerated tandem synthesis of unsymmetrical urea derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b02521</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b02521" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2nurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=992-999&author=A.+R.+Kulkarniauthor=S.+Garaiauthor=G.+A.+Thakur&title=Scalable%2C+one-pot%2C+microwave-accelerated+tandem+synthesis+of+unsymmetrical+urea+derivatives&doi=10.1021%2Facs.joc.6b02521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable, One-Pot, Microwave-Accelerated Tandem Synthesis of Unsymmetrical Urea Derivatives</span></div><div class="casAuthors">Kulkarni, Abhijit R.; Garai, Sumanta; Thakur, Ganesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">992-999</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a facile, microwave-accelerated, one-pot tandem synthesis of unsym. ureas via Curtius rearrangement.  In this method, one-pot microwave irradn. of com. available (hetero)arom. acids and amines in presence of diphenylphosphorylazide enabled extremely rapid (1-5 mins) construction of an array of unsym. ureas in good to excellent yields.  We demonstrate the utility of our method in efficient, gram-scale synthesis of key biol. active compds. targeting the cannabinoid 1 and α7 nicotinic acetylcholine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoctWwDicAShbVg90H21EOLACvtfcHk0lj3AlHpr3A_hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2nurbM&md5=4eed27924c955b05fed3b794c96a25f7</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b02521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b02521%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DA.%2BR.%26aulast%3DGarai%26aufirst%3DS.%26aulast%3DThakur%26aufirst%3DG.%2BA.%26atitle%3DScalable%252C%2520one-pot%252C%2520microwave-accelerated%2520tandem%2520synthesis%2520of%2520unsymmetrical%2520urea%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D992%26epage%3D999%26doi%3D10.1021%2Facs.joc.6b02521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. M.</span></span> <span> </span><span class="NLM_article-title">Highly efficient synthesis of ureas and carbamates from amides by iodosylbenzene-induced Hofmann rearrangement</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">1994</span>– <span class="NLM_lpage">2000</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201101784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201101784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1WmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1994-2000&author=P.+Liuauthor=Z.+M.+Wangauthor=X.+M.+Hu&title=Highly+efficient+synthesis+of+ureas+and+carbamates+from+amides+by+iodosylbenzene-induced+Hofmann+rearrangement&doi=10.1002%2Fejoc.201101784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient Synthesis of Ureas and Carbamates from Amides by Iodosylbenzene-Induced Hofmann Rearrangement</span></div><div class="casAuthors">Liu, Peng; Wang, Zhiming; Hu, Xianming</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1994-2000, S1994/1-S1994/38</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A simple and efficient method for the synthesis of 1,3-disubstituted ureas and carbamates from amides by using iodosylbenzene as the oxidant is described.  Sym. and asym. ureas and carbamates can be prepd. by this procedure in up to 98 % yield.  Ureidopeptides can also be prepd. in good yield by this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroQoakyCi6wLVg90H21EOLACvtfcHk0lhLPj42gcWEEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1WmtLk%253D&md5=f22738c3c3a87bfcb9f4cffb518d3420</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201101784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201101784%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DZ.%2BM.%26aulast%3DHu%26aufirst%3DX.%2BM.%26atitle%3DHighly%2520efficient%2520synthesis%2520of%2520ureas%2520and%2520carbamates%2520from%2520amides%2520by%2520iodosylbenzene-induced%2520Hofmann%2520rearrangement%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D1994%26epage%3D2000%26doi%3D10.1002%2Fejoc.201101784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, T. C.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of <i>N</i>-monosubstituted ureas from nitriles via Tiemann rearrangement</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1823</span>– <span class="NLM_lpage">1826</span>, <span class="refDoi"> DOI: 10.1055/s-0034-1381007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0034-1381007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2rsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=1823-1826&author=C.+H.+Wangauthor=T.+H.+Hsiehauthor=C.+C.+Linauthor=W.+H.+Yehauthor=C.+A.+Linauthor=T.+C.+Chien&title=One-pot+synthesis+of+N-monosubstituted+ureas+from+nitriles+via+Tiemann+rearrangement&doi=10.1055%2Fs-0034-1381007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Synthesis of N-Monosubstituted Ureas from Nitriles via Tiemann Rearrangement</span></div><div class="casAuthors">Wang, Chien-Hong; Hsieh, Tsung-Han; Lin, Chia-Chi; Yeh, Wen-Hsiung; Lin, Chih-An; Chien, Tun-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1823-1826</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Amidoximes, obtained from the reaction of nitriles with hydroxylamine, underwent Tiemann rearrangement in the presence of benzenesulfonyl chlorides (TsCl or o-NsCl) to form the N-substituted cyanamides.  Subsequently, acidic hydrolysis of the cyanamides afforded the corresponding N-monosubstituted ureas.  The synthesis of N-monosubstituted ureas from nitriles was accomplished by three steps in one pot, which provides a direct access to versatile N-monosubstituted urea derivs. from a wide variety of nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1jAs8AXBZc7Vg90H21EOLACvtfcHk0lhLPj42gcWEEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2rsL3O&md5=40667ce2551cd4d1fa13ec7c3169829d</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1055%2Fs-0034-1381007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0034-1381007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DT.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DYeh%26aufirst%3DW.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BA.%26aulast%3DChien%26aufirst%3DT.%2BC.%26atitle%3DOne-pot%2520synthesis%2520of%2520N-monosubstituted%2520ureas%2520from%2520nitriles%2520via%2520Tiemann%2520rearrangement%26jtitle%3DSynlett%26date%3D2015%26volume%3D26%26spage%3D1823%26epage%3D1826%26doi%3D10.1055%2Fs-0034-1381007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feberero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez-Pantiga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabello, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, R.</span></span> <span> </span><span class="NLM_article-title">1,5-O --> N Carbamoyl Snieckus-Fries-type rearrangement</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2437</span>– <span class="NLM_lpage">2440</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b00782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b00782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVKhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=2437-2440&author=C.+Febereroauthor=S.+Suarez-Pantigaauthor=Z.+Cabelloauthor=R.+Sanz&title=1%2C5-O+%2D%2D%3E+N+Carbamoyl+Snieckus-Fries-type+rearrangement&doi=10.1021%2Facs.orglett.8b00782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-O → N Carbamoyl Snieckus-Fries-Type Rearrangement</span></div><div class="casAuthors">Feberero, Claudia; Suarez-Pantiga, Samuel; Cabello, Zaida; Sanz, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2437-2440</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The reaction of o-lithiated O-aryl N,N-diethylcarbamates with (hetero)arom. nitriles gives rise to functionalized salicylidene urea derivs. in high yields through a new 1,5-O → N carbamoyl migration.  This Snieckus-Fries-type rearrangement nicely complements previously known O → C and O → O related shifts.  In addn., when dimethylmalononitrile is used as the electrophilic partner, the carbamoyl shift is preferred over the expected transnitrilation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_PBxX6Huv3LVg90H21EOLACvtfcHk0lgA7dwB_-o3LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVKhs7g%253D&md5=b88ab257c22364568c9caf10a497c8ce</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b00782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b00782%26sid%3Dliteratum%253Aachs%26aulast%3DFeberero%26aufirst%3DC.%26aulast%3DSuarez-Pantiga%26aufirst%3DS.%26aulast%3DCabello%26aufirst%3DZ.%26aulast%3DSanz%26aufirst%3DR.%26atitle%3D1%252C5-O%2520--%253E%2520N%2520Carbamoyl%2520Snieckus-Fries-type%2520rearrangement%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D2437%26epage%3D2440%26doi%3D10.1021%2Facs.orglett.8b00782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conforti, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccinno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, G.</span></span> <span> </span><span class="NLM_article-title">Clean synthesis in water: uncatalysed preparation of ylidenemalononitriles</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1039/b001246g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fb001246g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktV2iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=101-103&author=F.+Bigiauthor=M.+L.+Confortiauthor=R.+Maggiauthor=A.+Piccinnoauthor=G.+Sartori&title=Clean+synthesis+in+water%3A+uncatalysed+preparation+of+ylidenemalononitriles&doi=10.1039%2Fb001246g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Clean synthesis in water: uncatalyzed preparation of ylidenemalononitriles</span></div><div class="casAuthors">Bigi, Franca; Conforti, Maria Lina; Maggi, Raimondo; Piccinno, Annalisa; Sartori, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">101-103</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A simple, efficient and environment-friendly procedure is developed for the condensation of malononitrile with arom., heteroarom. and aliph. aldehydes in water.  The ylidenemalononitriles are synthesized in high yields (84-98%) and selectivities (87-98%) in distd. water at 65° for 1 h, avoiding the addn. of any catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMaclXyT4pI7Vg90H21EOLACvtfcHk0lgA7dwB_-o3LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktV2iurk%253D&md5=ebe400cff5104c68353e8c260a6a7aff</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1039%2Fb001246g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb001246g%26sid%3Dliteratum%253Aachs%26aulast%3DBigi%26aufirst%3DF.%26aulast%3DConforti%26aufirst%3DM.%2BL.%26aulast%3DMaggi%26aufirst%3DR.%26aulast%3DPiccinno%26aufirst%3DA.%26aulast%3DSartori%26aufirst%3DG.%26atitle%3DClean%2520synthesis%2520in%2520water%253A%2520uncatalysed%2520preparation%2520of%2520ylidenemalononitriles%26jtitle%3DGreen%2520Chem.%26date%3D2000%26volume%3D2%26spage%3D101%26epage%3D103%26doi%3D10.1039%2Fb001246g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darko, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElwee-White, L.</span></span> <span> </span><span class="NLM_article-title">Transition metal-catalyzed oxidative carbonylation of amines to ureas</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">4453</span>– <span class="NLM_lpage">4465</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200700148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.200700148" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=4453-4465&author=D.+J.+Diazauthor=A.+K.+Darkoauthor=L.+McElwee-White&title=Transition+metal-catalyzed+oxidative+carbonylation+of+amines+to+ureas&doi=10.1002%2Fejoc.200700148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200700148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200700148%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DD.%2BJ.%26aulast%3DDarko%26aufirst%3DA.%2BK.%26aulast%3DMcElwee-White%26aufirst%3DL.%26atitle%3DTransition%2520metal-catalyzed%2520oxidative%2520carbonylation%2520of%2520amines%2520to%2520ureas%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D4453%26epage%3D4465%26doi%3D10.1002%2Fejoc.200700148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, N.</span></span> <span> </span><span class="NLM_article-title">Organic synthesis by means of noble-metal compounds. Palladium-catalyzed carbonylation of amines</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_fpage">380</span>, <span class="refDoi"> DOI: 10.1039/c19660000380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc19660000380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaF28Xktlyisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=380&author=J.+Tsujiauthor=N.+Iwamoto&title=Organic+synthesis+by+means+of+noble-metal+compounds.+Palladium-catalyzed+carbonylation+of+amines&doi=10.1039%2Fc19660000380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis by means of noble-metal compounds. Palladium-catalyzed carbonylation of amines</span></div><div class="casAuthors">Tsuji, J.; Iwamoto, N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (London)</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">380</span>CODEN:
                <span class="NLM_cas:coden">CCOMA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-241X</span>.
    </div><div class="casAbstract">Primary amines can be carbonylated to form disubstituted ureas and oxamides while H is produced.  Thus, 7.9 g. n-decylamine, 0.5 g. PdCl2, and 30 ml. benzene in a glass vessel was placed in an autoclave.  A CO pressure of 10 kg./cm.2 was applied and the reaction carried out by shaking 20 hrs. at 180°. N,N'-Didecyloxamide (m. 122°) (3.8 g.) and 2.2 g. 1,3-didecylurea (m. 97-8) were obtained.  The H formation was followed by gas chromatography.  Classes and proportions of the products depend mainly on the catalyst form and the amines used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotc-VJZSM-TLVg90H21EOLACvtfcHk0lhzL2i_cHn-rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28Xktlyisrk%253D&md5=17a63c2ec4d7cb1bb67bc843dcd27ef2</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1039%2Fc19660000380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc19660000380%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DJ.%26aulast%3DIwamoto%26aufirst%3DN.%26atitle%3DOrganic%2520synthesis%2520by%2520means%2520of%2520noble-metal%2520compounds.%2520Palladium-catalyzed%2520carbonylation%2520of%2520amines%26jtitle%3DChem.%2520Commun.%26date%3D1966%26spage%3D380%26doi%3D10.1039%2Fc19660000380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, G.</span></span> <span> </span><span class="NLM_article-title">Oxidative carbonylation as a powerful tool for the direct synthesis of carbonylated heterocycles</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">6825</span>– <span class="NLM_lpage">6839</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201200794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201200794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=6825-6839&author=B.+Gabrieleauthor=R.+Mancusoauthor=G.+Salerno&title=Oxidative+carbonylation+as+a+powerful+tool+for+the+direct+synthesis+of+carbonylated+heterocycles&doi=10.1002%2Fejoc.201200794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative carbonylation as a powerful tool for the direct synthesis of carbonylated heterocycles</span></div><div class="casAuthors">Gabriele, Bartolo; Mancuso, Raffaella; Salerno, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">6825-6839</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Recent advances in the field of oxidative carbonylation reactions leading to carbonylated heterocyclic derivs. were presented (coverage: 2006 to the beginning of 2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCCFM0DpzpBLVg90H21EOLACvtfcHk0lg71UfcM-zJBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrnN&md5=bb64a1e3b829b7f2852cc50d798a97d5</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201200794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201200794%26sid%3Dliteratum%253Aachs%26aulast%3DGabriele%26aufirst%3DB.%26aulast%3DMancuso%26aufirst%3DR.%26aulast%3DSalerno%26aufirst%3DG.%26atitle%3DOxidative%2520carbonylation%2520as%2520a%2520powerful%2520tool%2520for%2520the%2520direct%2520synthesis%2520of%2520carbonylated%2520heterocycles%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D6825%26epage%3D6839%26doi%3D10.1002%2Fejoc.201200794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukuoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, M.</span></span> <span> </span><span class="NLM_article-title">A novel catalytic synthesis of carbamates by oxydative alkoxycarbonylation of amines in the presence of palladium and iodide</span>. <i>J. Chem. Soc., Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1039/c39840000399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc39840000399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaL2cXkvFSmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=399-400&author=S.+Fukuokaauthor=M.+Chonoauthor=M.+Kohno&title=A+novel+catalytic+synthesis+of+carbamates+by+oxydative+alkoxycarbonylation+of+amines+in+the+presence+of+palladium+and+iodide&doi=10.1039%2Fc39840000399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">A novel catalytic synthesis of carbamates by oxidative alkoxycarbonylation of amines in the presence of palladium and iodide</span></div><div class="casAuthors">Fukuoka, Shinsuke; Chono, Masazumi; Kohno, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">399-400</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">Oxidative carbonylation of amines by CO, O, and alcs. to give high yields of carbamates was catalyzed by metallic Pd and I-.  A mixt. of PhNH2, EtOH, Pd black, and NaI under 80 kg/cm2 CO was further pressurized to 86 kg/cm2 by O and heated 2 h at 160-170° to give 93% EtO2CNHPh with 98% selectivity and 95% conversion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRHruWd5n6UrVg90H21EOLACvtfcHk0lg71UfcM-zJBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvFSmsbw%253D&md5=c9d4d561144f87771f25849f1db0035a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1039%2Fc39840000399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39840000399%26sid%3Dliteratum%253Aachs%26aulast%3DFukuoka%26aufirst%3DS.%26aulast%3DChono%26aufirst%3DM.%26aulast%3DKohno%26aufirst%3DM.%26atitle%3DA%2520novel%2520catalytic%2520synthesis%2520of%2520carbamates%2520by%2520oxydative%2520alkoxycarbonylation%2520of%2520amines%2520in%2520the%2520presence%2520of%2520palladium%2520and%2520iodide%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1984%26spage%3D399%26epage%3D400%26doi%3D10.1039%2Fc39840000399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolhe, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagasabapathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, R. V.</span></span> <span> </span><span class="NLM_article-title">Selectivity behavior in catalytic oxidative carbonylation of alkylamines</span>. <i>Ind. Eng. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1021/ie00001a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ie00001a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK38XktVyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=172-176&author=A.+A.+Kelkarauthor=D.+S.+Kolheauthor=S.+Kanagasabapathyauthor=R.+V.+Chaudhari&title=Selectivity+behavior+in+catalytic+oxidative+carbonylation+of+alkylamines&doi=10.1021%2Fie00001a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity behavior in catalytic oxidative carbonylation of alkyl amines</span></div><div class="casAuthors">Kelkar, Ashutosh A.; Kolhe, Devidas S.; Kanagasabapathy, Subbareddy; Chaudhari, Raghunath V.</div><div class="citationInfo"><span class="NLM_cas:title">Industrial & Engineering Chemistry Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-6</span>CODEN:
                <span class="NLM_cas:coden">IECRED</span>;
        ISSN:<span class="NLM_cas:issn">0888-5885</span>.
    </div><div class="casAbstract">Alkyl carbamates are prepd. in good yields by oxidative carbonylation of alkylamines using a transition-metal catalyst and sodium iodide promoter.  Various homogeneous and heterogeneous transition-metal catalysts are studied.  Synthesis of Me N-methylcarbamate by oxidative carbonylation of methylamine is reported for the first time using the Pd-NaI catalyst system.  The effects of various process parameters on oxidative carbonylation of methylamine are studied in detail.  It is found that the selectivity pattern is strongly dependent on the type of catalyst used, the concn. of methylamine, the CO:O2 ratio, and the temp.  A possible mechanism based on the results is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPT_1on_doNLVg90H21EOLACvtfcHk0liSd7QaA0cUmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVyrtA%253D%253D&md5=cd7f542aa3ebc2df1bb3bc5437631291</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fie00001a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fie00001a024%26sid%3Dliteratum%253Aachs%26aulast%3DKelkar%26aufirst%3DA.%2BA.%26aulast%3DKolhe%26aufirst%3DD.%2BS.%26aulast%3DKanagasabapathy%26aufirst%3DS.%26aulast%3DChaudhari%26aufirst%3DR.%2BV.%26atitle%3DSelectivity%2520behavior%2520in%2520catalytic%2520oxidative%2520carbonylation%2520of%2520alkylamines%26jtitle%3DInd.%2520Eng.%2520Chem.%2520Res.%26date%3D1992%26volume%3D31%26spage%3D172%26epage%3D176%26doi%3D10.1021%2Fie00001a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiusoli, G. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-oxazolidinones by direct palladium-catalyzed oxidative carbonylation of 2-amino-1-alkanols</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1021/ol9913789</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9913789" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVCrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=625-627&author=B.+Gabrieleauthor=G.+Salernoauthor=D.+Brindisiauthor=M.+Costaauthor=G.+P.+Chiusoli&title=Synthesis+of+2-oxazolidinones+by+direct+palladium-catalyzed+oxidative+carbonylation+of+2-amino-1-alkanols&doi=10.1021%2Fol9913789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-oxazolidinones by direct palladium-catalyzed oxidative carbonylation of 2-amino-1-alkanols</span></div><div class="casAuthors">Gabriele, Bartolo; Salerno, Giuseppe; Brindisi, Donatella; Costa, Mirco; Chiusoli, Gian Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-627</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The oxazolidinones I (R, R1 = H, H; Me, H; Ph, H; H, Me; H, Ph; H, i-Pr; H, benzyl) were obtained in excellent yields (up to 100%) and with unprecedented catalytic efficiencies (up to 2000 mol of product/mol of catalyst used) by direct PdI2/KI-catalyzed oxidative carbonylation of the readily available 2-amino-1-alkanols HOCHRCHR1NH2.  The reactions were carried out in MeOH at 100° using a 1/6/5 CO/O2/air mixt. with 60 atm total pressure at 25°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlv163ZcOY7Vg90H21EOLACvtfcHk0liSd7QaA0cUmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVCrsbs%253D&md5=906c74be10fec588ad9a2c325fff0831</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fol9913789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9913789%26sid%3Dliteratum%253Aachs%26aulast%3DGabriele%26aufirst%3DB.%26aulast%3DSalerno%26aufirst%3DG.%26aulast%3DBrindisi%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DChiusoli%26aufirst%3DG.%2BP.%26atitle%3DSynthesis%2520of%25202-oxazolidinones%2520by%2520direct%2520palladium-catalyzed%2520oxidative%2520carbonylation%2520of%25202-amino-1-alkanols%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D625%26epage%3D627%26doi%3D10.1021%2Fol9913789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enquist, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Super fast cobalt carbonyl-mediated synthesis of ureas</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3335</span>– <span class="NLM_lpage">3339</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2005.03.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tetlet.2005.03.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlKns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=3335-3339&author=P.+A.+Enquistauthor=P.+Nilssonauthor=J.+Edinauthor=M.+Larhed&title=Super+fast+cobalt+carbonyl-mediated+synthesis+of+ureas&doi=10.1016%2Fj.tetlet.2005.03.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Super fast cobalt carbonyl-mediated synthesis of ureas</span></div><div class="casAuthors">Enquist, Per-Anders; Nilsson, Peter; Edin, Johan; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3335-3339</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fast cobalt carbonyl-mediated generation of ureas from primary amines was performed using high-d. microwave irradn.  This enhanced method permitted the prepn. of sym. ureas in good yields and unsym. ureas in moderate yields.  The reaction times varied between 10 s and 40 min.  The proposed mechanism for the reaction includes in situ generation of an intermediate isocyanate that subsequently traps the free amine, producing the urea product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmHUKtF6gnrVg90H21EOLACvtfcHk0lgzt8BaO0HsWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlKns7g%253D&md5=6b57d297c781ee2319c923229c64b341</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.03.076%26sid%3Dliteratum%253Aachs%26aulast%3DEnquist%26aufirst%3DP.%2BA.%26aulast%3DNilsson%26aufirst%3DP.%26aulast%3DEdin%26aufirst%3DJ.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DSuper%2520fast%2520cobalt%2520carbonyl-mediated%2520synthesis%2520of%2520ureas%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D3335%26epage%3D3339%26doi%3D10.1016%2Fj.tetlet.2005.03.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tafesh, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiguny, J.</span></span> <span> </span><span class="NLM_article-title">A review of the selective catalytic reduction of aromatic nitro compounds into aromatic amines, isocyanates, carbamates, and ureas using CO</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2035</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.1021/cr950083f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr950083f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK28XlsFWhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=2035-2052&author=A.+M.+Tafeshauthor=J.+Weiguny&title=A+review+of+the+selective+catalytic+reduction+of+aromatic+nitro+compounds+into+aromatic+amines%2C+isocyanates%2C+carbamates%2C+and+ureas+using+CO&doi=10.1021%2Fcr950083f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of the Selective Catalytic Reduction of Aromatic Nitro Compounds into Aromatic Amines, Isocyanates, Carbamates, and Ureas Using CO</span></div><div class="casAuthors">Tafesh, Ahmed M.; Weiguny, Jens</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2035-2052</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 127 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbq_89gOYUD7Vg90H21EOLACvtfcHk0lgzt8BaO0HsWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFWhtrs%253D&md5=039e52fcb03801f48fb22f25968d3ab1</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fcr950083f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950083f%26sid%3Dliteratum%253Aachs%26aulast%3DTafesh%26aufirst%3DA.%2BM.%26aulast%3DWeiguny%26aufirst%3DJ.%26atitle%3DA%2520review%2520of%2520the%2520selective%2520catalytic%2520reduction%2520of%2520aromatic%2520nitro%2520compounds%2520into%2520aromatic%2520amines%252C%2520isocyanates%252C%2520carbamates%252C%2520and%2520ureas%2520using%2520CO%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D2035%26epage%3D2052%26doi%3D10.1021%2Fcr950083f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Pd/C Catalyzed carbonylation of azides in the presence of amines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1736</span>– <span class="NLM_lpage">1739</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVKjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1736-1739&author=J.+Zhaoauthor=Z.+Liauthor=S.+Yanauthor=S.+Xuauthor=M.+A.+Wangauthor=B.+Fuauthor=Z.+Zhang&title=Pd%2FC+Catalyzed+carbonylation+of+azides+in+the+presence+of+amines&doi=10.1021%2Facs.orglett.6b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Pd/C Catalyzed Carbonylation of Azides in the Presence of Amines</span></div><div class="casAuthors">Zhao, Jin; Li, Zongyang; Yan, Shuaihu; Xu, Shiyang; Wang, Ming-An; Fu, Bin; Zhang, Zhenhua</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1736-1739</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile and efficient Pd/C-catalyzed carbonylation of both aliph. and arom. azides in the presence of amines is reported.  Serving as the widely existed fragments in an array of biol. pharmaceuticals, functionalized unsym. ureas were straightforwardly synthesized by using readily available and cheap azides with amines under CO atm., with the extrusion of N2 as the only byproduct.  It was found that not only aryl azides but also benzyl and alkyl azides were suited for this methodol.  Another feature of this procedure was the employment of a highly efficient palladium charcoal catalytic system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjJ3A_jq07d7Vg90H21EOLACvtfcHk0lgsilp4_8qruA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVKjtr8%253D&md5=e62e70633dd94a379bab698809073c06</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b00381%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%2BA.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DPd%252FC%2520Catalyzed%2520carbonylation%2520of%2520azides%2520in%2520the%2520presence%2520of%2520amines%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D1736%26epage%3D1739%26doi%3D10.1021%2Facs.orglett.6b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fors, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling of aryl chlorides and triflates with sodium cyanate: a practical synthesis of unsymmetrical ureas</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">11132</span>– <span class="NLM_lpage">11135</span>, <span class="refDoi"> DOI: 10.1021/ja305212v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja305212v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFartb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=11132-11135&author=E.+V.+Vinogradovaauthor=B.+P.+Forsauthor=S.+L.+Buchwald&title=Palladium-catalyzed+cross-coupling+of+aryl+chlorides+and+triflates+with+sodium+cyanate%3A+a+practical+synthesis+of+unsymmetrical+ureas&doi=10.1021%2Fja305212v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling of Aryl Chlorides and Triflates with Sodium Cyanate: A Practical Synthesis of Unsymmetrical Ureas</span></div><div class="casAuthors">Vinogradova, Ekaterina V.; Fors, Brett P.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">11132-11135</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method for palladium-catalyzed cross-coupling of aryl chlorides and triflates with sodium cyanate is reported.  The protocol allows for the synthesis of unsym. N,N'-di- and N,N,N'-trisubstituted ureas in one pot and is tolerant of a wide range of functional groups.  Insight into the mechanism of aryl isocyanate formation was gleaned through studies of the transmetalation and reductive elimination steps of the reaction, including the first demonstration of reductive elimination from an arylpalladium isocyanate complex to produce an aryl isocyanate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtjsO5TnI5m7Vg90H21EOLACvtfcHk0lgsilp4_8qruA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFartb8%253D&md5=1a59556ae499f90fec8def64025c0a50</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fja305212v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305212v%26sid%3Dliteratum%253Aachs%26aulast%3DVinogradova%26aufirst%3DE.%2BV.%26aulast%3DFors%26aufirst%3DB.%2BP.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520of%2520aryl%2520chlorides%2520and%2520triflates%2520with%2520sodium%2520cyanate%253A%2520a%2520practical%2520synthesis%2520of%2520unsymmetrical%2520ureas%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D11132%26epage%3D11135%26doi%3D10.1021%2Fja305212v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raut, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Ca, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carfagna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, B.</span></span> <span> </span><span class="NLM_article-title">Catalytic oxidative carbonylation of amino moieties to ureas, oxamides, 2-oxazolidinones, and benzoxazolones</span>. <i>ChemSusChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2204</span>– <span class="NLM_lpage">2211</span>, <span class="refDoi"> DOI: 10.1002/cssc.201500343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fcssc.201500343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26089244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVensLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=2204-2211&author=R.+Mancusoauthor=D.+S.+Rautauthor=N.+Della+Caauthor=F.+Finiauthor=C.+Carfagnaauthor=B.+Gabriele&title=Catalytic+oxidative+carbonylation+of+amino+moieties+to+ureas%2C+oxamides%2C+2-oxazolidinones%2C+and+benzoxazolones&doi=10.1002%2Fcssc.201500343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Oxidative Carbonylation of Amino Moieties to Ureas, Oxamides, 2-Oxazolidinones, and Benzoxazolones</span></div><div class="casAuthors">Mancuso, Raffaella; Raut, Dnyaneshwar S.; Della Ca, Nicola; Fini, Francesco; Carfagna, Carla; Gabriele, Bartolo</div><div class="citationInfo"><span class="NLM_cas:title">ChemSusChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2204-2211</span>CODEN:
                <span class="NLM_cas:coden">CHEMIZ</span>;
        ISSN:<span class="NLM_cas:issn">1864-5631</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The direct synthesis of ureas RNHC(O)NHR [R = (CH2)3CH3, 4-ClC6H4, 4-(H3C)2CHC6H4, etc.], oxamides R1C(O)C(O)R1 (R1 = morpholin-4-yl, pyrrolidin-1-yl, diethylamino, butylamino, etc.), 2-oxazolidinones, e.g., I, and benzoxazolones, e.g., II, by the oxidative carbonylation of amines, U+03B2-amino alcs., and 2-aminophenols has been reported.  It is possible to perform these transformations using the PdI2/KI catalytic system in an ionic liq., such as 1-butyl-3-methylimidazolium tetrafluoroborate, as the solvent, the solvent/catalyst system can be recycled several times with only a slight loss of activity, and the product can be recovered easily by crystn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9jcN4xaso_bVg90H21EOLACvtfcHk0livYfGsjWp35A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVensLzK&md5=4952818cca38c025fd84d42cab77b089</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1002%2Fcssc.201500343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcssc.201500343%26sid%3Dliteratum%253Aachs%26aulast%3DMancuso%26aufirst%3DR.%26aulast%3DRaut%26aufirst%3DD.%2BS.%26aulast%3DDella%2BCa%26aufirst%3DN.%26aulast%3DFini%26aufirst%3DF.%26aulast%3DCarfagna%26aufirst%3DC.%26aulast%3DGabriele%26aufirst%3DB.%26atitle%3DCatalytic%2520oxidative%2520carbonylation%2520of%2520amino%2520moieties%2520to%2520ureas%252C%2520oxamides%252C%25202-oxazolidinones%252C%2520and%2520benzoxazolones%26jtitle%3DChemSusChem%26date%3D2015%26volume%3D8%26spage%3D2204%26epage%3D2211%26doi%3D10.1002%2Fcssc.201500343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youn, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Pd(II)/Ag(I)-Promoted one-pot synthesis of cyclic ureas from (hetero)aromatic amines and isocyanates</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6140</span>– <span class="NLM_lpage">6143</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b03151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b03151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWgtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=6140-6143&author=S.+W.+Younauthor=Y.+H.+Kim&title=Pd%28II%29%2FAg%28I%29-Promoted+one-pot+synthesis+of+cyclic+ureas+from+%28hetero%29aromatic+amines+and+isocyanates&doi=10.1021%2Facs.orglett.6b03151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Pd(II)/Ag(I)-Promoted One-Pot Synthesis of Cyclic Ureas from (Hetero)Aromatic Amines and Isocyanates</span></div><div class="casAuthors">Youn, So Won; Kim, Yi Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6140-6143</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple and facile one-pot reaction has been developed to afford a diverse range of N,N'-disubstituted benzimidazolones and imidazopyridinones contg. two differently substituted N atoms.  A cooperative Pd(II)/Ag(I) system promotes the sequential addn./intramol. C-H amidation reaction of (hetero)arom. amines and isocyanates, leading to the formation of two C-N bonds.  A mechanism involving radical intermediates generated by single-electron transfer (SET) in the presence of a Ag2CO3 oxidant and Pd(OAc)2 Lewis acid is proposed.  This protocol offers an operationally easy, simple, and robust approach with the use of readily available starting materials, good functional group tolerance, and high efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu42FGYH-bXbVg90H21EOLACvtfcHk0lhSy4WiWrAz2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWgtb7J&md5=39bd7a40d5cb59111aa8d14c60a6cee0</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b03151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b03151%26sid%3Dliteratum%253Aachs%26aulast%3DYoun%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DPd%2528II%2529%252FAg%2528I%2529-Promoted%2520one-pot%2520synthesis%2520of%2520cyclic%2520ureas%2520from%2520%2528hetero%2529aromatic%2520amines%2520and%2520isocyanates%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D6140%26epage%3D6143%26doi%3D10.1021%2Facs.orglett.6b03151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient palladium-catalyzed reductive carbonylation of aryl iodides with dual role of formic acid</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5835</span>– <span class="NLM_lpage">5838</span>, <span class="refDoi"> DOI: 10.1002/chem.201600387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.201600387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26934464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlOgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=5835-5838&author=X.+Qiauthor=C.+L.+Liauthor=X.+F.+Wu&title=A+convenient+palladium-catalyzed+reductive+carbonylation+of+aryl+iodides+with+dual+role+of+formic+acid&doi=10.1002%2Fchem.201600387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Palladium-Catalyzed Reductive Carbonylation of Aryl Iodides with Dual Role of Formic Acid</span></div><div class="casAuthors">Qi, Xinxin; Li, Chong-Liang; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5835-5838</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In this communication, palladium catalyzed reductive carbonylation of aryl iodides with formic acid as the formyl source is developed.  As a convenient, practical, and environmental friendly methodol., no addnl. silane or H2 was required.  A variety of arom. aldehydes were isolated in moderate to excellent yields under mild reaction conditions.  Notably, this is the first procedure on using formic acid as the formyl source.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOo36sZw1oubVg90H21EOLACvtfcHk0lhSy4WiWrAz2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlOgtbc%253D&md5=42de399fa2fff7d54424c0e99a63c729</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1002%2Fchem.201600387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201600387%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520palladium-catalyzed%2520reductive%2520carbonylation%2520of%2520aryl%2520iodides%2520with%2520dual%2520role%2520of%2520formic%2520acid%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2016%26volume%3D22%26spage%3D5835%26epage%3D5838%26doi%3D10.1002%2Fchem.201600387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed one-pot carbonylative Sonogashira reaction employing formic acid as the CO source</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1870</span>– <span class="NLM_lpage">1873</span>, <span class="refDoi"> DOI: 10.1002/asia.201500518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fasia.201500518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26097102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWjtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1870-1873&author=X.+Qiauthor=L.+B.+Jiangauthor=C.+L.+Liauthor=R.+Liauthor=X.+F.+Wu&title=Palladium-catalyzed+one-pot+carbonylative+Sonogashira+reaction+employing+formic+acid+as+the+CO+source&doi=10.1002%2Fasia.201500518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed One-Pot Carbonylative Sonogashira Reaction Employing Formic acid as the CO Source</span></div><div class="casAuthors">Qi, Xinxin; Jiang, Li-Bing; Li, Chong-Liang; Li, Rui; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1870-1873</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A convenient palladium-catalyzed carbonylative coupling of aryl iodides and terminal alkynes with formic acid as the CO precursor was developed.  A variety of alkynones were obtained in good yields in a one-pot manner for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA_5VEFJ4bNbVg90H21EOLACvtfcHk0lhQzac0kAo-RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWjtr7F&md5=b9569b429aaa9f69505516d67c9f45ac</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1002%2Fasia.201500518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201500518%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%2BB.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPalladium-catalyzed%2520one-pot%2520carbonylative%2520Sonogashira%2520reaction%2520employing%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2015%26volume%3D10%26spage%3D1870%26epage%3D1873%26doi%3D10.1002%2Fasia.201500518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient palladium-catalyzed carbonylative Suzuki coupling of aryl halides with formic acid as the carbon monoxide source</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">17650</span>– <span class="NLM_lpage">17656</span>, <span class="refDoi"> DOI: 10.1002/chem.201502943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.201502943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26486227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSmsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=17650-17656&author=X.+Qiauthor=L.+B.+Jiangauthor=H.+P.+Liauthor=X.+F.+Wu&title=A+convenient+palladium-catalyzed+carbonylative+Suzuki+coupling+of+aryl+halides+with+formic+acid+as+the+carbon+monoxide+source&doi=10.1002%2Fchem.201502943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Palladium-Catalyzed Carbonylative Suzuki Coupling of Aryl Halides with Formic Acid as the Carbon Monoxide Source</span></div><div class="casAuthors">Qi, Xinxin; Jiang, Li-Bing; Li, Hao-Peng; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17650-17656</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A practical palladium-catalyzed carbonylative Suzuki coupling of aryl halides under carbon monoxide gas-free conditions has been developed.  Here, formic acid was utilized as the carbon monoxide source for the first time with acetic anhydride as the additive.  A variety of diarylketones were produced in moderate to excellent yields from the corresponding aryl halides and arylboronic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGCBXUzGuLULVg90H21EOLACvtfcHk0liL9E-xIcTOBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSmsLvM&md5=e9253458ed142451fe242c5392ae9a0c</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502943%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%2BB.%26aulast%3DLi%26aufirst%3DH.%2BP.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520palladium-catalyzed%2520carbonylative%2520Suzuki%2520coupling%2520of%2520aryl%2520halides%2520with%2520formic%2520acid%2520as%2520the%2520carbon%2520monoxide%2520source%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D17650%26epage%3D17656%26doi%3D10.1002%2Fchem.201502943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed alkoxycarbonylation of aryl halides with phenols employing formic acid as the CO source</span>. <i>Catal. Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3107</span>, <span class="refDoi"> DOI: 10.1039/C5CY01957E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC5CY01957E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKitLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=3099-3107&author=X.+X.+Qiauthor=C.+L.+Liauthor=L.+B.+Jiangauthor=W.+Q.+Zhangauthor=X.+F.+Wu&title=Palladium-catalyzed+alkoxycarbonylation+of+aryl+halides+with+phenols+employing+formic+acid+as+the+CO+source&doi=10.1039%2FC5CY01957E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed alkoxycarbonylation of aryl halides with phenols employing formic acid as the CO source</span></div><div class="casAuthors">Qi, Xinxin; Li, Chong-Liang; Jiang, Li-Bing; Zhang, Wan-Quan; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Catalysis Science & Technology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3099-3107</span>CODEN:
                <span class="NLM_cas:coden">CSTAGD</span>;
        ISSN:<span class="NLM_cas:issn">2044-4753</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">An efficient palladium-catalyzed alkoxycarbonylation of aryl halides with phenols was developed.  Various aryl benzoates were isolated in good to excellent yields with formic acid as the CO source.  The reaction proceeds smoothly under mild conditions and good functional group tolerance was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wOnejx8nFbVg90H21EOLACvtfcHk0liL9E-xIcTOBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKitLjP&md5=0b1c852351fae1f1e192483cd5c371b7</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1039%2FC5CY01957E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CY01957E%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DX.%2BX.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DJiang%26aufirst%3DL.%2BB.%26aulast%3DZhang%26aufirst%3DW.%2BQ.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPalladium-catalyzed%2520alkoxycarbonylation%2520of%2520aryl%2520halides%2520with%2520phenols%2520employing%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DCatal.%2520Sci.%2520Technol.%26date%3D2016%26volume%3D6%26spage%3D3099%26epage%3D3107%26doi%3D10.1039%2FC5CY01957E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient and efficient palladium-catalyzed carbonylative Sonogashira transformation with formic acid as the CO source</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1434</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201700076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201700076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVWgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1434-1437&author=J.+B.+Pengauthor=F.+P.+Wuauthor=C.+L.+Liauthor=X.+Qiauthor=X.+F.+Wu&title=A+convenient+and+efficient+palladium-catalyzed+carbonylative+Sonogashira+transformation+with+formic+acid+as+the+CO+source&doi=10.1002%2Fejoc.201700076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient and Efficient Palladium-Catalyzed Carbonylative Sonogashira Transformation with Formic Acid as the CO Source</span></div><div class="casAuthors">Peng, Jin-Bao; Wu, Fu-Peng; Li, Chong-Liang; Qi, Xinxin; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1434-1437</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A practical, convenient, and efficient palladium-catalyzed carbonylative Sonogashira reaction of aryl iodides was developed.  With formic acid as the CO source and dicyclohexylcarbodiimide as the activator, various alkynones were produced in good to excellent yields.  Thus, e.g., reaction of iodobenzene with phenylacetylene using HCOOH and DCC as CO source in presence of Pd(OAc)2, PPh3 and Et3N in toluene afforded alkynone I (97% isolated).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhNJP9c7bu8rVg90H21EOLACvtfcHk0lh46NbYrVPvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVWgt7g%253D&md5=61e3beb392e7bd467daa40c6e654d6c8</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201700076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201700076%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%2BB.%26aulast%3DWu%26aufirst%3DF.%2BP.%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520and%2520efficient%2520palladium-catalyzed%2520carbonylative%2520Sonogashira%2520transformation%2520with%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1434%26epage%3D1437%26doi%3D10.1002%2Fejoc.201700076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed carbonylative synthesis of alkynones from aryl iodides and phenylpropiolic acid employing formic acid as the CO source</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>838</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2017.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.jorganchem.2017.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=838&publication_year=2017&pages=9-11&author=C.+L.+Liauthor=W.+Q.+Zhangauthor=X.+X.+Qiauthor=J.+B.+Pengauthor=X.+F.+Wu&title=Palladium-catalyzed+carbonylative+synthesis+of+alkynones+from+aryl+iodides+and+phenylpropiolic+acid+employing+formic+acid+as+the+CO+source&doi=10.1016%2Fj.jorganchem.2017.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed carbonylative synthesis of alkynones from aryl iodides and phenylpropiolic acid employing formic acid as the CO source</span></div><div class="casAuthors">Li, Chong-Liang; Zhang, Wan-Quan; Qi, Xinxin; Peng, Jin-Bao; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">838</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-11</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A palladium-catalyzed procedure for the decarboxylative-carbonylation of phenylpropiolic acid with iodobenzenes to the corresponding alkynones with formic acid as carbon monoxide source was developed.  Various alkynones were produced in moderate to good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11V2fDeC1QbVg90H21EOLACvtfcHk0li2LjeMK_ntUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKqtbY%253D&md5=3db5de2f57bf6fa9ad424ce9c75e1531</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2017.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2017.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BL.%26aulast%3DZhang%26aufirst%3DW.%2BQ.%26aulast%3DQi%26aufirst%3DX.%2BX.%26aulast%3DPeng%26aufirst%3DJ.%2BB.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPalladium-catalyzed%2520carbonylative%2520synthesis%2520of%2520alkynones%2520from%2520aryl%2520iodides%2520and%2520phenylpropiolic%2520acid%2520employing%2520formic%2520acid%2520as%2520the%2520CO%2520source%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2017%26volume%3D838%26spage%3D9%26epage%3D11%26doi%3D10.1016%2Fj.jorganchem.2017.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">Pd/C-Catalyzed aminocarbonylation of aryl iodides with anthranils in water using Mo(CO)<sub>6</sub> as the CO source</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">15026</span>– <span class="NLM_lpage">15029</span>, <span class="refDoi"> DOI: 10.1002/chem.201703994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fchem.201703994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=28929551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CitLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=15026-15029&author=Z.+Wangauthor=Z.+Yinauthor=X.+F.+Wu&title=Pd%2FC-Catalyzed+aminocarbonylation+of+aryl+iodides+with+anthranils+in+water+using+Mo%28CO%296+as+the+CO+source&doi=10.1002%2Fchem.201703994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Pd/C-Catalyzed Aminocarbonylation of Aryl Iodides with Anthranils in Water Using Mo(CO)6 as the CO Source</span></div><div class="casAuthors">Wang, Zechao; Yin, Zhiping; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">15026-15029</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A convenient procedure for the synthesis of N-(2-carbonylaryl)benzamides was developed.  Through Pd/C-catalyzed aminocarbonylation of anthranils with various hindered and functionalized aryl iodides, the desired amides were afforded in moderate to good yields.  The protocol was advantageous due to the recyclable Pd/C catalyst, safe Mo(CO)6 as the solid CO source, and environmentally benign water as solvent.  No inert atm. protection was needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq474ofE9Dy1rVg90H21EOLACvtfcHk0lh-BFs2TWuSOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CitLvO&md5=d1564352314895f44fce99a08c04fa71</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703994%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DPd%252FC-Catalyzed%2520aminocarbonylation%2520of%2520aryl%2520iodides%2520with%2520anthranils%2520in%2520water%2520using%2520Mo%2528CO%25296%2520as%2520the%2520CO%2520source%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D15026%26epage%3D15029%26doi%3D10.1002%2Fchem.201703994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span> <span> </span><span class="NLM_article-title">A convenient palladium-catalyzed carbonylative synthesis of 4(3H)-quinazolinones from 2-bromoformanilides and organo nitros with Mo(CO)<sub>6</sub> as a multiple promoter</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3763</span>– <span class="NLM_lpage">3767</span>, <span class="refDoi"> DOI: 10.1039/C4GC00801D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC4GC00801D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3763-3767&author=L.+Heauthor=M.+Sharifauthor=H.+Neumannauthor=M.+Bellerauthor=X.+F.+Wu&title=A+convenient+palladium-catalyzed+carbonylative+synthesis+of+4%283H%29-quinazolinones+from+2-bromoformanilides+and+organo+nitros+with+Mo%28CO%296+as+a+multiple+promoter&doi=10.1039%2FC4GC00801D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient palladium-catalyzed carbonylative synthesis of 4(3H)-quinazolinones from 2-bromoformanilides and organo nitros with Mo(CO)6 as a multiple promoter</span></div><div class="casAuthors">He, Lin; Sharif, Muhammad; Neumann, Helfried; Beller, Matthias; Wu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3763-3767</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel and convenient procedure for the synthesis of quinazolinones has been developed.  Using 2-bromoformanilides and organo nitros as substrates and Mo(CO)6 as a multiple promoter, the desired products were isolated in moderate to excellent yields in the presence of a palladium catalyst.  Here, Mo(CO)6 was not only a CO source, but also a nitro compd. reducing reagent and a cyclization promoter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGZFYMBW7M7Vg90H21EOLACvtfcHk0lh-BFs2TWuSOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsrvO&md5=0c0fe12a9053fd4ffc3b9a47b0fa37bf</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1039%2FC4GC00801D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4GC00801D%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DSharif%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DH.%26aulast%3DBeller%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%2BF.%26atitle%3DA%2520convenient%2520palladium-catalyzed%2520carbonylative%2520synthesis%2520of%25204%25283H%2529-quinazolinones%2520from%25202-bromoformanilides%2520and%2520organo%2520nitros%2520with%2520Mo%2528CO%25296%2520as%2520a%2520multiple%2520promoter%26jtitle%3DGreen%2520Chem.%26date%3D2014%26volume%3D16%26spage%3D3763%26epage%3D3767%26doi%3D10.1039%2FC4GC00801D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oschatz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, P.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed carbonylative synthesis of <i>N</i>-benzoylindoles with Mo(CO)<sub>6</sub> as the carbon monoxide source</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2641</span>– <span class="NLM_lpage">2646</span>, <span class="refDoi"> DOI: 10.1055/s-0034-1380752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1055%2Fs-0034-1380752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Srsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=2641-2646&author=X.+F.+Wuauthor=S.+Oschatzauthor=M.+Sharifauthor=P.+Langer&title=Palladium-catalyzed+carbonylative+synthesis+of+N-benzoylindoles+with+Mo%28CO%296+as+the+carbon+monoxide+source&doi=10.1055%2Fs-0034-1380752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Carbonylative Synthesis of N-Benzoylindoles with Mo(CO)6 as the Carbon Monoxide Source</span></div><div class="casAuthors">Wu, Xiao-Feng; Oschatz, Stefan; Sharif, Muhammad; Langer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2641-2646</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A mild and carbon monoxide gas-free palladium-catalyzed aminocarbonylation of indole has been developed for the synthesis of N-benzoylindoles.  This method uses Mo(CO)6 as a convenient CO-precursor and BuPAd2 as the ligand.  A no. of substituents on the aryl bromide species is tolerated under the presented conditions and gave the desired products in up to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvDXKuAK-UCbVg90H21EOLACvtfcHk0lhnrJzw-d7eBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Srsb8%253D&md5=7674363cbb43cdd633770b94aaba8b6f</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1055%2Fs-0034-1380752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0034-1380752%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%2BF.%26aulast%3DOschatz%26aufirst%3DS.%26aulast%3DSharif%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DP.%26atitle%3DPalladium-catalyzed%2520carbonylative%2520synthesis%2520of%2520N-benzoylindoles%2520with%2520Mo%2528CO%25296%2520as%2520the%2520carbon%2520monoxide%2520source%26jtitle%3DSynthesis%26date%3D2015%26volume%3D47%26spage%3D2641%26epage%3D2646%26doi%3D10.1055%2Fs-0034-1380752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. H.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed urea synthesis using methanol as the C1 source</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.5b03328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b03328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks12jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=212-215&author=S.+H.+Kimauthor=S.+H.+Hong&title=Ruthenium-catalyzed+urea+synthesis+using+methanol+as+the+C1+source&doi=10.1021%2Facs.orglett.5b03328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Urea Synthesis Using Methanol as the C1 Source</span></div><div class="casAuthors">Kim, Seung Hyo; Hong, Soon Hyeok</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-215</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An unprecedented protocol for urea synthesis directly from methanol and amine was accomplished.  The reaction is highly atom-economical, producing hydrogen as the sole byproduct.  Com. available ruthenium pincer complexes were used as catalysts.  In addn., no additive, such as a base, oxidant, or hydrogen acceptor, was required.  Furthermore, unsym. urea derivs. were successfully obtained via a one-pot, two-step reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoYQHFGzkhSLVg90H21EOLACvtfcHk0li_HdoPGkZ-lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks12jsQ%253D%253D&md5=1ee491be22642c34f7b83c955ad035ea</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b03328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b03328%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BH.%26atitle%3DRuthenium-catalyzed%2520urea%2520synthesis%2520using%2520methanol%2520as%2520the%2520C1%2520source%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D212%26epage%3D215%26doi%3D10.1021%2Facs.orglett.5b03328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnakumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunanathan, C.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed urea synthesis by N-H activation of amines</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7278</span>– <span class="NLM_lpage">7284</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b00962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b00962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFWrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=7278-7284&author=V.+Krishnakumarauthor=B.+Chatterjeeauthor=C.+Gunanathan&title=Ruthenium-catalyzed+urea+synthesis+by+N-H+activation+of+amines&doi=10.1021%2Facs.inorgchem.7b00962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Urea Synthesis by N-H Activation of Amines</span></div><div class="casAuthors">Krishnakumar, Varadhan; Chatterjee, Basujit; Gunanathan, Chidambaram</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7278-7284</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the presence of a bis(diphenylphosphinoethyl)amine ruthenium pincer complex and KOt-Bu, primary benzyl- and alkylamines underwent condensation reactions with N,N-dimethylformamide at 130-150° to yield sym. and unsym. N,N'-disubstituted ureas; the method avoids the use of carbon monoxide and stoichiometric activating agents.  Three bis(diphenylphosphinoethyl)amine ruthenium benzylamine complexes were prepd.; the structure of a bis(diphenylphosphinoethyl)amine ruthenium fluorobenzylamine complex was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVnLS9EoKe9rVg90H21EOLACvtfcHk0ljfMzStSzyoPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFWrs78%253D&md5=3308b761089e529f2ab84ec2797ed2cf</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b00962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b00962%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnakumar%26aufirst%3DV.%26aulast%3DChatterjee%26aufirst%3DB.%26aulast%3DGunanathan%26aufirst%3DC.%26atitle%3DRuthenium-catalyzed%2520urea%2520synthesis%2520by%2520N-H%2520activation%2520of%2520amines%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D7278%26epage%3D7284%26doi%3D10.1021%2Facs.inorgchem.7b00962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darko, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElwee-White, L.</span></span> <span> </span><span class="NLM_article-title">Catalytic oxidative carbonylation of arylamines to ureas with W(CO)(6)/I-2 as catalyst</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">6261</span>– <span class="NLM_lpage">6268</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201100657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201100657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=6261-6268&author=L.+Zhangauthor=A.+K.+Darkoauthor=J.+I.+Johnsauthor=L.+McElwee-White&title=Catalytic+oxidative+carbonylation+of+arylamines+to+ureas+with+W%28CO%29%286%29%2FI-2+as+catalyst&doi=10.1002%2Fejoc.201100657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Oxidative Carbonylation of Arylamines to Ureas with W(CO)6/I2 as Catalyst</span></div><div class="casAuthors">Zhang, Li; Darko, Ampofo K.; Johns, Jennifer I.; McElwee-White, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6261-6268</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The oxidative carbonylation of aniline to N,N'-diphenylurea was carried out by using W(CO)6 as the catalyst, I2 as the oxidant, CO as the carbonyl source and 4-(dimethylamino)pyridine (DMAP) as the base.  The reaction conditions were optimized with respect to different bases, molar ratio of DMAP/iodine, temp., time, and CO pressure.  Various p-substituted arylamines can be converted into the resp. sym. and unsym. N,N'-disubstituted ureas in moderate to good yields.  The reaction demonstrated broad tolerance of functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFZ4XitaupLVg90H21EOLACvtfcHk0ljfMzStSzyoPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers7rO&md5=374afeee80d837d3d2aaa4e296aeb322</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201100657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201100657%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDarko%26aufirst%3DA.%2BK.%26aulast%3DJohns%26aufirst%3DJ.%2BI.%26aulast%3DMcElwee-White%26aufirst%3DL.%26atitle%3DCatalytic%2520oxidative%2520carbonylation%2520of%2520arylamines%2520to%2520ureas%2520with%2520W%2528CO%2529%25286%2529%252FI-2%2520as%2520catalyst%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2011%26volume%3D2011%26spage%3D6261%26epage%3D6268%26doi%3D10.1002%2Fejoc.201100657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-oxazolidinones by salen-Co-complexes catalyzed oxidative carbonylation of beta-amino alcohols</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tetlet.2006.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=929-932&author=J.+M.+Liuauthor=X.+G.+Pengauthor=J.+H.+Liuauthor=S.+Z.+Zhengauthor=W.+Sunauthor=C.+G.+Xia&title=Synthesis+of+2-oxazolidinones+by+salen-Co-complexes+catalyzed+oxidative+carbonylation+of+beta-amino+alcohols&doi=10.1016%2Fj.tetlet.2006.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-oxazolidinones by salen-Co-complexes catalyzed oxidative carbonylation of β-amino alcohols</span></div><div class="casAuthors">Liu, Jian-Ming; Peng, Xin-Gao; Liu, Jian-Hua; Zheng, Shu-Zhan; Sun, Wei; Xia, Chun-Gu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">2-Oxazolidinones are synthesized in high yield by oxidative carbonylation of β-amino alcs. using salen-Co(II)/NaI or salen-Co(III)-I as a catalyst and using CO as the carbonyl source.  Studies of functional group compatibility using a series of substituted salen-Co(II) or salen-Co(III)-I complexes demonstrate a broad tolerance of functionality during the carbonylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrapiWIquu9DLVg90H21EOLACvtfcHk0lgfFwMdhqlP5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFGgsQ%253D%253D&md5=76baffdfa56ef391ddc8f98db86a427c</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26aulast%3DPeng%26aufirst%3DX.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DZheng%26aufirst%3DS.%2BZ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DXia%26aufirst%3DC.%2BG.%26atitle%3DSynthesis%2520of%25202-oxazolidinones%2520by%2520salen-Co-complexes%2520catalyzed%2520oxidative%2520carbonylation%2520of%2520beta-amino%2520alcohols%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D929%26epage%3D932%26doi%3D10.1016%2Fj.tetlet.2006.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C. G.</span></span> <span> </span><span class="NLM_article-title">A novel and efficient (NHC)Cu-I (NHC = N-heterocyclic carbene) catalyst for the oxidative carbonylation of amino compounds</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5883</span>– <span class="NLM_lpage">5886</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.tetlet.2007.06.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotV2rt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=5883-5886&author=S.+Z.+Zhengauthor=F.+W.+Liauthor=J.+M.+Liuauthor=C.+G.+Xia&title=A+novel+and+efficient+%28NHC%29Cu-I+%28NHC+%3D+N-heterocyclic+carbene%29+catalyst+for+the+oxidative+carbonylation+of+amino+compounds&doi=10.1016%2Fj.tetlet.2007.06.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and efficient (NHC)CuI (NHC = N-heterocyclic carbene) catalyst for the oxidative carbonylation of amino compounds</span></div><div class="casAuthors">Zheng, Shuzhan; Li, Fuwei; Liu, Jianming; Xia, Chungu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5883-5886</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Oxidative carbonylation of β-amino alcs. and primary amines to prep. corresponding 2-oxazolidinones, ureas, and carbamates selectively in the presence of (NHC)CuI without any additives was achieved for the first time in good yields and selectivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcRcpI0oIs4bVg90H21EOLACvtfcHk0li9CdAV80tPLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotV2rt7o%253D&md5=1c5810fa152bbaf5df552574768508e9</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%2BZ.%26aulast%3DLi%26aufirst%3DF.%2BW.%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26aulast%3DXia%26aufirst%3DC.%2BG.%26atitle%3DA%2520novel%2520and%2520efficient%2520%2528NHC%2529Cu-I%2520%2528NHC%2520%253D%2520N-heterocyclic%2520carbene%2529%2520catalyst%2520for%2520the%2520oxidative%2520carbonylation%2520of%2520amino%2520compounds%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D5883%26epage%3D5886%26doi%3D10.1016%2Fj.tetlet.2007.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casiello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iannone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotugno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monopoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cioffi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciminale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzeciak, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacci, A.</span></span> <span> </span><span class="NLM_article-title">Copper(II)-catalysed oxidative carbonylation of aminols and amines in water: A direct access to oxazolidinones, ureas and carbamates</span>. <i>J. Mol. Catal. A: Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.molcata.2015.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.molcata.2015.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2015&pages=8-14&author=M.+Casielloauthor=F.+Iannoneauthor=P.+Cotugnoauthor=A.+Monopoliauthor=N.+Cioffiauthor=F.+Ciminaleauthor=A.+M.+Trzeciakauthor=A.+Nacci&title=Copper%28II%29-catalysed+oxidative+carbonylation+of+aminols+and+amines+in+water%3A+A+direct+access+to+oxazolidinones%2C+ureas+and+carbamates&doi=10.1016%2Fj.molcata.2015.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(II)-catalysed oxidative carbonylation of aminols and amines in water: A direct access to oxazolidinones, ureas and carbamates</span></div><div class="casAuthors">Casiello, Michele; Iannone, Francesco; Cotugno, Pietro; Monopoli, Antonio; Cioffi, Nicola; Ciminale, Francesco; Trzeciak, Anna M.; Nacci, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Catalysis A: Chemical</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-14</span>CODEN:
                <span class="NLM_cas:coden">JMCCF2</span>;
        ISSN:<span class="NLM_cas:issn">1381-1169</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Copper(II) chloride catalyzes the oxidative carbonylation of aminols, amine and alcs. to give 2-oxazolidinones, ureas and carbamates.  Reaction proceeds smoothly in water under homogeneous conditions (Ptot = 4 MPa; PO2 = 0.6 MPa, PCO), at 100 °C in relatively short reaction times (4 h) and without using bases or any other additives.  This methodol. represents an economic and environmentally benign non-phosgene alternative for the prepn. of these three important N-contg. carbonyl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukwxc7Mm38bVg90H21EOLACvtfcHk0li9CdAV80tPLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtrrF&md5=8ee0dcd89ce98eb2ef864e9ca4566b8f</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.molcata.2015.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcata.2015.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DCasiello%26aufirst%3DM.%26aulast%3DIannone%26aufirst%3DF.%26aulast%3DCotugno%26aufirst%3DP.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DCioffi%26aufirst%3DN.%26aulast%3DCiminale%26aufirst%3DF.%26aulast%3DTrzeciak%26aufirst%3DA.%2BM.%26aulast%3DNacci%26aufirst%3DA.%26atitle%3DCopper%2528II%2529-catalysed%2520oxidative%2520carbonylation%2520of%2520aminols%2520and%2520amines%2520in%2520water%253A%2520A%2520direct%2520access%2520to%2520oxazolidinones%252C%2520ureas%2520and%2520carbamates%26jtitle%3DJ.%2520Mol.%2520Catal.%2520A%253A%2520Chem.%26date%3D2015%26volume%3D407%26spage%3D8%26epage%3D14%26doi%3D10.1016%2Fj.molcata.2015.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spyropoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokotos, C. G.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of ureas from Boc-protected amines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">4477</span>– <span class="NLM_lpage">4483</span>, <span class="refDoi"> DOI: 10.1021/jo500492x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo500492x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=4477-4483&author=C.+Spyropoulosauthor=C.+G.+Kokotos&title=One-pot+synthesis+of+ureas+from+Boc-protected+amines&doi=10.1021%2Fjo500492x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Synthesis of Ureas from Boc-Protected Amines</span></div><div class="casAuthors">Spyropoulos, Constantinos; Kokotos, Christoforos G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4477-4483</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical one-pot synthesis of ureas is described.  Boc-protected amines can be transformed into nonsym. and sym. disubstituted and trisubstituted ureas utilizing 2-chloropyridine and trifluoromethanesulfonyl anhydride for the in situ generation of an isocyanate, which reacts with an amine.  A variety of amines can be employed successfully, leading to high yields of isolated ureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZxf9z4HcUZ7Vg90H21EOLACvtfcHk0liA7Y1xoTYnmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtbY%253D&md5=b3528b1ce3b9873117bae9e3bbac0792</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fjo500492x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo500492x%26sid%3Dliteratum%253Aachs%26aulast%3DSpyropoulos%26aufirst%3DC.%26aulast%3DKokotos%26aufirst%3DC.%2BG.%26atitle%3DOne-pot%2520synthesis%2520of%2520ureas%2520from%2520Boc-protected%2520amines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D4477%26epage%3D4483%26doi%3D10.1021%2Fjo500492x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span> <span> </span><span class="NLM_article-title">Facile one-pot synthesis of unsymmetrical ureas, carbamates, and thiocarbamates from Cbz-protected amines</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7345</span>– <span class="NLM_lpage">7353</span>, <span class="refDoi"> DOI: 10.1039/C6OB01290F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC6OB01290F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27406041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaiu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=7345-7353&author=H.+K.+Kimauthor=A.+Lee&title=Facile+one-pot+synthesis+of+unsymmetrical+ureas%2C+carbamates%2C+and+thiocarbamates+from+Cbz-protected+amines&doi=10.1039%2FC6OB01290F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Facile one-pot synthesis of unsymmetrical ureas, carbamates, and thiocarbamates from Cbz-protected amines</span></div><div class="casAuthors">Kim, Hee-Kwon; Lee, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7345-7353</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel one-pot synthesis of unsym. ureas, carbamates and thiocarbamates from Cbz-protected amines has been developed.  In the presence of 2-chloropyridine and trifluoromethanesulfonyl anhydride, isocyanates are generated in situ, which facilitate rapid reaction with amines, alcs., and thiols to afford the corresponding ureas, carbamates and thiocarbamates in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob7iU0BTSo1LVg90H21EOLACvtfcHk0ljiq9m1c6XY2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaiu7nJ&md5=dc0a56279a51cfb486504c70e4bb846b</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1039%2FC6OB01290F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB01290F%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DA.%26atitle%3DFacile%2520one-pot%2520synthesis%2520of%2520unsymmetrical%2520ureas%252C%2520carbamates%252C%2520and%2520thiocarbamates%2520from%2520Cbz-protected%2520amines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D7345%26epage%3D7353%26doi%3D10.1039%2FC6OB01290F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lako, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, N. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szigetvari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis of urea derivatives in two sequential continuous-flow reactors</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.7b00019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.7b00019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=611-622&author=P.+Banaauthor=A.+Lakoauthor=N.+Z.+Kissauthor=Z.+Beniauthor=A.+Szigetvariauthor=J.+Kotiauthor=G.+I.+Turosauthor=J.+Elesauthor=I.+Greiner&title=Synthesis+of+urea+derivatives+in+two+sequential+continuous-flow+reactors&doi=10.1021%2Facs.oprd.7b00019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Urea Derivatives in Two Sequential Continuous-Flow Reactors</span></div><div class="casAuthors">Bana, Peter; Lako, Agnes; Kiss, Nora Zsuzsa; Beni, Zoltan; Szigetvari, Aron; Koti, Janos; Turos, Gyorgy Istvan; Eles, Janos; Greiner, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">611-622</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A continuous-flow system consisting of two sequential microreactors was developed for the synthesis of non-sym. substituted ureas starting from tert-butoxycarbonyl protected amines.  Short reaction times could be achieved under mild conditions.  In-line FT-IR anal. technique was used to monitor the reaction, including the formation of the isocyanate intermediate, thus allowing optimization of the reagent ratios.  The mechanistic role of the applied base was also clarified.  The set-up was successfully utilized for the synthesis of several urea derivs. including the active pharmaceutical ingredient cariprazine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCjBLF8PCb7Vg90H21EOLACvtfcHk0ljTfvEW6AIKBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVagtbk%253D&md5=b6e1ffb930915b7df9ea51e444df4336</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.7b00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.7b00019%26sid%3Dliteratum%253Aachs%26aulast%3DBana%26aufirst%3DP.%26aulast%3DLako%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DN.%2BZ.%26aulast%3DBeni%26aufirst%3DZ.%26aulast%3DSzigetvari%26aufirst%3DA.%26aulast%3DKoti%26aufirst%3DJ.%26aulast%3DTuros%26aufirst%3DG.%2BI.%26aulast%3DEles%26aufirst%3DJ.%26aulast%3DGreiner%26aufirst%3DI.%26atitle%3DSynthesis%2520of%2520urea%2520derivatives%2520in%2520two%2520sequential%2520continuous-flow%2520reactors%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2017%26volume%3D21%26spage%3D611%26epage%3D622%26doi%3D10.1021%2Facs.oprd.7b00019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riesco-Dominguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Ania, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutjes, F. P. J. T.</span></span> <span> </span><span class="NLM_article-title">Continuous flow synthesis of urea-containing compound libraries based on the piperidin-4-one scaffold</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">1312</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201701539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fejoc.201701539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=1312-1320&author=A.+Riesco-Dominguezauthor=D.+Blanco-Aniaauthor=F.+P.+J.+T.+Rutjes&title=Continuous+flow+synthesis+of+urea-containing+compound+libraries+based+on+the+piperidin-4-one+scaffold&doi=10.1002%2Fejoc.201701539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Flow Synthesis of Urea-Containing Compound Libraries Based on the Piperidin-4-one Scaffold</span></div><div class="casAuthors">Riesco-Dominguez, Alejandra; Blanco-Ania, Daniel; Rutjes, Floris P. J. T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1312-1320</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The advantages of performing reactions in continuous flow vs. the classic batch processes render flow chem. a suitable technique for library synthesis.  Inspired by the authors' recent work to create fluorine-contg. nitrogen heterocycles and by the potential of the urea group in drug design, the authors herewith describe the combination of both aspects in the continuous flow synthesis of two libraries of urea derivs. based on the piperidin-4-one scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI-sR426easLVg90H21EOLACvtfcHk0ljTfvEW6AIKBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOmurw%253D&md5=9dfb037331a94c43df5bdb66e2ba637f</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201701539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201701539%26sid%3Dliteratum%253Aachs%26aulast%3DRiesco-Dominguez%26aufirst%3DA.%26aulast%3DBlanco-Ania%26aufirst%3DD.%26aulast%3DRutjes%26aufirst%3DF.%2BP.%2BJ.%2BT.%26atitle%3DContinuous%2520flow%2520synthesis%2520of%2520urea-containing%2520compound%2520libraries%2520based%2520on%2520the%2520piperidin-4-one%2520scaffold%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D2018%26spage%3D1312%26epage%3D1320%26doi%3D10.1002%2Fejoc.201701539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganem, B.</span></span> <span> </span><span class="NLM_article-title">Trifluoroacetic anhydride-catalyzed oxidation of isonitriles by DMSO: a rapid, convenient synthesis of isocyanates</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2585</span>, <span class="refDoi"> DOI: 10.1021/ol200695y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol200695y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslemtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=2584-2585&author=H.+V.+Leauthor=B.+Ganem&title=Trifluoroacetic+anhydride-catalyzed+oxidation+of+isonitriles+by+DMSO%3A+a+rapid%2C+convenient+synthesis+of+isocyanates&doi=10.1021%2Fol200695y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroacetic Anhydride-Catalyzed Oxidation of Isonitriles by DMSO: A Rapid, Convenient Synthesis of Isocyanates</span></div><div class="casAuthors">Le, Hoang V.; Ganem, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2584-2585</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A smooth and efficient oxidn. of isonitriles to isocyanates by sulfoxides is catalyzed by trifluoroacetic anhydride.  With use of DMSO as the oxidant and 5 mol % TFAA (dichloromethane, -60 to 0 °C), the process is complete in a few minutes, forming di-Me sulfide as the only byproduct.  The newly formed isocyanates may be used directly or isolated in high purity by solvent evapn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOFugvTQiSpbVg90H21EOLACvtfcHk0lh0G-j_WNEbJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslemtLk%253D&md5=6a50018388a2c936d7f675ebe56937ad</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1021%2Fol200695y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol200695y%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DGanem%26aufirst%3DB.%26atitle%3DTrifluoroacetic%2520anhydride-catalyzed%2520oxidation%2520of%2520isonitriles%2520by%2520DMSO%253A%2520a%2520rapid%252C%2520convenient%2520synthesis%2520of%2520isocyanates%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D2584%26epage%3D2585%26doi%3D10.1021%2Fol200695y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senadi, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutra, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. J.</span></span> <span> </span><span class="NLM_article-title">Oximes as reusable templates for the synthesis of ureas and carbamates by an in situ generation of carbamoyl oximes</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4272</span>– <span class="NLM_lpage">4277</span>, <span class="refDoi"> DOI: 10.1039/C7GC01449J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC7GC01449J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OjsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=4272-4277&author=G.+C.+Senadiauthor=M.+R.+Mutraauthor=T.+Y.+Luauthor=J.+J.+Wang&title=Oximes+as+reusable+templates+for+the+synthesis+of+ureas+and+carbamates+by+an+in+situ+generation+of+carbamoyl+oximes&doi=10.1039%2FC7GC01449J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Oximes as reusable templates for the synthesis of ureas and carbamates by an in situ generation of carbamoyl oximes</span></div><div class="casAuthors">Senadi, Gopal Chandru; Mutra, Mohana Reddy; Lu, Ting-Yi; Wang, Jeh-Jeng</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4272-4277</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Oximes have been identified as reusable templates for the synthesis of ureas and carbamates by an in situ generation of carbamoyl oximes under metal-free conditions.  The recovered oxime has been utilized for three trials in the synthesis of urea derivs. without any loss in the yield and efficiency.  In addn., this template approach could override the usage of hazardous and less stable isocyanates as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLWKuHi_Io1LVg90H21EOLACvtfcHk0lh0G-j_WNEbJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OjsLjK&md5=72965362050b03fddc2a2557501bcad0</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1039%2FC7GC01449J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7GC01449J%26sid%3Dliteratum%253Aachs%26aulast%3DSenadi%26aufirst%3DG.%2BC.%26aulast%3DMutra%26aufirst%3DM.%2BR.%26aulast%3DLu%26aufirst%3DT.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26atitle%3DOximes%2520as%2520reusable%2520templates%2520for%2520the%2520synthesis%2520of%2520ureas%2520and%2520carbamates%2520by%2520an%2520in%2520situ%2520generation%2520of%2520carbamoyl%2520oximes%26jtitle%3DGreen%2520Chem.%26date%3D2017%26volume%3D19%26spage%3D4272%26epage%3D4277%26doi%3D10.1039%2FC7GC01449J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stucka, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span> <span> </span><span class="NLM_article-title">Parallel synthesis of ureas and carbamates from amines and CO2 under mild conditions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/ol100259j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100259j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Cltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1340-1343&author=S.+L.+Petersonauthor=S.+M.+Stuckaauthor=C.+J.+Dinsmore&title=Parallel+synthesis+of+ureas+and+carbamates+from+amines+and+CO2+under+mild+conditions&doi=10.1021%2Fol100259j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel Synthesis of Ureas and Carbamates from Amines and CO2 under Mild Conditions</span></div><div class="casAuthors">Peterson, Scott L.; Stucka, Sabrina M.; Dinsmore, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1340-1343</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild and efficient library synthesis technique has been developed for the synthesis of ureas and carbamates from carbamic acids derived from the DBU-catalyzed reaction of amines and gaseous carbon dioxide.  Carbamic acids derived from primary amines reacted with Mitsunobu reagents to generate isocyanates in situ which were condensed with primary and secondary amines to afford the desired ureas.  Similarly, carbamic acids from secondary amines reacted with alcs. activated with Mitsunobu reagents to form carbamates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDbIeFW48qMrVg90H21EOLACvtfcHk0lh87JYw2o1FFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Cltb4%253D&md5=8103430c5a397ea2b8efb4286846e0ad</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1021%2Fol100259j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100259j%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DS.%2BL.%26aulast%3DStucka%26aufirst%3DS.%2BM.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26atitle%3DParallel%2520synthesis%2520of%2520ureas%2520and%2520carbamates%2520from%2520amines%2520and%2520CO2%2520under%2520mild%2520conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1340%26epage%3D1343%26doi%3D10.1021%2Fol100259j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aversa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geuna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdembri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montemurro, F.</span></span> <span> </span><span class="NLM_article-title">Linifanib: current status and future potential in cancer therapy</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1586/14737140.2015.1042369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1586%2F14737140.2015.1042369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25936222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=677-687&author=C.+Aversaauthor=F.+Leoneauthor=G.+Zucchiniauthor=G.+Seriniauthor=E.+Geunaauthor=A.+Milaniauthor=D.+Valdembriauthor=R.+Martinelloauthor=F.+Montemurro&title=Linifanib%3A+current+status+and+future+potential+in+cancer+therapy&doi=10.1586%2F14737140.2015.1042369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Linifanib: current status and future potential in cancer therapy</span></div><div class="casAuthors">Aversa, Caterina; Leone, Francesco; Zucchini, Giorgia; Serini, Guido; Geuna, Elena; Milani, Andrea; Valdembri, Donatella; Martinello, Rossella; Montemurro, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">677-687</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is one of the major mechanisms controlling tumor proliferation and metastatic spreading.  Targeting of pro-angiogenic factors and their downstream effectors represents an appealing therapeutic option in the treatment of different cancer types.  Linifanib (ABT-869) is a novel tyrosine-kinase inhibitor (TKI) inhibitor and its anti-angiogenic activity has been explored in numerous clin. trials.  Here, we review preclin. development of linifanib focusing on its pharmacodynamic and pharmacokinetic characteristics and briefly summarize its evaluation in clin. trials.  Linifanib selectively targets VEGFR and PDGFR and has low off-target inhibitory activity.  Preclin. and early-phase trials have been showing promising efficacy results However, although signals of anti-tumor activity have been proven in some malignancies, linifanib late-phase development has been facing some challenges due to limited efficacy and increased toxicities.  New strategies aimed at finding biomarkers of response and minimizing toxicities are needed to allow the further development of a promising compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVwBBHC7UrqLVg90H21EOLACvtfcHk0lhn5f7ftku6eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1KktL8%253D&md5=246812e3151d49c64fdbb953c8dc9d99</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1586%2F14737140.2015.1042369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.2015.1042369%26sid%3Dliteratum%253Aachs%26aulast%3DAversa%26aufirst%3DC.%26aulast%3DLeone%26aufirst%3DF.%26aulast%3DZucchini%26aufirst%3DG.%26aulast%3DSerini%26aufirst%3DG.%26aulast%3DGeuna%26aufirst%3DE.%26aulast%3DMilani%26aufirst%3DA.%26aulast%3DValdembri%26aufirst%3DD.%26aulast%3DMartinello%26aufirst%3DR.%26aulast%3DMontemurro%26aufirst%3DF.%26atitle%3DLinifanib%253A%2520current%2520status%2520and%2520future%2520potential%2520in%2520cancer%2520therapy%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2015%26volume%3D15%26spage%3D677%26epage%3D687%26doi%3D10.1586%2F14737140.2015.1042369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratain, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowinsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruzzese, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simantov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dwyer, P. J.</span></span> <span> </span><span class="NLM_article-title">Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2505</span>– <span class="NLM_lpage">2512</span>, <span class="refDoi"> DOI: 10.1200/JCO.2005.03.6723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1200%2FJCO.2005.03.6723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16636341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVOmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2505-2512&author=M.+J.+Ratainauthor=T.+Eisenauthor=W.+M.+Stadlerauthor=K.+T.+Flahertyauthor=S.+B.+Kayeauthor=G.+L.+Rosnerauthor=M.+Goreauthor=A.+A.+Desaiauthor=A.+Patnaikauthor=H.+Q.+Xiongauthor=E.+Rowinskyauthor=J.+L.+Abbruzzeseauthor=C.+Xiaauthor=R.+Simantovauthor=B.+Schwartzauthor=P.+J.+O%E2%80%99Dwyer&title=Phase+II+placebo-controlled+randomized+discontinuation+trial+of+sorafenib+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1200%2FJCO.2005.03.6723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Ratain, Mark J.; Eisen, Tim; Stadler, Walter M.; Flaherty, Keith T.; Kaye, Stan B.; Rosner, Gary L.; Gore, Martin; Desai, Apurva A.; Patnaik, Amita; Xiong, Henry Q.; Rowinsky, Eric; Abbruzzese, James L.; Xia, Chenghua; Simantov, Ronit; Schwartz, Brian; O'Dwyer, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2505-2512</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This phase II randomized discontinuation trial evaluated the effects of sorafenib (BAY 43-9006), an oral multikinase inhibitor targeting the tumor and vasculature, on tumor growth in patients with metastatic renal cell carcinoma.  Patients and Methods: Patients initially received oral sorafenib 400 mg twice daily during the initial run-in period.  After 12 wk, patients with changes in bidimensional tumor measurements that were less than 25% from baseline were randomly assigned to sorafenib or placebo for an addnl. 12 wk; patients with ≥25% tumor shrinkage continued open-label sorafenib; patients with ≥25% tumor growth discontinued treatment.  The primary end point was the percentage of randomly assigned patients remaining progression free at 24 wk after the initiation of sorafenib.  Results: Of 202 patients treated during the run-in period, 73 patients had tumor shrinkage of ≥25%.  Sixty-five patients with stable disease at 12 wk were randomly assigned to sorafenib (n = 32) or placebo (n = 33).  At 24 wk, 50% of the sorafenib-treated patients were progression free vs. 18% of the placebo-treated patients (P = .0077).  Median progression-free survival (PFS) from randomization was significantly longer with sorafenib (24 wk) than placebo (6 wk; P = .0087).  Median overall PFS was 29 wk for the entire renal cell carcinoma population (n = 202).  Sorafenib was readministered in 28 patients whose disease progressed on placebo; these patients continued on sorafenib until further progression, for a median of 24 wk.  Common adverse events were skin rash/desquamation, hand-foot skin reaction, and fatigue; 9% of patients discontinued therapy, and no patients died from toxicity.  Conclusion: Sorafenib has significant disease-stabilizing activity in metastatic renal cell carcinoma and is tolerable with chronic daily therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUM2n0Jl3GurVg90H21EOLACvtfcHk0lhn5f7ftku6eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVOmtrk%253D&md5=9c0c7184c9681c9e354e48e5582aa431</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.6723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.6723%26sid%3Dliteratum%253Aachs%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26aulast%3DEisen%26aufirst%3DT.%26aulast%3DStadler%26aufirst%3DW.%2BM.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DRosner%26aufirst%3DG.%2BL.%26aulast%3DGore%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DA.%2BA.%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DXiong%26aufirst%3DH.%2BQ.%26aulast%3DRowinsky%26aufirst%3DE.%26aulast%3DAbbruzzese%26aufirst%3DJ.%2BL.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DP.%2BJ.%26atitle%3DPhase%2520II%2520placebo-controlled%2520randomized%2520discontinuation%2520trial%2520of%2520sorafenib%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2505%26epage%3D2512%26doi%3D10.1200%2FJCO.2005.03.6723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukowski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreicer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. A.</span></span> <span> </span><span class="NLM_article-title">A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1007/s10637-010-9516-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs10637-010-9516-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=20711630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=364-367&author=D.+R.+Shepardauthor=M.+M.+Cooneyauthor=P.+Elsonauthor=R.+M.+Bukowskiauthor=R.+Dreicerauthor=B.+I.+Riniauthor=J.+A.+Garcia&title=A+phase+II+study+of+tandutinib+%28MLN518%29%2C+a+selective+inhibitor+of+type+III+tyrosine+receptor+kinases%2C+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1007%2Fs10637-010-9516-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Shepard, Dale R.; Cooney, Matthew M.; Elson, Paul; Bukowski, Ronald M.; Dreicer, Robert; Rini, Brian I.; Garcia, Jorge A.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">364-367</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Therapies which target VEGF and mTOR are now available for patients with metastatic renal cell carcinoma, but there is a continued need to develop agents for patients who become refractory to these initial agents.  Tandutinib is a relatively selective inhibitor of type III tyrosine kinase receptor kinases with promising activity in some tumors.  In this trial, 10 patients with metastatic renal cell carcinoma refractory to previous therapy with sunitinib or sorafenib (median age 61 years, 80% performance status 0, 60% intermediate MSKCC risk classification) received tandutinib 500 mg bid daily with RECIST-defined response as the primary endpoint and progression-free survival (PFS) and overall survival (OS) as secondary endpoints.  No patient had more than 2 cycles of therapy and 50% of patients only received 1 cycle with 70% of patients discontinuing for progressive disease and 30% for toxicity.  Tandutinib was not well tolerated with dose redn. in 60% of patients due to adverse events.  The most common grade 3 toxicity was fatigue (30%).  Tandutinib had no clin. activity and due to the excessive toxicity should not be developed further in patients with sunitinib or sorafenib-refractory metastatic renal cell carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiUZspSDA4LrVg90H21EOLACvtfcHk0ljfaZtxFOJGNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVWisQ%253D%253D&md5=2909607b7c96ffa157c3d072d9242a1d</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1007%2Fs10637-010-9516-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-010-9516-1%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DD.%2BR.%26aulast%3DCooney%26aufirst%3DM.%2BM.%26aulast%3DElson%26aufirst%3DP.%26aulast%3DBukowski%26aufirst%3DR.%2BM.%26aulast%3DDreicer%26aufirst%3DR.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DGarcia%26aufirst%3DJ.%2BA.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520tandutinib%2520%2528MLN518%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520type%2520III%2520tyrosine%2520receptor%2520kinases%252C%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D364%26epage%3D367%26doi%3D10.1007%2Fs10637-010-9516-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimer, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klisovic, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligiuri, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecerf, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karol, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. C.</span></span> <span> </span><span class="NLM_article-title">Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">3674</span>– <span class="NLM_lpage">3681</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-02-005702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1182%2Fblood-2006-02-005702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=16902153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Kgs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=3674-3681&author=D.+J.+DeAngeloauthor=R.+M.+Stoneauthor=M.+L.+Heaneyauthor=S.+D.+Nimerauthor=R.+L.+Paquetteauthor=R.+B.+Klisovicauthor=M.+A.+Caligiuriauthor=M.+R.+Cooperauthor=J.+M.+Lecerfauthor=M.+D.+Karolauthor=S.+Shengauthor=N.+Holfordauthor=P.+T.+Curtinauthor=B.+J.+Drukerauthor=M.+C.+Heinrich&title=Phase+1+clinical+results+with+tandutinib+%28MLN518%29%2C+a+novel+FLT3+antagonist%2C+in+patients+with+acute+myelogenous+leukemia+or+high-risk+myelodysplastic+syndrome%3A+safety%2C+pharmacokinetics%2C+and+pharmacodynamics&doi=10.1182%2Fblood-2006-02-005702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics</span></div><div class="casAuthors">DeAngelo, Daniel J.; Stone, Richard M.; Heaney, Mark L.; Nimer, Stephen D.; Paquette, Ronald L.; Klisovic, Rebecca B.; Caligiuri, Michael A.; Cooper, Michael R.; Lecerf, Jean-Michel; Karol, Michael D.; Sheng, Shihong; Holford, Nick; Curtin, Peter T.; Druker, Brian J.; Heinrich, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3674-3681</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Tandutinib (MLN518/CT53518) is a novel quinazoline-based inhibitor of the type III receptor tyrosine kinases: FMS-like tyrosine kinase 3 (FLT3), platelet-derived growth factor receptor (PDGFR), and KIT.  Because of the correlation between FLT3 internal tandem duplication (ITD) mutations and poor prognosis in acute myelogenous leukemia (AML), we conducted a phase 1 trial of tandutinib in 40 patients with either AML or high-risk myelodysplastic syndrome (MDS).  Tandutinib was given orally in doses ranging from 50 mg to 700 mg twice daily The principal dose-limiting toxicity (DLT) of tandutinib was reversible generalized muscular weakness, fatigue, or both, occurring at doses of 525 mg and 700 mg twice daily.  Tandutinib's pharmacokinetics were characterized by slow elimination, with achievement of steady-state plasma concns. requiring greater than 1 wk of dosing.  Western blotting showed that tandutinib inhibited phosphorylation of FLT3 in circulating leukemic blasts.  Eight patients had FLT3-ITD mutations; 5 of these were evaluable for assessment of tandutinib's antileukemic effect.  Two of the 5 patients, treated at 525 mg and 700 mg twice daily, showed evidence of antileukemic activity, with decreases in both peripheral and bone marrow blasts.  Tandutinib at the MTD (525 mg twice daily) should be evaluated more extensively in patients with AML with FLT3-ITD mutations to better define its antileukemic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraXRBv_Gv-TLVg90H21EOLACvtfcHk0lgvk1mPabl76Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Kgs7%252FM&md5=42c0b5a4c193955023198d6c6d12c463</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-02-005702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-02-005702%26sid%3Dliteratum%253Aachs%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DHeaney%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DPaquette%26aufirst%3DR.%2BL.%26aulast%3DKlisovic%26aufirst%3DR.%2BB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DLecerf%26aufirst%3DJ.%2BM.%26aulast%3DKarol%26aufirst%3DM.%2BD.%26aulast%3DSheng%26aufirst%3DS.%26aulast%3DHolford%26aufirst%3DN.%26aulast%3DCurtin%26aufirst%3DP.%2BT.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26atitle%3DPhase%25201%2520clinical%2520results%2520with%2520tandutinib%2520%2528MLN518%2529%252C%2520a%2520novel%2520FLT3%2520antagonist%252C%2520in%2520patients%2520with%2520acute%2520myelogenous%2520leukemia%2520or%2520high-risk%2520myelodysplastic%2520syndrome%253A%2520safety%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26spage%3D3674%26epage%3D3681%26doi%3D10.1182%2Fblood-2006-02-005702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><a href="https://www.clinicaltrials.gov/ct2/show/NCT02438761" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02438761</a> (accessed April 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02438761+%28accessed+April+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W. J.</span></span> <span> </span><span class="NLM_article-title">The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1006/excr.1999.4706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1006%2Fexcr.1999.4706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10579913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK1MXnsF2itL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=78-87&author=H.+Kimauthor=W.+J.+Muller&title=The+role+of+the+epidermal+growth+factor+receptor+family+in+mammary+tumorigenesis+and+metastasis&doi=10.1006%2Fexcr.1999.4706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis</span></div><div class="casAuthors">Kim, Harold; Muller, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-87</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 109 refs.  A no. of receptor systems have been implicated to play an important role in the development and progression of many human cancers.  The epidermal growth factor (EGF) receptor tyrosine kinase family has been found to consistently play a leading role in tumor progression.  Indeed, in human breast cancer cases the prognosis of a patient is inversely correlated with the overexpression and/or amplification of this receptor family.  Furthermore, downstream signaling components such as the Src kinases, PI3'K, and the Ras pathway display evidence of deregulation that can accelerate tumor progression.  The transgenic mouse system has been ideal in elucidating the biol. significance of this receptor family in mammary tumorigenesis.  Mol. events involved in mammary tumorigenesis such as ligand binding, receptor dimerization, and the activation of downstream pathways have been addressed using this system.  Although there are many mol. steps that appear to drive each stage of tumor development, the EGF receptor family appears to play a causal role in the progression to a transformed phenotype.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptCmIjyIHglrVg90H21EOLACvtfcHk0lgxzM5skOM8gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsF2itL8%253D&md5=fd74f320166f00185f17af2f372cddf0</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4706%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520role%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520in%2520mammary%2520tumorigenesis%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D78%26epage%3D87%26doi%3D10.1006%2Fexcr.1999.4706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarden, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwkowski, M. X.</span></span> <span> </span><span class="NLM_article-title">Untangling the ErbB signalling network</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1038/35052073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2F35052073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11252954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=127-137&author=Y.+Yardenauthor=M.+X.+Sliwkowski&title=Untangling+the+ErbB+signalling+network&doi=10.1038%2F35052073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Untangling the ErbB signalling network</span></div><div class="casAuthors">Yarden, Yosef; Sliwkowski, Mark X.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 112 refs.  When epidermal growth factor and its relatives bind the ErbB family of receptors, they trigger a rich network of signaling pathways, culminating in responses ranging from cell division to death, motility to adhesion.  The network is often dysregulated in cancer and lends credence to the mantra that mol. understanding yields clin. benefit: over 25,000 women with breast cancer have now been treated with Herceptin, a recombinant antibody designed to block the receptor ErbB2.  Likewise, small-mol. enzyme inhibitors and monoclonal antibodies to ErbB1 are in advanced phases of clin. testing.  What can this pathway teach us about translating basic science into clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovhWL1HObvNrVg90H21EOLACvtfcHk0lgxzM5skOM8gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVWnt7k%253D&md5=1561a9666f77fce888be821399870cd6</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1038%2F35052073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35052073%26sid%3Dliteratum%253Aachs%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26atitle%3DUntangling%2520the%2520ErbB%2520signalling%2520network%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2001%26volume%3D2%26spage%3D127%26epage%3D137%26doi%3D10.1038%2F35052073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A.</span></span> <span> </span><span class="NLM_article-title">ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1002/med.20209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1002%2Fmed.20209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22183797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ehurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=166-215&author=R.+Saxenaauthor=A.+Dwivedi&title=ErbB+family+receptor+inhibitors+as+therapeutic+agents+in+breast+cancer%3A+current+status+and+future+clinical+perspective&doi=10.1002%2Fmed.20209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective</span></div><div class="casAuthors">Saxena, Ruchi; Dwivedi, Anila</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">166-215</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Breast cancer is the most common cancer diagnosed in women and the second most common cause of female cancer-related deaths, with more than one million new cases diagnosed per yr throughout the world.  With the recent advances in the knowledge of cellular processes and signaling pathways involved in the pathogenesis of breast cancer, the current focus of researchers and clinicians is to develop novel treatment strategies that can be included in the armamentarium against breast cancer.  With the failure of endocrine-targeted therapy and the development of resistance to existing chemotherapy, the most explored pathway as next generation target for breast cancer therapy has been the epidermal growth factor receptor (EGFR) (ErbB-1)/herceptin-2 (HER-2) (ErbB-2) pathway.  This review focuses on the rationale for targeting members of ErbB receptor family and numerous agents that are in use for inhibiting the pathway.  The mechanism of action, preclin. and clin. trial data of the agents that are in use for targeting the EGFR/HER-2 pathway and the current status, thereof, have been discussed in detail.  In addn., the future clin. trial promises these agents hold either as monotherapy or as combination therapy with conventional agents or with other antisignaling agents have been pondered, so as to provide better and more efficacious treatment strategies for breast cancer patients. © 2010 Wiley Periodicals, Inc.  Med Res Rev 32:166-215, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmiIlr-zXabVg90H21EOLACvtfcHk0lgmqL5GWKlHwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ehurfL&md5=5a5b35fb0b1c8da860119a53689c3711</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1002%2Fmed.20209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20209%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DDwivedi%26aufirst%3DA.%26atitle%3DErbB%2520family%2520receptor%2520inhibitors%2520as%2520therapeutic%2520agents%2520in%2520breast%2520cancer%253A%2520current%2520status%2520and%2520future%2520clinical%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D166%26epage%3D215%26doi%3D10.1002%2Fmed.20209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mowafy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farag, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouzid, K. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2012.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23142066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Kjsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=132-145&author=S.+Mowafyauthor=N.+A.+Faragauthor=K.+A.+Abouzid&title=Design%2C+synthesis+and+in+vitro+anti-proliferative+activity+of+4%2C6-quinazolinediamines+as+potent+EGFR-TK+inhibitors&doi=10.1016%2Fj.ejmech.2012.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors</span></div><div class="casAuthors">Mowafy, Samar; Farag, Nahla A.; Abouzid, Khaled A. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-145</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Anilino-6-substituted-quinazolines were designed, synthesized and evaluated for EGFR-TK and tumor growth inhibitory activities.  The target compds. were designed with enamine ester or urea moieties appended at the C-6 of quinazoline as addnl. hydrogen bond acceptor functions.  Most of the synthesized compds. displayed potent EGFR-TK inhibitory activity at 10 μM and the 6-ureido-anilinoquinazoline deriv. (I) showed IC50 value of 0.061 μM.  Moreover, six compds. were tested by National Cancer Institute (NCI), USA for their anti-proliferative activity at 10 μM in full NCI 60 cell panel.  Compd. I was further assayed for five dose molar ranges in full NCI 60 cell panel and exhibited remarkable growth inhibitory activity pattern against Non-Small Cell Lung Cancer EKVX (GI50 = 0.37 μM), NCI-H322M (GI50 = 0.36 μM), Renal Cancer A498 (GI50 = 0.46 μM), TK-10 (GI50 = 0.99 μM) and Breast Cancer MDA-MB-468 (GI50 = 1.096 μM) which are of high EGFR expression.  Docking study was performed for the active compds. into ATP binding site of EGFR-TK which showed similar binding mode to gefitinib and addnl. binding with Cys-773 at the gatekeeper of EGFR-TK enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ6Ian6C596LVg90H21EOLACvtfcHk0lgmqL5GWKlHwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Kjsb3E&md5=e74abcf0e7ff68497f022ac4e1400ab1</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DMowafy%26aufirst%3DS.%26aulast%3DFarag%26aufirst%3DN.%2BA.%26aulast%3DAbouzid%26aufirst%3DK.%2BA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520anti-proliferative%2520activity%2520of%25204%252C6-quinazolinediamines%2520as%2520potent%2520EGFR-TK%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D61%26spage%3D132%26epage%3D145%26doi%3D10.1016%2Fj.ejmech.2012.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7988</span>– <span class="NLM_lpage">7998</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmc.2013.09.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24183742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSlsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7988-7998&author=X.+Zhangauthor=T.+Pengauthor=X.+Jiauthor=J.+Liauthor=L.+Tongauthor=Z.+Liauthor=W.+Yangauthor=Y.+Xuauthor=M.+Liauthor=J.+Dingauthor=H.+Jiangauthor=H.+Xieauthor=H.+Liu&title=Design%2C+synthesis+and+biological+evaluation+of+novel+4-anilinoquinazolines+with+C-6+urea-linked+side+chains+as+inhibitors+of+the+epidermal+growth+factor+receptor&doi=10.1016%2Fj.bmc.2013.09.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor</span></div><div class="casAuthors">Zhang, Xu; Peng, Ting; Ji, Xun; Li, Jian; Tong, Linjiang; Li, Zeng; Yang, Wei; Xu, Yungen; Li, Mengyuan; Ding, Jian; Jiang, Hualiang; Xie, Hua; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7988-7998</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of anilinoquinazoline compds. with C-6 urea-linked side chains was designed and synthesized as reversible inhibitors of epidermal growth factor receptor (EGFR) based on the structure-activity relationships (SARs) of anilinoquinazoline inhibitors.  All compds. demonstrated good inhibition of EGFR wild type (EGFR wt) and inhibited proliferation of A431cell line.  Compds. (I) and (II) almost completely blocked the phosphorylation of EGFR in A431 cell line at 0.01 μM.  Interestingly, all of the compds. also demonstrated moderate inhibition of EGFR/T790M/L858R.  In addn., compds. (III) and (IV) blocked the autophosphorylation of EGFR in NCI-H1975 cells at high concn. (10 μM), and compd. 8f was confirmed to be an irreversible inhibitor through the diln. method.  Importantly, the compds. with C-6 urea-linked side chains which did not contain Michael acceptors demonstrated moderate to strong irreversible EGFR inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm9A3kxR7nTbVg90H21EOLACvtfcHk0ljuYA1eUdlPcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSlsLrI&md5=30a7a86cd500a9073efe50cd1660bf4b</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.049%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25204-anilinoquinazolines%2520with%2520C-6%2520urea-linked%2520side%2520chains%2520as%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7988%26epage%3D7998%26doi%3D10.1016%2Fj.bmc.2013.09.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. Y.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1039/c3md00096f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2Fc3md00096f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotleqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=979-986&author=Q.+W.+Zhangauthor=Y.+Y.+Diaoauthor=F.+Wangauthor=Y.+Fuauthor=F.+Tangauthor=Q.+D.+Youauthor=H.+Y.+Zhou&title=Design+and+discovery+of+4-anilinoquinazoline+ureas+as+multikinase+inhibitors+targeting+BRAF%2C+VEGFR-2+and+EGFR&doi=10.1039%2Fc3md00096f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR</span></div><div class="casAuthors">Zhang, Qingwen; Diao, Yuanyuan; Wang, Fei; Fu, Ying; Tang, Fei; You, Qidong; Zhou, Houyuan</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">979-986</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">4-Anilinoquinazoline ureas were envisaged according to the hybrid-design approach based upon two privileged pharmacophores in kinase drug discovery, i.e. 4-anilinoquinazoline and unsym. diaryl urea.  In our structure-activity relationships (SAR) campaign, title compds. were synthesized and profiled in biochem. assay for their kinase inhibitory activity.  Title compds. 18-20 were found to be multikinase inhibitors with profound activity against BRAF, BRAF V600E, VEGFR-2 and EGFR.  Mol. docking into DFG-out conformations of BRAF and VEGFR-2 suggested that they might be type II inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNq-LAIAB3urVg90H21EOLACvtfcHk0ljuYA1eUdlPcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotleqsr0%253D&md5=8749fa7cffe96ef37e379bf205010499</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1039%2Fc3md00096f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00096f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%2BW.%26aulast%3DDiao%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DZhou%26aufirst%3DH.%2BY.%26atitle%3DDesign%2520and%2520discovery%2520of%25204-anilinoquinazoline%2520ureas%2520as%2520multikinase%2520inhibitors%2520targeting%2520BRAF%252C%2520VEGFR-2%2520and%2520EGFR%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D979%26epage%3D986%26doi%3D10.1039%2Fc3md00096f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. P.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2016.09.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27688180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFymsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=245-254&author=H.+Q.+Zhangauthor=F.+H.+Gongauthor=J.+Q.+Yeauthor=C.+Zhangauthor=X.+H.+Yueauthor=C.+G.+Liauthor=Y.+G.+Xuauthor=L.+P.+Sun&title=Design+and+discovery+of+4-anilinoquinazoline-urea+derivatives+as+dual+TK+inhibitors+of+EGFR+and+VEGFR-2&doi=10.1016%2Fj.ejmech.2016.09.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2</span></div><div class="casAuthors">Zhang, Hai-Qi; Gong, Fei-Hu; Ye, Ji-Qing; Zhang, Chi; Yue, Xiao-Hong; Li, Chuan-Gui; Xu, Yun-Gen; Sun, Li-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-254</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">EGFR and VEGFR-2 are involved in pathol. disorders and the progression of different kinds of tumors, the combined blockade of EGFR and VEGFR signaling pathways appears to be an attractive approach to cancer therapy.  In this work, a series of 4-anilinoquinazoline derivs. contg. substituted diaryl urea or glycine Me ester moiety were designed and identified as EGFR and VEGFR-2 dual inhibitors.  Compds. I, II and III exhibited the most potent inhibitory activities against EGFR (IC50 = 1 nM, 78 nM and 51 nM, resp.) and VEGFR-2 (IC50 = 79 nM, 14 nM and 14 nM, resp.), they showed good antiproliferative activities as well.  Mol. docking established the interaction of I with the DFG-out conformation of VEGFR-2, suggesting that they might be type II kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyAsg6-6mJ5LVg90H21EOLACvtfcHk0lief9_4u94pEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFymsb3N&md5=f97387e248ed7557360b9cf4d496c4d6</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BQ.%26aulast%3DGong%26aufirst%3DF.%2BH.%26aulast%3DYe%26aufirst%3DJ.%2BQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DYue%26aufirst%3DX.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DY.%2BG.%26aulast%3DSun%26aufirst%3DL.%2BP.%26atitle%3DDesign%2520and%2520discovery%2520of%25204-anilinoquinazoline-urea%2520derivatives%2520as%2520dual%2520TK%2520inhibitors%2520of%2520EGFR%2520and%2520VEGFR-2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D245%26epage%3D254%26doi%3D10.1016%2Fj.ejmech.2016.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">The hallmarks of cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81683-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer&doi=10.1016%2FS0092-8674%2800%2981683-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lief9_4u94pEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70%26doi%3D10.1016%2FS0092-8674%2800%2981683-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pralhad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhusudan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendrakumar, K.</span></span> <span> </span><span class="NLM_article-title">Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1211/0022357021819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1211%2F0022357021819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12956893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=1045-1053&author=T.+Pralhadauthor=S.+Madhusudanauthor=K.+Rajendrakumar&title=Concept%2C+mechanisms+and+therapeutics+of+angiogenesis+in+cancer+and+other+diseases&doi=10.1211%2F0022357021819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Pralhad, Tayade; Madhusudan, Saraf; Rajendrakumar, Kale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1045-1053</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  Angiogenesis supports normal physiol. as well as contributing to the progression of various diseases including cancer.  Detn. of the key role of angiogenesis in cancer has led to much optimism for the development of targeted drugs without cytotoxic side-effects.  Currently, research in angiogenesis therapy is robust, with the discovery of a growing no. of pro- and anti-angiogenic mols.  More time, however, is required to be able to elucidate the complex interactions among these mols., how they affect vasculature, and their functions in different environments.  As more is learned about the mol. mechanisms of angiogenesis, a no. of effective methods to treat cancer and other diseases will be developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuQLA1HzTRkrVg90H21EOLACvtfcHk0lhT3w9nsYHM4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGnsb8%253D&md5=7051a61be69e134ad9d427feff2f3648</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1211%2F0022357021819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357021819%26sid%3Dliteratum%253Aachs%26aulast%3DPralhad%26aufirst%3DT.%26aulast%3DMadhusudan%26aufirst%3DS.%26aulast%3DRajendrakumar%26aufirst%3DK.%26atitle%3DConcept%252C%2520mechanisms%2520and%2520therapeutics%2520of%2520angiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2003%26volume%3D55%26spage%3D1045%26epage%3D1053%26doi%3D10.1211%2F0022357021819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span> <span> </span><span class="NLM_article-title">Development and strategies of VEGFR-2/KDR inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1839</span>– <span class="NLM_lpage">1852</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.4155%2Ffmc.12.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23043480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOhsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1839-1852&author=L.+Huangauthor=Z.+Huangauthor=Z.+Baiauthor=R.+Xieauthor=L.+Sunauthor=K.+Lin&title=Development+and+strategies+of+VEGFR-2%2FKDR+inhibitors&doi=10.4155%2Ffmc.12.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Development and strategies of VEGFR-2/KDR inhibitors</span></div><div class="casAuthors">Huang, Lingyi; Huang, Zhengui; Bai, Zhiqiang; Xie, Rui; Sun, Liping; Lin, Kejiang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1839-1852</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  VEGF is an important signaling protein involved in both vasculogenesis and angiogenesis.  As an essential receptor protein tyrosine kinase propagating cellular signal transduction processes, VEGFR-2 is a central target for drug discovery against tumor-assocd. angiogenesis.  Since the autophosphorylation of VEGFR-2 represents a key step in this signal pathway that contributes to angiogenesis, the discovery of small mol. inhibitors that block this reaction has attracted great interest for novel drugs research and development.  Advances in the understanding of catalytic cleft and the conformational changes of DFG motif have resulted in the development of small mol. inhibitors known as type I and type II.  High-resoln. crystal structures of various inhibitors in complex with the receptor offer an insight into the relationship among binding modes, inhibition mechanisms, activity, selectivity and resistance.  To control selectivity, improve activity and introduce intellectual property novelty, the strategies for the further development are discussed through structural and conformational anal. in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMgCdblpbQc7Vg90H21EOLACvtfcHk0lhTk8lJsQ_j4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOhsb3O&md5=96cc54622cc92d45a8549eb88d551a7f</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.121%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DK.%26atitle%3DDevelopment%2520and%2520strategies%2520of%2520VEGFR-2%252FKDR%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1839%26epage%3D1852%26doi%3D10.4155%2Ffmc.12.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldehna, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aly, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abou-Seri, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aziz, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abou El Ella, D. A.</span></span> <span> </span><span class="NLM_article-title">Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2015.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26071861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=89-97&author=W.+M.+Eldehnaauthor=M.+Faresauthor=H.+S.+Ibrahimauthor=M.+H.+Alyauthor=S.+Zadaauthor=M.+M.+Aliauthor=S.+M.+Abou-Seriauthor=H.+A.+Abdel-Azizauthor=D.+A.+Abou+El+Ella&title=Indoline+ureas+as+potential+anti-hepatocellular+carcinoma+agents+targeting+VEGFR-2%3A+Synthesis%2C+in+vitro+biological+evaluation+and+molecular+docking&doi=10.1016%2Fj.ejmech.2015.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking</span></div><div class="casAuthors">Eldehna, Wagdy M.; Fares, Mohamed; Ibrahim, Hany S.; Aly, Mohamed H.; Zada, Suher; Ali, Mamdouh M.; Abou-Seri, Sahar M.; Abdel-Aziz, Hatem A.; Abou El Ella, Dalal A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In our effort to develop potent and effective agents with anti-proliferative activity towards HepG2 hepatocellular carcinoma cells with potential inhibitory activity against VEGFR-2, a novel series of 1-(4-((2-oxoindolin-3-ylidene)amino)phenyl)-3-arylureas was designed and synthesized.  All the newly prepd. ureas were evaluated in vitro for their anti-proliferative activity against HepG2 hepatocellular carcinoma cell line.  Some compds. exhibited good activity against HepG2 cancer cells (IC50 = 1.22 ± 0.11-8.37 ± 0.85 μM) comparable to that of doxorubicin and sorafinib (IC50 = 2.90 ± 0.36 and 3.40 ± 0.25 μM, resp.).  These compds. were further evaluated for their inhibitory activity against VEGFR-2.  Compd. I emerged as the most active counterpart against VEGFR-2 with IC50 value of 0.31 ± 0.04 μM.  Furthermore, a mol. docking of the tested compds. was carried out in order to investigate their binding pattern with the prospective target, VEGFR-2 (PDB-code: 4ASD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDlQoeELeaMLVg90H21EOLACvtfcHk0lhTk8lJsQ_j4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjM&md5=7d81fe853234fa7009fe39266c767ad0</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DEldehna%26aufirst%3DW.%2BM.%26aulast%3DFares%26aufirst%3DM.%26aulast%3DIbrahim%26aufirst%3DH.%2BS.%26aulast%3DAly%26aufirst%3DM.%2BH.%26aulast%3DZada%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DM.%2BM.%26aulast%3DAbou-Seri%26aufirst%3DS.%2BM.%26aulast%3DAbdel-Aziz%26aufirst%3DH.%2BA.%26aulast%3DAbou%2BEl%2BElla%26aufirst%3DD.%2BA.%26atitle%3DIndoline%2520ureas%2520as%2520potential%2520anti-hepatocellular%2520carcinoma%2520agents%2520targeting%2520VEGFR-2%253A%2520Synthesis%252C%2520in%2520vitro%2520biological%2520evaluation%2520and%2520molecular%2520docking%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D100%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.ejmech.2015.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Six, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofalo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depreux, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24747748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=369-381&author=S.+Ravezauthor=A.+Barczykauthor=P.+Sixauthor=A.+Cagnonauthor=A.+Garofaloauthor=L.+Goossensauthor=P.+Depreux&title=Inhibition+of+tumor+cell+growth+and+angiogenesis+by+7-aminoalkoxy-4-aryloxy-quinazoline+ureas%2C+a+novel+series+of+multi-tyrosine+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2014.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor cell growth and angiogenesis by 7-Aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors</span></div><div class="casAuthors">Ravez, Severine; Barczyk, Amelie; Six, Perrine; Cagnon, Aurelie; Garofalo, Antonio; Goossens, Laurence; Depreux, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-381</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Several regulatory and signaling mols. governing angiogenesis are targets of interest for the development of drugs in the cancer, including growth factors such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF).  A series of 4-aryloxy-6,7-dimethoxyquinazolines, previously synthesized in our lab., has shown a nanomolar inhibition of kinase enzymic activity of VEGFR, PDGFR and c-Kit.  We have therefore studied the impact of the variation in the 7-position substitution of the quinazoline core.  Substitution by aminoalkoxy chains led to new highly potent ATP-competitive inhibitors of VEGFR, PDGFR and c-Kit enzyme with IC50 values in the nanomolar range and this substitution has increased greatly antiproliferative activity on cancer cell lines (PC3, MCF7, HT29) and HUVEC (human umbilical vein endothelial cells).  One of the most promising compds. (36) was assessed for its ability to limit the induction of web like network of capillary tubes by the human umbilical vascular endothelial cells (HUVEC) and for its ability to inhibit invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eAoR7W7m1rVg90H21EOLACvtfcHk0ljNEH04K_pUbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWgurY%253D&md5=b0e3b6efa1cf399a29c8715c310f7a4b</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DRavez%26aufirst%3DS.%26aulast%3DBarczyk%26aufirst%3DA.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DCagnon%26aufirst%3DA.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%2520and%2520angiogenesis%2520by%25207-aminoalkoxy-4-aryloxy-quinazoline%2520ureas%252C%2520a%2520novel%2520series%2520of%2520multi-tyrosine%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D369%26epage%3D381%26doi%3D10.1016%2Fj.ejmech.2014.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peyssonnaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eychene, A.</span></span> <span> </span><span class="NLM_article-title">The Raf/MEK/ERK pathway: new concepts of activation</span>. <i>Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/S0248-4900(01)01125-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0248-4900%2801%2901125-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11730323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=53-62&author=C.+Peyssonnauxauthor=A.+Eychene&title=The+Raf%2FMEK%2FERK+pathway%3A+new+concepts+of+activation&doi=10.1016%2FS0248-4900%2801%2901125-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">The Raf/MEK/ERK pathway: New concepts of activation</span></div><div class="casAuthors">Peyssonnaux, Carole; Eychene, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Biology of the Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BCELDF</span>;
        ISSN:<span class="NLM_cas:issn">0248-4900</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review.  The Raf/MEK/ERK signaling was the first MAP kinase cascade to be characterized.  It is probably one of the most well known signal transduction pathways among biologists because of its implication in a wide variety of cellular functions as diverse -and occasionally contradictory- as cell proliferation, cell-cycle arrest, terminal differentiation and apoptosis.  Discovery and understanding of this pathway have benefited from the combination of both genetic studies in worms and flies and biochem. studies in mammalian cells.  However, ten years after, this field is still under debate and new mol. partners in the cascade continue to increase the complexity of its regulation.  This review deals with the emergence of new concepts in the activation and regulation of the Raf/MEK/ERK module.  In particular, the preponderant role of B-Raf is underlined, and the role of novel regulators such as KSR is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyjiXSFlBQ6rVg90H21EOLACvtfcHk0ljNEH04K_pUbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D&md5=cde3db5b205a1305dc2e6262deea65ec</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2FS0248-4900%2801%2901125-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0248-4900%252801%252901125-X%26sid%3Dliteratum%253Aachs%26aulast%3DPeyssonnaux%26aufirst%3DC.%26aulast%3DEychene%26aufirst%3DA.%26atitle%3DThe%2520Raf%252FMEK%252FERK%2520pathway%253A%2520new%2520concepts%2520of%2520activation%26jtitle%3DBiol.%2520Cell%26date%3D2001%26volume%3D93%26spage%3D53%26epage%3D62%26doi%3D10.1016%2FS0248-4900%2801%2901125-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C.</span></span> <span> </span><span class="NLM_article-title">Targeted cancer therapy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1038/nature03095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnature03095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15549090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=294-297&author=C.+Sawyers&title=Targeted+cancer+therapy&doi=10.1038%2Fnature03095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy</span></div><div class="casAuthors">Sawyers, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">294-297</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer.  Complex networks of regulatory factors, the tumor microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.  Recent progress in understanding the mol. changes that underlie cancer development offer the prospect of specifically targeting malfunctioning mols. and pathways to achieve more effective and rational cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAGMTW2TYsubVg90H21EOLACvtfcHk0lgmDvBOPrA7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D&md5=5bd377d2c9ddcffc136d5cf181facd02</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1038%2Fnature03095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03095%26sid%3Dliteratum%253Aachs%26aulast%3DSawyers%26aufirst%3DC.%26atitle%3DTargeted%2520cancer%2520therapy%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D294%26epage%3D297%26doi%3D10.1038%2Fnature03095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu-Duvaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marais, R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">867</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(04)00215-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0092-8674%2804%2900215-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15035987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=855-867&author=P.+T.+Wanauthor=M.+J.+Garnettauthor=S.+M.+Roeauthor=S.+Leeauthor=D.+Niculescu-Duvazauthor=V.+M.+Goodauthor=C.+M.+Jonesauthor=C.+J.+Marshallauthor=C.+J.+Springerauthor=D.+Barfordauthor=R.+Marais&title=Mechanism+of+activation+of+the+RAF-ERK+signaling+pathway+by+oncogenic+mutations+of+B-RAF&doi=10.1016%2FS0092-8674%2804%2900215-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF</span></div><div class="casAuthors">Wan, Paul T. C.; Garnett, Mathew J.; Roe, S. Mark; Lee, Sharlene; Niculescu-Duvaz, Dan; Good, Valerie M.; Project, Cancer Genome; Jones, C. Michael; Marshall, Christopher J.; Springer, Caroline J.; Barford, David; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">855-867</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Over 30 mutations of the B-RAF gene assocd. with human cancers have been identified, the majority of which are located within the kinase domain.  Here the authors show that of 22 B-RAF mutants analyzed, 18 have elevated kinase activity and signal to ERK in vivo.  Surprisingly, three mutants have reduced kinase activity towards MEK in vitro but, by activating C-RAF in vivo, signal to ERK in cells.  The structures of wild type and oncogenic V599EB-RAF kinase domains in complex with the RAF inhibitor BAY43-9006 show that the activation segment is held in an inactive conformation by assocn. with the P loop.  The clustering of most mutations to these two regions suggests that disruption of this interaction converts B-RAF into its active conformation.  The high activity mutants signal to ERK by directly phosphorylating MEK, whereas the impaired activity mutants stimulate MEK by activating endogenous C-RAF, possibly via an allosteric or transphosphorylation mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYiQicwc1xVLVg90H21EOLACvtfcHk0lhPkLGSUMV-5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D&md5=4cc020056c64e514286c000666da1972</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900215-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900215-6%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DP.%2BT.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DNiculescu-Duvaz%26aufirst%3DD.%26aulast%3DGood%26aufirst%3DV.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BM.%26aulast%3DMarshall%26aufirst%3DC.%2BJ.%26aulast%3DSpringer%26aufirst%3DC.%2BJ.%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DMechanism%2520of%2520activation%2520of%2520the%2520RAF-ERK%2520signaling%2520pathway%2520by%2520oncogenic%2520mutations%2520of%2520B-RAF%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D855%26epage%3D867%26doi%3D10.1016%2FS0092-8674%2804%2900215-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mambo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trink, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westra, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladenson, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, D.</span></span> <span> </span><span class="NLM_article-title">BRAF mutation in papillary thyroid carcinoma</span>. <i>J. Natl. Cancer Inst</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1093/jnci/95.8.625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1093%2Fjnci%2F95.8.625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12697856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=625-627&author=Y.+Cohenauthor=M.+Xingauthor=E.+Mamboauthor=Z.+Guoauthor=G.+Wuauthor=B.+Trinkauthor=U.+Bellerauthor=W.+H.+Westraauthor=P.+W.+Ladensonauthor=D.+Sidransky&title=BRAF+mutation+in+papillary+thyroid+carcinoma&doi=10.1093%2Fjnci%2F95.8.625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF Mutation in Papillary Thyroid Carcinoma</span></div><div class="casAuthors">Cohen, Yoram; Xing, Mingzhao; Mambo, Elizabeth; Guo, Zhongmin; Wu, Guogun; Trink, Barry; Beller, Uziel; Westra, William H.; Ladenson, Paul W.; Sidransky, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">625-627</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The BRAF gene has been found to be activated by mutation in human cancers, predominantly in malignant melanoma.  We tested 476 primary tumors, including 214 lung, 126 head and neck, 54 thyroid, 27 bladder, 38 cervical, and 17 prostate cancers, for the BRAF T1796A mutation by polymerase chain reaction (PCR)-restriction enzyme anal. of BRAF exon 15.  In 24 (69%) of the 35 papillary thyroid carcinomas examd., we found a missense thymine (T) adenine (A) transversion at nucleotide 1796 in the BRAF gene (T1796A).  The T1796A mutation was detected in four lung cancers and in six head and neck cancers but not in bladder, cervical, or prostate cancers.  Our data suggest that activating BRAF mutations may be an important event in the development of papillary thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_OIrIo68gtLVg90H21EOLACvtfcHk0ljljsufqv8Kzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWqsbw%253D&md5=a28b118adbca62616d62ab88bc94dff6</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.8.625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.8.625%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DM.%26aulast%3DMambo%26aufirst%3DE.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DTrink%26aufirst%3DB.%26aulast%3DBeller%26aufirst%3DU.%26aulast%3DWestra%26aufirst%3DW.%2BH.%26aulast%3DLadenson%26aufirst%3DP.%2BW.%26aulast%3DSidransky%26aufirst%3DD.%26atitle%3DBRAF%2520mutation%2520in%2520papillary%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst%26date%3D2003%26volume%3D95%26spage%3D625%26epage%3D627%26doi%3D10.1093%2Fjnci%2F95.8.625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25462267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOjtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=581-596&author=W.+Yangauthor=Y.+Chenauthor=X.+Zhouauthor=Y.+Guauthor=W.+Qianauthor=F.+Zhangauthor=W.+Hanauthor=T.+Luauthor=W.+Tang&title=Design%2C+synthesis+and+biological+evaluation+of+bis-aryl+ureas+and+amides+based+on+2-amino-3-purinylpyridine+scaffold+as+DFG-out+B-Raf+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2014.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors</span></div><div class="casAuthors">Yang, Weimin; Chen, Yadong; Zhou, Xiang; Gu, Yazhou; Qian, Wenqi; Zhang, Fan; Han, Wei; Lu, Tao; Tang, Weifang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">581-596</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">By combining the scaffolds of UI-125 and Sorafenib, a series of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine moiety were designed and synthesized as novel DFG-out B-RafV600E inhibitors.  Several of these compds. displayed potent antiproliferative activities against melanoma A375 (B-RafV600E) cell lines with IC50 values of 3.190, 2.276, 1.856, 1.632 μM and 1.839 μM, resp., comparable with the pos. control Vemurafenib (IC50 = 3.32 μM).  Selected compds. were tested for the ERK inhibition in human melanoma A375 (B-RafV600E) and SK-MEL-2 (B-RafWT) cell lines by Western blot.  The results revealed that our compds. inhibited the proliferation of melanoma A375 cells (B-RafV600E) through ERK pathway, without paradoxical activation of ERK in melanoma SK-MEL-2 cells (B-RafWT).  Eventually, two compds. were selected to confirm their inhibitory effects on tumor growth in A375 xenograft models in mice.  Compd. I exhibited equiv. antitumor efficacy in vivo (T/C = 44.37%), compared to Sorafenib (T/C = 37.35%), by 23-day repetitive administration of a single dose of 50 mg/kg without significant body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq84bBDYugz1bVg90H21EOLACvtfcHk0ljljsufqv8Kzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOjtL7I&md5=6a65e09b0121c8f2f32facbfeae8f86b</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520bis-aryl%2520ureas%2520and%2520amides%2520based%2520on%25202-amino-3-purinylpyridine%2520scaffold%2520as%2520DFG-out%2520B-Raf%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D581%26epage%3D596%26doi%3D10.1016%2Fj.ejmech.2014.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Damasy, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, G.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2016.02.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27017549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVymu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=201-216&author=A.+K.+El-Damasyauthor=J.+H.+Leeauthor=S.+H.+Seoauthor=N.+C.+Choauthor=A.+N.+Paeauthor=G.+Keum&title=Design+and+synthesis+of+new+potent+anticancer+benzothiazole+amides+and+ureas+featuring+pyridylamide+moiety+and+possessing+dual+B-Raf%28V600E%29+and+C-Raf+kinase+inhibitory+activities&doi=10.1016%2Fj.ejmech.2016.02.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities</span></div><div class="casAuthors">El-Damasy, Ashraf Kareem; Lee, Ju-Hyeon; Seo, Seon Hee; Cho, Nam-Chul; Pae, Ae Nim; Keum, Gyochang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-216</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new series of benzothiazole amide and urea derivs. tethered with the privileged pyridylamide moiety by ether linkage at the 6-position of benzothiazole (22 final compds.) has been designed and synthesized as potent anticancer sorafenib analogs.  A selected group of twelve derivs. was appraised for its antiproliferative activity over a panel of 60 human cancer cell lines at a single dose concn. of 10 μM at National Cancer Institute (NCI, USA).  Some compds. exhibited promising growth inhibitions and thus were further tested in advanced 5-dose testing assay to det. their GI50 values.  The cellular based assay results revealed that 3,5-bis-trifluoromethylphenyl urea deriv. I is the best deriv. with superior potency and efficacy compared to sorafenib as well as notable extended spectrum activity covering 57 human cancer cell lines.  Kinase screening of compd. I showed its kinase inhibitory effect against both B-RafV600E and C-Raf.  Moreover, the most potent derivs. in cells were investigated for their RAF inhibitory activities, and the results were rationalized with the mol. docking study.  Profiling of CYP450 and hERG channel inhibitory effects for the active compds. revealed their low possibilities to exhibit undesirable drug-drug interactions and cardiac side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrZG_38JUm7Vg90H21EOLACvtfcHk0lg4yTH20HrHrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVymu7c%253D&md5=1b8d482241d0f75e6df8f518b7fc3bbc</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.039%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Damasy%26aufirst%3DA.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSeo%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DN.%2BC.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DKeum%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520potent%2520anticancer%2520benzothiazole%2520amides%2520and%2520ureas%2520featuring%2520pyridylamide%2520moiety%2520and%2520possessing%2520dual%2520B-Raf%2528V600E%2529%2520and%2520C-Raf%2520kinase%2520inhibitory%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D201%26epage%3D216%26doi%3D10.1016%2Fj.ejmech.2016.02.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogeti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telikepalli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutkoski, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogeti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kays, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipskind, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobleski, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobb, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clay, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walgren, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clawson, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglicmot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groshong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starling, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, D. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3- d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4165</span>– <span class="NLM_lpage">4179</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlCisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4165-4179&author=J.+R.+Henryauthor=M.+D.+Kaufmanauthor=S.+B.+Pengauthor=Y.+M.+Ahnauthor=T.+M.+Caldwellauthor=L.+Vogetiauthor=H.+Telikepalliauthor=W.+P.+Luauthor=M.+M.+Hoodauthor=T.+J.+Rutkoskiauthor=B.+D.+Smithauthor=S.+Vogetiauthor=D.+Millerauthor=S.+C.+Wiseauthor=L.+Chunauthor=X.+Zhangauthor=Y.+Zhangauthor=L.+Kaysauthor=P.+A.+Hipskindauthor=A.+D.+Wrobleskiauthor=K.+L.+Lobbauthor=J.+M.+Clayauthor=J.+D.+Cohenauthor=J.+L.+Walgrenauthor=D.+McCannauthor=P.+Patelauthor=D.+K.+Clawsonauthor=S.+Guoauthor=D.+Manglicmotauthor=C.+Groshongauthor=C.+Loganauthor=J.+J.+Starlingauthor=D.+L.+Flynn&title=Discovery+of+1-%283%2C3-dimethylbutyl%29-3-%282-fluoro-4-methyl-5-%287-methyl-2-%28methylamino%29pyrido%5B2%2C3-+d%5Dpyrimidin-6-yl%29phenyl%29urea+%28LY3009120%29+as+a+pan-RAF+inhibitor+with+minimal+paradoxical+activation+and+activity+against+BRAF+or+RAS+mutant+tumor+cells&doi=10.1021%2Facs.jmedchem.5b00067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells</span></div><div class="casAuthors">Henry, James R.; Kaufman, Michael D.; Peng, Sheng-Bin; Ahn, Yu Mi; Caldwell, Timothy M.; Vogeti, Lakshminarayana; Telikepalli, Hanumaiah; Lu, Wei-Ping; Hood, Molly M.; Rutkoski, Thomas J.; Smith, Bryan D.; Vogeti, Subha; Miller, David; Wise, Scott C.; Chun, Lawrence; Zhang, Xiaoyi; Zhang, Youyan; Kays, Lisa; Hipskind, Philip A.; Wrobleski, Aaron D.; Lobb, Karen L.; Clay, Julia M.; Cohen, Jeffrey D.; Walgren, Jennie L.; McCann, Denis; Patel, Phenil; Clawson, David K.; Guo, Sherry; Manglicmot, Danalyn; Groshong, Chris; Logan, Cheyenne; Starling, James J.; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4165-4179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The RAS-RAF-MEK-MAPK cascade is an essential signaling pathway, with activation typically mediated through cell surface receptors.  The kinase inhibitors vemurafenib and dabrafenib, which target oncogenic BRAF V600E, have shown significant clin. efficacy in melanoma patients harboring this mutation.  Because of paradoxical pathway activation, both agents were demonstrated to promote growth and metastasis of tumor cells with RAS mutations in preclin. models and are contraindicated for treatment of cancer patients with BRAF WT background, including patients with KRAS or NRAS mutations.  To eliminate the issues assocd. with paradoxical MAPK pathway activation and to provide therapeutic benefit to patients with RAS mutant cancers, we sought to identify a compd. not only active against BRAF V600E but also wild type BRAF and CRAF.  On the basis of its superior in vitro and in vivo profile, compd. 13 was selected for further development and is currently being evaluated in phase I clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXIUwbnhct2rVg90H21EOLACvtfcHk0lgJYy1ZqJ5SaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlCisL0%253D&md5=9e5bc7ee7f45d238e2fa40e1d5cfc739</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00067%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DCaldwell%26aufirst%3DT.%2BM.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DTelikepalli%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DRutkoski%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DVogeti%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKays%26aufirst%3DL.%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26aulast%3DWrobleski%26aufirst%3DA.%2BD.%26aulast%3DLobb%26aufirst%3DK.%2BL.%26aulast%3DClay%26aufirst%3DJ.%2BM.%26aulast%3DCohen%26aufirst%3DJ.%2BD.%26aulast%3DWalgren%26aufirst%3DJ.%2BL.%26aulast%3DMcCann%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DClawson%26aufirst%3DD.%2BK.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DManglicmot%26aufirst%3DD.%26aulast%3DGroshong%26aufirst%3DC.%26aulast%3DLogan%26aufirst%3DC.%26aulast%3DStarling%26aufirst%3DJ.%2BJ.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DDiscovery%2520of%25201-%25283%252C3-dimethylbutyl%2529-3-%25282-fluoro-4-methyl-5-%25287-methyl-2-%2528methylamino%2529pyrido%255B2%252C3-%2520d%255Dpyrimidin-6-yl%2529phenyl%2529urea%2520%2528LY3009120%2529%2520as%2520a%2520pan-RAF%2520inhibitor%2520with%2520minimal%2520paradoxical%2520activation%2520and%2520activity%2520against%2520BRAF%2520or%2520RAS%2520mutant%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4165%26epage%3D4179%26doi%3D10.1021%2Facs.jmedchem.5b00067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vakana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blosser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowless, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancato, L. F.</span></span> <span> </span><span class="NLM_article-title">LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">9251</span>– <span class="NLM_lpage">9266</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.14002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.18632%2Foncotarget.14002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27999210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FmvFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=9251-9266&author=E.+Vakanaauthor=S.+Prattauthor=W.+Blosserauthor=M.+Dowlessauthor=N.+Simpsonauthor=X.+J.+Yuanauthor=S.+Jakenauthor=J.+Manroauthor=J.+Stephensauthor=Y.+Zhangauthor=L.+Huberauthor=S.+B.+Pengauthor=L.+F.+Stancato&title=LY3009120%2C+a+panRAF+inhibitor%2C+has+significant+anti-tumor+activity+in+BRAF+and+KRAS+mutant+preclinical+models+of+colorectal+cancer&doi=10.18632%2Foncotarget.14002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer</span></div><div class="casAuthors">Vakana Eliza; Pratt Susan; Blosser Wayne; Dowless Michele; Stephens Jennifer; Zhang Youyan; Huber Lysiane; Peng Sheng-Bin; Stancato Louis F; Simpson Nicholas; Yuan Xiu-Juan; Jaken Susan; Manro Jason</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">9251-9266</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Activating mutations in the KRAS and BRAF genes, leading to hyperactivation of the RAS/RAF/MAPK oncogenic signaling cascade, are common in patients with colorectal cancer (CRC).  While selective BRAF inhibitors are efficacious in BRAFmut melanoma, they have limited efficacy in BRAFmut CRC patients.  In a RASmut background, selective BRAF inhibitors are contraindicated due to paradoxical activation of the MAPK pathway through potentiation of CRAF kinase activity.  A way to overcome such paradoxical activation is through concurrent inhibition of the kinase activity of both RAF isoforms.  Here, we further examined the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of CRC with various mutational backgrounds.  We demonstrate that LY3009120 induced anti-proliferative effects in BRAFmut and KRASmut CRC cell lines through G1-cell cycle arrest.  The anti-proliferative effects of LY3009120 in KRASmut CRC cell lines phenocopied molecular inhibition of RAF isoforms by simultaneous siRNA-mediated knockdown of ARAF, BRAF and CRAF.  Additionally, LY3009120 displayed significant activity in in vivo BRAFmut and KRASmut CRC xenograft models.  Examination of potential resistance to LY3009120 demonstrated RAF-independent ERK and AKT activation in the KRASmut CRC cell line HCT 116.  These findings describe the preclinical activity of a panRAF inhibitor in a BRAFmut and KRASmut CRC setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6nK1jxnNjuvh3YQQtAhNufW6udTcc2eYBsOWAgc0uYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FmvFamuw%253D%253D&md5=d995e803ce26baeff079855005acddac</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.14002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.14002%26sid%3Dliteratum%253Aachs%26aulast%3DVakana%26aufirst%3DE.%26aulast%3DPratt%26aufirst%3DS.%26aulast%3DBlosser%26aufirst%3DW.%26aulast%3DDowless%26aufirst%3DM.%26aulast%3DSimpson%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DX.%2BJ.%26aulast%3DJaken%26aufirst%3DS.%26aulast%3DManro%26aufirst%3DJ.%26aulast%3DStephens%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DStancato%26aufirst%3DL.%2BF.%26atitle%3DLY3009120%252C%2520a%2520panRAF%2520inhibitor%252C%2520has%2520significant%2520anti-tumor%2520activity%2520in%2520BRAF%2520and%2520KRAS%2520mutant%2520preclinical%2520models%2520of%2520colorectal%2520cancer%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D9251%26epage%3D9266%26doi%3D10.18632%2Foncotarget.14002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, H. G.</span></span> <span> </span><span class="NLM_article-title">Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=8618433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaK283gtV2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=588-599&author=H.+G.+Drexler&title=Expression+of+FLT3+receptor+and+response+to+FLT3+ligand+by+leukemic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells</span></div><div class="casAuthors">Drexler H G</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">588-99</span>
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    </div><div class="casAbstract">The novel hematopoietic growth factor FLT3 ligand (FL) is the cognate ligand for the FLT3, tyrosine kinase receptor (R), also referred to as FLK-2 and STK-1.  The FLT3R belongs to a family of receptor tyrosine kinases involved in hematopoiesis that also includes KIT, the receptor for SCF (stem cell factor), and FMS. the receptor for M-CSF (macrophage colony- stimulating factor).  Restricted FLT3R expression was seen on human and murine hematopoietic progenitor cells.  In functional assays recombinant FL stimulated the proliferation and colony formation of human hematopoietic progenitor cells, i.e.  CD34+ cord and peripheral blood, bone marrow and fetal liver cells.  Synergy was reported for co-stimulation with G-CSF (granulocyte-CSF).  GM-CSF (granulocyte-macrophage CSF), M-CSF, interleukin-3 (IL-3), PIXY-321 (an IL-3/GM-CSF fusion protein) and SCF.  In the mouse, FL potently enhanced growth of various types of progenitor/precursor cells in synergy with G-CSF, GM-CSF, M-CSF, IL-3, IL-6, IL-7, IL-11, IL-12 and SCF.  The well-documented involvement of this ligand-receptor pair in physiological hematopoiesis brought forth the question whether FLT3R and FL might also have a role in the pathobiology of leukemia.  At the mRNA level FLT3R was expressed by most (80-100%) cases of AML (acute myeloid leukemia) throughout the different morphological subtypes (MO-M7), of ALL(acute lymphoblastic leukemia) of the immunological subtypes T-ALL and BCP-ALL (B cell precursor ALL including pre-pre B-ALL, cALL and pre B-ALL), of AMLL (acute mixed-lineage leukemia), and of CML (chronic myeloid leukemia) in lymphoid or mixed blast crisis.  Analysis of cell surface expression of FLT3R by flow cytometry confirmed these observations for AML (66% positivity when the data from all studies are combined), BCP-ALL (64%) and CML lymphoid blast crisis (86%) whereas less than 30% of T-ALL were FLT3R+.  The myeloid, monocytic and pre B cell type categories also contained the highest proportions of FLT3R+ leukemia cell lines .  In contrast to the selective expression of the receptor, FL expression was detected in 90-100% of the various cell types of leukemia cell lines from all hematopoietic cell lineages.  The potential of FL to induce proliferation of leukemia cells in vitro was also examined in primary and continuously cultured leukemia cells.  The data on FL-stimulated leukemia cell growth underline the extensive heterogeneity of primary AML and ALL samples in terms of cytokine-inducible DNA synthesis that has been seen with other effective cytokines.  While the majority of T-ALL (0-33% of the cases responded proliferatively; mean 11%) and BCP-ALL (0-30%; mean 20%) failed to proliferate in the presence of FL despite strong expression of surface FLT3R, FL caused a proliferative response in a significantly higher percentage of AML cases (22-90%; mean 53%).  In the panel of leukemia cell lines examined only myeloid and monocytic growth factor- dependent cell lines increased their proliferation upon incubation with FL, whereas all growth factor-independent cell lines were refractory to stimulation.  Combinations of FL with G-CSF, GM-CSF, M-CSF, IL-3, PIXY- 321 or SCF and FL with IL-3 or IL-7 had synergistic or additive mitogenic effects on primary AML and ALL cells, respectively.  The potent stimulation of the myelomonocytic cell lines was further augmented by addition of bFGF (basic fibroblast growth factor), GM-CSF, IL-3 or SCF.  The inhibitory effects of TGF-beta 1 (transforming growth factor-beta 1) on FL- supported proliferation were abrogated by bFGF.  Taken together, these results demonstrate the expression of functional FLT3R capable of mediating FL- dependent mitogenic signaling in a subset of AML and ALL cases further underline the heterogeneity of AML and ALL samples in their proliferative response to cytokine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_MDUZMlgnZlm8bhe6roZYfW6udTcc2eYrJN7i62b8drntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283gtV2qsA%253D%253D&md5=d9d427a65fa9b8b1b279c442d353f18f</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrexler%26aufirst%3DH.%2BG.%26atitle%3DExpression%2520of%2520FLT3%2520receptor%2520and%2520response%2520to%2520FLT3%2520ligand%2520by%2520leukemic%2520cells%26jtitle%3DLeukemia%26date%3D1996%26volume%3D10%26spage%3D588%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. C.</span></span> <span> </span><span class="NLM_article-title">Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.2174/1389557043487394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F1389557043487394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=15032673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=255-271&author=M.+C.+Heinrich&title=Targeting+FLT3+kinase+in+acute+myelogenous+leukemia%3A+progress%2C+perils%2C+and+prospects&doi=10.2174%2F1389557043487394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects</span></div><div class="casAuthors">Heinrich, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-271</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Activating mutations of the FLT3 receptor tyrosine kinase are the most common recurring genetic abnormality in acute myelogenous leukemia (AM).  Inhibition of FLT3 kinase activity by small mol. inhibitors has been proposed as a novel therapeutic approach AML.  The pre-clin. and clin. development of candidate FLT3 inhibitors will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpymzaJRL2RMLVg90H21EOLACvtfcHk0lhKEwO8JQOqhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKhtbc%253D&md5=9894e760a02d0a6c81a507124dac3f50</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.2174%2F1389557043487394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557043487394%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26atitle%3DTargeting%2520FLT3%2520kinase%2520in%2520acute%2520myelogenous%2520leukemia%253A%2520progress%252C%2520perils%252C%2520and%2520prospects%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D255%26epage%3D271%26doi%3D10.2174%2F1389557043487394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprankle, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardane, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, S. S.</span></span> <span> </span><span class="NLM_article-title">Identification of N-(5-tert-butyl-isoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1, 3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7808</span>– <span class="NLM_lpage">7816</span>, <span class="refDoi"> DOI: 10.1021/jm9007533</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9007533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7808-7816&author=Q.+Chaoauthor=K.+G.+Sprankleauthor=R.+M.+Grotzfeldauthor=A.+G.+Laiauthor=T.+A.+Carterauthor=A.+M.+Velascoauthor=R.+N.+Gunawardaneauthor=M.+D.+Cramerauthor=M.+F.+Gardnerauthor=J.+Jamesauthor=P.+P.+Zarrinkarauthor=H.+K.+Patelauthor=S.+S.+Bhagwat&title=Identification+of+N-%285-tert-butyl-isoxazol-3-yl%29-N%E2%80%99-%7B4-%5B7-%282-morpholin-4-yl-ethoxy%29imidazo%5B2%2C1-b%5D%5B1%2C+3%5Dbenzothiazol-2-yl%5Dphenyl%7Durea+dihydrochloride+%28AC220%29%2C+a+uniquely+potent%2C+selective%2C+and+efficacious+FMS-like+tyrosine+kinase-3+%28FLT3%29+inhibitor&doi=10.1021%2Fjm9007533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor</span></div><div class="casAuthors">Chao, Qi; Sprankle, Kelly G.; Grotzfeld, Robert M.; Lai, Andiliy G.; Carter, Todd A.; Velasco, Anne Marie; Gunawardane, Ruwanthi N.; Cramer, Merryl D.; Gardner, Michael F.; James, Joyce; Zarrinkar, Patrick P.; Patel, Hitesh K.; Bhagwat, Shripad S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7808-7816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of AML patients with small mol. inhibitors of FLT3 kinase has been explored as a viable therapy.  However, these agents are found to be less than optimal for the treatment of AML because of lack of sufficient potency or suboptimal oral pharmacokinetics (PK) or lack of adequate tolerability at efficacious doses.  We have developed a series of extremely potent and highly selective FLT3 inhibitors with good oral PK properties.  The first series of compds. represented by 1 (AB530) was found to be a potent and selective FLT3 kinase inhibitor with good PK properties.  The aq. soly. and oral PK properties at higher doses in rodents were found to be less than optimal for clin. development.  A novel series of compds. were designed lacking the carboxamide group of 1 with an added water solubilizing group.  Compd. 7 (AC220) was identified from this series to be the most potent and selective FLT3 inhibitor with good pharmaceutical properties, excellent PK profile, and superior efficacy and tolerability in tumor xenograft models.  Compd. 7 has demonstrated a desirable safety and PK profile in humans and is currently in phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAtNhT4frlQ7Vg90H21EOLACvtfcHk0lhKEwO8JQOqhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7zK&md5=1b64254428a51c637da0ff647ac8d567</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1021%2Fjm9007533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9007533%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DQ.%26aulast%3DSprankle%26aufirst%3DK.%2BG.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DGunawardane%26aufirst%3DR.%2BN.%26aulast%3DCramer%26aufirst%3DM.%2BD.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DJ.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26atitle%3DIdentification%2520of%2520N-%25285-tert-butyl-isoxazol-3-yl%2529-N%25E2%2580%2599-%257B4-%255B7-%25282-morpholin-4-yl-ethoxy%2529imidazo%255B2%252C1-b%255D%255B1%252C%25203%255Dbenzothiazol-2-yl%255Dphenyl%257Durea%2520dihydrochloride%2520%2528AC220%2529%252C%2520a%2520uniquely%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520FMS-like%2520tyrosine%2520kinase-3%2520%2528FLT3%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7808%26epage%3D7816%26doi%3D10.1021%2Fjm9007533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><a href="https://clinicaltrials.gov/ct2/results?term=quizartinib&amp;Search=Search" class="extLink">https://clinicaltrials.gov/ct2/results?term=quizartinib&Search=Search</a> (accessed April 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fterm%3Dquizartinib%26Search%3DSearch+%28accessed+April+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Accumulation of FLT3(+) CD11c (+) dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor</span>. <i>Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1007/s12026-014-8521-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs12026-014-8521-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24895100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFelt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=112-126&author=H.+X.+Yanauthor=W.+W.+Liauthor=Y.+Zhangauthor=X.+W.+Weiauthor=L.+X.+Fuauthor=G.+B.+Shenauthor=T.+Yinauthor=X.+Y.+Liauthor=H.+S.+Shiauthor=Y.+Wanauthor=Q.+Y.+Zhangauthor=J.+Liauthor=S.+Y.+Yangauthor=Y.+Q.+Wei&title=Accumulation+of+FLT3%28%2B%29+CD11c+%28%2B%29+dendritic+cells+in+psoriatic+lesions+and+the+anti-psoriatic+effect+of+a+selective+FLT3+inhibitor&doi=10.1007%2Fs12026-014-8521-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of FLT3+ CD11c+ dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor</span></div><div class="casAuthors">Yan, Heng-Xiu; Li, Wei-Wei; Zhang, Yan; Wei, Xia-Wei; Fu, Li-Xin; Shen, Guo-Bo; Yin, Tao; Li, Xiu-Ying; Shi, Hua-Shan; Wan, Yang; Zhang, Qing-Yin; Li, Jiong; Yang, Sheng-Yong; Wei, Yu-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Immunologic Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-126</span>CODEN:
                <span class="NLM_cas:coden">IMRSEB</span>;
        ISSN:<span class="NLM_cas:issn">0257-277X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Psoriasis is a common chronic T-cell-mediated autoimmune skin disease, and traditional immunotherapies for psoriasis have focused on the direct inhibition of T cells, which often causes toxicity and lacks long-term effectiveness.  Safe and effective therapeutic strategies are strongly needed for psoriasis.  In this study, we show for the first time a significant accumulation of FLT3+ CD11c+ dendritic cells (DCs) in human psoriatic lesions and in the skin of exptl. preclin. K14-VEGF transgenic homozygous mice, our animal model, although not an exact match for human psoriasis, displays many characteristics of inflammatory skin inflammation.  SKLB4771, a potent and selective FLT3 inhibitor that we designed and synthesized, was used to treat cutaneous inflammation and psoriasis-like symptoms of disease in mice and almost completely cured the psoriasis-like disease without obvious toxicity.  Mechanistic studies indicated that SKLB4771 treatment significantly decreased the no. and activation of pDCs and mDCs in vitro and in vivo, and subsequent T-cell cascade reactions mediated by Th1/Th17 pathways.  These findings show that targeted inhibition of FLT3, and hence direct interference with DCs, may be a novel therapeutic approach for the treatment of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-pjgFK0m2irVg90H21EOLACvtfcHk0lj9dTHw6WrgDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFelt7g%253D&md5=cccc42ce83e27f8d222d9f3087481a1a</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1007%2Fs12026-014-8521-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12026-014-8521-4%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%2BX.%26aulast%3DLi%26aufirst%3DW.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DX.%2BW.%26aulast%3DFu%26aufirst%3DL.%2BX.%26aulast%3DShen%26aufirst%3DG.%2BB.%26aulast%3DYin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DShi%26aufirst%3DH.%2BS.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DWei%26aufirst%3DY.%2BQ.%26atitle%3DAccumulation%2520of%2520FLT3%2528%252B%2529%2520CD11c%2520%2528%252B%2529%2520dendritic%2520cells%2520in%2520psoriatic%2520lesions%2520and%2520the%2520anti-psoriatic%2520effect%2520of%2520a%2520selective%2520FLT3%2520inhibitor%26jtitle%3DImmunol.%2520Res.%26date%3D2014%26volume%3D60%26spage%3D112%26epage%3D126%26doi%3D10.1007%2Fs12026-014-8521-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Drug discovery against psoriasis: identification of a new potent FMS-like tyrosine kinase 3 (FLT3) inhibitor, 1-(4-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)iso xazol-3-yl)urea, that showed potent activity in a psoriatic animal model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8293</span>– <span class="NLM_lpage">8305</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOgt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8293-8305&author=G.+B.+Liauthor=S.+Maauthor=L.+L.+Yangauthor=S.+Jiauthor=Z.+Fangauthor=G.+Zhangauthor=L.+J.+Wangauthor=J.+M.+Zhongauthor=Y.+Xiongauthor=J.+H.+Wangauthor=S.+Z.+Huangauthor=L.+L.+Liauthor=R.+Xiangauthor=D.+Niuauthor=Y.+C.+Chenauthor=S.+Y.+Yang&title=Drug+discovery+against+psoriasis%3A+identification+of+a+new+potent+FMS-like+tyrosine+kinase+3+%28FLT3%29+inhibitor%2C+1-%284-%28%281H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-yl%29oxy%29-3-fluorophenyl%29-3-%285-%28tert-butyl%29iso+xazol-3-yl%29urea%2C+that+showed+potent+activity+in+a+psoriatic+animal+model&doi=10.1021%2Facs.jmedchem.6b00604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model</span></div><div class="casAuthors">Li, Guo-Bo; Ma, Shuang; Yang, Ling-Ling; Ji, Sen; Fang, Zhen; Zhang, Guo; Wang, Li-Jiao; Zhong, Jie-Min; Xiong, Yu; Wang, Jiang-Hong; Huang, Shen-Zhen; Li, Lin-Li; Xiang, Rong; Niu, Dawen; Chen, Ying-Chun; Yang, Sheng-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8293-8305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Psoriasis is a chronic T-cell-mediated autoimmune disease, and FMS-like tyrosine kinase 3 (FLT3) has been considered as a potential mol. target for the treatment of psoriasis.  In this investigation, structural optimization was performed on a lead compd., 1-(4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl)-3-(4-chloro-3- (trifluoromethyl)phenyl)urea, which showed a moderate inhibitory activity against FLT3.  A series of pyrazolo[3,4-d]pyrimidine derivs. were synthesized, and structure-activity relationship anal. led to the discovery of a no. of potent FLT3 inhibitors.  One of the most active compds., 1-(4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-3-fluorophenyl)-3-(5-tert-butylisoxazol-3-yl)urea (I), was then chosen for in-depth anti-psoriasis studies because this compd. displayed the highest potency in a preliminary anti-psoriasis test.  Compd. I exhibited significant anti-psoriatic effects in the K14-VEGF transgenic mouse model of psoriasis, and no recurrence was found 15 days later after the last administration.  Detailed mechanisms of action of compd. I were also investigated.  Collectively, compd. I could be a potential drug candidate for psoriasis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbj6cxXp78VbVg90H21EOLACvtfcHk0lhkD52i8SdBXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOgt73L&md5=82b107175f8c3b7a2e1fc3e5db6d488e</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00604%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BB.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%2BL.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DZhong%26aufirst%3DJ.%2BM.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DHuang%26aufirst%3DS.%2BZ.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DDrug%2520discovery%2520against%2520psoriasis%253A%2520identification%2520of%2520a%2520new%2520potent%2520FMS-like%2520tyrosine%2520kinase%25203%2520%2528FLT3%2529%2520inhibitor%252C%25201-%25284-%2528%25281H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-yl%2529oxy%2529-3-fluorophenyl%2529-3-%25285-%2528tert-butyl%2529iso%2520xazol-3-yl%2529urea%252C%2520that%2520showed%2520potent%2520activity%2520in%2520a%2520psoriatic%2520animal%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8293%26epage%3D8305%26doi%3D10.1021%2Facs.jmedchem.6b00604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhmanova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, M. O.</span></span> <span> </span><span class="NLM_article-title">Control of microtubule organization and dynamics: two ends in the limelight</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1038/nrm4084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fnrm4084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26562752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=711-726&author=A.+Akhmanovaauthor=M.+O.+Steinmetz&title=Control+of+microtubule+organization+and+dynamics%3A+two+ends+in+the+limelight&doi=10.1038%2Fnrm4084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Control of microtubule organization and dynamics: two ends in the limelight</span></div><div class="casAuthors">Akhmanova, Anna; Steinmetz, Michel O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">711-726</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules have fundamental roles in many essential biol. processes, including cell division and intracellular transport.  They assemble and disassemble from their two ends, denoted the plus end and the minus end.  Significant advances have been made in our understanding of microtubule plus-end-tracking proteins (+TIPs) such as end-binding protein 1 (EB1), XMAP215, selected kinesins and dynein.  By contrast, information on microtubule minus-end-targeting proteins (-TIPs), such as the calmodulin-regulated spectrin-assocd. proteins (CAMSAPs) and Patronin, has only recently started to emerge.  Here, we review our current knowledge of factors, including microtubule-targeting agents, that assoc. with microtubule ends to control the dynamics and function of microtubules during the cell cycle and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps4xzvh0o6PbVg90H21EOLACvtfcHk0liIvcmb72k02A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7%252FI&md5=7c941bcce8d5d51aef6a8deb140356d3</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1038%2Fnrm4084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm4084%26sid%3Dliteratum%253Aachs%26aulast%3DAkhmanova%26aufirst%3DA.%26aulast%3DSteinmetz%26aufirst%3DM.%2BO.%26atitle%3DControl%2520of%2520microtubule%2520organization%2520and%2520dynamics%253A%2520two%2520ends%2520in%2520the%2520limelight%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D711%26epage%3D726%26doi%3D10.1038%2Fnrm4084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kueh, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span> <span> </span><span class="NLM_article-title">Structural plasticity in actin and tubulin polymer dynamics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">960</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1126/science.1168823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1126%2Fscience.1168823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19696342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtValsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=960-963&author=H.+Y.+Kuehauthor=T.+J.+Mitchison&title=Structural+plasticity+in+actin+and+tubulin+polymer+dynamics&doi=10.1126%2Fscience.1168823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Structural plasticity in actin and tubulin polymer dynamics</span></div><div class="casAuthors">Kueh, Hao Yuan; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5943</span>),
    <span class="NLM_cas:pages">960-963</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Actin filaments and microtubules polymerize and depolymerize by adding and removing subunits.  Since A. Wegner (1976) proposed the treadmilling theory for actin, it has largely been assumed that the chem. state of the bound nucleotide dets. the rates of subunit addn. and removal.  This chem. kinetics view is difficult to reconcile with observations revealing multiple structural states of the polymer that influence polymn. dynamics but that are not strictly coupled to the bound nucleotide state.  The authors refer to these phenomena as "structural plasticity" and discuss emerging evidence that they play a central role in polymer dynamics and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraIvJeoXqOabVg90H21EOLACvtfcHk0lhESkC4U0z_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtValsrnN&md5=bbb2322ee14296739eff093d66e3ae71</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168823%26sid%3Dliteratum%253Aachs%26aulast%3DKueh%26aufirst%3DH.%2BY.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DStructural%2520plasticity%2520in%2520actin%2520and%2520tubulin%2520polymer%2520dynamics%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D960%26epage%3D963%26doi%3D10.1126%2Fscience.1168823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span> <span> </span><span class="NLM_article-title">Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3094</span>– <span class="NLM_lpage">3103</span>, <span class="refDoi"> DOI: 10.1021/jm070890u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070890u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3094-3103&author=D.+Q.+Songauthor=Y.+Wangauthor=L.+Z.+Wuauthor=P.+Yangauthor=Y.+M.+Wangauthor=L.+M.+Gaoauthor=Y.+Liauthor=J.+R.+Quauthor=Y.+H.+Wangauthor=Y.+H.+Liauthor=N.+N.+Duauthor=Y.+X.+Hanauthor=Z.+P.+Zhangauthor=J.+D.+Jiang&title=Benzoylurea+derivatives+as+a+novel+class+of+antimitotic+agents%3A+synthesis%2C+anticancer+activity%2C+and+structure-activity+relationships&doi=10.1021%2Fjm070890u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoylurea Derivatives as a Novel Class of Antimitotic Agents: Synthesis, Anticancer Activity, and Structure-Activity Relationships</span></div><div class="casAuthors">Song, Dan-Qing; Wang, Yan; Wu, Lian-Zong; Yang, Peng; Wang, Yue-Ming; Gao, Li-Mei; Li, Yan; Qu, Jing-Rong; Wang, Yong-Hong; Li, Ying-Hong; Du, Na-Na; Han, Yan-Xing; Zhang, Zhi-Ping; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3094-3103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Forty-six new compds. I (R1 = H, 2-Me, 4-MeO, 6-Br, 5-COOMe, etc.; R2 = CH2Br, CH2Cl, CH2I, CHBrMe, CHClMe) and II (X = O, S) were synthesized as 3-haloacylamino benzoylurea analogs and their anticancer activity has been studied.  Structure-activity relationship (SAR) anal. indicated that (i) the configuration of the chiral center in I (R1 = H; R2 = CHBrMe) is not indispensable for the activity, (ii) the Ph ring is essential, and (iii) a substitution at the 6-position of the Ph ring with a halogen enhances the activity.  Among the analogs, I (R1 = 6-F; R2 = CH2Br, CH2I) bearing 6-fluoro substituent showed potent activities against nine human tumor cell lines, including CEM (leukemia), Daudi (lymphoma), MCF-7 (breast cancer), Bel-7402 (hepatoma), DU-145 (prostate cancer), PC-3 (prostate cancer), DND-1A (melanoma), LOVO (colon cancer), and MIA Paca (pancreatic cancer) with IC50 values between 0.01 and 0.30 μM.  I (R1 = 6-F; R2 = CH2I) inhibited human hepatocarcinoma by 86% in vol. in nude mice.  The mechanism of action for this compd. is to inhibit microtubule assembly, followed by the M-phase arrest, bcl-2 inactivation, and then apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ3kIz_0cP4LVg90H21EOLACvtfcHk0lhESkC4U0z_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVKntLg%253D&md5=a9e11b26f34c21b844ebe435857f6a7c</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1021%2Fjm070890u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070890u%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.%2BQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%2BZ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DGao%26aufirst%3DL.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DLi%26aufirst%3DY.%2BH.%26aulast%3DDu%26aufirst%3DN.%2BN.%26aulast%3DHan%26aufirst%3DY.%2BX.%26aulast%3DZhang%26aufirst%3DZ.%2BP.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26atitle%3DBenzoylurea%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520antimitotic%2520agents%253A%2520synthesis%252C%2520anticancer%2520activity%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3094%26epage%3D3103%26doi%3D10.1021%2Fjm070890u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1007/s10637-010-9577-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1007%2Fs10637-010-9577-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21080210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=490-507&author=J.+Zhangauthor=J.+Zhouauthor=X.+Renauthor=Y.+Diaoauthor=H.+Liauthor=H.+Jiangauthor=K.+Dingauthor=D.+Pei&title=A+new+diaryl+urea+compound%2C+D181%2C+induces+cell+cycle+arrest+in+the+G1+and+M+phases+by+targeting+receptor+tyrosine+kinases+and+the+microtubule+skeleton&doi=10.1007%2Fs10637-010-9577-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton</span></div><div class="casAuthors">Zhang, Jin; Zhou, Jing; Ren, Xiaomei; Diao, Yanyan; Li, Honglin; Jiang, Hualiang; Ding, Ke; Pei, Duanqing</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">490-507</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Receptor tyrosine kinases (RTKs) modulate a variety of cellular events, including cell proliferation, differentiation, mobility and apoptosis.  In addn., RTKs have been validated as targets for cancer therapies.  Microtubules are another class of proven targets for many clin. anticancer drugs.  Here, we report that 1-(4-chloro-3-(trifluoromethyl) phenyl)-3-(2-cyano-4-hydroxyphenyl)urea (D181) functions as both a receptor tyrosine kinase inhibitor and a tubulin polymn. enhancer.  D181 displayed potent inhibitory activities against a panel of RTKs, including Flt3, VEGFR, cKit, FGFR1 and PDGFRβ.  D181 also enhanced tubulin polymn. and modified the secondary structure of tubulin proteins to disrupt their dynamic instability.  Because of synergistic cooperation, D181 strongly inhibited the proliferation of various cancer cell lines, induced LoVo cell cycle arrest in the G1 and M phases and suppressed tumor growth in nude mice bearing human LoVo and HT29 xenografts.  Our studies have provided a new, promising lead compd. and novel clues for multi-target anticancer drug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyanTqNl3fSrVg90H21EOLACvtfcHk0ljDtbse7PXbzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGmsbc%253D&md5=b410c9d24274f9b50f60093efeb80032</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1007%2Fs10637-010-9577-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-010-9577-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DDiao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DA%2520new%2520diaryl%2520urea%2520compound%252C%2520D181%252C%2520induces%2520cell%2520cycle%2520arrest%2520in%2520the%2520G1%2520and%2520M%2520phases%2520by%2520targeting%2520receptor%2520tyrosine%2520kinases%2520and%2520the%2520microtubule%2520skeleton%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D490%26epage%3D507%26doi%3D10.1007%2Fs10637-010-9577-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leggans, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleicher, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20’ urea derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1021/jm3015684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3015684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=628-639&author=E.+K.+Leggansauthor=K.+K.+Duncanauthor=T.+J.+Barkerauthor=K.+D.+Schleicherauthor=D.+L.+Boger&title=A+remarkable+series+of+vinblastine+analogues+displaying+enhanced+activity+and+an+unprecedented+tubulin+binding+steric+tolerance%3A+C20%E2%80%99+urea+derivatives&doi=10.1021%2Fjm3015684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">A Remarkable Series of Vinblastine Analogues Displaying Enhanced Activity and an Unprecedented Tubulin Binding Steric Tolerance: C20' Urea Derivatives</span></div><div class="casAuthors">Leggans, Erick K.; Duncan, Katharine K.; Barker, Timothy J.; Schleicher, Kristin D.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">628-639</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A systematic series of previously inaccessible key C20' urea and thiourea derivs. of vinblastine were prepd. from 20'-aminovinblastine that was made accessible through a unique Fe(III)/NaBH4-mediated alkene functionalization reaction of anhydrovinblastine.  Their examn. defined key structural features of the urea-based analogs that contribute to their properties and provided derivs. that match or exceed the potency of vinblastine by as much as 10-fold in cell-based functional assays, which is directly related to their relative tubulin binding affinity.  In contrast to expectations based on apparent steric constraints of the tubulin binding site surrounding the vinblastine C20' center depicted in an X-ray cocrystal structure, remarkably large C20' urea derivs. are accommodated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyFGNDiwuMM7Vg90H21EOLACvtfcHk0lhvKakOpNumFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqs7fJ&md5=3af29fd43a2de5b0d6bcc7f79f5ce280</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1021%2Fjm3015684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3015684%26sid%3Dliteratum%253Aachs%26aulast%3DLeggans%26aufirst%3DE.%2BK.%26aulast%3DDuncan%26aufirst%3DK.%2BK.%26aulast%3DBarker%26aufirst%3DT.%2BJ.%26aulast%3DSchleicher%26aufirst%3DK.%2BD.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DA%2520remarkable%2520series%2520of%2520vinblastine%2520analogues%2520displaying%2520enhanced%2520activity%2520and%2520an%2520unprecedented%2520tubulin%2520binding%2520steric%2520tolerance%253A%2520C20%25E2%2580%2599%2520urea%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D628%26epage%3D639%26doi%3D10.1021%2Fjm3015684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gagne-Boulet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacroix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">R, C. G.</span></span> <span> </span><span class="NLM_article-title">Styryl-N-phenyl-N’-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26069928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=34-43&author=M.+Gagne-Bouletauthor=S.+Fortinauthor=J.+Lacroixauthor=C.+A.+Lefebvreauthor=M.+F.+Coteauthor=C.+G.+R&title=Styryl-N-phenyl-N%E2%80%99-%282-chloroethyl%29ureas+and+styrylphenylimidazolidin-2-ones+as+new+potent+microtubule-disrupting+agents+using+combretastatin+A-4+as+model&doi=10.1016%2Fj.ejmech.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model</span></div><div class="casAuthors">Gagne-Boulet, Mathieu; Fortin, Sebastien; Lacroix, Jacques; Lefebvre, Carole-Anne; Cote, Marie-France; C.-Gaudreault, Rene</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Combretastatin A-4 (CA-4) is a well-studied and attractive mol. template to develop new antimitotics.  Several thousand of modifications were performed on the ring B and the ethenyl bridge of CA-4 but only a few involved the trimethoxyphenyl moiety (TMP, ring A) often considered essential to the antiproliferative and antimicrotubule activities.  In this study, the authors described the design, the prepn., the characterization and the biol. evaluation of three new series of CA-4 analogs namely styryl-N-phenyl-N'-ethylureas (SEUs), styryl-N-phenyl-N'-(2-chloroethyl)ureas I [R = 3-Cl; 3,5-Me; 3,4,5-MeO] (SCEUs) and styrylphenylimidazolidin-2-ones (SIMZs) II [R = 3-Cl; 3,5-Me; 3,4,5-MeO].  All SCEU and SIMZ Z-isomers were active in the high and the low nanomolar range, resp.  Conversely to SEUs and their E-isomers that were significantly less active or inactive.  Interestingly, the TMP moiety is giving rise to derivs. exhibiting the lowest antiproliferative activity in the SCEU series I [R = 3,4,5-MeO] and the most active compd. in the SIMZ series II [R = 3,4,5-MeO].  Moreover, Z-isomers of II [R = 3-Cl] or II [R = 3,5-Me] exhibited antiproliferative activities that are also in the same order of magnitude as II [R = 3,4,5-MeO].  All SCEU and SIMZ Z-isomers also arrested the cell cycle progression in G2/M phase, bound to the colchicine-binding site and disrupted the cytoskeleton of cancer cells.  In addn. to the promising and innovative microtubule-disrupting properties of SCEUs and SIMZs, these results show that the TMP moiety is not essential for the cytocidal activity of these new CA-4 analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2U9fMsB49q7Vg90H21EOLACvtfcHk0lja7IE_Ygij7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltLjO&md5=ea36725803d74dc3fbbd99a44565c1a9</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DGagne-Boulet%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DS.%26aulast%3DLacroix%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DC.%2BA.%26aulast%3DCote%26aufirst%3DM.%2BF.%26aulast%3DR%26aufirst%3DC.%2BG.%26atitle%3DStyryl-N-phenyl-N%25E2%2580%2599-%25282-chloroethyl%2529ureas%2520and%2520styrylphenylimidazolidin-2-ones%2520as%2520new%2520potent%2520microtubule-disrupting%2520agents%2520using%2520combretastatin%2520A-4%2520as%2520model%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D100%26spage%3D34%26epage%3D43%26doi%3D10.1016%2Fj.ejmech.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peserico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, C.</span></span> <span> </span><span class="NLM_article-title">Physical and functional HAT/HDAC interplay regulates protein acetylation balance</span>. <i>J. Biomed. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">371832</span>, <span class="refDoi"> DOI: 10.1155/2011/371832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1155%2F2011%2F371832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21151613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1Wjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=371832&author=A.+Pesericoauthor=C.+Simone&title=Physical+and+functional+HAT%2FHDAC+interplay+regulates+protein+acetylation+balance&doi=10.1155%2F2011%2F371832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Physical and functional HAT/HDAC interplay regulates protein acetylation balance</span></div><div class="casAuthors">Peserico Alessia; Simone Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedicine & biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371832</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The balance between protein acetylation and deacetylation controls several physiological and pathological cellular processes, and the enzymes involved in the maintenance of this equilibrium-acetyltransferases (HATs) and deacetylases (HDACs)-have been widely studied.  Presently, the evidences obtained in this field suggest that the dynamic acetylation equilibrium is mostly maintained through the physical and functional interplay between HAT and HDAC activities.  This model overcomes the classical vision in which the epigenetic marks of acetylation have only an activating function whereas deacetylation marks have a repressing activity.  Given the existence of several players involved in the preservation of this equilibrium, the identification of these complex networks of interacting proteins will likely foster our understanding of how cells regulate intracellular processes and respond to the extracellular environment and will offer the rationale for new therapeutic approaches based on epigenetic drugs in human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRprtziIe4zZApJitSxOdIlfW6udTcc2eZTTXHOrdXuHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1Wjtw%253D%253D&md5=f0530de3d94caae16715b232b30d3c65</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1155%2F2011%2F371832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F371832%26sid%3Dliteratum%253Aachs%26aulast%3DPeserico%26aufirst%3DA.%26aulast%3DSimone%26aufirst%3DC.%26atitle%3DPhysical%2520and%2520functional%2520HAT%252FHDAC%2520interplay%2520regulates%2520protein%2520acetylation%2520balance%26jtitle%3DJ.%2520Biomed.%2520Biotechnol.%26date%3D2011%26volume%3D2011%26spage%3D371832%26doi%3D10.1155%2F2011%2F371832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5310</span>– <span class="NLM_lpage">5318</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1038%2Fsj.onc.1210599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17694074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5310-5318&author=X.+J.+Yangauthor=E.+Seto&title=HATs+and+HDACs%3A+from+structure%2C+function+and+regulation+to+novel+strategies+for+therapy+and+prevention&doi=10.1038%2Fsj.onc.1210599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span></div><div class="casAuthors">Yang, X.-J.; Seto, E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5310-5318</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The acetylation of the ε-NH2 group of a Lys residue was 1st discovered with histones in 1968, but the responsible enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs), were not identified until the mid-1990s.  In the past decade, knowledge about this modification has exploded, with targets rapidly expanding from histones to transcription factors and other nuclear proteins, and then to the cytoskeleton, metabolic enzymes, and signaling regulators in the cytoplasm.  Thus, protein Lys acetylation has emerged as a major post-translational modification to rival phosphorylation.  Here, various aspects of the enzymes governing Lys acetylation, esp. about their intimate links to cancer are reviewed.  For central themes are highlighted: (1) multisubunit enzymic complexes; (2) non-histone substrates in diverse cellular processes; (3) interplay of Lys acetylation with other regulatory mechanisms, such as noncoding RNA-mediated gene silencing and activation; and (4) novel therapeutic strategies and preventive measures to combat cancer and other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuGSkc-b3umrVg90H21EOLACvtfcHk0liLhkSVzCaVYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D&md5=de49d71791356a55d90fd797cbecaf4b</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210599%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BJ.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHATs%2520and%2520HDACs%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520novel%2520strategies%2520for%2520therapy%2520and%2520prevention%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5310%26epage%3D5318%26doi%3D10.1038%2Fsj.onc.1210599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9891</span>– <span class="NLM_lpage">9899</span>, <span class="refDoi"> DOI: 10.1021/jm301098e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9891-9899&author=J.+A.+Bergmanauthor=K.+Woanauthor=P.+Perez-Villarroelauthor=A.+Villagraauthor=E.+M.+Sotomayorauthor=A.+P.+Kozikowski&title=Selective+histone+deacetylase+6+inhibitors+bearing+substituted+urea+linkers+inhibit+melanoma+cell+growth&doi=10.1021%2Fjm301098e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span></div><div class="casAuthors">Bergman, Joel A.; Woan, Karrune; Perez-Villarroel, Patricio; Villagra, Alejandro; Sotomayor, Eduardo M.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9891-9899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incidence of malignant melanoma has dramatically increased in recent years thus requiring the need for improved therapeutic strategies.  In our efforts to design selective histone deactylase inhibitors (HDACI), we discovered that the aryl urea 1 is a modestly potent yet nonselective inhibitor.  Structure-activity relationship studies revealed that adding substituents to the nitrogen atom of the urea so as to generate compds. bearing a branched linker group results in increased potency and selectivity for HDAC6.  Compd. 5g shows low nanomolar inhibitory potency against HDAC6 and a selectivity of ∼600-fold relative to the inhibition of HDAC1.  These HDACIs were evaluated for their ability to inhibit the growth of B16 melanoma cells with the most potent and selective HDAC6I being found to decrease tumor cell growth.  To the best of our knowledge, this work constitutes the first report of HDAC6-selective inhibitors that possess antiproliferative effects against melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkTtPLqvwsrVg90H21EOLACvtfcHk0liLhkSVzCaVYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ&md5=d6be4c0efb3922fc35d814ba00ae9ed1</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1021%2Fjm301098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301098e%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DWoan%26aufirst%3DK.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DVillagra%26aufirst%3DA.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%2520histone%2520deacetylase%25206%2520inhibitors%2520bearing%2520substituted%2520urea%2520linkers%2520inhibit%2520melanoma%2520cell%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9891%26epage%3D9899%26doi%3D10.1021%2Fjm301098e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnekenburger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazumder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogister, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouider, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefranc, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklos, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Tullio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of R/S-N-3-cyanophenyl-N’-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1- benzopyran-4-yl)urea, a new histone deacetylase class III inhibitor exerting antiproliferative activity against cancer cell lines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4714</span>– <span class="NLM_lpage">4733</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00533</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1Cgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4714-4733&author=M.+Schnekenburgerauthor=E.+Goffinauthor=J.+Y.+Leeauthor=J.+Y.+Jangauthor=A.+Mazumderauthor=S.+Jiauthor=B.+Rogisterauthor=N.+Bouiderauthor=F.+Lefrancauthor=W.+Miklosauthor=V.+Mathieuauthor=P.+de+Tullioauthor=K.+W.+Kimauthor=M.+Dicatoauthor=W.+Bergerauthor=B.+W.+Hanauthor=R.+Kissauthor=B.+Pirotteauthor=M.+Diederich&title=Discovery+and+characterization+of+R%2FS-N-3-cyanophenyl-N%E2%80%99-%286-tert-butoxycarbonylamino-3%2C4-dihydro-2%2C2-dimethyl-2H-1-+benzopyran-4-yl%29urea%2C+a+new+histone+deacetylase+class+III+inhibitor+exerting+antiproliferative+activity+against+cancer+cell+lines&doi=10.1021%2Facs.jmedchem.7b00533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines</span></div><div class="casAuthors">Schnekenburger, Michael; Goffin, Eric; Lee, Jin-Young; Jang, Jun Young; Mazumder, Aloran; Ji, Seungwon; Rogister, Bernard; Bouider, Nafila; Lefranc, Florence; Miklos, Walter; Mathieu, Veronique; de Tullio, Pascal; Kim, Kyu-Won; Dicato, Mario; Berger, Walter; Han, Byung Woo; Kiss, Robert; Pirotte, Bernard; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4714-4733</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of (N-aryl-N'-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examd. as putative anticancer agents targeting sirtuins in glioma cells.  On the basis of computational docking combined to in vitro sirtuin 1/2 inhibition assays, we selected compd. I [R/S-N-3-cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea] which displays a potent antiproliferative activity on various glioma cell types, assessed by quant. video microscopy, eventually triggering senescence.  The impact on normal glial cells was lower with a selectivity index of >10.  Furthermore, human U373 and Hs683 glioblastoma cell lines served to demonstrate the inhibitory activity of I against histone deacetylase (HDAC) class III sirtuins 1 and 2 (SIRT1/2) by quantifying acetylation levels of histone and non-histone proteins.  The translational potential of I was validated by an NCI-60 cell line screen and validation of growth inhibition of drug resistant cancer cell models.  Eventually, the anticancer potential of I was validated in 3D glioblastoma spheroids and in vivo by zebrafish xenografts.  In summary, compd. I is the first representative of a new class of SIRT inhibitors opening new perspectives in the medicinal chem. of HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyMh16OaJ1hrVg90H21EOLACvtfcHk0li9lCyPXXUiAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1Cgsro%253D&md5=812f2ad6ed54dd8fd1e10ca7151562ab</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00533%26sid%3Dliteratum%253Aachs%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DJang%26aufirst%3DJ.%2BY.%26aulast%3DMazumder%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DRogister%26aufirst%3DB.%26aulast%3DBouider%26aufirst%3DN.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DMiklos%26aufirst%3DW.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DB.%2BW.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520R%252FS-N-3-cyanophenyl-N%25E2%2580%2599-%25286-tert-butoxycarbonylamino-3%252C4-dihydro-2%252C2-dimethyl-2H-1-%2520benzopyran-4-yl%2529urea%252C%2520a%2520new%2520histone%2520deacetylase%2520class%2520III%2520inhibitor%2520exerting%2520antiproliferative%2520activity%2520against%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4714%26epage%3D4733%26doi%3D10.1021%2Facs.jmedchem.7b00533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barinka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomper, M.</span></span> <span> </span><span class="NLM_article-title">Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.2174/092986712799034888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F092986712799034888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22214450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=856-870&author=C.+Barinkaauthor=C.+Rojasauthor=B.+Slusherauthor=M.+Pomper&title=Glutamate+carboxypeptidase+II+in+diagnosis+and+treatment+of+neurologic+disorders+and+prostate+cancer&doi=10.2174%2F092986712799034888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer</span></div><div class="casAuthors">Barinka, C.; Rojas, C.; Slusher, B.; Pomper, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">856-870</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate carboxypeptidase II (GCPII) is a membrane-bound binuclear zinc metallopeptidase with the highest expression levels found in the nervous and prostatic tissue.  Throughout the nervous system, glia-bound GCPII is intimately involved in the neuronneuron and neuron-glia signaling via the hydrolysis of N-acetylaspartylglutamate (NAAG), the most abundant mammalian peptidic neurotransmitter.  The inhibition of the GCPII-controlled NAAG catabolism has been shown to attenuate neurotoxicity assocd. with enhanced glutamate transmission and GCPII-specific inhibitors demonstrate efficacy in multiple preclin. models including traumatic brain injury, stroke, neuropathic and inflammatory pain, amyotrophic lateral sclerosis, and schizophrenia.  The second major area of pharmacol. interventions targeting GCPII focuses on prostate carcinoma; GCPII expression levels are highly increased in androgen-independent and metastatic disease.  Consequently, the enzyme serves as a potential target for imaging and therapy.  This review offers a summary of GCPII structure, physiol. functions in healthy tissues, and its assocn. with various pathologies.  The review also outlines the development of GCPII-specific small-mol. compds. and their use in preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyUBiL7cpnjrVg90H21EOLACvtfcHk0lhKlMUV52QkbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D&md5=1d4a526d7ecd78b11f6b405112d6220a</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.2174%2F092986712799034888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799034888%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGlutamate%2520carboxypeptidase%2520II%2520in%2520diagnosis%2520and%2520treatment%2520of%2520neurologic%2520disorders%2520and%2520prostate%2520cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D856%26epage%3D870%26doi%3D10.2174%2F092986712799034888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silver, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellicer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fair, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heston, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordon-Cardo, C.</span></span> <span> </span><span class="NLM_article-title">Prostate-specific membrane antigen expression in normal and malignant human tissues</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9815541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=81-85&author=D.+A.+Silverauthor=I.+Pellicerauthor=W.+R.+Fairauthor=W.+D.+Hestonauthor=C.+Cordon-Cardo&title=Prostate-specific+membrane+antigen+expression+in+normal+and+malignant+human+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen expression in normal and malignant human tissues</span></div><div class="casAuthors">Silver D A; Pellicer I; Fair W R; Heston W D; Cordon-Cardo C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-5</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">Prostate-specific membrane antigen is a type II membrane protein with folate hydrolase activity produced by prostatic epithelium.  The expression of this molecule has also been documented in extraprostatic tissues, including small bowel and brain.  In the present study, an extensive immunohistochemical analysis was performed on a panel of well-characterized normal and malignant human tissues to further define the pattern of prostate-specific membrane antigen (PSMA) expression.  Detectable PSMA levels were identified in prostatic epithelium, duodenal mucosa, and a subset of proximal renal tubules.  A subpopulation of neuroendocrine cells in the colonic crypts also exhibited PSMA immunoreactivity.  All other normal tissues, including cerebral cortex and cerebellum, had undetectable levels of PSMA.  Thirty-three of 35 primary prostate adenocarcinomas and 7 of 8 lymph node metastases displayed tumor cell PSMA immunostaining.  Eight of 18 prostate tumors metastatic to bone expressed PSMA.  All of the other nonprostatic primary tumors studied had undetectable PSMA levels.  However, intense staining was observed in endothelial cells of capillary vessels in peritumoral and endotumoral areas of certain malignancies, including 8 of 17 renal cell carcinomas, 7 of 13 transitional cell carcinomas, and 3 of 19 colon carcinomas.  Extraprostatic PSMA expression appears to be highly restricted.  Nevertheless, its diverse anatomical distribution implies a broader functional significance than previously suspected.  The decrease in PSMA immunoreactivity noted in advanced prostate cancer suggests that expression of this molecule may be linked to the degree of tumor differentiation.  The neoexpression of PSMA in endothelial cells of capillary beds in certain tumors may be related to tumor angiogenesis and suggests a potential mechanism for specific targeting of tumor neovasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa3hRIf6mlYUcLvDNbOD4DfW6udTcc2eZBKulhuAdzhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D&md5=06fb3a1b21fc371a5e42843ed558e5eb</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DD.%2BA.%26aulast%3DPellicer%26aufirst%3DI.%26aulast%3DFair%26aufirst%3DW.%2BR.%26aulast%3DHeston%26aufirst%3DW.%2BD.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520expression%2520in%2520normal%2520and%2520malignant%2520human%2520tissues%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saji, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7890</span>– <span class="NLM_lpage">7901</span>, <span class="refDoi"> DOI: 10.1021/jm400895s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400895s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7890-7901&author=N.+Haradaauthor=H.+Kimuraauthor=M.+Onoauthor=H.+Saji&title=Preparation+of+asymmetric+urea+derivatives+that+target+prostate-specific+membrane+antigen+for+SPECT+imaging&doi=10.1021%2Fjm400895s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging</span></div><div class="casAuthors">Harada, Naoya; Kimura, Hiroyuki; Ono, Masahiro; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7890-7901</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA) has been identified as a diagnostic and therapeutic target for prostate cancer.  (S)-2-[3-[(R)-1-Carboxy-2-mercaptoethyl]ureido]pentanedioic acid (Cys-CO-Glu) were used to design novel PSMA targeting probes by nucleophilic conjugate addn. between cysteine and maleimide based reagents.  [123I]I ([123I]-IGLCE) was synthesized by this strategy and showed high affinity for PSMA.  Results of binding inhibition assays of these derivs. suggested the importance of an arom. group and succinimide moiety for high affinity.  [123I]I was evaluated in vivo with PSMA pos. LNCaP and PSMA neg. PC-3 human prostate cancer xenograft bearing mice.  [125I]I accumulated in LNCaP tumors but not in PC-3 tumors, and the accumulation was inhibited by 2-(phosphonomethyl)-pentanedioic acid (2-PMPA).  Use of [123I]I provided pos. images of LNCaP tumors in single photon emission tomog. scans.  These results warrant further evaluation of [123I]I and its derivs. as radiolabeled probes for the diagnosis of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWMd3vED-FxrVg90H21EOLACvtfcHk0lhti5yhw5h_5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbJ&md5=db971b6cfcf9a0a8f333f43a67822f4d</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1021%2Fjm400895s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400895s%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520asymmetric%2520urea%2520derivatives%2520that%2520target%2520prostate-specific%2520membrane%2520antigen%2520for%2520SPECT%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7890%26epage%3D7901%26doi%3D10.1021%2Fjm400895s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beliveau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasioukhin, V.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1352</span>– <span class="NLM_lpage">1362</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.18632%2Foncotarget.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24657880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC2crmtlensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1352-1362&author=X.+Tangauthor=S.+S.+Mahajanauthor=L.+T.+Nguyenauthor=F.+Beliveauauthor=R.+Leducauthor=J.+A.+Simonauthor=V.+Vasioukhin&title=Targeted+inhibition+of+cell-surface+serine+protease+Hepsin+blocks+prostate+cancer+bone+metastasis&doi=10.18632%2Foncotarget.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis</span></div><div class="casAuthors">Tang Xi; Mahajan Sumit S; Nguyen Liem T; Beliveau Francois; Leduc Richard; Simon Julian A; Vasioukhin Valeri</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1352-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of effective therapies inhibiting prostate cancer progression and metastasis may substantially impact prostate cancer mortality and potentially reduce the rates of invasive treatments by enhancing the safety of active surveillance strategies.  Hepsin (HPN) is a cell surface serine protease amplified in a subset of human sarcomas (7.2%), as well as in ovarian (10%), lung adeno (5.4%), lung squamous cell (4.5%), adenoid cystic (5%), breast (2.6%), uterine (1.7%) and colon (1.4%) carcinomas.  While HPN is not amplified in prostate cancer, it is one of the most prominently overexpressed genes in the majority of human prostate tumors and genetic experiments in mice indicate that Hepsin promotes prostate cancer metastasis, particularly metastasis to the bone marrow.  We report here the development, analysis and animal trial of the small-molecule Hepsin inhibitor HepIn-13.  Long-term exposure to HepIn-13 inhibited bone, liver and lung metastasis in a murine model of metastatic prostate cancer.  These findings indicate that inhibition of Hepsin with small-molecule compounds could provide an effective tool for attenuation of prostate cancer progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ4F7N8tAxh9LIORRPd5lbfW6udTcc2eYYSp470ZqFjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmtlensw%253D%253D&md5=8d1079ed49024e41ce122f378e1ab87d</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1817%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DNguyen%26aufirst%3DL.%2BT.%26aulast%3DBeliveau%26aufirst%3DF.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DVasioukhin%26aufirst%3DV.%26atitle%3DTargeted%2520inhibition%2520of%2520cell-surface%2520serine%2520protease%2520Hepsin%2520blocks%2520prostate%2520cancer%2520bone%2520metastasis%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D1352%26epage%3D1362%26doi%3D10.18632%2Foncotarget.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ok, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomper, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2016.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27128184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslWquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=208-218&author=M.+Subediauthor=I.+Minnauthor=J.+Chenauthor=Y.+Kimauthor=K.+Okauthor=Y.+W.+Jungauthor=M.+G.+Pomperauthor=Y.+Byun&title=Design%2C+synthesis+and+biological+evaluation+of+PSMA%2Fhepsin-targeted+heterobivalent+ligands&doi=10.1016%2Fj.ejmech.2016.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands</span></div><div class="casAuthors">Subedi, Milan; Minn, Il; Chen, Jianbo; Kim, YunHye; Ok, Kiwon; Jung, Yong Woo; Pomper, Martin G.; Byun, Youngjoo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">208-218</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cell surface biomarkers such as prostate-specific membrane antigen (PSMA) and hepsin have received considerable attention as targets for imaging prostate cancer (PCa) due to their high cell surface expression in such tumors and easy access for imaging probes.  Novel amidine-contg. indole analogs as hepsin inhibitors were designed and synthesized.  These compds. showed in vitro inhibitory activity against hepsin with IC50 values from 5.9 to 70 μM.  Based on the SAR of amidine-derived analogs, the novel heterobivalent compd. , targeting both hepsin and PSMA, was synthesized by linking compd. 2-[40-(Aminomethyl)-4-hydroxy[1,10-biphenyl]-3-yl]-1H-indole-5-carboximidamide with Lys-urea-Glu, the key scaffold for the specific binding to PSMA, followed by the conjugation of the optical dye SulfoCy7.  Prepd. compd. exhibited inhibitory activities against PSMA and hepsin, with IC50 values of 28 nM and 2.8 μM, resp.  In vitro cell uptake and preliminary in vivo optical imaging studies of 30 showed selective binding and retention in both PSMA and hepsin high-expressing PC3/ML-PSMA-HPN cells as compared with low-expressing PC3/ML cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokdqUSbkjI1bVg90H21EOLACvtfcHk0ljfyb3Cz-oNmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslWquro%253D&md5=2e2bc57f314721f5a8fb3f7135c96502</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DSubedi%26aufirst%3DM.%26aulast%3DMinn%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DOk%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DY.%2BW.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DByun%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520PSMA%252Fhepsin-targeted%2520heterobivalent%2520ligands%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D208%26epage%3D218%26doi%3D10.1016%2Fj.ejmech.2016.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkskas, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3889</span>– <span class="NLM_lpage">3897</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2009.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19447524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlersLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=3889-3897&author=F.+Azamauthor=I.+A.+Alkskasauthor=M.+A.+Ahmed&title=Synthesis+of+some+urea+and+thiourea+derivatives+of+3-phenyl%2Fethyl-2-thioxo-2%2C3-dihydrothiazolo%5B4%2C5-d%5Dpyrimidine+and+their+antagonistic+effects+on+haloperidol-induced+catalepsy+and+oxidative+stress+in+mice&doi=10.1016%2Fj.ejmech.2009.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice</span></div><div class="casAuthors">Azam, Faizul; Alkskas, Ismail A.; Ahmed, Musa A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3889-3897</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7-yl urea and thiourea derivs. were designed and synthesized.  All the compds. have been evaluated for their antiparkinsonian activity in catalepsy induced by haloperidol in mice.  A majority of the compds. exhibited significant antiparkinsonian activity after i.p. administration.  The most active compd. carries methoxy group at 2-position of the Ph ring.  Some of the potent compds. I (R1 = Ph, Et; R2 = O, S) were selected for biochem. estns. of malondialdehyde, glutathione, superoxide dismutase and glutathione peroxidase from brain homogenate to highlight the neuroprotective properties assocd. with them.  The results obtained in the present study may lead to the development of a suitable approach to the treatment of Parkinson's disease and may be the starting point for the future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM371dHezPJrVg90H21EOLACvtfcHk0lj70PbPfBjz8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlersLk%253D&md5=2f0ff8303c1ea1da6ffa0343d29f1f73</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DF.%26aulast%3DAlkskas%26aufirst%3DI.%2BA.%26aulast%3DAhmed%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%2520of%2520some%2520urea%2520and%2520thiourea%2520derivatives%2520of%25203-phenyl%252Fethyl-2-thioxo-2%252C3-dihydrothiazolo%255B4%252C5-d%255Dpyrimidine%2520and%2520their%2520antagonistic%2520effects%2520on%2520haloperidol-induced%2520catalepsy%2520and%2520oxidative%2520stress%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D3889%26epage%3D3897%26doi%3D10.1016%2Fj.ejmech.2009.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettinetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bothmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rosa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncarati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valacchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanaletti, R.</span></span> <span> </span><span class="NLM_article-title">SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5247</span>– <span class="NLM_lpage">5258</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmc.2009.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19515567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5247-5258&author=S.+N.+Haydarauthor=C.+Ghironauthor=L.+Bettinettiauthor=H.+Bothmannauthor=T.+A.+Comeryauthor=J.+Dunlopauthor=S.+La+Rosaauthor=I.+Miccoauthor=M.+Pollastriniauthor=J.+Quinnauthor=R.+Roncaratiauthor=C.+Scaliauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanaletti&title=SAR+and+biological+evaluation+of+SEN12333%2FWAY-317538%3A+Novel+alpha+7+nicotinic+acetylcholine+receptor+agonist&doi=10.1016%2Fj.bmc.2009.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist</span></div><div class="casAuthors">Haydar, Simon N.; Ghiron, Chiara; Bettinetti, Laura; Bothmann, Hendrick; Comery, Thomas A.; Dunlop, John; La Rosa, Salvatore; Micco, Iolanda; Pollastrini, Martina; Quinn, Joanna; Roncarati, Renza; Scali, Carla; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5247-5258</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alpha 7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment assocd. with a variety of disorders including Alzheimer's disease and schizophrenia.  Alpha 7 nAChRs are expressed in brain regions assocd. with cognitive function, regulate cholinergic neurotransmission and have been shown to be down regulated in both schizophrenia and Alzheimer's disease.  Herein we report a novel, potent small mol. agonist of the alpha 7 nAChR, SEN12333/WAY-317538.  This compd. is a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, excellent brain penetration and oral bioavailability, and demonstrates in vivo efficacy in multiple behavioral cognition models.  The SAR and biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyFjYGluXw3bVg90H21EOLACvtfcHk0lj70PbPfBjz8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D&md5=293ee7e518e64386330cfde5ca72c584</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26atitle%3DSAR%2520and%2520biological%2520evaluation%2520of%2520SEN12333%252FWAY-317538%253A%2520Novel%2520alpha%25207%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5247%26epage%3D5258%26doi%3D10.1016%2Fj.bmc.2009.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghiron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aschmies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bothmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocconcelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jow, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rosa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncarati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terstappen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turlizzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valacchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanaletti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanelli, U.</span></span> <span> </span><span class="NLM_article-title">Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4379</span>– <span class="NLM_lpage">4389</span>, <span class="refDoi"> DOI: 10.1021/jm901692q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901692q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4379-4389&author=C.+Ghironauthor=S.+N.+Haydarauthor=S.+Aschmiesauthor=H.+Bothmannauthor=C.+Castaldoauthor=G.+Cocconcelliauthor=T.+A.+Comeryauthor=L.+Diauthor=J.+Dunlopauthor=T.+Lockauthor=A.+Kramerauthor=D.+Kowalauthor=F.+Jowauthor=S.+Grauerauthor=B.+Harrisonauthor=S.+La+Rosaauthor=L.+Maccariauthor=K.+L.+Marquisauthor=I.+Miccoauthor=A.+Nenciniauthor=J.+Quinnauthor=A.+J.+Robichaudauthor=R.+Roncaratiauthor=C.+Scaliauthor=G.+C.+Terstappenauthor=E.+Turlizziauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanalettiauthor=U.+Zanelli&title=Novel+alpha-7+nicotinic+acetylcholine+receptor+agonists+containing+a+urea+moiety%3A+identification+and+characterization+of+the+potent%2C+selective%2C+and+orally+efficacious+agonist+1-%5B6-%284-fluorophenyl%29pyridin-3-yl%5D-3-%284-piperidin-1-ylbutyl%29+urea+%28SEN34625%2FWYE-103914%29&doi=10.1021%2Fjm901692q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonists Containing a Urea Moiety: Identification and Characterization of the Potent, Selective, and Orally Efficacious Agonist 1-[6-(4-Fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) Urea (SEN34625/WYE-103914)</span></div><div class="casAuthors">Ghiron, Chiara; Haydar, Simon N.; Aschmies, Suzan; Bothmann, Hendrick; Castaldo, Cristiana; Cocconcelli, Giuseppe; Comery, Thomas A.; Di, Li; Dunlop, John; Lock, Tim; Kramer, Angela; Kowal, Dianne; Jow, Flora; Grauer, Steve; Harrison, Boyd; La Rosa, Salvatore; Maccari, Laura; Marquis, Karen L.; Micco, Iolanda; Nencini, Arianna; Quinn, Joanna; Robichaud, Albert J.; Roncarati, Renza; Scali, Carla; Terstappen, Georg C.; Turlizzi, Elisa; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo; Zanelli, Ugo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4379-4389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alpha-7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment.  We report a series of novel, potent small mol. agonists (4-18) of the α7 nAChR deriving from our continuing efforts in the areas of Alzheimer's disease and schizophrenia.  One of the compds. of the series contg. a urea moiety (16)(I) was further shown to be a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, brain penetration, and oral bioavailability and demonstrated in vivo efficacy in multiple behavioral cognition models.  Structural modifications leading to the improved selectivity profile and the biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlg-l6HJigrrVg90H21EOLACvtfcHk0lhFxbP47T08cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D&md5=f15ad80636d6ba345752ce1ddc7be15b</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1021%2Fjm901692q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901692q%26sid%3Dliteratum%253Aachs%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DCastaldo%26aufirst%3DC.%26aulast%3DCocconcelli%26aufirst%3DG.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMaccari%26aufirst%3DL.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DTurlizzi%26aufirst%3DE.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26aulast%3DZanelli%26aufirst%3DU.%26atitle%3DNovel%2520alpha-7%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520containing%2520a%2520urea%2520moiety%253A%2520identification%2520and%2520characterization%2520of%2520the%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520agonist%25201-%255B6-%25284-fluorophenyl%2529pyridin-3-yl%255D-3-%25284-piperidin-1-ylbutyl%2529%2520urea%2520%2528SEN34625%252FWYE-103914%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4379%26epage%3D4389%26doi%3D10.1021%2Fjm901692q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genesio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turlizzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanaletti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a hybrid series of potent and selective agonists of alpha7 nicotinic acetylcholine receptor</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24704613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=401-418&author=A.+Nenciniauthor=C.+Castaldoauthor=T.+A.+Comeryauthor=J.+Dunlopauthor=E.+Genesioauthor=C.+Ghironauthor=S.+Haydarauthor=L.+Maccariauthor=I.+Miccoauthor=E.+Turlizziauthor=R.+Zanalettiauthor=J.+Zhang&title=Design+and+synthesis+of+a+hybrid+series+of+potent+and+selective+agonists+of+alpha7+nicotinic+acetylcholine+receptor&doi=10.1016%2Fj.ejmech.2014.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor</span></div><div class="casAuthors">Nencini, Arianna; Castaldo, Cristiana; Comery, Thomas A.; Dunlop, John; Genesio, Eva; Ghiron, Chiara; Haydar, Simon; Maccari, Laura; Micco, Iolanda; Turlizzi, Elisa; Zanaletti, Riccardo; Zhang, Jean</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401-418</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">α7 Nicotinic acetylcholine receptor agonists are promising therapeutic candidates for the treatment of cognitive impairment.  As a follow up of our internal medicinal chem. program we investigated a novel series of α7 nAChR agonists.  Starting from mol. docking studies on two series of mols. recently developed in our labs., an alternative scaffold was designed attempting to combine the optimal features of these previously identified urea and pyrazole compds.  Based on our previous SAR knowledge and on predicted drug-like properties, a small library was synthesized in parallel manner, affording compds. with excellent α7 nAChR activity, selectivity and preliminary ADME profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfIXbX0n7YLVg90H21EOLACvtfcHk0lic1A_Z0sCpbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWntLo%253D&md5=3b5fc8e8eead70d1c6dc8310f4ad39f4</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DCastaldo%26aufirst%3DC.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DGenesio%26aufirst%3DE.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%26aulast%3DMaccari%26aufirst%3DL.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DTurlizzi%26aufirst%3DE.%26aulast%3DZanaletti%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520hybrid%2520series%2520of%2520potent%2520and%2520selective%2520agonists%2520of%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D78%26spage%3D401%26epage%3D418%26doi%3D10.1016%2Fj.ejmech.2014.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkamhawy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, E. J.</span></span> <span> </span><span class="NLM_article-title">Novel quinazoline-urea analogues as modulators for Abeta-induced mitochondrial dysfunction: design, synthesis, and molecular docking study</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.07.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25050879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=466-475&author=A.+Elkamhawyauthor=J.+Leeauthor=B.+G.+Parkauthor=I.+Parkauthor=A.+N.+Paeauthor=E.+J.+Roh&title=Novel+quinazoline-urea+analogues+as+modulators+for+Abeta-induced+mitochondrial+dysfunction%3A+design%2C+synthesis%2C+and+molecular+docking+study&doi=10.1016%2Fj.ejmech.2014.07.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Novel quinazoline-urea analogues as modulators for Aβ-induced mitochondrial dysfunction: Design, synthesis, and molecular docking study</span></div><div class="casAuthors">Elkamhawy, Ahmed; Lee, Jiyoun; Park, Beoung-Geon; Park, Insun; Pae, Ae Nim; Roh, Eun Joo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">466-475</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A novel series of twenty-six quinazoline-urea derivs. was designed and synthesized.  Their blocking activities against β-amyloid peptide (Aβ) induced mitochondrial permeability transition pore (mPTP) opening were evaluated by JC-1 assay which measured the change of mitochondrial membrane potential.  Seven compds. showed better inhibitory activities than the std. Cyclosporin A (CsA).  The most active analogs were tested by MTT assay to evaluate their toxicity on the cellular survival; they revealed excellent cellular viability.  To explain the difference in inhibitory activity, mol. docking study using (GOLD) program was performed for selected sets of the most active and inactive compds. on cyclophilin D (CypD) receptor as a major component of mPTP.  Moreover, ADME profiling, in silico toxicity, drug-likeness, and drug-score studies were discussed.  From these results, we report compd. I as the most active nonpeptidyl mPTP blocker possessing quinazoline-urea scaffold; 2 folds of CsA activity, which would constitute a new direction for the design of novel mPTP modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow1rB8rasuJLVg90H21EOLACvtfcHk0lj1cELuIJVAjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL%252FP&md5=d6ef5366cbb4e47bf261ce7afd61d3bc</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DElkamhawy%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DB.%2BG.%26aulast%3DPark%26aufirst%3DI.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DRoh%26aufirst%3DE.%2BJ.%26atitle%3DNovel%2520quinazoline-urea%2520analogues%2520as%2520modulators%2520for%2520Abeta-induced%2520mitochondrial%2520dysfunction%253A%2520design%252C%2520synthesis%252C%2520and%2520molecular%2520docking%2520study%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D466%26epage%3D475%26doi%3D10.1016%2Fj.ejmech.2014.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macalino, S. J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of conformationally restricted human glutaminyl cyclase inhibitors as potent anti-Alzheimer’s agents by structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8027</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8011-8027&author=V.+H.+Hoangauthor=V.+T.+H.+Ngoauthor=M.+Cuiauthor=N.+V.+Manhauthor=P.+T.+Tranauthor=J.+Annauthor=H.+J.+Haauthor=H.+Kimauthor=K.+Choiauthor=Y.+H.+Kimauthor=H.+Changauthor=S.+J.+Y.+Macalinoauthor=J.+Leeauthor=S.+Choi&title=Discovery+of+conformationally+restricted+human+glutaminyl+cyclase+inhibitors+as+potent+anti-Alzheimer%E2%80%99s+agents+by+structure-based+design&doi=10.1021%2Facs.jmedchem.9b00751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design</span></div><div class="casAuthors">Hoang, Van-Hai; Ngo, Van T. H.; Cui, Minghua; Manh, Nguyen Van; Tran, Phuong-Thao; Ann, Jihyae; Ha, Hee-Jin; Kim, Hee; Choi, Kwanghyun; Kim, Young-Ho; Chang, Hyerim; Macalino, Stephani Joy Y.; Lee, Jiyoun; Choi, Sun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8011-8027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD.  Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of β-amyloid in the brains of AD patients.  On the basis of a putative active conformation of the prototype inhibitor 1, a series of N-substituted thiourea, urea, and α-substituted amide derivs. were developed.  The structure-activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogs, and several selected compds. demonstrated desirable therapeutic activity in an AD mouse model.  The conformational anal. of a representative inhibitor indicated that the inhibitor appeared to maintain the Z-E conformation at the active site, as it is crit. for its potent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKWajqMIkJrVg90H21EOLACvtfcHk0lj1cELuIJVAjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP&md5=5830439908c727943bfc534ff1030308</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00751%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DNgo%26aufirst%3DV.%2BT.%2BH.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DManh%26aufirst%3DN.%2BV.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DMacalino%26aufirst%3DS.%2BJ.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520conformationally%2520restricted%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520potent%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8011%26epage%3D8027%26doi%3D10.1021%2Facs.jmedchem.9b00751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaiser, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcher-Rorsted, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropke Jorgensen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frykman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brauner-Osborne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiesen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejer Pedersen, D.</span></span> <span> </span><span class="NLM_article-title">Probing the existence of a metastable binding site at the beta2-adrenergic receptor with homobivalent bitopic ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7806</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlOhu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7806-7839&author=B.+I.+Gaiserauthor=M.+Danielsenauthor=E.+Marcher-Rorstedauthor=K.+Ropke+Jorgensenauthor=T.+M.+Wrobelauthor=M.+Frykmanauthor=H.+Johanssonauthor=H.+Brauner-Osborneauthor=D.+E.+Gloriamauthor=J.+M.+Mathiesenauthor=D.+Sejer+Pedersen&title=Probing+the+existence+of+a+metastable+binding+site+at+the+beta2-adrenergic+receptor+with+homobivalent+bitopic+ligands&doi=10.1021%2Facs.jmedchem.9b00595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Existence of a Metastable Binding Site at the β2-Adrenergic Receptor with Homobivalent Bitopic Ligands</span></div><div class="casAuthors">Gaiser, Birgit I.; Danielsen, Mia; Marcher-Roersted, Emil; Roepke Joergensen, Kira; Wrobel, Tomasz M.; Frykman, Mikael; Johansson, Henrik; Brauner-Osborne, Hans; Gloriam, David E.; Mathiesen, Jesper Mosolff; Sejer Pedersen, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7806-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we report the development of bitopic ligands aimed at targeting the orthosteric binding site (OBS) and a metastable binding site (MBS) within the same receptor unit.  Previous mol. dynamics studies on ligand binding to the β2-adrenergic receptor (β2AR) suggested that ligands pause at transient, less-conserved MBSs.  We envisioned that MBSs can be regarded as allosteric binding sites and targeted by homobivalent bitopic ligands linking two identical pharmacophores.  Such ligands were designed based on docking of the antagonist (S)-alprenolol into the OBS and an MBS and synthesized.  Pharmacol. characterization revealed ligands with similar potency and affinity, slightly increased β2/β1AR-selectivity, and/or substantially slower β2AR off-rates compared to (S)-alprenolol.  Truncated bitopic ligands suggested the major contribution of the metastable pharmacophore to be a hydrophobic interaction with the β2AR, while the linkers alone decreased the potency of the orthosteric fragment.  Altogether, the study underlines the potential of targeting MBSs for improving the pharmacol. profiles of ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt_nqROQHIBrVg90H21EOLACvtfcHk0lhK9b9L_O41AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlOhu7%252FI&md5=411f11f6df72b940f3919b21510adf0b</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00595%26sid%3Dliteratum%253Aachs%26aulast%3DGaiser%26aufirst%3DB.%2BI.%26aulast%3DDanielsen%26aufirst%3DM.%26aulast%3DMarcher-Rorsted%26aufirst%3DE.%26aulast%3DRopke%2BJorgensen%26aufirst%3DK.%26aulast%3DWrobel%26aufirst%3DT.%2BM.%26aulast%3DFrykman%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DH.%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26aulast%3DSejer%2BPedersen%26aufirst%3DD.%26atitle%3DProbing%2520the%2520existence%2520of%2520a%2520metastable%2520binding%2520site%2520at%2520the%2520beta2-adrenergic%2520receptor%2520with%2520homobivalent%2520bitopic%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7806%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.9b00595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurt, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazioglu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basile, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonmez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucukislamoglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guccione, S.</span></span> <span> </span><span class="NLM_article-title">Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2015.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=26244990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Ogs7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2015&pages=80-92&author=B.+Z.+Kurtauthor=I.+Gaziogluauthor=L.+Basileauthor=F.+Sonmezauthor=T.+Ginexauthor=M.+Kucukislamogluauthor=S.+Guccione&title=Potential+of+aryl-urea-benzofuranylthiazoles+hybrids+as+multitasking+agents+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease</span></div><div class="casAuthors">Kurt, Belma Zengin; Gazioglu, Isil; Basile, Livia; Sonmez, Fatih; Ginex, Tiziana; Kucukislamoglu, Mustafa; Guccione, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80-92</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The new benzofuranylthiazole derivs. contg. the aryl-urea I [R = H, Br, NO2; R1 = H, 2-NO2, 3-OCH3, 4-CH3, etc.] moiety were synthesized and evaluated in vitro as dual acetylcholinesterase (AChE)-butyrylcholinesterase (BuChE) inhibitors.  In addn., the cupric reducing antioxidant capacities (CUPRAC) and ABTS cation radical scavenging abilities of the synthesized compds. I were assayed.  The result showed that all the synthesized compds. I exhibited inhibitory activity on both AChE and BuChE with I [R = Br; R1 = 2-F] (IC50 value of 3.85 μM) and I [R = NO2; R1 = 4-I] (IC50 value of 2.03 μM) as the strongest inhibitors against AChE and BuChE, resp.  The compd. I [R = NO2; R1 = 4-I] was 8.5-fold more potent than galanthamine.  The selectivity index of I [R = Br, NO2; R1 = 2-F, 4-I] was 2.40 and 0.37 against AChE and BuChE, resp.  The compd. I [R = H; R1 = 3-OCH3, 4-CH3, 4-F] (IC50 = 0.2, 0.5 and 1.13 μM, resp.) showed a better ABTS cation radical scavenging ability than the std. quercetin (IC50 = 1.18 μM).  Best poses of compds. I [R = NO2; R1 = 4-I] on BuChE and I [R = Br; R1 = 2-F] on AChE indicate that the thiazole ring and the amidic moiety are important sites of interaction with both ChEs.  In addn., the benzofuran ring and Ph ring are anchored to the side chains of both enzymes by π-π interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxx3fVuauPmbVg90H21EOLACvtfcHk0lhK9b9L_O41AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Ogs7zK&md5=a7d6c69966904dc7626f5e53d41356f2</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DKurt%26aufirst%3DB.%2BZ.%26aulast%3DGazioglu%26aufirst%3DI.%26aulast%3DBasile%26aufirst%3DL.%26aulast%3DSonmez%26aufirst%3DF.%26aulast%3DGinex%26aufirst%3DT.%26aulast%3DKucukislamoglu%26aufirst%3DM.%26aulast%3DGuccione%26aufirst%3DS.%26atitle%3DPotential%2520of%2520aryl-urea-benzofuranylthiazoles%2520hybrids%2520as%2520multitasking%2520agents%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D102%26spage%3D80%26epage%3D92%26doi%3D10.1016%2Fj.ejmech.2015.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and antiepileptic properties of novel 1-(substituted benzylidene)-3-(1-(morpholino/piperidino methyl)-2,3-dioxoindolin-5-yl)urea derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6057</span>– <span class="NLM_lpage">6065</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2011.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=22037252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKqtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=6057-6065&author=C.+R.+Prakashauthor=S.+Raja&title=Design%2C+synthesis+and+antiepileptic+properties+of+novel+1-%28substituted+benzylidene%29-3-%281-%28morpholino%2Fpiperidino+methyl%29-2%2C3-dioxoindolin-5-yl%29urea+derivatives&doi=10.1016%2Fj.ejmech.2011.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and antiepileptic properties of novel 1-(substituted benzylidene)-3-(1-(morpholino/piperidino methyl)-2,3-dioxoindolin-5-yl)urea derivatives</span></div><div class="casAuthors">Prakash, Chinnasamy Rajaram; Raja, Sundararajan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6057-6065</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Twenty new 1-(substituted benzylidene)-3-(1-(morpholino/piperidinomethyl)-2,3-dioxoindolin-5-yl)urea derivs. were designed and synthesized.  Antiepileptic screening was performed using MES and scPTZ seizures tests.  The neurotoxicity was detd. by rotorod test.  In the preliminary screening, several compds. were found active in the MES model, while one compd. showed significant antiepileptic activity in the scPTZ model.  Five compds. were administered orally to rats, and they showed better activity than Phenytoin in the oral route.  Among these compds., compd. I revealed protection in MES at a dose of 30 mg/kg and 100 mg/kg 0.5 h and 4 h after i.p. administration resp.  This mol. provided also protection in the scPTZ at a dose of 300 mg/kg in both time intervals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9C_z8OoAatbVg90H21EOLACvtfcHk0lggscCi5t7HUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKqtb7P&md5=32ebdb5f18c0e0399008abc9868d9625</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DC.%2BR.%26aulast%3DRaja%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antiepileptic%2520properties%2520of%2520novel%25201-%2528substituted%2520benzylidene%2529-3-%25281-%2528morpholino%252Fpiperidino%2520methyl%2529-2%252C3-dioxoindolin-5-yl%2529urea%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D6057%26epage%3D6065%26doi%3D10.1016%2Fj.ejmech.2011.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2236</span>– <span class="NLM_lpage">2242</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2011.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21435751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2236-2242&author=N.+Siddiquiauthor=M.+S.+Alamauthor=J.+P.+Stables&title=Synthesis+and+anticonvulsant+properties+of+1-%28amino-N-arylmethanethio%29-3-%281-substituted+benzyl-2%2C+3-dioxoindolin-5-yl%29+urea+derivatives&doi=10.1016%2Fj.ejmech.2011.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives</span></div><div class="casAuthors">Siddiqui, Nadeem; Alam, M. Shamsher; Stables, James P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2236-2242</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Various 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea were designed keeping in view the structural requirements suggested in the pharmacophore model for anticonvulsant activity.  Their in vivo anticonvulsant screenings were performed by two most adopted seizure models, maximal electroshock seizure (MES) and s.c. pentylenetetrazole (scPTZ).  Compd. I (R = Ph, R' = 2-OMePh) was found active in MES screening while compds. I (R = Ph, R' = 4-OMePh; R = 2-ClPh, R' = Ph, 2-MePh, and 4-MePh)showed significant anticonvulsant activity in both the screenings and were devoid of any neurotoxicity.  Compd. I (R = Ph, R' = 4-OMePh; R = 2-ClPh, R' = Ph) showed marked protection at 300 mg/kg against MES and scPTZ screening.  Compd. I (R = 2-ClPh, R' = Ph) also showed protection against MES screening at the dose of 100 mg/kg.  In 6 Hz screening these two compds. showed significant protection and emerged as lead compds. for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPIplz9F2CCbVg90H21EOLACvtfcHk0li1KTIlITjPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCnt7k%253D&md5=0aeaa69ccddc22809dd325a6debe2695</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DN.%26aulast%3DAlam%26aufirst%3DM.%2BS.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26atitle%3DSynthesis%2520and%2520anticonvulsant%2520properties%2520of%25201-%2528amino-N-arylmethanethio%2529-3-%25281-substituted%2520benzyl-2%252C%25203-dioxoindolin-5-yl%2529%2520urea%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2236%26epage%3D2242%26doi%3D10.1016%2Fj.ejmech.2011.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Substituted 1-Phenyl-3-(pyridin-2-yl)urea negative allosteric modulators of mGlu5: discovery of a new tool compound VU0463841 with activity in rat models of cocaine addiction</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1021/cn400070k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400070k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1217-1228&author=R.+J.+Amatoauthor=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=D.+F.+Venableauthor=R.+D.+Morrisonauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jonesauthor=K.+A.+Emmitte&title=Substituted+1-Phenyl-3-%28pyridin-2-yl%29urea+negative+allosteric+modulators+of+mGlu5%3A+discovery+of+a+new+tool+compound+VU0463841+with+activity+in+rat+models+of+cocaine+addiction&doi=10.1021%2Fcn400070k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu5: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction</span></div><div class="casAuthors">Amato, Russell J.; Felts, Andrew S.; Rodriguez, Alice L.; Venable, Daryl F.; Morrison, Ryan D.; Byers, Frank W.; Daniels, J. Scott; Niswender, Colleen M.; Conn, P. Jeffrey; Lindsley, Craig W.; Jones, Carrie K.; Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1217-1228</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cocaine is a powerful and highly addictive stimulant that disrupts the normal reward circuitry in the central nervous system (CNS), producing euphoric effects.  Cocaine use can lead to acute and life threatening emergencies, and abuse is assocd. with increased risk for contracting infectious diseases.  Though certain types of behavioral therapy have proven effective for treatment of cocaine addiction, relapse remains high, and there are currently no approved medications for the treatment of cocaine abuse.  Evidence has continued to accumulate that indicates a crit. role for the metabotropic glutamate receptor subtype 5 (mGlu5) in the modulation of neural circuitry assocd. with the addictive properties of cocaine.  While the small mol. mGlu5 neg. allosteric modulator (NAM) field is relatively advanced, investigation into the potential of small mol. mGlu5 NAMs for the treatment of cocaine addiction remains an area of high interest.  Herein the authors describe the discovery and characterization of a potent and selective compd. 29 (VU0463841) with good CNS exposure in rats.  The utility of compd. 29 (VU0463841) was demonstrated by its ability to attenuate drug seeking behaviors in relevant rat models of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7d7-mYwmD5LVg90H21EOLACvtfcHk0li1KTIlITjPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGhs74%253D&md5=393278d7d07d3316ebee0e6759b065bf</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1021%2Fcn400070k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400070k%26sid%3Dliteratum%253Aachs%26aulast%3DAmato%26aufirst%3DR.%2BJ.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DSubstituted%25201-Phenyl-3-%2528pyridin-2-yl%2529urea%2520negative%2520allosteric%2520modulators%2520of%2520mGlu5%253A%2520discovery%2520of%2520a%2520new%2520tool%2520compound%2520VU0463841%2520with%2520activity%2520in%2520rat%2520models%2520of%2520cocaine%2520addiction%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1217%26epage%3D1228%26doi%3D10.1021%2Fcn400070k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of CNS penetrant CXCR2 antagonists for the potential treatment of CNS demyelinating disorders</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00489</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00489" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Ojsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=397-402&author=H.+Xuauthor=H.+Luauthor=Z.+Xuauthor=L.+Luanauthor=C.+Liauthor=Y.+Xuauthor=K.+Dongauthor=J.+Zhangauthor=X.+Liauthor=Y.+Liauthor=G.+Liuauthor=S.+Gongauthor=Y.+G.+Zhaoauthor=A.+Liuauthor=Y.+Zhangauthor=W.+Zhangauthor=X.+Caiauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=X.+Lin&title=Discovery+of+CNS+penetrant+CXCR2+antagonists+for+the+potential+treatment+of+CNS+demyelinating+disorders&doi=10.1021%2Facsmedchemlett.5b00489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders</span></div><div class="casAuthors">Xu, Heng; Lu, Hongfu; Xu, Zhongmiao; Luan, Linbo; Li, Chengyong; Xu, Yan; Dong, Kelly; Zhang, Jinqiang; Li, Xiong; Li, Yvonne; Liu, Gentao; Gong, Sophie; Zhao, Yong-Gang; Liu, Ailian; Zhang, Yueting; Zhang, Wei; Cai, Xin; Xiang, Jia-Ning; Elliott, John D.; Lin, Xichen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-402</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationship exploration of the historical biarylurea series led to the identification of novel CNS penetrant CXCR2 antagonists with nanomolar potency, favorable PK profile, and good developability potentials.  More importantly, the key compd. I showed efficacy in a cuprizone-induced demyelination model with twice daily oral administration, thereby supporting CXCR2 to be a potential therapeutic target for the treatment of demyelinating diseases such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKTCTsJmbuwrVg90H21EOLACvtfcHk0ljegn3iwQeqLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Ojsr4%253D&md5=8ee345c1bd7f4f840cb516a02a558481</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00489%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLuan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGong%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%2BG.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520CNS%2520penetrant%2520CXCR2%2520antagonists%2520for%2520the%2520potential%2520treatment%2520of%2520CNS%2520demyelinating%2520disorders%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D397%26epage%3D402%26doi%3D10.1021%2Facsmedchemlett.5b00489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref255"><div class="reference"><strong class="refLabel"><a href="#ref255" class="rightTabRefNumLink">255</a></strong><div class="NLM_citation" id="rightTab-cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of cyclic urea as potent CCR5 antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6381</span>– <span class="NLM_lpage">6385</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmcl.2011.08.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=21930378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6381-6385&author=M.+Duanauthor=W.+M.+Kazmierskiauthor=M.+Tallantauthor=J.+H.+Junauthor=M.+Edelsteinauthor=R.+Ferrisauthor=D.+Toddauthor=P.+Wheelanauthor=Z.+Xiong&title=Discovery+of+a+novel+series+of+cyclic+urea+as+potent+CCR5+antagonists&doi=10.1016%2Fj.bmcl.2011.08.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel series of cyclic urea as potent CCR5 antagonists</span></div><div class="casAuthors">Duan, Mao-Sheng; Kazmierski, Wieslaw M.; Tallant, Matt; Jun, Jung-Ho; Edelstein, Mark; Ferris, Rob; Todd, Dan; Wheelan, Pat; Xiong, Zhi-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6381-6385</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of cyclic urea-based CCR5 antagonists was designed aiming to resolve instability issue in the fasted simulated intestinal fluid (FSIF) assocd. with the acyclic urea moiety in 1 (I).  This class of CCR5 compds. demonstrated high antiviral activities against HIV-1 infection in both HOS and PBL assays.  Further evaluation of these compds. indicated that the I analog 16-R not only substantially enhanced its stability, but also exhibited excellent pharmacokinetics properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx6ist8zyP47Vg90H21EOLACvtfcHk0liX_TKzK4R9AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FF&md5=52accac06c1550e1e0fc17c7f8395470</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.096%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DTallant%26aufirst%3DM.%26aulast%3DJun%26aufirst%3DJ.%2BH.%26aulast%3DEdelstein%26aufirst%3DM.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DTodd%26aufirst%3DD.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520cyclic%2520urea%2520as%2520potent%2520CCR5%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6381%26epage%3D6385%26doi%3D10.1016%2Fj.bmcl.2011.08.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref256"><div class="reference"><strong class="refLabel"><a href="#ref256" class="rightTabRefNumLink">256</a></strong><div class="NLM_citation" id="rightTab-cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamatake, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvest, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3021</span>– <span class="NLM_lpage">3026</span>, <span class="refDoi"> DOI: 10.1021/jm201278q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201278q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3021-3026&author=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.+J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wangauthor=X.+Liauthor=S.+Zhangauthor=Y.+K.+Zhangauthor=Y.+Liuauthor=C.+Z.+Dingauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liu&title=Discovery+of+novel+urea-based+hepatitis+C+protease+inhibitors+with+high+potency+against+protease-inhibitor-resistant+mutants&doi=10.1021%2Fjm201278q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Hamatake, Robert; Duan, Maosheng; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Wang, Amy; Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3021-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors were prepd. and characterized in replicase HCV protease-resistant mutants assay.  Several compds., exemplified by I, were found to be more potent in HCV replicon assays than leading second generation inhibitors such as danoprevir and TMC-435350.  Addnl., following oral administration, inhibitor I was found in rat liver in significantly higher concns. than those reported for both danoprevir and TMC-435350, suggesting that inhibitor I has the combination of anti-HCV and pharmacokinetic properties that warrants further development of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZf8snkMwqSrVg90H21EOLACvtfcHk0liX_TKzK4R9AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D&md5=43f9016626357a5fea8d6d1e9784e2d8</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1021%2Fjm201278q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201278q%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520urea-based%2520hepatitis%2520C%2520protease%2520inhibitors%2520with%2520high%2520potency%2520against%2520protease-inhibitor-resistant%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3021%26epage%3D3026%26doi%3D10.1021%2Fjm201278q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref257"><div class="reference"><strong class="refLabel"><a href="#ref257" class="rightTabRefNumLink">257</a></strong><div class="NLM_citation" id="rightTab-cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drlica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span> <span> </span><span class="NLM_article-title">DNA gyrase, topoisomerase IV, and the 4-quinolones</span>. <i>Microbiol Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1128%2F.61.3.377-392.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=9293187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1yhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=377-392&author=K.+Drlicaauthor=X.+Zhao&title=DNA+gyrase%2C+topoisomerase+IV%2C+and+the+4-quinolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">DNA gyrase, topoisomerase IV, and the 4-quinolones</span></div><div class="casAuthors">Drlica, Karl; Zhao, Xilin</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-392</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review with 214 refs. on the antibacterial action of 4-quinolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpePsktP7PDhrVg90H21EOLACvtfcHk0ljfM5k46gxiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1yhsL0%253D&md5=a8c0f1314b8a568873bd1fc8d044b72a</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1128%2F.61.3.377-392.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252F.61.3.377-392.1997%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DDNA%2520gyrase%252C%2520topoisomerase%2520IV%252C%2520and%2520the%25204-quinolones%26jtitle%3DMicrobiol%2520Mol.%2520Biol.%2520Rev.%26date%3D1997%26volume%3D61%26spage%3D377%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref258"><div class="reference"><strong class="refLabel"><a href="#ref258" class="rightTabRefNumLink">258</a></strong><div class="NLM_citation" id="rightTab-cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases: structure, function, and mechanism</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.70.1.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1146%2Fannurev.biochem.70.1.369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11395412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=369-413&author=J.+J.+Champoux&title=DNA+topoisomerases%3A+structure%2C+function%2C+and+mechanism&doi=10.1146%2Fannurev.biochem.70.1.369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases: structure, function, and mechanism</span></div><div class="casAuthors">Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-413</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 196 refs.  DNA topoisomerases solve the topol. problems assocd. with DNA replication, transcription, recombination, and chromatin remodeling by introducing temporary single- or double-strand breaks in the DNA.  In addn., these enzymes fine-tune the steady-state level of DNA supercoiling both to facilitate protein interactions with the DNA and to prevent excessive supercoiling that is deleterious.  In recent years, the crystal structures of a no. of topoisomerase fragments, representing nearly all of the known classes of enzymes, have been solved.  These structures provide remarkable insights into the mechanisms of these enzymes and complement previous conclusions based on biochem. analyses.  Surprisingly, despite little or no sequence homol., both type IA and type IIA topoisomerases from prokaryotes and the type IIA enzymes from eukaryotes share structural folds that appear to reflect functional motifs within crit. regions of the enzymes.  The type IB enzymes are structurally distinct from all other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases.  The structural themes common to all topoisomerases include hinged clamps that open and close to bind DNA, the presence of DNA binding cavities for temporary storage of DNA segments, and the coupling of protein conformational changes to DNA rotation or DNA movement.  For the type II topoisomerases, the binding and hydrolysis of ATP further modulate conformational changes in the enzymes to effect changes in DNA topol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4rDyIYy17Vg90H21EOLACvtfcHk0ljfM5k46gxiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D&md5=67c3e38eb4fcb85527b33d7077309482</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.369%26sid%3Dliteratum%253Aachs%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DDNA%2520topoisomerases%253A%2520structure%252C%2520function%252C%2520and%2520mechanism%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D369%26epage%3D413%26doi%3D10.1146%2Fannurev.biochem.70.1.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref259"><div class="reference"><strong class="refLabel"><a href="#ref259" class="rightTabRefNumLink">259</a></strong><div class="NLM_citation" id="rightTab-cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, D. M.</span></span> <span> </span><span class="NLM_article-title">The ATP-binding site of type II topoisomerases as a target for antibacterial drugs</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.2174/1568026033452500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.2174%2F1568026033452500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12570764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Cluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=283-303&author=A.+Maxwellauthor=D.+M.+Lawson&title=The+ATP-binding+site+of+type+II+topoisomerases+as+a+target+for+antibacterial+drugs&doi=10.2174%2F1568026033452500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">The ATP-binding site of type II topoisomerases as a target for antibacterial drugs</span></div><div class="casAuthors">Maxwell, Anthony; Lawson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-303</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are essential enzymes in all cell types and have been valuable drug targets both for antibacterial and anti-cancer chemotherapy.  Type II topoisomerases possess a binding site for ATP, which can be exploited as a target for chemo-therapeutic agents.  High-resoln. structures of protein fragments contg. this site complexed with antibiotics or an ATP analog have provided vital information for the understanding of the action of existing drugs and for the potential development of novel anti-bacterial agents.  In this article we have reviewed the structure and function of the ATPase domain of DNA gyrase (bacterial topoisomerase II), particularly highlighting novel information that has been revealed by structural studies.  We discuss the efficacy and mode of action of existing drugs and consider the prospects for the development of novel agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooHh_snP6iBbVg90H21EOLACvtfcHk0lgZQ_jOQCrdIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Cluw%253D%253D&md5=9b3d6e867a5d29e523842811f3d4b046</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.2174%2F1568026033452500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452500%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DLawson%26aufirst%3DD.%2BM.%26atitle%3DThe%2520ATP-binding%2520site%2520of%2520type%2520II%2520topoisomerases%2520as%2520a%2520target%2520for%2520antibacterial%2520drugs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D283%26epage%3D303%26doi%3D10.2174%2F1568026033452500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref260"><div class="reference"><strong class="refLabel"><a href="#ref260" class="rightTabRefNumLink">260</a></strong><div class="NLM_citation" id="rightTab-cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drumm, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeTiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessier, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5243</span>– <span class="NLM_lpage">5263</span>, <span class="refDoi"> DOI: 10.1021/jm800318d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800318d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5243-5263&author=P.+S.+Charifsonauthor=A.+L.+Grillotauthor=T.+H.+Grossmanauthor=J.+D.+Parsonsauthor=M.+Badiaauthor=S.+Bellonauthor=D.+D.+Deiningerauthor=J.+E.+Drummauthor=C.+H.+Grossauthor=A.+LeTiranauthor=Y.+Liaoauthor=N.+Maniauthor=D.+P.+Nicolauauthor=E.+Perolaauthor=S.+Ronkinauthor=D.+Shannonauthor=L.+L.+Swensonauthor=Q.+Tangauthor=P.+R.+Tessierauthor=S.+K.+Tianauthor=M.+Trudeauauthor=T.+Wangauthor=Y.+Weiauthor=H.+Zhangauthor=D.+Stamos&title=Novel+dual-targeting+benzimidazole+urea+inhibitors+of+DNA+gyrase+and+topoisomerase+IV+possessing+potent+antibacterial+activity%3A+intelligent+design+and+evolution+through+the+judicious+use+of+structure-guided+design+and+structure-activity+relationships&doi=10.1021%2Fjm800318d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Structure-Activity Relationships</span></div><div class="casAuthors">Charifson, Paul S.; Grillot, Anne-Laure; Grossman, Trudy H.; Parsons, Jonathan D.; Badia, Michael; Bellon, Steve; Deininger, David D.; Drumm, Joseph E.; Gross, Christian H.; LeTiran, Arnaud; Liao, Yusheng; Mani, Nagraj; Nicolau, David P.; Perola, Emanuele; Ronkin, Steven; Shannon, Dean; Swenson, Lora L.; Tang, Qing; Tessier, Pamela R.; Tian, Ski-Kai; Trudeau, Martin; Wang, Tiansheng; Wei, Yunyi; Zhang, Hong; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5243-5263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new antibacterial agents with novel mechanisms of action is necessary to overcome the problem of bacterial resistance that affects all currently used classes of antibiotics.  Bacterial DNA gyrase and topoisomerase IV are well-characterized clin. validated targets of the fluoroquinolone antibiotics which exert their antibacterial activity through inhibition of the catalytic subunits.  Inhibition of these targets through interaction with their ATP sites has been less clin. successful.  The discovery and characterization of a new class of low mol. wt., synthetic inhibitors of gyrase and topoisomerase IV that bind to the ATP sites are presented.  The benzimidazole ureas are dual targeting inhibitors of both enzymes and possess potent antibacterial activity against a wide spectrum of relevant pathogens responsible for hospital- and community-acquired infections.  The discovery and optimization of this novel class of antibacterials by the use of structure-guided design, modeling, and structure-activity relationships are described.  Data are presented for enzyme inhibition, antibacterial activity, and in vivo efficacy by oral and i.v. administration in two rodent infection models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSg-NiMYqXebVg90H21EOLACvtfcHk0lgZQ_jOQCrdIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D&md5=284d19912422bcadd38d9c021cd71ef8</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Fjm800318d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800318d%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrillot%26aufirst%3DA.%2BL.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DBadia%26aufirst%3DM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DTian%26aufirst%3DS.%2BK.%26aulast%3DTrudeau%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DNovel%2520dual-targeting%2520benzimidazole%2520urea%2520inhibitors%2520of%2520DNA%2520gyrase%2520and%2520topoisomerase%2520IV%2520possessing%2520potent%2520antibacterial%2520activity%253A%2520intelligent%2520design%2520and%2520evolution%2520through%2520the%2520judicious%2520use%2520of%2520structure-guided%2520design%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5243%26epage%3D5263%26doi%3D10.1021%2Fjm800318d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref261"><div class="reference"><strong class="refLabel"><a href="#ref261" class="rightTabRefNumLink">261</a></strong><div class="NLM_citation" id="rightTab-cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzelka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8792</span>– <span class="NLM_lpage">8816</span>, <span class="refDoi"> DOI: 10.1021/jm500563g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500563g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8792-8816&author=A.+L.+Grillotauthor=A.+Le+Tiranauthor=D.+Shannonauthor=E.+Kruegerauthor=Y.+Liaoauthor=H.+O%E2%80%99Dowdauthor=Q.+Tangauthor=S.+Ronkinauthor=T.+Wangauthor=N.+Waalauthor=P.+Liauthor=D.+Laufferauthor=E.+Sizenskyauthor=J.+Tanouryauthor=E.+Perolaauthor=T.+H.+Grossmanauthor=T.+Doyleauthor=B.+Hanzelkaauthor=S.+Jonesauthor=V.+Dixitauthor=N.+Ewingauthor=S.+Liaoauthor=B.+Boucherauthor=M.+Jacobsauthor=Y.+Bennaniauthor=P.+S.+Charifson&title=Second-generation+antibacterial+benzimidazole+ureas%3A+discovery+of+a+preclinical+candidate+with+reduced+metabolic+liability&doi=10.1021%2Fjm500563g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span></div><div class="casAuthors">Grillot, Anne-Laure; Tiran, Arnaud Le; Shannon, Dean; Krueger, Elaine; Liao, Yusheng; O'Dowd, Hardwin; Tang, Qing; Ronkin, Steve; Wang, Tiansheng; Waal, Nathan; Li, Pan; Lauffer, David; Sizensky, Emmanuelle; Tanoury, Jerry; Perola, Emanuele; Grossman, Trudy H.; Doyle, Tim; Hanzelka, Brian; Jones, Steven; Dixit, Vaishali; Ewing, Nigel; Liao, Shengkai; Boucher, Brian; Jacobs, Marc; Bennani, Youssef; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8792-8816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. 3 is a potent aminobenzimidazole urea with broad-spectrum Gram-pos. antibacterial activity resulting from dual inhibition of bacterial gyrase (GyrB) and topoisomerase IV (ParE), and it demonstrates efficacy in rodent models of bacterial infection.  Preclin. in vitro and in vivo studies showed that compd. 3 covalently labels liver proteins, presumably via formation of a reactive metabolite, and hence presented a potential safety liability.  The urea moiety in compd. 3 was identified as being potentially responsible for reactive metabolite formation, but its replacement resulted in loss of antibacterial activity and/or oral exposure due to poor physicochem. parameters.  To identify second-generation aminobenzimidazole ureas devoid of reactive metabolite formation potential, we implemented a metabolic shift strategy, which focused on shifting metab. away from the urea moiety by introducing metabolic soft spots elsewhere in the mol.  Aminobenzimidazole urea 34, identified through this strategy, exhibits similar antibacterial activity as that of 3 and did not label liver proteins in vivo, indicating reduced/no potential for reactive metabolite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1TXw5pd6rXbVg90H21EOLACvtfcHk0liHl80D3FTelw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J&md5=493a19ab7eaa9997f836228e25fe3125</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1021%2Fjm500563g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500563g%26sid%3Dliteratum%253Aachs%26aulast%3DGrillot%26aufirst%3DA.%2BL.%26aulast%3DLe%2BTiran%26aufirst%3DA.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DKrueger%26aufirst%3DE.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLauffer%26aufirst%3DD.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%26aulast%3DEwing%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSecond-generation%2520antibacterial%2520benzimidazole%2520ureas%253A%2520discovery%2520of%2520a%2520preclinical%2520candidate%2520with%2520reduced%2520metabolic%2520liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8792%26epage%3D8816%26doi%3D10.1021%2Fjm500563g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref262"><div class="reference"><strong class="refLabel"><a href="#ref262" class="rightTabRefNumLink">262</a></strong><div class="NLM_citation" id="rightTab-cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomaides-Brears, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaplewski, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunniss, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peasley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydon, D. J.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5977</span>– <span class="NLM_lpage">5986</span>, <span class="refDoi"> DOI: 10.1128/AAC.00719-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1128%2FAAC.00719-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24041906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5977-5986&author=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=S.+Barkerauthor=J.+M.+Bennettauthor=J.+Berryauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=V.+Gambleauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=H.+Peasleyauthor=S.+Pommierauthor=D.+Priceauthor=C.+Smeeauthor=D.+J.+Haydon&title=Biological+evaluation+of+benzothiazole+ethyl+urea+inhibitors+of+bacterial+type+II+topoisomerases&doi=10.1128%2FAAC.00719-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span></div><div class="casAuthors">Stokes Neil R; Thomaides-Brears Helena B; Barker Stephanie; Bennett James M; Berry Joanne; Collins Ian; Czaplewski Lloyd G; Gamble Vicki; Lancett Paul; Logan Alastair; Lunniss Christopher J; Peasley Hilary; Pommier Stephanie; Price Daniel; Smee Carol; Haydon David J</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5977-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The type II topoisomerases DNA gyrase (GyrA/GyrB) and topoisomerase IV (ParC/ParE) are well-validated targets for antibacterial drug discovery.  Because of their structural and functional homology, these enzymes are amenable to dual targeting by a single ligand.  In this study, two novel benzothiazole ethyl urea-based small molecules, designated compound A and compound B, were evaluated for their biochemical, antibacterial, and pharmacokinetic properties.  The two compounds inhibited the ATPase activity of GyrB and ParE with 50% inhibitory concentrations of <0.1 μg/ml.  Prevention of DNA supercoiling by DNA gyrase was also observed.  Both compounds potently inhibited the growth of a range of bacterial organisms, including staphylococci, streptococci, enterococci, Clostridium difficile, and selected Gram-negative respiratory pathogens.  MIC90s against clinical isolates ranged from 0.015 μg/ml for Streptococcus pneumoniae to 0.25 μg/ml for Staphylococcus aureus.  No cross-resistance with common drug resistance phenotypes was observed.  In addition, no synergistic or antagonistic interactions between compound A or compound B and other antibiotics, including the topoisomerase inhibitors novobiocin and levofloxacin, were detected in checkerboard experiments.  The frequencies of spontaneous resistance for S. aureus were <2.3 × 10(-10) with compound A and <5.8 × 10(-11) with compound B at concentrations equivalent to 8× the MICs.  These values indicate a multitargeting mechanism of action.  The pharmacokinetic properties of both compounds were profiled in rats.  Following intravenous administration, compound B showed approximately 3-fold improvement over compound A in terms of both clearance and the area under the concentration-time curve.  The measured oral bioavailability of compound B was 47.7%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB7u8-ATVsmBFwe7cAcrfPfW6udTcc2eaaBZpyL3bNm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D&md5=6ede7459b1d20c528f016a29446253c4</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1128%2FAAC.00719-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00719-13%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBerry%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DGamble%26aufirst%3DV.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DPeasley%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DSmee%26aufirst%3DC.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DBiological%2520evaluation%2520of%2520benzothiazole%2520ethyl%2520urea%2520inhibitors%2520of%2520bacterial%2520type%2520II%2520topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5977%26epage%3D5986%26doi%3D10.1128%2FAAC.00719-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref263"><div class="reference"><strong class="refLabel"><a href="#ref263" class="rightTabRefNumLink">263</a></strong><div class="NLM_citation" id="rightTab-cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yule, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaplewski, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narramore, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span> <span> </span><span class="NLM_article-title">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2014.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25137573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=31-38&author=I.+A.+Yuleauthor=L.+G.+Czaplewskiauthor=S.+Pommierauthor=D.+T.+Daviesauthor=S.+K.+Narramoreauthor=C.+W.+Fishwick&title=Pyridine-3-carboxamide-6-yl-ureas+as+novel+inhibitors+of+bacterial+DNA+gyrase%3A+structure+based+design%2C+synthesis%2C+SAR+and+antimicrobial+activity&doi=10.1016%2Fj.ejmech.2014.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity</span></div><div class="casAuthors">Yule, Ian A.; Czaplewski, Lloyd G.; Pommier, Stephanie; Davies, David T.; Narramore, Sarah K.; Fishwick, Colin W. G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of antibacterial drugs based on novel chemotypes is essential to the future management of serious drug resistant infections.  We herein report the design, synthesis and SAR of a novel series of N-ethylurea inhibitors based on a pyridine-3-carboxamide scaffold targeting the ATPase sub-unit of DNA gyrase.  Consideration of structural aspects of the GyrB ATPase site has aided the development of this series resulting in derivs. that demonstrate excellent enzyme inhibitory activity coupled to potent Gram pos. antibacterial efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa7ay8GaYorVg90H21EOLACvtfcHk0lgLspDYIedrkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL&md5=0b6959bec14a8d28d3321db46b33b4fa</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DYule%26aufirst%3DI.%2BA.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%2BT.%26aulast%3DNarramore%26aufirst%3DS.%2BK.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26atitle%3DPyridine-3-carboxamide-6-yl-ureas%2520as%2520novel%2520inhibitors%2520of%2520bacterial%2520DNA%2520gyrase%253A%2520structure%2520based%2520design%252C%2520synthesis%252C%2520SAR%2520and%2520antimicrobial%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D31%26epage%3D38%26doi%3D10.1016%2Fj.ejmech.2014.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref264"><div class="reference"><strong class="refLabel"><a href="#ref264" class="rightTabRefNumLink">264</a></strong><div class="NLM_citation" id="rightTab-cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. C.</span></span> <span> </span><span class="NLM_article-title">Linezolid: the first oxazolidinone antimicrobial</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-138-2-200301210-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.7326%2F0003-4819-138-2-200301210-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=12529096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=135-142&author=R.+C.+Moellering&title=Linezolid%3A+the+first+oxazolidinone+antimicrobial&doi=10.7326%2F0003-4819-138-2-200301210-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid: the first oxazolidinone antimicrobial</span></div><div class="casAuthors">Moellering, Robert C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-142</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians-American Society of Internal Medicine</span>)
        </div><div class="casAbstract">A review.  Linezolid is the first of a new class of antimicrobial agents, the oxazolidinones, to be approved for clin. use in the United States and elsewhere.  The drug is a totally synthetic compd., which lessens the likelihood of naturally occurring resistance mechanisms.  It has excellent activity against virtually all important gram-pos. pathogens, including methicillin-resistant staphylococci, penicillin-resistant pneumococci, macrolide-resistant streptococci, and vancomycin-resistant enterococci.  Development of resistance to the compd. has been infrequent thus far.  Linezolid is 100% bioavailable, so it can be given in equal doses orally or parenterally.  Its elimination half-life allows dosing twice per day, and alteration of drug dosage is not required in patients with impaired renal or hepatic function.  Linezolid has approved indications for skin and soft tissue infections; lower respiratory tract infections; and vancomycin-resistant Enterococcus faecium infections, including cases with concurrent bacteremia.  The drug has an acceptable profile of adverse events, but reversible myelosuppression has occurred in patients receiving high doses for more than 2 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj72PaeTyuRLVg90H21EOLACvtfcHk0lg456U4RIKR3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVWks78%253D&md5=0a1217e18504e1d8ad2a0fc98cc4c89e</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-138-2-200301210-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-138-2-200301210-00015%26sid%3Dliteratum%253Aachs%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26atitle%3DLinezolid%253A%2520the%2520first%2520oxazolidinone%2520antimicrobial%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2003%26volume%3D138%26spage%3D135%26epage%3D142%26doi%3D10.7326%2F0003-4819-138-2-200301210-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref265"><div class="reference"><strong class="refLabel"><a href="#ref265" class="rightTabRefNumLink">265</a></strong><div class="NLM_citation" id="rightTab-cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsiodras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoulas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliopoulos, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennersten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, M. J.</span></span> <span> </span><span class="NLM_article-title">Linezolid resistance in a clinical isolate of Staphylococcus aureus</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(01)05410-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0140-6736%2801%2905410-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11476839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=207-208&author=S.+Tsiodrasauthor=H.+S.+Goldauthor=G.+Sakoulasauthor=G.+M.+Eliopoulosauthor=C.+Wennerstenauthor=L.+Venkataramanauthor=R.+C.+Moelleringauthor=M.+J.+Ferraro&title=Linezolid+resistance+in+a+clinical+isolate+of+Staphylococcus+aureus&doi=10.1016%2FS0140-6736%2801%2905410-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in a clinical isolate of Staphylococcus aureus</span></div><div class="casAuthors">Tsiodras, S.; Gold, H. S.; Sakoulas, G.; Eliopoulos, G. M.; Wennersten, C.; Venkataraman, L.; Moellering, R. C.; Ferraro, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">9277</span>),
    <span class="NLM_cas:pages">207-208</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various Gram-pos. bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).  Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clin. isolates of S aureus.  The authors have characterized an MRSA isolate resistant to linezolid that was recovered from a patient treated with this agent for dialysis-assocd. peritonitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRryTK5F9tc7Vg90H21EOLACvtfcHk0lg456U4RIKR3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D&md5=d8574bd50d0f1129cbc8d5dae0ac8127</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2801%2905410-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252801%252905410-1%26sid%3Dliteratum%253Aachs%26aulast%3DTsiodras%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DH.%2BS.%26aulast%3DSakoulas%26aufirst%3DG.%26aulast%3DEliopoulos%26aufirst%3DG.%2BM.%26aulast%3DWennersten%26aufirst%3DC.%26aulast%3DVenkataraman%26aufirst%3DL.%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26aulast%3DFerraro%26aufirst%3DM.%2BJ.%26atitle%3DLinezolid%2520resistance%2520in%2520a%2520clinical%2520isolate%2520of%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D207%26epage%3D208%26doi%3D10.1016%2FS0140-6736%2801%2905410-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref266"><div class="reference"><strong class="refLabel"><a href="#ref266" class="rightTabRefNumLink">266</a></strong><div class="NLM_citation" id="rightTab-cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreckenberger, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DenBesten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. P.</span></span> <span> </span><span class="NLM_article-title">Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1179</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(00)04376-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS0140-6736%2800%2904376-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=11323048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFaqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1179&author=R.+D.+Gonzalesauthor=P.+C.+Schreckenbergerauthor=M.+B.+Grahamauthor=S.+Kelkarauthor=K.+DenBestenauthor=J.+P.+Quinn&title=Infections+due+to+vancomycin-resistant+Enterococcus+faecium+resistant+to+linezolid&doi=10.1016%2FS0140-6736%2800%2904376-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid</span></div><div class="casAuthors">Gonzales, R. D.; Schreckenberger, P. C.; Graham, M. B.; Kelkar, S.; DenBesten, K.; Quinn, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9263</span>),
    <span class="NLM_cas:pages">1179</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">Linezolid is a new oxazolidinone antibiotic used to treat infections caused by vancomycin-resistant enterococci (VRE).  In early clin. trials, emergence of resistance occurred rarely.  The authors report clin. details and antibiotic susceptibility from 5 patients treated with linezolid for VRE infections who had resistant organisms isolated during therapy.  Four were transplant patients receiving protracted courses of the drug; 3 cases were assocd. with treatment failure.  One of 45 linezolid-treated patients developed resistance during therapy.  Susceptibility testing should be done in all cases on starting therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdnzIal5XYyLVg90H21EOLACvtfcHk0ljqAAyAry5g4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFaqsb0%253D&md5=accd02388931411eaa373b9b69a01347</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2904376-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252904376-2%26sid%3Dliteratum%253Aachs%26aulast%3DGonzales%26aufirst%3DR.%2BD.%26aulast%3DSchreckenberger%26aufirst%3DP.%2BC.%26aulast%3DGraham%26aufirst%3DM.%2BB.%26aulast%3DKelkar%26aufirst%3DS.%26aulast%3DDenBesten%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DJ.%2BP.%26atitle%3DInfections%2520due%2520to%2520vancomycin-resistant%2520Enterococcus%2520faecium%2520resistant%2520to%2520linezolid%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1179%26doi%3D10.1016%2FS0140-6736%2800%2904376-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref267"><div class="reference"><strong class="refLabel"><a href="#ref267" class="rightTabRefNumLink">267</a></strong><div class="NLM_citation" id="rightTab-cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toh, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villegas, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankin, A. S.</span></span> <span> </span><span class="NLM_article-title">Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1506</span>– <span class="NLM_lpage">1514</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2007.05744.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1111%2Fj.1365-2958.2007.05744.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=17555436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1506-1514&author=S.+M.+Tohauthor=L.+Xiongauthor=C.+A.+Ariasauthor=M.+V.+Villegasauthor=K.+Lolansauthor=J.+Quinnauthor=A.+S.+Mankin&title=Acquisition+of+a+natural+resistance+gene+renders+a+clinical+strain+of+methicillin-resistant+Staphylococcus+aureus+resistant+to+the+synthetic+antibiotic+linezolid&doi=10.1111%2Fj.1365-2958.2007.05744.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid</span></div><div class="casAuthors">Toh, Seok-Ming; Xiong, Liqun; Arias, Cesar A.; Villegas, Maria V.; Lolans, Karen; Quinn, John; Mankin, Alexander S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1506-1514</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Linezolid, which targets the ribosome, is a new synthetic antibiotic that is used for treatment of infections caused by Gram-pos. pathogens.  Clin. resistance to linezolid, so far, has been developing only slowly and has involved exclusively target site mutations.  We have discovered that linezolid resistance in a methicillin-resistant Staphylococcus aureus hospital strain from Colombia is detd. by the presence of the cfr gene whose product, Cfr methyltransferase, modifies adenosine at position 2503 in 23S rRNA in the large ribosomal subunit.  The mol. model of the linezolid-ribosome complex reveals localization of A2503 within the drug binding site.  The natural function of cfr likely involves protection against natural antibiotics whose site of action overlaps that of linezolid.  In the chromosome of the clin. strain, cfr is linked to ermB, a gene responsible for dimethylation of A2058 in 23S rRNA.  Coexpression of these two genes confers resistance to all the clin. relevant antibiotics that target the large ribosomal subunit.  The assocn. of the ermB/cfr operon with transposon and plasmid genetic elements indicates its possible mobile nature.  This is the first example of clin. resistance to the synthetic drug linezolid which involves a natural resistance gene with the capability of disseminating among Gram-pos. pathogenic strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBz3CL3GnHirVg90H21EOLACvtfcHk0ljqAAyAry5g4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvVaisLk%253D&md5=0d2e6ae18e8e638530a0ad6191ba0677</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2007.05744.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2007.05744.x%26sid%3Dliteratum%253Aachs%26aulast%3DToh%26aufirst%3DS.%2BM.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DArias%26aufirst%3DC.%2BA.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DLolans%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DMankin%26aufirst%3DA.%2BS.%26atitle%3DAcquisition%2520of%2520a%2520natural%2520resistance%2520gene%2520renders%2520a%2520clinical%2520strain%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520resistant%2520to%2520the%2520synthetic%2520antibiotic%2520linezolid%26jtitle%3DMol.%2520Microbiol.%26date%3D2007%26volume%3D64%26spage%3D1506%26epage%3D1514%26doi%3D10.1111%2Fj.1365-2958.2007.05744.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref268"><div class="reference"><strong class="refLabel"><a href="#ref268" class="rightTabRefNumLink">268</a></strong><div class="NLM_citation" id="rightTab-cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsunomiya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasukata, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2013.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24044938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaqs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=262-277&author=H.+Suzukiauthor=I.+Utsunomiyaauthor=K.+Shudoauthor=N.+Fukuharaauthor=T.+Iwakiauthor=T.+Yasukata&title=Synthesis+and+in+vitro%2Fin+vivo+antibacterial+activity+of+oxazolidinones+having+thiocarbamate+at+C-5+on+the+A-ring+and+an+amide-+or+urea-substituted+%5B1%2C2%2C5%5Dtriazepane+or+%5B1%2C2%2C5%5Doxadiazepane+as+the+C-ring&doi=10.1016%2Fj.ejmech.2013.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring</span></div><div class="casAuthors">Suzuki, Hideyuki; Utsunomiya, Iwao; Shudo, Koichi; Fukuhara, Norio; Iwaki, Tsutomu; Yasukata, Tatsuro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">262-277</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Oxazolidinones (e.g., I) bearing a seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane heterocycle substituted with an amide or urea functionality as the C-ring and having a [1,2,3]triazole, a thiocarbamate, an isoxazole-3-ylamino, or a thioacetamide C-5 side chain unit on the A-ring instead of the typical acetamide were synthesized and their in vitro antibacterial activities towards various pathogens were evaluated.  Several derivs. exhibited potent in vitro antibacterial activity toward not only Gram-pos., but also Gram-neg. and linezolid-resistant pathogens.  The in vivo therapeutic effects of amide 11a and ureas 16e, 17a were 2- to 3-fold greater than that of linezolid in a systemic mouse infection model treated by i.v. administration.  Furthermore, compds. 11a and 17a showed lower monoamine oxidase (MAO)-inhibitory activity than our previously reported potent oxazolidinone antibacterials 3a and 3b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQG9zCkR5umLVg90H21EOLACvtfcHk0liI_FcvsP3kHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaqs7%252FP&md5=aba5a71f79c670f5f917cdac48a0d44d</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DUtsunomiya%26aufirst%3DI.%26aulast%3DShudo%26aufirst%3DK.%26aulast%3DFukuhara%26aufirst%3DN.%26aulast%3DIwaki%26aufirst%3DT.%26aulast%3DYasukata%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in%2520vitro%252Fin%2520vivo%2520antibacterial%2520activity%2520of%2520oxazolidinones%2520having%2520thiocarbamate%2520at%2520C-5%2520on%2520the%2520A-ring%2520and%2520an%2520amide-%2520or%2520urea-substituted%2520%255B1%252C2%252C5%255Dtriazepane%2520or%2520%255B1%252C2%252C5%255Doxadiazepane%2520as%2520the%2520C-ring%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D262%26epage%3D277%26doi%3D10.1016%2Fj.ejmech.2013.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref269"><div class="reference"><strong class="refLabel"><a href="#ref269" class="rightTabRefNumLink">269</a></strong><div class="NLM_citation" id="rightTab-cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanfardino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notomista, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichelhaus, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saturnino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varcamonti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriente, A.</span></span> <span> </span><span class="NLM_article-title">Novel promising linezolid analogues: rational design, synthesis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2013.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24099997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=779-785&author=M.+De+Rosaauthor=A.+Zanfardinoauthor=E.+Notomistaauthor=T.+A.+Wichelhausauthor=C.+Saturninoauthor=M.+Varcamontiauthor=A.+Soriente&title=Novel+promising+linezolid+analogues%3A+rational+design%2C+synthesis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2013.09.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Novel promising linezolid analogues: Rational design, synthesis and biological evaluation</span></div><div class="casAuthors">De Rosa, Margherita; Zanfardino, Anna; Notomista, Eugenio; Wichelhaus, Thomas A.; Saturnino, Carmela; Varcamonti, Mario; Soriente, Annunziata</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">779-785</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new series of 5-substituted oxazolidinones derived from linezolid, having urea and thiourea moieties at the C-5 side chain of the oxazolidinone ring, were prepd. and their in vitro antibacterial activity was evaluated.  The compd. 10f demonstrated high antimicrobial activity, comparable to that of linezolid against Staphylococcus aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxz-aHlAQN7Vg90H21EOLACvtfcHk0liI_FcvsP3kHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartLnM&md5=d67d6e7184e3bcb04a2264a3f221993f</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DZanfardino%26aufirst%3DA.%26aulast%3DNotomista%26aufirst%3DE.%26aulast%3DWichelhaus%26aufirst%3DT.%2BA.%26aulast%3DSaturnino%26aufirst%3DC.%26aulast%3DVarcamonti%26aufirst%3DM.%26aulast%3DSoriente%26aufirst%3DA.%26atitle%3DNovel%2520promising%2520linezolid%2520analogues%253A%2520rational%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D779%26epage%3D785%26doi%3D10.1016%2Fj.ejmech.2013.09.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref270"><div class="reference"><strong class="refLabel"><a href="#ref270" class="rightTabRefNumLink">270</a></strong><div class="NLM_citation" id="rightTab-cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanpithakpong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhasivanon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindegardh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Socheat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin resistance in Plasmodium falciparum malaria</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0808859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1056%2FNEJMoa0808859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=19641202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=455-467&author=A.+M.+Dondorpauthor=F.+Nostenauthor=P.+Yiauthor=D.+Dasauthor=A.+P.+Phyoauthor=J.+Tarningauthor=K.+M.+Lwinauthor=F.+Arieyauthor=W.+Hanpithakpongauthor=S.+J.+Leeauthor=P.+Ringwaldauthor=K.+Silamutauthor=M.+Imwongauthor=K.+Chotivanichauthor=P.+Limauthor=T.+Herdmanauthor=S.+S.+Anauthor=S.+Yeungauthor=P.+Singhasivanonauthor=N.+P.+Dayauthor=N.+Lindegardhauthor=D.+Socheatauthor=N.+J.+White&title=Artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa0808859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Dondorp, Arjen M.; Nosten, Francois; Yi, Poravuth; Das, Debashish; Phyo, Aung Phae; Tarning, Joel; Lwin, Khin Maung; Ariey, Frederic; Hanpithakpong, Warunee; Lee, Sue J.; Ringwald, Pascal; Silamut, Kamolrat; Imwong, Mallika; Chotivanich, Kesinee; Lim, Pharath; Herdman, Trent; Sam An, Sen; Yeung, Shunmay; Singhasivanon, Pratap; Day, Nicholas P. J.; Lindegardh, Niklas; Socheat, Duong; White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-467</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease.  There are recent concerns that the efficacy of such therapies has declined on the Thai-Cambodian border, historically a site of emerging antimalarial-drug resistance.  METHODS: In two open-label, randomized trials, we compared the efficacies of two treatments for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, northwestern Thailand: oral artesunate given at a dose of 2 mg per kg of body wt. per day, for 7 days, and artesunate given at a dose of 4 mg per kg per day, for 3 days, followed by mefloqine at two doses totaling 25 mg per kg.  We assessed in vitro and in vivo Plasmodium-falciparum susceptibility, artesunate pharmacokinetics, and mol. markers of resistance.  RESULTS: We studied 40 patients in each of the two locations.  The overall median parasite clearance times were 84 h (interquartile range, 60 to 96) in Pailin and 48 h (interquartile range, 36 to 66) in Wang Pha (P < 0.001).  Recrudescence confirmed by means of polymerase-chain-reaction assay occurred in 6 of 20 patients (30%) receiving artesunate monotherapy and 1 of 20 (5%) receiving artesunate-mefloqine therapy in Pailin, as compared with 2 of 20 (10%) and 1 of 20 (5%), resp., in Wang Pha (P = 0.31).  These markedly different parasitol. responses were not explained by differences in age, artesunate or dihydroartemisinin pharmacokinetics, results of isotopic in vitro sensitivity tests, or putative mol. correlates of P.falciparum drug resistance (mutations or amplifications of the gene encoding a multidrug resistance protein [PfMDR1] or mutations in the gene encoding sarco-endoplasmic reticulum calcium ATPase6 [PfSERCA]).  Adverse events were mild and did not differ significantly between the two treatment groups.  CONCLUSIONS: P.falciparum has reduced in vivo susceptibility to artesunate in western Cambodia as compared with northwestern Thailand.  Resistance is characterized by slow parasite clearance in vivo without corresponding redns. on conventional in vitro susceptibility testing.  Containment measures are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfVvi4ozTDSLVg90H21EOLACvtfcHk0ljkL1k2hdyJLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D&md5=ae3098a15e9fb82c80fa0ddd05378220</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808859%26sid%3Dliteratum%253Aachs%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DLwin%26aufirst%3DK.%2BM.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DHanpithakpong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DHerdman%26aufirst%3DT.%26aulast%3DAn%26aufirst%3DS.%2BS.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DSinghasivanon%26aufirst%3DP.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DLindegardh%26aufirst%3DN.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DArtemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D455%26epage%3D467%26doi%3D10.1056%2FNEJMoa0808859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref271"><div class="reference"><strong class="refLabel"><a href="#ref271" class="rightTabRefNumLink">271</a></strong><div class="NLM_citation" id="rightTab-cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wongsrichanalai, C.</span></span> <span> </span><span class="NLM_article-title">Artemisinin resistance or artemisinin-based combination therapy resistance?</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(12)70349-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS1473-3099%2812%2970349-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=23347632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Git7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=114-115&author=C.+Wongsrichanalai&title=Artemisinin+resistance+or+artemisinin-based+combination+therapy+resistance%3F&doi=10.1016%2FS1473-3099%2812%2970349-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance or artemisinin-based combination therapy resistance?</span></div><div class="casAuthors">Wongsrichanalai, Chansuda</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">114-115</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The research of Breman (2012) entitled 'Resistance to artemisinin-based combination therapy' and of Amaratunga et al. (2012) entitled 'Artemisinin-resistant Plasmodium falciparum malaria in Pursat province, western Cambodia: a parasite-clearance-rate study' are reviewed with commentary and refs.  Breman discussed parasite resistance to artemisinin-based combination therapy (ACT) and the heritability of this resistance.  The differences between artemisinin resistance and resistance to ACT merit further clarification.  Amaratunga et al. delayed mefloquine administration to exclude the contribution of mefloquine in parasite clearance during the first 72 h - the period most relevant to artemisinin action.  This approach deviates from the std. treatment schedule for the purpose of their study, i.e., to investigate the genetic basis of artemisinin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv8REl73iD67Vg90H21EOLACvtfcHk0lhMUlvBfMJWwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Git7s%253D&md5=12e10152d71f896e6bfdf20f920b240f</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2812%2970349-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252812%252970349-3%26sid%3Dliteratum%253Aachs%26aulast%3DWongsrichanalai%26aufirst%3DC.%26atitle%3DArtemisinin%2520resistance%2520or%2520artemisinin-based%2520combination%2520therapy%2520resistance%253F%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2013%26volume%3D13%26spage%3D114%26epage%3D115%26doi%3D10.1016%2FS1473-3099%2812%2970349-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref272"><div class="reference"><strong class="refLabel"><a href="#ref272" class="rightTabRefNumLink">272</a></strong><div class="NLM_citation" id="rightTab-cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, C. H.</span></span> <span> </span><span class="NLM_article-title">Tracking artemisinin resistance in Plasmodium falciparum</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">999</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(13)70260-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2FS1473-3099%2813%2970260-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24035557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOntr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=999-1000&author=C.+H.+Sibley&title=Tracking+artemisinin+resistance+in+Plasmodium+falciparum&doi=10.1016%2FS1473-3099%2813%2970260-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking artemisinin resistance in Plasmodium falciparum</span></div><div class="casAuthors">Sibley, Carol Hopkins</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">999-1000</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This article reports the tracking artemisinin resistance in Plasmodium falciparum.  The important artemisinin combination therapies are described in this article.  The adapted parasites from individual patients and tested them in their short-pulse assay.  After an initial 3 h pulse of drug, parasites from slow clearing patients showed significantly better survival than those from patients whose parasites cleared rapidly.  This made a direct link between the clearance phenotype in patients and the response of those parasites in the assay.  The response of Plasmodium falciparum fresh parasite isolates from the peripheral blood was tested with no synchronization step, and showed that this simple assay also clearly identified parasites with the slow clearance phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOQiM3NeHqRrVg90H21EOLACvtfcHk0lhMUlvBfMJWwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOntr7O&md5=783aff4a7de213debdc11df30e359f9c</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2813%2970260-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252813%252970260-3%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DC.%2BH.%26atitle%3DTracking%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2013%26volume%3D13%26spage%3D999%26epage%3D1000%26doi%3D10.1016%2FS1473-3099%2813%2970260-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref273"><div class="reference"><strong class="refLabel"><a href="#ref273" class="rightTabRefNumLink">273</a></strong><div class="NLM_citation" id="rightTab-cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verlinden, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woster, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel alkylated (bis)urea and (bis)thiourea polyamine analogues with potent antimalarial activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6624</span>– <span class="NLM_lpage">6633</span>, <span class="refDoi"> DOI: 10.1021/jm200463z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200463z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOmsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6624-6633&author=B.+K.+Verlindenauthor=J.+Niemandauthor=J.+Snymanauthor=S.+K.+Sharmaauthor=R.+J.+Beattieauthor=P.+M.+Wosterauthor=L.+M.+Birkholtz&title=Discovery+of+novel+alkylated+%28bis%29urea+and+%28bis%29thiourea+polyamine+analogues+with+potent+antimalarial+activities&doi=10.1021%2Fjm200463z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Alkylated (bis)Urea and (bis)Thiourea Polyamine Analogues with Potent Antimalarial Activities</span></div><div class="casAuthors">Verlinden, Bianca K.; Niemand, Jandeli; Snyman, Janette; Sharma, Shiv K.; Beattie, Ross J.; Woster, Patrick M.; Birkholtz, Lyn-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6624-6633</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of alkylated (bis)urea and (bis)thiourea polyamine analogs were synthesized and screened for antimalarial activity against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro.  All analogs showed growth inhibitory activity against P. falciparum at less than 3 μM, with the majority having effective IC50 values in the 100-650 nM range.  Analogs arrested parasitic growth within 24 h of exposure due to a block in nuclear division and therefore asexual development.  Moreover, this effect appears to be cytotoxic and highly selective to malaria parasites (>7000-fold lower IC50 against P. falciparum) and is not reversible by the exogenous addn. of polyamines.  With this first report of potent antimalarial activity of polyamine analogs contg. 3-7-3 or 3-6-3 carbon backbones and substituted terminal urea- or thiourea moieties, we propose that these compds. represent a structurally novel class of antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULINvA9vpULVg90H21EOLACvtfcHk0lisX0N2QZnmQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOmsbbI&md5=fbf96c2f4250c133624b37f998800a9d</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1021%2Fjm200463z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200463z%26sid%3Dliteratum%253Aachs%26aulast%3DVerlinden%26aufirst%3DB.%2BK.%26aulast%3DNiemand%26aufirst%3DJ.%26aulast%3DSnyman%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DBeattie%26aufirst%3DR.%2BJ.%26aulast%3DWoster%26aufirst%3DP.%2BM.%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26atitle%3DDiscovery%2520of%2520novel%2520alkylated%2520%2528bis%2529urea%2520and%2520%2528bis%2529thiourea%2520polyamine%2520analogues%2520with%2520potent%2520antimalarial%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6624%26epage%3D6633%26doi%3D10.1021%2Fjm200463z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref274"><div class="reference"><strong class="refLabel"><a href="#ref274" class="rightTabRefNumLink">274</a></strong><div class="NLM_citation" id="rightTab-cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span> <span> </span><span class="NLM_article-title">Urea/oxalamide tethered beta-lactam-7-chloroquinoline conjugates: synthesis and in vitro antimalarial evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.10.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.ejmech.2013.10.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=24287561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=128-134&author=P.+Singhauthor=R.+Rajauthor=J.+Gutauthor=P.+J.+Rosenthalauthor=V.+Kumar&title=Urea%2Foxalamide+tethered+beta-lactam-7-chloroquinoline+conjugates%3A+synthesis+and+in+vitro+antimalarial+evaluation&doi=10.1016%2Fj.ejmech.2013.10.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit274R"><div class="casContent"><span class="casTitleNuber">274</span><div class="casTitle"><span class="NLM_cas:atitle">Urea/oxalamide tethered β-lactam-7-chloroquinoline conjugates: Synthesis and in vitro antimalarial evaluation</span></div><div class="casAuthors">Singh, Pardeep; Raj, Raghu; Singh, Parvesh; Gut, Jiri; Rosenthal, Philip J.; Kumar, Vipan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The manuscript pertains to the synthesis of urea/oxalamide tethered β-lactam-7-chloroquinoline conjugates, e.g., I (R = C6H11, n = 2, 3, 4, 6; R = 4-MeC6H4, n = 2, 3, 4, 6), with well modulated chain lengths and their antimalarial evaluation.  The results reveal the dependence of activity profiles on the N-1 substituent of the β-lactam ring, the nature of the linker as well as the length of the alkyl chain.  The most potent of the tested compds. showed an IC50 of 34.97 nM against chloroquine resistant W2 strain of Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-C47BUed9qrVg90H21EOLACvtfcHk0lisX0N2QZnmQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGrtro%253D&md5=ca2f6d8942c4f62854e507239aa431cf</span></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.10.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.10.079%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DRaj%26aufirst%3DR.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DUrea%252Foxalamide%2520tethered%2520beta-lactam-7-chloroquinoline%2520conjugates%253A%2520synthesis%2520and%2520in%2520vitro%2520antimalarial%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D71%26spage%3D128%26epage%3D134%26doi%3D10.1016%2Fj.ejmech.2013.10.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref275"><div class="reference"><strong class="refLabel"><a href="#ref275" class="rightTabRefNumLink">275</a></strong><div class="NLM_citation" id="rightTab-cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coster, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouwer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healy, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1558</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1039/C4OB01849D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1039%2FC4OB01849D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=25490858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2jur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=1558-1570&author=B.+D.+Schwartzauthor=T.+S.+Skinner-Adamsauthor=K.+T.+Andrewsauthor=M.+J.+Costerauthor=M.+D.+Edsteinauthor=D.+MacKenzieauthor=S.+A.+Charmanauthor=M.+Koltunauthor=S.+Blundellauthor=A.+Campbellauthor=R.+H.+Pouwerauthor=R.+J.+Quinnauthor=K.+D.+Beattieauthor=P.+C.+Healyauthor=R.+A.+Davis&title=Synthesis+and+antimalarial+evaluation+of+amide+and+urea+derivatives+based+on+the+thiaplakortone+A+natural+product+scaffold&doi=10.1039%2FC4OB01849D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold</span></div><div class="casAuthors">Schwartz, Brett D.; Skinner-Adams, Tina S.; Andrews, Katherine T.; Coster, Mark J.; Edstein, Michael D.; MacKenzie, Donna; Charman, Susan A.; Koltun, Maria; Blundell, Scott; Campbell, Anna; Pouwer, Rebecca H.; Quinn, Ronald J.; Beattie, Karren D.; Healy, Peter C.; Davis, Rohan A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1558-1570</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of amide and urea analogs I (R = Me, Et, cyclopropyl, furan-3-yl, Ph, NHBu, NMeOMe ,etc., R1 = H; R = Me, R1 = Me, cyclopentyl, PhCH2, etc.) based on the thiaplakortone A natural product scaffold were synthesized and screened for in vitro antimalarial activity against chloroquine-sensitive (3D7) and chloroquine- and mefloquine-resistant (Dd2) Plasmodium falciparum parasite lines.  Several analogs displayed potent inhibition of P. falciparum growth (IC50 <500 nM) and good selectivity for P. falciparum vs. human neonatal foreskin fibroblast cells (selectivity index >100).  Two of these compds., I (R = Me, NHBu, R1 = H), exhibited good aq. soly. and metabolic stability, and when administered s.c. to mice (32 mg kg-1), plasma concns. remained above 0.2 μM for at least 8 h.  Both I (R = Me, NHBu, R1 = H) were well tolerated in mice after s.c. administration of 32 mg kg-1 twice daily for 4 days.  Using this regimen blood stage P. berghei was suppressed by 52% for I (R = Me, R1 = H) and 26% for I (R = NHBu, R1 = H), relative to the vehicle control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5UgQDexwzrVg90H21EOLACvtfcHk0lj6W8XjdjYspw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2jur3I&md5=42668d6a4e4146424e142e2b75ce0d62</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1039%2FC4OB01849D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01849D%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DB.%2BD.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCoster%26aufirst%3DM.%2BJ.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DMacKenzie%26aufirst%3DD.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DBlundell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DPouwer%26aufirst%3DR.%2BH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26aulast%3DBeattie%26aufirst%3DK.%2BD.%26aulast%3DHealy%26aufirst%3DP.%2BC.%26aulast%3DDavis%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520antimalarial%2520evaluation%2520of%2520amide%2520and%2520urea%2520derivatives%2520based%2520on%2520the%2520thiaplakortone%2520A%2520natural%2520product%2520scaffold%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D1558%26epage%3D1570%26doi%3D10.1039%2FC4OB01849D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref276"><div class="reference"><strong class="refLabel"><a href="#ref276" class="rightTabRefNumLink">276</a></strong><div class="NLM_citation" id="rightTab-cit276"><span><a href="http://www.who.int/mediacentre/factsheets/fs259/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs259/en/</a> (accessed April 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs259%2Fen%2F+%28accessed+April+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref277"><div class="reference"><strong class="refLabel"><a href="#ref277" class="rightTabRefNumLink">277</a></strong><div class="NLM_citation" id="rightTab-cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2451</span>– <span class="NLM_lpage">2465</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=10.1016%2Fj.bmc.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=27102161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2451-2465&author=D.+A.+Patrickauthor=T.+Wenzlerauthor=S.+Yangauthor=P.+T.+Weiserauthor=M.+Z.+Wangauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+of+novel+amide+and+urea+derivatives+of+thiazol-2-ethylamines+and+their+activity+against+Trypanosoma+brucei+rhodesiense&doi=10.1016%2Fj.bmc.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense</span></div><div class="casAuthors">Patrick, Donald A.; Wenzler, Tanja; Yang, Sihyung; Weiser, Patrick T.; Wang, Michael Zhuo; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2451-2465</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-(2-Benzamido)ethyl-4-phenylthiazole I was one of 1035 mols. (grouped into 115 distinct scaffolds) found to be inhibitory to Trypanosoma brucei, the pathogen causing human African trypanosomiasis, at concns. below 3.6 μM and nontoxic to mammalian (Huh7) cells in a phenotypic high-throughput screen of a 700,000 compd. library performed by the Genomics Institute of the Novartis Research Foundation (GNF).  Compd. I and 72 analogs were synthesized in this lab. by one of two general pathways.  These plus 10 com. available analogs were tested against T. brucei rhodesiense STIB900 and L6 rat myoblast cells (for cytotoxicity) in vitro.  Forty-four derivs. were more potent than I, including eight with IC50 values below 100 nM.  The most potent and most selective for the parasite was the urea analog 2-(2-piperidin-1-ylamido)ethyl-4-(3-fluorophenyl)thiazole II (IC50 = 9 nM, SI > 18,000).  None of 33 compds. tested were able to cure mice infected with the parasite; however, seven compds. caused temporary redns. of parasitemia (≥97%) but with subsequent relapses.  The lack of in vivo efficacy was at least partially due to their poor metabolic stability, as demonstrated by the short half-lives of 15 analogs against mouse and human liver microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV78D13zDrJ7Vg90H21EOLACvtfcHk0ljK70Wa3bOl6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D&md5=d371dc632576f40e4002cd96b67c5a77</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWeiser%26aufirst%3DP.%2BT.%26aulast%3DWang%26aufirst%3DM.%2BZ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520of%2520novel%2520amide%2520and%2520urea%2520derivatives%2520of%2520thiazol-2-ethylamines%2520and%2520their%2520activity%2520against%2520Trypanosoma%2520brucei%2520rhodesiense%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2451%26epage%3D2465%26doi%3D10.1016%2Fj.bmc.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref278"><div class="reference"><strong class="refLabel"><a href="#ref278" class="rightTabRefNumLink">278</a></strong><div class="NLM_citation" id="rightTab-cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laydbak, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucker, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span> <span> </span><span class="NLM_article-title">Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6342</span>– <span class="NLM_lpage">6351</span>, <span class="refDoi"> DOI: 10.1021/jm300303e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300303e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6342-6351&author=S.+Shibataauthor=J.+R.+Gillespieauthor=R.+M.+Ranadeauthor=C.+Y.+Kohauthor=J.+E.+Kimauthor=J.+U.+Laydbakauthor=F.+H.+Zuckerauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=F.+S.+Bucknerauthor=E.+Fan&title=Urea-based+inhibitors+of+Trypanosoma+brucei+methionyl-tRNA+synthetase%3A+selectivity+and+in+vivo+characterization&doi=10.1021%2Fjm300303e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Urea-Based Inhibitors of Trypanosoma brucei Methionyl-tRNA Synthetase: Selectivity and in Vivo Characterization</span></div><div class="casAuthors">Shibata, Sayaka; Gillespie, J. Robert; Ranade, Ranae M.; Koh, Cho Yeow; Kim, Jessica E.; Laydbak, Joy U.; Zucker, Frank H.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Fan, Erkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6342-6351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based methionyl-tRNA synthetase inhibitors were designed, synthesized, and evaluated for their potential toward treating human African trypanosomiasis (HAT).  With the aid of a homol. model and a structure-activity-relationship approach, low nM inhibitors were discovered that show high selectivity toward the parasite enzyme over the closest human homolog.  These compds. inhibit parasite growth with EC50 values as low as 0.15 μM while having low toxicity to mammalian cells.  Two compds. (2 and 26) showed excellent membrane permeation in the MDR1-MDCKII model and encouraging oral pharmacokinetic properties in mice.  Compd. 2 (I) was confirmed to enter the CNS in mice.  Compd. 26 had modest suppressive activity against Trpanosoma brucei rhodesiense in the mouse model, suggesting that more potent analogs or compds. with higher exposures need to be developed.  The urea-based inhibitors are thus a promising starting point for further optimization toward the discovery of orally available and CNS active drugs to treat HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobDMlz2d57bLVg90H21EOLACvtfcHk0ljK70Wa3bOl6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqsLg%253D&md5=a7029357bdc79d52992a4b6eeff53e80</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1021%2Fjm300303e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300303e%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DKoh%26aufirst%3DC.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLaydbak%26aufirst%3DJ.%2BU.%26aulast%3DZucker%26aufirst%3DF.%2BH.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DFan%26aufirst%3DE.%26atitle%3DUrea-based%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520methionyl-tRNA%2520synthetase%253A%2520selectivity%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6342%26epage%3D6351%26doi%3D10.1021%2Fjm300303e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IPU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IPU','PDB','3IPU'); return false;">PDB: 3IPU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EV9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EV9','PDB','4EV9'); return false;">PDB: 4EV9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L2Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L2Y','PDB','1L2Y'); return false;">PDB: 1L2Y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMP','PDB','1DMP'); return false;">PDB: 1DMP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ASD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ASD','PDB','4ASD'); return false;">PDB: 4ASD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WZD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WZD','PDB','3WZD'); return false;">PDB: 3WZD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KV2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KV2','PDB','1KV2'); return false;">PDB: 1KV2</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01541%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01541" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c2621a753dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
